{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "c3bff316",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Este c√≥digo intenta buscar factores en el dataframe ya etiquetado o labeled\n",
    "import pandas as pd\n",
    "import os\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import mysql.connector\n",
    "import matplotlib as plt\n",
    "import warnings\n",
    "import seaborn as sns\n",
    "import requests\n",
    "import matplotlib.pyplot as plt\n",
    "from mpl_toolkits.mplot3d import Axes3D\n",
    "from sklearn.preprocessing import LabelEncoder\n",
    "warnings.filterwarnings('ignore')\n",
    "from sqlalchemy import create_engine\n",
    "import pymysql\n",
    "import seaborn as sns\n",
    "from datetime import datetime, timedelta\n",
    "from datetime import datetime\n",
    "import re\n",
    "import time\n",
    "import ast\n",
    "from datetime import datetime\n",
    "from finvizfinance.screener.overview import Overview\n",
    "from finvizfinance.quote import finvizfinance\n",
    "import yfinance as yf\n",
    "from yahoo_fin import news as yf_news\n",
    "now = datetime.now()\n",
    "# Format the date and time as a string\n",
    "date_str = now.strftime(\"%Y%m%d\")\n",
    "pd.set_option(\"display.max_colwidth\", 150)\n",
    "pd.set_option('display.max_rows', None)\n",
    "pd.options.display.float_format = '{:.2f}'.format"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "f83e5056",
   "metadata": {},
   "outputs": [],
   "source": [
    "directory = 'input'\n",
    "filename = 'labeled_biothec_2024-12-17.csv'\n",
    "\n",
    "file_path = os.path.join(directory, filename)\n",
    "df = pd.read_csv(file_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "76c01758",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ticker</th>\n",
       "      <th>Company</th>\n",
       "      <th>ipo_date</th>\n",
       "      <th>MarketCap_M</th>\n",
       "      <th>Employees</th>\n",
       "      <th>Volume_m</th>\n",
       "      <th>revenueM</th>\n",
       "      <th>ebitdaM</th>\n",
       "      <th>web</th>\n",
       "      <th>Country</th>\n",
       "      <th>Industry</th>\n",
       "      <th>BusinessSummary</th>\n",
       "      <th>ipo_price</th>\n",
       "      <th>Price</th>\n",
       "      <th>Fall</th>\n",
       "      <th>days</th>\n",
       "      <th>RoK</th>\n",
       "      <th>term</th>\n",
       "      <th>profit</th>\n",
       "      <th>animal</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>TECH</td>\n",
       "      <td>Bio-Techne Corp</td>\n",
       "      <td>1989-02-09</td>\n",
       "      <td>12101.22</td>\n",
       "      <td>3100</td>\n",
       "      <td>922.00</td>\n",
       "      <td>1171.58</td>\n",
       "      <td>308.52</td>\n",
       "      <td>https://www.bio-techne.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the...</td>\n",
       "      <td>0.09</td>\n",
       "      <td>75.69</td>\n",
       "      <td>82131.76</td>\n",
       "      <td>13095</td>\n",
       "      <td>2.55</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>VRTX</td>\n",
       "      <td>Vertex Pharmaceuticals, Inc</td>\n",
       "      <td>1991-07-24</td>\n",
       "      <td>120546.75</td>\n",
       "      <td>5400</td>\n",
       "      <td>1171.00</td>\n",
       "      <td>10625.80</td>\n",
       "      <td>4446.60</td>\n",
       "      <td>https://www.vrtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF...</td>\n",
       "      <td>4.50</td>\n",
       "      <td>463.73</td>\n",
       "      <td>10205.11</td>\n",
       "      <td>12200</td>\n",
       "      <td>3.69</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>UTHR</td>\n",
       "      <td>United Therapeutics Corp</td>\n",
       "      <td>1999-06-17</td>\n",
       "      <td>16644.81</td>\n",
       "      <td>1168</td>\n",
       "      <td>330.00</td>\n",
       "      <td>2756.20</td>\n",
       "      <td>1412.10</td>\n",
       "      <td>https://www.unither.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medica...</td>\n",
       "      <td>6.09</td>\n",
       "      <td>361.81</td>\n",
       "      <td>5837.39</td>\n",
       "      <td>9315</td>\n",
       "      <td>8.48</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>INCY</td>\n",
       "      <td>Incyte Corp</td>\n",
       "      <td>1993-11-04</td>\n",
       "      <td>13446.97</td>\n",
       "      <td>2524</td>\n",
       "      <td>2066.00</td>\n",
       "      <td>4075.86</td>\n",
       "      <td>80.49</td>\n",
       "      <td>https://www.incyte.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncol...</td>\n",
       "      <td>1.88</td>\n",
       "      <td>68.55</td>\n",
       "      <td>3556.00</td>\n",
       "      <td>11366</td>\n",
       "      <td>0.60</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ALNY</td>\n",
       "      <td>Alnylam Pharmaceuticals Inc</td>\n",
       "      <td>2004-06-01</td>\n",
       "      <td>31470.08</td>\n",
       "      <td>2100</td>\n",
       "      <td>772.00</td>\n",
       "      <td>2094.80</td>\n",
       "      <td>-132.15</td>\n",
       "      <td>https://www.alnylam.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ri...</td>\n",
       "      <td>7.00</td>\n",
       "      <td>245.44</td>\n",
       "      <td>3406.29</td>\n",
       "      <td>7504</td>\n",
       "      <td>-0.42</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>REGN</td>\n",
       "      <td>Regeneron Pharmaceuticals, Inc</td>\n",
       "      <td>1991-04-02</td>\n",
       "      <td>79655.96</td>\n",
       "      <td>14165</td>\n",
       "      <td>814.00</td>\n",
       "      <td>13847.10</td>\n",
       "      <td>4598.00</td>\n",
       "      <td>https://www.regeneron.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. ...</td>\n",
       "      <td>21.12</td>\n",
       "      <td>731.30</td>\n",
       "      <td>3361.78</td>\n",
       "      <td>12313</td>\n",
       "      <td>5.77</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>ARGX</td>\n",
       "      <td>Argen X SE ADR</td>\n",
       "      <td>2017-05-18</td>\n",
       "      <td>37829.53</td>\n",
       "      <td>1148</td>\n",
       "      <td>262.00</td>\n",
       "      <td>1908.66</td>\n",
       "      <td>-150.08</td>\n",
       "      <td>https://www.argenx.com</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, ...</td>\n",
       "      <td>23.00</td>\n",
       "      <td>607.21</td>\n",
       "      <td>2540.02</td>\n",
       "      <td>2770</td>\n",
       "      <td>-0.40</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>BHST</td>\n",
       "      <td>BioHarvest Sciences Inc</td>\n",
       "      <td>2021-01-08</td>\n",
       "      <td>106.57</td>\n",
       "      <td>0</td>\n",
       "      <td>7.00</td>\n",
       "      <td>19.13</td>\n",
       "      <td>-7.21</td>\n",
       "      <td>https://www.bioharvest.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develop...</td>\n",
       "      <td>0.29</td>\n",
       "      <td>6.15</td>\n",
       "      <td>2020.69</td>\n",
       "      <td>1439</td>\n",
       "      <td>-6.77</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>KRYS</td>\n",
       "      <td>Krystal Biotech Inc</td>\n",
       "      <td>2017-09-20</td>\n",
       "      <td>4820.55</td>\n",
       "      <td>229</td>\n",
       "      <td>233.00</td>\n",
       "      <td>241.52</td>\n",
       "      <td>69.14</td>\n",
       "      <td>https://www.krystalbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare ...</td>\n",
       "      <td>10.64</td>\n",
       "      <td>163.64</td>\n",
       "      <td>1437.97</td>\n",
       "      <td>2645</td>\n",
       "      <td>1.43</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>TVTX</td>\n",
       "      <td>Travere Therapeutics Inc</td>\n",
       "      <td>2012-11-08</td>\n",
       "      <td>1523.10</td>\n",
       "      <td>380</td>\n",
       "      <td>1695.00</td>\n",
       "      <td>203.45</td>\n",
       "      <td>-238.74</td>\n",
       "      <td>https://www.travere.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabo...</td>\n",
       "      <td>1.50</td>\n",
       "      <td>17.32</td>\n",
       "      <td>1054.67</td>\n",
       "      <td>4422</td>\n",
       "      <td>-15.67</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>HALO</td>\n",
       "      <td>Halozyme Therapeutics Inc</td>\n",
       "      <td>2004-03-16</td>\n",
       "      <td>6110.71</td>\n",
       "      <td>373</td>\n",
       "      <td>1658.00</td>\n",
       "      <td>947.36</td>\n",
       "      <td>553.00</td>\n",
       "      <td>https://halozyme.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in ...</td>\n",
       "      <td>4.25</td>\n",
       "      <td>48.00</td>\n",
       "      <td>1029.41</td>\n",
       "      <td>7581</td>\n",
       "      <td>9.05</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>AXSM</td>\n",
       "      <td>Axsome Therapeutics Inc</td>\n",
       "      <td>2015-11-19</td>\n",
       "      <td>4346.11</td>\n",
       "      <td>607</td>\n",
       "      <td>476.00</td>\n",
       "      <td>338.46</td>\n",
       "      <td>-244.62</td>\n",
       "      <td>https://www.axsome.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders i...</td>\n",
       "      <td>8.74</td>\n",
       "      <td>90.10</td>\n",
       "      <td>930.89</td>\n",
       "      <td>3316</td>\n",
       "      <td>-5.63</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>BNTX</td>\n",
       "      <td>BioNTech SE ADR</td>\n",
       "      <td>2019-10-10</td>\n",
       "      <td>27383.10</td>\n",
       "      <td>6133</td>\n",
       "      <td>907.00</td>\n",
       "      <td>3040.10</td>\n",
       "      <td>-274.50</td>\n",
       "      <td>https://www.biontech.de</td>\n",
       "      <td>Germany</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is develop...</td>\n",
       "      <td>14.05</td>\n",
       "      <td>120.38</td>\n",
       "      <td>756.56</td>\n",
       "      <td>1895</td>\n",
       "      <td>-1.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>JAZZ</td>\n",
       "      <td>Jazz Pharmaceuticals plc</td>\n",
       "      <td>2007-06-01</td>\n",
       "      <td>7568.92</td>\n",
       "      <td>2800</td>\n",
       "      <td>611.00</td>\n",
       "      <td>3992.71</td>\n",
       "      <td>1518.48</td>\n",
       "      <td>https://www.jazzpharma.com</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, an...</td>\n",
       "      <td>17.73</td>\n",
       "      <td>123.04</td>\n",
       "      <td>593.97</td>\n",
       "      <td>6409</td>\n",
       "      <td>20.06</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>ASND</td>\n",
       "      <td>Ascendis Pharma A/S ADR</td>\n",
       "      <td>2015-01-28</td>\n",
       "      <td>8163.27</td>\n",
       "      <td>879</td>\n",
       "      <td>486.00</td>\n",
       "      <td>317.63</td>\n",
       "      <td>-347.19</td>\n",
       "      <td>https://ascendispharma.com</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patient...</td>\n",
       "      <td>18.83</td>\n",
       "      <td>129.87</td>\n",
       "      <td>589.70</td>\n",
       "      <td>3611</td>\n",
       "      <td>-4.25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>BGNE</td>\n",
       "      <td>BeiGene Ltd ADR</td>\n",
       "      <td>2016-02-03</td>\n",
       "      <td>19806.62</td>\n",
       "      <td>10600</td>\n",
       "      <td>378.00</td>\n",
       "      <td>23507.73</td>\n",
       "      <td>-5576.40</td>\n",
       "      <td>https://www.beigene.com</td>\n",
       "      <td>Cayman Islands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Euro...</td>\n",
       "      <td>28.32</td>\n",
       "      <td>179.35</td>\n",
       "      <td>533.30</td>\n",
       "      <td>3240</td>\n",
       "      <td>-28.15</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>BLTE</td>\n",
       "      <td>Belite Bio Inc ADR</td>\n",
       "      <td>2022-04-29</td>\n",
       "      <td>1948.48</td>\n",
       "      <td>20</td>\n",
       "      <td>73.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-35.30</td>\n",
       "      <td>https://www.belitebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics target...</td>\n",
       "      <td>10.59</td>\n",
       "      <td>62.34</td>\n",
       "      <td>488.67</td>\n",
       "      <td>963</td>\n",
       "      <td>-1.81</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>VKTX</td>\n",
       "      <td>Viking Therapeutics Inc</td>\n",
       "      <td>2015-04-28</td>\n",
       "      <td>5263.12</td>\n",
       "      <td>30</td>\n",
       "      <td>4125.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.vikingtherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine d...</td>\n",
       "      <td>8.00</td>\n",
       "      <td>47.03</td>\n",
       "      <td>487.87</td>\n",
       "      <td>3521</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>GMAB</td>\n",
       "      <td>Genmab ADR</td>\n",
       "      <td>2009-06-01</td>\n",
       "      <td>12832.72</td>\n",
       "      <td>2635</td>\n",
       "      <td>1210.00</td>\n",
       "      <td>19844.00</td>\n",
       "      <td>6855.00</td>\n",
       "      <td>https://www.genmab.com</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a hum...</td>\n",
       "      <td>3.77</td>\n",
       "      <td>20.17</td>\n",
       "      <td>434.73</td>\n",
       "      <td>5678</td>\n",
       "      <td>53.42</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>BHVN</td>\n",
       "      <td>Biohaven Ltd</td>\n",
       "      <td>2022-09-23</td>\n",
       "      <td>4190.50</td>\n",
       "      <td>239</td>\n",
       "      <td>1026.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-841.60</td>\n",
       "      <td>https://www.biohaven.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and...</td>\n",
       "      <td>7.30</td>\n",
       "      <td>38.47</td>\n",
       "      <td>426.99</td>\n",
       "      <td>816</td>\n",
       "      <td>-20.08</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>BMRN</td>\n",
       "      <td>Biomarin Pharmaceutical Inc</td>\n",
       "      <td>1999-07-26</td>\n",
       "      <td>12490.81</td>\n",
       "      <td>3401</td>\n",
       "      <td>1530.00</td>\n",
       "      <td>2752.81</td>\n",
       "      <td>426.09</td>\n",
       "      <td>https://www.biomarin.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioMarin Pharmaceutical Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare disea...</td>\n",
       "      <td>13.00</td>\n",
       "      <td>66.01</td>\n",
       "      <td>407.77</td>\n",
       "      <td>9276</td>\n",
       "      <td>3.41</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>ACLX</td>\n",
       "      <td>Arcellx Inc</td>\n",
       "      <td>2022-02-04</td>\n",
       "      <td>4510.91</td>\n",
       "      <td>130</td>\n",
       "      <td>561.00</td>\n",
       "      <td>155.82</td>\n",
       "      <td>-65.30</td>\n",
       "      <td>https://www.arcellx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable di...</td>\n",
       "      <td>16.80</td>\n",
       "      <td>83.80</td>\n",
       "      <td>398.81</td>\n",
       "      <td>1047</td>\n",
       "      <td>-1.45</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>BPMC</td>\n",
       "      <td>Blueprint Medicines Corp</td>\n",
       "      <td>2015-04-30</td>\n",
       "      <td>6059.73</td>\n",
       "      <td>638</td>\n",
       "      <td>642.00</td>\n",
       "      <td>434.42</td>\n",
       "      <td>-262.13</td>\n",
       "      <td>https://www.blueprintmedicines.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United...</td>\n",
       "      <td>18.87</td>\n",
       "      <td>93.19</td>\n",
       "      <td>393.85</td>\n",
       "      <td>3519</td>\n",
       "      <td>-4.33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>MLTX</td>\n",
       "      <td>MoonLake Immunotherapeutics</td>\n",
       "      <td>2020-10-20</td>\n",
       "      <td>3341.13</td>\n",
       "      <td>50</td>\n",
       "      <td>291.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-108.45</td>\n",
       "      <td>https://www.moonlaketx.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investi...</td>\n",
       "      <td>10.49</td>\n",
       "      <td>51.34</td>\n",
       "      <td>389.42</td>\n",
       "      <td>1519</td>\n",
       "      <td>-3.25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>NUVL</td>\n",
       "      <td>Nuvalent Inc</td>\n",
       "      <td>2021-07-29</td>\n",
       "      <td>6211.42</td>\n",
       "      <td>127</td>\n",
       "      <td>464.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.nuvalent.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product can...</td>\n",
       "      <td>18.75</td>\n",
       "      <td>86.86</td>\n",
       "      <td>363.25</td>\n",
       "      <td>1237</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>CORT</td>\n",
       "      <td>Corcept Therapeutics Inc</td>\n",
       "      <td>2004-04-14</td>\n",
       "      <td>5807.68</td>\n",
       "      <td>352</td>\n",
       "      <td>1022.00</td>\n",
       "      <td>628.56</td>\n",
       "      <td>144.09</td>\n",
       "      <td>https://www.corcept.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, ...</td>\n",
       "      <td>12.23</td>\n",
       "      <td>55.40</td>\n",
       "      <td>352.98</td>\n",
       "      <td>7552</td>\n",
       "      <td>2.48</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>MRUS</td>\n",
       "      <td>Merus N.V</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2930.25</td>\n",
       "      <td>172</td>\n",
       "      <td>543.00</td>\n",
       "      <td>35.93</td>\n",
       "      <td>-228.46</td>\n",
       "      <td>https://www.merus.nl</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antib...</td>\n",
       "      <td>10.04</td>\n",
       "      <td>42.83</td>\n",
       "      <td>326.59</td>\n",
       "      <td>3134</td>\n",
       "      <td>-7.80</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>VERA</td>\n",
       "      <td>Vera Therapeutics Inc</td>\n",
       "      <td>2021-05-14</td>\n",
       "      <td>2783.68</td>\n",
       "      <td>82</td>\n",
       "      <td>761.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://veratx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious im...</td>\n",
       "      <td>11.50</td>\n",
       "      <td>44.05</td>\n",
       "      <td>283.04</td>\n",
       "      <td>1313</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>XENE</td>\n",
       "      <td>Xenon Pharmaceuticals Inc</td>\n",
       "      <td>2014-11-05</td>\n",
       "      <td>3149.46</td>\n",
       "      <td>251</td>\n",
       "      <td>366.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-233.68</td>\n",
       "      <td>https://www.xenon-pharma.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with ne...</td>\n",
       "      <td>10.50</td>\n",
       "      <td>40.05</td>\n",
       "      <td>281.43</td>\n",
       "      <td>3695</td>\n",
       "      <td>-7.42</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>IONS</td>\n",
       "      <td>Ionis Pharmaceuticals Inc</td>\n",
       "      <td>1991-05-17</td>\n",
       "      <td>6015.88</td>\n",
       "      <td>927</td>\n",
       "      <td>1442.00</td>\n",
       "      <td>803.07</td>\n",
       "      <td>-336.27</td>\n",
       "      <td>https://www.ionispharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular...</td>\n",
       "      <td>10.00</td>\n",
       "      <td>36.61</td>\n",
       "      <td>266.10</td>\n",
       "      <td>12268</td>\n",
       "      <td>-5.59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>PTGX</td>\n",
       "      <td>Protagonist Therapeutics Inc</td>\n",
       "      <td>2016-08-11</td>\n",
       "      <td>2470.93</td>\n",
       "      <td>126</td>\n",
       "      <td>688.00</td>\n",
       "      <td>323.80</td>\n",
       "      <td>150.07</td>\n",
       "      <td>https://www.protagonist-inc.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and...</td>\n",
       "      <td>11.70</td>\n",
       "      <td>41.08</td>\n",
       "      <td>251.11</td>\n",
       "      <td>3050</td>\n",
       "      <td>6.07</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>CPRX</td>\n",
       "      <td>Catalyst Pharmaceuticals Inc</td>\n",
       "      <td>2006-11-08</td>\n",
       "      <td>2582.26</td>\n",
       "      <td>167</td>\n",
       "      <td>947.00</td>\n",
       "      <td>460.48</td>\n",
       "      <td>211.43</td>\n",
       "      <td>https://www.catalystpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with ...</td>\n",
       "      <td>6.10</td>\n",
       "      <td>21.38</td>\n",
       "      <td>250.49</td>\n",
       "      <td>6614</td>\n",
       "      <td>8.19</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>LGND</td>\n",
       "      <td>Ligand Pharmaceuticals, Inc</td>\n",
       "      <td>1992-11-18</td>\n",
       "      <td>2311.66</td>\n",
       "      <td>58</td>\n",
       "      <td>114.00</td>\n",
       "      <td>152.42</td>\n",
       "      <td>52.63</td>\n",
       "      <td>https://www.ligand.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. ...</td>\n",
       "      <td>34.38</td>\n",
       "      <td>116.91</td>\n",
       "      <td>240.08</td>\n",
       "      <td>11717</td>\n",
       "      <td>2.28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>PCVX</td>\n",
       "      <td>Vaxcyte Inc</td>\n",
       "      <td>2020-06-12</td>\n",
       "      <td>11153.76</td>\n",
       "      <td>254</td>\n",
       "      <td>1064.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-599.03</td>\n",
       "      <td>https://vaxcyte.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. ...</td>\n",
       "      <td>26.15</td>\n",
       "      <td>87.72</td>\n",
       "      <td>235.45</td>\n",
       "      <td>1649</td>\n",
       "      <td>-5.37</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>MIRM</td>\n",
       "      <td>Mirum Pharmaceuticals Inc</td>\n",
       "      <td>2019-07-18</td>\n",
       "      <td>2034.91</td>\n",
       "      <td>311</td>\n",
       "      <td>389.00</td>\n",
       "      <td>307.03</td>\n",
       "      <td>-72.90</td>\n",
       "      <td>https://www.mirumpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rar...</td>\n",
       "      <td>13.21</td>\n",
       "      <td>42.44</td>\n",
       "      <td>221.27</td>\n",
       "      <td>1979</td>\n",
       "      <td>-3.58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>SRPT</td>\n",
       "      <td>Sarepta Therapeutics Inc</td>\n",
       "      <td>1997-06-04</td>\n",
       "      <td>12110.93</td>\n",
       "      <td>1314</td>\n",
       "      <td>965.00</td>\n",
       "      <td>1640.35</td>\n",
       "      <td>119.67</td>\n",
       "      <td>https://www.sarepta.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, g...</td>\n",
       "      <td>39.00</td>\n",
       "      <td>123.71</td>\n",
       "      <td>217.21</td>\n",
       "      <td>10058</td>\n",
       "      <td>0.99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>CRSP</td>\n",
       "      <td>CRISPR Therapeutics AG</td>\n",
       "      <td>2016-10-19</td>\n",
       "      <td>3776.04</td>\n",
       "      <td>407</td>\n",
       "      <td>1506.00</td>\n",
       "      <td>202.83</td>\n",
       "      <td>-313.08</td>\n",
       "      <td>https://www.crisprtx.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularl...</td>\n",
       "      <td>14.09</td>\n",
       "      <td>43.78</td>\n",
       "      <td>210.72</td>\n",
       "      <td>2981</td>\n",
       "      <td>-8.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>VRNA</td>\n",
       "      <td>Verona Pharma Plc ADR</td>\n",
       "      <td>2017-04-28</td>\n",
       "      <td>3492.56</td>\n",
       "      <td>79</td>\n",
       "      <td>1006.00</td>\n",
       "      <td>5.62</td>\n",
       "      <td>-150.30</td>\n",
       "      <td>https://www.veronapharma.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of resp...</td>\n",
       "      <td>13.50</td>\n",
       "      <td>41.42</td>\n",
       "      <td>206.81</td>\n",
       "      <td>2790</td>\n",
       "      <td>-4.30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>XNCR</td>\n",
       "      <td>Xencor Inc</td>\n",
       "      <td>2013-12-03</td>\n",
       "      <td>1715.96</td>\n",
       "      <td>280</td>\n",
       "      <td>527.00</td>\n",
       "      <td>85.16</td>\n",
       "      <td>-202.48</td>\n",
       "      <td>https://www.xencor.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine ...</td>\n",
       "      <td>8.34</td>\n",
       "      <td>24.03</td>\n",
       "      <td>188.13</td>\n",
       "      <td>4032</td>\n",
       "      <td>-11.80</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>PTCT</td>\n",
       "      <td>PTC Therapeutics Inc</td>\n",
       "      <td>2013-06-20</td>\n",
       "      <td>3749.05</td>\n",
       "      <td>988</td>\n",
       "      <td>834.00</td>\n",
       "      <td>900.66</td>\n",
       "      <td>21.85</td>\n",
       "      <td>https://www.ptcbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with ra...</td>\n",
       "      <td>16.49</td>\n",
       "      <td>46.37</td>\n",
       "      <td>181.20</td>\n",
       "      <td>4198</td>\n",
       "      <td>0.58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>SRRK</td>\n",
       "      <td>Scholar Rock Holding Corp</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>4013.27</td>\n",
       "      <td>150</td>\n",
       "      <td>2124.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-228.52</td>\n",
       "      <td>https://scholarrock.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment ...</td>\n",
       "      <td>15.00</td>\n",
       "      <td>41.98</td>\n",
       "      <td>179.87</td>\n",
       "      <td>2398</td>\n",
       "      <td>-5.69</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>GLSI</td>\n",
       "      <td>Greenwich LifeSciences Inc</td>\n",
       "      <td>2020-09-25</td>\n",
       "      <td>169.57</td>\n",
       "      <td>3</td>\n",
       "      <td>28.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-10.53</td>\n",
       "      <td>https://greenwichlifesciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/n...</td>\n",
       "      <td>5.00</td>\n",
       "      <td>13.51</td>\n",
       "      <td>170.20</td>\n",
       "      <td>1544</td>\n",
       "      <td>-6.21</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>IMVT</td>\n",
       "      <td>Immunovant Inc</td>\n",
       "      <td>2019-06-21</td>\n",
       "      <td>4055.67</td>\n",
       "      <td>207</td>\n",
       "      <td>813.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-352.16</td>\n",
       "      <td>https://immunovant.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company...</td>\n",
       "      <td>9.95</td>\n",
       "      <td>26.28</td>\n",
       "      <td>164.12</td>\n",
       "      <td>2006</td>\n",
       "      <td>-8.68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>ACAD</td>\n",
       "      <td>Acadia Pharmaceuticals Inc</td>\n",
       "      <td>2004-05-27</td>\n",
       "      <td>2885.24</td>\n",
       "      <td>620</td>\n",
       "      <td>1469.00</td>\n",
       "      <td>929.24</td>\n",
       "      <td>124.54</td>\n",
       "      <td>https://www.acadia.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet...</td>\n",
       "      <td>6.70</td>\n",
       "      <td>17.26</td>\n",
       "      <td>157.61</td>\n",
       "      <td>7509</td>\n",
       "      <td>4.32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>TARS</td>\n",
       "      <td>Tarsus Pharmaceuticals Inc</td>\n",
       "      <td>2020-10-16</td>\n",
       "      <td>1977.48</td>\n",
       "      <td>244</td>\n",
       "      <td>704.00</td>\n",
       "      <td>129.62</td>\n",
       "      <td>-139.46</td>\n",
       "      <td>https://www.tarsusrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic ...</td>\n",
       "      <td>20.58</td>\n",
       "      <td>52.50</td>\n",
       "      <td>155.10</td>\n",
       "      <td>1523</td>\n",
       "      <td>-7.05</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>JANX</td>\n",
       "      <td>Janux Therapeutics Inc</td>\n",
       "      <td>2021-06-11</td>\n",
       "      <td>3609.44</td>\n",
       "      <td>76</td>\n",
       "      <td>964.00</td>\n",
       "      <td>13.05</td>\n",
       "      <td>-83.88</td>\n",
       "      <td>https://www.januxrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) a...</td>\n",
       "      <td>25.15</td>\n",
       "      <td>61.11</td>\n",
       "      <td>142.98</td>\n",
       "      <td>1285</td>\n",
       "      <td>-2.32</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>EXEL</td>\n",
       "      <td>Exelixis Inc</td>\n",
       "      <td>2000-04-17</td>\n",
       "      <td>10300.83</td>\n",
       "      <td>1310</td>\n",
       "      <td>2129.00</td>\n",
       "      <td>2081.60</td>\n",
       "      <td>635.96</td>\n",
       "      <td>https://www.exelixis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers ...</td>\n",
       "      <td>14.75</td>\n",
       "      <td>35.03</td>\n",
       "      <td>137.49</td>\n",
       "      <td>9010</td>\n",
       "      <td>6.17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>APLS</td>\n",
       "      <td>Apellis Pharmaceuticals Inc</td>\n",
       "      <td>2017-11-09</td>\n",
       "      <td>4187.07</td>\n",
       "      <td>702</td>\n",
       "      <td>3420.00</td>\n",
       "      <td>715.22</td>\n",
       "      <td>-221.51</td>\n",
       "      <td>https://www.apellis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of thera...</td>\n",
       "      <td>14.03</td>\n",
       "      <td>33.19</td>\n",
       "      <td>136.56</td>\n",
       "      <td>2595</td>\n",
       "      <td>-5.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>AUPH</td>\n",
       "      <td>Aurinia Pharmaceuticals Inc</td>\n",
       "      <td>2014-09-03</td>\n",
       "      <td>1378.81</td>\n",
       "      <td>300</td>\n",
       "      <td>1262.00</td>\n",
       "      <td>220.36</td>\n",
       "      <td>0.50</td>\n",
       "      <td>https://www.auriniapharma.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various d...</td>\n",
       "      <td>4.00</td>\n",
       "      <td>9.37</td>\n",
       "      <td>134.25</td>\n",
       "      <td>3758</td>\n",
       "      <td>0.04</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NAMS</td>\n",
       "      <td>NewAmsterdam Pharma Company NV</td>\n",
       "      <td>2021-02-09</td>\n",
       "      <td>2645.28</td>\n",
       "      <td>62</td>\n",
       "      <td>680.00</td>\n",
       "      <td>33.59</td>\n",
       "      <td>-184.06</td>\n",
       "      <td>https://www.newamsterdampharma.com</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic...</td>\n",
       "      <td>10.61</td>\n",
       "      <td>24.69</td>\n",
       "      <td>132.66</td>\n",
       "      <td>1407</td>\n",
       "      <td>-6.96</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>IDYA</td>\n",
       "      <td>Ideaya Biosciences Inc</td>\n",
       "      <td>2019-05-23</td>\n",
       "      <td>2251.55</td>\n",
       "      <td>124</td>\n",
       "      <td>930.00</td>\n",
       "      <td>3.92</td>\n",
       "      <td>-222.31</td>\n",
       "      <td>https://www.ideayabio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, discovers and develops targeted therapeutics for pati...</td>\n",
       "      <td>11.19</td>\n",
       "      <td>25.19</td>\n",
       "      <td>125.11</td>\n",
       "      <td>2035</td>\n",
       "      <td>-9.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>MRNA</td>\n",
       "      <td>Moderna Inc</td>\n",
       "      <td>2018-12-07</td>\n",
       "      <td>16100.78</td>\n",
       "      <td>5600</td>\n",
       "      <td>7060.00</td>\n",
       "      <td>5081.00</td>\n",
       "      <td>-2362.00</td>\n",
       "      <td>https://www.modernatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infec...</td>\n",
       "      <td>18.60</td>\n",
       "      <td>41.83</td>\n",
       "      <td>124.89</td>\n",
       "      <td>2202</td>\n",
       "      <td>-14.67</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>RYTM</td>\n",
       "      <td>Rhythm Pharmaceuticals Inc</td>\n",
       "      <td>2017-10-09</td>\n",
       "      <td>3395.50</td>\n",
       "      <td>226</td>\n",
       "      <td>497.00</td>\n",
       "      <td>112.53</td>\n",
       "      <td>-263.92</td>\n",
       "      <td>https://rhythmtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead produc...</td>\n",
       "      <td>24.57</td>\n",
       "      <td>55.24</td>\n",
       "      <td>124.83</td>\n",
       "      <td>2626</td>\n",
       "      <td>-7.77</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>JUNS</td>\n",
       "      <td>Jupiter Neurosciences Inc</td>\n",
       "      <td>2024-12-03</td>\n",
       "      <td>337.64</td>\n",
       "      <td>4</td>\n",
       "      <td>767.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://jupiterneurosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products primarily fo...</td>\n",
       "      <td>5.49</td>\n",
       "      <td>12.21</td>\n",
       "      <td>122.40</td>\n",
       "      <td>14</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>CRNX</td>\n",
       "      <td>Crinetics Pharmaceuticals Inc</td>\n",
       "      <td>2018-07-18</td>\n",
       "      <td>5066.26</td>\n",
       "      <td>290</td>\n",
       "      <td>734.00</td>\n",
       "      <td>1.04</td>\n",
       "      <td>-304.51</td>\n",
       "      <td>https://www.crinetics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel th...</td>\n",
       "      <td>24.51</td>\n",
       "      <td>53.66</td>\n",
       "      <td>118.93</td>\n",
       "      <td>2344</td>\n",
       "      <td>-6.01</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>ADMA</td>\n",
       "      <td>Adma Biologics Inc</td>\n",
       "      <td>2013-10-17</td>\n",
       "      <td>4486.68</td>\n",
       "      <td>624</td>\n",
       "      <td>4785.00</td>\n",
       "      <td>382.81</td>\n",
       "      <td>125.89</td>\n",
       "      <td>https://www.admabiologics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the ...</td>\n",
       "      <td>8.55</td>\n",
       "      <td>18.59</td>\n",
       "      <td>117.43</td>\n",
       "      <td>4079</td>\n",
       "      <td>2.81</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>MNMD</td>\n",
       "      <td>Mind Medicine Inc</td>\n",
       "      <td>2016-11-15</td>\n",
       "      <td>542.65</td>\n",
       "      <td>57</td>\n",
       "      <td>1154.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.mindmed.co</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's l...</td>\n",
       "      <td>3.38</td>\n",
       "      <td>7.16</td>\n",
       "      <td>112.15</td>\n",
       "      <td>2954</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>APGE</td>\n",
       "      <td>Apogee Therapeutics Inc</td>\n",
       "      <td>2023-07-14</td>\n",
       "      <td>2686.39</td>\n",
       "      <td>91</td>\n",
       "      <td>478.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.apogeetherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermati...</td>\n",
       "      <td>21.23</td>\n",
       "      <td>44.50</td>\n",
       "      <td>109.61</td>\n",
       "      <td>522</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>DYAI</td>\n",
       "      <td>Dyadic International Inc., DE</td>\n",
       "      <td>2008-01-16</td>\n",
       "      <td>44.09</td>\n",
       "      <td>7</td>\n",
       "      <td>41.00</td>\n",
       "      <td>1.80</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.dyadic.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and in...</td>\n",
       "      <td>0.80</td>\n",
       "      <td>1.63</td>\n",
       "      <td>103.75</td>\n",
       "      <td>6180</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>MDXG</td>\n",
       "      <td>Mimedx Group Inc</td>\n",
       "      <td>2008-02-12</td>\n",
       "      <td>1391.58</td>\n",
       "      <td>895</td>\n",
       "      <td>756.00</td>\n",
       "      <td>342.80</td>\n",
       "      <td>67.51</td>\n",
       "      <td>https://www.mimedx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissue...</td>\n",
       "      <td>4.64</td>\n",
       "      <td>9.16</td>\n",
       "      <td>97.55</td>\n",
       "      <td>6153</td>\n",
       "      <td>4.85</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>PRTA</td>\n",
       "      <td>Prothena Corporation plc</td>\n",
       "      <td>2012-12-18</td>\n",
       "      <td>678.53</td>\n",
       "      <td>173</td>\n",
       "      <td>545.00</td>\n",
       "      <td>133.35</td>\n",
       "      <td>-167.23</td>\n",
       "      <td>https://www.prothena.com</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases c...</td>\n",
       "      <td>7.20</td>\n",
       "      <td>12.79</td>\n",
       "      <td>77.64</td>\n",
       "      <td>4382</td>\n",
       "      <td>-24.65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>OCS</td>\n",
       "      <td>Oculis Holding AG</td>\n",
       "      <td>2021-05-18</td>\n",
       "      <td>717.26</td>\n",
       "      <td>36</td>\n",
       "      <td>53.00</td>\n",
       "      <td>0.87</td>\n",
       "      <td>-68.00</td>\n",
       "      <td>https://oculis.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product c...</td>\n",
       "      <td>9.70</td>\n",
       "      <td>17.09</td>\n",
       "      <td>76.19</td>\n",
       "      <td>1309</td>\n",
       "      <td>-9.48</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>IZTC</td>\n",
       "      <td>Invizyne Technologies Inc</td>\n",
       "      <td>2024-11-13</td>\n",
       "      <td>148.27</td>\n",
       "      <td>29</td>\n",
       "      <td>36.00</td>\n",
       "      <td>-0.00</td>\n",
       "      <td>-4.68</td>\n",
       "      <td>https://www.invizyne.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that pro...</td>\n",
       "      <td>8.65</td>\n",
       "      <td>15.17</td>\n",
       "      <td>75.38</td>\n",
       "      <td>34</td>\n",
       "      <td>-3.16</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>SMMT</td>\n",
       "      <td>Summit Therapeutics Inc</td>\n",
       "      <td>2015-03-05</td>\n",
       "      <td>13775.53</td>\n",
       "      <td>105</td>\n",
       "      <td>3017.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-181.49</td>\n",
       "      <td>https://www.summittxinc.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, ...</td>\n",
       "      <td>10.19</td>\n",
       "      <td>17.83</td>\n",
       "      <td>74.98</td>\n",
       "      <td>3575</td>\n",
       "      <td>-1.32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>GLPG</td>\n",
       "      <td>Galapagos NV ADR</td>\n",
       "      <td>2012-02-27</td>\n",
       "      <td>1773.29</td>\n",
       "      <td>1123</td>\n",
       "      <td>199.00</td>\n",
       "      <td>260.09</td>\n",
       "      <td>-136.03</td>\n",
       "      <td>https://www.glpg.com</td>\n",
       "      <td>Belgium</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The compa...</td>\n",
       "      <td>15.37</td>\n",
       "      <td>26.82</td>\n",
       "      <td>74.50</td>\n",
       "      <td>4677</td>\n",
       "      <td>-7.67</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>SWTX</td>\n",
       "      <td>SpringWorks Therapeutics Inc</td>\n",
       "      <td>2019-09-13</td>\n",
       "      <td>2827.43</td>\n",
       "      <td>305</td>\n",
       "      <td>1127.00</td>\n",
       "      <td>135.49</td>\n",
       "      <td>-292.26</td>\n",
       "      <td>https://www.springworkstx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for un...</td>\n",
       "      <td>22.63</td>\n",
       "      <td>38.30</td>\n",
       "      <td>69.24</td>\n",
       "      <td>1922</td>\n",
       "      <td>-10.34</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>DNTH</td>\n",
       "      <td>Dianthus Therapeutics Inc</td>\n",
       "      <td>2018-06-21</td>\n",
       "      <td>711.22</td>\n",
       "      <td>53</td>\n",
       "      <td>262.00</td>\n",
       "      <td>5.37</td>\n",
       "      <td>-82.81</td>\n",
       "      <td>https://dianthustx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and infl...</td>\n",
       "      <td>14.52</td>\n",
       "      <td>23.81</td>\n",
       "      <td>63.98</td>\n",
       "      <td>2371</td>\n",
       "      <td>-11.64</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>AKRO</td>\n",
       "      <td>Akero Therapeutics Inc</td>\n",
       "      <td>2019-06-20</td>\n",
       "      <td>2040.23</td>\n",
       "      <td>60</td>\n",
       "      <td>577.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-269.27</td>\n",
       "      <td>https://akerotx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in t...</td>\n",
       "      <td>18.32</td>\n",
       "      <td>28.89</td>\n",
       "      <td>57.70</td>\n",
       "      <td>2007</td>\n",
       "      <td>-13.20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>RVMD</td>\n",
       "      <td>Revolution Medicines Inc</td>\n",
       "      <td>2020-02-13</td>\n",
       "      <td>8262.18</td>\n",
       "      <td>490</td>\n",
       "      <td>1583.00</td>\n",
       "      <td>0.74</td>\n",
       "      <td>-621.56</td>\n",
       "      <td>https://www.revmed.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's...</td>\n",
       "      <td>28.90</td>\n",
       "      <td>45.01</td>\n",
       "      <td>55.74</td>\n",
       "      <td>1769</td>\n",
       "      <td>-7.52</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>ELVN</td>\n",
       "      <td>Enliven Therapeutics Inc</td>\n",
       "      <td>2020-03-12</td>\n",
       "      <td>1151.61</td>\n",
       "      <td>46</td>\n",
       "      <td>263.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-98.78</td>\n",
       "      <td>https://www.enliventherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to h...</td>\n",
       "      <td>15.00</td>\n",
       "      <td>23.15</td>\n",
       "      <td>54.33</td>\n",
       "      <td>1741</td>\n",
       "      <td>-8.58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>DRUG</td>\n",
       "      <td>Bright Minds Biosciences Inc</td>\n",
       "      <td>2021-03-22</td>\n",
       "      <td>273.64</td>\n",
       "      <td>0</td>\n",
       "      <td>3108.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://brightmindsbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering disea...</td>\n",
       "      <td>27.00</td>\n",
       "      <td>41.00</td>\n",
       "      <td>51.85</td>\n",
       "      <td>1366</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>BEAM</td>\n",
       "      <td>Beam Therapeutics Inc</td>\n",
       "      <td>2020-02-06</td>\n",
       "      <td>2395.57</td>\n",
       "      <td>472</td>\n",
       "      <td>1073.00</td>\n",
       "      <td>349.64</td>\n",
       "      <td>-160.83</td>\n",
       "      <td>https://beamtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious dis...</td>\n",
       "      <td>18.75</td>\n",
       "      <td>27.93</td>\n",
       "      <td>48.96</td>\n",
       "      <td>1776</td>\n",
       "      <td>-6.71</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>NVCT</td>\n",
       "      <td>Nuvectis Pharma Inc</td>\n",
       "      <td>2022-02-04</td>\n",
       "      <td>94.09</td>\n",
       "      <td>13</td>\n",
       "      <td>172.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.nuvectis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical n...</td>\n",
       "      <td>3.25</td>\n",
       "      <td>4.70</td>\n",
       "      <td>44.62</td>\n",
       "      <td>1047</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>INVA</td>\n",
       "      <td>Innoviva Inc</td>\n",
       "      <td>2004-10-05</td>\n",
       "      <td>1153.11</td>\n",
       "      <td>112</td>\n",
       "      <td>619.00</td>\n",
       "      <td>352.74</td>\n",
       "      <td>221.19</td>\n",
       "      <td>https://www.inva.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's...</td>\n",
       "      <td>13.59</td>\n",
       "      <td>18.58</td>\n",
       "      <td>36.75</td>\n",
       "      <td>7378</td>\n",
       "      <td>19.18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>AVBP</td>\n",
       "      <td>ArriVent BioPharma Inc</td>\n",
       "      <td>2024-01-26</td>\n",
       "      <td>892.30</td>\n",
       "      <td>40</td>\n",
       "      <td>235.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.arrivent.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercializa...</td>\n",
       "      <td>20.00</td>\n",
       "      <td>26.72</td>\n",
       "      <td>33.60</td>\n",
       "      <td>326</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>COYA</td>\n",
       "      <td>Coya Therapeutics Inc</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>94.56</td>\n",
       "      <td>8</td>\n",
       "      <td>90.00</td>\n",
       "      <td>9.55</td>\n",
       "      <td>-11.11</td>\n",
       "      <td>https://www.coyatherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the func...</td>\n",
       "      <td>4.57</td>\n",
       "      <td>5.89</td>\n",
       "      <td>28.88</td>\n",
       "      <td>719</td>\n",
       "      <td>-11.75</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>KYMR</td>\n",
       "      <td>Kymera Therapeutics Inc</td>\n",
       "      <td>2020-08-21</td>\n",
       "      <td>2788.79</td>\n",
       "      <td>184</td>\n",
       "      <td>443.00</td>\n",
       "      <td>87.56</td>\n",
       "      <td>-190.49</td>\n",
       "      <td>https://www.kymeratx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively d...</td>\n",
       "      <td>33.26</td>\n",
       "      <td>42.13</td>\n",
       "      <td>26.67</td>\n",
       "      <td>1579</td>\n",
       "      <td>-6.83</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>AGIO</td>\n",
       "      <td>Agios Pharmaceuticals Inc</td>\n",
       "      <td>2013-07-24</td>\n",
       "      <td>2434.62</td>\n",
       "      <td>383</td>\n",
       "      <td>736.00</td>\n",
       "      <td>32.87</td>\n",
       "      <td>-401.29</td>\n",
       "      <td>https://www.agios.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United State...</td>\n",
       "      <td>31.28</td>\n",
       "      <td>38.97</td>\n",
       "      <td>24.58</td>\n",
       "      <td>4164</td>\n",
       "      <td>-16.48</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>LENZ</td>\n",
       "      <td>LENZ Therapeutics Inc</td>\n",
       "      <td>2021-06-25</td>\n",
       "      <td>848.40</td>\n",
       "      <td>0</td>\n",
       "      <td>159.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-68.34</td>\n",
       "      <td>https://www.lenz-tx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. ...</td>\n",
       "      <td>25.13</td>\n",
       "      <td>30.97</td>\n",
       "      <td>23.24</td>\n",
       "      <td>1271</td>\n",
       "      <td>-8.06</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>ARVN</td>\n",
       "      <td>Arvinas Inc</td>\n",
       "      <td>2018-09-27</td>\n",
       "      <td>1304.86</td>\n",
       "      <td>445</td>\n",
       "      <td>663.00</td>\n",
       "      <td>161.10</td>\n",
       "      <td>-352.60</td>\n",
       "      <td>https://www.arvinas.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade diseas...</td>\n",
       "      <td>16.05</td>\n",
       "      <td>19.50</td>\n",
       "      <td>21.50</td>\n",
       "      <td>2273</td>\n",
       "      <td>-27.02</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>OSTX</td>\n",
       "      <td>OS Therapies Inc</td>\n",
       "      <td>2024-08-01</td>\n",
       "      <td>73.91</td>\n",
       "      <td>0</td>\n",
       "      <td>45.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-3.18</td>\n",
       "      <td>https://ostherapies.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatm...</td>\n",
       "      <td>2.51</td>\n",
       "      <td>3.02</td>\n",
       "      <td>20.32</td>\n",
       "      <td>138</td>\n",
       "      <td>-4.30</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>GPCR</td>\n",
       "      <td>Structure Therapeutics Inc ADR</td>\n",
       "      <td>2023-02-03</td>\n",
       "      <td>1775.08</td>\n",
       "      <td>136</td>\n",
       "      <td>787.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.84</td>\n",
       "      <td>https://structuretx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of ...</td>\n",
       "      <td>26.00</td>\n",
       "      <td>31.25</td>\n",
       "      <td>20.19</td>\n",
       "      <td>683</td>\n",
       "      <td>-6.86</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>EPRX</td>\n",
       "      <td>Eupraxia Pharmaceuticals Inc</td>\n",
       "      <td>2024-04-05</td>\n",
       "      <td>122.47</td>\n",
       "      <td>29</td>\n",
       "      <td>16.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.76</td>\n",
       "      <td>https://www.eupraxiapharma.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the...</td>\n",
       "      <td>2.95</td>\n",
       "      <td>3.44</td>\n",
       "      <td>16.71</td>\n",
       "      <td>256</td>\n",
       "      <td>-25.93</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>SNDX</td>\n",
       "      <td>Syndax Pharmaceuticals Inc</td>\n",
       "      <td>2016-03-02</td>\n",
       "      <td>1177.08</td>\n",
       "      <td>184</td>\n",
       "      <td>1562.00</td>\n",
       "      <td>16.00</td>\n",
       "      <td>-321.20</td>\n",
       "      <td>https://www.syndax.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candida...</td>\n",
       "      <td>12.00</td>\n",
       "      <td>13.93</td>\n",
       "      <td>16.08</td>\n",
       "      <td>3212</td>\n",
       "      <td>-27.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>BCRX</td>\n",
       "      <td>Biocryst Pharmaceuticals Inc</td>\n",
       "      <td>1994-03-04</td>\n",
       "      <td>1545.21</td>\n",
       "      <td>536</td>\n",
       "      <td>1985.00</td>\n",
       "      <td>412.58</td>\n",
       "      <td>-31.94</td>\n",
       "      <td>https://www.biocryst.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company...</td>\n",
       "      <td>6.50</td>\n",
       "      <td>7.53</td>\n",
       "      <td>15.85</td>\n",
       "      <td>11246</td>\n",
       "      <td>-2.07</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>BCYC</td>\n",
       "      <td>Bicycle Therapeutics Plc ADR</td>\n",
       "      <td>2019-05-23</td>\n",
       "      <td>1043.98</td>\n",
       "      <td>284</td>\n",
       "      <td>542.00</td>\n",
       "      <td>36.90</td>\n",
       "      <td>-189.32</td>\n",
       "      <td>https://www.bicycletherapeutics.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing ...</td>\n",
       "      <td>12.00</td>\n",
       "      <td>13.81</td>\n",
       "      <td>15.08</td>\n",
       "      <td>2035</td>\n",
       "      <td>-18.13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>RNA</td>\n",
       "      <td>Avidity Biosciences Inc</td>\n",
       "      <td>2020-06-12</td>\n",
       "      <td>3983.73</td>\n",
       "      <td>253</td>\n",
       "      <td>1284.00</td>\n",
       "      <td>10.12</td>\n",
       "      <td>-322.04</td>\n",
       "      <td>https://www.aviditybiosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugat...</td>\n",
       "      <td>28.50</td>\n",
       "      <td>32.49</td>\n",
       "      <td>14.00</td>\n",
       "      <td>1649</td>\n",
       "      <td>-8.08</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>ROIV</td>\n",
       "      <td>Roivant Sciences Ltd</td>\n",
       "      <td>2020-12-08</td>\n",
       "      <td>8808.20</td>\n",
       "      <td>908</td>\n",
       "      <td>5928.00</td>\n",
       "      <td>129.13</td>\n",
       "      <td>-1199.66</td>\n",
       "      <td>https://roivant.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammatio...</td>\n",
       "      <td>10.40</td>\n",
       "      <td>11.84</td>\n",
       "      <td>13.85</td>\n",
       "      <td>1470</td>\n",
       "      <td>-13.62</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>RARE</td>\n",
       "      <td>Ultragenyx Pharmaceutical Inc</td>\n",
       "      <td>2014-01-31</td>\n",
       "      <td>4192.43</td>\n",
       "      <td>1276</td>\n",
       "      <td>709.00</td>\n",
       "      <td>522.74</td>\n",
       "      <td>-501.06</td>\n",
       "      <td>https://www.ultragenyx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of nov...</td>\n",
       "      <td>42.25</td>\n",
       "      <td>45.78</td>\n",
       "      <td>8.36</td>\n",
       "      <td>3973</td>\n",
       "      <td>-11.95</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>DYN</td>\n",
       "      <td>Dyne Therapeutics Inc</td>\n",
       "      <td>2020-09-17</td>\n",
       "      <td>2656.09</td>\n",
       "      <td>173</td>\n",
       "      <td>1014.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-312.84</td>\n",
       "      <td>https://www.dyne-tx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for g...</td>\n",
       "      <td>23.90</td>\n",
       "      <td>25.73</td>\n",
       "      <td>7.66</td>\n",
       "      <td>1552</td>\n",
       "      <td>-11.78</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>DNLI</td>\n",
       "      <td>Denali Therapeutics Inc</td>\n",
       "      <td>2017-12-08</td>\n",
       "      <td>3351.94</td>\n",
       "      <td>390</td>\n",
       "      <td>803.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-511.85</td>\n",
       "      <td>https://www.denalitherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for ...</td>\n",
       "      <td>21.45</td>\n",
       "      <td>22.97</td>\n",
       "      <td>7.09</td>\n",
       "      <td>2566</td>\n",
       "      <td>-15.27</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>NRIX</td>\n",
       "      <td>Nurix Therapeutics Inc</td>\n",
       "      <td>2020-07-24</td>\n",
       "      <td>1474.10</td>\n",
       "      <td>284</td>\n",
       "      <td>919.00</td>\n",
       "      <td>56.42</td>\n",
       "      <td>-186.40</td>\n",
       "      <td>https://www.nurixtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecu...</td>\n",
       "      <td>19.01</td>\n",
       "      <td>20.27</td>\n",
       "      <td>6.63</td>\n",
       "      <td>1607</td>\n",
       "      <td>-12.65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>AVXL</td>\n",
       "      <td>Anavex Life Sciences Corporation</td>\n",
       "      <td>2006-08-02</td>\n",
       "      <td>778.42</td>\n",
       "      <td>40</td>\n",
       "      <td>1159.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.anavex.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central ne...</td>\n",
       "      <td>8.00</td>\n",
       "      <td>8.46</td>\n",
       "      <td>5.75</td>\n",
       "      <td>6712</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>QURE</td>\n",
       "      <td>uniQure N.V</td>\n",
       "      <td>2014-02-05</td>\n",
       "      <td>848.13</td>\n",
       "      <td>480</td>\n",
       "      <td>1953.00</td>\n",
       "      <td>28.59</td>\n",
       "      <td>-189.32</td>\n",
       "      <td>https://www.uniqure.com</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III ...</td>\n",
       "      <td>14.61</td>\n",
       "      <td>15.40</td>\n",
       "      <td>5.41</td>\n",
       "      <td>3968</td>\n",
       "      <td>-22.32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>SEPN</td>\n",
       "      <td>Septerna Inc</td>\n",
       "      <td>2024-10-25</td>\n",
       "      <td>963.09</td>\n",
       "      <td>68</td>\n",
       "      <td>299.00</td>\n",
       "      <td>0.84</td>\n",
       "      <td>-57.77</td>\n",
       "      <td>https://septerna.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products cand...</td>\n",
       "      <td>21.40</td>\n",
       "      <td>22.39</td>\n",
       "      <td>4.63</td>\n",
       "      <td>53</td>\n",
       "      <td>-6.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>TLX</td>\n",
       "      <td>Telix Pharmaceuticals Ltd. ADR</td>\n",
       "      <td>2024-11-14</td>\n",
       "      <td>5295.33</td>\n",
       "      <td>0</td>\n",
       "      <td>21.00</td>\n",
       "      <td>645.68</td>\n",
       "      <td>73.14</td>\n",
       "      <td>https://telixpharma.com</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and d...</td>\n",
       "      <td>15.15</td>\n",
       "      <td>15.76</td>\n",
       "      <td>4.03</td>\n",
       "      <td>33</td>\n",
       "      <td>1.38</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>TELO</td>\n",
       "      <td>Telomir Pharmaceuticals Inc</td>\n",
       "      <td>2024-02-09</td>\n",
       "      <td>146.98</td>\n",
       "      <td>1</td>\n",
       "      <td>167.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://telomirpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Telomir Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, is engaged in the advancement of age reversal science. The company is d...</td>\n",
       "      <td>5.00</td>\n",
       "      <td>5.20</td>\n",
       "      <td>4.00</td>\n",
       "      <td>312</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>MDCX</td>\n",
       "      <td>Medicus Pharma Ltd</td>\n",
       "      <td>2024-11-14</td>\n",
       "      <td>34.86</td>\n",
       "      <td>0</td>\n",
       "      <td>52.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.65</td>\n",
       "      <td>2.75</td>\n",
       "      <td>3.77</td>\n",
       "      <td>33</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>MURA</td>\n",
       "      <td>Mural Oncology plc</td>\n",
       "      <td>2023-11-24</td>\n",
       "      <td>58.69</td>\n",
       "      <td>107</td>\n",
       "      <td>146.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-168.40</td>\n",
       "      <td>https://www.muraloncology.com</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with ca...</td>\n",
       "      <td>3.52</td>\n",
       "      <td>3.64</td>\n",
       "      <td>3.41</td>\n",
       "      <td>389</td>\n",
       "      <td>-286.93</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>ACTU</td>\n",
       "      <td>Actuate Therapeutics Inc</td>\n",
       "      <td>2024-08-13</td>\n",
       "      <td>169.73</td>\n",
       "      <td>11</td>\n",
       "      <td>50.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://actuatetherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company'...</td>\n",
       "      <td>8.61</td>\n",
       "      <td>8.62</td>\n",
       "      <td>0.12</td>\n",
       "      <td>126</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>BBIO</td>\n",
       "      <td>BridgeBio Pharma Inc</td>\n",
       "      <td>2019-06-27</td>\n",
       "      <td>5236.91</td>\n",
       "      <td>550</td>\n",
       "      <td>2018.00</td>\n",
       "      <td>217.76</td>\n",
       "      <td>-509.90</td>\n",
       "      <td>https://bridgebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat pa...</td>\n",
       "      <td>27.55</td>\n",
       "      <td>27.49</td>\n",
       "      <td>-0.22</td>\n",
       "      <td>2000</td>\n",
       "      <td>-9.74</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>LQDA</td>\n",
       "      <td>Liquidia Corp</td>\n",
       "      <td>2018-07-26</td>\n",
       "      <td>933.54</td>\n",
       "      <td>145</td>\n",
       "      <td>873.00</td>\n",
       "      <td>14.84</td>\n",
       "      <td>-95.84</td>\n",
       "      <td>https://www.liquidia.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the Unit...</td>\n",
       "      <td>11.10</td>\n",
       "      <td>10.92</td>\n",
       "      <td>-1.62</td>\n",
       "      <td>2336</td>\n",
       "      <td>-10.27</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>ZYME</td>\n",
       "      <td>Zymeworks BC Inc</td>\n",
       "      <td>2017-04-28</td>\n",
       "      <td>948.44</td>\n",
       "      <td>294</td>\n",
       "      <td>515.00</td>\n",
       "      <td>62.20</td>\n",
       "      <td>-114.71</td>\n",
       "      <td>https://www.zymeworks.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. T...</td>\n",
       "      <td>13.00</td>\n",
       "      <td>12.58</td>\n",
       "      <td>-3.23</td>\n",
       "      <td>2790</td>\n",
       "      <td>-12.09</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>CADL</td>\n",
       "      <td>Candel Therapeutics Inc</td>\n",
       "      <td>2021-07-27</td>\n",
       "      <td>199.89</td>\n",
       "      <td>42</td>\n",
       "      <td>2785.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-34.66</td>\n",
       "      <td>https://www.candeltx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It deve...</td>\n",
       "      <td>7.00</td>\n",
       "      <td>6.75</td>\n",
       "      <td>-3.57</td>\n",
       "      <td>1239</td>\n",
       "      <td>-17.34</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>MDGL</td>\n",
       "      <td>Madrigal Pharmaceuticals Inc</td>\n",
       "      <td>2007-02-06</td>\n",
       "      <td>6782.82</td>\n",
       "      <td>376</td>\n",
       "      <td>418.00</td>\n",
       "      <td>76.81</td>\n",
       "      <td>-547.18</td>\n",
       "      <td>https://www.madrigalpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-al...</td>\n",
       "      <td>318.15</td>\n",
       "      <td>304.50</td>\n",
       "      <td>-4.29</td>\n",
       "      <td>6524</td>\n",
       "      <td>-8.07</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>ACOG</td>\n",
       "      <td>Alpha Cognition Inc</td>\n",
       "      <td>2024-11-12</td>\n",
       "      <td>79.14</td>\n",
       "      <td>0</td>\n",
       "      <td>134.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.70</td>\n",
       "      <td>5.42</td>\n",
       "      <td>-4.91</td>\n",
       "      <td>35</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>LEGN</td>\n",
       "      <td>Legend Biotech Corp ADR</td>\n",
       "      <td>2020-06-05</td>\n",
       "      <td>6055.68</td>\n",
       "      <td>2400</td>\n",
       "      <td>1437.00</td>\n",
       "      <td>520.18</td>\n",
       "      <td>-340.56</td>\n",
       "      <td>https://www.legendbiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufactu...</td>\n",
       "      <td>37.00</td>\n",
       "      <td>35.12</td>\n",
       "      <td>-5.08</td>\n",
       "      <td>1656</td>\n",
       "      <td>-5.62</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>RCUS</td>\n",
       "      <td>Arcus Biosciences Inc</td>\n",
       "      <td>2018-03-15</td>\n",
       "      <td>1510.86</td>\n",
       "      <td>577</td>\n",
       "      <td>747.00</td>\n",
       "      <td>263.00</td>\n",
       "      <td>-288.00</td>\n",
       "      <td>https://www.arcusbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The compan...</td>\n",
       "      <td>17.00</td>\n",
       "      <td>16.08</td>\n",
       "      <td>-5.41</td>\n",
       "      <td>2469</td>\n",
       "      <td>-19.06</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>ZLAB</td>\n",
       "      <td>Zai Lab Limited ADR</td>\n",
       "      <td>2017-09-20</td>\n",
       "      <td>2846.68</td>\n",
       "      <td>2175</td>\n",
       "      <td>1009.00</td>\n",
       "      <td>355.75</td>\n",
       "      <td>-326.92</td>\n",
       "      <td>https://www.zailaboratory.com</td>\n",
       "      <td>China</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commerci...</td>\n",
       "      <td>27.93</td>\n",
       "      <td>26.33</td>\n",
       "      <td>-5.73</td>\n",
       "      <td>2645</td>\n",
       "      <td>-11.48</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>KROS</td>\n",
       "      <td>Keros Therapeutics Inc</td>\n",
       "      <td>2020-04-08</td>\n",
       "      <td>786.65</td>\n",
       "      <td>160</td>\n",
       "      <td>698.00</td>\n",
       "      <td>0.65</td>\n",
       "      <td>-202.89</td>\n",
       "      <td>https://www.kerostx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders t...</td>\n",
       "      <td>20.08</td>\n",
       "      <td>18.83</td>\n",
       "      <td>-6.23</td>\n",
       "      <td>1714</td>\n",
       "      <td>-25.79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>CRGX</td>\n",
       "      <td>CARGO Therapeutics Inc</td>\n",
       "      <td>2023-11-13</td>\n",
       "      <td>667.40</td>\n",
       "      <td>170</td>\n",
       "      <td>269.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-169.78</td>\n",
       "      <td>https://cargo-tx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. T...</td>\n",
       "      <td>14.69</td>\n",
       "      <td>13.74</td>\n",
       "      <td>-6.47</td>\n",
       "      <td>400</td>\n",
       "      <td>-25.44</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>IMNM</td>\n",
       "      <td>Immunome Inc</td>\n",
       "      <td>2020-10-02</td>\n",
       "      <td>776.46</td>\n",
       "      <td>55</td>\n",
       "      <td>795.00</td>\n",
       "      <td>10.13</td>\n",
       "      <td>-110.44</td>\n",
       "      <td>https://immunome.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamm...</td>\n",
       "      <td>13.45</td>\n",
       "      <td>12.58</td>\n",
       "      <td>-6.47</td>\n",
       "      <td>1537</td>\n",
       "      <td>-14.22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>EWTX</td>\n",
       "      <td>Edgewise Therapeutics Inc</td>\n",
       "      <td>2021-03-26</td>\n",
       "      <td>3095.37</td>\n",
       "      <td>108</td>\n",
       "      <td>1087.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-145.18</td>\n",
       "      <td>https://www.edgewisetx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders....</td>\n",
       "      <td>30.00</td>\n",
       "      <td>27.62</td>\n",
       "      <td>-7.93</td>\n",
       "      <td>1362</td>\n",
       "      <td>-4.69</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>UPB</td>\n",
       "      <td>Upstream Bio Inc</td>\n",
       "      <td>2024-10-11</td>\n",
       "      <td>1018.87</td>\n",
       "      <td>0</td>\n",
       "      <td>350.00</td>\n",
       "      <td>2.21</td>\n",
       "      <td>-65.72</td>\n",
       "      <td>https://upstreambio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disor...</td>\n",
       "      <td>22.00</td>\n",
       "      <td>20.25</td>\n",
       "      <td>-7.95</td>\n",
       "      <td>67</td>\n",
       "      <td>-6.45</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>ANAB</td>\n",
       "      <td>AnaptysBio Inc</td>\n",
       "      <td>2017-01-26</td>\n",
       "      <td>506.64</td>\n",
       "      <td>117</td>\n",
       "      <td>526.00</td>\n",
       "      <td>57.17</td>\n",
       "      <td>-139.45</td>\n",
       "      <td>https://www.anaptysbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 ...</td>\n",
       "      <td>17.00</td>\n",
       "      <td>15.59</td>\n",
       "      <td>-8.29</td>\n",
       "      <td>2882</td>\n",
       "      <td>-27.52</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>CTNM</td>\n",
       "      <td>Contineum Therapeutics Inc</td>\n",
       "      <td>2024-04-05</td>\n",
       "      <td>352.12</td>\n",
       "      <td>31</td>\n",
       "      <td>87.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-43.30</td>\n",
       "      <td>https://www.contineum-tx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapie...</td>\n",
       "      <td>15.40</td>\n",
       "      <td>14.03</td>\n",
       "      <td>-8.90</td>\n",
       "      <td>256</td>\n",
       "      <td>-12.30</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>RAPP</td>\n",
       "      <td>Rapport Therapeutics Inc</td>\n",
       "      <td>2024-06-07</td>\n",
       "      <td>678.86</td>\n",
       "      <td>0</td>\n",
       "      <td>152.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-73.70</td>\n",
       "      <td>https://www.rapportrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for p...</td>\n",
       "      <td>20.80</td>\n",
       "      <td>18.77</td>\n",
       "      <td>-9.76</td>\n",
       "      <td>193</td>\n",
       "      <td>-10.86</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>ARTV</td>\n",
       "      <td>Artiva Biotherapeutics Inc</td>\n",
       "      <td>2024-07-19</td>\n",
       "      <td>252.61</td>\n",
       "      <td>82</td>\n",
       "      <td>130.00</td>\n",
       "      <td>2.60</td>\n",
       "      <td>-58.57</td>\n",
       "      <td>https://www.artivabio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients ...</td>\n",
       "      <td>12.00</td>\n",
       "      <td>10.62</td>\n",
       "      <td>-11.50</td>\n",
       "      <td>151</td>\n",
       "      <td>-23.19</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>CSBR</td>\n",
       "      <td>Champions Oncology Inc</td>\n",
       "      <td>2007-02-02</td>\n",
       "      <td>84.96</td>\n",
       "      <td>210</td>\n",
       "      <td>25.00</td>\n",
       "      <td>51.66</td>\n",
       "      <td>-1.17</td>\n",
       "      <td>https://www.championsoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development i...</td>\n",
       "      <td>7.20</td>\n",
       "      <td>6.33</td>\n",
       "      <td>-12.08</td>\n",
       "      <td>6528</td>\n",
       "      <td>-1.38</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>CELC</td>\n",
       "      <td>Celcuity Inc</td>\n",
       "      <td>2017-09-20</td>\n",
       "      <td>465.98</td>\n",
       "      <td>55</td>\n",
       "      <td>252.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-85.28</td>\n",
       "      <td>https://www.celcuity.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors ...</td>\n",
       "      <td>14.29</td>\n",
       "      <td>12.52</td>\n",
       "      <td>-12.39</td>\n",
       "      <td>2645</td>\n",
       "      <td>-18.30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>HRMY</td>\n",
       "      <td>Harmony Biosciences Holdings Inc</td>\n",
       "      <td>2020-08-19</td>\n",
       "      <td>1885.45</td>\n",
       "      <td>246</td>\n",
       "      <td>771.00</td>\n",
       "      <td>681.88</td>\n",
       "      <td>199.56</td>\n",
       "      <td>https://www.harmonybiosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients wi...</td>\n",
       "      <td>37.01</td>\n",
       "      <td>32.39</td>\n",
       "      <td>-12.48</td>\n",
       "      <td>1581</td>\n",
       "      <td>10.58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>OMER</td>\n",
       "      <td>Omeros Corporation</td>\n",
       "      <td>2009-10-08</td>\n",
       "      <td>439.84</td>\n",
       "      <td>198</td>\n",
       "      <td>765.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-172.51</td>\n",
       "      <td>https://www.omeros.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, a...</td>\n",
       "      <td>8.73</td>\n",
       "      <td>7.63</td>\n",
       "      <td>-12.60</td>\n",
       "      <td>5549</td>\n",
       "      <td>-39.22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>ABVX</td>\n",
       "      <td>Abivax ADR</td>\n",
       "      <td>2023-10-20</td>\n",
       "      <td>500.36</td>\n",
       "      <td>62</td>\n",
       "      <td>131.00</td>\n",
       "      <td>9.03</td>\n",
       "      <td>-169.87</td>\n",
       "      <td>https://www.abivax.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ABIVAX Soci√©t√© Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mech...</td>\n",
       "      <td>8.30</td>\n",
       "      <td>7.11</td>\n",
       "      <td>-14.34</td>\n",
       "      <td>424</td>\n",
       "      <td>-33.95</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>INBX</td>\n",
       "      <td>Inhibrx Biosciences Inc</td>\n",
       "      <td>2024-06-04</td>\n",
       "      <td>210.77</td>\n",
       "      <td>166</td>\n",
       "      <td>79.00</td>\n",
       "      <td>1.69</td>\n",
       "      <td>-300.93</td>\n",
       "      <td>https://inhibrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-th...</td>\n",
       "      <td>17.21</td>\n",
       "      <td>14.62</td>\n",
       "      <td>-15.05</td>\n",
       "      <td>196</td>\n",
       "      <td>-142.78</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>WVE</td>\n",
       "      <td>Wave Life Sciences Ltd</td>\n",
       "      <td>2015-11-11</td>\n",
       "      <td>2051.39</td>\n",
       "      <td>266</td>\n",
       "      <td>1966.00</td>\n",
       "      <td>53.61</td>\n",
       "      <td>-147.98</td>\n",
       "      <td>https://www.wavelifesciences.com</td>\n",
       "      <td>Singapore</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PR...</td>\n",
       "      <td>16.00</td>\n",
       "      <td>13.44</td>\n",
       "      <td>-16.00</td>\n",
       "      <td>3324</td>\n",
       "      <td>-7.21</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>KOD</td>\n",
       "      <td>Kodiak Sciences Inc</td>\n",
       "      <td>2018-10-04</td>\n",
       "      <td>427.31</td>\n",
       "      <td>111</td>\n",
       "      <td>349.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-192.78</td>\n",
       "      <td>https://kodiak.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to t...</td>\n",
       "      <td>10.16</td>\n",
       "      <td>8.47</td>\n",
       "      <td>-16.63</td>\n",
       "      <td>2266</td>\n",
       "      <td>-45.11</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>REPL</td>\n",
       "      <td>Replimune Group Inc</td>\n",
       "      <td>2018-07-20</td>\n",
       "      <td>960.41</td>\n",
       "      <td>331</td>\n",
       "      <td>828.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-226.71</td>\n",
       "      <td>https://www.replimune.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The compan...</td>\n",
       "      <td>15.16</td>\n",
       "      <td>12.55</td>\n",
       "      <td>-17.22</td>\n",
       "      <td>2342</td>\n",
       "      <td>-23.61</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>URGN</td>\n",
       "      <td>UroGen Pharma Ltd</td>\n",
       "      <td>2017-05-04</td>\n",
       "      <td>476.85</td>\n",
       "      <td>217</td>\n",
       "      <td>559.00</td>\n",
       "      <td>89.36</td>\n",
       "      <td>-83.28</td>\n",
       "      <td>https://www.urogen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. I...</td>\n",
       "      <td>13.98</td>\n",
       "      <td>11.35</td>\n",
       "      <td>-18.81</td>\n",
       "      <td>2784</td>\n",
       "      <td>-17.46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>MBX</td>\n",
       "      <td>MBX Biosciences Inc</td>\n",
       "      <td>2024-09-13</td>\n",
       "      <td>639.61</td>\n",
       "      <td>38</td>\n",
       "      <td>130.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-59.35</td>\n",
       "      <td>https://mbxbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the...</td>\n",
       "      <td>23.65</td>\n",
       "      <td>18.94</td>\n",
       "      <td>-19.92</td>\n",
       "      <td>95</td>\n",
       "      <td>-9.28</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>CGON</td>\n",
       "      <td>Cg Oncology Inc</td>\n",
       "      <td>2024-01-25</td>\n",
       "      <td>1975.46</td>\n",
       "      <td>61</td>\n",
       "      <td>686.00</td>\n",
       "      <td>0.68</td>\n",
       "      <td>-95.94</td>\n",
       "      <td>https://cgoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CG Oncology, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing backbone bladder-sparing therapeutic...</td>\n",
       "      <td>37.17</td>\n",
       "      <td>28.76</td>\n",
       "      <td>-22.63</td>\n",
       "      <td>327</td>\n",
       "      <td>-4.86</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>CNTA</td>\n",
       "      <td>Centessa Pharmaceuticals plc ADR</td>\n",
       "      <td>2021-05-28</td>\n",
       "      <td>2208.40</td>\n",
       "      <td>76</td>\n",
       "      <td>556.00</td>\n",
       "      <td>6.85</td>\n",
       "      <td>-161.30</td>\n",
       "      <td>https://www.centessa.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipe...</td>\n",
       "      <td>21.75</td>\n",
       "      <td>16.57</td>\n",
       "      <td>-23.82</td>\n",
       "      <td>1299</td>\n",
       "      <td>-7.30</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>IMTX</td>\n",
       "      <td>Immatics N.V</td>\n",
       "      <td>2018-12-12</td>\n",
       "      <td>883.67</td>\n",
       "      <td>542</td>\n",
       "      <td>607.00</td>\n",
       "      <td>70.87</td>\n",
       "      <td>-95.19</td>\n",
       "      <td>https://www.immatics.com</td>\n",
       "      <td>Germany</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies...</td>\n",
       "      <td>9.60</td>\n",
       "      <td>7.21</td>\n",
       "      <td>-24.90</td>\n",
       "      <td>2197</td>\n",
       "      <td>-10.77</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>BCAX</td>\n",
       "      <td>Bicara Therapeutics Inc</td>\n",
       "      <td>2024-09-13</td>\n",
       "      <td>947.38</td>\n",
       "      <td>0</td>\n",
       "      <td>347.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-69.38</td>\n",
       "      <td>https://www.bicara.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficera...</td>\n",
       "      <td>23.41</td>\n",
       "      <td>17.50</td>\n",
       "      <td>-25.25</td>\n",
       "      <td>95</td>\n",
       "      <td>-7.32</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>TRDA</td>\n",
       "      <td>Entrada Therapeutics Inc</td>\n",
       "      <td>2021-10-29</td>\n",
       "      <td>673.93</td>\n",
       "      <td>177</td>\n",
       "      <td>138.00</td>\n",
       "      <td>215.23</td>\n",
       "      <td>61.30</td>\n",
       "      <td>https://www.entradatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of mult...</td>\n",
       "      <td>23.95</td>\n",
       "      <td>17.66</td>\n",
       "      <td>-26.26</td>\n",
       "      <td>1145</td>\n",
       "      <td>9.10</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>NTRB</td>\n",
       "      <td>Nutriband Inc</td>\n",
       "      <td>2021-10-01</td>\n",
       "      <td>49.42</td>\n",
       "      <td>0</td>\n",
       "      <td>32.00</td>\n",
       "      <td>2.02</td>\n",
       "      <td>-5.46</td>\n",
       "      <td>https://www.nutriband.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse...</td>\n",
       "      <td>5.74</td>\n",
       "      <td>4.14</td>\n",
       "      <td>-27.84</td>\n",
       "      <td>1173</td>\n",
       "      <td>-11.05</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>CAMP</td>\n",
       "      <td>CAMP4 Therapeutics Corp</td>\n",
       "      <td>2024-10-11</td>\n",
       "      <td>128.22</td>\n",
       "      <td>58</td>\n",
       "      <td>111.00</td>\n",
       "      <td>0.35</td>\n",
       "      <td>-49.62</td>\n",
       "      <td>https://www.camp4tx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a ra...</td>\n",
       "      <td>10.72</td>\n",
       "      <td>7.63</td>\n",
       "      <td>-28.82</td>\n",
       "      <td>67</td>\n",
       "      <td>-38.70</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>IBO</td>\n",
       "      <td>Impact BioMedical Inc</td>\n",
       "      <td>2024-09-16</td>\n",
       "      <td>26.69</td>\n",
       "      <td>1</td>\n",
       "      <td>81.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-2.82</td>\n",
       "      <td>https://www.impactbiomedinc.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healt...</td>\n",
       "      <td>2.68</td>\n",
       "      <td>1.89</td>\n",
       "      <td>-29.48</td>\n",
       "      <td>92</td>\n",
       "      <td>-10.57</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>LXEO</td>\n",
       "      <td>Lexeo Therapeutics Inc</td>\n",
       "      <td>2023-11-03</td>\n",
       "      <td>234.19</td>\n",
       "      <td>69</td>\n",
       "      <td>442.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-81.46</td>\n",
       "      <td>https://www.lexeotx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company devel...</td>\n",
       "      <td>10.05</td>\n",
       "      <td>6.88</td>\n",
       "      <td>-31.54</td>\n",
       "      <td>410</td>\n",
       "      <td>-34.78</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>ALDX</td>\n",
       "      <td>Aldeyra Therapeutics Inc</td>\n",
       "      <td>2014-05-02</td>\n",
       "      <td>301.32</td>\n",
       "      <td>9</td>\n",
       "      <td>475.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-49.39</td>\n",
       "      <td>https://www.aldeyra.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidat...</td>\n",
       "      <td>7.20</td>\n",
       "      <td>4.90</td>\n",
       "      <td>-31.94</td>\n",
       "      <td>3882</td>\n",
       "      <td>-16.39</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>GDTC</td>\n",
       "      <td>CytoMed Therapeutics Ltd</td>\n",
       "      <td>2023-04-14</td>\n",
       "      <td>30.58</td>\n",
       "      <td>0</td>\n",
       "      <td>19.00</td>\n",
       "      <td>0.45</td>\n",
       "      <td>-3.12</td>\n",
       "      <td>https://w2.cytomed.sg</td>\n",
       "      <td>Singapore</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment o...</td>\n",
       "      <td>4.00</td>\n",
       "      <td>2.72</td>\n",
       "      <td>-32.10</td>\n",
       "      <td>613</td>\n",
       "      <td>-10.20</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>IMCR</td>\n",
       "      <td>Immunocore Holdings plc ADR</td>\n",
       "      <td>2021-02-05</td>\n",
       "      <td>1467.46</td>\n",
       "      <td>497</td>\n",
       "      <td>259.00</td>\n",
       "      <td>296.31</td>\n",
       "      <td>-64.89</td>\n",
       "      <td>https://www.immunocore.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infe...</td>\n",
       "      <td>43.20</td>\n",
       "      <td>28.91</td>\n",
       "      <td>-33.08</td>\n",
       "      <td>1411</td>\n",
       "      <td>-4.42</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>THRD</td>\n",
       "      <td>Third Harmonic Bio Inc</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>501.05</td>\n",
       "      <td>51</td>\n",
       "      <td>261.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-52.79</td>\n",
       "      <td>https://www.thirdharmonicbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and ga...</td>\n",
       "      <td>17.00</td>\n",
       "      <td>11.26</td>\n",
       "      <td>-33.76</td>\n",
       "      <td>825</td>\n",
       "      <td>-10.54</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>OCUL</td>\n",
       "      <td>Ocular Therapeutix Inc</td>\n",
       "      <td>2014-07-25</td>\n",
       "      <td>1411.81</td>\n",
       "      <td>267</td>\n",
       "      <td>1177.00</td>\n",
       "      <td>61.10</td>\n",
       "      <td>-110.75</td>\n",
       "      <td>https://www.ocutx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases an...</td>\n",
       "      <td>13.15</td>\n",
       "      <td>8.69</td>\n",
       "      <td>-33.92</td>\n",
       "      <td>3798</td>\n",
       "      <td>-7.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>KAPA</td>\n",
       "      <td>Kairos Pharma Ltd</td>\n",
       "      <td>2024-09-16</td>\n",
       "      <td>21.39</td>\n",
       "      <td>0</td>\n",
       "      <td>337.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-1.73</td>\n",
       "      <td>https://kairospharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients. Its therapeutics include antibodies an...</td>\n",
       "      <td>2.60</td>\n",
       "      <td>1.70</td>\n",
       "      <td>-34.62</td>\n",
       "      <td>92</td>\n",
       "      <td>-8.09</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>FOLD</td>\n",
       "      <td>Amicus Therapeutics Inc</td>\n",
       "      <td>2007-05-31</td>\n",
       "      <td>2958.18</td>\n",
       "      <td>500</td>\n",
       "      <td>2630.00</td>\n",
       "      <td>493.67</td>\n",
       "      <td>23.09</td>\n",
       "      <td>https://amicusrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial...</td>\n",
       "      <td>14.43</td>\n",
       "      <td>9.36</td>\n",
       "      <td>-35.14</td>\n",
       "      <td>6410</td>\n",
       "      <td>0.78</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>MLYS</td>\n",
       "      <td>Mineralys Therapeutics Inc</td>\n",
       "      <td>2023-02-10</td>\n",
       "      <td>605.19</td>\n",
       "      <td>28</td>\n",
       "      <td>175.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://mineralystx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kid...</td>\n",
       "      <td>18.44</td>\n",
       "      <td>11.90</td>\n",
       "      <td>-35.47</td>\n",
       "      <td>676</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>KURA</td>\n",
       "      <td>Kura Oncology Inc</td>\n",
       "      <td>2015-09-16</td>\n",
       "      <td>775.69</td>\n",
       "      <td>142</td>\n",
       "      <td>1354.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-216.64</td>\n",
       "      <td>https://kuraoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists o...</td>\n",
       "      <td>15.00</td>\n",
       "      <td>9.63</td>\n",
       "      <td>-35.80</td>\n",
       "      <td>3380</td>\n",
       "      <td>-27.93</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>PLRZ</td>\n",
       "      <td>Polyrizon Ltd</td>\n",
       "      <td>2024-10-29</td>\n",
       "      <td>4.19</td>\n",
       "      <td>0</td>\n",
       "      <td>351.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-0.65</td>\n",
       "      <td>https://www.polyrizon-biotech.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses ...</td>\n",
       "      <td>1.55</td>\n",
       "      <td>0.99</td>\n",
       "      <td>-36.06</td>\n",
       "      <td>49</td>\n",
       "      <td>-15.51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>PHVS</td>\n",
       "      <td>Pharvaris NV</td>\n",
       "      <td>2021-02-05</td>\n",
       "      <td>1003.31</td>\n",
       "      <td>83</td>\n",
       "      <td>100.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-116.10</td>\n",
       "      <td>https://pharvaris.com</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The c...</td>\n",
       "      <td>29.00</td>\n",
       "      <td>18.40</td>\n",
       "      <td>-36.55</td>\n",
       "      <td>1411</td>\n",
       "      <td>-11.57</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>ALMS</td>\n",
       "      <td>Alumis Inc</td>\n",
       "      <td>2024-06-28</td>\n",
       "      <td>466.81</td>\n",
       "      <td>107</td>\n",
       "      <td>157.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-239.06</td>\n",
       "      <td>https://www.alumis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. I...</td>\n",
       "      <td>13.30</td>\n",
       "      <td>8.39</td>\n",
       "      <td>-36.92</td>\n",
       "      <td>172</td>\n",
       "      <td>-51.21</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>FTRE</td>\n",
       "      <td>Fortrea Holdings Inc</td>\n",
       "      <td>2023-06-20</td>\n",
       "      <td>1821.81</td>\n",
       "      <td>15500</td>\n",
       "      <td>1574.00</td>\n",
       "      <td>2975.60</td>\n",
       "      <td>27.10</td>\n",
       "      <td>https://www.fortrea.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device develo...</td>\n",
       "      <td>32.00</td>\n",
       "      <td>20.00</td>\n",
       "      <td>-37.50</td>\n",
       "      <td>546</td>\n",
       "      <td>1.49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>PLRX</td>\n",
       "      <td>Pliant Therapeutics Inc</td>\n",
       "      <td>2020-06-03</td>\n",
       "      <td>834.91</td>\n",
       "      <td>166</td>\n",
       "      <td>452.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-219.95</td>\n",
       "      <td>https://pliantrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment o...</td>\n",
       "      <td>21.30</td>\n",
       "      <td>13.30</td>\n",
       "      <td>-37.56</td>\n",
       "      <td>1658</td>\n",
       "      <td>-26.34</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>PSTX</td>\n",
       "      <td>Poseida Therapeutics Inc</td>\n",
       "      <td>2020-07-10</td>\n",
       "      <td>926.91</td>\n",
       "      <td>350</td>\n",
       "      <td>1215.00</td>\n",
       "      <td>150.86</td>\n",
       "      <td>-57.02</td>\n",
       "      <td>https://poseida.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical ne...</td>\n",
       "      <td>15.35</td>\n",
       "      <td>9.51</td>\n",
       "      <td>-38.05</td>\n",
       "      <td>1621</td>\n",
       "      <td>-6.15</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>ENGN</td>\n",
       "      <td>enGene Holdings Inc</td>\n",
       "      <td>2022-02-01</td>\n",
       "      <td>321.15</td>\n",
       "      <td>31</td>\n",
       "      <td>212.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-55.00</td>\n",
       "      <td>https://www.engene.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines thro...</td>\n",
       "      <td>9.86</td>\n",
       "      <td>6.08</td>\n",
       "      <td>-38.34</td>\n",
       "      <td>1050</td>\n",
       "      <td>-17.13</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>RPRX</td>\n",
       "      <td>Royalty Pharma plc</td>\n",
       "      <td>2020-06-16</td>\n",
       "      <td>14729.57</td>\n",
       "      <td>0</td>\n",
       "      <td>2526.00</td>\n",
       "      <td>2266.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.royaltypharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United ...</td>\n",
       "      <td>40.35</td>\n",
       "      <td>24.84</td>\n",
       "      <td>-38.43</td>\n",
       "      <td>1645</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>NMRA</td>\n",
       "      <td>Neumora Therapeutics Inc</td>\n",
       "      <td>2023-09-14</td>\n",
       "      <td>1756.17</td>\n",
       "      <td>124</td>\n",
       "      <td>1168.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-250.00</td>\n",
       "      <td>https://www.neumoratx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsyc...</td>\n",
       "      <td>17.00</td>\n",
       "      <td>10.32</td>\n",
       "      <td>-39.29</td>\n",
       "      <td>460</td>\n",
       "      <td>-14.24</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>INMB</td>\n",
       "      <td>INmune Bio Inc</td>\n",
       "      <td>2019-02-04</td>\n",
       "      <td>112.64</td>\n",
       "      <td>11</td>\n",
       "      <td>238.00</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.inmunebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease...</td>\n",
       "      <td>7.99</td>\n",
       "      <td>4.75</td>\n",
       "      <td>-40.55</td>\n",
       "      <td>2143</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>NTLA</td>\n",
       "      <td>Intellia Therapeutics Inc</td>\n",
       "      <td>2016-05-06</td>\n",
       "      <td>1362.74</td>\n",
       "      <td>526</td>\n",
       "      <td>2485.00</td>\n",
       "      <td>43.09</td>\n",
       "      <td>-527.52</td>\n",
       "      <td>https://www.intelliatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include...</td>\n",
       "      <td>22.10</td>\n",
       "      <td>12.90</td>\n",
       "      <td>-41.63</td>\n",
       "      <td>3147</td>\n",
       "      <td>-38.71</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>ARQT</td>\n",
       "      <td>Arcutis Biotherapeutics Inc</td>\n",
       "      <td>2020-01-31</td>\n",
       "      <td>1588.30</td>\n",
       "      <td>296</td>\n",
       "      <td>2045.00</td>\n",
       "      <td>138.71</td>\n",
       "      <td>-179.41</td>\n",
       "      <td>https://www.arcutis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its ...</td>\n",
       "      <td>21.80</td>\n",
       "      <td>12.69</td>\n",
       "      <td>-41.79</td>\n",
       "      <td>1782</td>\n",
       "      <td>-11.30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>MREO</td>\n",
       "      <td>Mereo Biopharma Group Plc ADR</td>\n",
       "      <td>2019-04-24</td>\n",
       "      <td>535.25</td>\n",
       "      <td>33</td>\n",
       "      <td>712.00</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-37.48</td>\n",
       "      <td>https://www.mereobiopharma.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases i...</td>\n",
       "      <td>6.50</td>\n",
       "      <td>3.74</td>\n",
       "      <td>-42.46</td>\n",
       "      <td>2064</td>\n",
       "      <td>-7.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>TYRA</td>\n",
       "      <td>Tyra Biosciences Inc</td>\n",
       "      <td>2021-09-15</td>\n",
       "      <td>762.08</td>\n",
       "      <td>49</td>\n",
       "      <td>341.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-99.59</td>\n",
       "      <td>https://tyra.bio</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology ...</td>\n",
       "      <td>26.00</td>\n",
       "      <td>14.94</td>\n",
       "      <td>-42.54</td>\n",
       "      <td>1189</td>\n",
       "      <td>-13.07</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>MESO</td>\n",
       "      <td>Mesoblast Ltd ADR</td>\n",
       "      <td>2010-01-20</td>\n",
       "      <td>1380.90</td>\n",
       "      <td>73</td>\n",
       "      <td>215.00</td>\n",
       "      <td>5.90</td>\n",
       "      <td>-56.08</td>\n",
       "      <td>https://www.mesoblast.com</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its pr...</td>\n",
       "      <td>20.50</td>\n",
       "      <td>11.76</td>\n",
       "      <td>-42.63</td>\n",
       "      <td>5445</td>\n",
       "      <td>-4.06</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>AURA</td>\n",
       "      <td>Aura Biosciences Inc</td>\n",
       "      <td>2021-10-29</td>\n",
       "      <td>444.07</td>\n",
       "      <td>88</td>\n",
       "      <td>199.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-91.84</td>\n",
       "      <td>https://www.aurabiosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's...</td>\n",
       "      <td>14.80</td>\n",
       "      <td>8.41</td>\n",
       "      <td>-43.18</td>\n",
       "      <td>1145</td>\n",
       "      <td>-20.68</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>TLSA</td>\n",
       "      <td>Tiziana Life Sciences Ltd</td>\n",
       "      <td>2018-11-20</td>\n",
       "      <td>96.49</td>\n",
       "      <td>9</td>\n",
       "      <td>272.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.79</td>\n",
       "      <td>https://www.tizianalifesciences.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and ...</td>\n",
       "      <td>1.67</td>\n",
       "      <td>0.94</td>\n",
       "      <td>-43.74</td>\n",
       "      <td>2219</td>\n",
       "      <td>-16.36</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>CRMD</td>\n",
       "      <td>CorMedix Inc</td>\n",
       "      <td>2010-05-13</td>\n",
       "      <td>504.23</td>\n",
       "      <td>82</td>\n",
       "      <td>1174.00</td>\n",
       "      <td>12.26</td>\n",
       "      <td>-50.77</td>\n",
       "      <td>https://www.cormedix.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of inf...</td>\n",
       "      <td>15.00</td>\n",
       "      <td>8.38</td>\n",
       "      <td>-44.13</td>\n",
       "      <td>5332</td>\n",
       "      <td>-10.07</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>IMMX</td>\n",
       "      <td>Immix Biopharma Inc</td>\n",
       "      <td>2021-12-16</td>\n",
       "      <td>53.64</td>\n",
       "      <td>14</td>\n",
       "      <td>166.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.18</td>\n",
       "      <td>https://www.immixbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysre...</td>\n",
       "      <td>3.67</td>\n",
       "      <td>2.04</td>\n",
       "      <td>-44.41</td>\n",
       "      <td>1097</td>\n",
       "      <td>-37.62</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>ANVS</td>\n",
       "      <td>Annovis Bio Inc</td>\n",
       "      <td>2020-01-29</td>\n",
       "      <td>68.99</td>\n",
       "      <td>6</td>\n",
       "      <td>269.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.annovisbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Bunt...</td>\n",
       "      <td>9.59</td>\n",
       "      <td>5.31</td>\n",
       "      <td>-44.63</td>\n",
       "      <td>1784</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>ABUS</td>\n",
       "      <td>Arbutus Biopharma Corp</td>\n",
       "      <td>2007-07-26</td>\n",
       "      <td>672.70</td>\n",
       "      <td>73</td>\n",
       "      <td>974.00</td>\n",
       "      <td>6.74</td>\n",
       "      <td>-77.14</td>\n",
       "      <td>https://www.arbutusbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the Unite...</td>\n",
       "      <td>6.30</td>\n",
       "      <td>3.48</td>\n",
       "      <td>-44.76</td>\n",
       "      <td>6354</td>\n",
       "      <td>-11.47</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>DAWN</td>\n",
       "      <td>Day One Biopharmaceuticals Inc</td>\n",
       "      <td>2021-05-27</td>\n",
       "      <td>1272.68</td>\n",
       "      <td>174</td>\n",
       "      <td>1107.00</td>\n",
       "      <td>101.95</td>\n",
       "      <td>-205.50</td>\n",
       "      <td>https://dayonebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with gen...</td>\n",
       "      <td>23.50</td>\n",
       "      <td>12.75</td>\n",
       "      <td>-45.74</td>\n",
       "      <td>1300</td>\n",
       "      <td>-16.15</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>PHAR</td>\n",
       "      <td>Pharming Group N.V. ADR</td>\n",
       "      <td>2020-12-23</td>\n",
       "      <td>614.52</td>\n",
       "      <td>382</td>\n",
       "      <td>7.00</td>\n",
       "      <td>285.74</td>\n",
       "      <td>-3.06</td>\n",
       "      <td>https://www.pharming.com</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatm...</td>\n",
       "      <td>16.70</td>\n",
       "      <td>8.98</td>\n",
       "      <td>-46.22</td>\n",
       "      <td>1455</td>\n",
       "      <td>-0.50</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>VIR</td>\n",
       "      <td>Vir Biotechnology Inc</td>\n",
       "      <td>2019-10-11</td>\n",
       "      <td>1041.16</td>\n",
       "      <td>587</td>\n",
       "      <td>1226.00</td>\n",
       "      <td>78.62</td>\n",
       "      <td>-533.94</td>\n",
       "      <td>https://www.vir.bio</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical devel...</td>\n",
       "      <td>14.02</td>\n",
       "      <td>7.45</td>\n",
       "      <td>-46.86</td>\n",
       "      <td>1894</td>\n",
       "      <td>-51.28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>PRTC</td>\n",
       "      <td>PureTech Health Plc ADR</td>\n",
       "      <td>2020-11-16</td>\n",
       "      <td>530.32</td>\n",
       "      <td>90</td>\n",
       "      <td>5.00</td>\n",
       "      <td>0.47</td>\n",
       "      <td>-134.73</td>\n",
       "      <td>https://www.puretechhealth.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The comp...</td>\n",
       "      <td>38.50</td>\n",
       "      <td>20.35</td>\n",
       "      <td>-47.14</td>\n",
       "      <td>1492</td>\n",
       "      <td>-25.41</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>TRVI</td>\n",
       "      <td>Trevi Therapeutics Inc</td>\n",
       "      <td>2019-05-07</td>\n",
       "      <td>325.91</td>\n",
       "      <td>27</td>\n",
       "      <td>1607.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-48.07</td>\n",
       "      <td>https://www.trevitherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the ...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>4.17</td>\n",
       "      <td>-47.15</td>\n",
       "      <td>2051</td>\n",
       "      <td>-14.75</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>GERN</td>\n",
       "      <td>Geron Corp</td>\n",
       "      <td>1996-07-31</td>\n",
       "      <td>2303.15</td>\n",
       "      <td>141</td>\n",
       "      <td>8245.00</td>\n",
       "      <td>29.48</td>\n",
       "      <td>-207.45</td>\n",
       "      <td>https://www.geron.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid h...</td>\n",
       "      <td>7.33</td>\n",
       "      <td>3.86</td>\n",
       "      <td>-47.30</td>\n",
       "      <td>10366</td>\n",
       "      <td>-9.01</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>ICCC</td>\n",
       "      <td>Immucell Corp</td>\n",
       "      <td>1987-05-05</td>\n",
       "      <td>41.80</td>\n",
       "      <td>75</td>\n",
       "      <td>19.00</td>\n",
       "      <td>23.22</td>\n",
       "      <td>-0.63</td>\n",
       "      <td>https://immucell.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and b...</td>\n",
       "      <td>9.38</td>\n",
       "      <td>4.92</td>\n",
       "      <td>-47.52</td>\n",
       "      <td>13741</td>\n",
       "      <td>-1.51</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>VERU</td>\n",
       "      <td>Veru Inc</td>\n",
       "      <td>1999-02-11</td>\n",
       "      <td>114.97</td>\n",
       "      <td>189</td>\n",
       "      <td>833.00</td>\n",
       "      <td>14.09</td>\n",
       "      <td>-65.04</td>\n",
       "      <td>https://verupharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acu...</td>\n",
       "      <td>1.38</td>\n",
       "      <td>0.72</td>\n",
       "      <td>-47.77</td>\n",
       "      <td>9441</td>\n",
       "      <td>-56.57</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>CRVS</td>\n",
       "      <td>Corvus Pharmaceuticals Inc</td>\n",
       "      <td>2016-03-23</td>\n",
       "      <td>443.38</td>\n",
       "      <td>28</td>\n",
       "      <td>785.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.28</td>\n",
       "      <td>https://www.corvuspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator pro...</td>\n",
       "      <td>14.25</td>\n",
       "      <td>7.38</td>\n",
       "      <td>-48.21</td>\n",
       "      <td>3191</td>\n",
       "      <td>-5.25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>FENC</td>\n",
       "      <td>Fennec Pharmaceuticals Inc</td>\n",
       "      <td>2017-09-15</td>\n",
       "      <td>164.08</td>\n",
       "      <td>29</td>\n",
       "      <td>122.00</td>\n",
       "      <td>49.35</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.fennecpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a form...</td>\n",
       "      <td>12.00</td>\n",
       "      <td>6.05</td>\n",
       "      <td>-49.58</td>\n",
       "      <td>2650</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>RCKT</td>\n",
       "      <td>Rocket Pharmaceuticals Inc</td>\n",
       "      <td>2015-02-18</td>\n",
       "      <td>1250.52</td>\n",
       "      <td>268</td>\n",
       "      <td>1029.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-264.84</td>\n",
       "      <td>https://www.rocketpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene thera...</td>\n",
       "      <td>24.00</td>\n",
       "      <td>12.02</td>\n",
       "      <td>-49.92</td>\n",
       "      <td>3590</td>\n",
       "      <td>-21.18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>LEXX</td>\n",
       "      <td>Lexaria Bioscience Corp</td>\n",
       "      <td>2021-01-12</td>\n",
       "      <td>37.70</td>\n",
       "      <td>5</td>\n",
       "      <td>144.00</td>\n",
       "      <td>0.41</td>\n",
       "      <td>-4.53</td>\n",
       "      <td>https://lexariabioscience.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, whic...</td>\n",
       "      <td>4.48</td>\n",
       "      <td>2.24</td>\n",
       "      <td>-50.00</td>\n",
       "      <td>1435</td>\n",
       "      <td>-12.02</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>IPHA</td>\n",
       "      <td>Innate Pharma ADR</td>\n",
       "      <td>2019-10-17</td>\n",
       "      <td>196.20</td>\n",
       "      <td>168</td>\n",
       "      <td>460.00</td>\n",
       "      <td>33.79</td>\n",
       "      <td>-35.96</td>\n",
       "      <td>https://www.innate-pharma.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products in...</td>\n",
       "      <td>6.05</td>\n",
       "      <td>3.02</td>\n",
       "      <td>-50.08</td>\n",
       "      <td>1888</td>\n",
       "      <td>-18.33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>CYTK</td>\n",
       "      <td>Cytokinetics Inc</td>\n",
       "      <td>2004-04-30</td>\n",
       "      <td>5785.05</td>\n",
       "      <td>423</td>\n",
       "      <td>1198.00</td>\n",
       "      <td>3.22</td>\n",
       "      <td>-511.14</td>\n",
       "      <td>https://www.cytokinetics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and ...</td>\n",
       "      <td>97.56</td>\n",
       "      <td>48.65</td>\n",
       "      <td>-50.13</td>\n",
       "      <td>7536</td>\n",
       "      <td>-8.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>ZBIO</td>\n",
       "      <td>Zenas Biopharma Inc</td>\n",
       "      <td>2024-09-13</td>\n",
       "      <td>366.51</td>\n",
       "      <td>0</td>\n",
       "      <td>210.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-132.91</td>\n",
       "      <td>https://zenasbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-b...</td>\n",
       "      <td>18.15</td>\n",
       "      <td>8.92</td>\n",
       "      <td>-50.85</td>\n",
       "      <td>95</td>\n",
       "      <td>-36.26</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>VNDA</td>\n",
       "      <td>Vanda Pharmaceuticals Inc</td>\n",
       "      <td>2006-04-12</td>\n",
       "      <td>269.97</td>\n",
       "      <td>203</td>\n",
       "      <td>682.00</td>\n",
       "      <td>190.86</td>\n",
       "      <td>-30.16</td>\n",
       "      <td>https://www.vandapharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medic...</td>\n",
       "      <td>9.68</td>\n",
       "      <td>4.61</td>\n",
       "      <td>-52.38</td>\n",
       "      <td>6824</td>\n",
       "      <td>-11.17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>SPRY</td>\n",
       "      <td>ARS Pharmaceuticals Inc</td>\n",
       "      <td>2020-12-04</td>\n",
       "      <td>1155.05</td>\n",
       "      <td>24</td>\n",
       "      <td>1074.00</td>\n",
       "      <td>2.57</td>\n",
       "      <td>-60.44</td>\n",
       "      <td>https://ars-pharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a need...</td>\n",
       "      <td>25.00</td>\n",
       "      <td>11.90</td>\n",
       "      <td>-52.40</td>\n",
       "      <td>1474</td>\n",
       "      <td>-5.23</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>STOK</td>\n",
       "      <td>Stoke Therapeutics Inc</td>\n",
       "      <td>2019-06-19</td>\n",
       "      <td>648.32</td>\n",
       "      <td>110</td>\n",
       "      <td>574.00</td>\n",
       "      <td>16.74</td>\n",
       "      <td>-115.03</td>\n",
       "      <td>https://www.stoketherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases i...</td>\n",
       "      <td>25.57</td>\n",
       "      <td>12.06</td>\n",
       "      <td>-52.84</td>\n",
       "      <td>2008</td>\n",
       "      <td>-17.74</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>CALC</td>\n",
       "      <td>CalciMedica Inc</td>\n",
       "      <td>2023-06-14</td>\n",
       "      <td>37.88</td>\n",
       "      <td>13</td>\n",
       "      <td>60.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.39</td>\n",
       "      <td>https://www.calcimedica.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunol...</td>\n",
       "      <td>5.84</td>\n",
       "      <td>2.73</td>\n",
       "      <td>-53.25</td>\n",
       "      <td>552</td>\n",
       "      <td>-56.47</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>GNTA</td>\n",
       "      <td>Genenta Science SpA ADR</td>\n",
       "      <td>2021-12-15</td>\n",
       "      <td>96.94</td>\n",
       "      <td>14</td>\n",
       "      <td>14.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-9.41</td>\n",
       "      <td>https://www.genenta.com</td>\n",
       "      <td>Italy</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treat...</td>\n",
       "      <td>11.00</td>\n",
       "      <td>5.13</td>\n",
       "      <td>-53.36</td>\n",
       "      <td>1098</td>\n",
       "      <td>-9.71</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>OBIO</td>\n",
       "      <td>Orchestra BioMed Holdings Inc</td>\n",
       "      <td>2020-08-04</td>\n",
       "      <td>193.49</td>\n",
       "      <td>56</td>\n",
       "      <td>55.00</td>\n",
       "      <td>2.65</td>\n",
       "      <td>-59.81</td>\n",
       "      <td>https://orchestrabiomed.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Ne...</td>\n",
       "      <td>11.40</td>\n",
       "      <td>5.26</td>\n",
       "      <td>-53.86</td>\n",
       "      <td>1596</td>\n",
       "      <td>-30.91</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>MAIA</td>\n",
       "      <td>MAIA Biotechnology Inc</td>\n",
       "      <td>2022-07-28</td>\n",
       "      <td>55.73</td>\n",
       "      <td>13</td>\n",
       "      <td>121.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://maiabiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechan...</td>\n",
       "      <td>4.46</td>\n",
       "      <td>2.00</td>\n",
       "      <td>-55.16</td>\n",
       "      <td>873</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>INSM</td>\n",
       "      <td>Insmed Inc</td>\n",
       "      <td>2000-06-01</td>\n",
       "      <td>13129.69</td>\n",
       "      <td>912</td>\n",
       "      <td>1549.00</td>\n",
       "      <td>342.96</td>\n",
       "      <td>-695.06</td>\n",
       "      <td>https://www.insmed.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United ...</td>\n",
       "      <td>165.00</td>\n",
       "      <td>71.63</td>\n",
       "      <td>-56.59</td>\n",
       "      <td>8965</td>\n",
       "      <td>-5.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>TBPH</td>\n",
       "      <td>Theravance Biopharma Inc</td>\n",
       "      <td>2014-05-16</td>\n",
       "      <td>481.91</td>\n",
       "      <td>99</td>\n",
       "      <td>197.00</td>\n",
       "      <td>63.19</td>\n",
       "      <td>-38.24</td>\n",
       "      <td>https://www.theravance.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Eu...</td>\n",
       "      <td>22.96</td>\n",
       "      <td>9.88</td>\n",
       "      <td>-56.97</td>\n",
       "      <td>3868</td>\n",
       "      <td>-7.94</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>ACRV</td>\n",
       "      <td>Acrivon Therapeutics Inc</td>\n",
       "      <td>2022-11-15</td>\n",
       "      <td>217.95</td>\n",
       "      <td>58</td>\n",
       "      <td>73.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-75.56</td>\n",
       "      <td>https://www.acrivon.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are...</td>\n",
       "      <td>16.64</td>\n",
       "      <td>7.06</td>\n",
       "      <td>-57.57</td>\n",
       "      <td>763</td>\n",
       "      <td>-34.67</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>HUMA</td>\n",
       "      <td>Humacyte Inc</td>\n",
       "      <td>2020-12-01</td>\n",
       "      <td>558.42</td>\n",
       "      <td>183</td>\n",
       "      <td>3063.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-105.28</td>\n",
       "      <td>https://www.humacyte.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of dise...</td>\n",
       "      <td>9.67</td>\n",
       "      <td>4.10</td>\n",
       "      <td>-57.60</td>\n",
       "      <td>1477</td>\n",
       "      <td>-18.85</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>CDXS</td>\n",
       "      <td>Codexis Inc</td>\n",
       "      <td>2010-04-22</td>\n",
       "      <td>456.53</td>\n",
       "      <td>174</td>\n",
       "      <td>718.00</td>\n",
       "      <td>64.45</td>\n",
       "      <td>-45.78</td>\n",
       "      <td>https://www.codexis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel ...</td>\n",
       "      <td>13.26</td>\n",
       "      <td>5.53</td>\n",
       "      <td>-58.30</td>\n",
       "      <td>5353</td>\n",
       "      <td>-10.03</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>NRXS</td>\n",
       "      <td>Neuraxis Inc</td>\n",
       "      <td>2023-08-09</td>\n",
       "      <td>17.52</td>\n",
       "      <td>19</td>\n",
       "      <td>18.00</td>\n",
       "      <td>2.27</td>\n",
       "      <td>-8.65</td>\n",
       "      <td>https://neuraxis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in ch...</td>\n",
       "      <td>6.00</td>\n",
       "      <td>2.48</td>\n",
       "      <td>-58.67</td>\n",
       "      <td>496</td>\n",
       "      <td>-49.37</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>CLGN</td>\n",
       "      <td>CollPlant Biotechnologies Ltd</td>\n",
       "      <td>2018-01-31</td>\n",
       "      <td>41.51</td>\n",
       "      <td>75</td>\n",
       "      <td>13.00</td>\n",
       "      <td>0.69</td>\n",
       "      <td>-17.31</td>\n",
       "      <td>https://www.collplant.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs...</td>\n",
       "      <td>8.95</td>\n",
       "      <td>3.69</td>\n",
       "      <td>-58.77</td>\n",
       "      <td>2512</td>\n",
       "      <td>-41.70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>MGTX</td>\n",
       "      <td>MeiraGTx Holdings plc</td>\n",
       "      <td>2018-06-08</td>\n",
       "      <td>490.80</td>\n",
       "      <td>387</td>\n",
       "      <td>295.00</td>\n",
       "      <td>8.12</td>\n",
       "      <td>-155.31</td>\n",
       "      <td>https://meiragtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company de...</td>\n",
       "      <td>15.00</td>\n",
       "      <td>6.12</td>\n",
       "      <td>-59.20</td>\n",
       "      <td>2384</td>\n",
       "      <td>-31.64</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>ITOS</td>\n",
       "      <td>ITeos Therapeutics Inc</td>\n",
       "      <td>2020-07-24</td>\n",
       "      <td>283.87</td>\n",
       "      <td>157</td>\n",
       "      <td>591.00</td>\n",
       "      <td>35.00</td>\n",
       "      <td>-144.95</td>\n",
       "      <td>https://www.iteostherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for...</td>\n",
       "      <td>19.05</td>\n",
       "      <td>7.68</td>\n",
       "      <td>-59.69</td>\n",
       "      <td>1607</td>\n",
       "      <td>-51.06</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>GHRS</td>\n",
       "      <td>GH Research PLC</td>\n",
       "      <td>2021-06-25</td>\n",
       "      <td>426.63</td>\n",
       "      <td>49</td>\n",
       "      <td>63.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-45.53</td>\n",
       "      <td>https://www.ghres.com</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurol...</td>\n",
       "      <td>19.25</td>\n",
       "      <td>7.74</td>\n",
       "      <td>-59.79</td>\n",
       "      <td>1271</td>\n",
       "      <td>-10.67</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>YMAB</td>\n",
       "      <td>Y-Mabs Therapeutics Inc</td>\n",
       "      <td>2018-09-21</td>\n",
       "      <td>444.31</td>\n",
       "      <td>100</td>\n",
       "      <td>246.00</td>\n",
       "      <td>84.55</td>\n",
       "      <td>-23.35</td>\n",
       "      <td>https://www.ymabs.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therap...</td>\n",
       "      <td>24.00</td>\n",
       "      <td>9.43</td>\n",
       "      <td>-60.71</td>\n",
       "      <td>2279</td>\n",
       "      <td>-5.26</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>201</th>\n",
       "      <td>CGEM</td>\n",
       "      <td>Cullinan Therapeutics Inc</td>\n",
       "      <td>2021-01-08</td>\n",
       "      <td>687.09</td>\n",
       "      <td>85</td>\n",
       "      <td>540.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-187.05</td>\n",
       "      <td>https://cullinantherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cullinan Therapeutics, Inc., a biopharmaceutical company, focuses on developing oncology therapies for cancer patients in the United States. The c...</td>\n",
       "      <td>29.91</td>\n",
       "      <td>11.75</td>\n",
       "      <td>-60.72</td>\n",
       "      <td>1439</td>\n",
       "      <td>-27.22</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>OABI</td>\n",
       "      <td>OmniAb Inc</td>\n",
       "      <td>2021-09-30</td>\n",
       "      <td>458.64</td>\n",
       "      <td>106</td>\n",
       "      <td>407.00</td>\n",
       "      <td>20.41</td>\n",
       "      <td>-58.73</td>\n",
       "      <td>https://www.omniab.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States....</td>\n",
       "      <td>9.76</td>\n",
       "      <td>3.79</td>\n",
       "      <td>-61.17</td>\n",
       "      <td>1174</td>\n",
       "      <td>-12.81</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>203</th>\n",
       "      <td>GNLX</td>\n",
       "      <td>Genelux Corp</td>\n",
       "      <td>2023-01-26</td>\n",
       "      <td>81.51</td>\n",
       "      <td>24</td>\n",
       "      <td>163.00</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-26.96</td>\n",
       "      <td>https://www.genelux.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patient...</td>\n",
       "      <td>6.15</td>\n",
       "      <td>2.33</td>\n",
       "      <td>-62.11</td>\n",
       "      <td>691</td>\n",
       "      <td>-33.08</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>ARDX</td>\n",
       "      <td>Ardelyx Inc</td>\n",
       "      <td>2014-06-19</td>\n",
       "      <td>1276.64</td>\n",
       "      <td>267</td>\n",
       "      <td>4062.00</td>\n",
       "      <td>251.85</td>\n",
       "      <td>-62.15</td>\n",
       "      <td>https://www.ardelyx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeuti...</td>\n",
       "      <td>14.11</td>\n",
       "      <td>5.22</td>\n",
       "      <td>-63.00</td>\n",
       "      <td>3834</td>\n",
       "      <td>-4.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>ETNB</td>\n",
       "      <td>89bio Inc</td>\n",
       "      <td>2019-11-11</td>\n",
       "      <td>928.90</td>\n",
       "      <td>70</td>\n",
       "      <td>797.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-303.81</td>\n",
       "      <td>https://www.89bio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver ...</td>\n",
       "      <td>20.80</td>\n",
       "      <td>7.69</td>\n",
       "      <td>-63.03</td>\n",
       "      <td>1863</td>\n",
       "      <td>-32.71</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>SVRA</td>\n",
       "      <td>Savara Inc</td>\n",
       "      <td>2017-04-28</td>\n",
       "      <td>559.48</td>\n",
       "      <td>37</td>\n",
       "      <td>1515.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-88.72</td>\n",
       "      <td>https://www.savarapharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramosti...</td>\n",
       "      <td>8.76</td>\n",
       "      <td>3.21</td>\n",
       "      <td>-63.36</td>\n",
       "      <td>2790</td>\n",
       "      <td>-15.86</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>TERN</td>\n",
       "      <td>Terns Pharmaceuticals Inc</td>\n",
       "      <td>2021-02-05</td>\n",
       "      <td>592.87</td>\n",
       "      <td>66</td>\n",
       "      <td>1529.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-99.66</td>\n",
       "      <td>https://www.ternspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology,...</td>\n",
       "      <td>18.39</td>\n",
       "      <td>6.73</td>\n",
       "      <td>-63.40</td>\n",
       "      <td>1411</td>\n",
       "      <td>-16.81</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>PEPG</td>\n",
       "      <td>PepGen Inc</td>\n",
       "      <td>2022-05-06</td>\n",
       "      <td>147.01</td>\n",
       "      <td>76</td>\n",
       "      <td>136.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-92.73</td>\n",
       "      <td>https://pepgen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe...</td>\n",
       "      <td>12.89</td>\n",
       "      <td>4.68</td>\n",
       "      <td>-63.69</td>\n",
       "      <td>956</td>\n",
       "      <td>-63.08</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>THTX</td>\n",
       "      <td>Theratechnologies Inc</td>\n",
       "      <td>2009-02-13</td>\n",
       "      <td>75.41</td>\n",
       "      <td>103</td>\n",
       "      <td>52.00</td>\n",
       "      <td>84.32</td>\n",
       "      <td>14.40</td>\n",
       "      <td>https://www.theratech.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet me...</td>\n",
       "      <td>4.24</td>\n",
       "      <td>1.52</td>\n",
       "      <td>-64.15</td>\n",
       "      <td>5786</td>\n",
       "      <td>19.10</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>GLUE</td>\n",
       "      <td>Monte Rosa Therapeutics Inc</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>471.83</td>\n",
       "      <td>133</td>\n",
       "      <td>2638.00</td>\n",
       "      <td>14.98</td>\n",
       "      <td>-121.07</td>\n",
       "      <td>https://www.monterosatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that...</td>\n",
       "      <td>21.18</td>\n",
       "      <td>7.56</td>\n",
       "      <td>-64.31</td>\n",
       "      <td>1272</td>\n",
       "      <td>-25.66</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>VYGR</td>\n",
       "      <td>Voyager Therapeutics Inc</td>\n",
       "      <td>2015-11-11</td>\n",
       "      <td>353.97</td>\n",
       "      <td>162</td>\n",
       "      <td>605.00</td>\n",
       "      <td>163.78</td>\n",
       "      <td>14.13</td>\n",
       "      <td>https://www.voyagertherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical ...</td>\n",
       "      <td>17.75</td>\n",
       "      <td>6.27</td>\n",
       "      <td>-64.68</td>\n",
       "      <td>3324</td>\n",
       "      <td>3.99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>SLXN</td>\n",
       "      <td>Silexion Therapeutics Corp</td>\n",
       "      <td>2021-04-07</td>\n",
       "      <td>5.21</td>\n",
       "      <td>0</td>\n",
       "      <td>5681.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-1.36</td>\n",
       "      <td>https://silexion.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to...</td>\n",
       "      <td>10.00</td>\n",
       "      <td>3.52</td>\n",
       "      <td>-64.80</td>\n",
       "      <td>1350</td>\n",
       "      <td>-26.10</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>213</th>\n",
       "      <td>ENTA</td>\n",
       "      <td>Enanta Pharmaceuticals Inc</td>\n",
       "      <td>2013-03-21</td>\n",
       "      <td>133.74</td>\n",
       "      <td>145</td>\n",
       "      <td>253.00</td>\n",
       "      <td>71.96</td>\n",
       "      <td>-120.34</td>\n",
       "      <td>https://www.enanta.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver...</td>\n",
       "      <td>17.18</td>\n",
       "      <td>6.03</td>\n",
       "      <td>-64.90</td>\n",
       "      <td>4289</td>\n",
       "      <td>-89.98</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>XBIT</td>\n",
       "      <td>XBiotech Inc</td>\n",
       "      <td>2015-04-15</td>\n",
       "      <td>210.95</td>\n",
       "      <td>82</td>\n",
       "      <td>54.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-40.57</td>\n",
       "      <td>https://www.xbiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases...</td>\n",
       "      <td>20.03</td>\n",
       "      <td>6.95</td>\n",
       "      <td>-65.31</td>\n",
       "      <td>3534</td>\n",
       "      <td>-19.23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>INTS</td>\n",
       "      <td>Intensity Therapeutics Inc</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>30.74</td>\n",
       "      <td>5</td>\n",
       "      <td>23.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.intensitytherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs...</td>\n",
       "      <td>5.96</td>\n",
       "      <td>2.06</td>\n",
       "      <td>-65.44</td>\n",
       "      <td>536</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>216</th>\n",
       "      <td>ENTX</td>\n",
       "      <td>Entera Bio Ltd</td>\n",
       "      <td>2018-06-28</td>\n",
       "      <td>79.93</td>\n",
       "      <td>17</td>\n",
       "      <td>69.00</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-9.16</td>\n",
       "      <td>https://www.enterabio.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs where an or...</td>\n",
       "      <td>6.28</td>\n",
       "      <td>2.16</td>\n",
       "      <td>-65.61</td>\n",
       "      <td>2364</td>\n",
       "      <td>-11.46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217</th>\n",
       "      <td>SLN</td>\n",
       "      <td>Silence Therapeutics Plc ADR</td>\n",
       "      <td>2020-09-08</td>\n",
       "      <td>318.23</td>\n",
       "      <td>109</td>\n",
       "      <td>438.00</td>\n",
       "      <td>17.90</td>\n",
       "      <td>-48.16</td>\n",
       "      <td>https://www.silence-therapeutics.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonu...</td>\n",
       "      <td>19.50</td>\n",
       "      <td>6.45</td>\n",
       "      <td>-66.92</td>\n",
       "      <td>1561</td>\n",
       "      <td>-15.13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>ORIC</td>\n",
       "      <td>ORIC Pharmaceuticals Inc</td>\n",
       "      <td>2020-04-24</td>\n",
       "      <td>581.47</td>\n",
       "      <td>112</td>\n",
       "      <td>419.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-133.69</td>\n",
       "      <td>https://www.oricpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of can...</td>\n",
       "      <td>25.77</td>\n",
       "      <td>8.52</td>\n",
       "      <td>-66.94</td>\n",
       "      <td>1698</td>\n",
       "      <td>-22.99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219</th>\n",
       "      <td>ARCT</td>\n",
       "      <td>Arcturus Therapeutics Holdings Inc</td>\n",
       "      <td>2013-05-22</td>\n",
       "      <td>439.90</td>\n",
       "      <td>180</td>\n",
       "      <td>387.00</td>\n",
       "      <td>160.40</td>\n",
       "      <td>-77.01</td>\n",
       "      <td>https://arcturusrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious d...</td>\n",
       "      <td>52.85</td>\n",
       "      <td>17.21</td>\n",
       "      <td>-67.44</td>\n",
       "      <td>4227</td>\n",
       "      <td>-17.51</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>220</th>\n",
       "      <td>PHAT</td>\n",
       "      <td>Phathom Pharmaceuticals Inc</td>\n",
       "      <td>2019-10-25</td>\n",
       "      <td>556.59</td>\n",
       "      <td>452</td>\n",
       "      <td>1291.00</td>\n",
       "      <td>26.27</td>\n",
       "      <td>-287.14</td>\n",
       "      <td>https://www.phathompharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The ...</td>\n",
       "      <td>24.60</td>\n",
       "      <td>7.89</td>\n",
       "      <td>-67.93</td>\n",
       "      <td>1880</td>\n",
       "      <td>-51.59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>ZURA</td>\n",
       "      <td>Zura Bio Ltd</td>\n",
       "      <td>2023-03-21</td>\n",
       "      <td>162.58</td>\n",
       "      <td>14</td>\n",
       "      <td>502.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://zurabio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops...</td>\n",
       "      <td>7.24</td>\n",
       "      <td>2.28</td>\n",
       "      <td>-68.51</td>\n",
       "      <td>637</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>MGX</td>\n",
       "      <td>Metagenomi Inc</td>\n",
       "      <td>2024-02-09</td>\n",
       "      <td>116.20</td>\n",
       "      <td>236</td>\n",
       "      <td>1665.00</td>\n",
       "      <td>55.08</td>\n",
       "      <td>-83.33</td>\n",
       "      <td>https://www.metagenomi.co</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United ...</td>\n",
       "      <td>10.31</td>\n",
       "      <td>3.24</td>\n",
       "      <td>-68.57</td>\n",
       "      <td>312</td>\n",
       "      <td>-71.71</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>LRMR</td>\n",
       "      <td>Larimar Therapeutics Inc</td>\n",
       "      <td>2014-06-19</td>\n",
       "      <td>308.19</td>\n",
       "      <td>42</td>\n",
       "      <td>756.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-73.44</td>\n",
       "      <td>https://www.larimartx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetr...</td>\n",
       "      <td>19.75</td>\n",
       "      <td>6.17</td>\n",
       "      <td>-68.76</td>\n",
       "      <td>3834</td>\n",
       "      <td>-23.83</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>ORMP</td>\n",
       "      <td>Oramed Pharmaceuticals, Inc</td>\n",
       "      <td>2007-05-01</td>\n",
       "      <td>96.35</td>\n",
       "      <td>0</td>\n",
       "      <td>125.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.85</td>\n",
       "      <td>https://www.oramed.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of o...</td>\n",
       "      <td>7.92</td>\n",
       "      <td>2.47</td>\n",
       "      <td>-68.81</td>\n",
       "      <td>6440</td>\n",
       "      <td>-13.34</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td>DRTS</td>\n",
       "      <td>Alpha Tau Medical Ltd</td>\n",
       "      <td>2021-03-08</td>\n",
       "      <td>217.32</td>\n",
       "      <td>121</td>\n",
       "      <td>36.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-35.22</td>\n",
       "      <td>https://www.alphatau.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha...</td>\n",
       "      <td>10.10</td>\n",
       "      <td>3.07</td>\n",
       "      <td>-69.60</td>\n",
       "      <td>1380</td>\n",
       "      <td>-16.21</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>226</th>\n",
       "      <td>BMEA</td>\n",
       "      <td>Biomea Fusion Inc</td>\n",
       "      <td>2021-04-16</td>\n",
       "      <td>212.00</td>\n",
       "      <td>107</td>\n",
       "      <td>815.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-149.62</td>\n",
       "      <td>https://biomeafusion.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to trea...</td>\n",
       "      <td>18.60</td>\n",
       "      <td>5.64</td>\n",
       "      <td>-69.68</td>\n",
       "      <td>1341</td>\n",
       "      <td>-70.58</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>TRML</td>\n",
       "      <td>Tourmaline Bio Inc</td>\n",
       "      <td>2021-05-07</td>\n",
       "      <td>566.70</td>\n",
       "      <td>74</td>\n",
       "      <td>236.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-78.78</td>\n",
       "      <td>https://www.tourmalinebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory ...</td>\n",
       "      <td>72.18</td>\n",
       "      <td>21.81</td>\n",
       "      <td>-69.78</td>\n",
       "      <td>1320</td>\n",
       "      <td>-13.90</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>228</th>\n",
       "      <td>TNGX</td>\n",
       "      <td>Tango Therapeutics Inc</td>\n",
       "      <td>2020-09-03</td>\n",
       "      <td>316.88</td>\n",
       "      <td>140</td>\n",
       "      <td>1861.00</td>\n",
       "      <td>43.38</td>\n",
       "      <td>-137.20</td>\n",
       "      <td>https://www.tangotx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthet...</td>\n",
       "      <td>10.23</td>\n",
       "      <td>3.06</td>\n",
       "      <td>-70.09</td>\n",
       "      <td>1566</td>\n",
       "      <td>-43.30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>229</th>\n",
       "      <td>RENB</td>\n",
       "      <td>Renovaro Inc</td>\n",
       "      <td>2018-02-07</td>\n",
       "      <td>250.77</td>\n",
       "      <td>25</td>\n",
       "      <td>669.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.27</td>\n",
       "      <td>https://renovarobio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment ...</td>\n",
       "      <td>5.90</td>\n",
       "      <td>1.76</td>\n",
       "      <td>-70.17</td>\n",
       "      <td>2505</td>\n",
       "      <td>-10.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>IGMS</td>\n",
       "      <td>IGM Biosciences Inc</td>\n",
       "      <td>2019-09-18</td>\n",
       "      <td>440.04</td>\n",
       "      <td>198</td>\n",
       "      <td>280.00</td>\n",
       "      <td>2.92</td>\n",
       "      <td>-223.95</td>\n",
       "      <td>https://igmbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmu...</td>\n",
       "      <td>24.30</td>\n",
       "      <td>7.17</td>\n",
       "      <td>-70.49</td>\n",
       "      <td>1917</td>\n",
       "      <td>-50.89</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>231</th>\n",
       "      <td>FULC</td>\n",
       "      <td>Fulcrum Therapeutics Inc</td>\n",
       "      <td>2019-07-18</td>\n",
       "      <td>238.41</td>\n",
       "      <td>76</td>\n",
       "      <td>966.00</td>\n",
       "      <td>81.63</td>\n",
       "      <td>-30.88</td>\n",
       "      <td>https://www.fulcrumtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with ge...</td>\n",
       "      <td>13.50</td>\n",
       "      <td>3.96</td>\n",
       "      <td>-70.67</td>\n",
       "      <td>1979</td>\n",
       "      <td>-12.95</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>232</th>\n",
       "      <td>OKYO</td>\n",
       "      <td>OKYO Pharma Limited</td>\n",
       "      <td>2022-05-17</td>\n",
       "      <td>35.19</td>\n",
       "      <td>8</td>\n",
       "      <td>57.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.75</td>\n",
       "      <td>https://okyopharma.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and o...</td>\n",
       "      <td>3.62</td>\n",
       "      <td>1.06</td>\n",
       "      <td>-70.72</td>\n",
       "      <td>945</td>\n",
       "      <td>-44.76</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>FHTX</td>\n",
       "      <td>Foghorn Therapeutics Inc</td>\n",
       "      <td>2020-10-23</td>\n",
       "      <td>306.32</td>\n",
       "      <td>116</td>\n",
       "      <td>150.00</td>\n",
       "      <td>25.52</td>\n",
       "      <td>-98.53</td>\n",
       "      <td>https://foghorntx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically...</td>\n",
       "      <td>18.12</td>\n",
       "      <td>5.30</td>\n",
       "      <td>-70.75</td>\n",
       "      <td>1516</td>\n",
       "      <td>-32.17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>CABA</td>\n",
       "      <td>Cabaletta Bio Inc</td>\n",
       "      <td>2019-10-25</td>\n",
       "      <td>132.46</td>\n",
       "      <td>136</td>\n",
       "      <td>2310.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-98.61</td>\n",
       "      <td>https://www.cabalettabio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients ...</td>\n",
       "      <td>10.00</td>\n",
       "      <td>2.82</td>\n",
       "      <td>-71.80</td>\n",
       "      <td>1880</td>\n",
       "      <td>-74.45</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235</th>\n",
       "      <td>FATE</td>\n",
       "      <td>Fate Therapeutics Inc</td>\n",
       "      <td>2013-10-01</td>\n",
       "      <td>227.79</td>\n",
       "      <td>181</td>\n",
       "      <td>2447.00</td>\n",
       "      <td>13.45</td>\n",
       "      <td>-164.67</td>\n",
       "      <td>https://www.fatetherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders ...</td>\n",
       "      <td>6.62</td>\n",
       "      <td>1.83</td>\n",
       "      <td>-72.36</td>\n",
       "      <td>4095</td>\n",
       "      <td>-72.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>MOLN</td>\n",
       "      <td>Molecular Partners AG ADR</td>\n",
       "      <td>2021-06-16</td>\n",
       "      <td>197.22</td>\n",
       "      <td>167</td>\n",
       "      <td>25.00</td>\n",
       "      <td>6.00</td>\n",
       "      <td>-62.16</td>\n",
       "      <td>https://www.molecularpartners.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncolog...</td>\n",
       "      <td>19.65</td>\n",
       "      <td>5.43</td>\n",
       "      <td>-72.37</td>\n",
       "      <td>1280</td>\n",
       "      <td>-31.52</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>237</th>\n",
       "      <td>SGMT</td>\n",
       "      <td>Sagimet Biosciences Inc</td>\n",
       "      <td>2023-07-17</td>\n",
       "      <td>184.48</td>\n",
       "      <td>8</td>\n",
       "      <td>1507.00</td>\n",
       "      <td>2.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.sagimet.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the t...</td>\n",
       "      <td>15.95</td>\n",
       "      <td>4.39</td>\n",
       "      <td>-72.48</td>\n",
       "      <td>519</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>CNTX</td>\n",
       "      <td>Context Therapeutics Inc</td>\n",
       "      <td>2021-10-20</td>\n",
       "      <td>102.00</td>\n",
       "      <td>5</td>\n",
       "      <td>306.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.01</td>\n",
       "      <td>https://www.contexttherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76...</td>\n",
       "      <td>5.10</td>\n",
       "      <td>1.39</td>\n",
       "      <td>-72.75</td>\n",
       "      <td>1154</td>\n",
       "      <td>-19.62</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>RGNX</td>\n",
       "      <td>Regenxbio Inc</td>\n",
       "      <td>2015-09-17</td>\n",
       "      <td>423.12</td>\n",
       "      <td>344</td>\n",
       "      <td>825.00</td>\n",
       "      <td>84.33</td>\n",
       "      <td>-223.55</td>\n",
       "      <td>https://www.regenxbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the...</td>\n",
       "      <td>30.45</td>\n",
       "      <td>8.28</td>\n",
       "      <td>-72.81</td>\n",
       "      <td>3379</td>\n",
       "      <td>-52.83</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240</th>\n",
       "      <td>TCRX</td>\n",
       "      <td>Tscan Therapeutics Inc</td>\n",
       "      <td>2021-07-16</td>\n",
       "      <td>160.65</td>\n",
       "      <td>188</td>\n",
       "      <td>297.00</td>\n",
       "      <td>9.36</td>\n",
       "      <td>-114.79</td>\n",
       "      <td>https://www.tscan.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatme...</td>\n",
       "      <td>10.50</td>\n",
       "      <td>2.85</td>\n",
       "      <td>-72.86</td>\n",
       "      <td>1250</td>\n",
       "      <td>-71.45</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>NKTR</td>\n",
       "      <td>Nektar Therapeutics</td>\n",
       "      <td>1994-05-03</td>\n",
       "      <td>184.46</td>\n",
       "      <td>137</td>\n",
       "      <td>1740.00</td>\n",
       "      <td>93.14</td>\n",
       "      <td>-130.18</td>\n",
       "      <td>https://www.nektar.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to t...</td>\n",
       "      <td>3.75</td>\n",
       "      <td>1.01</td>\n",
       "      <td>-73.07</td>\n",
       "      <td>11186</td>\n",
       "      <td>-70.57</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>NUVB</td>\n",
       "      <td>Nuvation Bio Inc</td>\n",
       "      <td>2020-08-26</td>\n",
       "      <td>905.37</td>\n",
       "      <td>203</td>\n",
       "      <td>1995.00</td>\n",
       "      <td>2.16</td>\n",
       "      <td>-133.93</td>\n",
       "      <td>https://www.nuvationbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's le...</td>\n",
       "      <td>9.70</td>\n",
       "      <td>2.61</td>\n",
       "      <td>-73.09</td>\n",
       "      <td>1574</td>\n",
       "      <td>-14.79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>RVPH</td>\n",
       "      <td>Reviva Pharmaceuticals Holdings Inc</td>\n",
       "      <td>2018-10-18</td>\n",
       "      <td>76.91</td>\n",
       "      <td>15</td>\n",
       "      <td>1198.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.revivapharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for disea...</td>\n",
       "      <td>9.71</td>\n",
       "      <td>2.61</td>\n",
       "      <td>-73.12</td>\n",
       "      <td>2252</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>OPT</td>\n",
       "      <td>Opthea Limited ADR</td>\n",
       "      <td>2020-10-16</td>\n",
       "      <td>513.98</td>\n",
       "      <td>33</td>\n",
       "      <td>31.00</td>\n",
       "      <td>0.26</td>\n",
       "      <td>-191.82</td>\n",
       "      <td>https://opthea.com</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States....</td>\n",
       "      <td>12.30</td>\n",
       "      <td>3.25</td>\n",
       "      <td>-73.58</td>\n",
       "      <td>1523</td>\n",
       "      <td>-37.32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245</th>\n",
       "      <td>IMRN</td>\n",
       "      <td>Immuron Limited ADR</td>\n",
       "      <td>2017-06-09</td>\n",
       "      <td>11.97</td>\n",
       "      <td>7</td>\n",
       "      <td>8.00</td>\n",
       "      <td>4.90</td>\n",
       "      <td>-5.21</td>\n",
       "      <td>https://www.immuron.com.au</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, t...</td>\n",
       "      <td>8.35</td>\n",
       "      <td>2.12</td>\n",
       "      <td>-74.57</td>\n",
       "      <td>2748</td>\n",
       "      <td>-43.53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>246</th>\n",
       "      <td>ANNX</td>\n",
       "      <td>Annexon Inc</td>\n",
       "      <td>2020-07-24</td>\n",
       "      <td>539.37</td>\n",
       "      <td>71</td>\n",
       "      <td>1406.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-124.79</td>\n",
       "      <td>https://www.annexonbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead c...</td>\n",
       "      <td>17.76</td>\n",
       "      <td>4.44</td>\n",
       "      <td>-75.00</td>\n",
       "      <td>1607</td>\n",
       "      <td>-23.14</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>TSVT</td>\n",
       "      <td>2seventy bio Inc</td>\n",
       "      <td>2021-11-03</td>\n",
       "      <td>168.18</td>\n",
       "      <td>274</td>\n",
       "      <td>309.00</td>\n",
       "      <td>45.62</td>\n",
       "      <td>-134.27</td>\n",
       "      <td>https://www.2seventybio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the U...</td>\n",
       "      <td>13.77</td>\n",
       "      <td>3.27</td>\n",
       "      <td>-76.25</td>\n",
       "      <td>1140</td>\n",
       "      <td>-79.84</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>LTRN</td>\n",
       "      <td>Lantern Pharma Inc</td>\n",
       "      <td>2020-06-11</td>\n",
       "      <td>38.39</td>\n",
       "      <td>21</td>\n",
       "      <td>53.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-19.53</td>\n",
       "      <td>https://www.lanternpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline ...</td>\n",
       "      <td>14.95</td>\n",
       "      <td>3.44</td>\n",
       "      <td>-76.96</td>\n",
       "      <td>1650</td>\n",
       "      <td>-50.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>249</th>\n",
       "      <td>AMLX</td>\n",
       "      <td>Amylyx Pharmaceuticals Inc</td>\n",
       "      <td>2022-01-07</td>\n",
       "      <td>286.53</td>\n",
       "      <td>384</td>\n",
       "      <td>1430.00</td>\n",
       "      <td>196.48</td>\n",
       "      <td>-248.25</td>\n",
       "      <td>https://amylyx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic late...</td>\n",
       "      <td>18.07</td>\n",
       "      <td>4.12</td>\n",
       "      <td>-77.20</td>\n",
       "      <td>1075</td>\n",
       "      <td>-86.64</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>SCPH</td>\n",
       "      <td>scPharmaceuticals Inc</td>\n",
       "      <td>2017-11-17</td>\n",
       "      <td>160.13</td>\n",
       "      <td>135</td>\n",
       "      <td>398.00</td>\n",
       "      <td>30.28</td>\n",
       "      <td>-63.67</td>\n",
       "      <td>https://www.scpharmaceuticals.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead pr...</td>\n",
       "      <td>14.10</td>\n",
       "      <td>3.19</td>\n",
       "      <td>-77.38</td>\n",
       "      <td>2587</td>\n",
       "      <td>-39.76</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>RXRX</td>\n",
       "      <td>Recursion Pharmaceuticals Inc</td>\n",
       "      <td>2021-04-16</td>\n",
       "      <td>2893.71</td>\n",
       "      <td>500</td>\n",
       "      <td>8324.00</td>\n",
       "      <td>65.18</td>\n",
       "      <td>-364.15</td>\n",
       "      <td>https://www.recursion.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological i...</td>\n",
       "      <td>31.30</td>\n",
       "      <td>6.95</td>\n",
       "      <td>-77.80</td>\n",
       "      <td>1341</td>\n",
       "      <td>-12.58</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>252</th>\n",
       "      <td>NRSN</td>\n",
       "      <td>NeuroSense Therapeutics Ltd</td>\n",
       "      <td>2021-12-09</td>\n",
       "      <td>20.44</td>\n",
       "      <td>18</td>\n",
       "      <td>197.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-11.69</td>\n",
       "      <td>https://www.neurosense-tx.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from...</td>\n",
       "      <td>4.04</td>\n",
       "      <td>0.86</td>\n",
       "      <td>-78.71</td>\n",
       "      <td>1104</td>\n",
       "      <td>-57.19</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>IRON</td>\n",
       "      <td>Disc Medicine Inc</td>\n",
       "      <td>2020-08-12</td>\n",
       "      <td>1969.36</td>\n",
       "      <td>82</td>\n",
       "      <td>318.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-124.71</td>\n",
       "      <td>https://www.discmedicine.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commer...</td>\n",
       "      <td>309.00</td>\n",
       "      <td>64.89</td>\n",
       "      <td>-79.00</td>\n",
       "      <td>1588</td>\n",
       "      <td>-6.33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>JSPR</td>\n",
       "      <td>Jasper Therapeutics Inc</td>\n",
       "      <td>2020-01-10</td>\n",
       "      <td>321.78</td>\n",
       "      <td>45</td>\n",
       "      <td>278.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-67.27</td>\n",
       "      <td>https://www.jaspertherapeutics.com/</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gen...</td>\n",
       "      <td>98.20</td>\n",
       "      <td>20.60</td>\n",
       "      <td>-79.02</td>\n",
       "      <td>1803</td>\n",
       "      <td>-20.91</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>PBYI</td>\n",
       "      <td>Puma Biotechnology Inc</td>\n",
       "      <td>2012-04-24</td>\n",
       "      <td>147.26</td>\n",
       "      <td>185</td>\n",
       "      <td>397.00</td>\n",
       "      <td>243.57</td>\n",
       "      <td>44.60</td>\n",
       "      <td>https://www.pumabiotechnology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the ...</td>\n",
       "      <td>14.00</td>\n",
       "      <td>2.88</td>\n",
       "      <td>-79.43</td>\n",
       "      <td>4620</td>\n",
       "      <td>30.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>ANEB</td>\n",
       "      <td>Anebulo Pharmaceuticals Inc</td>\n",
       "      <td>2021-05-07</td>\n",
       "      <td>33.71</td>\n",
       "      <td>2</td>\n",
       "      <td>10.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.anebulo.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acut...</td>\n",
       "      <td>7.10</td>\n",
       "      <td>1.40</td>\n",
       "      <td>-80.28</td>\n",
       "      <td>1320</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>NBTX</td>\n",
       "      <td>Nanobiotix ADR</td>\n",
       "      <td>2020-12-11</td>\n",
       "      <td>165.44</td>\n",
       "      <td>110</td>\n",
       "      <td>22.00</td>\n",
       "      <td>42.20</td>\n",
       "      <td>-22.30</td>\n",
       "      <td>https://www.nanobiotix.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical need...</td>\n",
       "      <td>16.98</td>\n",
       "      <td>3.33</td>\n",
       "      <td>-80.39</td>\n",
       "      <td>1467</td>\n",
       "      <td>-13.48</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>CYBN</td>\n",
       "      <td>Cybin Inc</td>\n",
       "      <td>2019-09-13</td>\n",
       "      <td>198.12</td>\n",
       "      <td>50</td>\n",
       "      <td>365.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-86.20</td>\n",
       "      <td>https://www.cybin.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health condi...</td>\n",
       "      <td>49.99</td>\n",
       "      <td>9.78</td>\n",
       "      <td>-80.43</td>\n",
       "      <td>1922</td>\n",
       "      <td>-43.51</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>PRQR</td>\n",
       "      <td>ProQR Therapeutics N.V</td>\n",
       "      <td>2014-09-18</td>\n",
       "      <td>261.59</td>\n",
       "      <td>156</td>\n",
       "      <td>1501.00</td>\n",
       "      <td>18.39</td>\n",
       "      <td>-28.60</td>\n",
       "      <td>https://www.proqr.com</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products ...</td>\n",
       "      <td>14.73</td>\n",
       "      <td>2.83</td>\n",
       "      <td>-80.79</td>\n",
       "      <td>3743</td>\n",
       "      <td>-10.93</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>MNPR</td>\n",
       "      <td>Monopar Therapeutics Inc</td>\n",
       "      <td>2019-12-19</td>\n",
       "      <td>140.92</td>\n",
       "      <td>9</td>\n",
       "      <td>620.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.monopartx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the Unite...</td>\n",
       "      <td>132.50</td>\n",
       "      <td>25.38</td>\n",
       "      <td>-80.85</td>\n",
       "      <td>1825</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>MRVI</td>\n",
       "      <td>Maravai LifeSciences Holdings Inc</td>\n",
       "      <td>2020-11-20</td>\n",
       "      <td>1409.11</td>\n",
       "      <td>580</td>\n",
       "      <td>1797.00</td>\n",
       "      <td>276.92</td>\n",
       "      <td>1.04</td>\n",
       "      <td>https://www.maravai.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel va...</td>\n",
       "      <td>29.85</td>\n",
       "      <td>5.67</td>\n",
       "      <td>-81.01</td>\n",
       "      <td>1488</td>\n",
       "      <td>0.07</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>262</th>\n",
       "      <td>ACIU</td>\n",
       "      <td>AC Immune SA</td>\n",
       "      <td>2016-09-23</td>\n",
       "      <td>288.91</td>\n",
       "      <td>133</td>\n",
       "      <td>115.00</td>\n",
       "      <td>40.97</td>\n",
       "      <td>-35.76</td>\n",
       "      <td>https://www.acimmune.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention an...</td>\n",
       "      <td>15.66</td>\n",
       "      <td>2.95</td>\n",
       "      <td>-81.16</td>\n",
       "      <td>3007</td>\n",
       "      <td>-12.38</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>263</th>\n",
       "      <td>PRME</td>\n",
       "      <td>Prime Medicine Inc</td>\n",
       "      <td>2022-10-20</td>\n",
       "      <td>393.48</td>\n",
       "      <td>234</td>\n",
       "      <td>1726.00</td>\n",
       "      <td>0.80</td>\n",
       "      <td>-207.13</td>\n",
       "      <td>https://primemedicine.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology...</td>\n",
       "      <td>15.37</td>\n",
       "      <td>2.88</td>\n",
       "      <td>-81.26</td>\n",
       "      <td>789</td>\n",
       "      <td>-52.64</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>NAUT</td>\n",
       "      <td>Nautilus Biotechnology Inc</td>\n",
       "      <td>2020-08-07</td>\n",
       "      <td>251.13</td>\n",
       "      <td>161</td>\n",
       "      <td>108.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-79.40</td>\n",
       "      <td>https://www.nautilus.bio</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking t...</td>\n",
       "      <td>10.44</td>\n",
       "      <td>1.95</td>\n",
       "      <td>-81.32</td>\n",
       "      <td>1593</td>\n",
       "      <td>-31.62</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>ANRO</td>\n",
       "      <td>Alto Neuroscience Inc</td>\n",
       "      <td>2024-02-02</td>\n",
       "      <td>101.14</td>\n",
       "      <td>0</td>\n",
       "      <td>810.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-62.93</td>\n",
       "      <td>https://www.altoneuroscience.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. Its product pipeline comprising ALTO-100, whi...</td>\n",
       "      <td>20.70</td>\n",
       "      <td>3.83</td>\n",
       "      <td>-81.50</td>\n",
       "      <td>319</td>\n",
       "      <td>-62.22</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>COGT</td>\n",
       "      <td>Cogent Biosciences Inc</td>\n",
       "      <td>2018-03-29</td>\n",
       "      <td>912.42</td>\n",
       "      <td>164</td>\n",
       "      <td>1354.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-258.01</td>\n",
       "      <td>https://www.cogentbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product ca...</td>\n",
       "      <td>44.44</td>\n",
       "      <td>8.15</td>\n",
       "      <td>-81.66</td>\n",
       "      <td>2455</td>\n",
       "      <td>-28.28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>IVA</td>\n",
       "      <td>Inventiva ADR</td>\n",
       "      <td>2020-07-10</td>\n",
       "      <td>209.46</td>\n",
       "      <td>123</td>\n",
       "      <td>218.00</td>\n",
       "      <td>19.27</td>\n",
       "      <td>-98.36</td>\n",
       "      <td>https://www.inventivapharma.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-a...</td>\n",
       "      <td>13.42</td>\n",
       "      <td>2.45</td>\n",
       "      <td>-81.74</td>\n",
       "      <td>1621</td>\n",
       "      <td>-46.96</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>268</th>\n",
       "      <td>CVKD</td>\n",
       "      <td>Cadrenal Therapeutics Inc</td>\n",
       "      <td>2023-01-20</td>\n",
       "      <td>18.25</td>\n",
       "      <td>4</td>\n",
       "      <td>65.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.94</td>\n",
       "      <td>https://www.cadrenal.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel or...</td>\n",
       "      <td>61.80</td>\n",
       "      <td>11.20</td>\n",
       "      <td>-81.88</td>\n",
       "      <td>697</td>\n",
       "      <td>-43.51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>269</th>\n",
       "      <td>LIXT</td>\n",
       "      <td>Lixte Biotechnology Holdings Inc</td>\n",
       "      <td>2007-10-25</td>\n",
       "      <td>4.72</td>\n",
       "      <td>3</td>\n",
       "      <td>585.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://lixte.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>LIXTE Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company, focuses on identifying targets for cancer drug development, and devel...</td>\n",
       "      <td>11.00</td>\n",
       "      <td>1.99</td>\n",
       "      <td>-81.91</td>\n",
       "      <td>6263</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>SLRN</td>\n",
       "      <td>Acelyrin Inc</td>\n",
       "      <td>2023-05-04</td>\n",
       "      <td>338.10</td>\n",
       "      <td>135</td>\n",
       "      <td>721.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-373.01</td>\n",
       "      <td>https://www.acelyrin.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transfo...</td>\n",
       "      <td>18.00</td>\n",
       "      <td>3.23</td>\n",
       "      <td>-82.06</td>\n",
       "      <td>593</td>\n",
       "      <td>-110.33</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271</th>\n",
       "      <td>TNYA</td>\n",
       "      <td>Tenaya Therapeutics Inc</td>\n",
       "      <td>2021-07-30</td>\n",
       "      <td>228.16</td>\n",
       "      <td>140</td>\n",
       "      <td>3245.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-114.18</td>\n",
       "      <td>https://www.tenayatherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develop...</td>\n",
       "      <td>15.35</td>\n",
       "      <td>2.75</td>\n",
       "      <td>-82.08</td>\n",
       "      <td>1236</td>\n",
       "      <td>-50.04</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>272</th>\n",
       "      <td>SAGE</td>\n",
       "      <td>Sage Therapeutics Inc</td>\n",
       "      <td>2014-07-18</td>\n",
       "      <td>326.97</td>\n",
       "      <td>487</td>\n",
       "      <td>796.00</td>\n",
       "      <td>106.40</td>\n",
       "      <td>-371.15</td>\n",
       "      <td>https://www.sagerx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO,...</td>\n",
       "      <td>30.10</td>\n",
       "      <td>5.39</td>\n",
       "      <td>-82.11</td>\n",
       "      <td>3805</td>\n",
       "      <td>-113.51</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>VERV</td>\n",
       "      <td>Verve Therapeutics Inc</td>\n",
       "      <td>2021-06-17</td>\n",
       "      <td>458.03</td>\n",
       "      <td>255</td>\n",
       "      <td>1425.00</td>\n",
       "      <td>24.40</td>\n",
       "      <td>-219.97</td>\n",
       "      <td>https://www.vervetx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovas...</td>\n",
       "      <td>31.92</td>\n",
       "      <td>5.71</td>\n",
       "      <td>-82.11</td>\n",
       "      <td>1279</td>\n",
       "      <td>-48.03</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>CDMO</td>\n",
       "      <td>Avid Bioservices Inc</td>\n",
       "      <td>1994-04-04</td>\n",
       "      <td>790.59</td>\n",
       "      <td>371</td>\n",
       "      <td>1898.00</td>\n",
       "      <td>142.36</td>\n",
       "      <td>-7.69</td>\n",
       "      <td>https://www.avidbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in...</td>\n",
       "      <td>69.30</td>\n",
       "      <td>12.34</td>\n",
       "      <td>-82.19</td>\n",
       "      <td>11215</td>\n",
       "      <td>-0.97</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>PROK</td>\n",
       "      <td>ProKidney Corp</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>1811.82</td>\n",
       "      <td>163</td>\n",
       "      <td>690.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-145.99</td>\n",
       "      <td>https://www.prokidney.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic ki...</td>\n",
       "      <td>10.11</td>\n",
       "      <td>1.79</td>\n",
       "      <td>-82.25</td>\n",
       "      <td>1266</td>\n",
       "      <td>-8.06</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>RNXT</td>\n",
       "      <td>RenovoRx Inc</td>\n",
       "      <td>2021-08-26</td>\n",
       "      <td>30.00</td>\n",
       "      <td>8</td>\n",
       "      <td>61.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://renovorx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeuti...</td>\n",
       "      <td>7.26</td>\n",
       "      <td>1.28</td>\n",
       "      <td>-82.37</td>\n",
       "      <td>1209</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>GALT</td>\n",
       "      <td>Galectin Therapeutics Inc</td>\n",
       "      <td>2002-09-04</td>\n",
       "      <td>144.98</td>\n",
       "      <td>14</td>\n",
       "      <td>256.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://galectintherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer,...</td>\n",
       "      <td>12.00</td>\n",
       "      <td>2.11</td>\n",
       "      <td>-82.42</td>\n",
       "      <td>8140</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>MNOV</td>\n",
       "      <td>Medicinova Inc</td>\n",
       "      <td>2006-12-08</td>\n",
       "      <td>103.49</td>\n",
       "      <td>13</td>\n",
       "      <td>72.00</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-9.80</td>\n",
       "      <td>https://www.medicinova.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases w...</td>\n",
       "      <td>12.10</td>\n",
       "      <td>2.10</td>\n",
       "      <td>-82.64</td>\n",
       "      <td>6584</td>\n",
       "      <td>-9.47</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>279</th>\n",
       "      <td>INZY</td>\n",
       "      <td>Inozyme Pharma Inc</td>\n",
       "      <td>2020-07-24</td>\n",
       "      <td>194.01</td>\n",
       "      <td>59</td>\n",
       "      <td>452.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-98.89</td>\n",
       "      <td>https://www.inozyme.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vascu...</td>\n",
       "      <td>17.54</td>\n",
       "      <td>3.03</td>\n",
       "      <td>-82.73</td>\n",
       "      <td>1607</td>\n",
       "      <td>-50.97</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>280</th>\n",
       "      <td>BOLD</td>\n",
       "      <td>Boundless Bio Inc</td>\n",
       "      <td>2024-03-28</td>\n",
       "      <td>55.97</td>\n",
       "      <td>72</td>\n",
       "      <td>83.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-67.75</td>\n",
       "      <td>https://boundlessbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified...</td>\n",
       "      <td>14.25</td>\n",
       "      <td>2.46</td>\n",
       "      <td>-82.74</td>\n",
       "      <td>264</td>\n",
       "      <td>-121.05</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>GNFT</td>\n",
       "      <td>Genfit ADR</td>\n",
       "      <td>2019-03-27</td>\n",
       "      <td>189.64</td>\n",
       "      <td>169</td>\n",
       "      <td>15.00</td>\n",
       "      <td>80.47</td>\n",
       "      <td>21.86</td>\n",
       "      <td>https://www.genfit.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-relat...</td>\n",
       "      <td>22.17</td>\n",
       "      <td>3.82</td>\n",
       "      <td>-82.77</td>\n",
       "      <td>2092</td>\n",
       "      <td>11.53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>CCCC</td>\n",
       "      <td>C4 Therapeutics Inc</td>\n",
       "      <td>2020-10-02</td>\n",
       "      <td>304.24</td>\n",
       "      <td>145</td>\n",
       "      <td>1108.00</td>\n",
       "      <td>33.67</td>\n",
       "      <td>-115.13</td>\n",
       "      <td>https://www.c4therapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for t...</td>\n",
       "      <td>25.49</td>\n",
       "      <td>4.38</td>\n",
       "      <td>-82.82</td>\n",
       "      <td>1537</td>\n",
       "      <td>-37.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>CMPX</td>\n",
       "      <td>Compass Therapeutics Inc</td>\n",
       "      <td>2021-04-05</td>\n",
       "      <td>205.01</td>\n",
       "      <td>32</td>\n",
       "      <td>497.00</td>\n",
       "      <td>0.85</td>\n",
       "      <td>-54.83</td>\n",
       "      <td>https://www.compasstherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to trea...</td>\n",
       "      <td>8.50</td>\n",
       "      <td>1.46</td>\n",
       "      <td>-82.82</td>\n",
       "      <td>1352</td>\n",
       "      <td>-26.75</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>ABSI</td>\n",
       "      <td>Absci Corp</td>\n",
       "      <td>2021-07-22</td>\n",
       "      <td>439.90</td>\n",
       "      <td>155</td>\n",
       "      <td>1380.00</td>\n",
       "      <td>4.21</td>\n",
       "      <td>-89.71</td>\n",
       "      <td>https://www.absci.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combine...</td>\n",
       "      <td>21.59</td>\n",
       "      <td>3.69</td>\n",
       "      <td>-82.89</td>\n",
       "      <td>1244</td>\n",
       "      <td>-20.39</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>PRAX</td>\n",
       "      <td>Praxis Precision Medicines Inc</td>\n",
       "      <td>2020-10-16</td>\n",
       "      <td>1349.00</td>\n",
       "      <td>82</td>\n",
       "      <td>298.00</td>\n",
       "      <td>1.60</td>\n",
       "      <td>-163.59</td>\n",
       "      <td>https://praxismedicines.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system d...</td>\n",
       "      <td>417.00</td>\n",
       "      <td>70.18</td>\n",
       "      <td>-83.17</td>\n",
       "      <td>1523</td>\n",
       "      <td>-12.13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>CRBP</td>\n",
       "      <td>Corbus Pharmaceuticals Holdings Inc</td>\n",
       "      <td>2014-10-27</td>\n",
       "      <td>173.92</td>\n",
       "      <td>19</td>\n",
       "      <td>680.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-45.62</td>\n",
       "      <td>https://www.corbuspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody ...</td>\n",
       "      <td>90.00</td>\n",
       "      <td>15.08</td>\n",
       "      <td>-83.24</td>\n",
       "      <td>3704</td>\n",
       "      <td>-26.23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>DSGN</td>\n",
       "      <td>Design Therapeutics Inc</td>\n",
       "      <td>2021-03-29</td>\n",
       "      <td>356.15</td>\n",
       "      <td>54</td>\n",
       "      <td>170.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-60.22</td>\n",
       "      <td>https://www.designtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the ...</td>\n",
       "      <td>34.01</td>\n",
       "      <td>5.60</td>\n",
       "      <td>-83.53</td>\n",
       "      <td>1359</td>\n",
       "      <td>-16.91</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>CLYM</td>\n",
       "      <td>Climb Bio Inc</td>\n",
       "      <td>2021-08-10</td>\n",
       "      <td>162.68</td>\n",
       "      <td>9</td>\n",
       "      <td>527.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://eliemtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an ...</td>\n",
       "      <td>15.90</td>\n",
       "      <td>2.60</td>\n",
       "      <td>-83.65</td>\n",
       "      <td>1225</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>XERS</td>\n",
       "      <td>Xeris Biopharma Holdings Inc</td>\n",
       "      <td>2018-06-21</td>\n",
       "      <td>502.40</td>\n",
       "      <td>377</td>\n",
       "      <td>1618.00</td>\n",
       "      <td>187.36</td>\n",
       "      <td>-33.06</td>\n",
       "      <td>https://www.xerispharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers G...</td>\n",
       "      <td>20.22</td>\n",
       "      <td>3.28</td>\n",
       "      <td>-83.78</td>\n",
       "      <td>2371</td>\n",
       "      <td>-6.58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>SLNO</td>\n",
       "      <td>Soleno Therapeutics Inc</td>\n",
       "      <td>2014-11-13</td>\n",
       "      <td>2066.62</td>\n",
       "      <td>33</td>\n",
       "      <td>679.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-136.50</td>\n",
       "      <td>https://soleno.life</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for ...</td>\n",
       "      <td>291.00</td>\n",
       "      <td>46.71</td>\n",
       "      <td>-83.95</td>\n",
       "      <td>3687</td>\n",
       "      <td>-6.60</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>FDMT</td>\n",
       "      <td>4D Molecular Therapeutics Inc</td>\n",
       "      <td>2020-12-11</td>\n",
       "      <td>299.56</td>\n",
       "      <td>147</td>\n",
       "      <td>938.00</td>\n",
       "      <td>0.02</td>\n",
       "      <td>-163.69</td>\n",
       "      <td>https://www.4dmoleculartherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platf...</td>\n",
       "      <td>40.50</td>\n",
       "      <td>6.50</td>\n",
       "      <td>-83.95</td>\n",
       "      <td>1467</td>\n",
       "      <td>-54.64</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>ANIX</td>\n",
       "      <td>Anixa Biosciences Inc</td>\n",
       "      <td>1983-10-07</td>\n",
       "      <td>90.10</td>\n",
       "      <td>4</td>\n",
       "      <td>90.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.anixa.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio cons...</td>\n",
       "      <td>17.92</td>\n",
       "      <td>2.85</td>\n",
       "      <td>-84.09</td>\n",
       "      <td>15047</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>GUTS</td>\n",
       "      <td>Fractyl Health Inc</td>\n",
       "      <td>2024-02-02</td>\n",
       "      <td>101.49</td>\n",
       "      <td>122</td>\n",
       "      <td>362.00</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-80.81</td>\n",
       "      <td>https://fractyl.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company dev...</td>\n",
       "      <td>12.85</td>\n",
       "      <td>2.04</td>\n",
       "      <td>-84.12</td>\n",
       "      <td>319</td>\n",
       "      <td>-79.62</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>IFRX</td>\n",
       "      <td>InflaRx N.V</td>\n",
       "      <td>2017-11-07</td>\n",
       "      <td>136.02</td>\n",
       "      <td>62</td>\n",
       "      <td>233.00</td>\n",
       "      <td>0.11</td>\n",
       "      <td>-39.67</td>\n",
       "      <td>https://www.inflarx.de</td>\n",
       "      <td>Germany</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States....</td>\n",
       "      <td>15.00</td>\n",
       "      <td>2.36</td>\n",
       "      <td>-84.27</td>\n",
       "      <td>2597</td>\n",
       "      <td>-29.16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>VIGL</td>\n",
       "      <td>Vigil Neuroscience Inc</td>\n",
       "      <td>2022-01-07</td>\n",
       "      <td>76.44</td>\n",
       "      <td>64</td>\n",
       "      <td>156.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-89.62</td>\n",
       "      <td>https://www.vigilneuro.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases ...</td>\n",
       "      <td>12.65</td>\n",
       "      <td>1.99</td>\n",
       "      <td>-84.27</td>\n",
       "      <td>1075</td>\n",
       "      <td>-117.24</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>CMRX</td>\n",
       "      <td>Chimerix Inc</td>\n",
       "      <td>2013-04-11</td>\n",
       "      <td>261.71</td>\n",
       "      <td>72</td>\n",
       "      <td>3739.00</td>\n",
       "      <td>0.16</td>\n",
       "      <td>-92.74</td>\n",
       "      <td>https://www.chimerix.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline p...</td>\n",
       "      <td>18.79</td>\n",
       "      <td>2.95</td>\n",
       "      <td>-84.30</td>\n",
       "      <td>4268</td>\n",
       "      <td>-35.44</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>ADPT</td>\n",
       "      <td>Adaptive Biotechnologies Corp</td>\n",
       "      <td>2019-06-27</td>\n",
       "      <td>1000.59</td>\n",
       "      <td>709</td>\n",
       "      <td>1221.00</td>\n",
       "      <td>177.28</td>\n",
       "      <td>-146.95</td>\n",
       "      <td>https://www.adaptivebiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various ...</td>\n",
       "      <td>40.30</td>\n",
       "      <td>6.30</td>\n",
       "      <td>-84.37</td>\n",
       "      <td>2000</td>\n",
       "      <td>-14.69</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>ABP</td>\n",
       "      <td>Abpro Holdings Inc</td>\n",
       "      <td>2022-03-09</td>\n",
       "      <td>65.94</td>\n",
       "      <td>15</td>\n",
       "      <td>28.00</td>\n",
       "      <td>0.07</td>\n",
       "      <td>-11.31</td>\n",
       "      <td>https://abpro.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and a...</td>\n",
       "      <td>9.90</td>\n",
       "      <td>1.53</td>\n",
       "      <td>-84.55</td>\n",
       "      <td>1014</td>\n",
       "      <td>-17.15</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>MRSN</td>\n",
       "      <td>Mersana Therapeutics Inc</td>\n",
       "      <td>2017-06-28</td>\n",
       "      <td>255.71</td>\n",
       "      <td>123</td>\n",
       "      <td>1013.00</td>\n",
       "      <td>34.84</td>\n",
       "      <td>-77.80</td>\n",
       "      <td>https://www.mersana.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet nee...</td>\n",
       "      <td>14.00</td>\n",
       "      <td>2.15</td>\n",
       "      <td>-84.64</td>\n",
       "      <td>2729</td>\n",
       "      <td>-30.43</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>ANL</td>\n",
       "      <td>Adlai Nortye Ltd. ADR</td>\n",
       "      <td>2023-09-29</td>\n",
       "      <td>87.08</td>\n",
       "      <td>127</td>\n",
       "      <td>15.00</td>\n",
       "      <td>5.00</td>\n",
       "      <td>-63.57</td>\n",
       "      <td>https://www.adlainortye.com</td>\n",
       "      <td>China</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and M...</td>\n",
       "      <td>15.00</td>\n",
       "      <td>2.29</td>\n",
       "      <td>-84.73</td>\n",
       "      <td>445</td>\n",
       "      <td>-73.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>RANI</td>\n",
       "      <td>Rani Therapeutics Holdings Inc</td>\n",
       "      <td>2021-07-30</td>\n",
       "      <td>93.10</td>\n",
       "      <td>140</td>\n",
       "      <td>1847.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-56.90</td>\n",
       "      <td>https://www.ranitherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, ph...</td>\n",
       "      <td>11.00</td>\n",
       "      <td>1.66</td>\n",
       "      <td>-84.91</td>\n",
       "      <td>1236</td>\n",
       "      <td>-61.12</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>VALN</td>\n",
       "      <td>Valneva SE ADR</td>\n",
       "      <td>2021-05-05</td>\n",
       "      <td>311.41</td>\n",
       "      <td>676</td>\n",
       "      <td>23.00</td>\n",
       "      <td>158.54</td>\n",
       "      <td>-76.15</td>\n",
       "      <td>https://valneva.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs...</td>\n",
       "      <td>26.41</td>\n",
       "      <td>3.93</td>\n",
       "      <td>-85.12</td>\n",
       "      <td>1322</td>\n",
       "      <td>-24.45</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>ERAS</td>\n",
       "      <td>Erasca Inc</td>\n",
       "      <td>2021-07-16</td>\n",
       "      <td>740.74</td>\n",
       "      <td>126</td>\n",
       "      <td>1764.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-150.91</td>\n",
       "      <td>https://www.erasca.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS...</td>\n",
       "      <td>17.43</td>\n",
       "      <td>2.56</td>\n",
       "      <td>-85.31</td>\n",
       "      <td>1250</td>\n",
       "      <td>-20.37</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>KYTX</td>\n",
       "      <td>Kyverna Therapeutics Inc</td>\n",
       "      <td>2024-02-09</td>\n",
       "      <td>183.05</td>\n",
       "      <td>96</td>\n",
       "      <td>368.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.75</td>\n",
       "      <td>https://kyvernatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmun...</td>\n",
       "      <td>30.10</td>\n",
       "      <td>4.42</td>\n",
       "      <td>-85.32</td>\n",
       "      <td>312</td>\n",
       "      <td>-66.51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>305</th>\n",
       "      <td>CGEN</td>\n",
       "      <td>Compugen Ltd</td>\n",
       "      <td>2000-08-11</td>\n",
       "      <td>142.36</td>\n",
       "      <td>68</td>\n",
       "      <td>303.00</td>\n",
       "      <td>42.72</td>\n",
       "      <td>-4.07</td>\n",
       "      <td>https://cgen.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product ca...</td>\n",
       "      <td>11.12</td>\n",
       "      <td>1.61</td>\n",
       "      <td>-85.53</td>\n",
       "      <td>8894</td>\n",
       "      <td>-2.86</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>306</th>\n",
       "      <td>MDWD</td>\n",
       "      <td>MediWound Ltd</td>\n",
       "      <td>2014-03-20</td>\n",
       "      <td>180.73</td>\n",
       "      <td>100</td>\n",
       "      <td>45.00</td>\n",
       "      <td>20.14</td>\n",
       "      <td>-14.50</td>\n",
       "      <td>https://www.mediwound.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tis...</td>\n",
       "      <td>120.89</td>\n",
       "      <td>17.29</td>\n",
       "      <td>-85.70</td>\n",
       "      <td>3925</td>\n",
       "      <td>-8.02</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>UNCY</td>\n",
       "      <td>Unicycive Therapeutics Inc</td>\n",
       "      <td>2021-07-12</td>\n",
       "      <td>72.66</td>\n",
       "      <td>14</td>\n",
       "      <td>1655.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-28.84</td>\n",
       "      <td>https://unicycive.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidate...</td>\n",
       "      <td>5.00</td>\n",
       "      <td>0.71</td>\n",
       "      <td>-85.70</td>\n",
       "      <td>1254</td>\n",
       "      <td>-39.69</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>TGTX</td>\n",
       "      <td>TG Therapeutics Inc</td>\n",
       "      <td>2010-05-03</td>\n",
       "      <td>5354.88</td>\n",
       "      <td>319</td>\n",
       "      <td>3519.00</td>\n",
       "      <td>264.79</td>\n",
       "      <td>-0.41</td>\n",
       "      <td>https://www.tgtherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treat...</td>\n",
       "      <td>225.00</td>\n",
       "      <td>32.02</td>\n",
       "      <td>-85.77</td>\n",
       "      <td>5342</td>\n",
       "      <td>-0.01</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>CLSD</td>\n",
       "      <td>Clearside Biomedical Inc</td>\n",
       "      <td>2016-06-02</td>\n",
       "      <td>76.60</td>\n",
       "      <td>30</td>\n",
       "      <td>721.00</td>\n",
       "      <td>7.52</td>\n",
       "      <td>-25.66</td>\n",
       "      <td>https://clearsidebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through t...</td>\n",
       "      <td>7.25</td>\n",
       "      <td>1.02</td>\n",
       "      <td>-85.93</td>\n",
       "      <td>3120</td>\n",
       "      <td>-33.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>STRO</td>\n",
       "      <td>Sutro Biopharma Inc</td>\n",
       "      <td>2018-09-27</td>\n",
       "      <td>170.69</td>\n",
       "      <td>302</td>\n",
       "      <td>819.00</td>\n",
       "      <td>160.96</td>\n",
       "      <td>-122.96</td>\n",
       "      <td>https://www.sutrobio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sutro Biopharma, Inc. operates as a clinical-stage oncology company. The company develops site-specific and novel-format antibody drug conjugates ...</td>\n",
       "      <td>15.20</td>\n",
       "      <td>2.12</td>\n",
       "      <td>-86.05</td>\n",
       "      <td>2273</td>\n",
       "      <td>-72.04</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>OLMA</td>\n",
       "      <td>Olema Pharmaceuticals Inc</td>\n",
       "      <td>2020-11-19</td>\n",
       "      <td>475.32</td>\n",
       "      <td>74</td>\n",
       "      <td>627.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-135.54</td>\n",
       "      <td>https://olema.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies...</td>\n",
       "      <td>49.00</td>\n",
       "      <td>6.75</td>\n",
       "      <td>-86.22</td>\n",
       "      <td>1489</td>\n",
       "      <td>-28.52</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>LCTX</td>\n",
       "      <td>Lineage Cell Therapeutics Inc</td>\n",
       "      <td>1992-03-05</td>\n",
       "      <td>110.21</td>\n",
       "      <td>68</td>\n",
       "      <td>1637.00</td>\n",
       "      <td>6.19</td>\n",
       "      <td>-21.40</td>\n",
       "      <td>https://www.lineagecell.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United State...</td>\n",
       "      <td>3.71</td>\n",
       "      <td>0.51</td>\n",
       "      <td>-86.26</td>\n",
       "      <td>11975</td>\n",
       "      <td>-19.42</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>SGMO</td>\n",
       "      <td>Sangamo Therapeutics Inc</td>\n",
       "      <td>2000-04-06</td>\n",
       "      <td>551.87</td>\n",
       "      <td>405</td>\n",
       "      <td>7588.00</td>\n",
       "      <td>52.29</td>\n",
       "      <td>-117.03</td>\n",
       "      <td>https://www.sangamo.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of p...</td>\n",
       "      <td>15.06</td>\n",
       "      <td>2.05</td>\n",
       "      <td>-86.39</td>\n",
       "      <td>9021</td>\n",
       "      <td>-21.21</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>RLAY</td>\n",
       "      <td>Relay Therapeutics Inc</td>\n",
       "      <td>2020-07-16</td>\n",
       "      <td>810.13</td>\n",
       "      <td>294</td>\n",
       "      <td>1855.00</td>\n",
       "      <td>10.01</td>\n",
       "      <td>-389.45</td>\n",
       "      <td>https://www.relaytx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an i...</td>\n",
       "      <td>35.05</td>\n",
       "      <td>4.71</td>\n",
       "      <td>-86.56</td>\n",
       "      <td>1615</td>\n",
       "      <td>-48.07</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>IPA</td>\n",
       "      <td>ImmunoPrecise Antibodies Ltd</td>\n",
       "      <td>2002-01-07</td>\n",
       "      <td>13.36</td>\n",
       "      <td>72</td>\n",
       "      <td>570.00</td>\n",
       "      <td>24.09</td>\n",
       "      <td>-11.50</td>\n",
       "      <td>https://www.ipatherapeutics.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ImmunoPrecise Antibodies Ltd., a biotechnology company, leverages multi-omics modeling and artificial intelligence through a series proprietary an...</td>\n",
       "      <td>3.00</td>\n",
       "      <td>0.40</td>\n",
       "      <td>-86.57</td>\n",
       "      <td>8380</td>\n",
       "      <td>-86.08</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>GANX</td>\n",
       "      <td>Gain Therapeutics Inc</td>\n",
       "      <td>2021-03-19</td>\n",
       "      <td>44.03</td>\n",
       "      <td>29</td>\n",
       "      <td>319.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.82</td>\n",
       "      <td>https://www.gaintherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. I...</td>\n",
       "      <td>12.20</td>\n",
       "      <td>1.63</td>\n",
       "      <td>-86.64</td>\n",
       "      <td>1369</td>\n",
       "      <td>-49.56</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>317</th>\n",
       "      <td>ZNTL</td>\n",
       "      <td>Zentalis Pharmaceuticals Inc</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>220.92</td>\n",
       "      <td>124</td>\n",
       "      <td>1344.00</td>\n",
       "      <td>40.56</td>\n",
       "      <td>-207.96</td>\n",
       "      <td>https://zentalis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for ...</td>\n",
       "      <td>23.20</td>\n",
       "      <td>3.09</td>\n",
       "      <td>-86.68</td>\n",
       "      <td>1719</td>\n",
       "      <td>-94.13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>318</th>\n",
       "      <td>DMAC</td>\n",
       "      <td>DiaMedica Therapeutics Inc</td>\n",
       "      <td>2012-08-03</td>\n",
       "      <td>227.06</td>\n",
       "      <td>18</td>\n",
       "      <td>85.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-22.35</td>\n",
       "      <td>https://www.diamedica.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases ...</td>\n",
       "      <td>41.08</td>\n",
       "      <td>5.38</td>\n",
       "      <td>-86.90</td>\n",
       "      <td>4519</td>\n",
       "      <td>-9.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>CDIO</td>\n",
       "      <td>Cardio Diagnostics Holdings Inc</td>\n",
       "      <td>2022-01-14</td>\n",
       "      <td>45.29</td>\n",
       "      <td>7</td>\n",
       "      <td>6292.00</td>\n",
       "      <td>0.04</td>\n",
       "      <td>-8.22</td>\n",
       "      <td>https://cardiodiagnosticsinc.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, ...</td>\n",
       "      <td>9.82</td>\n",
       "      <td>1.26</td>\n",
       "      <td>-87.17</td>\n",
       "      <td>1068</td>\n",
       "      <td>-18.15</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>320</th>\n",
       "      <td>MGNX</td>\n",
       "      <td>Macrogenics Inc</td>\n",
       "      <td>2013-10-10</td>\n",
       "      <td>202.73</td>\n",
       "      <td>339</td>\n",
       "      <td>603.00</td>\n",
       "      <td>141.33</td>\n",
       "      <td>-99.71</td>\n",
       "      <td>https://www.macrogenics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the Unit...</td>\n",
       "      <td>24.99</td>\n",
       "      <td>3.20</td>\n",
       "      <td>-87.19</td>\n",
       "      <td>4086</td>\n",
       "      <td>-49.18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>CHRS</td>\n",
       "      <td>Coherus Biosciences Inc</td>\n",
       "      <td>2014-11-06</td>\n",
       "      <td>195.86</td>\n",
       "      <td>235</td>\n",
       "      <td>5257.00</td>\n",
       "      <td>304.34</td>\n",
       "      <td>-116.92</td>\n",
       "      <td>https://www.coherus.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of cancer treatments primarily...</td>\n",
       "      <td>12.61</td>\n",
       "      <td>1.61</td>\n",
       "      <td>-87.23</td>\n",
       "      <td>3694</td>\n",
       "      <td>-59.70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>FBLG</td>\n",
       "      <td>FibroBiologics Inc</td>\n",
       "      <td>2024-02-01</td>\n",
       "      <td>74.86</td>\n",
       "      <td>10</td>\n",
       "      <td>219.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.36</td>\n",
       "      <td>https://www.fibrobiologics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for ...</td>\n",
       "      <td>17.50</td>\n",
       "      <td>2.22</td>\n",
       "      <td>-87.31</td>\n",
       "      <td>320</td>\n",
       "      <td>-16.51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>323</th>\n",
       "      <td>PYXS</td>\n",
       "      <td>Pyxis Oncology Inc</td>\n",
       "      <td>2021-10-08</td>\n",
       "      <td>99.90</td>\n",
       "      <td>54</td>\n",
       "      <td>1235.00</td>\n",
       "      <td>16.15</td>\n",
       "      <td>-61.25</td>\n",
       "      <td>https://www.pyxisoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (AD...</td>\n",
       "      <td>13.20</td>\n",
       "      <td>1.62</td>\n",
       "      <td>-87.73</td>\n",
       "      <td>1166</td>\n",
       "      <td>-61.31</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>ESLA</td>\n",
       "      <td>Estrella Immunopharma Inc</td>\n",
       "      <td>2021-09-14</td>\n",
       "      <td>45.95</td>\n",
       "      <td>0</td>\n",
       "      <td>142.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.estrellabio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the Unite...</td>\n",
       "      <td>9.75</td>\n",
       "      <td>1.19</td>\n",
       "      <td>-87.75</td>\n",
       "      <td>1190</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>APLT</td>\n",
       "      <td>Applied Therapeutics Inc</td>\n",
       "      <td>2019-05-14</td>\n",
       "      <td>133.81</td>\n",
       "      <td>37</td>\n",
       "      <td>5791.00</td>\n",
       "      <td>-0.21</td>\n",
       "      <td>-92.28</td>\n",
       "      <td>https://www.appliedtherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates again...</td>\n",
       "      <td>9.40</td>\n",
       "      <td>1.15</td>\n",
       "      <td>-87.77</td>\n",
       "      <td>2044</td>\n",
       "      <td>-68.96</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>326</th>\n",
       "      <td>CHRO</td>\n",
       "      <td>Channel Therapeutics Corporation</td>\n",
       "      <td>2024-02-16</td>\n",
       "      <td>3.56</td>\n",
       "      <td>4</td>\n",
       "      <td>168.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.chromocell.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to all...</td>\n",
       "      <td>4.80</td>\n",
       "      <td>0.58</td>\n",
       "      <td>-87.81</td>\n",
       "      <td>305</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>327</th>\n",
       "      <td>TECX</td>\n",
       "      <td>Tectonic Therapeutic Inc</td>\n",
       "      <td>2018-06-21</td>\n",
       "      <td>656.79</td>\n",
       "      <td>44</td>\n",
       "      <td>137.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-52.02</td>\n",
       "      <td>https://tectonictx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies...</td>\n",
       "      <td>374.40</td>\n",
       "      <td>45.33</td>\n",
       "      <td>-87.89</td>\n",
       "      <td>2371</td>\n",
       "      <td>-7.92</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>328</th>\n",
       "      <td>MIST</td>\n",
       "      <td>Milestone Pharmaceuticals Inc</td>\n",
       "      <td>2019-05-09</td>\n",
       "      <td>95.46</td>\n",
       "      <td>47</td>\n",
       "      <td>326.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-49.19</td>\n",
       "      <td>https://www.milestonepharma.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The com...</td>\n",
       "      <td>15.37</td>\n",
       "      <td>1.80</td>\n",
       "      <td>-88.29</td>\n",
       "      <td>2049</td>\n",
       "      <td>-51.53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>CRBU</td>\n",
       "      <td>Caribou Biosciences Inc</td>\n",
       "      <td>2021-07-23</td>\n",
       "      <td>172.96</td>\n",
       "      <td>158</td>\n",
       "      <td>1316.00</td>\n",
       "      <td>11.48</td>\n",
       "      <td>-157.80</td>\n",
       "      <td>https://cariboubio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for t...</td>\n",
       "      <td>16.32</td>\n",
       "      <td>1.91</td>\n",
       "      <td>-88.30</td>\n",
       "      <td>1243</td>\n",
       "      <td>-91.23</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>RVNC</td>\n",
       "      <td>Revance Therapeutics Inc</td>\n",
       "      <td>2014-02-06</td>\n",
       "      <td>322.57</td>\n",
       "      <td>597</td>\n",
       "      <td>2731.00</td>\n",
       "      <td>256.94</td>\n",
       "      <td>-187.62</td>\n",
       "      <td>https://www.revance.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various...</td>\n",
       "      <td>26.85</td>\n",
       "      <td>3.08</td>\n",
       "      <td>-88.53</td>\n",
       "      <td>3967</td>\n",
       "      <td>-58.16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>NVAX</td>\n",
       "      <td>Novavax, Inc</td>\n",
       "      <td>1995-12-05</td>\n",
       "      <td>1478.51</td>\n",
       "      <td>1543</td>\n",
       "      <td>5888.00</td>\n",
       "      <td>885.19</td>\n",
       "      <td>-243.25</td>\n",
       "      <td>https://www.novavax.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against ...</td>\n",
       "      <td>80.00</td>\n",
       "      <td>9.11</td>\n",
       "      <td>-88.61</td>\n",
       "      <td>10605</td>\n",
       "      <td>-16.45</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>332</th>\n",
       "      <td>KALV</td>\n",
       "      <td>KalVista Pharmaceuticals Inc</td>\n",
       "      <td>2015-04-09</td>\n",
       "      <td>442.29</td>\n",
       "      <td>150</td>\n",
       "      <td>401.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-154.72</td>\n",
       "      <td>https://www.kalvista.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug ther...</td>\n",
       "      <td>77.84</td>\n",
       "      <td>8.69</td>\n",
       "      <td>-88.84</td>\n",
       "      <td>3540</td>\n",
       "      <td>-34.98</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333</th>\n",
       "      <td>AVTE</td>\n",
       "      <td>Aerovate Therapeutics Inc</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>74.01</td>\n",
       "      <td>51</td>\n",
       "      <td>791.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-89.96</td>\n",
       "      <td>https://aerovatetx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmona...</td>\n",
       "      <td>22.83</td>\n",
       "      <td>2.53</td>\n",
       "      <td>-88.92</td>\n",
       "      <td>1266</td>\n",
       "      <td>-121.55</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>ALEC</td>\n",
       "      <td>Alector Inc</td>\n",
       "      <td>2019-02-07</td>\n",
       "      <td>193.91</td>\n",
       "      <td>241</td>\n",
       "      <td>1065.00</td>\n",
       "      <td>61.51</td>\n",
       "      <td>-177.39</td>\n",
       "      <td>https://www.alector.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products includ...</td>\n",
       "      <td>18.08</td>\n",
       "      <td>1.97</td>\n",
       "      <td>-89.10</td>\n",
       "      <td>2140</td>\n",
       "      <td>-91.48</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>335</th>\n",
       "      <td>VTYX</td>\n",
       "      <td>Ventyx Biosciences Inc</td>\n",
       "      <td>2021-10-21</td>\n",
       "      <td>159.10</td>\n",
       "      <td>75</td>\n",
       "      <td>1540.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-166.12</td>\n",
       "      <td>https://ventyxbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammator...</td>\n",
       "      <td>21.02</td>\n",
       "      <td>2.28</td>\n",
       "      <td>-89.15</td>\n",
       "      <td>1153</td>\n",
       "      <td>-104.41</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>ACXP</td>\n",
       "      <td>Acurx Pharmaceuticals Inc</td>\n",
       "      <td>2021-06-25</td>\n",
       "      <td>13.94</td>\n",
       "      <td>4</td>\n",
       "      <td>123.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.acurxpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead an...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>0.86</td>\n",
       "      <td>-89.16</td>\n",
       "      <td>1271</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>HLVX</td>\n",
       "      <td>HilleVax Inc</td>\n",
       "      <td>2022-04-29</td>\n",
       "      <td>97.12</td>\n",
       "      <td>90</td>\n",
       "      <td>190.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-134.04</td>\n",
       "      <td>https://www.hillevax.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It deve...</td>\n",
       "      <td>19.09</td>\n",
       "      <td>1.96</td>\n",
       "      <td>-89.73</td>\n",
       "      <td>963</td>\n",
       "      <td>-138.01</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>338</th>\n",
       "      <td>HOWL</td>\n",
       "      <td>Werewolf Therapeutics Inc</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>73.97</td>\n",
       "      <td>45</td>\n",
       "      <td>752.00</td>\n",
       "      <td>3.39</td>\n",
       "      <td>-64.38</td>\n",
       "      <td>https://werewolftx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment...</td>\n",
       "      <td>16.10</td>\n",
       "      <td>1.65</td>\n",
       "      <td>-89.75</td>\n",
       "      <td>1327</td>\n",
       "      <td>-87.04</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339</th>\n",
       "      <td>ABOS</td>\n",
       "      <td>Acumen Pharmaceuticals Inc</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>118.36</td>\n",
       "      <td>51</td>\n",
       "      <td>219.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-92.84</td>\n",
       "      <td>https://acumenpharm.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. Th...</td>\n",
       "      <td>20.10</td>\n",
       "      <td>2.03</td>\n",
       "      <td>-89.90</td>\n",
       "      <td>1265</td>\n",
       "      <td>-78.44</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>340</th>\n",
       "      <td>TVGN</td>\n",
       "      <td>Tevogen Bio Holdings Inc</td>\n",
       "      <td>2022-01-05</td>\n",
       "      <td>178.55</td>\n",
       "      <td>0</td>\n",
       "      <td>16906.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-42.29</td>\n",
       "      <td>https://tevogen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for ...</td>\n",
       "      <td>9.94</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-89.94</td>\n",
       "      <td>1077</td>\n",
       "      <td>-23.69</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>AUTL</td>\n",
       "      <td>Autolus Therapeutics plc ADR</td>\n",
       "      <td>2018-06-22</td>\n",
       "      <td>686.59</td>\n",
       "      <td>463</td>\n",
       "      <td>1663.00</td>\n",
       "      <td>10.09</td>\n",
       "      <td>-205.86</td>\n",
       "      <td>https://www.autolus.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune disease...</td>\n",
       "      <td>25.00</td>\n",
       "      <td>2.49</td>\n",
       "      <td>-90.04</td>\n",
       "      <td>2370</td>\n",
       "      <td>-29.98</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>SYRE</td>\n",
       "      <td>Spyre Therapeutics Inc</td>\n",
       "      <td>2016-04-07</td>\n",
       "      <td>1433.61</td>\n",
       "      <td>30</td>\n",
       "      <td>582.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-194.51</td>\n",
       "      <td>https://www.spyre.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowe...</td>\n",
       "      <td>244.25</td>\n",
       "      <td>24.12</td>\n",
       "      <td>-90.12</td>\n",
       "      <td>3176</td>\n",
       "      <td>-13.57</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>NGNE</td>\n",
       "      <td>Neurogene Inc</td>\n",
       "      <td>2014-03-07</td>\n",
       "      <td>373.30</td>\n",
       "      <td>91</td>\n",
       "      <td>366.00</td>\n",
       "      <td>0.92</td>\n",
       "      <td>-65.47</td>\n",
       "      <td>https://www.neurogene.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-4...</td>\n",
       "      <td>239.00</td>\n",
       "      <td>23.51</td>\n",
       "      <td>-90.16</td>\n",
       "      <td>3938</td>\n",
       "      <td>-17.54</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>344</th>\n",
       "      <td>BYSI</td>\n",
       "      <td>BeyondSpring Inc</td>\n",
       "      <td>2017-03-09</td>\n",
       "      <td>64.70</td>\n",
       "      <td>36</td>\n",
       "      <td>26.00</td>\n",
       "      <td>1.88</td>\n",
       "      <td>-16.72</td>\n",
       "      <td>https://beyondspringpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The...</td>\n",
       "      <td>16.80</td>\n",
       "      <td>1.64</td>\n",
       "      <td>-90.24</td>\n",
       "      <td>2840</td>\n",
       "      <td>-25.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>AVIR</td>\n",
       "      <td>Atea Pharmaceuticals Inc</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>261.84</td>\n",
       "      <td>75</td>\n",
       "      <td>214.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-124.88</td>\n",
       "      <td>https://ateapharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patient...</td>\n",
       "      <td>30.34</td>\n",
       "      <td>2.93</td>\n",
       "      <td>-90.34</td>\n",
       "      <td>1509</td>\n",
       "      <td>-47.69</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>346</th>\n",
       "      <td>IMMP</td>\n",
       "      <td>Immutep Limited ADR</td>\n",
       "      <td>2012-04-19</td>\n",
       "      <td>314.84</td>\n",
       "      <td>0</td>\n",
       "      <td>114.00</td>\n",
       "      <td>3.84</td>\n",
       "      <td>-44.54</td>\n",
       "      <td>https://www.immutep.com</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immutep Limited, a late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases ...</td>\n",
       "      <td>23.33</td>\n",
       "      <td>2.18</td>\n",
       "      <td>-90.66</td>\n",
       "      <td>4625</td>\n",
       "      <td>-14.15</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>347</th>\n",
       "      <td>SPRO</td>\n",
       "      <td>Spero Therapeutics Inc</td>\n",
       "      <td>2017-11-02</td>\n",
       "      <td>58.33</td>\n",
       "      <td>46</td>\n",
       "      <td>252.00</td>\n",
       "      <td>118.46</td>\n",
       "      <td>21.01</td>\n",
       "      <td>https://sperotherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for...</td>\n",
       "      <td>11.50</td>\n",
       "      <td>1.07</td>\n",
       "      <td>-90.70</td>\n",
       "      <td>2602</td>\n",
       "      <td>36.02</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>348</th>\n",
       "      <td>IMRX</td>\n",
       "      <td>Immuneering Corp</td>\n",
       "      <td>2021-07-30</td>\n",
       "      <td>53.72</td>\n",
       "      <td>66</td>\n",
       "      <td>1771.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-60.09</td>\n",
       "      <td>https://immuneering.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its ...</td>\n",
       "      <td>17.59</td>\n",
       "      <td>1.63</td>\n",
       "      <td>-90.70</td>\n",
       "      <td>1236</td>\n",
       "      <td>-111.86</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>349</th>\n",
       "      <td>MNKD</td>\n",
       "      <td>Mannkind Corp</td>\n",
       "      <td>2004-07-28</td>\n",
       "      <td>1729.13</td>\n",
       "      <td>411</td>\n",
       "      <td>2381.00</td>\n",
       "      <td>267.20</td>\n",
       "      <td>63.69</td>\n",
       "      <td>https://www.mannkindcorp.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine ...</td>\n",
       "      <td>70.40</td>\n",
       "      <td>6.54</td>\n",
       "      <td>-90.71</td>\n",
       "      <td>7447</td>\n",
       "      <td>3.68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>350</th>\n",
       "      <td>ANTX</td>\n",
       "      <td>AN2 Therapeutics Inc</td>\n",
       "      <td>2022-03-25</td>\n",
       "      <td>40.34</td>\n",
       "      <td>41</td>\n",
       "      <td>503.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.an2therapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious dis...</td>\n",
       "      <td>15.40</td>\n",
       "      <td>1.43</td>\n",
       "      <td>-90.71</td>\n",
       "      <td>998</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>ALGS</td>\n",
       "      <td>Aligos Therapeutics Inc</td>\n",
       "      <td>2020-10-16</td>\n",
       "      <td>120.77</td>\n",
       "      <td>68</td>\n",
       "      <td>337.00</td>\n",
       "      <td>6.00</td>\n",
       "      <td>-92.68</td>\n",
       "      <td>https://www.aligos.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical n...</td>\n",
       "      <td>371.25</td>\n",
       "      <td>34.07</td>\n",
       "      <td>-90.82</td>\n",
       "      <td>1523</td>\n",
       "      <td>-76.74</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>352</th>\n",
       "      <td>LVTX</td>\n",
       "      <td>LAVA Therapeutics NV</td>\n",
       "      <td>2021-03-26</td>\n",
       "      <td>26.82</td>\n",
       "      <td>37</td>\n",
       "      <td>77.00</td>\n",
       "      <td>7.40</td>\n",
       "      <td>-26.88</td>\n",
       "      <td>https://www.lavatherapeutics.com</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platf...</td>\n",
       "      <td>12.50</td>\n",
       "      <td>1.11</td>\n",
       "      <td>-91.12</td>\n",
       "      <td>1362</td>\n",
       "      <td>-100.22</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>353</th>\n",
       "      <td>MLEC</td>\n",
       "      <td>Moolec Science SA</td>\n",
       "      <td>2021-03-02</td>\n",
       "      <td>33.36</td>\n",
       "      <td>52</td>\n",
       "      <td>23.00</td>\n",
       "      <td>5.63</td>\n",
       "      <td>-8.16</td>\n",
       "      <td>https://moolecscience.com</td>\n",
       "      <td>Luxembourg</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Moolec Science SA, a science-based food ingredient company, focuses on developing ingredients for food, pet food, animal feed, and dietary supplem...</td>\n",
       "      <td>9.81</td>\n",
       "      <td>0.86</td>\n",
       "      <td>-91.23</td>\n",
       "      <td>1386</td>\n",
       "      <td>-24.46</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>NKGN</td>\n",
       "      <td>NKGen Biotech Inc</td>\n",
       "      <td>2023-10-02</td>\n",
       "      <td>16.00</td>\n",
       "      <td>63</td>\n",
       "      <td>1374.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-30.23</td>\n",
       "      <td>https://nkgenbiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, alloge...</td>\n",
       "      <td>5.71</td>\n",
       "      <td>0.50</td>\n",
       "      <td>-91.24</td>\n",
       "      <td>442</td>\n",
       "      <td>-188.94</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>CTMX</td>\n",
       "      <td>CytomX Therapeutics Inc</td>\n",
       "      <td>2015-10-08</td>\n",
       "      <td>90.00</td>\n",
       "      <td>120</td>\n",
       "      <td>1145.00</td>\n",
       "      <td>126.62</td>\n",
       "      <td>8.55</td>\n",
       "      <td>https://www.cytomx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized ...</td>\n",
       "      <td>12.90</td>\n",
       "      <td>1.11</td>\n",
       "      <td>-91.40</td>\n",
       "      <td>3358</td>\n",
       "      <td>9.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>TSHA</td>\n",
       "      <td>Taysha Gene Therapies Inc</td>\n",
       "      <td>2020-09-24</td>\n",
       "      <td>411.94</td>\n",
       "      <td>52</td>\n",
       "      <td>4343.00</td>\n",
       "      <td>9.91</td>\n",
       "      <td>-81.15</td>\n",
       "      <td>https://www.tayshagtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the...</td>\n",
       "      <td>24.06</td>\n",
       "      <td>2.07</td>\n",
       "      <td>-91.40</td>\n",
       "      <td>1545</td>\n",
       "      <td>-19.70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>OVID</td>\n",
       "      <td>Ovid Therapeutics Inc</td>\n",
       "      <td>2017-05-05</td>\n",
       "      <td>74.56</td>\n",
       "      <td>25</td>\n",
       "      <td>184.00</td>\n",
       "      <td>0.63</td>\n",
       "      <td>-65.06</td>\n",
       "      <td>https://www.ovidrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies a...</td>\n",
       "      <td>12.25</td>\n",
       "      <td>1.03</td>\n",
       "      <td>-91.59</td>\n",
       "      <td>2783</td>\n",
       "      <td>-87.26</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>IBRX</td>\n",
       "      <td>ImmunityBio Inc</td>\n",
       "      <td>2015-07-28</td>\n",
       "      <td>2234.30</td>\n",
       "      <td>672</td>\n",
       "      <td>5889.00</td>\n",
       "      <td>7.33</td>\n",
       "      <td>-341.30</td>\n",
       "      <td>https://immunitybio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to ...</td>\n",
       "      <td>34.64</td>\n",
       "      <td>2.87</td>\n",
       "      <td>-91.71</td>\n",
       "      <td>3430</td>\n",
       "      <td>-15.28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>CUE</td>\n",
       "      <td>Cue Biopharma Inc</td>\n",
       "      <td>2018-01-02</td>\n",
       "      <td>64.62</td>\n",
       "      <td>53</td>\n",
       "      <td>801.00</td>\n",
       "      <td>8.30</td>\n",
       "      <td>-47.71</td>\n",
       "      <td>https://www.cuebiopharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modul...</td>\n",
       "      <td>11.63</td>\n",
       "      <td>0.94</td>\n",
       "      <td>-91.92</td>\n",
       "      <td>2541</td>\n",
       "      <td>-73.83</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>IMAB</td>\n",
       "      <td>I-Mab ADR</td>\n",
       "      <td>2020-01-17</td>\n",
       "      <td>78.19</td>\n",
       "      <td>34</td>\n",
       "      <td>421.00</td>\n",
       "      <td>3.49</td>\n",
       "      <td>-169.25</td>\n",
       "      <td>https://ir.i-mabbiopharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics in the fields of immuno-oncology and immuno-i...</td>\n",
       "      <td>12.50</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-92.00</td>\n",
       "      <td>1796</td>\n",
       "      <td>-216.46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>EDIT</td>\n",
       "      <td>Editas Medicine Inc</td>\n",
       "      <td>2016-02-03</td>\n",
       "      <td>122.17</td>\n",
       "      <td>265</td>\n",
       "      <td>2437.00</td>\n",
       "      <td>61.76</td>\n",
       "      <td>-222.63</td>\n",
       "      <td>https://www.editasmedicine.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious...</td>\n",
       "      <td>18.20</td>\n",
       "      <td>1.44</td>\n",
       "      <td>-92.09</td>\n",
       "      <td>3240</td>\n",
       "      <td>-182.23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>DBVT</td>\n",
       "      <td>DBV Technologies ADR</td>\n",
       "      <td>2014-10-22</td>\n",
       "      <td>70.91</td>\n",
       "      <td>108</td>\n",
       "      <td>809.00</td>\n",
       "      <td>12.52</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.dbv-technologies.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products....</td>\n",
       "      <td>45.80</td>\n",
       "      <td>3.57</td>\n",
       "      <td>-92.21</td>\n",
       "      <td>3709</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>RLYB</td>\n",
       "      <td>Rallybio Corp</td>\n",
       "      <td>2021-07-29</td>\n",
       "      <td>42.73</td>\n",
       "      <td>43</td>\n",
       "      <td>77.00</td>\n",
       "      <td>0.60</td>\n",
       "      <td>-69.86</td>\n",
       "      <td>https://www.rallybio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for pati...</td>\n",
       "      <td>14.10</td>\n",
       "      <td>1.08</td>\n",
       "      <td>-92.34</td>\n",
       "      <td>1237</td>\n",
       "      <td>-163.49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>ALLO</td>\n",
       "      <td>Allogene Therapeutics Inc</td>\n",
       "      <td>2018-10-11</td>\n",
       "      <td>431.92</td>\n",
       "      <td>232</td>\n",
       "      <td>2290.00</td>\n",
       "      <td>0.04</td>\n",
       "      <td>-254.97</td>\n",
       "      <td>https://www.allogene.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therap...</td>\n",
       "      <td>25.00</td>\n",
       "      <td>1.89</td>\n",
       "      <td>-92.44</td>\n",
       "      <td>2259</td>\n",
       "      <td>-59.03</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>CKPT</td>\n",
       "      <td>Checkpoint Therapeutics Inc</td>\n",
       "      <td>2016-12-19</td>\n",
       "      <td>165.54</td>\n",
       "      <td>23</td>\n",
       "      <td>853.00</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://checkpointtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commerci...</td>\n",
       "      <td>50.00</td>\n",
       "      <td>3.67</td>\n",
       "      <td>-92.66</td>\n",
       "      <td>2920</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>AEON</td>\n",
       "      <td>AEON Biopharma Inc</td>\n",
       "      <td>2023-07-24</td>\n",
       "      <td>25.98</td>\n",
       "      <td>5</td>\n",
       "      <td>201.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-43.86</td>\n",
       "      <td>https://www.aeonbiopharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA)...</td>\n",
       "      <td>9.20</td>\n",
       "      <td>0.67</td>\n",
       "      <td>-92.67</td>\n",
       "      <td>512</td>\n",
       "      <td>-168.82</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>CDTX</td>\n",
       "      <td>Cidara Therapeutics Inc</td>\n",
       "      <td>2015-04-15</td>\n",
       "      <td>254.44</td>\n",
       "      <td>69</td>\n",
       "      <td>41.00</td>\n",
       "      <td>53.87</td>\n",
       "      <td>-30.11</td>\n",
       "      <td>https://www.cidara.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious disease...</td>\n",
       "      <td>320.00</td>\n",
       "      <td>22.88</td>\n",
       "      <td>-92.85</td>\n",
       "      <td>3534</td>\n",
       "      <td>-11.83</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>368</th>\n",
       "      <td>IOVA</td>\n",
       "      <td>Iovance Biotherapeutics Inc</td>\n",
       "      <td>2010-10-15</td>\n",
       "      <td>2389.48</td>\n",
       "      <td>557</td>\n",
       "      <td>6027.00</td>\n",
       "      <td>90.86</td>\n",
       "      <td>-408.32</td>\n",
       "      <td>https://www.iovance.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltr...</td>\n",
       "      <td>110.00</td>\n",
       "      <td>7.83</td>\n",
       "      <td>-92.88</td>\n",
       "      <td>5177</td>\n",
       "      <td>-17.09</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369</th>\n",
       "      <td>RAPT</td>\n",
       "      <td>RAPT Therapeutics Inc</td>\n",
       "      <td>2019-10-31</td>\n",
       "      <td>30.81</td>\n",
       "      <td>70</td>\n",
       "      <td>550.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-113.61</td>\n",
       "      <td>https://www.rapt.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of ...</td>\n",
       "      <td>13.00</td>\n",
       "      <td>0.91</td>\n",
       "      <td>-93.00</td>\n",
       "      <td>1874</td>\n",
       "      <td>-368.74</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370</th>\n",
       "      <td>ATAI</td>\n",
       "      <td>ATAI Life Sciences N.V</td>\n",
       "      <td>2021-06-18</td>\n",
       "      <td>223.18</td>\n",
       "      <td>83</td>\n",
       "      <td>1289.00</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-102.44</td>\n",
       "      <td>https://www.atai.life</td>\n",
       "      <td>Germany</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, ad...</td>\n",
       "      <td>19.45</td>\n",
       "      <td>1.36</td>\n",
       "      <td>-93.01</td>\n",
       "      <td>1278</td>\n",
       "      <td>-45.90</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>371</th>\n",
       "      <td>ADAG</td>\n",
       "      <td>Adagene Inc ADR</td>\n",
       "      <td>2021-02-09</td>\n",
       "      <td>89.87</td>\n",
       "      <td>174</td>\n",
       "      <td>71.00</td>\n",
       "      <td>0.82</td>\n",
       "      <td>-36.13</td>\n",
       "      <td>https://www.adagene.com</td>\n",
       "      <td>China</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancer...</td>\n",
       "      <td>29.99</td>\n",
       "      <td>2.06</td>\n",
       "      <td>-93.13</td>\n",
       "      <td>1407</td>\n",
       "      <td>-40.20</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>372</th>\n",
       "      <td>KRRO</td>\n",
       "      <td>Korro Bio Inc</td>\n",
       "      <td>2019-10-03</td>\n",
       "      <td>451.18</td>\n",
       "      <td>101</td>\n",
       "      <td>138.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-92.47</td>\n",
       "      <td>https://www.korrobio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing R...</td>\n",
       "      <td>685.00</td>\n",
       "      <td>46.88</td>\n",
       "      <td>-93.16</td>\n",
       "      <td>1902</td>\n",
       "      <td>-20.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>373</th>\n",
       "      <td>BDTX</td>\n",
       "      <td>Black Diamond Therapeutics Inc</td>\n",
       "      <td>2020-01-31</td>\n",
       "      <td>149.38</td>\n",
       "      <td>54</td>\n",
       "      <td>1194.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-81.02</td>\n",
       "      <td>https://www.blackdiamondtherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for ...</td>\n",
       "      <td>37.50</td>\n",
       "      <td>2.56</td>\n",
       "      <td>-93.17</td>\n",
       "      <td>1782</td>\n",
       "      <td>-54.24</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>LUMO</td>\n",
       "      <td>Lumos Pharma Inc</td>\n",
       "      <td>2011-11-11</td>\n",
       "      <td>37.54</td>\n",
       "      <td>30</td>\n",
       "      <td>95.00</td>\n",
       "      <td>2.20</td>\n",
       "      <td>-36.31</td>\n",
       "      <td>https://lumos-pharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of ...</td>\n",
       "      <td>63.72</td>\n",
       "      <td>4.34</td>\n",
       "      <td>-93.19</td>\n",
       "      <td>4785</td>\n",
       "      <td>-96.72</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>OCEA</td>\n",
       "      <td>Ocean Biomedical Inc</td>\n",
       "      <td>2021-11-08</td>\n",
       "      <td>22.32</td>\n",
       "      <td>0</td>\n",
       "      <td>51.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.oceanbiomedical.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infecti...</td>\n",
       "      <td>9.97</td>\n",
       "      <td>0.68</td>\n",
       "      <td>-93.22</td>\n",
       "      <td>1135</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>376</th>\n",
       "      <td>ALT</td>\n",
       "      <td>Altimmune Inc</td>\n",
       "      <td>2017-05-26</td>\n",
       "      <td>640.12</td>\n",
       "      <td>59</td>\n",
       "      <td>3005.00</td>\n",
       "      <td>0.05</td>\n",
       "      <td>-99.19</td>\n",
       "      <td>https://altimmune.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead p...</td>\n",
       "      <td>133.20</td>\n",
       "      <td>9.03</td>\n",
       "      <td>-93.22</td>\n",
       "      <td>2762</td>\n",
       "      <td>-15.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>377</th>\n",
       "      <td>OKUR</td>\n",
       "      <td>OnKure Therapeutics Inc</td>\n",
       "      <td>2021-04-08</td>\n",
       "      <td>121.12</td>\n",
       "      <td>0</td>\n",
       "      <td>64.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-45.12</td>\n",
       "      <td>https://onkuretherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target...</td>\n",
       "      <td>150.00</td>\n",
       "      <td>9.86</td>\n",
       "      <td>-93.43</td>\n",
       "      <td>1349</td>\n",
       "      <td>-37.25</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>SRZN</td>\n",
       "      <td>Surrozen Inc</td>\n",
       "      <td>2021-01-11</td>\n",
       "      <td>32.50</td>\n",
       "      <td>42</td>\n",
       "      <td>32.00</td>\n",
       "      <td>10.00</td>\n",
       "      <td>-25.02</td>\n",
       "      <td>https://www.surrozen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue ...</td>\n",
       "      <td>151.65</td>\n",
       "      <td>9.85</td>\n",
       "      <td>-93.50</td>\n",
       "      <td>1436</td>\n",
       "      <td>-76.98</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>BRNS</td>\n",
       "      <td>Barinthus Biotherapeutics Plc. ADR</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>39.19</td>\n",
       "      <td>130</td>\n",
       "      <td>50.00</td>\n",
       "      <td>14.97</td>\n",
       "      <td>-59.84</td>\n",
       "      <td>https://www.barinthusbio.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in development of novel T cell immunotherapeutic candidates des...</td>\n",
       "      <td>14.10</td>\n",
       "      <td>0.91</td>\n",
       "      <td>-93.52</td>\n",
       "      <td>1327</td>\n",
       "      <td>-152.69</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>380</th>\n",
       "      <td>ADCT</td>\n",
       "      <td>Adc Therapeutics SA</td>\n",
       "      <td>2020-05-18</td>\n",
       "      <td>193.38</td>\n",
       "      <td>273</td>\n",
       "      <td>737.00</td>\n",
       "      <td>70.72</td>\n",
       "      <td>-136.87</td>\n",
       "      <td>https://www.adctherapeutics.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for...</td>\n",
       "      <td>30.00</td>\n",
       "      <td>1.89</td>\n",
       "      <td>-93.70</td>\n",
       "      <td>1674</td>\n",
       "      <td>-70.78</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>381</th>\n",
       "      <td>PVLA</td>\n",
       "      <td>Pieris Pharmaceuticals Inc</td>\n",
       "      <td>2015-01-02</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>20.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>220.00</td>\n",
       "      <td>13.60</td>\n",
       "      <td>-93.82</td>\n",
       "      <td>3637</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>382</th>\n",
       "      <td>QNCX</td>\n",
       "      <td>Quince Therapeutics Inc</td>\n",
       "      <td>2019-05-09</td>\n",
       "      <td>84.04</td>\n",
       "      <td>32</td>\n",
       "      <td>574.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-29.13</td>\n",
       "      <td>https://www.quincetx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debil...</td>\n",
       "      <td>32.89</td>\n",
       "      <td>2.03</td>\n",
       "      <td>-93.83</td>\n",
       "      <td>2049</td>\n",
       "      <td>-34.66</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>383</th>\n",
       "      <td>XLO</td>\n",
       "      <td>Xilio Therapeutics Inc</td>\n",
       "      <td>2021-10-22</td>\n",
       "      <td>42.11</td>\n",
       "      <td>73</td>\n",
       "      <td>235.00</td>\n",
       "      <td>4.62</td>\n",
       "      <td>-62.43</td>\n",
       "      <td>https://xiliotx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology ther...</td>\n",
       "      <td>16.00</td>\n",
       "      <td>0.97</td>\n",
       "      <td>-93.94</td>\n",
       "      <td>1152</td>\n",
       "      <td>-148.25</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>384</th>\n",
       "      <td>OMGA</td>\n",
       "      <td>Omega Therapeutics Inc</td>\n",
       "      <td>2021-07-30</td>\n",
       "      <td>47.40</td>\n",
       "      <td>93</td>\n",
       "      <td>314.00</td>\n",
       "      <td>6.31</td>\n",
       "      <td>-78.89</td>\n",
       "      <td>https://omegatherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigeneti...</td>\n",
       "      <td>16.00</td>\n",
       "      <td>0.97</td>\n",
       "      <td>-93.94</td>\n",
       "      <td>1236</td>\n",
       "      <td>-166.43</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>385</th>\n",
       "      <td>CNTB</td>\n",
       "      <td>Connect Biopharma Holdings Ltd ADR</td>\n",
       "      <td>2021-03-19</td>\n",
       "      <td>60.23</td>\n",
       "      <td>81</td>\n",
       "      <td>28.00</td>\n",
       "      <td>24.12</td>\n",
       "      <td>-24.95</td>\n",
       "      <td>https://www.connectbiopharm.com</td>\n",
       "      <td>China</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cel...</td>\n",
       "      <td>18.49</td>\n",
       "      <td>1.12</td>\n",
       "      <td>-93.95</td>\n",
       "      <td>1369</td>\n",
       "      <td>-41.42</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>ACHL</td>\n",
       "      <td>Achilles Therapeutics Plc ADR</td>\n",
       "      <td>2021-03-31</td>\n",
       "      <td>42.16</td>\n",
       "      <td>204</td>\n",
       "      <td>712.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-65.90</td>\n",
       "      <td>https://www.achillestx.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutatio...</td>\n",
       "      <td>16.55</td>\n",
       "      <td>0.99</td>\n",
       "      <td>-94.02</td>\n",
       "      <td>1357</td>\n",
       "      <td>-156.31</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387</th>\n",
       "      <td>STTK</td>\n",
       "      <td>Shattuck Labs Inc</td>\n",
       "      <td>2020-10-09</td>\n",
       "      <td>52.04</td>\n",
       "      <td>75</td>\n",
       "      <td>675.00</td>\n",
       "      <td>4.12</td>\n",
       "      <td>-86.32</td>\n",
       "      <td>https://www.shattucklabs.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the Unite...</td>\n",
       "      <td>19.35</td>\n",
       "      <td>1.14</td>\n",
       "      <td>-94.11</td>\n",
       "      <td>1530</td>\n",
       "      <td>-165.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>388</th>\n",
       "      <td>IKT</td>\n",
       "      <td>Inhibikase Therapeutics Inc</td>\n",
       "      <td>2020-12-23</td>\n",
       "      <td>239.88</td>\n",
       "      <td>8</td>\n",
       "      <td>564.00</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-18.98</td>\n",
       "      <td>https://www.inhibikase.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its l...</td>\n",
       "      <td>59.40</td>\n",
       "      <td>3.44</td>\n",
       "      <td>-94.21</td>\n",
       "      <td>1455</td>\n",
       "      <td>-7.91</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>389</th>\n",
       "      <td>RPTX</td>\n",
       "      <td>Repare Therapeutics Inc</td>\n",
       "      <td>2020-06-19</td>\n",
       "      <td>68.02</td>\n",
       "      <td>179</td>\n",
       "      <td>240.00</td>\n",
       "      <td>66.52</td>\n",
       "      <td>-90.24</td>\n",
       "      <td>https://www.reparerx.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synth...</td>\n",
       "      <td>30.80</td>\n",
       "      <td>1.77</td>\n",
       "      <td>-94.25</td>\n",
       "      <td>1642</td>\n",
       "      <td>-132.67</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>HCWB</td>\n",
       "      <td>HCW Biologics Inc</td>\n",
       "      <td>2021-07-20</td>\n",
       "      <td>15.85</td>\n",
       "      <td>45</td>\n",
       "      <td>9478.00</td>\n",
       "      <td>3.92</td>\n",
       "      <td>-36.58</td>\n",
       "      <td>https://www.hcwbiologics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade...</td>\n",
       "      <td>6.30</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-94.33</td>\n",
       "      <td>1246</td>\n",
       "      <td>-230.79</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>391</th>\n",
       "      <td>CVAC</td>\n",
       "      <td>CureVac N.V</td>\n",
       "      <td>2020-08-14</td>\n",
       "      <td>695.45</td>\n",
       "      <td>999</td>\n",
       "      <td>487.00</td>\n",
       "      <td>65.86</td>\n",
       "      <td>-270.34</td>\n",
       "      <td>https://www.curevac.com</td>\n",
       "      <td>Germany</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It i...</td>\n",
       "      <td>55.90</td>\n",
       "      <td>3.16</td>\n",
       "      <td>-94.35</td>\n",
       "      <td>1586</td>\n",
       "      <td>-38.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>392</th>\n",
       "      <td>SNTI</td>\n",
       "      <td>Senti Biosciences Inc</td>\n",
       "      <td>2021-05-26</td>\n",
       "      <td>23.45</td>\n",
       "      <td>48</td>\n",
       "      <td>2307.00</td>\n",
       "      <td>0.34</td>\n",
       "      <td>-56.60</td>\n",
       "      <td>https://www.sentibio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its ...</td>\n",
       "      <td>99.80</td>\n",
       "      <td>5.57</td>\n",
       "      <td>-94.42</td>\n",
       "      <td>1301</td>\n",
       "      <td>-241.36</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>ELEV</td>\n",
       "      <td>Elevation Oncology Inc</td>\n",
       "      <td>2021-06-25</td>\n",
       "      <td>37.84</td>\n",
       "      <td>29</td>\n",
       "      <td>761.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-41.98</td>\n",
       "      <td>https://elevationoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of so...</td>\n",
       "      <td>11.44</td>\n",
       "      <td>0.64</td>\n",
       "      <td>-94.44</td>\n",
       "      <td>1271</td>\n",
       "      <td>-110.94</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>394</th>\n",
       "      <td>LIPO</td>\n",
       "      <td>Lipella Pharmaceuticals Inc</td>\n",
       "      <td>2022-12-19</td>\n",
       "      <td>3.26</td>\n",
       "      <td>5</td>\n",
       "      <td>207.00</td>\n",
       "      <td>0.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.lipella.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs an...</td>\n",
       "      <td>46.00</td>\n",
       "      <td>2.54</td>\n",
       "      <td>-94.48</td>\n",
       "      <td>729</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395</th>\n",
       "      <td>PTIX</td>\n",
       "      <td>Protagenic Therapeutics Inc</td>\n",
       "      <td>2021-04-27</td>\n",
       "      <td>3.50</td>\n",
       "      <td>1</td>\n",
       "      <td>177.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.00</td>\n",
       "      <td>https://www.protagenic.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuro...</td>\n",
       "      <td>9.04</td>\n",
       "      <td>0.50</td>\n",
       "      <td>-94.52</td>\n",
       "      <td>1330</td>\n",
       "      <td>-171.43</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>396</th>\n",
       "      <td>NXTC</td>\n",
       "      <td>Nextcure Inc</td>\n",
       "      <td>2019-05-09</td>\n",
       "      <td>28.29</td>\n",
       "      <td>82</td>\n",
       "      <td>84.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-60.40</td>\n",
       "      <td>https://www.nextcure.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other ...</td>\n",
       "      <td>19.90</td>\n",
       "      <td>1.08</td>\n",
       "      <td>-94.57</td>\n",
       "      <td>2049</td>\n",
       "      <td>-213.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>397</th>\n",
       "      <td>SANA</td>\n",
       "      <td>Sana Biotechnology Inc</td>\n",
       "      <td>2021-02-04</td>\n",
       "      <td>437.61</td>\n",
       "      <td>328</td>\n",
       "      <td>1567.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-273.80</td>\n",
       "      <td>https://www.sana.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engine...</td>\n",
       "      <td>35.10</td>\n",
       "      <td>1.89</td>\n",
       "      <td>-94.62</td>\n",
       "      <td>1412</td>\n",
       "      <td>-62.57</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>398</th>\n",
       "      <td>IPSC</td>\n",
       "      <td>Century Therapeutics Inc</td>\n",
       "      <td>2021-06-18</td>\n",
       "      <td>99.48</td>\n",
       "      <td>152</td>\n",
       "      <td>509.00</td>\n",
       "      <td>2.68</td>\n",
       "      <td>-117.93</td>\n",
       "      <td>https://www.centurytx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Century Therapeutics, Inc., a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatm...</td>\n",
       "      <td>22.83</td>\n",
       "      <td>1.22</td>\n",
       "      <td>-94.66</td>\n",
       "      <td>1278</td>\n",
       "      <td>-118.55</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>GOVX</td>\n",
       "      <td>Geovax Labs Inc</td>\n",
       "      <td>2020-09-25</td>\n",
       "      <td>21.61</td>\n",
       "      <td>17</td>\n",
       "      <td>1684.00</td>\n",
       "      <td>0.30</td>\n",
       "      <td>-27.16</td>\n",
       "      <td>https://www.geovax.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor...</td>\n",
       "      <td>44.10</td>\n",
       "      <td>2.35</td>\n",
       "      <td>-94.67</td>\n",
       "      <td>1544</td>\n",
       "      <td>-125.68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>400</th>\n",
       "      <td>GOSS</td>\n",
       "      <td>Gossamer Bio Inc</td>\n",
       "      <td>2019-02-08</td>\n",
       "      <td>194.38</td>\n",
       "      <td>135</td>\n",
       "      <td>1314.00</td>\n",
       "      <td>105.32</td>\n",
       "      <td>-61.80</td>\n",
       "      <td>https://www.gossamerbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmona...</td>\n",
       "      <td>17.94</td>\n",
       "      <td>0.93</td>\n",
       "      <td>-94.82</td>\n",
       "      <td>2139</td>\n",
       "      <td>-31.79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>IOBT</td>\n",
       "      <td>IO Biotech Inc</td>\n",
       "      <td>2021-11-05</td>\n",
       "      <td>51.85</td>\n",
       "      <td>74</td>\n",
       "      <td>400.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-93.16</td>\n",
       "      <td>https://www.iobiotech.com</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology...</td>\n",
       "      <td>15.65</td>\n",
       "      <td>0.81</td>\n",
       "      <td>-94.82</td>\n",
       "      <td>1138</td>\n",
       "      <td>-179.67</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>402</th>\n",
       "      <td>IKNA</td>\n",
       "      <td>Ikena Oncology Inc</td>\n",
       "      <td>2021-03-26</td>\n",
       "      <td>77.70</td>\n",
       "      <td>14</td>\n",
       "      <td>62.00</td>\n",
       "      <td>0.66</td>\n",
       "      <td>-63.58</td>\n",
       "      <td>https://ikenaoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growt...</td>\n",
       "      <td>32.00</td>\n",
       "      <td>1.65</td>\n",
       "      <td>-94.84</td>\n",
       "      <td>1362</td>\n",
       "      <td>-81.83</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>403</th>\n",
       "      <td>INKT</td>\n",
       "      <td>MiNK Therapeutics Inc</td>\n",
       "      <td>2021-10-15</td>\n",
       "      <td>22.94</td>\n",
       "      <td>31</td>\n",
       "      <td>40.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.25</td>\n",
       "      <td>https://minktherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, o...</td>\n",
       "      <td>12.00</td>\n",
       "      <td>0.62</td>\n",
       "      <td>-94.87</td>\n",
       "      <td>1159</td>\n",
       "      <td>-75.20</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>VCEL</td>\n",
       "      <td>Vericel Corp</td>\n",
       "      <td>1997-02-04</td>\n",
       "      <td>2786.78</td>\n",
       "      <td>314</td>\n",
       "      <td>392.00</td>\n",
       "      <td>226.84</td>\n",
       "      <td>3.95</td>\n",
       "      <td>https://vcel.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular...</td>\n",
       "      <td>1120.00</td>\n",
       "      <td>57.47</td>\n",
       "      <td>-94.87</td>\n",
       "      <td>10178</td>\n",
       "      <td>0.14</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>EQ</td>\n",
       "      <td>Equillium Inc</td>\n",
       "      <td>2018-10-12</td>\n",
       "      <td>22.68</td>\n",
       "      <td>45</td>\n",
       "      <td>169.00</td>\n",
       "      <td>42.62</td>\n",
       "      <td>-9.58</td>\n",
       "      <td>https://www.equilliumbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflam...</td>\n",
       "      <td>14.00</td>\n",
       "      <td>0.70</td>\n",
       "      <td>-95.00</td>\n",
       "      <td>2258</td>\n",
       "      <td>-42.24</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>NKTX</td>\n",
       "      <td>Nkarta Inc</td>\n",
       "      <td>2020-07-10</td>\n",
       "      <td>163.01</td>\n",
       "      <td>159</td>\n",
       "      <td>1244.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-118.14</td>\n",
       "      <td>https://www.nkartatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune dise...</td>\n",
       "      <td>47.90</td>\n",
       "      <td>2.34</td>\n",
       "      <td>-95.11</td>\n",
       "      <td>1621</td>\n",
       "      <td>-72.47</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>ALXO</td>\n",
       "      <td>Alx Oncology Holdings Inc</td>\n",
       "      <td>2020-07-17</td>\n",
       "      <td>81.22</td>\n",
       "      <td>89</td>\n",
       "      <td>812.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-159.01</td>\n",
       "      <td>https://www.alxoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. Th...</td>\n",
       "      <td>30.00</td>\n",
       "      <td>1.45</td>\n",
       "      <td>-95.17</td>\n",
       "      <td>1614</td>\n",
       "      <td>-195.78</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>MBRX</td>\n",
       "      <td>Moleculin Biotech Inc</td>\n",
       "      <td>2016-06-02</td>\n",
       "      <td>6.57</td>\n",
       "      <td>18</td>\n",
       "      <td>48.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-28.79</td>\n",
       "      <td>https://moleculin.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and v...</td>\n",
       "      <td>48.00</td>\n",
       "      <td>2.32</td>\n",
       "      <td>-95.17</td>\n",
       "      <td>3120</td>\n",
       "      <td>-438.20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>SILO</td>\n",
       "      <td>SILO Pharma Inc</td>\n",
       "      <td>2021-01-08</td>\n",
       "      <td>3.95</td>\n",
       "      <td>3</td>\n",
       "      <td>274.00</td>\n",
       "      <td>0.07</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://silopharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved cond...</td>\n",
       "      <td>17.50</td>\n",
       "      <td>0.83</td>\n",
       "      <td>-95.23</td>\n",
       "      <td>1439</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>ABCL</td>\n",
       "      <td>AbCellera Biologics Inc</td>\n",
       "      <td>2020-12-11</td>\n",
       "      <td>844.75</td>\n",
       "      <td>586</td>\n",
       "      <td>2208.00</td>\n",
       "      <td>32.96</td>\n",
       "      <td>-222.24</td>\n",
       "      <td>https://www.abcellera.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune respons...</td>\n",
       "      <td>58.90</td>\n",
       "      <td>2.81</td>\n",
       "      <td>-95.23</td>\n",
       "      <td>1467</td>\n",
       "      <td>-26.31</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>ZVRA</td>\n",
       "      <td>Zevra Therapeutics Inc</td>\n",
       "      <td>2015-04-16</td>\n",
       "      <td>450.49</td>\n",
       "      <td>65</td>\n",
       "      <td>842.00</td>\n",
       "      <td>24.49</td>\n",
       "      <td>-81.27</td>\n",
       "      <td>https://zevra.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zevra Therapeutics, Inc. discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company...</td>\n",
       "      <td>179.20</td>\n",
       "      <td>8.48</td>\n",
       "      <td>-95.27</td>\n",
       "      <td>3533</td>\n",
       "      <td>-18.04</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>GBIO</td>\n",
       "      <td>Generation Bio Co</td>\n",
       "      <td>2020-06-12</td>\n",
       "      <td>77.48</td>\n",
       "      <td>174</td>\n",
       "      <td>162.00</td>\n",
       "      <td>18.58</td>\n",
       "      <td>-92.19</td>\n",
       "      <td>https://generationbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid...</td>\n",
       "      <td>24.69</td>\n",
       "      <td>1.16</td>\n",
       "      <td>-95.30</td>\n",
       "      <td>1649</td>\n",
       "      <td>-118.99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>BCAB</td>\n",
       "      <td>BioAtla Inc</td>\n",
       "      <td>2020-12-16</td>\n",
       "      <td>65.27</td>\n",
       "      <td>65</td>\n",
       "      <td>1202.00</td>\n",
       "      <td>11.00</td>\n",
       "      <td>-85.17</td>\n",
       "      <td>https://www.bioatla.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid ...</td>\n",
       "      <td>31.02</td>\n",
       "      <td>1.45</td>\n",
       "      <td>-95.33</td>\n",
       "      <td>1462</td>\n",
       "      <td>-130.49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>SER</td>\n",
       "      <td>Serina Therapeutics Inc</td>\n",
       "      <td>2018-11-29</td>\n",
       "      <td>38.98</td>\n",
       "      <td>9</td>\n",
       "      <td>23.00</td>\n",
       "      <td>3.16</td>\n",
       "      <td>-11.12</td>\n",
       "      <td>https://serinatherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252,...</td>\n",
       "      <td>96.79</td>\n",
       "      <td>4.51</td>\n",
       "      <td>-95.34</td>\n",
       "      <td>2210</td>\n",
       "      <td>-28.53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>NERV</td>\n",
       "      <td>Minerva Neurosciences Inc</td>\n",
       "      <td>2014-07-01</td>\n",
       "      <td>15.32</td>\n",
       "      <td>9</td>\n",
       "      <td>17.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.49</td>\n",
       "      <td>https://www.minervaneurosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates fo...</td>\n",
       "      <td>48.40</td>\n",
       "      <td>2.21</td>\n",
       "      <td>-95.43</td>\n",
       "      <td>3822</td>\n",
       "      <td>-159.86</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>RNAC</td>\n",
       "      <td>Cartesian Therapeutics Inc</td>\n",
       "      <td>2016-06-22</td>\n",
       "      <td>478.31</td>\n",
       "      <td>37</td>\n",
       "      <td>119.00</td>\n",
       "      <td>47.94</td>\n",
       "      <td>-39.76</td>\n",
       "      <td>https://www.cartesiantherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimm...</td>\n",
       "      <td>420.00</td>\n",
       "      <td>18.68</td>\n",
       "      <td>-95.55</td>\n",
       "      <td>3100</td>\n",
       "      <td>-8.31</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>SEER</td>\n",
       "      <td>Seer Inc</td>\n",
       "      <td>2020-12-04</td>\n",
       "      <td>146.24</td>\n",
       "      <td>147</td>\n",
       "      <td>270.00</td>\n",
       "      <td>14.61</td>\n",
       "      <td>-92.70</td>\n",
       "      <td>https://seer.bio</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteog...</td>\n",
       "      <td>56.46</td>\n",
       "      <td>2.47</td>\n",
       "      <td>-95.63</td>\n",
       "      <td>1474</td>\n",
       "      <td>-63.39</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>TSBX</td>\n",
       "      <td>Turnstone Biologics Corp</td>\n",
       "      <td>2023-07-21</td>\n",
       "      <td>10.87</td>\n",
       "      <td>80</td>\n",
       "      <td>280.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-77.58</td>\n",
       "      <td>https://turnstonebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. T...</td>\n",
       "      <td>11.00</td>\n",
       "      <td>0.48</td>\n",
       "      <td>-95.64</td>\n",
       "      <td>515</td>\n",
       "      <td>-713.71</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>KPTI</td>\n",
       "      <td>Karyopharm Therapeutics Inc</td>\n",
       "      <td>2013-11-06</td>\n",
       "      <td>83.96</td>\n",
       "      <td>325</td>\n",
       "      <td>880.00</td>\n",
       "      <td>148.44</td>\n",
       "      <td>-125.63</td>\n",
       "      <td>https://www.karyopharm.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear ex...</td>\n",
       "      <td>16.05</td>\n",
       "      <td>0.70</td>\n",
       "      <td>-95.64</td>\n",
       "      <td>4059</td>\n",
       "      <td>-149.63</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>VRCA</td>\n",
       "      <td>Verrica Pharmaceuticals Inc</td>\n",
       "      <td>2018-06-15</td>\n",
       "      <td>65.03</td>\n",
       "      <td>100</td>\n",
       "      <td>889.00</td>\n",
       "      <td>9.21</td>\n",
       "      <td>-73.39</td>\n",
       "      <td>https://www.verrica.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases in the Un...</td>\n",
       "      <td>17.50</td>\n",
       "      <td>0.76</td>\n",
       "      <td>-95.65</td>\n",
       "      <td>2377</td>\n",
       "      <td>-112.86</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>KLTO</td>\n",
       "      <td>Klotho Neurosciences Inc</td>\n",
       "      <td>2022-04-29</td>\n",
       "      <td>9.43</td>\n",
       "      <td>0</td>\n",
       "      <td>529.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.klothoneuro.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics....</td>\n",
       "      <td>9.89</td>\n",
       "      <td>0.43</td>\n",
       "      <td>-95.65</td>\n",
       "      <td>963</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>CLLS</td>\n",
       "      <td>Cellectis ADR</td>\n",
       "      <td>2015-03-24</td>\n",
       "      <td>174.85</td>\n",
       "      <td>216</td>\n",
       "      <td>59.00</td>\n",
       "      <td>36.04</td>\n",
       "      <td>-67.22</td>\n",
       "      <td>https://www.cellectis.com</td>\n",
       "      <td>France</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen...</td>\n",
       "      <td>41.50</td>\n",
       "      <td>1.76</td>\n",
       "      <td>-95.76</td>\n",
       "      <td>3556</td>\n",
       "      <td>-38.44</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>NNVC</td>\n",
       "      <td>NanoViricides Inc</td>\n",
       "      <td>2005-10-26</td>\n",
       "      <td>21.23</td>\n",
       "      <td>7</td>\n",
       "      <td>153.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.76</td>\n",
       "      <td>https://www.nanoviricides.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral inf...</td>\n",
       "      <td>35.00</td>\n",
       "      <td>1.48</td>\n",
       "      <td>-95.77</td>\n",
       "      <td>6992</td>\n",
       "      <td>-36.55</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>PMVP</td>\n",
       "      <td>PMV Pharmaceuticals Inc</td>\n",
       "      <td>2020-09-25</td>\n",
       "      <td>80.73</td>\n",
       "      <td>63</td>\n",
       "      <td>203.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-77.12</td>\n",
       "      <td>https://www.pmvpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies f...</td>\n",
       "      <td>37.51</td>\n",
       "      <td>1.58</td>\n",
       "      <td>-95.79</td>\n",
       "      <td>1544</td>\n",
       "      <td>-95.53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>TIL</td>\n",
       "      <td>Instil Bio Inc</td>\n",
       "      <td>2021-03-19</td>\n",
       "      <td>146.83</td>\n",
       "      <td>49</td>\n",
       "      <td>158.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-66.02</td>\n",
       "      <td>https://instilbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell thera...</td>\n",
       "      <td>528.80</td>\n",
       "      <td>21.97</td>\n",
       "      <td>-95.85</td>\n",
       "      <td>1369</td>\n",
       "      <td>-44.96</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>ASMB</td>\n",
       "      <td>Assembly Biosciences Inc</td>\n",
       "      <td>2010-12-17</td>\n",
       "      <td>98.78</td>\n",
       "      <td>65</td>\n",
       "      <td>34.00</td>\n",
       "      <td>21.48</td>\n",
       "      <td>-50.27</td>\n",
       "      <td>https://www.assemblybio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a ...</td>\n",
       "      <td>378.00</td>\n",
       "      <td>15.38</td>\n",
       "      <td>-95.93</td>\n",
       "      <td>5114</td>\n",
       "      <td>-50.89</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>SABS</td>\n",
       "      <td>SAB Biotherapeutics Inc</td>\n",
       "      <td>2021-02-09</td>\n",
       "      <td>36.55</td>\n",
       "      <td>57</td>\n",
       "      <td>96.00</td>\n",
       "      <td>1.51</td>\n",
       "      <td>-46.91</td>\n",
       "      <td>https://www.sabbiotherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies...</td>\n",
       "      <td>101.50</td>\n",
       "      <td>4.08</td>\n",
       "      <td>-95.98</td>\n",
       "      <td>1407</td>\n",
       "      <td>-128.34</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>LYEL</td>\n",
       "      <td>Lyell Immunopharma Inc</td>\n",
       "      <td>2021-06-17</td>\n",
       "      <td>195.87</td>\n",
       "      <td>224</td>\n",
       "      <td>1409.00</td>\n",
       "      <td>0.06</td>\n",
       "      <td>-196.60</td>\n",
       "      <td>https://lyell.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops T cell reprogramming technologies for patients with solid tumors. The co...</td>\n",
       "      <td>16.89</td>\n",
       "      <td>0.67</td>\n",
       "      <td>-96.01</td>\n",
       "      <td>1279</td>\n",
       "      <td>-100.37</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429</th>\n",
       "      <td>ATRA</td>\n",
       "      <td>Atara Biotherapeutics Inc</td>\n",
       "      <td>2014-10-16</td>\n",
       "      <td>60.53</td>\n",
       "      <td>165</td>\n",
       "      <td>105.00</td>\n",
       "      <td>62.39</td>\n",
       "      <td>-162.12</td>\n",
       "      <td>https://www.atarabio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoim...</td>\n",
       "      <td>266.25</td>\n",
       "      <td>10.33</td>\n",
       "      <td>-96.12</td>\n",
       "      <td>3715</td>\n",
       "      <td>-267.83</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>KZR</td>\n",
       "      <td>Kezar Life Sciences Inc</td>\n",
       "      <td>2018-06-21</td>\n",
       "      <td>48.01</td>\n",
       "      <td>58</td>\n",
       "      <td>107.00</td>\n",
       "      <td>7.00</td>\n",
       "      <td>-98.46</td>\n",
       "      <td>https://www.kezarlifesciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics t...</td>\n",
       "      <td>177.50</td>\n",
       "      <td>6.75</td>\n",
       "      <td>-96.20</td>\n",
       "      <td>2371</td>\n",
       "      <td>-205.08</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>AFMD</td>\n",
       "      <td>Affimed N.V</td>\n",
       "      <td>2014-09-12</td>\n",
       "      <td>34.92</td>\n",
       "      <td>76</td>\n",
       "      <td>200.00</td>\n",
       "      <td>7.43</td>\n",
       "      <td>-71.17</td>\n",
       "      <td>https://www.affimed.com</td>\n",
       "      <td>Germany</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Ge...</td>\n",
       "      <td>57.00</td>\n",
       "      <td>2.15</td>\n",
       "      <td>-96.23</td>\n",
       "      <td>3749</td>\n",
       "      <td>-203.81</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>LPTX</td>\n",
       "      <td>Leap Therapeutics Inc</td>\n",
       "      <td>2017-01-25</td>\n",
       "      <td>115.34</td>\n",
       "      <td>54</td>\n",
       "      <td>353.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-64.69</td>\n",
       "      <td>https://www.leaptx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candi...</td>\n",
       "      <td>78.60</td>\n",
       "      <td>2.95</td>\n",
       "      <td>-96.25</td>\n",
       "      <td>2883</td>\n",
       "      <td>-56.09</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>CGTX</td>\n",
       "      <td>Cognition Therapeutics Inc</td>\n",
       "      <td>2021-10-08</td>\n",
       "      <td>18.74</td>\n",
       "      <td>25</td>\n",
       "      <td>1568.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-58.61</td>\n",
       "      <td>https://www.cogrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics ...</td>\n",
       "      <td>12.77</td>\n",
       "      <td>0.48</td>\n",
       "      <td>-96.26</td>\n",
       "      <td>1166</td>\n",
       "      <td>-312.75</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>BTAI</td>\n",
       "      <td>BioXcel Therapeutics Inc</td>\n",
       "      <td>2018-03-08</td>\n",
       "      <td>19.65</td>\n",
       "      <td>74</td>\n",
       "      <td>567.00</td>\n",
       "      <td>2.40</td>\n",
       "      <td>-104.30</td>\n",
       "      <td>https://www.bioxceltherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop trans...</td>\n",
       "      <td>11.03</td>\n",
       "      <td>0.41</td>\n",
       "      <td>-96.26</td>\n",
       "      <td>2476</td>\n",
       "      <td>-530.79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>435</th>\n",
       "      <td>XCUR</td>\n",
       "      <td>Exicure Inc</td>\n",
       "      <td>2018-05-22</td>\n",
       "      <td>47.22</td>\n",
       "      <td>5</td>\n",
       "      <td>1210.00</td>\n",
       "      <td>0.50</td>\n",
       "      <td>-5.80</td>\n",
       "      <td>https://www.exicuretx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic ...</td>\n",
       "      <td>465.00</td>\n",
       "      <td>17.31</td>\n",
       "      <td>-96.28</td>\n",
       "      <td>2401</td>\n",
       "      <td>-12.28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>436</th>\n",
       "      <td>KTTA</td>\n",
       "      <td>Pasithea Therapeutics Corp</td>\n",
       "      <td>2021-09-15</td>\n",
       "      <td>3.29</td>\n",
       "      <td>8</td>\n",
       "      <td>980.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.27</td>\n",
       "      <td>https://www.pasithea.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system dis...</td>\n",
       "      <td>71.20</td>\n",
       "      <td>2.65</td>\n",
       "      <td>-96.28</td>\n",
       "      <td>1189</td>\n",
       "      <td>-494.53</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>437</th>\n",
       "      <td>ADAP</td>\n",
       "      <td>Adaptimmune Therapeutics Plc ADR</td>\n",
       "      <td>2015-05-06</td>\n",
       "      <td>151.33</td>\n",
       "      <td>449</td>\n",
       "      <td>1722.00</td>\n",
       "      <td>141.46</td>\n",
       "      <td>-72.88</td>\n",
       "      <td>https://www.adaptimmune.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United...</td>\n",
       "      <td>16.00</td>\n",
       "      <td>0.58</td>\n",
       "      <td>-96.38</td>\n",
       "      <td>3513</td>\n",
       "      <td>-48.16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438</th>\n",
       "      <td>KRON</td>\n",
       "      <td>Kronos Bio Inc</td>\n",
       "      <td>2020-10-09</td>\n",
       "      <td>57.93</td>\n",
       "      <td>58</td>\n",
       "      <td>188.00</td>\n",
       "      <td>8.41</td>\n",
       "      <td>-94.24</td>\n",
       "      <td>https://www.kronosbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and othe...</td>\n",
       "      <td>27.07</td>\n",
       "      <td>0.98</td>\n",
       "      <td>-96.38</td>\n",
       "      <td>1530</td>\n",
       "      <td>-162.68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>AADI</td>\n",
       "      <td>Aadi Bioscience Inc</td>\n",
       "      <td>2018-02-16</td>\n",
       "      <td>58.66</td>\n",
       "      <td>53</td>\n",
       "      <td>117.00</td>\n",
       "      <td>25.07</td>\n",
       "      <td>-63.40</td>\n",
       "      <td>https://aadibio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers ...</td>\n",
       "      <td>67.50</td>\n",
       "      <td>2.41</td>\n",
       "      <td>-96.43</td>\n",
       "      <td>2496</td>\n",
       "      <td>-108.08</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>440</th>\n",
       "      <td>ADXN</td>\n",
       "      <td>Addex Therapeutics Ltd ADR</td>\n",
       "      <td>2020-02-12</td>\n",
       "      <td>8.49</td>\n",
       "      <td>23</td>\n",
       "      <td>43.00</td>\n",
       "      <td>0.86</td>\n",
       "      <td>-11.07</td>\n",
       "      <td>https://www.addextherapeutics.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders i...</td>\n",
       "      <td>226.00</td>\n",
       "      <td>8.00</td>\n",
       "      <td>-96.46</td>\n",
       "      <td>1770</td>\n",
       "      <td>-130.39</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>441</th>\n",
       "      <td>SLGL</td>\n",
       "      <td>Sol-Gel Technologies Ltd</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>12.98</td>\n",
       "      <td>36</td>\n",
       "      <td>65.00</td>\n",
       "      <td>6.56</td>\n",
       "      <td>-16.52</td>\n",
       "      <td>https://www.sol-gel.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe ...</td>\n",
       "      <td>13.64</td>\n",
       "      <td>0.48</td>\n",
       "      <td>-96.48</td>\n",
       "      <td>2511</td>\n",
       "      <td>-127.27</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>442</th>\n",
       "      <td>VTVT</td>\n",
       "      <td>vTv Therapeutics Inc</td>\n",
       "      <td>2015-07-30</td>\n",
       "      <td>40.33</td>\n",
       "      <td>16</td>\n",
       "      <td>30.00</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-22.77</td>\n",
       "      <td>https://vtvtherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and ...</td>\n",
       "      <td>435.60</td>\n",
       "      <td>15.03</td>\n",
       "      <td>-96.55</td>\n",
       "      <td>3428</td>\n",
       "      <td>-56.46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>443</th>\n",
       "      <td>ATHA</td>\n",
       "      <td>Athira Pharma Inc</td>\n",
       "      <td>2020-09-18</td>\n",
       "      <td>22.33</td>\n",
       "      <td>65</td>\n",
       "      <td>4893.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-120.43</td>\n",
       "      <td>https://www.athira.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow ne...</td>\n",
       "      <td>17.11</td>\n",
       "      <td>0.58</td>\n",
       "      <td>-96.58</td>\n",
       "      <td>1551</td>\n",
       "      <td>-539.32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>444</th>\n",
       "      <td>PASG</td>\n",
       "      <td>Passage Bio Inc</td>\n",
       "      <td>2020-02-28</td>\n",
       "      <td>44.60</td>\n",
       "      <td>58</td>\n",
       "      <td>547.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-84.65</td>\n",
       "      <td>https://www.passagebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1...</td>\n",
       "      <td>22.20</td>\n",
       "      <td>0.76</td>\n",
       "      <td>-96.58</td>\n",
       "      <td>1754</td>\n",
       "      <td>-189.80</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>445</th>\n",
       "      <td>VSTM</td>\n",
       "      <td>Verastem Inc</td>\n",
       "      <td>2012-01-27</td>\n",
       "      <td>208.29</td>\n",
       "      <td>73</td>\n",
       "      <td>1010.00</td>\n",
       "      <td>10.00</td>\n",
       "      <td>-114.48</td>\n",
       "      <td>https://www.verastem.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the ...</td>\n",
       "      <td>133.08</td>\n",
       "      <td>4.48</td>\n",
       "      <td>-96.63</td>\n",
       "      <td>4708</td>\n",
       "      <td>-54.96</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>446</th>\n",
       "      <td>ALLK</td>\n",
       "      <td>Allakos Inc</td>\n",
       "      <td>2018-07-19</td>\n",
       "      <td>94.70</td>\n",
       "      <td>131</td>\n",
       "      <td>679.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-154.72</td>\n",
       "      <td>https://www.allakos.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cell...</td>\n",
       "      <td>31.25</td>\n",
       "      <td>1.05</td>\n",
       "      <td>-96.64</td>\n",
       "      <td>2343</td>\n",
       "      <td>-163.38</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>447</th>\n",
       "      <td>SNPX</td>\n",
       "      <td>Synaptogenix Inc</td>\n",
       "      <td>2020-12-08</td>\n",
       "      <td>3.75</td>\n",
       "      <td>5</td>\n",
       "      <td>21.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.83</td>\n",
       "      <td>https://www.synaptogen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeut...</td>\n",
       "      <td>86.00</td>\n",
       "      <td>2.69</td>\n",
       "      <td>-96.87</td>\n",
       "      <td>1470</td>\n",
       "      <td>-182.13</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>448</th>\n",
       "      <td>SAVA</td>\n",
       "      <td>Cassava Sciences Inc</td>\n",
       "      <td>2000-07-14</td>\n",
       "      <td>127.97</td>\n",
       "      <td>29</td>\n",
       "      <td>5142.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-143.32</td>\n",
       "      <td>https://www.cassavasciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candid...</td>\n",
       "      <td>89.24</td>\n",
       "      <td>2.75</td>\n",
       "      <td>-96.92</td>\n",
       "      <td>8922</td>\n",
       "      <td>-111.99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>SYBX</td>\n",
       "      <td>Synlogic Inc</td>\n",
       "      <td>2015-09-30</td>\n",
       "      <td>17.37</td>\n",
       "      <td>6</td>\n",
       "      <td>30.00</td>\n",
       "      <td>3.17</td>\n",
       "      <td>-36.00</td>\n",
       "      <td>https://www.synlogictx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic disea...</td>\n",
       "      <td>49.00</td>\n",
       "      <td>1.50</td>\n",
       "      <td>-96.94</td>\n",
       "      <td>3366</td>\n",
       "      <td>-207.25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>450</th>\n",
       "      <td>PRLD</td>\n",
       "      <td>Prelude Therapeutics Inc</td>\n",
       "      <td>2020-09-25</td>\n",
       "      <td>49.30</td>\n",
       "      <td>128</td>\n",
       "      <td>351.00</td>\n",
       "      <td>3.00</td>\n",
       "      <td>-141.65</td>\n",
       "      <td>https://preludetx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer ...</td>\n",
       "      <td>26.20</td>\n",
       "      <td>0.80</td>\n",
       "      <td>-96.95</td>\n",
       "      <td>1544</td>\n",
       "      <td>-287.32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>451</th>\n",
       "      <td>PMCB</td>\n",
       "      <td>PharmaCyte Biotech Inc</td>\n",
       "      <td>2013-01-02</td>\n",
       "      <td>12.98</td>\n",
       "      <td>2</td>\n",
       "      <td>35.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://pharmacyte.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular th...</td>\n",
       "      <td>57.35</td>\n",
       "      <td>1.72</td>\n",
       "      <td>-97.00</td>\n",
       "      <td>4367</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>452</th>\n",
       "      <td>ELTX</td>\n",
       "      <td>Elicio Therapeutics Inc</td>\n",
       "      <td>2021-02-05</td>\n",
       "      <td>52.99</td>\n",
       "      <td>32</td>\n",
       "      <td>23.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-41.00</td>\n",
       "      <td>https://elicio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer. Its l...</td>\n",
       "      <td>170.20</td>\n",
       "      <td>5.07</td>\n",
       "      <td>-97.02</td>\n",
       "      <td>1411</td>\n",
       "      <td>-77.37</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>453</th>\n",
       "      <td>RIGL</td>\n",
       "      <td>Rigel Pharmaceuticals</td>\n",
       "      <td>2000-11-29</td>\n",
       "      <td>337.15</td>\n",
       "      <td>147</td>\n",
       "      <td>226.00</td>\n",
       "      <td>157.37</td>\n",
       "      <td>11.32</td>\n",
       "      <td>https://www.rigel.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patien...</td>\n",
       "      <td>639.84</td>\n",
       "      <td>18.91</td>\n",
       "      <td>-97.04</td>\n",
       "      <td>8784</td>\n",
       "      <td>3.36</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>454</th>\n",
       "      <td>LPCN</td>\n",
       "      <td>Lipocine Inc</td>\n",
       "      <td>2013-10-22</td>\n",
       "      <td>26.69</td>\n",
       "      <td>17</td>\n",
       "      <td>27.00</td>\n",
       "      <td>4.80</td>\n",
       "      <td>-9.67</td>\n",
       "      <td>https://www.lipocine.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of ...</td>\n",
       "      <td>170.00</td>\n",
       "      <td>5.02</td>\n",
       "      <td>-97.05</td>\n",
       "      <td>4074</td>\n",
       "      <td>-36.23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>455</th>\n",
       "      <td>CAPR</td>\n",
       "      <td>Capricor Therapeutics Inc</td>\n",
       "      <td>2007-02-13</td>\n",
       "      <td>631.12</td>\n",
       "      <td>101</td>\n",
       "      <td>3598.00</td>\n",
       "      <td>23.23</td>\n",
       "      <td>-34.77</td>\n",
       "      <td>https://www.capricor.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeut...</td>\n",
       "      <td>450.00</td>\n",
       "      <td>13.26</td>\n",
       "      <td>-97.05</td>\n",
       "      <td>6517</td>\n",
       "      <td>-5.51</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>CRIS</td>\n",
       "      <td>Curis Inc</td>\n",
       "      <td>2000-08-01</td>\n",
       "      <td>29.47</td>\n",
       "      <td>49</td>\n",
       "      <td>55.00</td>\n",
       "      <td>10.16</td>\n",
       "      <td>-49.30</td>\n",
       "      <td>https://www.curis.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United...</td>\n",
       "      <td>121.88</td>\n",
       "      <td>3.57</td>\n",
       "      <td>-97.07</td>\n",
       "      <td>8904</td>\n",
       "      <td>-167.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>CLDX</td>\n",
       "      <td>Celldex Therapeutics Inc</td>\n",
       "      <td>1986-05-15</td>\n",
       "      <td>1738.22</td>\n",
       "      <td>160</td>\n",
       "      <td>1228.00</td>\n",
       "      <td>9.98</td>\n",
       "      <td>-171.06</td>\n",
       "      <td>https://www.celldex.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment ...</td>\n",
       "      <td>877.50</td>\n",
       "      <td>25.41</td>\n",
       "      <td>-97.10</td>\n",
       "      <td>14096</td>\n",
       "      <td>-9.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>458</th>\n",
       "      <td>INAB</td>\n",
       "      <td>IN8bio Inc</td>\n",
       "      <td>2021-07-30</td>\n",
       "      <td>20.41</td>\n",
       "      <td>39</td>\n",
       "      <td>1218.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-30.63</td>\n",
       "      <td>https://in8bio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell thera...</td>\n",
       "      <td>10.00</td>\n",
       "      <td>0.28</td>\n",
       "      <td>-97.15</td>\n",
       "      <td>1236</td>\n",
       "      <td>-150.07</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>459</th>\n",
       "      <td>EVGN</td>\n",
       "      <td>Evogene Ltd</td>\n",
       "      <td>2010-10-15</td>\n",
       "      <td>8.97</td>\n",
       "      <td>142</td>\n",
       "      <td>292.00</td>\n",
       "      <td>9.45</td>\n",
       "      <td>-19.67</td>\n",
       "      <td>https://www.evogene.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life...</td>\n",
       "      <td>48.10</td>\n",
       "      <td>1.37</td>\n",
       "      <td>-97.15</td>\n",
       "      <td>5177</td>\n",
       "      <td>-219.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>460</th>\n",
       "      <td>PGEN</td>\n",
       "      <td>Precigen Inc</td>\n",
       "      <td>2013-08-08</td>\n",
       "      <td>197.28</td>\n",
       "      <td>202</td>\n",
       "      <td>823.00</td>\n",
       "      <td>4.39</td>\n",
       "      <td>-88.58</td>\n",
       "      <td>https://precigen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technolo...</td>\n",
       "      <td>24.73</td>\n",
       "      <td>0.68</td>\n",
       "      <td>-97.25</td>\n",
       "      <td>4149</td>\n",
       "      <td>-44.90</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>461</th>\n",
       "      <td>ATNM</td>\n",
       "      <td>Actinium Pharmaceuticals Inc</td>\n",
       "      <td>2012-12-27</td>\n",
       "      <td>39.62</td>\n",
       "      <td>49</td>\n",
       "      <td>289.00</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-46.48</td>\n",
       "      <td>https://www.actiniumpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people wh...</td>\n",
       "      <td>45.00</td>\n",
       "      <td>1.23</td>\n",
       "      <td>-97.27</td>\n",
       "      <td>4373</td>\n",
       "      <td>-117.31</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>462</th>\n",
       "      <td>GLYC</td>\n",
       "      <td>GlycoMimetics Inc</td>\n",
       "      <td>2014-01-10</td>\n",
       "      <td>15.47</td>\n",
       "      <td>35</td>\n",
       "      <td>20280.00</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-40.78</td>\n",
       "      <td>https://www.glycomimetics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the U...</td>\n",
       "      <td>9.01</td>\n",
       "      <td>0.24</td>\n",
       "      <td>-97.34</td>\n",
       "      <td>3994</td>\n",
       "      <td>-263.61</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>463</th>\n",
       "      <td>VOR</td>\n",
       "      <td>Vor Biopharma Inc</td>\n",
       "      <td>2021-02-05</td>\n",
       "      <td>70.05</td>\n",
       "      <td>168</td>\n",
       "      <td>590.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.20</td>\n",
       "      <td>https://www.vorbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel)...</td>\n",
       "      <td>37.50</td>\n",
       "      <td>0.99</td>\n",
       "      <td>-97.36</td>\n",
       "      <td>1411</td>\n",
       "      <td>-173.02</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>464</th>\n",
       "      <td>BIVI</td>\n",
       "      <td>BioVie Inc</td>\n",
       "      <td>2020-09-18</td>\n",
       "      <td>45.13</td>\n",
       "      <td>14</td>\n",
       "      <td>6151.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.95</td>\n",
       "      <td>https://bioviepharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanc...</td>\n",
       "      <td>99.90</td>\n",
       "      <td>2.64</td>\n",
       "      <td>-97.36</td>\n",
       "      <td>1551</td>\n",
       "      <td>-70.80</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>465</th>\n",
       "      <td>LSB</td>\n",
       "      <td>LakeShore Biopharma Co Ltd</td>\n",
       "      <td>2021-08-05</td>\n",
       "      <td>47.70</td>\n",
       "      <td>758</td>\n",
       "      <td>44.00</td>\n",
       "      <td>573.42</td>\n",
       "      <td>-315.90</td>\n",
       "      <td>https://www.ysbiopharm.com</td>\n",
       "      <td>China</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vac...</td>\n",
       "      <td>94.80</td>\n",
       "      <td>2.49</td>\n",
       "      <td>-97.37</td>\n",
       "      <td>1230</td>\n",
       "      <td>-662.26</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>466</th>\n",
       "      <td>IVVD</td>\n",
       "      <td>Invivyd Inc</td>\n",
       "      <td>2021-08-06</td>\n",
       "      <td>53.89</td>\n",
       "      <td>94</td>\n",
       "      <td>569.00</td>\n",
       "      <td>2.26</td>\n",
       "      <td>-210.66</td>\n",
       "      <td>https://invivyd.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based soluti...</td>\n",
       "      <td>20.88</td>\n",
       "      <td>0.55</td>\n",
       "      <td>-97.38</td>\n",
       "      <td>1229</td>\n",
       "      <td>-390.91</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>467</th>\n",
       "      <td>SXTP</td>\n",
       "      <td>60 Degrees Pharmaceuticals Inc</td>\n",
       "      <td>2023-07-12</td>\n",
       "      <td>3.47</td>\n",
       "      <td>3</td>\n",
       "      <td>279.00</td>\n",
       "      <td>0.44</td>\n",
       "      <td>-8.89</td>\n",
       "      <td>https://www.60degreespharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the preven...</td>\n",
       "      <td>56.16</td>\n",
       "      <td>1.41</td>\n",
       "      <td>-97.49</td>\n",
       "      <td>524</td>\n",
       "      <td>-256.20</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>468</th>\n",
       "      <td>LGVN</td>\n",
       "      <td>Longeveron Inc</td>\n",
       "      <td>2021-02-12</td>\n",
       "      <td>27.00</td>\n",
       "      <td>23</td>\n",
       "      <td>495.00</td>\n",
       "      <td>1.23</td>\n",
       "      <td>-17.22</td>\n",
       "      <td>https://longeveron.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the Unit...</td>\n",
       "      <td>74.10</td>\n",
       "      <td>1.86</td>\n",
       "      <td>-97.49</td>\n",
       "      <td>1404</td>\n",
       "      <td>-63.78</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>469</th>\n",
       "      <td>DNA</td>\n",
       "      <td>Ginkgo Bioworks Holdings Inc</td>\n",
       "      <td>2021-04-19</td>\n",
       "      <td>542.03</td>\n",
       "      <td>1218</td>\n",
       "      <td>1235.00</td>\n",
       "      <td>217.95</td>\n",
       "      <td>-525.77</td>\n",
       "      <td>https://www.ginkgobioworks.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used ...</td>\n",
       "      <td>404.80</td>\n",
       "      <td>9.44</td>\n",
       "      <td>-97.67</td>\n",
       "      <td>1338</td>\n",
       "      <td>-97.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>470</th>\n",
       "      <td>SNSE</td>\n",
       "      <td>Sensei Biotherapeutics Inc</td>\n",
       "      <td>2021-02-04</td>\n",
       "      <td>10.87</td>\n",
       "      <td>28</td>\n",
       "      <td>460.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-30.98</td>\n",
       "      <td>https://www.senseibio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The compan...</td>\n",
       "      <td>18.90</td>\n",
       "      <td>0.44</td>\n",
       "      <td>-97.67</td>\n",
       "      <td>1412</td>\n",
       "      <td>-285.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>471</th>\n",
       "      <td>CELU</td>\n",
       "      <td>Celularity Inc</td>\n",
       "      <td>2019-08-08</td>\n",
       "      <td>51.94</td>\n",
       "      <td>120</td>\n",
       "      <td>1106.00</td>\n",
       "      <td>42.69</td>\n",
       "      <td>-35.90</td>\n",
       "      <td>https://www.celularity.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of c...</td>\n",
       "      <td>98.00</td>\n",
       "      <td>2.22</td>\n",
       "      <td>-97.73</td>\n",
       "      <td>1958</td>\n",
       "      <td>-69.12</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>472</th>\n",
       "      <td>SPRB</td>\n",
       "      <td>Spruce Biosciences Inc</td>\n",
       "      <td>2020-10-09</td>\n",
       "      <td>16.05</td>\n",
       "      <td>29</td>\n",
       "      <td>589.00</td>\n",
       "      <td>7.10</td>\n",
       "      <td>-43.19</td>\n",
       "      <td>https://www.sprucebiosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The...</td>\n",
       "      <td>17.00</td>\n",
       "      <td>0.38</td>\n",
       "      <td>-97.75</td>\n",
       "      <td>1530</td>\n",
       "      <td>-269.10</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>473</th>\n",
       "      <td>BNOX</td>\n",
       "      <td>Bionomics Ltd. ADR</td>\n",
       "      <td>2021-12-16</td>\n",
       "      <td>5.57</td>\n",
       "      <td>8</td>\n",
       "      <td>9852.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.35</td>\n",
       "      <td>https://www.bionomics.com.au</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous s...</td>\n",
       "      <td>14.73</td>\n",
       "      <td>0.32</td>\n",
       "      <td>-97.81</td>\n",
       "      <td>1097</td>\n",
       "      <td>-311.49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>474</th>\n",
       "      <td>VINC</td>\n",
       "      <td>Vincerx Pharma Inc</td>\n",
       "      <td>2020-05-27</td>\n",
       "      <td>6.48</td>\n",
       "      <td>42</td>\n",
       "      <td>655.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.41</td>\n",
       "      <td>https://vincerx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatme...</td>\n",
       "      <td>9.35</td>\n",
       "      <td>0.19</td>\n",
       "      <td>-97.96</td>\n",
       "      <td>1665</td>\n",
       "      <td>-422.99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>475</th>\n",
       "      <td>CARA</td>\n",
       "      <td>Cara Therapeutics Inc</td>\n",
       "      <td>2014-01-31</td>\n",
       "      <td>14.15</td>\n",
       "      <td>55</td>\n",
       "      <td>538.00</td>\n",
       "      <td>11.00</td>\n",
       "      <td>-104.72</td>\n",
       "      <td>https://www.caratherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chroni...</td>\n",
       "      <td>12.91</td>\n",
       "      <td>0.26</td>\n",
       "      <td>-97.97</td>\n",
       "      <td>3973</td>\n",
       "      <td>-740.07</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>476</th>\n",
       "      <td>ADVM</td>\n",
       "      <td>Adverum Biotechnologies Inc</td>\n",
       "      <td>2014-07-31</td>\n",
       "      <td>109.42</td>\n",
       "      <td>121</td>\n",
       "      <td>231.00</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-99.02</td>\n",
       "      <td>https://adverum.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candi...</td>\n",
       "      <td>279.90</td>\n",
       "      <td>5.37</td>\n",
       "      <td>-98.08</td>\n",
       "      <td>3792</td>\n",
       "      <td>-90.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>CLDI</td>\n",
       "      <td>Calidi Biotherapeutics Inc</td>\n",
       "      <td>2021-11-01</td>\n",
       "      <td>30.65</td>\n",
       "      <td>41</td>\n",
       "      <td>1515.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-29.18</td>\n",
       "      <td>https://www.calidibio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate a...</td>\n",
       "      <td>97.80</td>\n",
       "      <td>1.85</td>\n",
       "      <td>-98.11</td>\n",
       "      <td>1142</td>\n",
       "      <td>-95.20</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>478</th>\n",
       "      <td>EYPT</td>\n",
       "      <td>EyePoint Pharmaceuticals Inc</td>\n",
       "      <td>2005-01-27</td>\n",
       "      <td>519.39</td>\n",
       "      <td>121</td>\n",
       "      <td>881.00</td>\n",
       "      <td>45.71</td>\n",
       "      <td>-114.58</td>\n",
       "      <td>https://eyepointpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the ...</td>\n",
       "      <td>401.60</td>\n",
       "      <td>7.46</td>\n",
       "      <td>-98.14</td>\n",
       "      <td>7264</td>\n",
       "      <td>-22.06</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479</th>\n",
       "      <td>EPIX</td>\n",
       "      <td>Essa Pharma Inc</td>\n",
       "      <td>2015-03-13</td>\n",
       "      <td>72.35</td>\n",
       "      <td>50</td>\n",
       "      <td>891.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.essapharma.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. T...</td>\n",
       "      <td>88.40</td>\n",
       "      <td>1.64</td>\n",
       "      <td>-98.14</td>\n",
       "      <td>3567</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>BLUE</td>\n",
       "      <td>Bluebird bio Inc</td>\n",
       "      <td>2013-06-19</td>\n",
       "      <td>75.93</td>\n",
       "      <td>375</td>\n",
       "      <td>387.00</td>\n",
       "      <td>54.90</td>\n",
       "      <td>-302.11</td>\n",
       "      <td>https://www.bluebirdbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the U...</td>\n",
       "      <td>348.58</td>\n",
       "      <td>6.34</td>\n",
       "      <td>-98.18</td>\n",
       "      <td>4199</td>\n",
       "      <td>-397.88</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>COEP</td>\n",
       "      <td>Coeptis Therapeutics Holdings Inc</td>\n",
       "      <td>2020-12-17</td>\n",
       "      <td>7.85</td>\n",
       "      <td>5</td>\n",
       "      <td>412.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.02</td>\n",
       "      <td>https://coeptistx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. It is developing cell therapy platfo...</td>\n",
       "      <td>9.90</td>\n",
       "      <td>0.18</td>\n",
       "      <td>-98.20</td>\n",
       "      <td>1461</td>\n",
       "      <td>-204.08</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>482</th>\n",
       "      <td>ALVR</td>\n",
       "      <td>AlloVir Inc</td>\n",
       "      <td>2020-07-30</td>\n",
       "      <td>52.24</td>\n",
       "      <td>8</td>\n",
       "      <td>353.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-120.46</td>\n",
       "      <td>https://www.allovir.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T ...</td>\n",
       "      <td>25.39</td>\n",
       "      <td>0.45</td>\n",
       "      <td>-98.23</td>\n",
       "      <td>1601</td>\n",
       "      <td>-230.59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>483</th>\n",
       "      <td>GLMD</td>\n",
       "      <td>Galmed Pharmaceuticals Ltd</td>\n",
       "      <td>2014-03-13</td>\n",
       "      <td>5.42</td>\n",
       "      <td>3</td>\n",
       "      <td>1088.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.14</td>\n",
       "      <td>https://www.galmedpharma.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It devel...</td>\n",
       "      <td>171.72</td>\n",
       "      <td>2.97</td>\n",
       "      <td>-98.27</td>\n",
       "      <td>3932</td>\n",
       "      <td>-113.28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>484</th>\n",
       "      <td>MCRB</td>\n",
       "      <td>Seres Therapeutics Inc</td>\n",
       "      <td>2015-06-26</td>\n",
       "      <td>151.96</td>\n",
       "      <td>233</td>\n",
       "      <td>3694.00</td>\n",
       "      <td>126.32</td>\n",
       "      <td>-36.50</td>\n",
       "      <td>https://www.serestherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Seres Therapeutics, Inc., a microbiome therapeutics company, develop microbiome therapeutics to treat the modulation of the colonic microbiome. It...</td>\n",
       "      <td>51.40</td>\n",
       "      <td>0.88</td>\n",
       "      <td>-98.29</td>\n",
       "      <td>3462</td>\n",
       "      <td>-24.02</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>485</th>\n",
       "      <td>ONCY</td>\n",
       "      <td>Oncolytics Biotech, Inc</td>\n",
       "      <td>2001-10-05</td>\n",
       "      <td>63.92</td>\n",
       "      <td>0</td>\n",
       "      <td>508.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-36.45</td>\n",
       "      <td>https://www.oncolyticsbiotech.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the t...</td>\n",
       "      <td>48.92</td>\n",
       "      <td>0.81</td>\n",
       "      <td>-98.34</td>\n",
       "      <td>8474</td>\n",
       "      <td>-57.02</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>486</th>\n",
       "      <td>NLSP</td>\n",
       "      <td>NLS Pharmaceutics Ltd</td>\n",
       "      <td>2021-01-29</td>\n",
       "      <td>4.41</td>\n",
       "      <td>0</td>\n",
       "      <td>355.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.30</td>\n",
       "      <td>https://nlspharma.com</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and...</td>\n",
       "      <td>115.60</td>\n",
       "      <td>1.91</td>\n",
       "      <td>-98.35</td>\n",
       "      <td>1418</td>\n",
       "      <td>-142.86</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>487</th>\n",
       "      <td>BOLT</td>\n",
       "      <td>Bolt Biotherapeutics Inc</td>\n",
       "      <td>2021-02-05</td>\n",
       "      <td>19.83</td>\n",
       "      <td>100</td>\n",
       "      <td>142.00</td>\n",
       "      <td>11.17</td>\n",
       "      <td>-72.23</td>\n",
       "      <td>https://www.boltbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer....</td>\n",
       "      <td>32.15</td>\n",
       "      <td>0.53</td>\n",
       "      <td>-98.36</td>\n",
       "      <td>1411</td>\n",
       "      <td>-364.25</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>488</th>\n",
       "      <td>ARTL</td>\n",
       "      <td>Artelo Biosciences Inc</td>\n",
       "      <td>2019-06-21</td>\n",
       "      <td>3.42</td>\n",
       "      <td>5</td>\n",
       "      <td>27.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.artelobio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathway...</td>\n",
       "      <td>69.75</td>\n",
       "      <td>1.11</td>\n",
       "      <td>-98.41</td>\n",
       "      <td>2006</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>489</th>\n",
       "      <td>HOOK</td>\n",
       "      <td>Hookipa Pharma Inc</td>\n",
       "      <td>2019-04-18</td>\n",
       "      <td>26.16</td>\n",
       "      <td>151</td>\n",
       "      <td>51.00</td>\n",
       "      <td>52.16</td>\n",
       "      <td>-47.71</td>\n",
       "      <td>https://www.hookipapharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on it...</td>\n",
       "      <td>140.00</td>\n",
       "      <td>2.13</td>\n",
       "      <td>-98.48</td>\n",
       "      <td>2070</td>\n",
       "      <td>-182.38</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>490</th>\n",
       "      <td>FGEN</td>\n",
       "      <td>FibroGen Inc</td>\n",
       "      <td>2014-11-14</td>\n",
       "      <td>32.76</td>\n",
       "      <td>486</td>\n",
       "      <td>1179.00</td>\n",
       "      <td>173.82</td>\n",
       "      <td>-165.84</td>\n",
       "      <td>https://www.fibrogen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead p...</td>\n",
       "      <td>22.00</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-98.49</td>\n",
       "      <td>3686</td>\n",
       "      <td>-506.23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>491</th>\n",
       "      <td>TARA</td>\n",
       "      <td>Protara Therapeutics Inc</td>\n",
       "      <td>2014-10-22</td>\n",
       "      <td>189.79</td>\n",
       "      <td>26</td>\n",
       "      <td>2219.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-43.90</td>\n",
       "      <td>https://www.protaratx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer ...</td>\n",
       "      <td>401.20</td>\n",
       "      <td>5.98</td>\n",
       "      <td>-98.51</td>\n",
       "      <td>3709</td>\n",
       "      <td>-23.13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>492</th>\n",
       "      <td>ATYR</td>\n",
       "      <td>Atyr Pharma Inc</td>\n",
       "      <td>2015-05-07</td>\n",
       "      <td>254.35</td>\n",
       "      <td>56</td>\n",
       "      <td>959.00</td>\n",
       "      <td>0.24</td>\n",
       "      <td>-67.34</td>\n",
       "      <td>https://www.atyrpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the U...</td>\n",
       "      <td>209.30</td>\n",
       "      <td>3.06</td>\n",
       "      <td>-98.54</td>\n",
       "      <td>3512</td>\n",
       "      <td>-26.48</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>SLDB</td>\n",
       "      <td>Solid Biosciences Inc</td>\n",
       "      <td>2018-01-26</td>\n",
       "      <td>183.79</td>\n",
       "      <td>88</td>\n",
       "      <td>298.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-109.92</td>\n",
       "      <td>https://www.solidbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead...</td>\n",
       "      <td>339.30</td>\n",
       "      <td>4.91</td>\n",
       "      <td>-98.55</td>\n",
       "      <td>2517</td>\n",
       "      <td>-59.81</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>CYCN</td>\n",
       "      <td>Cyclerion Therapeutics Inc</td>\n",
       "      <td>2019-03-18</td>\n",
       "      <td>9.57</td>\n",
       "      <td>1</td>\n",
       "      <td>3143.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.cyclerion.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally admini...</td>\n",
       "      <td>250.00</td>\n",
       "      <td>3.43</td>\n",
       "      <td>-98.63</td>\n",
       "      <td>2101</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>GLTO</td>\n",
       "      <td>Galecto Inc</td>\n",
       "      <td>2020-10-29</td>\n",
       "      <td>6.83</td>\n",
       "      <td>13</td>\n",
       "      <td>27.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.10</td>\n",
       "      <td>https://galecto.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related d...</td>\n",
       "      <td>375.00</td>\n",
       "      <td>5.08</td>\n",
       "      <td>-98.65</td>\n",
       "      <td>1510</td>\n",
       "      <td>-294.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>PMN</td>\n",
       "      <td>ProMIS Neurosciences Inc</td>\n",
       "      <td>2007-01-10</td>\n",
       "      <td>29.78</td>\n",
       "      <td>6</td>\n",
       "      <td>74.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-11.15</td>\n",
       "      <td>https://www.promisneurosciences.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded prote...</td>\n",
       "      <td>72.00</td>\n",
       "      <td>0.93</td>\n",
       "      <td>-98.71</td>\n",
       "      <td>6551</td>\n",
       "      <td>-37.44</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>NRXP</td>\n",
       "      <td>NRX Pharmaceuticals Inc</td>\n",
       "      <td>2017-12-04</td>\n",
       "      <td>14.51</td>\n",
       "      <td>0</td>\n",
       "      <td>144.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.26</td>\n",
       "      <td>https://www.nrxpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system di...</td>\n",
       "      <td>96.00</td>\n",
       "      <td>1.20</td>\n",
       "      <td>-98.75</td>\n",
       "      <td>2570</td>\n",
       "      <td>-160.30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>498</th>\n",
       "      <td>ATXS</td>\n",
       "      <td>Astria Therapeutics Inc</td>\n",
       "      <td>2015-06-25</td>\n",
       "      <td>545.72</td>\n",
       "      <td>59</td>\n",
       "      <td>338.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.astriatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic ...</td>\n",
       "      <td>780.00</td>\n",
       "      <td>9.52</td>\n",
       "      <td>-98.78</td>\n",
       "      <td>3463</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>499</th>\n",
       "      <td>ONVO</td>\n",
       "      <td>Organovo Holdings Inc</td>\n",
       "      <td>2012-02-14</td>\n",
       "      <td>5.99</td>\n",
       "      <td>12</td>\n",
       "      <td>149.00</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-12.49</td>\n",
       "      <td>https://www.organovo.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human ti...</td>\n",
       "      <td>33.00</td>\n",
       "      <td>0.40</td>\n",
       "      <td>-98.79</td>\n",
       "      <td>4690</td>\n",
       "      <td>-208.51</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>FBIO</td>\n",
       "      <td>Fortress Biotech Inc</td>\n",
       "      <td>2011-11-17</td>\n",
       "      <td>51.07</td>\n",
       "      <td>186</td>\n",
       "      <td>734.00</td>\n",
       "      <td>82.62</td>\n",
       "      <td>-90.31</td>\n",
       "      <td>https://www.fortressbiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The co...</td>\n",
       "      <td>165.00</td>\n",
       "      <td>1.94</td>\n",
       "      <td>-98.82</td>\n",
       "      <td>4779</td>\n",
       "      <td>-176.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>501</th>\n",
       "      <td>BCLI</td>\n",
       "      <td>Brainstorm Cell Therapeutics, Inc</td>\n",
       "      <td>2003-10-07</td>\n",
       "      <td>8.84</td>\n",
       "      <td>29</td>\n",
       "      <td>95.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.04</td>\n",
       "      <td>https://www.brainstorm-cell.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for ...</td>\n",
       "      <td>123.75</td>\n",
       "      <td>1.45</td>\n",
       "      <td>-98.83</td>\n",
       "      <td>7742</td>\n",
       "      <td>-181.45</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>502</th>\n",
       "      <td>EVAX</td>\n",
       "      <td>Evaxion Biotech A/S ADR</td>\n",
       "      <td>2021-02-05</td>\n",
       "      <td>6.16</td>\n",
       "      <td>49</td>\n",
       "      <td>56.00</td>\n",
       "      <td>3.30</td>\n",
       "      <td>-14.87</td>\n",
       "      <td>https://www.evaxion-biotech.com</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops...</td>\n",
       "      <td>98.90</td>\n",
       "      <td>1.14</td>\n",
       "      <td>-98.85</td>\n",
       "      <td>1411</td>\n",
       "      <td>-241.40</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>503</th>\n",
       "      <td>QTTB</td>\n",
       "      <td>Q32 Bio Inc</td>\n",
       "      <td>2018-03-28</td>\n",
       "      <td>42.63</td>\n",
       "      <td>42</td>\n",
       "      <td>228.00</td>\n",
       "      <td>-14.66</td>\n",
       "      <td>-76.89</td>\n",
       "      <td>https://www.q32bio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune...</td>\n",
       "      <td>335.88</td>\n",
       "      <td>3.70</td>\n",
       "      <td>-98.90</td>\n",
       "      <td>2456</td>\n",
       "      <td>-180.37</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>504</th>\n",
       "      <td>ADIL</td>\n",
       "      <td>Adial Pharmaceuticals Inc</td>\n",
       "      <td>2018-07-27</td>\n",
       "      <td>7.01</td>\n",
       "      <td>4</td>\n",
       "      <td>174.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.27</td>\n",
       "      <td>https://www.adialpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or preventio...</td>\n",
       "      <td>101.25</td>\n",
       "      <td>1.09</td>\n",
       "      <td>-98.92</td>\n",
       "      <td>2335</td>\n",
       "      <td>-103.71</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>505</th>\n",
       "      <td>ALRN</td>\n",
       "      <td>Aileron Therapeutics Inc</td>\n",
       "      <td>2017-06-29</td>\n",
       "      <td>45.93</td>\n",
       "      <td>15</td>\n",
       "      <td>92.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-25.40</td>\n",
       "      <td>https://www.aileronrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fi...</td>\n",
       "      <td>216.00</td>\n",
       "      <td>2.26</td>\n",
       "      <td>-98.95</td>\n",
       "      <td>2728</td>\n",
       "      <td>-55.30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>506</th>\n",
       "      <td>DTIL</td>\n",
       "      <td>Precision Biosciences Inc</td>\n",
       "      <td>2019-03-28</td>\n",
       "      <td>36.36</td>\n",
       "      <td>108</td>\n",
       "      <td>87.00</td>\n",
       "      <td>75.10</td>\n",
       "      <td>-11.98</td>\n",
       "      <td>https://www.precisionbiosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination,...</td>\n",
       "      <td>523.20</td>\n",
       "      <td>5.44</td>\n",
       "      <td>-98.96</td>\n",
       "      <td>2091</td>\n",
       "      <td>-32.95</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>507</th>\n",
       "      <td>LYRA</td>\n",
       "      <td>Lyra Therapeutics Inc</td>\n",
       "      <td>2020-05-01</td>\n",
       "      <td>12.15</td>\n",
       "      <td>88</td>\n",
       "      <td>1616.00</td>\n",
       "      <td>1.47</td>\n",
       "      <td>-67.04</td>\n",
       "      <td>https://lyratherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and del...</td>\n",
       "      <td>18.56</td>\n",
       "      <td>0.18</td>\n",
       "      <td>-99.01</td>\n",
       "      <td>1691</td>\n",
       "      <td>-551.77</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>508</th>\n",
       "      <td>RZLT</td>\n",
       "      <td>Rezolute Inc</td>\n",
       "      <td>2013-01-14</td>\n",
       "      <td>260.16</td>\n",
       "      <td>59</td>\n",
       "      <td>412.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-70.39</td>\n",
       "      <td>https://www.rezolutebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in th...</td>\n",
       "      <td>480.00</td>\n",
       "      <td>4.59</td>\n",
       "      <td>-99.04</td>\n",
       "      <td>4355</td>\n",
       "      <td>-27.06</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>509</th>\n",
       "      <td>ITRM</td>\n",
       "      <td>Iterum Therapeutics Plc</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>51.45</td>\n",
       "      <td>14</td>\n",
       "      <td>2872.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-37.36</td>\n",
       "      <td>https://www.iterumtx.com</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, a...</td>\n",
       "      <td>192.75</td>\n",
       "      <td>1.80</td>\n",
       "      <td>-99.07</td>\n",
       "      <td>2398</td>\n",
       "      <td>-72.61</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>510</th>\n",
       "      <td>CMMB</td>\n",
       "      <td>Chemomab Therapeutics Ltd ADR</td>\n",
       "      <td>2019-02-12</td>\n",
       "      <td>30.36</td>\n",
       "      <td>0</td>\n",
       "      <td>125.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.97</td>\n",
       "      <td>https://www.chemomab.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflamma...</td>\n",
       "      <td>172.80</td>\n",
       "      <td>1.58</td>\n",
       "      <td>-99.09</td>\n",
       "      <td>2135</td>\n",
       "      <td>-52.60</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>511</th>\n",
       "      <td>MTNB</td>\n",
       "      <td>Matinas Biopharma Holdings Inc</td>\n",
       "      <td>2014-07-21</td>\n",
       "      <td>2.75</td>\n",
       "      <td>32</td>\n",
       "      <td>219.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.38</td>\n",
       "      <td>https://www.matinasbiopharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nano...</td>\n",
       "      <td>65.00</td>\n",
       "      <td>0.57</td>\n",
       "      <td>-99.13</td>\n",
       "      <td>3802</td>\n",
       "      <td>-850.18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512</th>\n",
       "      <td>VRDN</td>\n",
       "      <td>Viridian Therapeutics Inc</td>\n",
       "      <td>2014-06-18</td>\n",
       "      <td>1706.24</td>\n",
       "      <td>94</td>\n",
       "      <td>1087.00</td>\n",
       "      <td>0.30</td>\n",
       "      <td>-282.47</td>\n",
       "      <td>https://www.viridiantherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeli...</td>\n",
       "      <td>2045.25</td>\n",
       "      <td>17.85</td>\n",
       "      <td>-99.13</td>\n",
       "      <td>3835</td>\n",
       "      <td>-16.56</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513</th>\n",
       "      <td>VRAX</td>\n",
       "      <td>Virax Biolabs Group Ltd</td>\n",
       "      <td>2022-07-21</td>\n",
       "      <td>6.69</td>\n",
       "      <td>17</td>\n",
       "      <td>1782.00</td>\n",
       "      <td>0.16</td>\n",
       "      <td>-6.05</td>\n",
       "      <td>https://viraxbiolabs.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Virax Biolabs Group Limited, a biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnos...</td>\n",
       "      <td>182.00</td>\n",
       "      <td>1.57</td>\n",
       "      <td>-99.14</td>\n",
       "      <td>880</td>\n",
       "      <td>-90.43</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514</th>\n",
       "      <td>EYEN</td>\n",
       "      <td>Eyenovia Inc</td>\n",
       "      <td>2018-01-25</td>\n",
       "      <td>9.09</td>\n",
       "      <td>57</td>\n",
       "      <td>7433.00</td>\n",
       "      <td>0.03</td>\n",
       "      <td>-34.80</td>\n",
       "      <td>https://www.eyenovia.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Eyenovia, Inc., a commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therape...</td>\n",
       "      <td>9.92</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-99.15</td>\n",
       "      <td>2518</td>\n",
       "      <td>-382.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>515</th>\n",
       "      <td>APLM</td>\n",
       "      <td>Apollomics Inc</td>\n",
       "      <td>2021-11-26</td>\n",
       "      <td>9.07</td>\n",
       "      <td>45</td>\n",
       "      <td>313.00</td>\n",
       "      <td>2.10</td>\n",
       "      <td>-53.10</td>\n",
       "      <td>https://www.apollomicsinc.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune...</td>\n",
       "      <td>990.00</td>\n",
       "      <td>8.34</td>\n",
       "      <td>-99.16</td>\n",
       "      <td>1117</td>\n",
       "      <td>-585.45</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>516</th>\n",
       "      <td>PDSB</td>\n",
       "      <td>PDS Biotechnology Corporation</td>\n",
       "      <td>2015-09-30</td>\n",
       "      <td>72.39</td>\n",
       "      <td>25</td>\n",
       "      <td>439.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-39.65</td>\n",
       "      <td>https://www.pdsbiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United ...</td>\n",
       "      <td>220.00</td>\n",
       "      <td>1.84</td>\n",
       "      <td>-99.16</td>\n",
       "      <td>3366</td>\n",
       "      <td>-54.77</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>517</th>\n",
       "      <td>CMND</td>\n",
       "      <td>Clearmind Medicine Inc</td>\n",
       "      <td>2022-11-15</td>\n",
       "      <td>5.74</td>\n",
       "      <td>0</td>\n",
       "      <td>263.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-5.86</td>\n",
       "      <td>https://www.clearmindmedicine.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada a...</td>\n",
       "      <td>177.00</td>\n",
       "      <td>1.47</td>\n",
       "      <td>-99.17</td>\n",
       "      <td>763</td>\n",
       "      <td>-102.09</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>518</th>\n",
       "      <td>CDT</td>\n",
       "      <td>Conduit Pharmaceuticals Inc</td>\n",
       "      <td>2022-03-28</td>\n",
       "      <td>8.86</td>\n",
       "      <td>7</td>\n",
       "      <td>25223.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.conduitpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical n...</td>\n",
       "      <td>9.94</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-99.18</td>\n",
       "      <td>995</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>519</th>\n",
       "      <td>MRNS</td>\n",
       "      <td>Marinus Pharmaceuticals Inc</td>\n",
       "      <td>2014-07-31</td>\n",
       "      <td>13.67</td>\n",
       "      <td>165</td>\n",
       "      <td>2657.00</td>\n",
       "      <td>30.26</td>\n",
       "      <td>-128.66</td>\n",
       "      <td>https://marinuspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients sufferi...</td>\n",
       "      <td>32.00</td>\n",
       "      <td>0.26</td>\n",
       "      <td>-99.18</td>\n",
       "      <td>3792</td>\n",
       "      <td>-941.19</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>ACET</td>\n",
       "      <td>Adicet Bio Inc</td>\n",
       "      <td>2018-01-26</td>\n",
       "      <td>79.32</td>\n",
       "      <td>143</td>\n",
       "      <td>579.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.50</td>\n",
       "      <td>https://www.adicetbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases a...</td>\n",
       "      <td>118.16</td>\n",
       "      <td>0.96</td>\n",
       "      <td>-99.18</td>\n",
       "      <td>2517</td>\n",
       "      <td>-153.18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>521</th>\n",
       "      <td>ICU</td>\n",
       "      <td>SeaStar Medical Holding Corp</td>\n",
       "      <td>2021-03-18</td>\n",
       "      <td>8.21</td>\n",
       "      <td>12</td>\n",
       "      <td>194.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.seastarmedical.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vita...</td>\n",
       "      <td>245.00</td>\n",
       "      <td>1.99</td>\n",
       "      <td>-99.19</td>\n",
       "      <td>1370</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>522</th>\n",
       "      <td>ATHE</td>\n",
       "      <td>Alterity Therapeutics Ltd ADR</td>\n",
       "      <td>2003-09-29</td>\n",
       "      <td>23.38</td>\n",
       "      <td>10</td>\n",
       "      <td>46.00</td>\n",
       "      <td>4.02</td>\n",
       "      <td>-19.57</td>\n",
       "      <td>https://alteritytherapeutics.com</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parki...</td>\n",
       "      <td>299.40</td>\n",
       "      <td>2.40</td>\n",
       "      <td>-99.20</td>\n",
       "      <td>7750</td>\n",
       "      <td>-83.70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>XFOR</td>\n",
       "      <td>X4 Pharmaceuticals Inc</td>\n",
       "      <td>2017-11-16</td>\n",
       "      <td>110.00</td>\n",
       "      <td>127</td>\n",
       "      <td>3090.00</td>\n",
       "      <td>0.56</td>\n",
       "      <td>-123.18</td>\n",
       "      <td>https://www.x4pharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel th...</td>\n",
       "      <td>84.18</td>\n",
       "      <td>0.67</td>\n",
       "      <td>-99.20</td>\n",
       "      <td>2588</td>\n",
       "      <td>-111.98</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>524</th>\n",
       "      <td>APRE</td>\n",
       "      <td>Aprea Therapeutics Inc</td>\n",
       "      <td>2019-10-03</td>\n",
       "      <td>17.72</td>\n",
       "      <td>7</td>\n",
       "      <td>27.00</td>\n",
       "      <td>1.28</td>\n",
       "      <td>-14.18</td>\n",
       "      <td>https://www.aprea.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based ca...</td>\n",
       "      <td>410.00</td>\n",
       "      <td>3.19</td>\n",
       "      <td>-99.22</td>\n",
       "      <td>1902</td>\n",
       "      <td>-80.02</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>525</th>\n",
       "      <td>ARWR</td>\n",
       "      <td>Arrowhead Pharmaceuticals Inc</td>\n",
       "      <td>1993-12-16</td>\n",
       "      <td>2783.59</td>\n",
       "      <td>525</td>\n",
       "      <td>1391.00</td>\n",
       "      <td>19.65</td>\n",
       "      <td>-529.78</td>\n",
       "      <td>https://arrowheadpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipel...</td>\n",
       "      <td>2925.00</td>\n",
       "      <td>21.85</td>\n",
       "      <td>-99.25</td>\n",
       "      <td>11324</td>\n",
       "      <td>-19.03</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>526</th>\n",
       "      <td>CTXR</td>\n",
       "      <td>Citius Pharmaceuticals Inc</td>\n",
       "      <td>2014-10-02</td>\n",
       "      <td>19.94</td>\n",
       "      <td>22</td>\n",
       "      <td>227.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-41.07</td>\n",
       "      <td>https://citiuspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR...</td>\n",
       "      <td>375.00</td>\n",
       "      <td>2.79</td>\n",
       "      <td>-99.26</td>\n",
       "      <td>3729</td>\n",
       "      <td>-205.97</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>527</th>\n",
       "      <td>IGC</td>\n",
       "      <td>IGC Pharma Inc</td>\n",
       "      <td>2006-05-24</td>\n",
       "      <td>28.39</td>\n",
       "      <td>67</td>\n",
       "      <td>465.00</td>\n",
       "      <td>1.06</td>\n",
       "      <td>-9.40</td>\n",
       "      <td>https://igcpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is...</td>\n",
       "      <td>55.60</td>\n",
       "      <td>0.41</td>\n",
       "      <td>-99.26</td>\n",
       "      <td>6782</td>\n",
       "      <td>-33.11</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>528</th>\n",
       "      <td>CBUS</td>\n",
       "      <td>Cibus Inc</td>\n",
       "      <td>2017-07-20</td>\n",
       "      <td>115.02</td>\n",
       "      <td>183</td>\n",
       "      <td>203.00</td>\n",
       "      <td>4.15</td>\n",
       "      <td>-60.30</td>\n",
       "      <td>https://www.cibus.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus...</td>\n",
       "      <td>562.50</td>\n",
       "      <td>4.08</td>\n",
       "      <td>-99.27</td>\n",
       "      <td>2707</td>\n",
       "      <td>-52.43</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>529</th>\n",
       "      <td>SCNI</td>\n",
       "      <td>Scinai Immunotherapeutics Ltd ADR</td>\n",
       "      <td>2015-05-11</td>\n",
       "      <td>2.94</td>\n",
       "      <td>31</td>\n",
       "      <td>28.00</td>\n",
       "      <td>0.28</td>\n",
       "      <td>-7.00</td>\n",
       "      <td>https://www.scinai.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products ...</td>\n",
       "      <td>500.00</td>\n",
       "      <td>3.42</td>\n",
       "      <td>-99.32</td>\n",
       "      <td>3508</td>\n",
       "      <td>-238.10</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>530</th>\n",
       "      <td>KZIA</td>\n",
       "      <td>Kazia Therapeutics Limited ADR</td>\n",
       "      <td>1999-01-06</td>\n",
       "      <td>14.50</td>\n",
       "      <td>0</td>\n",
       "      <td>115.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.52</td>\n",
       "      <td>https://www.kaziatherapeutics.com</td>\n",
       "      <td>Australia</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kazia Therapeutics Limited operates as an oncology-focused biotechnology company. The company's lead development candidate is Paxalisib, a small m...</td>\n",
       "      <td>526.66</td>\n",
       "      <td>3.55</td>\n",
       "      <td>-99.33</td>\n",
       "      <td>9477</td>\n",
       "      <td>-120.83</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>531</th>\n",
       "      <td>UBX</td>\n",
       "      <td>Unity Biotechnology Inc</td>\n",
       "      <td>2018-05-03</td>\n",
       "      <td>18.20</td>\n",
       "      <td>19</td>\n",
       "      <td>60.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.36</td>\n",
       "      <td>https://unitybiotechnology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of ...</td>\n",
       "      <td>166.50</td>\n",
       "      <td>1.12</td>\n",
       "      <td>-99.33</td>\n",
       "      <td>2420</td>\n",
       "      <td>-150.33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532</th>\n",
       "      <td>KALA</td>\n",
       "      <td>Kala Bio Inc</td>\n",
       "      <td>2017-07-20</td>\n",
       "      <td>28.17</td>\n",
       "      <td>43</td>\n",
       "      <td>27.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-40.98</td>\n",
       "      <td>https://www.kalarx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies fo...</td>\n",
       "      <td>924.50</td>\n",
       "      <td>6.18</td>\n",
       "      <td>-99.33</td>\n",
       "      <td>2707</td>\n",
       "      <td>-145.47</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>533</th>\n",
       "      <td>PHGE</td>\n",
       "      <td>BiomX Inc</td>\n",
       "      <td>2019-03-13</td>\n",
       "      <td>12.09</td>\n",
       "      <td>58</td>\n",
       "      <td>87.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.71</td>\n",
       "      <td>https://www.biomx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and k...</td>\n",
       "      <td>96.50</td>\n",
       "      <td>0.63</td>\n",
       "      <td>-99.34</td>\n",
       "      <td>2106</td>\n",
       "      <td>-229.20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>534</th>\n",
       "      <td>XBIO</td>\n",
       "      <td>Xenetic Biosciences Inc</td>\n",
       "      <td>2016-06-30</td>\n",
       "      <td>6.34</td>\n",
       "      <td>4</td>\n",
       "      <td>25.00</td>\n",
       "      <td>2.52</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.xeneticbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies for hard to treat cancers. The company's...</td>\n",
       "      <td>612.00</td>\n",
       "      <td>4.01</td>\n",
       "      <td>-99.34</td>\n",
       "      <td>3092</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>535</th>\n",
       "      <td>LXRX</td>\n",
       "      <td>Lexicon Pharmaceuticals Inc</td>\n",
       "      <td>2000-04-07</td>\n",
       "      <td>278.31</td>\n",
       "      <td>285</td>\n",
       "      <td>3851.00</td>\n",
       "      <td>5.23</td>\n",
       "      <td>-210.55</td>\n",
       "      <td>https://www.lexpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical product...</td>\n",
       "      <td>131.25</td>\n",
       "      <td>0.81</td>\n",
       "      <td>-99.38</td>\n",
       "      <td>9020</td>\n",
       "      <td>-75.65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>536</th>\n",
       "      <td>GNPX</td>\n",
       "      <td>Genprex Inc</td>\n",
       "      <td>2018-03-29</td>\n",
       "      <td>8.93</td>\n",
       "      <td>21</td>\n",
       "      <td>9653.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-26.28</td>\n",
       "      <td>https://www.genprex.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technol...</td>\n",
       "      <td>188.00</td>\n",
       "      <td>1.16</td>\n",
       "      <td>-99.38</td>\n",
       "      <td>2455</td>\n",
       "      <td>-294.29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>537</th>\n",
       "      <td>GRCE</td>\n",
       "      <td>Grace Therapeutics Inc</td>\n",
       "      <td>2012-02-07</td>\n",
       "      <td>36.91</td>\n",
       "      <td>0</td>\n",
       "      <td>49.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-13.27</td>\n",
       "      <td>https://www.acastipharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The c...</td>\n",
       "      <td>580.80</td>\n",
       "      <td>3.58</td>\n",
       "      <td>-99.38</td>\n",
       "      <td>4697</td>\n",
       "      <td>-35.95</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>538</th>\n",
       "      <td>VRPX</td>\n",
       "      <td>Virpax Pharmaceuticals Inc</td>\n",
       "      <td>2021-02-17</td>\n",
       "      <td>2.85</td>\n",
       "      <td>7</td>\n",
       "      <td>3463.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.virpaxpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies f...</td>\n",
       "      <td>65.30</td>\n",
       "      <td>0.40</td>\n",
       "      <td>-99.39</td>\n",
       "      <td>1399</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>539</th>\n",
       "      <td>RLMD</td>\n",
       "      <td>Relmada Therapeutics Inc</td>\n",
       "      <td>2014-06-20</td>\n",
       "      <td>11.73</td>\n",
       "      <td>20</td>\n",
       "      <td>747.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.relmada.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous sy...</td>\n",
       "      <td>60.00</td>\n",
       "      <td>0.37</td>\n",
       "      <td>-99.39</td>\n",
       "      <td>3833</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>540</th>\n",
       "      <td>PPBT</td>\n",
       "      <td>Purple Biotech Ltd ADR</td>\n",
       "      <td>2015-11-20</td>\n",
       "      <td>10.02</td>\n",
       "      <td>20</td>\n",
       "      <td>916.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-19.62</td>\n",
       "      <td>https://purple-biotech.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer pat...</td>\n",
       "      <td>638.00</td>\n",
       "      <td>3.83</td>\n",
       "      <td>-99.40</td>\n",
       "      <td>3315</td>\n",
       "      <td>-195.81</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>541</th>\n",
       "      <td>GYRE</td>\n",
       "      <td>Gyre Therapeutics Inc</td>\n",
       "      <td>2006-04-12</td>\n",
       "      <td>857.36</td>\n",
       "      <td>593</td>\n",
       "      <td>78.00</td>\n",
       "      <td>111.59</td>\n",
       "      <td>20.08</td>\n",
       "      <td>https://www.gyretx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti...</td>\n",
       "      <td>1648.19</td>\n",
       "      <td>9.64</td>\n",
       "      <td>-99.42</td>\n",
       "      <td>6824</td>\n",
       "      <td>2.34</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>542</th>\n",
       "      <td>CERO</td>\n",
       "      <td>CERo Therapeutics Holdings Inc</td>\n",
       "      <td>2021-11-30</td>\n",
       "      <td>7.67</td>\n",
       "      <td>8</td>\n",
       "      <td>69458.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.cero.bio</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatme...</td>\n",
       "      <td>9.93</td>\n",
       "      <td>0.06</td>\n",
       "      <td>-99.43</td>\n",
       "      <td>1113</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>543</th>\n",
       "      <td>VXRT</td>\n",
       "      <td>Vaxart Inc</td>\n",
       "      <td>1981-12-11</td>\n",
       "      <td>133.05</td>\n",
       "      <td>109</td>\n",
       "      <td>1297.00</td>\n",
       "      <td>13.93</td>\n",
       "      <td>-66.26</td>\n",
       "      <td>https://vaxart.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vacci...</td>\n",
       "      <td>103.65</td>\n",
       "      <td>0.59</td>\n",
       "      <td>-99.43</td>\n",
       "      <td>15712</td>\n",
       "      <td>-49.80</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>544</th>\n",
       "      <td>DWTX</td>\n",
       "      <td>Dogwood Therapeutics Inc</td>\n",
       "      <td>2020-12-17</td>\n",
       "      <td>3.26</td>\n",
       "      <td>4</td>\n",
       "      <td>110.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.dwtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associate...</td>\n",
       "      <td>417.75</td>\n",
       "      <td>2.36</td>\n",
       "      <td>-99.44</td>\n",
       "      <td>1461</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>APM</td>\n",
       "      <td>Aptorum Group Ltd</td>\n",
       "      <td>2018-12-18</td>\n",
       "      <td>4.04</td>\n",
       "      <td>3</td>\n",
       "      <td>43.00</td>\n",
       "      <td>0.43</td>\n",
       "      <td>-9.60</td>\n",
       "      <td>https://www.aptorumgroup.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aptorum Group Limited, through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development...</td>\n",
       "      <td>143.50</td>\n",
       "      <td>0.77</td>\n",
       "      <td>-99.47</td>\n",
       "      <td>2191</td>\n",
       "      <td>-237.62</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>546</th>\n",
       "      <td>XOMA</td>\n",
       "      <td>XOMA Royalty Corp</td>\n",
       "      <td>1986-06-06</td>\n",
       "      <td>327.79</td>\n",
       "      <td>13</td>\n",
       "      <td>28.00</td>\n",
       "      <td>21.61</td>\n",
       "      <td>-15.17</td>\n",
       "      <td>https://xoma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights...</td>\n",
       "      <td>5100.00</td>\n",
       "      <td>27.15</td>\n",
       "      <td>-99.47</td>\n",
       "      <td>14074</td>\n",
       "      <td>-4.63</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>547</th>\n",
       "      <td>FBRX</td>\n",
       "      <td>Forte Biosciences Inc</td>\n",
       "      <td>2017-04-13</td>\n",
       "      <td>27.72</td>\n",
       "      <td>11</td>\n",
       "      <td>548.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.fortebiorx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses vari...</td>\n",
       "      <td>4668.75</td>\n",
       "      <td>23.15</td>\n",
       "      <td>-99.50</td>\n",
       "      <td>2805</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>548</th>\n",
       "      <td>PYPD</td>\n",
       "      <td>Polypid Ltd</td>\n",
       "      <td>2020-06-26</td>\n",
       "      <td>16.53</td>\n",
       "      <td>59</td>\n",
       "      <td>13.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.94</td>\n",
       "      <td>https://www.polypid.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its ...</td>\n",
       "      <td>570.00</td>\n",
       "      <td>2.61</td>\n",
       "      <td>-99.54</td>\n",
       "      <td>1635</td>\n",
       "      <td>-132.73</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>549</th>\n",
       "      <td>BCTX</td>\n",
       "      <td>BriaCell Therapeutics Corp</td>\n",
       "      <td>2012-03-14</td>\n",
       "      <td>27.34</td>\n",
       "      <td>0</td>\n",
       "      <td>2866.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-33.25</td>\n",
       "      <td>https://briacell.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. It...</td>\n",
       "      <td>156.35</td>\n",
       "      <td>0.66</td>\n",
       "      <td>-99.58</td>\n",
       "      <td>4661</td>\n",
       "      <td>-121.62</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>550</th>\n",
       "      <td>CING</td>\n",
       "      <td>Cingulate Inc</td>\n",
       "      <td>2021-12-08</td>\n",
       "      <td>12.95</td>\n",
       "      <td>13</td>\n",
       "      <td>144.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.57</td>\n",
       "      <td>https://www.cingulate.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperact...</td>\n",
       "      <td>1068.00</td>\n",
       "      <td>4.21</td>\n",
       "      <td>-99.61</td>\n",
       "      <td>1105</td>\n",
       "      <td>-120.23</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>551</th>\n",
       "      <td>DARE</td>\n",
       "      <td>Dare Bioscience Inc</td>\n",
       "      <td>2014-04-10</td>\n",
       "      <td>27.67</td>\n",
       "      <td>23</td>\n",
       "      <td>48.00</td>\n",
       "      <td>2.84</td>\n",
       "      <td>-26.70</td>\n",
       "      <td>https://darebioscience.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Dar√© Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develop...</td>\n",
       "      <td>822.00</td>\n",
       "      <td>3.18</td>\n",
       "      <td>-99.61</td>\n",
       "      <td>3904</td>\n",
       "      <td>-96.49</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>552</th>\n",
       "      <td>HOTH</td>\n",
       "      <td>Hoth Therapeutics Inc</td>\n",
       "      <td>2019-02-15</td>\n",
       "      <td>5.59</td>\n",
       "      <td>2</td>\n",
       "      <td>1002.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://hoththerapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, ...</td>\n",
       "      <td>213.25</td>\n",
       "      <td>0.81</td>\n",
       "      <td>-99.62</td>\n",
       "      <td>2132</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>553</th>\n",
       "      <td>ENLV</td>\n",
       "      <td>Enlivex Therapeutics Ltd</td>\n",
       "      <td>2014-07-31</td>\n",
       "      <td>25.51</td>\n",
       "      <td>0</td>\n",
       "      <td>243.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.89</td>\n",
       "      <td>https://www.enlivex.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. ...</td>\n",
       "      <td>336.00</td>\n",
       "      <td>1.20</td>\n",
       "      <td>-99.64</td>\n",
       "      <td>3792</td>\n",
       "      <td>-70.13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>554</th>\n",
       "      <td>ELAB</td>\n",
       "      <td>Elevai Labs Inc</td>\n",
       "      <td>2023-11-21</td>\n",
       "      <td>6.33</td>\n",
       "      <td>18</td>\n",
       "      <td>880.00</td>\n",
       "      <td>2.47</td>\n",
       "      <td>-4.78</td>\n",
       "      <td>https://elevaiskincare.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Em...</td>\n",
       "      <td>680.00</td>\n",
       "      <td>2.29</td>\n",
       "      <td>-99.66</td>\n",
       "      <td>392</td>\n",
       "      <td>-75.51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>555</th>\n",
       "      <td>EDSA</td>\n",
       "      <td>Edesa Biotech Inc</td>\n",
       "      <td>2010-06-21</td>\n",
       "      <td>6.17</td>\n",
       "      <td>16</td>\n",
       "      <td>31.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.27</td>\n",
       "      <td>https://www.edesabiotech.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of ph...</td>\n",
       "      <td>588.00</td>\n",
       "      <td>1.94</td>\n",
       "      <td>-99.67</td>\n",
       "      <td>5293</td>\n",
       "      <td>-134.04</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>556</th>\n",
       "      <td>INO</td>\n",
       "      <td>Inovio Pharmaceuticals Inc</td>\n",
       "      <td>1998-12-08</td>\n",
       "      <td>77.61</td>\n",
       "      <td>127</td>\n",
       "      <td>545.00</td>\n",
       "      <td>0.59</td>\n",
       "      <td>-114.99</td>\n",
       "      <td>https://www.inovio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and ...</td>\n",
       "      <td>708.00</td>\n",
       "      <td>2.32</td>\n",
       "      <td>-99.67</td>\n",
       "      <td>9506</td>\n",
       "      <td>-148.16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>557</th>\n",
       "      <td>GTBP</td>\n",
       "      <td>GT Biopharma Inc</td>\n",
       "      <td>2018-03-27</td>\n",
       "      <td>5.61</td>\n",
       "      <td>2</td>\n",
       "      <td>23.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.gtbiopharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based...</td>\n",
       "      <td>846.60</td>\n",
       "      <td>2.75</td>\n",
       "      <td>-99.68</td>\n",
       "      <td>2457</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>558</th>\n",
       "      <td>XTLB</td>\n",
       "      <td>X.T.L. Biopharmaceuticals Ltd. ADR</td>\n",
       "      <td>2005-09-01</td>\n",
       "      <td>9.10</td>\n",
       "      <td>0</td>\n",
       "      <td>42.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.xtlbio.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment ...</td>\n",
       "      <td>571.00</td>\n",
       "      <td>1.80</td>\n",
       "      <td>-99.68</td>\n",
       "      <td>7047</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>559</th>\n",
       "      <td>NCNA</td>\n",
       "      <td>NuCana plc ADR</td>\n",
       "      <td>2017-09-28</td>\n",
       "      <td>4.97</td>\n",
       "      <td>25</td>\n",
       "      <td>296.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-33.22</td>\n",
       "      <td>https://www.nucana.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProT...</td>\n",
       "      <td>403.75</td>\n",
       "      <td>1.27</td>\n",
       "      <td>-99.69</td>\n",
       "      <td>2637</td>\n",
       "      <td>-668.41</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>560</th>\n",
       "      <td>RGLS</td>\n",
       "      <td>Regulus Therapeutics Inc</td>\n",
       "      <td>2012-10-09</td>\n",
       "      <td>107.42</td>\n",
       "      <td>32</td>\n",
       "      <td>365.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-44.26</td>\n",
       "      <td>https://www.regulusrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to tre...</td>\n",
       "      <td>525.60</td>\n",
       "      <td>1.58</td>\n",
       "      <td>-99.70</td>\n",
       "      <td>4452</td>\n",
       "      <td>-41.20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>561</th>\n",
       "      <td>AZTR</td>\n",
       "      <td>Azitra Inc</td>\n",
       "      <td>2023-06-16</td>\n",
       "      <td>3.35</td>\n",
       "      <td>10</td>\n",
       "      <td>211.00</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-11.06</td>\n",
       "      <td>https://azitrainc.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherape...</td>\n",
       "      <td>148.20</td>\n",
       "      <td>0.44</td>\n",
       "      <td>-99.70</td>\n",
       "      <td>550</td>\n",
       "      <td>-330.15</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>562</th>\n",
       "      <td>XRTX</td>\n",
       "      <td>XORTX Therapeutics Inc</td>\n",
       "      <td>2021-09-23</td>\n",
       "      <td>3.90</td>\n",
       "      <td>2</td>\n",
       "      <td>56.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-3.30</td>\n",
       "      <td>https://www.xortx.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat prog...</td>\n",
       "      <td>406.05</td>\n",
       "      <td>1.19</td>\n",
       "      <td>-99.71</td>\n",
       "      <td>1181</td>\n",
       "      <td>-84.62</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>563</th>\n",
       "      <td>BLRX</td>\n",
       "      <td>Bioline Rx Ltd ADR</td>\n",
       "      <td>2011-07-27</td>\n",
       "      <td>21.72</td>\n",
       "      <td>79</td>\n",
       "      <td>927.00</td>\n",
       "      <td>17.05</td>\n",
       "      <td>-33.08</td>\n",
       "      <td>https://www.biolinerx.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company...</td>\n",
       "      <td>75.45</td>\n",
       "      <td>0.22</td>\n",
       "      <td>-99.71</td>\n",
       "      <td>4892</td>\n",
       "      <td>-152.30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>564</th>\n",
       "      <td>HRTX</td>\n",
       "      <td>Heron Therapeutics Inc</td>\n",
       "      <td>1987-08-26</td>\n",
       "      <td>255.52</td>\n",
       "      <td>126</td>\n",
       "      <td>3245.00</td>\n",
       "      <td>137.74</td>\n",
       "      <td>-5.70</td>\n",
       "      <td>https://www.herontx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing t...</td>\n",
       "      <td>580.00</td>\n",
       "      <td>1.60</td>\n",
       "      <td>-99.72</td>\n",
       "      <td>13628</td>\n",
       "      <td>-2.23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>565</th>\n",
       "      <td>VANI</td>\n",
       "      <td>Vivani Medical Inc</td>\n",
       "      <td>2014-11-19</td>\n",
       "      <td>78.19</td>\n",
       "      <td>36</td>\n",
       "      <td>105.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.90</td>\n",
       "      <td>https://www.vivani.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat ...</td>\n",
       "      <td>479.28</td>\n",
       "      <td>1.31</td>\n",
       "      <td>-99.73</td>\n",
       "      <td>3681</td>\n",
       "      <td>-31.85</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>566</th>\n",
       "      <td>PBM</td>\n",
       "      <td>Psyence Biomedical Ltd</td>\n",
       "      <td>2021-12-10</td>\n",
       "      <td>1.56</td>\n",
       "      <td>0</td>\n",
       "      <td>776.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-2.75</td>\n",
       "      <td>https://www.psyencebiomed.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for t...</td>\n",
       "      <td>742.50</td>\n",
       "      <td>1.85</td>\n",
       "      <td>-99.75</td>\n",
       "      <td>1103</td>\n",
       "      <td>-176.28</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>567</th>\n",
       "      <td>CRDF</td>\n",
       "      <td>Cardiff Oncology Inc</td>\n",
       "      <td>2004-07-27</td>\n",
       "      <td>268.09</td>\n",
       "      <td>31</td>\n",
       "      <td>1753.00</td>\n",
       "      <td>0.69</td>\n",
       "      <td>-46.00</td>\n",
       "      <td>https://www.cardiffoncology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug can...</td>\n",
       "      <td>1620.00</td>\n",
       "      <td>3.92</td>\n",
       "      <td>-99.76</td>\n",
       "      <td>7448</td>\n",
       "      <td>-17.16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>568</th>\n",
       "      <td>IMUX</td>\n",
       "      <td>Immunic Inc</td>\n",
       "      <td>2014-04-17</td>\n",
       "      <td>99.99</td>\n",
       "      <td>85</td>\n",
       "      <td>924.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-95.68</td>\n",
       "      <td>https://imux.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and a...</td>\n",
       "      <td>480.00</td>\n",
       "      <td>1.13</td>\n",
       "      <td>-99.76</td>\n",
       "      <td>3897</td>\n",
       "      <td>-95.69</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>569</th>\n",
       "      <td>SPRC</td>\n",
       "      <td>SciSparc Ltd</td>\n",
       "      <td>2021-08-30</td>\n",
       "      <td>2.37</td>\n",
       "      <td>3</td>\n",
       "      <td>817.00</td>\n",
       "      <td>1.75</td>\n",
       "      <td>-5.89</td>\n",
       "      <td>https://scisparc.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-1...</td>\n",
       "      <td>117.00</td>\n",
       "      <td>0.27</td>\n",
       "      <td>-99.77</td>\n",
       "      <td>1205</td>\n",
       "      <td>-248.52</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>570</th>\n",
       "      <td>OTLK</td>\n",
       "      <td>Outlook Therapeutics Inc</td>\n",
       "      <td>2016-06-14</td>\n",
       "      <td>33.83</td>\n",
       "      <td>24</td>\n",
       "      <td>1646.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-61.19</td>\n",
       "      <td>https://www.outlooktherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodie...</td>\n",
       "      <td>683.20</td>\n",
       "      <td>1.48</td>\n",
       "      <td>-99.78</td>\n",
       "      <td>3108</td>\n",
       "      <td>-180.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>571</th>\n",
       "      <td>COCP</td>\n",
       "      <td>Cocrystal Pharma Inc</td>\n",
       "      <td>2012-02-22</td>\n",
       "      <td>20.55</td>\n",
       "      <td>12</td>\n",
       "      <td>19.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.15</td>\n",
       "      <td>https://www.cocrystalpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or c...</td>\n",
       "      <td>900.00</td>\n",
       "      <td>1.91</td>\n",
       "      <td>-99.79</td>\n",
       "      <td>4682</td>\n",
       "      <td>-102.92</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>572</th>\n",
       "      <td>PLX</td>\n",
       "      <td>Protalix BioTherapeutics Inc</td>\n",
       "      <td>1998-05-15</td>\n",
       "      <td>128.86</td>\n",
       "      <td>208</td>\n",
       "      <td>303.00</td>\n",
       "      <td>38.05</td>\n",
       "      <td>-13.53</td>\n",
       "      <td>https://www.protalix.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeu...</td>\n",
       "      <td>850.00</td>\n",
       "      <td>1.80</td>\n",
       "      <td>-99.79</td>\n",
       "      <td>9713</td>\n",
       "      <td>-10.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>573</th>\n",
       "      <td>INDP</td>\n",
       "      <td>Indaptus Therapeutics Inc</td>\n",
       "      <td>2015-08-04</td>\n",
       "      <td>11.53</td>\n",
       "      <td>7</td>\n",
       "      <td>116.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.48</td>\n",
       "      <td>https://indaptusrx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinic...</td>\n",
       "      <td>480.00</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-99.79</td>\n",
       "      <td>3423</td>\n",
       "      <td>-142.93</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>574</th>\n",
       "      <td>BNTC</td>\n",
       "      <td>Benitec Biopharma Inc</td>\n",
       "      <td>2014-06-24</td>\n",
       "      <td>292.06</td>\n",
       "      <td>16</td>\n",
       "      <td>42.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-22.40</td>\n",
       "      <td>https://benitec.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-di...</td>\n",
       "      <td>5909.30</td>\n",
       "      <td>11.77</td>\n",
       "      <td>-99.80</td>\n",
       "      <td>3829</td>\n",
       "      <td>-7.67</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>575</th>\n",
       "      <td>PRTG</td>\n",
       "      <td>Portage Biotech Inc</td>\n",
       "      <td>2002-01-02</td>\n",
       "      <td>3.64</td>\n",
       "      <td>7</td>\n",
       "      <td>939.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.04</td>\n",
       "      <td>https://www.portagebiotech.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. It...</td>\n",
       "      <td>1540.00</td>\n",
       "      <td>3.00</td>\n",
       "      <td>-99.81</td>\n",
       "      <td>8385</td>\n",
       "      <td>-440.66</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>576</th>\n",
       "      <td>CARM</td>\n",
       "      <td>Carisma Therapeutics Inc</td>\n",
       "      <td>2014-02-06</td>\n",
       "      <td>17.96</td>\n",
       "      <td>107</td>\n",
       "      <td>185.00</td>\n",
       "      <td>20.27</td>\n",
       "      <td>-63.37</td>\n",
       "      <td>https://www.carismatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other...</td>\n",
       "      <td>210.77</td>\n",
       "      <td>0.41</td>\n",
       "      <td>-99.81</td>\n",
       "      <td>3967</td>\n",
       "      <td>-352.84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>577</th>\n",
       "      <td>CANF</td>\n",
       "      <td>Can-Fite Biopharma Ltd ADR</td>\n",
       "      <td>2012-11-06</td>\n",
       "      <td>9.21</td>\n",
       "      <td>8</td>\n",
       "      <td>440.00</td>\n",
       "      <td>0.67</td>\n",
       "      <td>-7.78</td>\n",
       "      <td>https://www.canfite.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the trea...</td>\n",
       "      <td>825.00</td>\n",
       "      <td>1.58</td>\n",
       "      <td>-99.81</td>\n",
       "      <td>4424</td>\n",
       "      <td>-84.47</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>578</th>\n",
       "      <td>CASI</td>\n",
       "      <td>CASI Pharmaceuticals Inc</td>\n",
       "      <td>1996-06-12</td>\n",
       "      <td>48.70</td>\n",
       "      <td>176</td>\n",
       "      <td>38.00</td>\n",
       "      <td>23.10</td>\n",
       "      <td>-23.08</td>\n",
       "      <td>https://www.casipharmaceuticals.com</td>\n",
       "      <td>China</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Repu...</td>\n",
       "      <td>1732.50</td>\n",
       "      <td>3.11</td>\n",
       "      <td>-99.82</td>\n",
       "      <td>10415</td>\n",
       "      <td>-47.39</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>579</th>\n",
       "      <td>SKYE</td>\n",
       "      <td>Skye Bioscience Inc</td>\n",
       "      <td>2015-01-06</td>\n",
       "      <td>99.51</td>\n",
       "      <td>11</td>\n",
       "      <td>334.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.46</td>\n",
       "      <td>https://skyebioscience.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Skye Bioscience, Inc., a biopharmaceutical company, focuses on unlocking new therapeutic pathways for metabolic health through the development of ...</td>\n",
       "      <td>1937.50</td>\n",
       "      <td>3.38</td>\n",
       "      <td>-99.83</td>\n",
       "      <td>3633</td>\n",
       "      <td>-23.58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>580</th>\n",
       "      <td>VTGN</td>\n",
       "      <td>Vistagen Therapeutics Inc</td>\n",
       "      <td>2011-06-21</td>\n",
       "      <td>69.05</td>\n",
       "      <td>39</td>\n",
       "      <td>210.00</td>\n",
       "      <td>0.88</td>\n",
       "      <td>-45.47</td>\n",
       "      <td>https://www.vistagen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vistagen Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurol...</td>\n",
       "      <td>1470.00</td>\n",
       "      <td>2.43</td>\n",
       "      <td>-99.83</td>\n",
       "      <td>4928</td>\n",
       "      <td>-65.85</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>THAR</td>\n",
       "      <td>Tharimmune Inc</td>\n",
       "      <td>2022-01-12</td>\n",
       "      <td>3.22</td>\n",
       "      <td>2</td>\n",
       "      <td>1284.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.tharimmune.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncolog...</td>\n",
       "      <td>1305.00</td>\n",
       "      <td>2.14</td>\n",
       "      <td>-99.84</td>\n",
       "      <td>1070</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>582</th>\n",
       "      <td>PULM</td>\n",
       "      <td>Pulmatrix Inc</td>\n",
       "      <td>2014-03-21</td>\n",
       "      <td>22.06</td>\n",
       "      <td>22</td>\n",
       "      <td>470.00</td>\n",
       "      <td>11.39</td>\n",
       "      <td>-11.14</td>\n",
       "      <td>https://www.pulmatrix.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respira...</td>\n",
       "      <td>3625.00</td>\n",
       "      <td>5.75</td>\n",
       "      <td>-99.84</td>\n",
       "      <td>3924</td>\n",
       "      <td>-50.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>583</th>\n",
       "      <td>VCNX</td>\n",
       "      <td>Vaccinex Inc</td>\n",
       "      <td>2018-08-09</td>\n",
       "      <td>9.77</td>\n",
       "      <td>37</td>\n",
       "      <td>112.00</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-21.51</td>\n",
       "      <td>https://www.vaccinex.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neur...</td>\n",
       "      <td>2389.80</td>\n",
       "      <td>3.69</td>\n",
       "      <td>-99.85</td>\n",
       "      <td>2322</td>\n",
       "      <td>-220.16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>584</th>\n",
       "      <td>ENVB</td>\n",
       "      <td>Enveric Biosciences Inc</td>\n",
       "      <td>2015-05-04</td>\n",
       "      <td>3.58</td>\n",
       "      <td>7</td>\n",
       "      <td>557.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-9.87</td>\n",
       "      <td>https://www.enveric.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depres...</td>\n",
       "      <td>250.00</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-99.85</td>\n",
       "      <td>3515</td>\n",
       "      <td>-275.70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>585</th>\n",
       "      <td>MBIO</td>\n",
       "      <td>Mustang Bio Inc</td>\n",
       "      <td>2017-08-22</td>\n",
       "      <td>9.23</td>\n",
       "      <td>80</td>\n",
       "      <td>1886.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.53</td>\n",
       "      <td>https://www.mustangbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potent...</td>\n",
       "      <td>147.00</td>\n",
       "      <td>0.19</td>\n",
       "      <td>-99.87</td>\n",
       "      <td>2674</td>\n",
       "      <td>-222.43</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>ATOS</td>\n",
       "      <td>Atossa Therapeutics Inc</td>\n",
       "      <td>2012-11-08</td>\n",
       "      <td>134.61</td>\n",
       "      <td>12</td>\n",
       "      <td>663.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-29.46</td>\n",
       "      <td>https://www.atossatherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women...</td>\n",
       "      <td>864.00</td>\n",
       "      <td>1.12</td>\n",
       "      <td>-99.87</td>\n",
       "      <td>4422</td>\n",
       "      <td>-21.89</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>587</th>\n",
       "      <td>VYNE</td>\n",
       "      <td>VYNE Therapeutics Inc</td>\n",
       "      <td>2018-01-25</td>\n",
       "      <td>37.76</td>\n",
       "      <td>10</td>\n",
       "      <td>88.00</td>\n",
       "      <td>0.49</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.vynetherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno...</td>\n",
       "      <td>2067.12</td>\n",
       "      <td>2.56</td>\n",
       "      <td>-99.88</td>\n",
       "      <td>2518</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>588</th>\n",
       "      <td>OCGN</td>\n",
       "      <td>Ocugen Inc</td>\n",
       "      <td>2014-12-03</td>\n",
       "      <td>246.78</td>\n",
       "      <td>65</td>\n",
       "      <td>3728.00</td>\n",
       "      <td>4.70</td>\n",
       "      <td>-50.53</td>\n",
       "      <td>https://www.ocugen.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies an...</td>\n",
       "      <td>705.00</td>\n",
       "      <td>0.86</td>\n",
       "      <td>-99.88</td>\n",
       "      <td>3667</td>\n",
       "      <td>-20.48</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>589</th>\n",
       "      <td>INM</td>\n",
       "      <td>InMed Pharmaceuticals Inc</td>\n",
       "      <td>2014-05-05</td>\n",
       "      <td>3.73</td>\n",
       "      <td>13</td>\n",
       "      <td>40.00</td>\n",
       "      <td>4.60</td>\n",
       "      <td>-7.91</td>\n",
       "      <td>https://www.inmedpharma.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It o...</td>\n",
       "      <td>4389.00</td>\n",
       "      <td>5.26</td>\n",
       "      <td>-99.88</td>\n",
       "      <td>3879</td>\n",
       "      <td>-212.06</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>590</th>\n",
       "      <td>SYRS</td>\n",
       "      <td>Syros Pharmaceuticals Inc</td>\n",
       "      <td>2016-06-30</td>\n",
       "      <td>5.90</td>\n",
       "      <td>68</td>\n",
       "      <td>8563.00</td>\n",
       "      <td>0.39</td>\n",
       "      <td>-110.18</td>\n",
       "      <td>https://www.syros.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead...</td>\n",
       "      <td>181.50</td>\n",
       "      <td>0.21</td>\n",
       "      <td>-99.89</td>\n",
       "      <td>3092</td>\n",
       "      <td>-1867.46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>591</th>\n",
       "      <td>ELDN</td>\n",
       "      <td>Eledon Pharmaceuticals Inc</td>\n",
       "      <td>2014-09-17</td>\n",
       "      <td>267.03</td>\n",
       "      <td>20</td>\n",
       "      <td>465.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://eledon.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 L...</td>\n",
       "      <td>3849.12</td>\n",
       "      <td>4.38</td>\n",
       "      <td>-99.89</td>\n",
       "      <td>3744</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>592</th>\n",
       "      <td>IRD</td>\n",
       "      <td>Opus Genetics Inc</td>\n",
       "      <td>2005-11-10</td>\n",
       "      <td>31.57</td>\n",
       "      <td>14</td>\n",
       "      <td>161.00</td>\n",
       "      <td>8.38</td>\n",
       "      <td>-29.47</td>\n",
       "      <td>https://opusgtx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment ...</td>\n",
       "      <td>1080.00</td>\n",
       "      <td>1.02</td>\n",
       "      <td>-99.91</td>\n",
       "      <td>6977</td>\n",
       "      <td>-93.35</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>593</th>\n",
       "      <td>DRMA</td>\n",
       "      <td>Dermata Therapeutics Inc</td>\n",
       "      <td>2021-08-13</td>\n",
       "      <td>2.18</td>\n",
       "      <td>8</td>\n",
       "      <td>287.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.dermatarx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical produ...</td>\n",
       "      <td>1245.60</td>\n",
       "      <td>1.09</td>\n",
       "      <td>-99.91</td>\n",
       "      <td>1222</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>594</th>\n",
       "      <td>TCRT</td>\n",
       "      <td>Alaunos Therapeutics Inc</td>\n",
       "      <td>2005-08-24</td>\n",
       "      <td>2.63</td>\n",
       "      <td>1</td>\n",
       "      <td>26.00</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-12.58</td>\n",
       "      <td>https://www.alaunos.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell ther...</td>\n",
       "      <td>2400.00</td>\n",
       "      <td>1.90</td>\n",
       "      <td>-99.92</td>\n",
       "      <td>7055</td>\n",
       "      <td>-478.33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>595</th>\n",
       "      <td>AKTX</td>\n",
       "      <td>Akari Therapeutics Plc ADR</td>\n",
       "      <td>2014-01-06</td>\n",
       "      <td>26.15</td>\n",
       "      <td>6</td>\n",
       "      <td>41.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-18.08</td>\n",
       "      <td>https://www.akaritx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory dise...</td>\n",
       "      <td>1600.00</td>\n",
       "      <td>0.97</td>\n",
       "      <td>-99.94</td>\n",
       "      <td>3998</td>\n",
       "      <td>-69.14</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>596</th>\n",
       "      <td>ALZN</td>\n",
       "      <td>Alzamend Neuro Inc</td>\n",
       "      <td>2021-06-15</td>\n",
       "      <td>6.63</td>\n",
       "      <td>4</td>\n",
       "      <td>216.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.32</td>\n",
       "      <td>https://www.alzamend.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative an...</td>\n",
       "      <td>2025.00</td>\n",
       "      <td>1.19</td>\n",
       "      <td>-99.94</td>\n",
       "      <td>1281</td>\n",
       "      <td>-110.41</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>597</th>\n",
       "      <td>AGEN</td>\n",
       "      <td>Agenus Inc</td>\n",
       "      <td>2000-02-08</td>\n",
       "      <td>66.82</td>\n",
       "      <td>389</td>\n",
       "      <td>492.00</td>\n",
       "      <td>160.43</td>\n",
       "      <td>-85.52</td>\n",
       "      <td>https://www.agenusbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The...</td>\n",
       "      <td>5446.52</td>\n",
       "      <td>3.05</td>\n",
       "      <td>-99.94</td>\n",
       "      <td>9079</td>\n",
       "      <td>-127.99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>598</th>\n",
       "      <td>ATNF</td>\n",
       "      <td>180 Life Sciences Corp</td>\n",
       "      <td>2017-06-27</td>\n",
       "      <td>3.60</td>\n",
       "      <td>4</td>\n",
       "      <td>2073.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.83</td>\n",
       "      <td>https://180lifesciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, infla...</td>\n",
       "      <td>3686.00</td>\n",
       "      <td>1.93</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>2730</td>\n",
       "      <td>-245.28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>TFFP</td>\n",
       "      <td>Tff Pharmaceuticals Inc</td>\n",
       "      <td>2019-10-25</td>\n",
       "      <td>0.29</td>\n",
       "      <td>19</td>\n",
       "      <td>1683.00</td>\n",
       "      <td>1.20</td>\n",
       "      <td>-19.01</td>\n",
       "      <td>https://tffpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patent...</td>\n",
       "      <td>126.75</td>\n",
       "      <td>0.06</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>1880</td>\n",
       "      <td>-6555.17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>AVTX</td>\n",
       "      <td>Avalo Therapeutics Inc</td>\n",
       "      <td>2015-10-14</td>\n",
       "      <td>98.57</td>\n",
       "      <td>19</td>\n",
       "      <td>52.00</td>\n",
       "      <td>0.82</td>\n",
       "      <td>-31.17</td>\n",
       "      <td>https://www.avalotx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulatio...</td>\n",
       "      <td>18720.00</td>\n",
       "      <td>9.23</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>3352</td>\n",
       "      <td>-31.62</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>601</th>\n",
       "      <td>IBIO</td>\n",
       "      <td>iBio Inc</td>\n",
       "      <td>2008-08-19</td>\n",
       "      <td>21.50</td>\n",
       "      <td>16</td>\n",
       "      <td>144.00</td>\n",
       "      <td>0.18</td>\n",
       "      <td>-14.75</td>\n",
       "      <td>https://ibioinc.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer,...</td>\n",
       "      <td>4750.00</td>\n",
       "      <td>2.31</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>5964</td>\n",
       "      <td>-68.60</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>602</th>\n",
       "      <td>TPST</td>\n",
       "      <td>Tempest Therapeutics Inc</td>\n",
       "      <td>2012-11-12</td>\n",
       "      <td>34.91</td>\n",
       "      <td>17</td>\n",
       "      <td>3564.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.25</td>\n",
       "      <td>https://www.tempesttx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-me...</td>\n",
       "      <td>1687.50</td>\n",
       "      <td>0.80</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>4418</td>\n",
       "      <td>-89.52</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>603</th>\n",
       "      <td>PCSA</td>\n",
       "      <td>Processa Pharmaceuticals Inc</td>\n",
       "      <td>2014-03-07</td>\n",
       "      <td>3.40</td>\n",
       "      <td>13</td>\n",
       "      <td>350.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-11.79</td>\n",
       "      <td>https://www.processapharmaceuticals.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of canc...</td>\n",
       "      <td>2450.00</td>\n",
       "      <td>1.11</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>3938</td>\n",
       "      <td>-346.76</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>604</th>\n",
       "      <td>SCPX</td>\n",
       "      <td>Scorpius Holdings Inc</td>\n",
       "      <td>2013-07-24</td>\n",
       "      <td>1.31</td>\n",
       "      <td>82</td>\n",
       "      <td>144.00</td>\n",
       "      <td>9.85</td>\n",
       "      <td>-24.98</td>\n",
       "      <td>https://www.scorpiusbiologics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organi...</td>\n",
       "      <td>669.90</td>\n",
       "      <td>0.30</td>\n",
       "      <td>-99.96</td>\n",
       "      <td>4164</td>\n",
       "      <td>-1906.87</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>605</th>\n",
       "      <td>MEIP</td>\n",
       "      <td>MEI Pharma Inc</td>\n",
       "      <td>2003-12-18</td>\n",
       "      <td>17.19</td>\n",
       "      <td>28</td>\n",
       "      <td>46.00</td>\n",
       "      <td>65.30</td>\n",
       "      <td>26.38</td>\n",
       "      <td>https://meipharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develop...</td>\n",
       "      <td>6991.07</td>\n",
       "      <td>2.70</td>\n",
       "      <td>-99.96</td>\n",
       "      <td>7670</td>\n",
       "      <td>153.46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>606</th>\n",
       "      <td>PTN</td>\n",
       "      <td>Palatin Technologies Inc</td>\n",
       "      <td>1997-10-15</td>\n",
       "      <td>16.24</td>\n",
       "      <td>30</td>\n",
       "      <td>353.00</td>\n",
       "      <td>4.49</td>\n",
       "      <td>-29.94</td>\n",
       "      <td>https://palatin.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in...</td>\n",
       "      <td>2312.50</td>\n",
       "      <td>0.88</td>\n",
       "      <td>-99.96</td>\n",
       "      <td>9925</td>\n",
       "      <td>-184.36</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>ZVSA</td>\n",
       "      <td>ZyVersa Therapeutics Inc</td>\n",
       "      <td>2022-02-11</td>\n",
       "      <td>2.41</td>\n",
       "      <td>7</td>\n",
       "      <td>1276.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-10.25</td>\n",
       "      <td>https://www.zyversa.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflam...</td>\n",
       "      <td>3447.50</td>\n",
       "      <td>1.05</td>\n",
       "      <td>-99.97</td>\n",
       "      <td>1040</td>\n",
       "      <td>-425.31</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>608</th>\n",
       "      <td>CELZ</td>\n",
       "      <td>Creative Medical Technology Holdings Inc</td>\n",
       "      <td>2015-11-06</td>\n",
       "      <td>4.09</td>\n",
       "      <td>4</td>\n",
       "      <td>42.00</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-5.52</td>\n",
       "      <td>https://www.creativemedicaltechnology.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of im...</td>\n",
       "      <td>8250.00</td>\n",
       "      <td>2.19</td>\n",
       "      <td>-99.97</td>\n",
       "      <td>3329</td>\n",
       "      <td>-134.96</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>609</th>\n",
       "      <td>CVM</td>\n",
       "      <td>Cel-Sci Corp</td>\n",
       "      <td>1983-12-08</td>\n",
       "      <td>41.47</td>\n",
       "      <td>0</td>\n",
       "      <td>395.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-25.52</td>\n",
       "      <td>https://cel-sci.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of...</td>\n",
       "      <td>3125.00</td>\n",
       "      <td>0.69</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>14985</td>\n",
       "      <td>-61.54</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>610</th>\n",
       "      <td>ATXI</td>\n",
       "      <td>Avenue Therapeutics Inc</td>\n",
       "      <td>2017-06-27</td>\n",
       "      <td>3.57</td>\n",
       "      <td>3</td>\n",
       "      <td>45.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.avenuetx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of ...</td>\n",
       "      <td>9281.25</td>\n",
       "      <td>1.80</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>2730</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>611</th>\n",
       "      <td>BPTH</td>\n",
       "      <td>Bio-Path Holdings Inc</td>\n",
       "      <td>2008-03-04</td>\n",
       "      <td>2.89</td>\n",
       "      <td>10</td>\n",
       "      <td>1220.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.98</td>\n",
       "      <td>https://www.biopathholdings.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United Sta...</td>\n",
       "      <td>3600.00</td>\n",
       "      <td>0.66</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>6132</td>\n",
       "      <td>-449.13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>612</th>\n",
       "      <td>ONCO</td>\n",
       "      <td>Onconetix Inc</td>\n",
       "      <td>2022-02-18</td>\n",
       "      <td>3.48</td>\n",
       "      <td>12</td>\n",
       "      <td>774.00</td>\n",
       "      <td>1.46</td>\n",
       "      <td>-15.15</td>\n",
       "      <td>https://onconetix.gcs-web.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. ...</td>\n",
       "      <td>2296.00</td>\n",
       "      <td>0.40</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>1033</td>\n",
       "      <td>-435.34</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>613</th>\n",
       "      <td>AIM</td>\n",
       "      <td>AIM ImmunoTech Inc</td>\n",
       "      <td>1996-07-12</td>\n",
       "      <td>13.39</td>\n",
       "      <td>26</td>\n",
       "      <td>467.00</td>\n",
       "      <td>0.20</td>\n",
       "      <td>-31.36</td>\n",
       "      <td>https://aimimmuno.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral d...</td>\n",
       "      <td>1320.00</td>\n",
       "      <td>0.22</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>10385</td>\n",
       "      <td>-234.20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>614</th>\n",
       "      <td>HURA</td>\n",
       "      <td>TuHURA Biosciences Inc</td>\n",
       "      <td>2013-02-22</td>\n",
       "      <td>175.06</td>\n",
       "      <td>0</td>\n",
       "      <td>264.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29750.00</td>\n",
       "      <td>4.93</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>4316</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>615</th>\n",
       "      <td>PLUR</td>\n",
       "      <td>Pluri Inc</td>\n",
       "      <td>2003-06-30</td>\n",
       "      <td>25.83</td>\n",
       "      <td>106</td>\n",
       "      <td>26.00</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-21.90</td>\n",
       "      <td>https://www.pluri-biotech.com</td>\n",
       "      <td>Israel</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-bas...</td>\n",
       "      <td>28640.00</td>\n",
       "      <td>4.72</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>7841</td>\n",
       "      <td>-84.79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>616</th>\n",
       "      <td>ENSC</td>\n",
       "      <td>Ensysce Biosciences Inc</td>\n",
       "      <td>2018-03-14</td>\n",
       "      <td>8.36</td>\n",
       "      <td>7</td>\n",
       "      <td>1848.00</td>\n",
       "      <td>1.44</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.ensysce.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opi...</td>\n",
       "      <td>34380.00</td>\n",
       "      <td>5.62</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>2470</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>617</th>\n",
       "      <td>KPRX</td>\n",
       "      <td>Kiora Pharmaceuticals Inc</td>\n",
       "      <td>2015-02-13</td>\n",
       "      <td>10.80</td>\n",
       "      <td>12</td>\n",
       "      <td>26.00</td>\n",
       "      <td>16.02</td>\n",
       "      <td>6.32</td>\n",
       "      <td>https://www.kiorapharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for ...</td>\n",
       "      <td>32400.00</td>\n",
       "      <td>3.32</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>3595</td>\n",
       "      <td>58.52</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>618</th>\n",
       "      <td>APTO</td>\n",
       "      <td>Aptose Biosciences Inc</td>\n",
       "      <td>1992-03-16</td>\n",
       "      <td>11.50</td>\n",
       "      <td>35</td>\n",
       "      <td>487.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-36.16</td>\n",
       "      <td>https://www.aptose.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in o...</td>\n",
       "      <td>1890.00</td>\n",
       "      <td>0.19</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>11964</td>\n",
       "      <td>-314.43</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>619</th>\n",
       "      <td>RNAZ</td>\n",
       "      <td>TransCode Therapeutics Inc</td>\n",
       "      <td>2021-07-08</td>\n",
       "      <td>4.69</td>\n",
       "      <td>10</td>\n",
       "      <td>48.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.68</td>\n",
       "      <td>https://www.transcodetherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identi...</td>\n",
       "      <td>105600.00</td>\n",
       "      <td>7.42</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>1258</td>\n",
       "      <td>-376.97</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>620</th>\n",
       "      <td>HEPA</td>\n",
       "      <td>Hepion Pharmaceuticals Inc</td>\n",
       "      <td>2014-02-10</td>\n",
       "      <td>3.69</td>\n",
       "      <td>22</td>\n",
       "      <td>44.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.51</td>\n",
       "      <td>https://hepionpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the ...</td>\n",
       "      <td>8400.00</td>\n",
       "      <td>0.59</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>3963</td>\n",
       "      <td>-853.93</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>621</th>\n",
       "      <td>IMNN</td>\n",
       "      <td>Imunon Inc</td>\n",
       "      <td>1999-03-01</td>\n",
       "      <td>12.18</td>\n",
       "      <td>33</td>\n",
       "      <td>207.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.68</td>\n",
       "      <td>https://imunon.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious di...</td>\n",
       "      <td>12858.95</td>\n",
       "      <td>0.84</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>9423</td>\n",
       "      <td>-169.79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>622</th>\n",
       "      <td>BCDA</td>\n",
       "      <td>BioCardia Inc</td>\n",
       "      <td>1996-11-13</td>\n",
       "      <td>9.58</td>\n",
       "      <td>16</td>\n",
       "      <td>91.00</td>\n",
       "      <td>0.43</td>\n",
       "      <td>-8.53</td>\n",
       "      <td>https://www.biocardia.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary ...</td>\n",
       "      <td>36450.00</td>\n",
       "      <td>2.08</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>10261</td>\n",
       "      <td>-89.04</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>623</th>\n",
       "      <td>MTEM</td>\n",
       "      <td>Molecular Templates Inc</td>\n",
       "      <td>2005-02-04</td>\n",
       "      <td>2.45</td>\n",
       "      <td>62</td>\n",
       "      <td>14948.00</td>\n",
       "      <td>25.47</td>\n",
       "      <td>-13.86</td>\n",
       "      <td>https://www.mtem.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the t...</td>\n",
       "      <td>7068.60</td>\n",
       "      <td>0.40</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>7256</td>\n",
       "      <td>-565.71</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>624</th>\n",
       "      <td>QNRX</td>\n",
       "      <td>Quoin Pharmaceuticals Ltd ADR</td>\n",
       "      <td>2016-08-01</td>\n",
       "      <td>3.22</td>\n",
       "      <td>4</td>\n",
       "      <td>3021.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.84</td>\n",
       "      <td>https://quoinpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic pr...</td>\n",
       "      <td>15900.00</td>\n",
       "      <td>0.66</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3060</td>\n",
       "      <td>-274.53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>625</th>\n",
       "      <td>MTVA</td>\n",
       "      <td>MetaVia Inc</td>\n",
       "      <td>2016-08-05</td>\n",
       "      <td>19.04</td>\n",
       "      <td>8</td>\n",
       "      <td>41.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-28.87</td>\n",
       "      <td>https://www.metaviatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>MetaVia Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic dise...</td>\n",
       "      <td>55200.00</td>\n",
       "      <td>2.19</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3056</td>\n",
       "      <td>-151.63</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>626</th>\n",
       "      <td>GRI</td>\n",
       "      <td>GRI Bio Inc</td>\n",
       "      <td>2021-02-10</td>\n",
       "      <td>6.84</td>\n",
       "      <td>4</td>\n",
       "      <td>4559.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.36</td>\n",
       "      <td>https://www.gribio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases ...</td>\n",
       "      <td>20529.60</td>\n",
       "      <td>0.80</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1406</td>\n",
       "      <td>-122.22</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>627</th>\n",
       "      <td>ERNA</td>\n",
       "      <td>Eterna Therapeutics Inc</td>\n",
       "      <td>1991-08-29</td>\n",
       "      <td>13.95</td>\n",
       "      <td>8</td>\n",
       "      <td>699.00</td>\n",
       "      <td>0.16</td>\n",
       "      <td>-21.86</td>\n",
       "      <td>https://eternatx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming an...</td>\n",
       "      <td>7500.00</td>\n",
       "      <td>0.29</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>12164</td>\n",
       "      <td>-156.70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>628</th>\n",
       "      <td>REVB</td>\n",
       "      <td>Revelation Biosciences Inc</td>\n",
       "      <td>2020-11-17</td>\n",
       "      <td>1.49</td>\n",
       "      <td>9</td>\n",
       "      <td>1030.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.52</td>\n",
       "      <td>https://www.revbiosciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therap...</td>\n",
       "      <td>10248.00</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1491</td>\n",
       "      <td>-571.81</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>629</th>\n",
       "      <td>TTNP</td>\n",
       "      <td>Titan Pharmaceuticals, Inc. (de)</td>\n",
       "      <td>1996-01-18</td>\n",
       "      <td>3.10</td>\n",
       "      <td>4</td>\n",
       "      <td>15.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.09</td>\n",
       "      <td>https://www.titanpharm.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and intern...</td>\n",
       "      <td>126795.58</td>\n",
       "      <td>3.56</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>10561</td>\n",
       "      <td>-228.71</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>630</th>\n",
       "      <td>VIRX</td>\n",
       "      <td>Viracta Therapeutics Inc</td>\n",
       "      <td>2005-09-27</td>\n",
       "      <td>8.43</td>\n",
       "      <td>40</td>\n",
       "      <td>2166.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-49.04</td>\n",
       "      <td>https://www.viracta.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that ...</td>\n",
       "      <td>8210.53</td>\n",
       "      <td>0.20</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7021</td>\n",
       "      <td>-581.73</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>631</th>\n",
       "      <td>APVO</td>\n",
       "      <td>Aptevo Therapeutics Inc</td>\n",
       "      <td>2016-07-20</td>\n",
       "      <td>1.94</td>\n",
       "      <td>40</td>\n",
       "      <td>308.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.21</td>\n",
       "      <td>https://www.aptevotherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for ...</td>\n",
       "      <td>182336.00</td>\n",
       "      <td>4.09</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3072</td>\n",
       "      <td>-1247.94</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>632</th>\n",
       "      <td>SLRX</td>\n",
       "      <td>Salarius Pharmaceuticals Inc</td>\n",
       "      <td>2015-01-29</td>\n",
       "      <td>2.00</td>\n",
       "      <td>2</td>\n",
       "      <td>329.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.73</td>\n",
       "      <td>https://www.salariuspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its ...</td>\n",
       "      <td>74750.00</td>\n",
       "      <td>1.47</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3610</td>\n",
       "      <td>-336.50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>633</th>\n",
       "      <td>TENX</td>\n",
       "      <td>Tenax Therapeutics Inc</td>\n",
       "      <td>1994-04-04</td>\n",
       "      <td>19.91</td>\n",
       "      <td>5</td>\n",
       "      <td>65.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-13.03</td>\n",
       "      <td>https://www.tenaxthera.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertens...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>5.88</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>11215</td>\n",
       "      <td>-65.44</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>634</th>\n",
       "      <td>TNFA</td>\n",
       "      <td>TNF Pharmaceuticals Inc</td>\n",
       "      <td>2014-01-23</td>\n",
       "      <td>3.00</td>\n",
       "      <td>6</td>\n",
       "      <td>85.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://tnfpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of...</td>\n",
       "      <td>63475.20</td>\n",
       "      <td>1.15</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3981</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>635</th>\n",
       "      <td>ACHV</td>\n",
       "      <td>Achieve Life Sciences Inc</td>\n",
       "      <td>1995-10-12</td>\n",
       "      <td>142.03</td>\n",
       "      <td>22</td>\n",
       "      <td>113.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.04</td>\n",
       "      <td>https://www.achievelifesciences.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine...</td>\n",
       "      <td>272250.00</td>\n",
       "      <td>4.10</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>10659</td>\n",
       "      <td>-21.85</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>636</th>\n",
       "      <td>CNSP</td>\n",
       "      <td>Cns Pharmaceuticals Inc</td>\n",
       "      <td>2019-11-08</td>\n",
       "      <td>5.92</td>\n",
       "      <td>3</td>\n",
       "      <td>15646.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.98</td>\n",
       "      <td>https://www.cnspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain...</td>\n",
       "      <td>6855.00</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1866</td>\n",
       "      <td>-269.93</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>637</th>\n",
       "      <td>LSTA</td>\n",
       "      <td>Lisata Therapeutics Inc</td>\n",
       "      <td>1999-03-01</td>\n",
       "      <td>21.90</td>\n",
       "      <td>25</td>\n",
       "      <td>16.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.93</td>\n",
       "      <td>https://www.lisata.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative the...</td>\n",
       "      <td>173437.50</td>\n",
       "      <td>2.58</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>9423</td>\n",
       "      <td>-109.27</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>638</th>\n",
       "      <td>BRTX</td>\n",
       "      <td>BioRestorative Therapies Inc</td>\n",
       "      <td>2012-12-05</td>\n",
       "      <td>10.10</td>\n",
       "      <td>11</td>\n",
       "      <td>50.00</td>\n",
       "      <td>0.38</td>\n",
       "      <td>-11.90</td>\n",
       "      <td>https://www.biorestorative.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem ...</td>\n",
       "      <td>128000.00</td>\n",
       "      <td>1.45</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4395</td>\n",
       "      <td>-117.82</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>639</th>\n",
       "      <td>TOVX</td>\n",
       "      <td>Theriva Biologics Inc</td>\n",
       "      <td>2006-12-18</td>\n",
       "      <td>3.26</td>\n",
       "      <td>22</td>\n",
       "      <td>2961.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.40</td>\n",
       "      <td>https://therivabio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the U...</td>\n",
       "      <td>105000.00</td>\n",
       "      <td>1.18</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6574</td>\n",
       "      <td>-656.44</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>640</th>\n",
       "      <td>DOMH</td>\n",
       "      <td>Dominari Holdings Inc</td>\n",
       "      <td>1980-03-18</td>\n",
       "      <td>9.29</td>\n",
       "      <td>26</td>\n",
       "      <td>13.00</td>\n",
       "      <td>12.59</td>\n",
       "      <td>-14.18</td>\n",
       "      <td>https://www.dominariholdings.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Dominari Holdings Inc., through its subsidiaries, is engaged in wealth management, investment banking, sales and trading, and asset management. It...</td>\n",
       "      <td>231547.86</td>\n",
       "      <td>1.54</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>16345</td>\n",
       "      <td>-152.64</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>641</th>\n",
       "      <td>OGEN</td>\n",
       "      <td>Oragenics Inc</td>\n",
       "      <td>2004-02-25</td>\n",
       "      <td>4.27</td>\n",
       "      <td>5</td>\n",
       "      <td>459.00</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-19.64</td>\n",
       "      <td>https://www.oragenics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology an...</td>\n",
       "      <td>51000.00</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7601</td>\n",
       "      <td>-459.95</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>642</th>\n",
       "      <td>QLGN</td>\n",
       "      <td>Qualigen Therapeutics Inc</td>\n",
       "      <td>2015-06-23</td>\n",
       "      <td>3.23</td>\n",
       "      <td>4</td>\n",
       "      <td>91.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.33</td>\n",
       "      <td>https://www.qlgntx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and p...</td>\n",
       "      <td>625000.00</td>\n",
       "      <td>3.87</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3465</td>\n",
       "      <td>-257.89</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>NBY</td>\n",
       "      <td>Novabay Pharmaceuticals Inc</td>\n",
       "      <td>2007-10-26</td>\n",
       "      <td>2.77</td>\n",
       "      <td>24</td>\n",
       "      <td>2888.00</td>\n",
       "      <td>13.06</td>\n",
       "      <td>-5.02</td>\n",
       "      <td>https://novabay.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray...</td>\n",
       "      <td>110862.50</td>\n",
       "      <td>0.57</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6262</td>\n",
       "      <td>-181.23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>ARMP</td>\n",
       "      <td>Armata Pharmaceuticals Inc</td>\n",
       "      <td>1994-05-20</td>\n",
       "      <td>72.73</td>\n",
       "      <td>66</td>\n",
       "      <td>7.00</td>\n",
       "      <td>3.72</td>\n",
       "      <td>-40.91</td>\n",
       "      <td>https://www.armatapharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibi...</td>\n",
       "      <td>479062.50</td>\n",
       "      <td>2.19</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>11169</td>\n",
       "      <td>-56.25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>CSCI</td>\n",
       "      <td>COSCIENS Biopharma Inc</td>\n",
       "      <td>2000-05-10</td>\n",
       "      <td>9.10</td>\n",
       "      <td>0</td>\n",
       "      <td>5.00</td>\n",
       "      <td>4.83</td>\n",
       "      <td>-25.68</td>\n",
       "      <td>https://www.cosciensbio.com</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Can...</td>\n",
       "      <td>637500.00</td>\n",
       "      <td>2.90</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>8987</td>\n",
       "      <td>-282.20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>TRAW</td>\n",
       "      <td>Traws Pharma Inc</td>\n",
       "      <td>2013-07-25</td>\n",
       "      <td>14.21</td>\n",
       "      <td>17</td>\n",
       "      <td>12.00</td>\n",
       "      <td>0.23</td>\n",
       "      <td>-20.63</td>\n",
       "      <td>https://www.trawspharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral...</td>\n",
       "      <td>1118250.00</td>\n",
       "      <td>4.65</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4163</td>\n",
       "      <td>-145.18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>ORKA</td>\n",
       "      <td>Oruka Therapeutics Inc</td>\n",
       "      <td>1997-08-08</td>\n",
       "      <td>789.57</td>\n",
       "      <td>0</td>\n",
       "      <td>141.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7784915.00</td>\n",
       "      <td>21.94</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>9993</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>ENTO</td>\n",
       "      <td>Entero Therapeutics Inc</td>\n",
       "      <td>2016-10-11</td>\n",
       "      <td>2.71</td>\n",
       "      <td>9</td>\n",
       "      <td>474.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-19.99</td>\n",
       "      <td>https://www.enterothera.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for t...</td>\n",
       "      <td>209160.00</td>\n",
       "      <td>0.58</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>2989</td>\n",
       "      <td>-737.64</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>SLS</td>\n",
       "      <td>SELLAS Life Sciences Group Inc</td>\n",
       "      <td>2008-03-12</td>\n",
       "      <td>64.76</td>\n",
       "      <td>16</td>\n",
       "      <td>927.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.sellaslifesciences.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for ...</td>\n",
       "      <td>315300.00</td>\n",
       "      <td>0.87</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6124</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>ABEO</td>\n",
       "      <td>Abeona Therapeutics Inc</td>\n",
       "      <td>1980-09-19</td>\n",
       "      <td>256.04</td>\n",
       "      <td>84</td>\n",
       "      <td>276.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-54.75</td>\n",
       "      <td>https://www.abeonatherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead cli...</td>\n",
       "      <td>2291929.75</td>\n",
       "      <td>5.89</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>16160</td>\n",
       "      <td>-21.38</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>651</th>\n",
       "      <td>TCBP</td>\n",
       "      <td>TC BioPharm (Holdings) plc ADR</td>\n",
       "      <td>2022-02-11</td>\n",
       "      <td>4.51</td>\n",
       "      <td>41</td>\n",
       "      <td>1184.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.92</td>\n",
       "      <td>https://tcbiopharm.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogene...</td>\n",
       "      <td>212000.00</td>\n",
       "      <td>0.53</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1040</td>\n",
       "      <td>-286.47</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>MRKR</td>\n",
       "      <td>Marker Therapeutics Inc</td>\n",
       "      <td>2002-07-16</td>\n",
       "      <td>36.85</td>\n",
       "      <td>8</td>\n",
       "      <td>43.00</td>\n",
       "      <td>3.73</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://markertherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immuno...</td>\n",
       "      <td>1785000.00</td>\n",
       "      <td>4.07</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>8190</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>653</th>\n",
       "      <td>PSTV</td>\n",
       "      <td>Plus Therapeutics Inc</td>\n",
       "      <td>2001-07-11</td>\n",
       "      <td>6.90</td>\n",
       "      <td>20</td>\n",
       "      <td>88.00</td>\n",
       "      <td>5.51</td>\n",
       "      <td>-13.47</td>\n",
       "      <td>https://plustherapeutics.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for...</td>\n",
       "      <td>663750.00</td>\n",
       "      <td>1.27</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>8560</td>\n",
       "      <td>-195.22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>654</th>\n",
       "      <td>SNGX</td>\n",
       "      <td>Soligenix Inc</td>\n",
       "      <td>1994-04-04</td>\n",
       "      <td>7.65</td>\n",
       "      <td>13</td>\n",
       "      <td>114.00</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-7.86</td>\n",
       "      <td>https://www.soligenix.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United S...</td>\n",
       "      <td>2160000.00</td>\n",
       "      <td>3.16</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>11215</td>\n",
       "      <td>-102.75</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>ABVC</td>\n",
       "      <td>ABVC BioPharma Inc</td>\n",
       "      <td>2004-11-10</td>\n",
       "      <td>6.24</td>\n",
       "      <td>16</td>\n",
       "      <td>248.00</td>\n",
       "      <td>0.14</td>\n",
       "      <td>-8.51</td>\n",
       "      <td>https://www.abvcpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United ...</td>\n",
       "      <td>364430.00</td>\n",
       "      <td>0.50</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7342</td>\n",
       "      <td>-136.38</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>656</th>\n",
       "      <td>PHIO</td>\n",
       "      <td>Phio Pharmaceuticals Corp</td>\n",
       "      <td>2012-05-10</td>\n",
       "      <td>3.00</td>\n",
       "      <td>8</td>\n",
       "      <td>68.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.57</td>\n",
       "      <td>https://phiopharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an I...</td>\n",
       "      <td>2316600.00</td>\n",
       "      <td>2.81</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4604</td>\n",
       "      <td>-285.67</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>657</th>\n",
       "      <td>CYTO</td>\n",
       "      <td>Altamira Therapeutics Ltd</td>\n",
       "      <td>2014-08-06</td>\n",
       "      <td>1.58</td>\n",
       "      <td>10</td>\n",
       "      <td>113.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://altamiratherapeutics.com</td>\n",
       "      <td>Bermuda</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and suppli...</td>\n",
       "      <td>480000.00</td>\n",
       "      <td>0.43</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3786</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>658</th>\n",
       "      <td>ADTX</td>\n",
       "      <td>Aditxt Inc</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>4.34</td>\n",
       "      <td>47</td>\n",
       "      <td>2959.00</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-33.09</td>\n",
       "      <td>https://www.aditxt.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monit...</td>\n",
       "      <td>404800.00</td>\n",
       "      <td>0.35</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1631</td>\n",
       "      <td>-762.44</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>CRVO</td>\n",
       "      <td>CervoMed Inc</td>\n",
       "      <td>2008-05-23</td>\n",
       "      <td>16.09</td>\n",
       "      <td>8</td>\n",
       "      <td>326.00</td>\n",
       "      <td>10.07</td>\n",
       "      <td>0.00</td>\n",
       "      <td>https://www.cervomed.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its l...</td>\n",
       "      <td>2250000.00</td>\n",
       "      <td>1.90</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6052</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>PALI</td>\n",
       "      <td>Palisade Bio Inc</td>\n",
       "      <td>2007-03-30</td>\n",
       "      <td>3.15</td>\n",
       "      <td>9</td>\n",
       "      <td>1242.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-14.59</td>\n",
       "      <td>https://www.palisadebio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the in...</td>\n",
       "      <td>3744000.00</td>\n",
       "      <td>1.77</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6472</td>\n",
       "      <td>-463.17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>BDRX</td>\n",
       "      <td>Biodexa Pharmaceuticals Plc ADR</td>\n",
       "      <td>2015-12-07</td>\n",
       "      <td>2.41</td>\n",
       "      <td>21</td>\n",
       "      <td>288.00</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-6.44</td>\n",
       "      <td>https://www.biodexapharma.com</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 ...</td>\n",
       "      <td>14700000.00</td>\n",
       "      <td>4.20</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3298</td>\n",
       "      <td>-267.22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>SONN</td>\n",
       "      <td>Sonnet BioTherapeutics Holdings Inc</td>\n",
       "      <td>2006-10-31</td>\n",
       "      <td>1.52</td>\n",
       "      <td>12</td>\n",
       "      <td>1325.00</td>\n",
       "      <td>0.06</td>\n",
       "      <td>-12.26</td>\n",
       "      <td>https://www.sonnetbio.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The compa...</td>\n",
       "      <td>8008000.00</td>\n",
       "      <td>1.81</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6622</td>\n",
       "      <td>-806.58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>CYCC</td>\n",
       "      <td>Cyclacel Pharmaceuticals Inc</td>\n",
       "      <td>2004-03-16</td>\n",
       "      <td>2.16</td>\n",
       "      <td>0</td>\n",
       "      <td>1590.00</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-20.18</td>\n",
       "      <td>https://www.cyclacel.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative...</td>\n",
       "      <td>1842120.00</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7581</td>\n",
       "      <td>-934.26</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>ALLR</td>\n",
       "      <td>Allarity Therapeutics Inc</td>\n",
       "      <td>2021-12-21</td>\n",
       "      <td>4.23</td>\n",
       "      <td>5</td>\n",
       "      <td>425.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.90</td>\n",
       "      <td>https://www.allarity.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion...</td>\n",
       "      <td>8820000.00</td>\n",
       "      <td>1.02</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1092</td>\n",
       "      <td>-399.53</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665</th>\n",
       "      <td>CLRB</td>\n",
       "      <td>Cellectar Biosciences Inc</td>\n",
       "      <td>2005-11-10</td>\n",
       "      <td>10.64</td>\n",
       "      <td>20</td>\n",
       "      <td>1279.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-47.40</td>\n",
       "      <td>https://www.cellectar.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the t...</td>\n",
       "      <td>8262000.00</td>\n",
       "      <td>0.26</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6977</td>\n",
       "      <td>-445.49</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>666</th>\n",
       "      <td>JAGX</td>\n",
       "      <td>Jaguar Health Inc</td>\n",
       "      <td>2015-05-12</td>\n",
       "      <td>10.81</td>\n",
       "      <td>49</td>\n",
       "      <td>343.00</td>\n",
       "      <td>10.18</td>\n",
       "      <td>-29.43</td>\n",
       "      <td>https://jaguar.health</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals w...</td>\n",
       "      <td>100000000.00</td>\n",
       "      <td>0.97</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3507</td>\n",
       "      <td>-272.25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>WINT</td>\n",
       "      <td>Windtree Therapeutics Inc</td>\n",
       "      <td>1995-08-07</td>\n",
       "      <td>3.55</td>\n",
       "      <td>0</td>\n",
       "      <td>1725.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.66</td>\n",
       "      <td>https://windtreetx.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular disease...</td>\n",
       "      <td>155000000.00</td>\n",
       "      <td>0.35</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>10725</td>\n",
       "      <td>-694.65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>668</th>\n",
       "      <td>TNXP</td>\n",
       "      <td>Tonix Pharmaceuticals Holding Corp</td>\n",
       "      <td>2012-05-10</td>\n",
       "      <td>99.05</td>\n",
       "      <td>103</td>\n",
       "      <td>37182.00</td>\n",
       "      <td>12.46</td>\n",
       "      <td>-90.77</td>\n",
       "      <td>https://www.tonixpharma.com</td>\n",
       "      <td>USA</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics ...</td>\n",
       "      <td>192000000.00</td>\n",
       "      <td>0.24</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4604</td>\n",
       "      <td>-91.64</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Ticker                                   Company    ipo_date  MarketCap_M  \\\n",
       "0     TECH                           Bio-Techne Corp  1989-02-09     12101.22   \n",
       "1     VRTX               Vertex Pharmaceuticals, Inc  1991-07-24    120546.75   \n",
       "2     UTHR                  United Therapeutics Corp  1999-06-17     16644.81   \n",
       "3     INCY                               Incyte Corp  1993-11-04     13446.97   \n",
       "4     ALNY               Alnylam Pharmaceuticals Inc  2004-06-01     31470.08   \n",
       "5     REGN            Regeneron Pharmaceuticals, Inc  1991-04-02     79655.96   \n",
       "6     ARGX                            Argen X SE ADR  2017-05-18     37829.53   \n",
       "7     BHST                   BioHarvest Sciences Inc  2021-01-08       106.57   \n",
       "8     KRYS                       Krystal Biotech Inc  2017-09-20      4820.55   \n",
       "9     TVTX                  Travere Therapeutics Inc  2012-11-08      1523.10   \n",
       "10    HALO                 Halozyme Therapeutics Inc  2004-03-16      6110.71   \n",
       "11    AXSM                   Axsome Therapeutics Inc  2015-11-19      4346.11   \n",
       "12    BNTX                           BioNTech SE ADR  2019-10-10     27383.10   \n",
       "13    JAZZ                  Jazz Pharmaceuticals plc  2007-06-01      7568.92   \n",
       "14    ASND                   Ascendis Pharma A/S ADR  2015-01-28      8163.27   \n",
       "15    BGNE                           BeiGene Ltd ADR  2016-02-03     19806.62   \n",
       "16    BLTE                        Belite Bio Inc ADR  2022-04-29      1948.48   \n",
       "17    VKTX                   Viking Therapeutics Inc  2015-04-28      5263.12   \n",
       "18    GMAB                                Genmab ADR  2009-06-01     12832.72   \n",
       "19    BHVN                              Biohaven Ltd  2022-09-23      4190.50   \n",
       "20    BMRN               Biomarin Pharmaceutical Inc  1999-07-26     12490.81   \n",
       "21    ACLX                               Arcellx Inc  2022-02-04      4510.91   \n",
       "22    BPMC                  Blueprint Medicines Corp  2015-04-30      6059.73   \n",
       "23    MLTX               MoonLake Immunotherapeutics  2020-10-20      3341.13   \n",
       "24    NUVL                              Nuvalent Inc  2021-07-29      6211.42   \n",
       "25    CORT                  Corcept Therapeutics Inc  2004-04-14      5807.68   \n",
       "26    MRUS                                 Merus N.V  2016-05-19      2930.25   \n",
       "27    VERA                     Vera Therapeutics Inc  2021-05-14      2783.68   \n",
       "28    XENE                 Xenon Pharmaceuticals Inc  2014-11-05      3149.46   \n",
       "29    IONS                 Ionis Pharmaceuticals Inc  1991-05-17      6015.88   \n",
       "30    PTGX              Protagonist Therapeutics Inc  2016-08-11      2470.93   \n",
       "31    CPRX              Catalyst Pharmaceuticals Inc  2006-11-08      2582.26   \n",
       "32    LGND               Ligand Pharmaceuticals, Inc  1992-11-18      2311.66   \n",
       "33    PCVX                               Vaxcyte Inc  2020-06-12     11153.76   \n",
       "34    MIRM                 Mirum Pharmaceuticals Inc  2019-07-18      2034.91   \n",
       "35    SRPT                  Sarepta Therapeutics Inc  1997-06-04     12110.93   \n",
       "36    CRSP                    CRISPR Therapeutics AG  2016-10-19      3776.04   \n",
       "37    VRNA                     Verona Pharma Plc ADR  2017-04-28      3492.56   \n",
       "38    XNCR                                Xencor Inc  2013-12-03      1715.96   \n",
       "39    PTCT                      PTC Therapeutics Inc  2013-06-20      3749.05   \n",
       "40    SRRK                 Scholar Rock Holding Corp  2018-05-25      4013.27   \n",
       "41    GLSI                Greenwich LifeSciences Inc  2020-09-25       169.57   \n",
       "42    IMVT                            Immunovant Inc  2019-06-21      4055.67   \n",
       "43    ACAD                Acadia Pharmaceuticals Inc  2004-05-27      2885.24   \n",
       "44    TARS                Tarsus Pharmaceuticals Inc  2020-10-16      1977.48   \n",
       "45    JANX                    Janux Therapeutics Inc  2021-06-11      3609.44   \n",
       "46    EXEL                              Exelixis Inc  2000-04-17     10300.83   \n",
       "47    APLS               Apellis Pharmaceuticals Inc  2017-11-09      4187.07   \n",
       "48    AUPH               Aurinia Pharmaceuticals Inc  2014-09-03      1378.81   \n",
       "49    NAMS            NewAmsterdam Pharma Company NV  2021-02-09      2645.28   \n",
       "50    IDYA                    Ideaya Biosciences Inc  2019-05-23      2251.55   \n",
       "51    MRNA                               Moderna Inc  2018-12-07     16100.78   \n",
       "52    RYTM                Rhythm Pharmaceuticals Inc  2017-10-09      3395.50   \n",
       "53    JUNS                 Jupiter Neurosciences Inc  2024-12-03       337.64   \n",
       "54    CRNX             Crinetics Pharmaceuticals Inc  2018-07-18      5066.26   \n",
       "55    ADMA                        Adma Biologics Inc  2013-10-17      4486.68   \n",
       "56    MNMD                         Mind Medicine Inc  2016-11-15       542.65   \n",
       "57    APGE                   Apogee Therapeutics Inc  2023-07-14      2686.39   \n",
       "58    DYAI             Dyadic International Inc., DE  2008-01-16        44.09   \n",
       "59    MDXG                          Mimedx Group Inc  2008-02-12      1391.58   \n",
       "60    PRTA                  Prothena Corporation plc  2012-12-18       678.53   \n",
       "61     OCS                         Oculis Holding AG  2021-05-18       717.26   \n",
       "62    IZTC                 Invizyne Technologies Inc  2024-11-13       148.27   \n",
       "63    SMMT                   Summit Therapeutics Inc  2015-03-05     13775.53   \n",
       "64    GLPG                          Galapagos NV ADR  2012-02-27      1773.29   \n",
       "65    SWTX              SpringWorks Therapeutics Inc  2019-09-13      2827.43   \n",
       "66    DNTH                 Dianthus Therapeutics Inc  2018-06-21       711.22   \n",
       "67    AKRO                    Akero Therapeutics Inc  2019-06-20      2040.23   \n",
       "68    RVMD                  Revolution Medicines Inc  2020-02-13      8262.18   \n",
       "69    ELVN                  Enliven Therapeutics Inc  2020-03-12      1151.61   \n",
       "70    DRUG              Bright Minds Biosciences Inc  2021-03-22       273.64   \n",
       "71    BEAM                     Beam Therapeutics Inc  2020-02-06      2395.57   \n",
       "72    NVCT                       Nuvectis Pharma Inc  2022-02-04        94.09   \n",
       "73    INVA                              Innoviva Inc  2004-10-05      1153.11   \n",
       "74    AVBP                    ArriVent BioPharma Inc  2024-01-26       892.30   \n",
       "75    COYA                     Coya Therapeutics Inc  2022-12-29        94.56   \n",
       "76    KYMR                   Kymera Therapeutics Inc  2020-08-21      2788.79   \n",
       "77    AGIO                 Agios Pharmaceuticals Inc  2013-07-24      2434.62   \n",
       "78    LENZ                     LENZ Therapeutics Inc  2021-06-25       848.40   \n",
       "79    ARVN                               Arvinas Inc  2018-09-27      1304.86   \n",
       "80    OSTX                          OS Therapies Inc  2024-08-01        73.91   \n",
       "81    GPCR            Structure Therapeutics Inc ADR  2023-02-03      1775.08   \n",
       "82    EPRX              Eupraxia Pharmaceuticals Inc  2024-04-05       122.47   \n",
       "83    SNDX                Syndax Pharmaceuticals Inc  2016-03-02      1177.08   \n",
       "84    BCRX              Biocryst Pharmaceuticals Inc  1994-03-04      1545.21   \n",
       "85    BCYC              Bicycle Therapeutics Plc ADR  2019-05-23      1043.98   \n",
       "86     RNA                   Avidity Biosciences Inc  2020-06-12      3983.73   \n",
       "87    ROIV                      Roivant Sciences Ltd  2020-12-08      8808.20   \n",
       "88    RARE             Ultragenyx Pharmaceutical Inc  2014-01-31      4192.43   \n",
       "89     DYN                     Dyne Therapeutics Inc  2020-09-17      2656.09   \n",
       "90    DNLI                   Denali Therapeutics Inc  2017-12-08      3351.94   \n",
       "91    NRIX                    Nurix Therapeutics Inc  2020-07-24      1474.10   \n",
       "92    AVXL          Anavex Life Sciences Corporation  2006-08-02       778.42   \n",
       "93    QURE                               uniQure N.V  2014-02-05       848.13   \n",
       "94    SEPN                              Septerna Inc  2024-10-25       963.09   \n",
       "95     TLX            Telix Pharmaceuticals Ltd. ADR  2024-11-14      5295.33   \n",
       "96    TELO               Telomir Pharmaceuticals Inc  2024-02-09       146.98   \n",
       "97    MDCX                        Medicus Pharma Ltd  2024-11-14        34.86   \n",
       "98    MURA                        Mural Oncology plc  2023-11-24        58.69   \n",
       "99    ACTU                  Actuate Therapeutics Inc  2024-08-13       169.73   \n",
       "100   BBIO                      BridgeBio Pharma Inc  2019-06-27      5236.91   \n",
       "101   LQDA                             Liquidia Corp  2018-07-26       933.54   \n",
       "102   ZYME                          Zymeworks BC Inc  2017-04-28       948.44   \n",
       "103   CADL                   Candel Therapeutics Inc  2021-07-27       199.89   \n",
       "104   MDGL              Madrigal Pharmaceuticals Inc  2007-02-06      6782.82   \n",
       "105   ACOG                       Alpha Cognition Inc  2024-11-12        79.14   \n",
       "106   LEGN                   Legend Biotech Corp ADR  2020-06-05      6055.68   \n",
       "107   RCUS                     Arcus Biosciences Inc  2018-03-15      1510.86   \n",
       "108   ZLAB                       Zai Lab Limited ADR  2017-09-20      2846.68   \n",
       "109   KROS                    Keros Therapeutics Inc  2020-04-08       786.65   \n",
       "110   CRGX                    CARGO Therapeutics Inc  2023-11-13       667.40   \n",
       "111   IMNM                              Immunome Inc  2020-10-02       776.46   \n",
       "112   EWTX                 Edgewise Therapeutics Inc  2021-03-26      3095.37   \n",
       "113    UPB                          Upstream Bio Inc  2024-10-11      1018.87   \n",
       "114   ANAB                            AnaptysBio Inc  2017-01-26       506.64   \n",
       "115   CTNM                Contineum Therapeutics Inc  2024-04-05       352.12   \n",
       "116   RAPP                  Rapport Therapeutics Inc  2024-06-07       678.86   \n",
       "117   ARTV                Artiva Biotherapeutics Inc  2024-07-19       252.61   \n",
       "118   CSBR                    Champions Oncology Inc  2007-02-02        84.96   \n",
       "119   CELC                              Celcuity Inc  2017-09-20       465.98   \n",
       "120   HRMY          Harmony Biosciences Holdings Inc  2020-08-19      1885.45   \n",
       "121   OMER                        Omeros Corporation  2009-10-08       439.84   \n",
       "122   ABVX                                Abivax ADR  2023-10-20       500.36   \n",
       "123   INBX                   Inhibrx Biosciences Inc  2024-06-04       210.77   \n",
       "124    WVE                    Wave Life Sciences Ltd  2015-11-11      2051.39   \n",
       "125    KOD                       Kodiak Sciences Inc  2018-10-04       427.31   \n",
       "126   REPL                       Replimune Group Inc  2018-07-20       960.41   \n",
       "127   URGN                         UroGen Pharma Ltd  2017-05-04       476.85   \n",
       "128    MBX                       MBX Biosciences Inc  2024-09-13       639.61   \n",
       "129   CGON                           Cg Oncology Inc  2024-01-25      1975.46   \n",
       "130   CNTA          Centessa Pharmaceuticals plc ADR  2021-05-28      2208.40   \n",
       "131   IMTX                              Immatics N.V  2018-12-12       883.67   \n",
       "132   BCAX                   Bicara Therapeutics Inc  2024-09-13       947.38   \n",
       "133   TRDA                  Entrada Therapeutics Inc  2021-10-29       673.93   \n",
       "134   NTRB                             Nutriband Inc  2021-10-01        49.42   \n",
       "135   CAMP                   CAMP4 Therapeutics Corp  2024-10-11       128.22   \n",
       "136    IBO                     Impact BioMedical Inc  2024-09-16        26.69   \n",
       "137   LXEO                    Lexeo Therapeutics Inc  2023-11-03       234.19   \n",
       "138   ALDX                  Aldeyra Therapeutics Inc  2014-05-02       301.32   \n",
       "139   GDTC                  CytoMed Therapeutics Ltd  2023-04-14        30.58   \n",
       "140   IMCR               Immunocore Holdings plc ADR  2021-02-05      1467.46   \n",
       "141   THRD                    Third Harmonic Bio Inc  2022-09-14       501.05   \n",
       "142   OCUL                    Ocular Therapeutix Inc  2014-07-25      1411.81   \n",
       "143   KAPA                         Kairos Pharma Ltd  2024-09-16        21.39   \n",
       "144   FOLD                   Amicus Therapeutics Inc  2007-05-31      2958.18   \n",
       "145   MLYS                Mineralys Therapeutics Inc  2023-02-10       605.19   \n",
       "146   KURA                         Kura Oncology Inc  2015-09-16       775.69   \n",
       "147   PLRZ                             Polyrizon Ltd  2024-10-29         4.19   \n",
       "148   PHVS                              Pharvaris NV  2021-02-05      1003.31   \n",
       "149   ALMS                                Alumis Inc  2024-06-28       466.81   \n",
       "150   FTRE                      Fortrea Holdings Inc  2023-06-20      1821.81   \n",
       "151   PLRX                   Pliant Therapeutics Inc  2020-06-03       834.91   \n",
       "152   PSTX                  Poseida Therapeutics Inc  2020-07-10       926.91   \n",
       "153   ENGN                       enGene Holdings Inc  2022-02-01       321.15   \n",
       "154   RPRX                        Royalty Pharma plc  2020-06-16     14729.57   \n",
       "155   NMRA                  Neumora Therapeutics Inc  2023-09-14      1756.17   \n",
       "156   INMB                            INmune Bio Inc  2019-02-04       112.64   \n",
       "157   NTLA                 Intellia Therapeutics Inc  2016-05-06      1362.74   \n",
       "158   ARQT               Arcutis Biotherapeutics Inc  2020-01-31      1588.30   \n",
       "159   MREO             Mereo Biopharma Group Plc ADR  2019-04-24       535.25   \n",
       "160   TYRA                      Tyra Biosciences Inc  2021-09-15       762.08   \n",
       "161   MESO                         Mesoblast Ltd ADR  2010-01-20      1380.90   \n",
       "162   AURA                      Aura Biosciences Inc  2021-10-29       444.07   \n",
       "163   TLSA                 Tiziana Life Sciences Ltd  2018-11-20        96.49   \n",
       "164   CRMD                              CorMedix Inc  2010-05-13       504.23   \n",
       "165   IMMX                       Immix Biopharma Inc  2021-12-16        53.64   \n",
       "166   ANVS                           Annovis Bio Inc  2020-01-29        68.99   \n",
       "167   ABUS                    Arbutus Biopharma Corp  2007-07-26       672.70   \n",
       "168   DAWN            Day One Biopharmaceuticals Inc  2021-05-27      1272.68   \n",
       "169   PHAR                   Pharming Group N.V. ADR  2020-12-23       614.52   \n",
       "170    VIR                     Vir Biotechnology Inc  2019-10-11      1041.16   \n",
       "171   PRTC                   PureTech Health Plc ADR  2020-11-16       530.32   \n",
       "172   TRVI                    Trevi Therapeutics Inc  2019-05-07       325.91   \n",
       "173   GERN                                Geron Corp  1996-07-31      2303.15   \n",
       "174   ICCC                             Immucell Corp  1987-05-05        41.80   \n",
       "175   VERU                                  Veru Inc  1999-02-11       114.97   \n",
       "176   CRVS                Corvus Pharmaceuticals Inc  2016-03-23       443.38   \n",
       "177   FENC                Fennec Pharmaceuticals Inc  2017-09-15       164.08   \n",
       "178   RCKT                Rocket Pharmaceuticals Inc  2015-02-18      1250.52   \n",
       "179   LEXX                   Lexaria Bioscience Corp  2021-01-12        37.70   \n",
       "180   IPHA                         Innate Pharma ADR  2019-10-17       196.20   \n",
       "181   CYTK                          Cytokinetics Inc  2004-04-30      5785.05   \n",
       "182   ZBIO                       Zenas Biopharma Inc  2024-09-13       366.51   \n",
       "183   VNDA                 Vanda Pharmaceuticals Inc  2006-04-12       269.97   \n",
       "184   SPRY                   ARS Pharmaceuticals Inc  2020-12-04      1155.05   \n",
       "185   STOK                    Stoke Therapeutics Inc  2019-06-19       648.32   \n",
       "186   CALC                           CalciMedica Inc  2023-06-14        37.88   \n",
       "187   GNTA                   Genenta Science SpA ADR  2021-12-15        96.94   \n",
       "188   OBIO             Orchestra BioMed Holdings Inc  2020-08-04       193.49   \n",
       "189   MAIA                    MAIA Biotechnology Inc  2022-07-28        55.73   \n",
       "190   INSM                                Insmed Inc  2000-06-01     13129.69   \n",
       "191   TBPH                  Theravance Biopharma Inc  2014-05-16       481.91   \n",
       "192   ACRV                  Acrivon Therapeutics Inc  2022-11-15       217.95   \n",
       "193   HUMA                              Humacyte Inc  2020-12-01       558.42   \n",
       "194   CDXS                               Codexis Inc  2010-04-22       456.53   \n",
       "195   NRXS                              Neuraxis Inc  2023-08-09        17.52   \n",
       "196   CLGN             CollPlant Biotechnologies Ltd  2018-01-31        41.51   \n",
       "197   MGTX                     MeiraGTx Holdings plc  2018-06-08       490.80   \n",
       "198   ITOS                    ITeos Therapeutics Inc  2020-07-24       283.87   \n",
       "199   GHRS                           GH Research PLC  2021-06-25       426.63   \n",
       "200   YMAB                   Y-Mabs Therapeutics Inc  2018-09-21       444.31   \n",
       "201   CGEM                 Cullinan Therapeutics Inc  2021-01-08       687.09   \n",
       "202   OABI                                OmniAb Inc  2021-09-30       458.64   \n",
       "203   GNLX                              Genelux Corp  2023-01-26        81.51   \n",
       "204   ARDX                               Ardelyx Inc  2014-06-19      1276.64   \n",
       "205   ETNB                                 89bio Inc  2019-11-11       928.90   \n",
       "206   SVRA                                Savara Inc  2017-04-28       559.48   \n",
       "207   TERN                 Terns Pharmaceuticals Inc  2021-02-05       592.87   \n",
       "208   PEPG                                PepGen Inc  2022-05-06       147.01   \n",
       "209   THTX                     Theratechnologies Inc  2009-02-13        75.41   \n",
       "210   GLUE               Monte Rosa Therapeutics Inc  2021-06-24       471.83   \n",
       "211   VYGR                  Voyager Therapeutics Inc  2015-11-11       353.97   \n",
       "212   SLXN                Silexion Therapeutics Corp  2021-04-07         5.21   \n",
       "213   ENTA                Enanta Pharmaceuticals Inc  2013-03-21       133.74   \n",
       "214   XBIT                              XBiotech Inc  2015-04-15       210.95   \n",
       "215   INTS                Intensity Therapeutics Inc  2023-06-30        30.74   \n",
       "216   ENTX                            Entera Bio Ltd  2018-06-28        79.93   \n",
       "217    SLN              Silence Therapeutics Plc ADR  2020-09-08       318.23   \n",
       "218   ORIC                  ORIC Pharmaceuticals Inc  2020-04-24       581.47   \n",
       "219   ARCT        Arcturus Therapeutics Holdings Inc  2013-05-22       439.90   \n",
       "220   PHAT               Phathom Pharmaceuticals Inc  2019-10-25       556.59   \n",
       "221   ZURA                              Zura Bio Ltd  2023-03-21       162.58   \n",
       "222    MGX                            Metagenomi Inc  2024-02-09       116.20   \n",
       "223   LRMR                  Larimar Therapeutics Inc  2014-06-19       308.19   \n",
       "224   ORMP               Oramed Pharmaceuticals, Inc  2007-05-01        96.35   \n",
       "225   DRTS                     Alpha Tau Medical Ltd  2021-03-08       217.32   \n",
       "226   BMEA                         Biomea Fusion Inc  2021-04-16       212.00   \n",
       "227   TRML                        Tourmaline Bio Inc  2021-05-07       566.70   \n",
       "228   TNGX                    Tango Therapeutics Inc  2020-09-03       316.88   \n",
       "229   RENB                              Renovaro Inc  2018-02-07       250.77   \n",
       "230   IGMS                       IGM Biosciences Inc  2019-09-18       440.04   \n",
       "231   FULC                  Fulcrum Therapeutics Inc  2019-07-18       238.41   \n",
       "232   OKYO                       OKYO Pharma Limited  2022-05-17        35.19   \n",
       "233   FHTX                  Foghorn Therapeutics Inc  2020-10-23       306.32   \n",
       "234   CABA                         Cabaletta Bio Inc  2019-10-25       132.46   \n",
       "235   FATE                     Fate Therapeutics Inc  2013-10-01       227.79   \n",
       "236   MOLN                 Molecular Partners AG ADR  2021-06-16       197.22   \n",
       "237   SGMT                   Sagimet Biosciences Inc  2023-07-17       184.48   \n",
       "238   CNTX                  Context Therapeutics Inc  2021-10-20       102.00   \n",
       "239   RGNX                             Regenxbio Inc  2015-09-17       423.12   \n",
       "240   TCRX                    Tscan Therapeutics Inc  2021-07-16       160.65   \n",
       "241   NKTR                       Nektar Therapeutics  1994-05-03       184.46   \n",
       "242   NUVB                          Nuvation Bio Inc  2020-08-26       905.37   \n",
       "243   RVPH       Reviva Pharmaceuticals Holdings Inc  2018-10-18        76.91   \n",
       "244    OPT                        Opthea Limited ADR  2020-10-16       513.98   \n",
       "245   IMRN                       Immuron Limited ADR  2017-06-09        11.97   \n",
       "246   ANNX                               Annexon Inc  2020-07-24       539.37   \n",
       "247   TSVT                          2seventy bio Inc  2021-11-03       168.18   \n",
       "248   LTRN                        Lantern Pharma Inc  2020-06-11        38.39   \n",
       "249   AMLX                Amylyx Pharmaceuticals Inc  2022-01-07       286.53   \n",
       "250   SCPH                     scPharmaceuticals Inc  2017-11-17       160.13   \n",
       "251   RXRX             Recursion Pharmaceuticals Inc  2021-04-16      2893.71   \n",
       "252   NRSN               NeuroSense Therapeutics Ltd  2021-12-09        20.44   \n",
       "253   IRON                         Disc Medicine Inc  2020-08-12      1969.36   \n",
       "254   JSPR                   Jasper Therapeutics Inc  2020-01-10       321.78   \n",
       "255   PBYI                    Puma Biotechnology Inc  2012-04-24       147.26   \n",
       "256   ANEB               Anebulo Pharmaceuticals Inc  2021-05-07        33.71   \n",
       "257   NBTX                            Nanobiotix ADR  2020-12-11       165.44   \n",
       "258   CYBN                                 Cybin Inc  2019-09-13       198.12   \n",
       "259   PRQR                    ProQR Therapeutics N.V  2014-09-18       261.59   \n",
       "260   MNPR                  Monopar Therapeutics Inc  2019-12-19       140.92   \n",
       "261   MRVI         Maravai LifeSciences Holdings Inc  2020-11-20      1409.11   \n",
       "262   ACIU                              AC Immune SA  2016-09-23       288.91   \n",
       "263   PRME                        Prime Medicine Inc  2022-10-20       393.48   \n",
       "264   NAUT                Nautilus Biotechnology Inc  2020-08-07       251.13   \n",
       "265   ANRO                     Alto Neuroscience Inc  2024-02-02       101.14   \n",
       "266   COGT                    Cogent Biosciences Inc  2018-03-29       912.42   \n",
       "267    IVA                             Inventiva ADR  2020-07-10       209.46   \n",
       "268   CVKD                 Cadrenal Therapeutics Inc  2023-01-20        18.25   \n",
       "269   LIXT          Lixte Biotechnology Holdings Inc  2007-10-25         4.72   \n",
       "270   SLRN                              Acelyrin Inc  2023-05-04       338.10   \n",
       "271   TNYA                   Tenaya Therapeutics Inc  2021-07-30       228.16   \n",
       "272   SAGE                     Sage Therapeutics Inc  2014-07-18       326.97   \n",
       "273   VERV                    Verve Therapeutics Inc  2021-06-17       458.03   \n",
       "274   CDMO                      Avid Bioservices Inc  1994-04-04       790.59   \n",
       "275   PROK                            ProKidney Corp  2021-06-30      1811.82   \n",
       "276   RNXT                              RenovoRx Inc  2021-08-26        30.00   \n",
       "277   GALT                 Galectin Therapeutics Inc  2002-09-04       144.98   \n",
       "278   MNOV                            Medicinova Inc  2006-12-08       103.49   \n",
       "279   INZY                        Inozyme Pharma Inc  2020-07-24       194.01   \n",
       "280   BOLD                         Boundless Bio Inc  2024-03-28        55.97   \n",
       "281   GNFT                                Genfit ADR  2019-03-27       189.64   \n",
       "282   CCCC                       C4 Therapeutics Inc  2020-10-02       304.24   \n",
       "283   CMPX                  Compass Therapeutics Inc  2021-04-05       205.01   \n",
       "284   ABSI                                Absci Corp  2021-07-22       439.90   \n",
       "285   PRAX            Praxis Precision Medicines Inc  2020-10-16      1349.00   \n",
       "286   CRBP       Corbus Pharmaceuticals Holdings Inc  2014-10-27       173.92   \n",
       "287   DSGN                   Design Therapeutics Inc  2021-03-29       356.15   \n",
       "288   CLYM                             Climb Bio Inc  2021-08-10       162.68   \n",
       "289   XERS              Xeris Biopharma Holdings Inc  2018-06-21       502.40   \n",
       "290   SLNO                   Soleno Therapeutics Inc  2014-11-13      2066.62   \n",
       "291   FDMT             4D Molecular Therapeutics Inc  2020-12-11       299.56   \n",
       "292   ANIX                     Anixa Biosciences Inc  1983-10-07        90.10   \n",
       "293   GUTS                        Fractyl Health Inc  2024-02-02       101.49   \n",
       "294   IFRX                               InflaRx N.V  2017-11-07       136.02   \n",
       "295   VIGL                    Vigil Neuroscience Inc  2022-01-07        76.44   \n",
       "296   CMRX                              Chimerix Inc  2013-04-11       261.71   \n",
       "297   ADPT             Adaptive Biotechnologies Corp  2019-06-27      1000.59   \n",
       "298    ABP                        Abpro Holdings Inc  2022-03-09        65.94   \n",
       "299   MRSN                  Mersana Therapeutics Inc  2017-06-28       255.71   \n",
       "300    ANL                     Adlai Nortye Ltd. ADR  2023-09-29        87.08   \n",
       "301   RANI            Rani Therapeutics Holdings Inc  2021-07-30        93.10   \n",
       "302   VALN                            Valneva SE ADR  2021-05-05       311.41   \n",
       "303   ERAS                                Erasca Inc  2021-07-16       740.74   \n",
       "304   KYTX                  Kyverna Therapeutics Inc  2024-02-09       183.05   \n",
       "305   CGEN                              Compugen Ltd  2000-08-11       142.36   \n",
       "306   MDWD                             MediWound Ltd  2014-03-20       180.73   \n",
       "307   UNCY                Unicycive Therapeutics Inc  2021-07-12        72.66   \n",
       "308   TGTX                       TG Therapeutics Inc  2010-05-03      5354.88   \n",
       "309   CLSD                  Clearside Biomedical Inc  2016-06-02        76.60   \n",
       "310   STRO                       Sutro Biopharma Inc  2018-09-27       170.69   \n",
       "311   OLMA                 Olema Pharmaceuticals Inc  2020-11-19       475.32   \n",
       "312   LCTX             Lineage Cell Therapeutics Inc  1992-03-05       110.21   \n",
       "313   SGMO                  Sangamo Therapeutics Inc  2000-04-06       551.87   \n",
       "314   RLAY                    Relay Therapeutics Inc  2020-07-16       810.13   \n",
       "315    IPA              ImmunoPrecise Antibodies Ltd  2002-01-07        13.36   \n",
       "316   GANX                     Gain Therapeutics Inc  2021-03-19        44.03   \n",
       "317   ZNTL              Zentalis Pharmaceuticals Inc  2020-04-03       220.92   \n",
       "318   DMAC                DiaMedica Therapeutics Inc  2012-08-03       227.06   \n",
       "319   CDIO           Cardio Diagnostics Holdings Inc  2022-01-14        45.29   \n",
       "320   MGNX                           Macrogenics Inc  2013-10-10       202.73   \n",
       "321   CHRS                   Coherus Biosciences Inc  2014-11-06       195.86   \n",
       "322   FBLG                        FibroBiologics Inc  2024-02-01        74.86   \n",
       "323   PYXS                        Pyxis Oncology Inc  2021-10-08        99.90   \n",
       "324   ESLA                 Estrella Immunopharma Inc  2021-09-14        45.95   \n",
       "325   APLT                  Applied Therapeutics Inc  2019-05-14       133.81   \n",
       "326   CHRO          Channel Therapeutics Corporation  2024-02-16         3.56   \n",
       "327   TECX                  Tectonic Therapeutic Inc  2018-06-21       656.79   \n",
       "328   MIST             Milestone Pharmaceuticals Inc  2019-05-09        95.46   \n",
       "329   CRBU                   Caribou Biosciences Inc  2021-07-23       172.96   \n",
       "330   RVNC                  Revance Therapeutics Inc  2014-02-06       322.57   \n",
       "331   NVAX                              Novavax, Inc  1995-12-05      1478.51   \n",
       "332   KALV              KalVista Pharmaceuticals Inc  2015-04-09       442.29   \n",
       "333   AVTE                 Aerovate Therapeutics Inc  2021-06-30        74.01   \n",
       "334   ALEC                               Alector Inc  2019-02-07       193.91   \n",
       "335   VTYX                    Ventyx Biosciences Inc  2021-10-21       159.10   \n",
       "336   ACXP                 Acurx Pharmaceuticals Inc  2021-06-25        13.94   \n",
       "337   HLVX                              HilleVax Inc  2022-04-29        97.12   \n",
       "338   HOWL                 Werewolf Therapeutics Inc  2021-04-30        73.97   \n",
       "339   ABOS                Acumen Pharmaceuticals Inc  2021-07-01       118.36   \n",
       "340   TVGN                  Tevogen Bio Holdings Inc  2022-01-05       178.55   \n",
       "341   AUTL              Autolus Therapeutics plc ADR  2018-06-22       686.59   \n",
       "342   SYRE                    Spyre Therapeutics Inc  2016-04-07      1433.61   \n",
       "343   NGNE                             Neurogene Inc  2014-03-07       373.30   \n",
       "344   BYSI                          BeyondSpring Inc  2017-03-09        64.70   \n",
       "345   AVIR                  Atea Pharmaceuticals Inc  2020-10-30       261.84   \n",
       "346   IMMP                       Immutep Limited ADR  2012-04-19       314.84   \n",
       "347   SPRO                    Spero Therapeutics Inc  2017-11-02        58.33   \n",
       "348   IMRX                          Immuneering Corp  2021-07-30        53.72   \n",
       "349   MNKD                             Mannkind Corp  2004-07-28      1729.13   \n",
       "350   ANTX                      AN2 Therapeutics Inc  2022-03-25        40.34   \n",
       "351   ALGS                   Aligos Therapeutics Inc  2020-10-16       120.77   \n",
       "352   LVTX                      LAVA Therapeutics NV  2021-03-26        26.82   \n",
       "353   MLEC                         Moolec Science SA  2021-03-02        33.36   \n",
       "354   NKGN                         NKGen Biotech Inc  2023-10-02        16.00   \n",
       "355   CTMX                   CytomX Therapeutics Inc  2015-10-08        90.00   \n",
       "356   TSHA                 Taysha Gene Therapies Inc  2020-09-24       411.94   \n",
       "357   OVID                     Ovid Therapeutics Inc  2017-05-05        74.56   \n",
       "358   IBRX                           ImmunityBio Inc  2015-07-28      2234.30   \n",
       "359    CUE                         Cue Biopharma Inc  2018-01-02        64.62   \n",
       "360   IMAB                                 I-Mab ADR  2020-01-17        78.19   \n",
       "361   EDIT                       Editas Medicine Inc  2016-02-03       122.17   \n",
       "362   DBVT                      DBV Technologies ADR  2014-10-22        70.91   \n",
       "363   RLYB                             Rallybio Corp  2021-07-29        42.73   \n",
       "364   ALLO                 Allogene Therapeutics Inc  2018-10-11       431.92   \n",
       "365   CKPT               Checkpoint Therapeutics Inc  2016-12-19       165.54   \n",
       "366   AEON                        AEON Biopharma Inc  2023-07-24        25.98   \n",
       "367   CDTX                   Cidara Therapeutics Inc  2015-04-15       254.44   \n",
       "368   IOVA               Iovance Biotherapeutics Inc  2010-10-15      2389.48   \n",
       "369   RAPT                     RAPT Therapeutics Inc  2019-10-31        30.81   \n",
       "370   ATAI                    ATAI Life Sciences N.V  2021-06-18       223.18   \n",
       "371   ADAG                           Adagene Inc ADR  2021-02-09        89.87   \n",
       "372   KRRO                             Korro Bio Inc  2019-10-03       451.18   \n",
       "373   BDTX            Black Diamond Therapeutics Inc  2020-01-31       149.38   \n",
       "374   LUMO                          Lumos Pharma Inc  2011-11-11        37.54   \n",
       "375   OCEA                      Ocean Biomedical Inc  2021-11-08        22.32   \n",
       "376    ALT                             Altimmune Inc  2017-05-26       640.12   \n",
       "377   OKUR                   OnKure Therapeutics Inc  2021-04-08       121.12   \n",
       "378   SRZN                              Surrozen Inc  2021-01-11        32.50   \n",
       "379   BRNS        Barinthus Biotherapeutics Plc. ADR  2021-04-30        39.19   \n",
       "380   ADCT                       Adc Therapeutics SA  2020-05-18       193.38   \n",
       "381   PVLA                Pieris Pharmaceuticals Inc  2015-01-02         0.00   \n",
       "382   QNCX                   Quince Therapeutics Inc  2019-05-09        84.04   \n",
       "383    XLO                    Xilio Therapeutics Inc  2021-10-22        42.11   \n",
       "384   OMGA                    Omega Therapeutics Inc  2021-07-30        47.40   \n",
       "385   CNTB        Connect Biopharma Holdings Ltd ADR  2021-03-19        60.23   \n",
       "386   ACHL             Achilles Therapeutics Plc ADR  2021-03-31        42.16   \n",
       "387   STTK                         Shattuck Labs Inc  2020-10-09        52.04   \n",
       "388    IKT               Inhibikase Therapeutics Inc  2020-12-23       239.88   \n",
       "389   RPTX                   Repare Therapeutics Inc  2020-06-19        68.02   \n",
       "390   HCWB                         HCW Biologics Inc  2021-07-20        15.85   \n",
       "391   CVAC                               CureVac N.V  2020-08-14       695.45   \n",
       "392   SNTI                     Senti Biosciences Inc  2021-05-26        23.45   \n",
       "393   ELEV                    Elevation Oncology Inc  2021-06-25        37.84   \n",
       "394   LIPO               Lipella Pharmaceuticals Inc  2022-12-19         3.26   \n",
       "395   PTIX               Protagenic Therapeutics Inc  2021-04-27         3.50   \n",
       "396   NXTC                              Nextcure Inc  2019-05-09        28.29   \n",
       "397   SANA                    Sana Biotechnology Inc  2021-02-04       437.61   \n",
       "398   IPSC                  Century Therapeutics Inc  2021-06-18        99.48   \n",
       "399   GOVX                           Geovax Labs Inc  2020-09-25        21.61   \n",
       "400   GOSS                          Gossamer Bio Inc  2019-02-08       194.38   \n",
       "401   IOBT                            IO Biotech Inc  2021-11-05        51.85   \n",
       "402   IKNA                        Ikena Oncology Inc  2021-03-26        77.70   \n",
       "403   INKT                     MiNK Therapeutics Inc  2021-10-15        22.94   \n",
       "404   VCEL                              Vericel Corp  1997-02-04      2786.78   \n",
       "405     EQ                             Equillium Inc  2018-10-12        22.68   \n",
       "406   NKTX                                Nkarta Inc  2020-07-10       163.01   \n",
       "407   ALXO                 Alx Oncology Holdings Inc  2020-07-17        81.22   \n",
       "408   MBRX                     Moleculin Biotech Inc  2016-06-02         6.57   \n",
       "409   SILO                           SILO Pharma Inc  2021-01-08         3.95   \n",
       "410   ABCL                   AbCellera Biologics Inc  2020-12-11       844.75   \n",
       "411   ZVRA                    Zevra Therapeutics Inc  2015-04-16       450.49   \n",
       "412   GBIO                         Generation Bio Co  2020-06-12        77.48   \n",
       "413   BCAB                               BioAtla Inc  2020-12-16        65.27   \n",
       "414    SER                   Serina Therapeutics Inc  2018-11-29        38.98   \n",
       "415   NERV                 Minerva Neurosciences Inc  2014-07-01        15.32   \n",
       "416   RNAC                Cartesian Therapeutics Inc  2016-06-22       478.31   \n",
       "417   SEER                                  Seer Inc  2020-12-04       146.24   \n",
       "418   TSBX                  Turnstone Biologics Corp  2023-07-21        10.87   \n",
       "419   KPTI               Karyopharm Therapeutics Inc  2013-11-06        83.96   \n",
       "420   VRCA               Verrica Pharmaceuticals Inc  2018-06-15        65.03   \n",
       "421   KLTO                  Klotho Neurosciences Inc  2022-04-29         9.43   \n",
       "422   CLLS                             Cellectis ADR  2015-03-24       174.85   \n",
       "423   NNVC                         NanoViricides Inc  2005-10-26        21.23   \n",
       "424   PMVP                   PMV Pharmaceuticals Inc  2020-09-25        80.73   \n",
       "425    TIL                            Instil Bio Inc  2021-03-19       146.83   \n",
       "426   ASMB                  Assembly Biosciences Inc  2010-12-17        98.78   \n",
       "427   SABS                   SAB Biotherapeutics Inc  2021-02-09        36.55   \n",
       "428   LYEL                    Lyell Immunopharma Inc  2021-06-17       195.87   \n",
       "429   ATRA                 Atara Biotherapeutics Inc  2014-10-16        60.53   \n",
       "430    KZR                   Kezar Life Sciences Inc  2018-06-21        48.01   \n",
       "431   AFMD                               Affimed N.V  2014-09-12        34.92   \n",
       "432   LPTX                     Leap Therapeutics Inc  2017-01-25       115.34   \n",
       "433   CGTX                Cognition Therapeutics Inc  2021-10-08        18.74   \n",
       "434   BTAI                  BioXcel Therapeutics Inc  2018-03-08        19.65   \n",
       "435   XCUR                               Exicure Inc  2018-05-22        47.22   \n",
       "436   KTTA                Pasithea Therapeutics Corp  2021-09-15         3.29   \n",
       "437   ADAP          Adaptimmune Therapeutics Plc ADR  2015-05-06       151.33   \n",
       "438   KRON                            Kronos Bio Inc  2020-10-09        57.93   \n",
       "439   AADI                       Aadi Bioscience Inc  2018-02-16        58.66   \n",
       "440   ADXN                Addex Therapeutics Ltd ADR  2020-02-12         8.49   \n",
       "441   SLGL                  Sol-Gel Technologies Ltd  2018-02-01        12.98   \n",
       "442   VTVT                      vTv Therapeutics Inc  2015-07-30        40.33   \n",
       "443   ATHA                         Athira Pharma Inc  2020-09-18        22.33   \n",
       "444   PASG                           Passage Bio Inc  2020-02-28        44.60   \n",
       "445   VSTM                              Verastem Inc  2012-01-27       208.29   \n",
       "446   ALLK                               Allakos Inc  2018-07-19        94.70   \n",
       "447   SNPX                          Synaptogenix Inc  2020-12-08         3.75   \n",
       "448   SAVA                      Cassava Sciences Inc  2000-07-14       127.97   \n",
       "449   SYBX                              Synlogic Inc  2015-09-30        17.37   \n",
       "450   PRLD                  Prelude Therapeutics Inc  2020-09-25        49.30   \n",
       "451   PMCB                    PharmaCyte Biotech Inc  2013-01-02        12.98   \n",
       "452   ELTX                   Elicio Therapeutics Inc  2021-02-05        52.99   \n",
       "453   RIGL                     Rigel Pharmaceuticals  2000-11-29       337.15   \n",
       "454   LPCN                              Lipocine Inc  2013-10-22        26.69   \n",
       "455   CAPR                 Capricor Therapeutics Inc  2007-02-13       631.12   \n",
       "456   CRIS                                 Curis Inc  2000-08-01        29.47   \n",
       "457   CLDX                  Celldex Therapeutics Inc  1986-05-15      1738.22   \n",
       "458   INAB                                IN8bio Inc  2021-07-30        20.41   \n",
       "459   EVGN                               Evogene Ltd  2010-10-15         8.97   \n",
       "460   PGEN                              Precigen Inc  2013-08-08       197.28   \n",
       "461   ATNM              Actinium Pharmaceuticals Inc  2012-12-27        39.62   \n",
       "462   GLYC                         GlycoMimetics Inc  2014-01-10        15.47   \n",
       "463    VOR                         Vor Biopharma Inc  2021-02-05        70.05   \n",
       "464   BIVI                                BioVie Inc  2020-09-18        45.13   \n",
       "465    LSB                LakeShore Biopharma Co Ltd  2021-08-05        47.70   \n",
       "466   IVVD                               Invivyd Inc  2021-08-06        53.89   \n",
       "467   SXTP            60 Degrees Pharmaceuticals Inc  2023-07-12         3.47   \n",
       "468   LGVN                            Longeveron Inc  2021-02-12        27.00   \n",
       "469    DNA              Ginkgo Bioworks Holdings Inc  2021-04-19       542.03   \n",
       "470   SNSE                Sensei Biotherapeutics Inc  2021-02-04        10.87   \n",
       "471   CELU                            Celularity Inc  2019-08-08        51.94   \n",
       "472   SPRB                    Spruce Biosciences Inc  2020-10-09        16.05   \n",
       "473   BNOX                        Bionomics Ltd. ADR  2021-12-16         5.57   \n",
       "474   VINC                        Vincerx Pharma Inc  2020-05-27         6.48   \n",
       "475   CARA                     Cara Therapeutics Inc  2014-01-31        14.15   \n",
       "476   ADVM               Adverum Biotechnologies Inc  2014-07-31       109.42   \n",
       "477   CLDI                Calidi Biotherapeutics Inc  2021-11-01        30.65   \n",
       "478   EYPT              EyePoint Pharmaceuticals Inc  2005-01-27       519.39   \n",
       "479   EPIX                           Essa Pharma Inc  2015-03-13        72.35   \n",
       "480   BLUE                          Bluebird bio Inc  2013-06-19        75.93   \n",
       "481   COEP         Coeptis Therapeutics Holdings Inc  2020-12-17         7.85   \n",
       "482   ALVR                               AlloVir Inc  2020-07-30        52.24   \n",
       "483   GLMD                Galmed Pharmaceuticals Ltd  2014-03-13         5.42   \n",
       "484   MCRB                    Seres Therapeutics Inc  2015-06-26       151.96   \n",
       "485   ONCY                   Oncolytics Biotech, Inc  2001-10-05        63.92   \n",
       "486   NLSP                     NLS Pharmaceutics Ltd  2021-01-29         4.41   \n",
       "487   BOLT                  Bolt Biotherapeutics Inc  2021-02-05        19.83   \n",
       "488   ARTL                    Artelo Biosciences Inc  2019-06-21         3.42   \n",
       "489   HOOK                        Hookipa Pharma Inc  2019-04-18        26.16   \n",
       "490   FGEN                              FibroGen Inc  2014-11-14        32.76   \n",
       "491   TARA                  Protara Therapeutics Inc  2014-10-22       189.79   \n",
       "492   ATYR                           Atyr Pharma Inc  2015-05-07       254.35   \n",
       "493   SLDB                     Solid Biosciences Inc  2018-01-26       183.79   \n",
       "494   CYCN                Cyclerion Therapeutics Inc  2019-03-18         9.57   \n",
       "495   GLTO                               Galecto Inc  2020-10-29         6.83   \n",
       "496    PMN                  ProMIS Neurosciences Inc  2007-01-10        29.78   \n",
       "497   NRXP                   NRX Pharmaceuticals Inc  2017-12-04        14.51   \n",
       "498   ATXS                   Astria Therapeutics Inc  2015-06-25       545.72   \n",
       "499   ONVO                     Organovo Holdings Inc  2012-02-14         5.99   \n",
       "500   FBIO                      Fortress Biotech Inc  2011-11-17        51.07   \n",
       "501   BCLI         Brainstorm Cell Therapeutics, Inc  2003-10-07         8.84   \n",
       "502   EVAX                   Evaxion Biotech A/S ADR  2021-02-05         6.16   \n",
       "503   QTTB                               Q32 Bio Inc  2018-03-28        42.63   \n",
       "504   ADIL                 Adial Pharmaceuticals Inc  2018-07-27         7.01   \n",
       "505   ALRN                  Aileron Therapeutics Inc  2017-06-29        45.93   \n",
       "506   DTIL                 Precision Biosciences Inc  2019-03-28        36.36   \n",
       "507   LYRA                     Lyra Therapeutics Inc  2020-05-01        12.15   \n",
       "508   RZLT                              Rezolute Inc  2013-01-14       260.16   \n",
       "509   ITRM                   Iterum Therapeutics Plc  2018-05-25        51.45   \n",
       "510   CMMB             Chemomab Therapeutics Ltd ADR  2019-02-12        30.36   \n",
       "511   MTNB            Matinas Biopharma Holdings Inc  2014-07-21         2.75   \n",
       "512   VRDN                 Viridian Therapeutics Inc  2014-06-18      1706.24   \n",
       "513   VRAX                   Virax Biolabs Group Ltd  2022-07-21         6.69   \n",
       "514   EYEN                              Eyenovia Inc  2018-01-25         9.09   \n",
       "515   APLM                            Apollomics Inc  2021-11-26         9.07   \n",
       "516   PDSB             PDS Biotechnology Corporation  2015-09-30        72.39   \n",
       "517   CMND                    Clearmind Medicine Inc  2022-11-15         5.74   \n",
       "518    CDT               Conduit Pharmaceuticals Inc  2022-03-28         8.86   \n",
       "519   MRNS               Marinus Pharmaceuticals Inc  2014-07-31        13.67   \n",
       "520   ACET                            Adicet Bio Inc  2018-01-26        79.32   \n",
       "521    ICU              SeaStar Medical Holding Corp  2021-03-18         8.21   \n",
       "522   ATHE             Alterity Therapeutics Ltd ADR  2003-09-29        23.38   \n",
       "523   XFOR                    X4 Pharmaceuticals Inc  2017-11-16       110.00   \n",
       "524   APRE                    Aprea Therapeutics Inc  2019-10-03        17.72   \n",
       "525   ARWR             Arrowhead Pharmaceuticals Inc  1993-12-16      2783.59   \n",
       "526   CTXR                Citius Pharmaceuticals Inc  2014-10-02        19.94   \n",
       "527    IGC                            IGC Pharma Inc  2006-05-24        28.39   \n",
       "528   CBUS                                 Cibus Inc  2017-07-20       115.02   \n",
       "529   SCNI         Scinai Immunotherapeutics Ltd ADR  2015-05-11         2.94   \n",
       "530   KZIA            Kazia Therapeutics Limited ADR  1999-01-06        14.50   \n",
       "531    UBX                   Unity Biotechnology Inc  2018-05-03        18.20   \n",
       "532   KALA                              Kala Bio Inc  2017-07-20        28.17   \n",
       "533   PHGE                                 BiomX Inc  2019-03-13        12.09   \n",
       "534   XBIO                   Xenetic Biosciences Inc  2016-06-30         6.34   \n",
       "535   LXRX               Lexicon Pharmaceuticals Inc  2000-04-07       278.31   \n",
       "536   GNPX                               Genprex Inc  2018-03-29         8.93   \n",
       "537   GRCE                    Grace Therapeutics Inc  2012-02-07        36.91   \n",
       "538   VRPX                Virpax Pharmaceuticals Inc  2021-02-17         2.85   \n",
       "539   RLMD                  Relmada Therapeutics Inc  2014-06-20        11.73   \n",
       "540   PPBT                    Purple Biotech Ltd ADR  2015-11-20        10.02   \n",
       "541   GYRE                     Gyre Therapeutics Inc  2006-04-12       857.36   \n",
       "542   CERO            CERo Therapeutics Holdings Inc  2021-11-30         7.67   \n",
       "543   VXRT                                Vaxart Inc  1981-12-11       133.05   \n",
       "544   DWTX                  Dogwood Therapeutics Inc  2020-12-17         3.26   \n",
       "545    APM                         Aptorum Group Ltd  2018-12-18         4.04   \n",
       "546   XOMA                         XOMA Royalty Corp  1986-06-06       327.79   \n",
       "547   FBRX                     Forte Biosciences Inc  2017-04-13        27.72   \n",
       "548   PYPD                               Polypid Ltd  2020-06-26        16.53   \n",
       "549   BCTX                BriaCell Therapeutics Corp  2012-03-14        27.34   \n",
       "550   CING                             Cingulate Inc  2021-12-08        12.95   \n",
       "551   DARE                       Dare Bioscience Inc  2014-04-10        27.67   \n",
       "552   HOTH                     Hoth Therapeutics Inc  2019-02-15         5.59   \n",
       "553   ENLV                  Enlivex Therapeutics Ltd  2014-07-31        25.51   \n",
       "554   ELAB                           Elevai Labs Inc  2023-11-21         6.33   \n",
       "555   EDSA                         Edesa Biotech Inc  2010-06-21         6.17   \n",
       "556    INO                Inovio Pharmaceuticals Inc  1998-12-08        77.61   \n",
       "557   GTBP                          GT Biopharma Inc  2018-03-27         5.61   \n",
       "558   XTLB        X.T.L. Biopharmaceuticals Ltd. ADR  2005-09-01         9.10   \n",
       "559   NCNA                            NuCana plc ADR  2017-09-28         4.97   \n",
       "560   RGLS                  Regulus Therapeutics Inc  2012-10-09       107.42   \n",
       "561   AZTR                                Azitra Inc  2023-06-16         3.35   \n",
       "562   XRTX                    XORTX Therapeutics Inc  2021-09-23         3.90   \n",
       "563   BLRX                        Bioline Rx Ltd ADR  2011-07-27        21.72   \n",
       "564   HRTX                    Heron Therapeutics Inc  1987-08-26       255.52   \n",
       "565   VANI                        Vivani Medical Inc  2014-11-19        78.19   \n",
       "566    PBM                    Psyence Biomedical Ltd  2021-12-10         1.56   \n",
       "567   CRDF                      Cardiff Oncology Inc  2004-07-27       268.09   \n",
       "568   IMUX                               Immunic Inc  2014-04-17        99.99   \n",
       "569   SPRC                              SciSparc Ltd  2021-08-30         2.37   \n",
       "570   OTLK                  Outlook Therapeutics Inc  2016-06-14        33.83   \n",
       "571   COCP                      Cocrystal Pharma Inc  2012-02-22        20.55   \n",
       "572    PLX              Protalix BioTherapeutics Inc  1998-05-15       128.86   \n",
       "573   INDP                 Indaptus Therapeutics Inc  2015-08-04        11.53   \n",
       "574   BNTC                     Benitec Biopharma Inc  2014-06-24       292.06   \n",
       "575   PRTG                       Portage Biotech Inc  2002-01-02         3.64   \n",
       "576   CARM                  Carisma Therapeutics Inc  2014-02-06        17.96   \n",
       "577   CANF                Can-Fite Biopharma Ltd ADR  2012-11-06         9.21   \n",
       "578   CASI                  CASI Pharmaceuticals Inc  1996-06-12        48.70   \n",
       "579   SKYE                       Skye Bioscience Inc  2015-01-06        99.51   \n",
       "580   VTGN                 Vistagen Therapeutics Inc  2011-06-21        69.05   \n",
       "581   THAR                            Tharimmune Inc  2022-01-12         3.22   \n",
       "582   PULM                             Pulmatrix Inc  2014-03-21        22.06   \n",
       "583   VCNX                              Vaccinex Inc  2018-08-09         9.77   \n",
       "584   ENVB                   Enveric Biosciences Inc  2015-05-04         3.58   \n",
       "585   MBIO                           Mustang Bio Inc  2017-08-22         9.23   \n",
       "586   ATOS                   Atossa Therapeutics Inc  2012-11-08       134.61   \n",
       "587   VYNE                     VYNE Therapeutics Inc  2018-01-25        37.76   \n",
       "588   OCGN                                Ocugen Inc  2014-12-03       246.78   \n",
       "589    INM                 InMed Pharmaceuticals Inc  2014-05-05         3.73   \n",
       "590   SYRS                 Syros Pharmaceuticals Inc  2016-06-30         5.90   \n",
       "591   ELDN                Eledon Pharmaceuticals Inc  2014-09-17       267.03   \n",
       "592    IRD                         Opus Genetics Inc  2005-11-10        31.57   \n",
       "593   DRMA                  Dermata Therapeutics Inc  2021-08-13         2.18   \n",
       "594   TCRT                  Alaunos Therapeutics Inc  2005-08-24         2.63   \n",
       "595   AKTX                Akari Therapeutics Plc ADR  2014-01-06        26.15   \n",
       "596   ALZN                        Alzamend Neuro Inc  2021-06-15         6.63   \n",
       "597   AGEN                                Agenus Inc  2000-02-08        66.82   \n",
       "598   ATNF                    180 Life Sciences Corp  2017-06-27         3.60   \n",
       "599   TFFP                   Tff Pharmaceuticals Inc  2019-10-25         0.29   \n",
       "600   AVTX                    Avalo Therapeutics Inc  2015-10-14        98.57   \n",
       "601   IBIO                                  iBio Inc  2008-08-19        21.50   \n",
       "602   TPST                  Tempest Therapeutics Inc  2012-11-12        34.91   \n",
       "603   PCSA              Processa Pharmaceuticals Inc  2014-03-07         3.40   \n",
       "604   SCPX                     Scorpius Holdings Inc  2013-07-24         1.31   \n",
       "605   MEIP                            MEI Pharma Inc  2003-12-18        17.19   \n",
       "606    PTN                  Palatin Technologies Inc  1997-10-15        16.24   \n",
       "607   ZVSA                  ZyVersa Therapeutics Inc  2022-02-11         2.41   \n",
       "608   CELZ  Creative Medical Technology Holdings Inc  2015-11-06         4.09   \n",
       "609    CVM                              Cel-Sci Corp  1983-12-08        41.47   \n",
       "610   ATXI                   Avenue Therapeutics Inc  2017-06-27         3.57   \n",
       "611   BPTH                     Bio-Path Holdings Inc  2008-03-04         2.89   \n",
       "612   ONCO                             Onconetix Inc  2022-02-18         3.48   \n",
       "613    AIM                        AIM ImmunoTech Inc  1996-07-12        13.39   \n",
       "614   HURA                    TuHURA Biosciences Inc  2013-02-22       175.06   \n",
       "615   PLUR                                 Pluri Inc  2003-06-30        25.83   \n",
       "616   ENSC                   Ensysce Biosciences Inc  2018-03-14         8.36   \n",
       "617   KPRX                 Kiora Pharmaceuticals Inc  2015-02-13        10.80   \n",
       "618   APTO                    Aptose Biosciences Inc  1992-03-16        11.50   \n",
       "619   RNAZ                TransCode Therapeutics Inc  2021-07-08         4.69   \n",
       "620   HEPA                Hepion Pharmaceuticals Inc  2014-02-10         3.69   \n",
       "621   IMNN                                Imunon Inc  1999-03-01        12.18   \n",
       "622   BCDA                             BioCardia Inc  1996-11-13         9.58   \n",
       "623   MTEM                   Molecular Templates Inc  2005-02-04         2.45   \n",
       "624   QNRX             Quoin Pharmaceuticals Ltd ADR  2016-08-01         3.22   \n",
       "625   MTVA                               MetaVia Inc  2016-08-05        19.04   \n",
       "626    GRI                               GRI Bio Inc  2021-02-10         6.84   \n",
       "627   ERNA                   Eterna Therapeutics Inc  1991-08-29        13.95   \n",
       "628   REVB                Revelation Biosciences Inc  2020-11-17         1.49   \n",
       "629   TTNP          Titan Pharmaceuticals, Inc. (de)  1996-01-18         3.10   \n",
       "630   VIRX                  Viracta Therapeutics Inc  2005-09-27         8.43   \n",
       "631   APVO                   Aptevo Therapeutics Inc  2016-07-20         1.94   \n",
       "632   SLRX              Salarius Pharmaceuticals Inc  2015-01-29         2.00   \n",
       "633   TENX                    Tenax Therapeutics Inc  1994-04-04        19.91   \n",
       "634   TNFA                   TNF Pharmaceuticals Inc  2014-01-23         3.00   \n",
       "635   ACHV                 Achieve Life Sciences Inc  1995-10-12       142.03   \n",
       "636   CNSP                   Cns Pharmaceuticals Inc  2019-11-08         5.92   \n",
       "637   LSTA                   Lisata Therapeutics Inc  1999-03-01        21.90   \n",
       "638   BRTX              BioRestorative Therapies Inc  2012-12-05        10.10   \n",
       "639   TOVX                     Theriva Biologics Inc  2006-12-18         3.26   \n",
       "640   DOMH                     Dominari Holdings Inc  1980-03-18         9.29   \n",
       "641   OGEN                             Oragenics Inc  2004-02-25         4.27   \n",
       "642   QLGN                 Qualigen Therapeutics Inc  2015-06-23         3.23   \n",
       "643    NBY               Novabay Pharmaceuticals Inc  2007-10-26         2.77   \n",
       "644   ARMP                Armata Pharmaceuticals Inc  1994-05-20        72.73   \n",
       "645   CSCI                    COSCIENS Biopharma Inc  2000-05-10         9.10   \n",
       "646   TRAW                          Traws Pharma Inc  2013-07-25        14.21   \n",
       "647   ORKA                    Oruka Therapeutics Inc  1997-08-08       789.57   \n",
       "648   ENTO                   Entero Therapeutics Inc  2016-10-11         2.71   \n",
       "649    SLS            SELLAS Life Sciences Group Inc  2008-03-12        64.76   \n",
       "650   ABEO                   Abeona Therapeutics Inc  1980-09-19       256.04   \n",
       "651   TCBP            TC BioPharm (Holdings) plc ADR  2022-02-11         4.51   \n",
       "652   MRKR                   Marker Therapeutics Inc  2002-07-16        36.85   \n",
       "653   PSTV                     Plus Therapeutics Inc  2001-07-11         6.90   \n",
       "654   SNGX                             Soligenix Inc  1994-04-04         7.65   \n",
       "655   ABVC                        ABVC BioPharma Inc  2004-11-10         6.24   \n",
       "656   PHIO                 Phio Pharmaceuticals Corp  2012-05-10         3.00   \n",
       "657   CYTO                 Altamira Therapeutics Ltd  2014-08-06         1.58   \n",
       "658   ADTX                                Aditxt Inc  2020-06-30         4.34   \n",
       "659   CRVO                              CervoMed Inc  2008-05-23        16.09   \n",
       "660   PALI                          Palisade Bio Inc  2007-03-30         3.15   \n",
       "661   BDRX           Biodexa Pharmaceuticals Plc ADR  2015-12-07         2.41   \n",
       "662   SONN       Sonnet BioTherapeutics Holdings Inc  2006-10-31         1.52   \n",
       "663   CYCC              Cyclacel Pharmaceuticals Inc  2004-03-16         2.16   \n",
       "664   ALLR                 Allarity Therapeutics Inc  2021-12-21         4.23   \n",
       "665   CLRB                 Cellectar Biosciences Inc  2005-11-10        10.64   \n",
       "666   JAGX                         Jaguar Health Inc  2015-05-12        10.81   \n",
       "667   WINT                 Windtree Therapeutics Inc  1995-08-07         3.55   \n",
       "668   TNXP        Tonix Pharmaceuticals Holding Corp  2012-05-10        99.05   \n",
       "\n",
       "     Employees  Volume_m  revenueM  ebitdaM  \\\n",
       "0         3100    922.00   1171.58   308.52   \n",
       "1         5400   1171.00  10625.80  4446.60   \n",
       "2         1168    330.00   2756.20  1412.10   \n",
       "3         2524   2066.00   4075.86    80.49   \n",
       "4         2100    772.00   2094.80  -132.15   \n",
       "5        14165    814.00  13847.10  4598.00   \n",
       "6         1148    262.00   1908.66  -150.08   \n",
       "7            0      7.00     19.13    -7.21   \n",
       "8          229    233.00    241.52    69.14   \n",
       "9          380   1695.00    203.45  -238.74   \n",
       "10         373   1658.00    947.36   553.00   \n",
       "11         607    476.00    338.46  -244.62   \n",
       "12        6133    907.00   3040.10  -274.50   \n",
       "13        2800    611.00   3992.71  1518.48   \n",
       "14         879    486.00    317.63  -347.19   \n",
       "15       10600    378.00  23507.73 -5576.40   \n",
       "16          20     73.00      0.00   -35.30   \n",
       "17          30   4125.00      0.00     0.00   \n",
       "18        2635   1210.00  19844.00  6855.00   \n",
       "19         239   1026.00      0.00  -841.60   \n",
       "20        3401   1530.00   2752.81   426.09   \n",
       "21         130    561.00    155.82   -65.30   \n",
       "22         638    642.00    434.42  -262.13   \n",
       "23          50    291.00      0.00  -108.45   \n",
       "24         127    464.00      0.00     0.00   \n",
       "25         352   1022.00    628.56   144.09   \n",
       "26         172    543.00     35.93  -228.46   \n",
       "27          82    761.00      0.00     0.00   \n",
       "28         251    366.00      0.00  -233.68   \n",
       "29         927   1442.00    803.07  -336.27   \n",
       "30         126    688.00    323.80   150.07   \n",
       "31         167    947.00    460.48   211.43   \n",
       "32          58    114.00    152.42    52.63   \n",
       "33         254   1064.00      0.00  -599.03   \n",
       "34         311    389.00    307.03   -72.90   \n",
       "35        1314    965.00   1640.35   119.67   \n",
       "36         407   1506.00    202.83  -313.08   \n",
       "37          79   1006.00      5.62  -150.30   \n",
       "38         280    527.00     85.16  -202.48   \n",
       "39         988    834.00    900.66    21.85   \n",
       "40         150   2124.00      0.00  -228.52   \n",
       "41           3     28.00      0.00   -10.53   \n",
       "42         207    813.00      0.00  -352.16   \n",
       "43         620   1469.00    929.24   124.54   \n",
       "44         244    704.00    129.62  -139.46   \n",
       "45          76    964.00     13.05   -83.88   \n",
       "46        1310   2129.00   2081.60   635.96   \n",
       "47         702   3420.00    715.22  -221.51   \n",
       "48         300   1262.00    220.36     0.50   \n",
       "49          62    680.00     33.59  -184.06   \n",
       "50         124    930.00      3.92  -222.31   \n",
       "51        5600   7060.00   5081.00 -2362.00   \n",
       "52         226    497.00    112.53  -263.92   \n",
       "53           4    767.00      0.00     0.00   \n",
       "54         290    734.00      1.04  -304.51   \n",
       "55         624   4785.00    382.81   125.89   \n",
       "56          57   1154.00      0.00     0.00   \n",
       "57          91    478.00      0.00     0.00   \n",
       "58           7     41.00      1.80     0.00   \n",
       "59         895    756.00    342.80    67.51   \n",
       "60         173    545.00    133.35  -167.23   \n",
       "61          36     53.00      0.87   -68.00   \n",
       "62          29     36.00     -0.00    -4.68   \n",
       "63         105   3017.00      0.00  -181.49   \n",
       "64        1123    199.00    260.09  -136.03   \n",
       "65         305   1127.00    135.49  -292.26   \n",
       "66          53    262.00      5.37   -82.81   \n",
       "67          60    577.00      0.00  -269.27   \n",
       "68         490   1583.00      0.74  -621.56   \n",
       "69          46    263.00      0.00   -98.78   \n",
       "70           0   3108.00      0.00     0.00   \n",
       "71         472   1073.00    349.64  -160.83   \n",
       "72          13    172.00      0.00     0.00   \n",
       "73         112    619.00    352.74   221.19   \n",
       "74          40    235.00      0.00     0.00   \n",
       "75           8     90.00      9.55   -11.11   \n",
       "76         184    443.00     87.56  -190.49   \n",
       "77         383    736.00     32.87  -401.29   \n",
       "78           0    159.00      0.00   -68.34   \n",
       "79         445    663.00    161.10  -352.60   \n",
       "80           0     45.00      0.00    -3.18   \n",
       "81         136    787.00      0.00  -121.84   \n",
       "82          29     16.00      0.00   -31.76   \n",
       "83         184   1562.00     16.00  -321.20   \n",
       "84         536   1985.00    412.58   -31.94   \n",
       "85         284    542.00     36.90  -189.32   \n",
       "86         253   1284.00     10.12  -322.04   \n",
       "87         908   5928.00    129.13 -1199.66   \n",
       "88        1276    709.00    522.74  -501.06   \n",
       "89         173   1014.00      0.00  -312.84   \n",
       "90         390    803.00      0.00  -511.85   \n",
       "91         284    919.00     56.42  -186.40   \n",
       "92          40   1159.00      0.00     0.00   \n",
       "93         480   1953.00     28.59  -189.32   \n",
       "94          68    299.00      0.84   -57.77   \n",
       "95           0     21.00    645.68    73.14   \n",
       "96           1    167.00      0.00     0.00   \n",
       "97           0     52.00      0.00     0.00   \n",
       "98         107    146.00      0.00  -168.40   \n",
       "99          11     50.00      0.00     0.00   \n",
       "100        550   2018.00    217.76  -509.90   \n",
       "101        145    873.00     14.84   -95.84   \n",
       "102        294    515.00     62.20  -114.71   \n",
       "103         42   2785.00      0.00   -34.66   \n",
       "104        376    418.00     76.81  -547.18   \n",
       "105          0    134.00      0.00     0.00   \n",
       "106       2400   1437.00    520.18  -340.56   \n",
       "107        577    747.00    263.00  -288.00   \n",
       "108       2175   1009.00    355.75  -326.92   \n",
       "109        160    698.00      0.65  -202.89   \n",
       "110        170    269.00      0.00  -169.78   \n",
       "111         55    795.00     10.13  -110.44   \n",
       "112        108   1087.00      0.00  -145.18   \n",
       "113          0    350.00      2.21   -65.72   \n",
       "114        117    526.00     57.17  -139.45   \n",
       "115         31     87.00      0.00   -43.30   \n",
       "116          0    152.00      0.00   -73.70   \n",
       "117         82    130.00      2.60   -58.57   \n",
       "118        210     25.00     51.66    -1.17   \n",
       "119         55    252.00      0.00   -85.28   \n",
       "120        246    771.00    681.88   199.56   \n",
       "121        198    765.00      0.00  -172.51   \n",
       "122         62    131.00      9.03  -169.87   \n",
       "123        166     79.00      1.69  -300.93   \n",
       "124        266   1966.00     53.61  -147.98   \n",
       "125        111    349.00      0.00  -192.78   \n",
       "126        331    828.00      0.00  -226.71   \n",
       "127        217    559.00     89.36   -83.28   \n",
       "128         38    130.00      0.00   -59.35   \n",
       "129         61    686.00      0.68   -95.94   \n",
       "130         76    556.00      6.85  -161.30   \n",
       "131        542    607.00     70.87   -95.19   \n",
       "132          0    347.00      0.00   -69.38   \n",
       "133        177    138.00    215.23    61.30   \n",
       "134          0     32.00      2.02    -5.46   \n",
       "135         58    111.00      0.35   -49.62   \n",
       "136          1     81.00      0.00    -2.82   \n",
       "137         69    442.00      0.00   -81.46   \n",
       "138          9    475.00      0.00   -49.39   \n",
       "139          0     19.00      0.45    -3.12   \n",
       "140        497    259.00    296.31   -64.89   \n",
       "141         51    261.00      0.00   -52.79   \n",
       "142        267   1177.00     61.10  -110.75   \n",
       "143          0    337.00      0.00    -1.73   \n",
       "144        500   2630.00    493.67    23.09   \n",
       "145         28    175.00      0.00     0.00   \n",
       "146        142   1354.00      0.00  -216.64   \n",
       "147          0    351.00      0.00    -0.65   \n",
       "148         83    100.00      0.00  -116.10   \n",
       "149        107    157.00      0.00  -239.06   \n",
       "150      15500   1574.00   2975.60    27.10   \n",
       "151        166    452.00      0.00  -219.95   \n",
       "152        350   1215.00    150.86   -57.02   \n",
       "153         31    212.00      0.00   -55.00   \n",
       "154          0   2526.00   2266.00     0.00   \n",
       "155        124   1168.00      0.00  -250.00   \n",
       "156         11    238.00      0.04     0.00   \n",
       "157        526   2485.00     43.09  -527.52   \n",
       "158        296   2045.00    138.71  -179.41   \n",
       "159         33    712.00      1.00   -37.48   \n",
       "160         49    341.00      0.00   -99.59   \n",
       "161         73    215.00      5.90   -56.08   \n",
       "162         88    199.00      0.00   -91.84   \n",
       "163          9    272.00      0.00   -15.79   \n",
       "164         82   1174.00     12.26   -50.77   \n",
       "165         14    166.00      0.00   -20.18   \n",
       "166          6    269.00      0.00     0.00   \n",
       "167         73    974.00      6.74   -77.14   \n",
       "168        174   1107.00    101.95  -205.50   \n",
       "169        382      7.00    285.74    -3.06   \n",
       "170        587   1226.00     78.62  -533.94   \n",
       "171         90      5.00      0.47  -134.73   \n",
       "172         27   1607.00      0.00   -48.07   \n",
       "173        141   8245.00     29.48  -207.45   \n",
       "174         75     19.00     23.22    -0.63   \n",
       "175        189    833.00     14.09   -65.04   \n",
       "176         28    785.00      0.00   -23.28   \n",
       "177         29    122.00     49.35     0.00   \n",
       "178        268   1029.00      0.00  -264.84   \n",
       "179          5    144.00      0.41    -4.53   \n",
       "180        168    460.00     33.79   -35.96   \n",
       "181        423   1198.00      3.22  -511.14   \n",
       "182          0    210.00      0.00  -132.91   \n",
       "183        203    682.00    190.86   -30.16   \n",
       "184         24   1074.00      2.57   -60.44   \n",
       "185        110    574.00     16.74  -115.03   \n",
       "186         13     60.00      0.00   -21.39   \n",
       "187         14     14.00      0.00    -9.41   \n",
       "188         56     55.00      2.65   -59.81   \n",
       "189         13    121.00      0.00     0.00   \n",
       "190        912   1549.00    342.96  -695.06   \n",
       "191         99    197.00     63.19   -38.24   \n",
       "192         58     73.00      0.00   -75.56   \n",
       "193        183   3063.00      0.00  -105.28   \n",
       "194        174    718.00     64.45   -45.78   \n",
       "195         19     18.00      2.27    -8.65   \n",
       "196         75     13.00      0.69   -17.31   \n",
       "197        387    295.00      8.12  -155.31   \n",
       "198        157    591.00     35.00  -144.95   \n",
       "199         49     63.00      0.00   -45.53   \n",
       "200        100    246.00     84.55   -23.35   \n",
       "201         85    540.00      0.00  -187.05   \n",
       "202        106    407.00     20.41   -58.73   \n",
       "203         24    163.00      0.01   -26.96   \n",
       "204        267   4062.00    251.85   -62.15   \n",
       "205         70    797.00      0.00  -303.81   \n",
       "206         37   1515.00      0.00   -88.72   \n",
       "207         66   1529.00      0.00   -99.66   \n",
       "208         76    136.00      0.00   -92.73   \n",
       "209        103     52.00     84.32    14.40   \n",
       "210        133   2638.00     14.98  -121.07   \n",
       "211        162    605.00    163.78    14.13   \n",
       "212          0   5681.00      0.00    -1.36   \n",
       "213        145    253.00     71.96  -120.34   \n",
       "214         82     54.00      0.00   -40.57   \n",
       "215          5     23.00      0.00     0.00   \n",
       "216         17     69.00      0.10    -9.16   \n",
       "217        109    438.00     17.90   -48.16   \n",
       "218        112    419.00      0.00  -133.69   \n",
       "219        180    387.00    160.40   -77.01   \n",
       "220        452   1291.00     26.27  -287.14   \n",
       "221         14    502.00      0.00     0.00   \n",
       "222        236   1665.00     55.08   -83.33   \n",
       "223         42    756.00      0.00   -73.44   \n",
       "224          0    125.00      0.00   -12.85   \n",
       "225        121     36.00      0.00   -35.22   \n",
       "226        107    815.00      0.00  -149.62   \n",
       "227         74    236.00      0.00   -78.78   \n",
       "228        140   1861.00     43.38  -137.20   \n",
       "229         25    669.00      0.00   -27.27   \n",
       "230        198    280.00      2.92  -223.95   \n",
       "231         76    966.00     81.63   -30.88   \n",
       "232          8     57.00      0.00   -15.75   \n",
       "233        116    150.00     25.52   -98.53   \n",
       "234        136   2310.00      0.00   -98.61   \n",
       "235        181   2447.00     13.45  -164.67   \n",
       "236        167     25.00      6.00   -62.16   \n",
       "237          8   1507.00      2.00     0.00   \n",
       "238          5    306.00      0.00   -20.01   \n",
       "239        344    825.00     84.33  -223.55   \n",
       "240        188    297.00      9.36  -114.79   \n",
       "241        137   1740.00     93.14  -130.18   \n",
       "242        203   1995.00      2.16  -133.93   \n",
       "243         15   1198.00      0.00     0.00   \n",
       "244         33     31.00      0.26  -191.82   \n",
       "245          7      8.00      4.90    -5.21   \n",
       "246         71   1406.00      0.00  -124.79   \n",
       "247        274    309.00     45.62  -134.27   \n",
       "248         21     53.00      0.00   -19.53   \n",
       "249        384   1430.00    196.48  -248.25   \n",
       "250        135    398.00     30.28   -63.67   \n",
       "251        500   8324.00     65.18  -364.15   \n",
       "252         18    197.00      0.00   -11.69   \n",
       "253         82    318.00      0.00  -124.71   \n",
       "254         45    278.00      0.00   -67.27   \n",
       "255        185    397.00    243.57    44.60   \n",
       "256          2     10.00      0.00     0.00   \n",
       "257        110     22.00     42.20   -22.30   \n",
       "258         50    365.00      0.00   -86.20   \n",
       "259        156   1501.00     18.39   -28.60   \n",
       "260          9    620.00      0.00     0.00   \n",
       "261        580   1797.00    276.92     1.04   \n",
       "262        133    115.00     40.97   -35.76   \n",
       "263        234   1726.00      0.80  -207.13   \n",
       "264        161    108.00      0.00   -79.40   \n",
       "265          0    810.00      0.00   -62.93   \n",
       "266        164   1354.00      0.00  -258.01   \n",
       "267        123    218.00     19.27   -98.36   \n",
       "268          4     65.00      0.00    -7.94   \n",
       "269          3    585.00      0.00     0.00   \n",
       "270        135    721.00      0.00  -373.01   \n",
       "271        140   3245.00      0.00  -114.18   \n",
       "272        487    796.00    106.40  -371.15   \n",
       "273        255   1425.00     24.40  -219.97   \n",
       "274        371   1898.00    142.36    -7.69   \n",
       "275        163    690.00      0.00  -145.99   \n",
       "276          8     61.00      0.00     0.00   \n",
       "277         14    256.00      0.00     0.00   \n",
       "278         13     72.00      1.00    -9.80   \n",
       "279         59    452.00      0.00   -98.89   \n",
       "280         72     83.00      0.00   -67.75   \n",
       "281        169     15.00     80.47    21.86   \n",
       "282        145   1108.00     33.67  -115.13   \n",
       "283         32    497.00      0.85   -54.83   \n",
       "284        155   1380.00      4.21   -89.71   \n",
       "285         82    298.00      1.60  -163.59   \n",
       "286         19    680.00      0.00   -45.62   \n",
       "287         54    170.00      0.00   -60.22   \n",
       "288          9    527.00      0.00     0.00   \n",
       "289        377   1618.00    187.36   -33.06   \n",
       "290         33    679.00      0.00  -136.50   \n",
       "291        147    938.00      0.02  -163.69   \n",
       "292          4     90.00      0.00     0.00   \n",
       "293        122    362.00      0.10   -80.81   \n",
       "294         62    233.00      0.11   -39.67   \n",
       "295         64    156.00      0.00   -89.62   \n",
       "296         72   3739.00      0.16   -92.74   \n",
       "297        709   1221.00    177.28  -146.95   \n",
       "298         15     28.00      0.07   -11.31   \n",
       "299        123   1013.00     34.84   -77.80   \n",
       "300        127     15.00      5.00   -63.57   \n",
       "301        140   1847.00      0.00   -56.90   \n",
       "302        676     23.00    158.54   -76.15   \n",
       "303        126   1764.00      0.00  -150.91   \n",
       "304         96    368.00      0.00  -121.75   \n",
       "305         68    303.00     42.72    -4.07   \n",
       "306        100     45.00     20.14   -14.50   \n",
       "307         14   1655.00      0.00   -28.84   \n",
       "308        319   3519.00    264.79    -0.41   \n",
       "309         30    721.00      7.52   -25.66   \n",
       "310        302    819.00    160.96  -122.96   \n",
       "311         74    627.00      0.00  -135.54   \n",
       "312         68   1637.00      6.19   -21.40   \n",
       "313        405   7588.00     52.29  -117.03   \n",
       "314        294   1855.00     10.01  -389.45   \n",
       "315         72    570.00     24.09   -11.50   \n",
       "316         29    319.00      0.00   -21.82   \n",
       "317        124   1344.00     40.56  -207.96   \n",
       "318         18     85.00      0.00   -22.35   \n",
       "319          7   6292.00      0.04    -8.22   \n",
       "320        339    603.00    141.33   -99.71   \n",
       "321        235   5257.00    304.34  -116.92   \n",
       "322         10    219.00      0.00   -12.36   \n",
       "323         54   1235.00     16.15   -61.25   \n",
       "324          0    142.00      0.00     0.00   \n",
       "325         37   5791.00     -0.21   -92.28   \n",
       "326          4    168.00      0.00     0.00   \n",
       "327         44    137.00      0.00   -52.02   \n",
       "328         47    326.00      0.00   -49.19   \n",
       "329        158   1316.00     11.48  -157.80   \n",
       "330        597   2731.00    256.94  -187.62   \n",
       "331       1543   5888.00    885.19  -243.25   \n",
       "332        150    401.00      0.00  -154.72   \n",
       "333         51    791.00      0.00   -89.96   \n",
       "334        241   1065.00     61.51  -177.39   \n",
       "335         75   1540.00      0.00  -166.12   \n",
       "336          4    123.00      0.00     0.00   \n",
       "337         90    190.00      0.00  -134.04   \n",
       "338         45    752.00      3.39   -64.38   \n",
       "339         51    219.00      0.00   -92.84   \n",
       "340          0  16906.00      0.00   -42.29   \n",
       "341        463   1663.00     10.09  -205.86   \n",
       "342         30    582.00      0.00  -194.51   \n",
       "343         91    366.00      0.92   -65.47   \n",
       "344         36     26.00      1.88   -16.72   \n",
       "345         75    214.00      0.00  -124.88   \n",
       "346          0    114.00      3.84   -44.54   \n",
       "347         46    252.00    118.46    21.01   \n",
       "348         66   1771.00      0.00   -60.09   \n",
       "349        411   2381.00    267.20    63.69   \n",
       "350         41    503.00      0.00     0.00   \n",
       "351         68    337.00      6.00   -92.68   \n",
       "352         37     77.00      7.40   -26.88   \n",
       "353         52     23.00      5.63    -8.16   \n",
       "354         63   1374.00      0.00   -30.23   \n",
       "355        120   1145.00    126.62     8.55   \n",
       "356         52   4343.00      9.91   -81.15   \n",
       "357         25    184.00      0.63   -65.06   \n",
       "358        672   5889.00      7.33  -341.30   \n",
       "359         53    801.00      8.30   -47.71   \n",
       "360         34    421.00      3.49  -169.25   \n",
       "361        265   2437.00     61.76  -222.63   \n",
       "362        108    809.00     12.52     0.00   \n",
       "363         43     77.00      0.60   -69.86   \n",
       "364        232   2290.00      0.04  -254.97   \n",
       "365         23    853.00      0.08     0.00   \n",
       "366          5    201.00      0.00   -43.86   \n",
       "367         69     41.00     53.87   -30.11   \n",
       "368        557   6027.00     90.86  -408.32   \n",
       "369         70    550.00      0.00  -113.61   \n",
       "370         83   1289.00      0.33  -102.44   \n",
       "371        174     71.00      0.82   -36.13   \n",
       "372        101    138.00      0.00   -92.47   \n",
       "373         54   1194.00      0.00   -81.02   \n",
       "374         30     95.00      2.20   -36.31   \n",
       "375          0     51.00      0.00     0.00   \n",
       "376         59   3005.00      0.05   -99.19   \n",
       "377          0     64.00      0.00   -45.12   \n",
       "378         42     32.00     10.00   -25.02   \n",
       "379        130     50.00     14.97   -59.84   \n",
       "380        273    737.00     70.72  -136.87   \n",
       "381          0     20.00      0.00     0.00   \n",
       "382         32    574.00      0.00   -29.13   \n",
       "383         73    235.00      4.62   -62.43   \n",
       "384         93    314.00      6.31   -78.89   \n",
       "385         81     28.00     24.12   -24.95   \n",
       "386        204    712.00      0.00   -65.90   \n",
       "387         75    675.00      4.12   -86.32   \n",
       "388          8    564.00      0.08   -18.98   \n",
       "389        179    240.00     66.52   -90.24   \n",
       "390         45   9478.00      3.92   -36.58   \n",
       "391        999    487.00     65.86  -270.34   \n",
       "392         48   2307.00      0.34   -56.60   \n",
       "393         29    761.00      0.00   -41.98   \n",
       "394          5    207.00      0.51     0.00   \n",
       "395          1    177.00      0.00    -6.00   \n",
       "396         82     84.00      0.00   -60.40   \n",
       "397        328   1567.00      0.00  -273.80   \n",
       "398        152    509.00      2.68  -117.93   \n",
       "399         17   1684.00      0.30   -27.16   \n",
       "400        135   1314.00    105.32   -61.80   \n",
       "401         74    400.00      0.00   -93.16   \n",
       "402         14     62.00      0.66   -63.58   \n",
       "403         31     40.00      0.00   -17.25   \n",
       "404        314    392.00    226.84     3.95   \n",
       "405         45    169.00     42.62    -9.58   \n",
       "406        159   1244.00      0.00  -118.14   \n",
       "407         89    812.00      0.00  -159.01   \n",
       "408         18     48.00      0.00   -28.79   \n",
       "409          3    274.00      0.07     0.00   \n",
       "410        586   2208.00     32.96  -222.24   \n",
       "411         65    842.00     24.49   -81.27   \n",
       "412        174    162.00     18.58   -92.19   \n",
       "413         65   1202.00     11.00   -85.17   \n",
       "414          9     23.00      3.16   -11.12   \n",
       "415          9     17.00      0.00   -24.49   \n",
       "416         37    119.00     47.94   -39.76   \n",
       "417        147    270.00     14.61   -92.70   \n",
       "418         80    280.00      0.00   -77.58   \n",
       "419        325    880.00    148.44  -125.63   \n",
       "420        100    889.00      9.21   -73.39   \n",
       "421          0    529.00      0.00     0.00   \n",
       "422        216     59.00     36.04   -67.22   \n",
       "423          7    153.00      0.00    -7.76   \n",
       "424         63    203.00      0.00   -77.12   \n",
       "425         49    158.00      0.00   -66.02   \n",
       "426         65     34.00     21.48   -50.27   \n",
       "427         57     96.00      1.51   -46.91   \n",
       "428        224   1409.00      0.06  -196.60   \n",
       "429        165    105.00     62.39  -162.12   \n",
       "430         58    107.00      7.00   -98.46   \n",
       "431         76    200.00      7.43   -71.17   \n",
       "432         54    353.00      0.00   -64.69   \n",
       "433         25   1568.00      0.00   -58.61   \n",
       "434         74    567.00      2.40  -104.30   \n",
       "435          5   1210.00      0.50    -5.80   \n",
       "436          8    980.00      0.00   -16.27   \n",
       "437        449   1722.00    141.46   -72.88   \n",
       "438         58    188.00      8.41   -94.24   \n",
       "439         53    117.00     25.07   -63.40   \n",
       "440         23     43.00      0.86   -11.07   \n",
       "441         36     65.00      6.56   -16.52   \n",
       "442         16     30.00      1.00   -22.77   \n",
       "443         65   4893.00      0.00  -120.43   \n",
       "444         58    547.00      0.00   -84.65   \n",
       "445         73   1010.00     10.00  -114.48   \n",
       "446        131    679.00      0.00  -154.72   \n",
       "447          5     21.00      0.00    -6.83   \n",
       "448         29   5142.00      0.00  -143.32   \n",
       "449          6     30.00      3.17   -36.00   \n",
       "450        128    351.00      3.00  -141.65   \n",
       "451          2     35.00      0.00     0.00   \n",
       "452         32     23.00      0.00   -41.00   \n",
       "453        147    226.00    157.37    11.32   \n",
       "454         17     27.00      4.80    -9.67   \n",
       "455        101   3598.00     23.23   -34.77   \n",
       "456         49     55.00     10.16   -49.30   \n",
       "457        160   1228.00      9.98  -171.06   \n",
       "458         39   1218.00      0.00   -30.63   \n",
       "459        142    292.00      9.45   -19.67   \n",
       "460        202    823.00      4.39   -88.58   \n",
       "461         49    289.00      0.08   -46.48   \n",
       "462         35  20280.00      0.01   -40.78   \n",
       "463        168    590.00      0.00  -121.20   \n",
       "464         14   6151.00      0.00   -31.95   \n",
       "465        758     44.00    573.42  -315.90   \n",
       "466         94    569.00      2.26  -210.66   \n",
       "467          3    279.00      0.44    -8.89   \n",
       "468         23    495.00      1.23   -17.22   \n",
       "469       1218   1235.00    217.95  -525.77   \n",
       "470         28    460.00      0.00   -30.98   \n",
       "471        120   1106.00     42.69   -35.90   \n",
       "472         29    589.00      7.10   -43.19   \n",
       "473          8   9852.00      0.00   -17.35   \n",
       "474         42    655.00      0.00   -27.41   \n",
       "475         55    538.00     11.00  -104.72   \n",
       "476        121    231.00      1.00   -99.02   \n",
       "477         41   1515.00      0.00   -29.18   \n",
       "478        121    881.00     45.71  -114.58   \n",
       "479         50    891.00      0.00     0.00   \n",
       "480        375    387.00     54.90  -302.11   \n",
       "481          5    412.00      0.00   -16.02   \n",
       "482          8    353.00      0.00  -120.46   \n",
       "483          3   1088.00      0.00    -6.14   \n",
       "484        233   3694.00    126.32   -36.50   \n",
       "485          0    508.00      0.00   -36.45   \n",
       "486          0    355.00      0.00    -6.30   \n",
       "487        100    142.00     11.17   -72.23   \n",
       "488          5     27.00      0.00     0.00   \n",
       "489        151     51.00     52.16   -47.71   \n",
       "490        486   1179.00    173.82  -165.84   \n",
       "491         26   2219.00      0.00   -43.90   \n",
       "492         56    959.00      0.24   -67.34   \n",
       "493         88    298.00      0.00  -109.92   \n",
       "494          1   3143.00      0.00     0.00   \n",
       "495         13     27.00      0.00   -20.10   \n",
       "496          6     74.00      0.00   -11.15   \n",
       "497          0    144.00      0.00   -23.26   \n",
       "498         59    338.00      0.00     0.00   \n",
       "499         12    149.00      0.10   -12.49   \n",
       "500        186    734.00     82.62   -90.31   \n",
       "501         29     95.00      0.00   -16.04   \n",
       "502         49     56.00      3.30   -14.87   \n",
       "503         42    228.00    -14.66   -76.89   \n",
       "504          4    174.00      0.00    -7.27   \n",
       "505         15     92.00      0.00   -25.40   \n",
       "506        108     87.00     75.10   -11.98   \n",
       "507         88   1616.00      1.47   -67.04   \n",
       "508         59    412.00      0.00   -70.39   \n",
       "509         14   2872.00      0.00   -37.36   \n",
       "510          0    125.00      0.00   -15.97   \n",
       "511         32    219.00      0.00   -23.38   \n",
       "512         94   1087.00      0.30  -282.47   \n",
       "513         17   1782.00      0.16    -6.05   \n",
       "514         57   7433.00      0.03   -34.80   \n",
       "515         45    313.00      2.10   -53.10   \n",
       "516         25    439.00      0.00   -39.65   \n",
       "517          0    263.00      0.00    -5.86   \n",
       "518          7  25223.00      0.00     0.00   \n",
       "519        165   2657.00     30.26  -128.66   \n",
       "520        143    579.00      0.00  -121.50   \n",
       "521         12    194.00      0.00     0.00   \n",
       "522         10     46.00      4.02   -19.57   \n",
       "523        127   3090.00      0.56  -123.18   \n",
       "524          7     27.00      1.28   -14.18   \n",
       "525        525   1391.00     19.65  -529.78   \n",
       "526         22    227.00      0.00   -41.07   \n",
       "527         67    465.00      1.06    -9.40   \n",
       "528        183    203.00      4.15   -60.30   \n",
       "529         31     28.00      0.28    -7.00   \n",
       "530          0    115.00      0.00   -17.52   \n",
       "531         19     60.00      0.00   -27.36   \n",
       "532         43     27.00      0.00   -40.98   \n",
       "533         58     87.00      0.00   -27.71   \n",
       "534          4     25.00      2.52     0.00   \n",
       "535        285   3851.00      5.23  -210.55   \n",
       "536         21   9653.00      0.00   -26.28   \n",
       "537          0     49.00      0.00   -13.27   \n",
       "538          7   3463.00      0.00     0.00   \n",
       "539         20    747.00      0.00     0.00   \n",
       "540         20    916.00      0.00   -19.62   \n",
       "541        593     78.00    111.59    20.08   \n",
       "542          8  69458.00      0.00     0.00   \n",
       "543        109   1297.00     13.93   -66.26   \n",
       "544          4    110.00      0.00     0.00   \n",
       "545          3     43.00      0.43    -9.60   \n",
       "546         13     28.00     21.61   -15.17   \n",
       "547         11    548.00      0.00     0.00   \n",
       "548         59     13.00      0.00   -21.94   \n",
       "549          0   2866.00      0.00   -33.25   \n",
       "550         13    144.00      0.00   -15.57   \n",
       "551         23     48.00      2.84   -26.70   \n",
       "552          2   1002.00      0.00     0.00   \n",
       "553          0    243.00      0.00   -17.89   \n",
       "554         18    880.00      2.47    -4.78   \n",
       "555         16     31.00      0.00    -8.27   \n",
       "556        127    545.00      0.59  -114.99   \n",
       "557          2     23.00      0.00     0.00   \n",
       "558          0     42.00      0.00     0.00   \n",
       "559         25    296.00      0.00   -33.22   \n",
       "560         32    365.00      0.00   -44.26   \n",
       "561         10    211.00      0.10   -11.06   \n",
       "562          2     56.00      0.00    -3.30   \n",
       "563         79    927.00     17.05   -33.08   \n",
       "564        126   3245.00    137.74    -5.70   \n",
       "565         36    105.00      0.00   -24.90   \n",
       "566          0    776.00      0.00    -2.75   \n",
       "567         31   1753.00      0.69   -46.00   \n",
       "568         85    924.00      0.00   -95.68   \n",
       "569          3    817.00      1.75    -5.89   \n",
       "570         24   1646.00      0.00   -61.19   \n",
       "571         12     19.00      0.00   -21.15   \n",
       "572        208    303.00     38.05   -13.53   \n",
       "573          7    116.00      0.00   -16.48   \n",
       "574         16     42.00      0.00   -22.40   \n",
       "575          7    939.00      0.00   -16.04   \n",
       "576        107    185.00     20.27   -63.37   \n",
       "577          8    440.00      0.67    -7.78   \n",
       "578        176     38.00     23.10   -23.08   \n",
       "579         11    334.00      0.00   -23.46   \n",
       "580         39    210.00      0.88   -45.47   \n",
       "581          2   1284.00      0.00     0.00   \n",
       "582         22    470.00     11.39   -11.14   \n",
       "583         37    112.00      0.36   -21.51   \n",
       "584          7    557.00      0.00    -9.87   \n",
       "585         80   1886.00      0.00   -20.53   \n",
       "586         12    663.00      0.00   -29.46   \n",
       "587         10     88.00      0.49     0.00   \n",
       "588         65   3728.00      4.70   -50.53   \n",
       "589         13     40.00      4.60    -7.91   \n",
       "590         68   8563.00      0.39  -110.18   \n",
       "591         20    465.00      0.00     0.00   \n",
       "592         14    161.00      8.38   -29.47   \n",
       "593          8    287.00      0.00     0.00   \n",
       "594          1     26.00      0.01   -12.58   \n",
       "595          6     41.00      0.00   -18.08   \n",
       "596          4    216.00      0.00    -7.32   \n",
       "597        389    492.00    160.43   -85.52   \n",
       "598          4   2073.00      0.00    -8.83   \n",
       "599         19   1683.00      1.20   -19.01   \n",
       "600         19     52.00      0.82   -31.17   \n",
       "601         16    144.00      0.18   -14.75   \n",
       "602         17   3564.00      0.00   -31.25   \n",
       "603         13    350.00      0.00   -11.79   \n",
       "604         82    144.00      9.85   -24.98   \n",
       "605         28     46.00     65.30    26.38   \n",
       "606         30    353.00      4.49   -29.94   \n",
       "607          7   1276.00      0.00   -10.25   \n",
       "608          4     42.00      0.01    -5.52   \n",
       "609          0    395.00      0.00   -25.52   \n",
       "610          3     45.00      0.00     0.00   \n",
       "611         10   1220.00      0.00   -12.98   \n",
       "612         12    774.00      1.46   -15.15   \n",
       "613         26    467.00      0.20   -31.36   \n",
       "614          0    264.00      0.00     0.00   \n",
       "615        106     26.00      0.33   -21.90   \n",
       "616          7   1848.00      1.44     0.00   \n",
       "617         12     26.00     16.02     6.32   \n",
       "618         35    487.00      0.00   -36.16   \n",
       "619         10     48.00      0.00   -17.68   \n",
       "620         22     44.00      0.00   -31.51   \n",
       "621         33    207.00      0.00   -20.68   \n",
       "622         16     91.00      0.43    -8.53   \n",
       "623         62  14948.00     25.47   -13.86   \n",
       "624          4   3021.00      0.00    -8.84   \n",
       "625          8     41.00      0.00   -28.87   \n",
       "626          4   4559.00      0.00    -8.36   \n",
       "627          8    699.00      0.16   -21.86   \n",
       "628          9   1030.00      0.00    -8.52   \n",
       "629          4     15.00      0.00    -7.09   \n",
       "630         40   2166.00      0.00   -49.04   \n",
       "631         40    308.00      0.00   -24.21   \n",
       "632          2    329.00      0.00    -6.73   \n",
       "633          5     65.00      0.00   -13.03   \n",
       "634          6     85.00      0.00     0.00   \n",
       "635         22    113.00      0.00   -31.04   \n",
       "636          3  15646.00      0.00   -15.98   \n",
       "637         25     16.00      0.00   -23.93   \n",
       "638         11     50.00      0.38   -11.90   \n",
       "639         22   2961.00      0.00   -21.40   \n",
       "640         26     13.00     12.59   -14.18   \n",
       "641          5    459.00      0.01   -19.64   \n",
       "642          4     91.00      0.00    -8.33   \n",
       "643         24   2888.00     13.06    -5.02   \n",
       "644         66      7.00      3.72   -40.91   \n",
       "645          0      5.00      4.83   -25.68   \n",
       "646         17     12.00      0.23   -20.63   \n",
       "647          0    141.00      0.00     0.00   \n",
       "648          9    474.00      0.00   -19.99   \n",
       "649         16    927.00      0.00     0.00   \n",
       "650         84    276.00      0.00   -54.75   \n",
       "651         41   1184.00      0.00   -12.92   \n",
       "652          8     43.00      3.73     0.00   \n",
       "653         20     88.00      5.51   -13.47   \n",
       "654         13    114.00      0.36    -7.86   \n",
       "655         16    248.00      0.14    -8.51   \n",
       "656          8     68.00      0.00    -8.57   \n",
       "657         10    113.00      0.00     0.00   \n",
       "658         47   2959.00      0.33   -33.09   \n",
       "659          8    326.00     10.07     0.00   \n",
       "660          9   1242.00      0.00   -14.59   \n",
       "661         21    288.00      0.08    -6.44   \n",
       "662         12   1325.00      0.06   -12.26   \n",
       "663          0   1590.00      0.08   -20.18   \n",
       "664          5    425.00      0.00   -16.90   \n",
       "665         20   1279.00      0.00   -47.40   \n",
       "666         49    343.00     10.18   -29.43   \n",
       "667          0   1725.00      0.00   -24.66   \n",
       "668        103  37182.00     12.46   -90.77   \n",
       "\n",
       "                                           web         Country       Industry  \\\n",
       "0                   https://www.bio-techne.com             USA  Biotechnology   \n",
       "1                         https://www.vrtx.com             USA  Biotechnology   \n",
       "2                      https://www.unither.com             USA  Biotechnology   \n",
       "3                       https://www.incyte.com             USA  Biotechnology   \n",
       "4                      https://www.alnylam.com             USA  Biotechnology   \n",
       "5                    https://www.regeneron.com             USA  Biotechnology   \n",
       "6                       https://www.argenx.com     Netherlands  Biotechnology   \n",
       "7                   https://www.bioharvest.com          Canada  Biotechnology   \n",
       "8                   https://www.krystalbio.com             USA  Biotechnology   \n",
       "9                      https://www.travere.com             USA  Biotechnology   \n",
       "10                        https://halozyme.com             USA  Biotechnology   \n",
       "11                      https://www.axsome.com             USA  Biotechnology   \n",
       "12                     https://www.biontech.de         Germany  Biotechnology   \n",
       "13                  https://www.jazzpharma.com         Ireland  Biotechnology   \n",
       "14                  https://ascendispharma.com         Denmark  Biotechnology   \n",
       "15                     https://www.beigene.com  Cayman Islands  Biotechnology   \n",
       "16                   https://www.belitebio.com             USA  Biotechnology   \n",
       "17          https://www.vikingtherapeutics.com             USA  Biotechnology   \n",
       "18                      https://www.genmab.com         Denmark  Biotechnology   \n",
       "19                    https://www.biohaven.com             USA  Biotechnology   \n",
       "20                    https://www.biomarin.com             USA  Biotechnology   \n",
       "21                     https://www.arcellx.com             USA  Biotechnology   \n",
       "22          https://www.blueprintmedicines.com             USA  Biotechnology   \n",
       "23                  https://www.moonlaketx.com     Switzerland  Biotechnology   \n",
       "24                    https://www.nuvalent.com             USA  Biotechnology   \n",
       "25                     https://www.corcept.com             USA  Biotechnology   \n",
       "26                        https://www.merus.nl     Netherlands  Biotechnology   \n",
       "27                          https://veratx.com             USA  Biotechnology   \n",
       "28                https://www.xenon-pharma.com          Canada  Biotechnology   \n",
       "29                 https://www.ionispharma.com             USA  Biotechnology   \n",
       "30             https://www.protagonist-inc.com             USA  Biotechnology   \n",
       "31              https://www.catalystpharma.com             USA  Biotechnology   \n",
       "32                      https://www.ligand.com             USA  Biotechnology   \n",
       "33                         https://vaxcyte.com             USA  Biotechnology   \n",
       "34                 https://www.mirumpharma.com             USA  Biotechnology   \n",
       "35                     https://www.sarepta.com             USA  Biotechnology   \n",
       "36                    https://www.crisprtx.com     Switzerland  Biotechnology   \n",
       "37                https://www.veronapharma.com  United Kingdom  Biotechnology   \n",
       "38                      https://www.xencor.com             USA  Biotechnology   \n",
       "39                      https://www.ptcbio.com             USA  Biotechnology   \n",
       "40                     https://scholarrock.com             USA  Biotechnology   \n",
       "41           https://greenwichlifesciences.com             USA  Biotechnology   \n",
       "42                      https://immunovant.com             USA  Biotechnology   \n",
       "43                      https://www.acadia.com             USA  Biotechnology   \n",
       "44                    https://www.tarsusrx.com             USA  Biotechnology   \n",
       "45                     https://www.januxrx.com             USA  Biotechnology   \n",
       "46                    https://www.exelixis.com             USA  Biotechnology   \n",
       "47                     https://www.apellis.com             USA  Biotechnology   \n",
       "48               https://www.auriniapharma.com          Canada  Biotechnology   \n",
       "49          https://www.newamsterdampharma.com     Netherlands  Biotechnology   \n",
       "50                   https://www.ideayabio.com             USA  Biotechnology   \n",
       "51                   https://www.modernatx.com             USA  Biotechnology   \n",
       "52                        https://rhythmtx.com             USA  Biotechnology   \n",
       "53            https://jupiterneurosciences.com             USA  Biotechnology   \n",
       "54                   https://www.crinetics.com             USA  Biotechnology   \n",
       "55               https://www.admabiologics.com             USA  Biotechnology   \n",
       "56                      https://www.mindmed.co             USA  Biotechnology   \n",
       "57          https://www.apogeetherapeutics.com             USA  Biotechnology   \n",
       "58                      https://www.dyadic.com             USA  Biotechnology   \n",
       "59                      https://www.mimedx.com             USA  Biotechnology   \n",
       "60                    https://www.prothena.com         Ireland  Biotechnology   \n",
       "61                          https://oculis.com     Switzerland  Biotechnology   \n",
       "62                    https://www.invizyne.com             USA  Biotechnology   \n",
       "63                 https://www.summittxinc.com             USA  Biotechnology   \n",
       "64                        https://www.glpg.com         Belgium  Biotechnology   \n",
       "65               https://www.springworkstx.com             USA  Biotechnology   \n",
       "66                      https://dianthustx.com             USA  Biotechnology   \n",
       "67                         https://akerotx.com             USA  Biotechnology   \n",
       "68                      https://www.revmed.com             USA  Biotechnology   \n",
       "69         https://www.enliventherapeutics.com             USA  Biotechnology   \n",
       "70                  https://brightmindsbio.com             USA  Biotechnology   \n",
       "71                          https://beamtx.com             USA  Biotechnology   \n",
       "72                    https://www.nuvectis.com             USA  Biotechnology   \n",
       "73                        https://www.inva.com             USA  Biotechnology   \n",
       "74                    https://www.arrivent.com             USA  Biotechnology   \n",
       "75            https://www.coyatherapeutics.com             USA  Biotechnology   \n",
       "76                    https://www.kymeratx.com             USA  Biotechnology   \n",
       "77                       https://www.agios.com             USA  Biotechnology   \n",
       "78                     https://www.lenz-tx.com             USA  Biotechnology   \n",
       "79                     https://www.arvinas.com             USA  Biotechnology   \n",
       "80                     https://ostherapies.com             USA  Biotechnology   \n",
       "81                     https://structuretx.com             USA  Biotechnology   \n",
       "82              https://www.eupraxiapharma.com          Canada  Biotechnology   \n",
       "83                      https://www.syndax.com             USA  Biotechnology   \n",
       "84                    https://www.biocryst.com             USA  Biotechnology   \n",
       "85         https://www.bicycletherapeutics.com  United Kingdom  Biotechnology   \n",
       "86          https://www.aviditybiosciences.com             USA  Biotechnology   \n",
       "87                         https://roivant.com  United Kingdom  Biotechnology   \n",
       "88                  https://www.ultragenyx.com             USA  Biotechnology   \n",
       "89                     https://www.dyne-tx.com             USA  Biotechnology   \n",
       "90          https://www.denalitherapeutics.com             USA  Biotechnology   \n",
       "91                     https://www.nurixtx.com             USA  Biotechnology   \n",
       "92                      https://www.anavex.com             USA  Biotechnology   \n",
       "93                     https://www.uniqure.com     Netherlands  Biotechnology   \n",
       "94                        https://septerna.com             USA  Biotechnology   \n",
       "95                     https://telixpharma.com       Australia  Biotechnology   \n",
       "96                   https://telomirpharma.com             USA  Biotechnology   \n",
       "97                                         NaN          Canada  Biotechnology   \n",
       "98               https://www.muraloncology.com         Ireland  Biotechnology   \n",
       "99             https://actuatetherapeutics.com             USA  Biotechnology   \n",
       "100                      https://bridgebio.com             USA  Biotechnology   \n",
       "101                   https://www.liquidia.com             USA  Biotechnology   \n",
       "102                  https://www.zymeworks.com             USA  Biotechnology   \n",
       "103                   https://www.candeltx.com             USA  Biotechnology   \n",
       "104             https://www.madrigalpharma.com             USA  Biotechnology   \n",
       "105                                        NaN          Canada  Biotechnology   \n",
       "106              https://www.legendbiotech.com             USA  Biotechnology   \n",
       "107                   https://www.arcusbio.com             USA  Biotechnology   \n",
       "108              https://www.zailaboratory.com           China  Biotechnology   \n",
       "109                    https://www.kerostx.com             USA  Biotechnology   \n",
       "110                       https://cargo-tx.com             USA  Biotechnology   \n",
       "111                       https://immunome.com             USA  Biotechnology   \n",
       "112                 https://www.edgewisetx.com             USA  Biotechnology   \n",
       "113                    https://upstreambio.com             USA  Biotechnology   \n",
       "114                 https://www.anaptysbio.com             USA  Biotechnology   \n",
       "115               https://www.contineum-tx.com             USA  Biotechnology   \n",
       "116                  https://www.rapportrx.com             USA  Biotechnology   \n",
       "117                  https://www.artivabio.com             USA  Biotechnology   \n",
       "118          https://www.championsoncology.com             USA  Biotechnology   \n",
       "119                   https://www.celcuity.com             USA  Biotechnology   \n",
       "120         https://www.harmonybiosciences.com             USA  Biotechnology   \n",
       "121                     https://www.omeros.com             USA  Biotechnology   \n",
       "122                     https://www.abivax.com          France  Biotechnology   \n",
       "123                        https://inhibrx.com             USA  Biotechnology   \n",
       "124           https://www.wavelifesciences.com       Singapore  Biotechnology   \n",
       "125                         https://kodiak.com             USA  Biotechnology   \n",
       "126                  https://www.replimune.com             USA  Biotechnology   \n",
       "127                     https://www.urogen.com             USA  Biotechnology   \n",
       "128                         https://mbxbio.com             USA  Biotechnology   \n",
       "129                     https://cgoncology.com             USA  Biotechnology   \n",
       "130                   https://www.centessa.com  United Kingdom  Biotechnology   \n",
       "131                   https://www.immatics.com         Germany  Biotechnology   \n",
       "132                     https://www.bicara.com             USA  Biotechnology   \n",
       "133                  https://www.entradatx.com             USA  Biotechnology   \n",
       "134                  https://www.nutriband.com             USA  Biotechnology   \n",
       "135                    https://www.camp4tx.com             USA  Biotechnology   \n",
       "136            https://www.impactbiomedinc.com             USA  Biotechnology   \n",
       "137                    https://www.lexeotx.com             USA  Biotechnology   \n",
       "138                    https://www.aldeyra.com             USA  Biotechnology   \n",
       "139                      https://w2.cytomed.sg       Singapore  Biotechnology   \n",
       "140                 https://www.immunocore.com  United Kingdom  Biotechnology   \n",
       "141           https://www.thirdharmonicbio.com             USA  Biotechnology   \n",
       "142                      https://www.ocutx.com             USA  Biotechnology   \n",
       "143                   https://kairospharma.com             USA  Biotechnology   \n",
       "144                       https://amicusrx.com             USA  Biotechnology   \n",
       "145                    https://mineralystx.com             USA  Biotechnology   \n",
       "146                   https://kuraoncology.com             USA  Biotechnology   \n",
       "147          https://www.polyrizon-biotech.com          Israel  Biotechnology   \n",
       "148                      https://pharvaris.com     Netherlands  Biotechnology   \n",
       "149                     https://www.alumis.com             USA  Biotechnology   \n",
       "150                    https://www.fortrea.com             USA  Biotechnology   \n",
       "151                       https://pliantrx.com             USA  Biotechnology   \n",
       "152                        https://poseida.com             USA  Biotechnology   \n",
       "153                     https://www.engene.com          Canada  Biotechnology   \n",
       "154              https://www.royaltypharma.com             USA  Biotechnology   \n",
       "155                  https://www.neumoratx.com             USA  Biotechnology   \n",
       "156                  https://www.inmunebio.com             USA  Biotechnology   \n",
       "157                 https://www.intelliatx.com             USA  Biotechnology   \n",
       "158                    https://www.arcutis.com             USA  Biotechnology   \n",
       "159             https://www.mereobiopharma.com  United Kingdom  Biotechnology   \n",
       "160                           https://tyra.bio             USA  Biotechnology   \n",
       "161                  https://www.mesoblast.com       Australia  Biotechnology   \n",
       "162            https://www.aurabiosciences.com             USA  Biotechnology   \n",
       "163        https://www.tizianalifesciences.com  United Kingdom  Biotechnology   \n",
       "164                   https://www.cormedix.com             USA  Biotechnology   \n",
       "165                   https://www.immixbio.com             USA  Biotechnology   \n",
       "166                 https://www.annovisbio.com             USA  Biotechnology   \n",
       "167                 https://www.arbutusbio.com             USA  Biotechnology   \n",
       "168                      https://dayonebio.com             USA  Biotechnology   \n",
       "169                   https://www.pharming.com     Netherlands  Biotechnology   \n",
       "170                        https://www.vir.bio             USA  Biotechnology   \n",
       "171             https://www.puretechhealth.com             USA  Biotechnology   \n",
       "172          https://www.trevitherapeutics.com             USA  Biotechnology   \n",
       "173                      https://www.geron.com             USA  Biotechnology   \n",
       "174                       https://immucell.com             USA  Biotechnology   \n",
       "175                     https://verupharma.com             USA  Biotechnology   \n",
       "176               https://www.corvuspharma.com             USA  Biotechnology   \n",
       "177               https://www.fennecpharma.com             USA  Biotechnology   \n",
       "178               https://www.rocketpharma.com             USA  Biotechnology   \n",
       "179              https://lexariabioscience.com          Canada  Biotechnology   \n",
       "180              https://www.innate-pharma.com          France  Biotechnology   \n",
       "181               https://www.cytokinetics.com             USA  Biotechnology   \n",
       "182                       https://zenasbio.com             USA  Biotechnology   \n",
       "183                https://www.vandapharma.com             USA  Biotechnology   \n",
       "184                     https://ars-pharma.com             USA  Biotechnology   \n",
       "185          https://www.stoketherapeutics.com             USA  Biotechnology   \n",
       "186                https://www.calcimedica.com             USA  Biotechnology   \n",
       "187                    https://www.genenta.com           Italy  Biotechnology   \n",
       "188                https://orchestrabiomed.com             USA  Biotechnology   \n",
       "189                    https://maiabiotech.com             USA  Biotechnology   \n",
       "190                     https://www.insmed.com             USA  Biotechnology   \n",
       "191                 https://www.theravance.com             USA  Biotechnology   \n",
       "192                    https://www.acrivon.com             USA  Biotechnology   \n",
       "193                   https://www.humacyte.com             USA  Biotechnology   \n",
       "194                    https://www.codexis.com             USA  Biotechnology   \n",
       "195                       https://neuraxis.com             USA  Biotechnology   \n",
       "196                  https://www.collplant.com          Israel  Biotechnology   \n",
       "197                       https://meiragtx.com             USA  Biotechnology   \n",
       "198          https://www.iteostherapeutics.com             USA  Biotechnology   \n",
       "199                      https://www.ghres.com         Ireland  Biotechnology   \n",
       "200                      https://www.ymabs.com             USA  Biotechnology   \n",
       "201           https://cullinantherapeutics.com             USA  Biotechnology   \n",
       "202                     https://www.omniab.com             USA  Biotechnology   \n",
       "203                    https://www.genelux.com             USA  Biotechnology   \n",
       "204                    https://www.ardelyx.com             USA  Biotechnology   \n",
       "205                      https://www.89bio.com             USA  Biotechnology   \n",
       "206               https://www.savarapharma.com             USA  Biotechnology   \n",
       "207                https://www.ternspharma.com             USA  Biotechnology   \n",
       "208                         https://pepgen.com             USA  Biotechnology   \n",
       "209                  https://www.theratech.com          Canada  Biotechnology   \n",
       "210                https://www.monterosatx.com             USA  Biotechnology   \n",
       "211        https://www.voyagertherapeutics.com             USA  Biotechnology   \n",
       "212                       https://silexion.com          Israel  Biotechnology   \n",
       "213                     https://www.enanta.com             USA  Biotechnology   \n",
       "214                   https://www.xbiotech.com             USA  Biotechnology   \n",
       "215      https://www.intensitytherapeutics.com             USA  Biotechnology   \n",
       "216                  https://www.enterabio.com          Israel  Biotechnology   \n",
       "217       https://www.silence-therapeutics.com  United Kingdom  Biotechnology   \n",
       "218                 https://www.oricpharma.com             USA  Biotechnology   \n",
       "219                     https://arcturusrx.com             USA  Biotechnology   \n",
       "220              https://www.phathompharma.com             USA  Biotechnology   \n",
       "221                        https://zurabio.com             USA  Biotechnology   \n",
       "222                  https://www.metagenomi.co             USA  Biotechnology   \n",
       "223                  https://www.larimartx.com             USA  Biotechnology   \n",
       "224                     https://www.oramed.com             USA  Biotechnology   \n",
       "225                   https://www.alphatau.com          Israel  Biotechnology   \n",
       "226                   https://biomeafusion.com             USA  Biotechnology   \n",
       "227              https://www.tourmalinebio.com             USA  Biotechnology   \n",
       "228                    https://www.tangotx.com             USA  Biotechnology   \n",
       "229                    https://renovarobio.com             USA  Biotechnology   \n",
       "230                         https://igmbio.com             USA  Biotechnology   \n",
       "231                  https://www.fulcrumtx.com             USA  Biotechnology   \n",
       "232                     https://okyopharma.com  United Kingdom  Biotechnology   \n",
       "233                      https://foghorntx.com             USA  Biotechnology   \n",
       "234               https://www.cabalettabio.com             USA  Biotechnology   \n",
       "235           https://www.fatetherapeutics.com             USA  Biotechnology   \n",
       "236          https://www.molecularpartners.com     Switzerland  Biotechnology   \n",
       "237                    https://www.sagimet.com             USA  Biotechnology   \n",
       "238        https://www.contexttherapeutics.com             USA  Biotechnology   \n",
       "239                  https://www.regenxbio.com             USA  Biotechnology   \n",
       "240                      https://www.tscan.com             USA  Biotechnology   \n",
       "241                     https://www.nektar.com             USA  Biotechnology   \n",
       "242                https://www.nuvationbio.com             USA  Biotechnology   \n",
       "243               https://www.revivapharma.com             USA  Biotechnology   \n",
       "244                         https://opthea.com       Australia  Biotechnology   \n",
       "245                 https://www.immuron.com.au       Australia  Biotechnology   \n",
       "246                 https://www.annexonbio.com             USA  Biotechnology   \n",
       "247                https://www.2seventybio.com             USA  Biotechnology   \n",
       "248              https://www.lanternpharma.com             USA  Biotechnology   \n",
       "249                         https://amylyx.com             USA  Biotechnology   \n",
       "250          https://www.scpharmaceuticals.com             USA  Biotechnology   \n",
       "251                  https://www.recursion.com             USA  Biotechnology   \n",
       "252              https://www.neurosense-tx.com          Israel  Biotechnology   \n",
       "253               https://www.discmedicine.com             USA  Biotechnology   \n",
       "254        https://www.jaspertherapeutics.com/             USA  Biotechnology   \n",
       "255          https://www.pumabiotechnology.com             USA  Biotechnology   \n",
       "256                    https://www.anebulo.com             USA  Biotechnology   \n",
       "257                 https://www.nanobiotix.com          France  Biotechnology   \n",
       "258                      https://www.cybin.com          Canada  Biotechnology   \n",
       "259                      https://www.proqr.com     Netherlands  Biotechnology   \n",
       "260                  https://www.monopartx.com             USA  Biotechnology   \n",
       "261                    https://www.maravai.com             USA  Biotechnology   \n",
       "262                   https://www.acimmune.com     Switzerland  Biotechnology   \n",
       "263                  https://primemedicine.com             USA  Biotechnology   \n",
       "264                   https://www.nautilus.bio             USA  Biotechnology   \n",
       "265           https://www.altoneuroscience.com             USA  Biotechnology   \n",
       "266                  https://www.cogentbio.com             USA  Biotechnology   \n",
       "267            https://www.inventivapharma.com          France  Biotechnology   \n",
       "268                   https://www.cadrenal.com             USA  Biotechnology   \n",
       "269                          https://lixte.com             USA  Biotechnology   \n",
       "270                   https://www.acelyrin.com             USA  Biotechnology   \n",
       "271         https://www.tenayatherapeutics.com             USA  Biotechnology   \n",
       "272                     https://www.sagerx.com             USA  Biotechnology   \n",
       "273                    https://www.vervetx.com             USA  Biotechnology   \n",
       "274                    https://www.avidbio.com             USA  Biotechnology   \n",
       "275                  https://www.prokidney.com             USA  Biotechnology   \n",
       "276                       https://renovorx.com             USA  Biotechnology   \n",
       "277           https://galectintherapeutics.com             USA  Biotechnology   \n",
       "278                 https://www.medicinova.com             USA  Biotechnology   \n",
       "279                    https://www.inozyme.com             USA  Biotechnology   \n",
       "280                   https://boundlessbio.com             USA  Biotechnology   \n",
       "281                     https://www.genfit.com          France  Biotechnology   \n",
       "282             https://www.c4therapeutics.com             USA  Biotechnology   \n",
       "283        https://www.compasstherapeutics.com             USA  Biotechnology   \n",
       "284                      https://www.absci.com             USA  Biotechnology   \n",
       "285                https://praxismedicines.com             USA  Biotechnology   \n",
       "286               https://www.corbuspharma.com             USA  Biotechnology   \n",
       "287                   https://www.designtx.com             USA  Biotechnology   \n",
       "288                        https://eliemtx.com             USA  Biotechnology   \n",
       "289                https://www.xerispharma.com             USA  Biotechnology   \n",
       "290                        https://soleno.life             USA  Biotechnology   \n",
       "291    https://www.4dmoleculartherapeutics.com             USA  Biotechnology   \n",
       "292                      https://www.anixa.com             USA  Biotechnology   \n",
       "293                        https://fractyl.com             USA  Biotechnology   \n",
       "294                     https://www.inflarx.de         Germany  Biotechnology   \n",
       "295                 https://www.vigilneuro.com             USA  Biotechnology   \n",
       "296                   https://www.chimerix.com             USA  Biotechnology   \n",
       "297            https://www.adaptivebiotech.com             USA  Biotechnology   \n",
       "298                          https://abpro.com             USA  Biotechnology   \n",
       "299                    https://www.mersana.com             USA  Biotechnology   \n",
       "300                https://www.adlainortye.com           China  Biotechnology   \n",
       "301           https://www.ranitherapeutics.com             USA  Biotechnology   \n",
       "302                        https://valneva.com          France  Biotechnology   \n",
       "303                     https://www.erasca.com             USA  Biotechnology   \n",
       "304                      https://kyvernatx.com             USA  Biotechnology   \n",
       "305                           https://cgen.com          Israel  Biotechnology   \n",
       "306                  https://www.mediwound.com          Israel  Biotechnology   \n",
       "307                      https://unicycive.com             USA  Biotechnology   \n",
       "308             https://www.tgtherapeutics.com             USA  Biotechnology   \n",
       "309                   https://clearsidebio.com             USA  Biotechnology   \n",
       "310                   https://www.sutrobio.com             USA  Biotechnology   \n",
       "311                          https://olema.com             USA  Biotechnology   \n",
       "312                https://www.lineagecell.com             USA  Biotechnology   \n",
       "313                    https://www.sangamo.com             USA  Biotechnology   \n",
       "314                    https://www.relaytx.com             USA  Biotechnology   \n",
       "315            https://www.ipatherapeutics.com          Canada  Biotechnology   \n",
       "316           https://www.gaintherapeutics.com             USA  Biotechnology   \n",
       "317                       https://zentalis.com             USA  Biotechnology   \n",
       "318                  https://www.diamedica.com             USA  Biotechnology   \n",
       "319           https://cardiodiagnosticsinc.com             USA  Biotechnology   \n",
       "320                https://www.macrogenics.com             USA  Biotechnology   \n",
       "321                    https://www.coherus.com             USA  Biotechnology   \n",
       "322             https://www.fibrobiologics.com             USA  Biotechnology   \n",
       "323              https://www.pyxisoncology.com             USA  Biotechnology   \n",
       "324                https://www.estrellabio.com             USA  Biotechnology   \n",
       "325        https://www.appliedtherapeutics.com             USA  Biotechnology   \n",
       "326                 https://www.chromocell.com             USA  Biotechnology   \n",
       "327                     https://tectonictx.com             USA  Biotechnology   \n",
       "328            https://www.milestonepharma.com          Canada  Biotechnology   \n",
       "329                     https://cariboubio.com             USA  Biotechnology   \n",
       "330                    https://www.revance.com             USA  Biotechnology   \n",
       "331                    https://www.novavax.com             USA  Biotechnology   \n",
       "332                   https://www.kalvista.com             USA  Biotechnology   \n",
       "333                     https://aerovatetx.com             USA  Biotechnology   \n",
       "334                    https://www.alector.com             USA  Biotechnology   \n",
       "335                      https://ventyxbio.com             USA  Biotechnology   \n",
       "336                https://www.acurxpharma.com             USA  Biotechnology   \n",
       "337                   https://www.hillevax.com             USA  Biotechnology   \n",
       "338                     https://werewolftx.com             USA  Biotechnology   \n",
       "339                    https://acumenpharm.com             USA  Biotechnology   \n",
       "340                        https://tevogen.com             USA  Biotechnology   \n",
       "341                    https://www.autolus.com  United Kingdom  Biotechnology   \n",
       "342                      https://www.spyre.com             USA  Biotechnology   \n",
       "343                  https://www.neurogene.com             USA  Biotechnology   \n",
       "344             https://beyondspringpharma.com             USA  Biotechnology   \n",
       "345                     https://ateapharma.com             USA  Biotechnology   \n",
       "346                    https://www.immutep.com       Australia  Biotechnology   \n",
       "347              https://sperotherapeutics.com             USA  Biotechnology   \n",
       "348                    https://immuneering.com             USA  Biotechnology   \n",
       "349               https://www.mannkindcorp.com             USA  Biotechnology   \n",
       "350            https://www.an2therapeutics.com             USA  Biotechnology   \n",
       "351                     https://www.aligos.com             USA  Biotechnology   \n",
       "352           https://www.lavatherapeutics.com     Netherlands  Biotechnology   \n",
       "353                  https://moolecscience.com      Luxembourg  Biotechnology   \n",
       "354                   https://nkgenbiotech.com             USA  Biotechnology   \n",
       "355                     https://www.cytomx.com             USA  Biotechnology   \n",
       "356                  https://www.tayshagtx.com             USA  Biotechnology   \n",
       "357                     https://www.ovidrx.com             USA  Biotechnology   \n",
       "358                    https://immunitybio.com             USA  Biotechnology   \n",
       "359               https://www.cuebiopharma.com             USA  Biotechnology   \n",
       "360              https://ir.i-mabbiopharma.com             USA  Biotechnology   \n",
       "361             https://www.editasmedicine.com             USA  Biotechnology   \n",
       "362           https://www.dbv-technologies.com          France  Biotechnology   \n",
       "363                   https://www.rallybio.com             USA  Biotechnology   \n",
       "364                   https://www.allogene.com             USA  Biotechnology   \n",
       "365                   https://checkpointtx.com             USA  Biotechnology   \n",
       "366              https://www.aeonbiopharma.com             USA  Biotechnology   \n",
       "367                     https://www.cidara.com             USA  Biotechnology   \n",
       "368                    https://www.iovance.com             USA  Biotechnology   \n",
       "369                       https://www.rapt.com             USA  Biotechnology   \n",
       "370                      https://www.atai.life         Germany  Biotechnology   \n",
       "371                    https://www.adagene.com           China  Biotechnology   \n",
       "372                   https://www.korrobio.com             USA  Biotechnology   \n",
       "373   https://www.blackdiamondtherapeutics.com             USA  Biotechnology   \n",
       "374                   https://lumos-pharma.com             USA  Biotechnology   \n",
       "375            https://www.oceanbiomedical.com             USA  Biotechnology   \n",
       "376                      https://altimmune.com             USA  Biotechnology   \n",
       "377             https://onkuretherapeutics.com             USA  Biotechnology   \n",
       "378                   https://www.surrozen.com             USA  Biotechnology   \n",
       "379               https://www.barinthusbio.com  United Kingdom  Biotechnology   \n",
       "380            https://www.adctherapeutics.com     Switzerland  Biotechnology   \n",
       "381                                        NaN             USA  Biotechnology   \n",
       "382                   https://www.quincetx.com             USA  Biotechnology   \n",
       "383                        https://xiliotx.com             USA  Biotechnology   \n",
       "384              https://omegatherapeutics.com             USA  Biotechnology   \n",
       "385            https://www.connectbiopharm.com           China  Biotechnology   \n",
       "386                 https://www.achillestx.com  United Kingdom  Biotechnology   \n",
       "387               https://www.shattucklabs.com             USA  Biotechnology   \n",
       "388                 https://www.inhibikase.com             USA  Biotechnology   \n",
       "389                   https://www.reparerx.com          Canada  Biotechnology   \n",
       "390               https://www.hcwbiologics.com             USA  Biotechnology   \n",
       "391                    https://www.curevac.com         Germany  Biotechnology   \n",
       "392                   https://www.sentibio.com             USA  Biotechnology   \n",
       "393              https://elevationoncology.com             USA  Biotechnology   \n",
       "394                    https://www.lipella.com             USA  Biotechnology   \n",
       "395                 https://www.protagenic.com             USA  Biotechnology   \n",
       "396                   https://www.nextcure.com             USA  Biotechnology   \n",
       "397                       https://www.sana.com             USA  Biotechnology   \n",
       "398                  https://www.centurytx.com             USA  Biotechnology   \n",
       "399                     https://www.geovax.com             USA  Biotechnology   \n",
       "400                https://www.gossamerbio.com             USA  Biotechnology   \n",
       "401                  https://www.iobiotech.com         Denmark  Biotechnology   \n",
       "402                  https://ikenaoncology.com             USA  Biotechnology   \n",
       "403               https://minktherapeutics.com             USA  Biotechnology   \n",
       "404                           https://vcel.com             USA  Biotechnology   \n",
       "405               https://www.equilliumbio.com             USA  Biotechnology   \n",
       "406                   https://www.nkartatx.com             USA  Biotechnology   \n",
       "407                https://www.alxoncology.com             USA  Biotechnology   \n",
       "408                      https://moleculin.com             USA  Biotechnology   \n",
       "409                     https://silopharma.com             USA  Biotechnology   \n",
       "410                  https://www.abcellera.com          Canada  Biotechnology   \n",
       "411                          https://zevra.com             USA  Biotechnology   \n",
       "412                  https://generationbio.com             USA  Biotechnology   \n",
       "413                    https://www.bioatla.com             USA  Biotechnology   \n",
       "414             https://serinatherapeutics.com             USA  Biotechnology   \n",
       "415       https://www.minervaneurosciences.com             USA  Biotechnology   \n",
       "416      https://www.cartesiantherapeutics.com             USA  Biotechnology   \n",
       "417                           https://seer.bio             USA  Biotechnology   \n",
       "418                   https://turnstonebio.com             USA  Biotechnology   \n",
       "419                 https://www.karyopharm.com             USA  Biotechnology   \n",
       "420                    https://www.verrica.com             USA  Biotechnology   \n",
       "421                https://www.klothoneuro.com             USA  Biotechnology   \n",
       "422                  https://www.cellectis.com          France  Biotechnology   \n",
       "423              https://www.nanoviricides.com             USA  Biotechnology   \n",
       "424                  https://www.pmvpharma.com             USA  Biotechnology   \n",
       "425                      https://instilbio.com             USA  Biotechnology   \n",
       "426                https://www.assemblybio.com             USA  Biotechnology   \n",
       "427         https://www.sabbiotherapeutics.com             USA  Biotechnology   \n",
       "428                          https://lyell.com             USA  Biotechnology   \n",
       "429                   https://www.atarabio.com             USA  Biotechnology   \n",
       "430          https://www.kezarlifesciences.com             USA  Biotechnology   \n",
       "431                    https://www.affimed.com         Germany  Biotechnology   \n",
       "432                     https://www.leaptx.com             USA  Biotechnology   \n",
       "433                      https://www.cogrx.com             USA  Biotechnology   \n",
       "434        https://www.bioxceltherapeutics.com             USA  Biotechnology   \n",
       "435                  https://www.exicuretx.com             USA  Biotechnology   \n",
       "436                   https://www.pasithea.com             USA  Biotechnology   \n",
       "437                https://www.adaptimmune.com  United Kingdom  Biotechnology   \n",
       "438                  https://www.kronosbio.com             USA  Biotechnology   \n",
       "439                        https://aadibio.com             USA  Biotechnology   \n",
       "440          https://www.addextherapeutics.com     Switzerland  Biotechnology   \n",
       "441                    https://www.sol-gel.com          Israel  Biotechnology   \n",
       "442                https://vtvtherapeutics.com             USA  Biotechnology   \n",
       "443                     https://www.athira.com             USA  Biotechnology   \n",
       "444                 https://www.passagebio.com             USA  Biotechnology   \n",
       "445                   https://www.verastem.com             USA  Biotechnology   \n",
       "446                    https://www.allakos.com             USA  Biotechnology   \n",
       "447                 https://www.synaptogen.com             USA  Biotechnology   \n",
       "448            https://www.cassavasciences.com             USA  Biotechnology   \n",
       "449                 https://www.synlogictx.com             USA  Biotechnology   \n",
       "450                      https://preludetx.com             USA  Biotechnology   \n",
       "451                     https://pharmacyte.com             USA  Biotechnology   \n",
       "452                         https://elicio.com             USA  Biotechnology   \n",
       "453                      https://www.rigel.com             USA  Biotechnology   \n",
       "454                   https://www.lipocine.com             USA  Biotechnology   \n",
       "455                   https://www.capricor.com             USA  Biotechnology   \n",
       "456                      https://www.curis.com             USA  Biotechnology   \n",
       "457                    https://www.celldex.com             USA  Biotechnology   \n",
       "458                         https://in8bio.com             USA  Biotechnology   \n",
       "459                    https://www.evogene.com          Israel  Biotechnology   \n",
       "460                       https://precigen.com             USA  Biotechnology   \n",
       "461             https://www.actiniumpharma.com             USA  Biotechnology   \n",
       "462              https://www.glycomimetics.com             USA  Biotechnology   \n",
       "463                     https://www.vorbio.com             USA  Biotechnology   \n",
       "464                   https://bioviepharma.com             USA  Biotechnology   \n",
       "465                 https://www.ysbiopharm.com           China  Biotechnology   \n",
       "466                        https://invivyd.com             USA  Biotechnology   \n",
       "467            https://www.60degreespharma.com             USA  Biotechnology   \n",
       "468                     https://longeveron.com             USA  Biotechnology   \n",
       "469             https://www.ginkgobioworks.com             USA  Biotechnology   \n",
       "470                  https://www.senseibio.com             USA  Biotechnology   \n",
       "471                 https://www.celularity.com             USA  Biotechnology   \n",
       "472          https://www.sprucebiosciences.com             USA  Biotechnology   \n",
       "473               https://www.bionomics.com.au       Australia  Biotechnology   \n",
       "474                        https://vincerx.com             USA  Biotechnology   \n",
       "475           https://www.caratherapeutics.com             USA  Biotechnology   \n",
       "476                        https://adverum.com             USA  Biotechnology   \n",
       "477                  https://www.calidibio.com             USA  Biotechnology   \n",
       "478                 https://eyepointpharma.com             USA  Biotechnology   \n",
       "479                 https://www.essapharma.com          Canada  Biotechnology   \n",
       "480                https://www.bluebirdbio.com             USA  Biotechnology   \n",
       "481                      https://coeptistx.com             USA  Biotechnology   \n",
       "482                    https://www.allovir.com             USA  Biotechnology   \n",
       "483               https://www.galmedpharma.com          Israel  Biotechnology   \n",
       "484          https://www.serestherapeutics.com             USA  Biotechnology   \n",
       "485          https://www.oncolyticsbiotech.com          Canada  Biotechnology   \n",
       "486                      https://nlspharma.com     Switzerland  Biotechnology   \n",
       "487                    https://www.boltbio.com             USA  Biotechnology   \n",
       "488                  https://www.artelobio.com             USA  Biotechnology   \n",
       "489              https://www.hookipapharma.com             USA  Biotechnology   \n",
       "490                   https://www.fibrogen.com             USA  Biotechnology   \n",
       "491                  https://www.protaratx.com             USA  Biotechnology   \n",
       "492                 https://www.atyrpharma.com             USA  Biotechnology   \n",
       "493                   https://www.solidbio.com             USA  Biotechnology   \n",
       "494                  https://www.cyclerion.com             USA  Biotechnology   \n",
       "495                        https://galecto.com             USA  Biotechnology   \n",
       "496        https://www.promisneurosciences.com          Canada  Biotechnology   \n",
       "497                  https://www.nrxpharma.com             USA  Biotechnology   \n",
       "498                   https://www.astriatx.com             USA  Biotechnology   \n",
       "499                   https://www.organovo.com             USA  Biotechnology   \n",
       "500            https://www.fortressbiotech.com             USA  Biotechnology   \n",
       "501            https://www.brainstorm-cell.com             USA  Biotechnology   \n",
       "502            https://www.evaxion-biotech.com         Denmark  Biotechnology   \n",
       "503                     https://www.q32bio.com             USA  Biotechnology   \n",
       "504                https://www.adialpharma.com             USA  Biotechnology   \n",
       "505                  https://www.aileronrx.com             USA  Biotechnology   \n",
       "506       https://www.precisionbiosciences.com             USA  Biotechnology   \n",
       "507               https://lyratherapeutics.com             USA  Biotechnology   \n",
       "508                https://www.rezolutebio.com             USA  Biotechnology   \n",
       "509                   https://www.iterumtx.com         Ireland  Biotechnology   \n",
       "510                   https://www.chemomab.com          Israel  Biotechnology   \n",
       "511           https://www.matinasbiopharma.com             USA  Biotechnology   \n",
       "512       https://www.viridiantherapeutics.com             USA  Biotechnology   \n",
       "513                   https://viraxbiolabs.com  United Kingdom  Biotechnology   \n",
       "514                   https://www.eyenovia.com             USA  Biotechnology   \n",
       "515              https://www.apollomicsinc.com             USA  Biotechnology   \n",
       "516                 https://www.pdsbiotech.com             USA  Biotechnology   \n",
       "517          https://www.clearmindmedicine.com          Canada  Biotechnology   \n",
       "518              https://www.conduitpharma.com             USA  Biotechnology   \n",
       "519                  https://marinuspharma.com             USA  Biotechnology   \n",
       "520                  https://www.adicetbio.com             USA  Biotechnology   \n",
       "521             https://www.seastarmedical.com             USA  Biotechnology   \n",
       "522           https://alteritytherapeutics.com       Australia  Biotechnology   \n",
       "523                   https://www.x4pharma.com             USA  Biotechnology   \n",
       "524                      https://www.aprea.com             USA  Biotechnology   \n",
       "525                https://arrowheadpharma.com             USA  Biotechnology   \n",
       "526                   https://citiuspharma.com             USA  Biotechnology   \n",
       "527                      https://igcpharma.com             USA  Biotechnology   \n",
       "528                      https://www.cibus.com             USA  Biotechnology   \n",
       "529                     https://www.scinai.com          Israel  Biotechnology   \n",
       "530          https://www.kaziatherapeutics.com       Australia  Biotechnology   \n",
       "531             https://unitybiotechnology.com             USA  Biotechnology   \n",
       "532                     https://www.kalarx.com             USA  Biotechnology   \n",
       "533                      https://www.biomx.com             USA  Biotechnology   \n",
       "534                 https://www.xeneticbio.com             USA  Biotechnology   \n",
       "535                  https://www.lexpharma.com             USA  Biotechnology   \n",
       "536                    https://www.genprex.com             USA  Biotechnology   \n",
       "537               https://www.acastipharma.com             USA  Biotechnology   \n",
       "538               https://www.virpaxpharma.com             USA  Biotechnology   \n",
       "539                    https://www.relmada.com             USA  Biotechnology   \n",
       "540                 https://purple-biotech.com          Israel  Biotechnology   \n",
       "541                     https://www.gyretx.com             USA  Biotechnology   \n",
       "542                       https://www.cero.bio             USA  Biotechnology   \n",
       "543                         https://vaxart.com             USA  Biotechnology   \n",
       "544                       https://www.dwtx.com             USA  Biotechnology   \n",
       "545               https://www.aptorumgroup.com  United Kingdom  Biotechnology   \n",
       "546                           https://xoma.com             USA  Biotechnology   \n",
       "547                 https://www.fortebiorx.com             USA  Biotechnology   \n",
       "548                    https://www.polypid.com          Israel  Biotechnology   \n",
       "549                       https://briacell.com          Canada  Biotechnology   \n",
       "550                  https://www.cingulate.com             USA  Biotechnology   \n",
       "551                 https://darebioscience.com             USA  Biotechnology   \n",
       "552               https://hoththerapeutics.com             USA  Biotechnology   \n",
       "553                    https://www.enlivex.com          Israel  Biotechnology   \n",
       "554                 https://elevaiskincare.com             USA  Biotechnology   \n",
       "555               https://www.edesabiotech.com          Canada  Biotechnology   \n",
       "556                     https://www.inovio.com             USA  Biotechnology   \n",
       "557                https://www.gtbiopharma.com             USA  Biotechnology   \n",
       "558                     https://www.xtlbio.com          Israel  Biotechnology   \n",
       "559                     https://www.nucana.com  United Kingdom  Biotechnology   \n",
       "560                  https://www.regulusrx.com             USA  Biotechnology   \n",
       "561                      https://azitrainc.com             USA  Biotechnology   \n",
       "562                      https://www.xortx.com          Canada  Biotechnology   \n",
       "563                  https://www.biolinerx.com          Israel  Biotechnology   \n",
       "564                    https://www.herontx.com             USA  Biotechnology   \n",
       "565                     https://www.vivani.com             USA  Biotechnology   \n",
       "566              https://www.psyencebiomed.com          Canada  Biotechnology   \n",
       "567            https://www.cardiffoncology.com             USA  Biotechnology   \n",
       "568                           https://imux.com             USA  Biotechnology   \n",
       "569                       https://scisparc.com          Israel  Biotechnology   \n",
       "570        https://www.outlooktherapeutics.com             USA  Biotechnology   \n",
       "571            https://www.cocrystalpharma.com             USA  Biotechnology   \n",
       "572                   https://www.protalix.com             USA  Biotechnology   \n",
       "573                     https://indaptusrx.com             USA  Biotechnology   \n",
       "574                        https://benitec.com             USA  Biotechnology   \n",
       "575             https://www.portagebiotech.com             USA  Biotechnology   \n",
       "576                  https://www.carismatx.com             USA  Biotechnology   \n",
       "577                    https://www.canfite.com          Israel  Biotechnology   \n",
       "578        https://www.casipharmaceuticals.com           China  Biotechnology   \n",
       "579                 https://skyebioscience.com             USA  Biotechnology   \n",
       "580                   https://www.vistagen.com             USA  Biotechnology   \n",
       "581                 https://www.tharimmune.com             USA  Biotechnology   \n",
       "582                  https://www.pulmatrix.com             USA  Biotechnology   \n",
       "583                   https://www.vaccinex.com             USA  Biotechnology   \n",
       "584                    https://www.enveric.com             USA  Biotechnology   \n",
       "585                 https://www.mustangbio.com             USA  Biotechnology   \n",
       "586         https://www.atossatherapeutics.com             USA  Biotechnology   \n",
       "587           https://www.vynetherapeutics.com             USA  Biotechnology   \n",
       "588                     https://www.ocugen.com             USA  Biotechnology   \n",
       "589                https://www.inmedpharma.com          Canada  Biotechnology   \n",
       "590                      https://www.syros.com             USA  Biotechnology   \n",
       "591                         https://eledon.com             USA  Biotechnology   \n",
       "592                        https://opusgtx.com             USA  Biotechnology   \n",
       "593                  https://www.dermatarx.com             USA  Biotechnology   \n",
       "594                    https://www.alaunos.com             USA  Biotechnology   \n",
       "595                    https://www.akaritx.com             USA  Biotechnology   \n",
       "596                   https://www.alzamend.com             USA  Biotechnology   \n",
       "597                  https://www.agenusbio.com             USA  Biotechnology   \n",
       "598                https://180lifesciences.com             USA  Biotechnology   \n",
       "599                      https://tffpharma.com             USA  Biotechnology   \n",
       "600                    https://www.avalotx.com             USA  Biotechnology   \n",
       "601                        https://ibioinc.com             USA  Biotechnology   \n",
       "602                  https://www.tempesttx.com             USA  Biotechnology   \n",
       "603    https://www.processapharmaceuticals.com             USA  Biotechnology   \n",
       "604          https://www.scorpiusbiologics.com             USA  Biotechnology   \n",
       "605                      https://meipharma.com             USA  Biotechnology   \n",
       "606                        https://palatin.com             USA  Biotechnology   \n",
       "607                    https://www.zyversa.com             USA  Biotechnology   \n",
       "608  https://www.creativemedicaltechnology.com             USA  Biotechnology   \n",
       "609                        https://cel-sci.com             USA  Biotechnology   \n",
       "610                   https://www.avenuetx.com             USA  Biotechnology   \n",
       "611            https://www.biopathholdings.com             USA  Biotechnology   \n",
       "612              https://onconetix.gcs-web.com             USA  Biotechnology   \n",
       "613                      https://aimimmuno.com             USA  Biotechnology   \n",
       "614                                        NaN             USA  Biotechnology   \n",
       "615              https://www.pluri-biotech.com          Israel  Biotechnology   \n",
       "616                    https://www.ensysce.com             USA  Biotechnology   \n",
       "617                https://www.kiorapharma.com             USA  Biotechnology   \n",
       "618                     https://www.aptose.com          Canada  Biotechnology   \n",
       "619      https://www.transcodetherapeutics.com             USA  Biotechnology   \n",
       "620                   https://hepionpharma.com             USA  Biotechnology   \n",
       "621                         https://imunon.com             USA  Biotechnology   \n",
       "622                  https://www.biocardia.com             USA  Biotechnology   \n",
       "623                       https://www.mtem.com             USA  Biotechnology   \n",
       "624                    https://quoinpharma.com             USA  Biotechnology   \n",
       "625                  https://www.metaviatx.com             USA  Biotechnology   \n",
       "626                     https://www.gribio.com             USA  Biotechnology   \n",
       "627                       https://eternatx.com             USA  Biotechnology   \n",
       "628             https://www.revbiosciences.com             USA  Biotechnology   \n",
       "629                 https://www.titanpharm.com             USA  Biotechnology   \n",
       "630                    https://www.viracta.com             USA  Biotechnology   \n",
       "631         https://www.aptevotherapeutics.com             USA  Biotechnology   \n",
       "632             https://www.salariuspharma.com             USA  Biotechnology   \n",
       "633                 https://www.tenaxthera.com             USA  Biotechnology   \n",
       "634                      https://tnfpharma.com             USA  Biotechnology   \n",
       "635        https://www.achievelifesciences.com          Canada  Biotechnology   \n",
       "636                  https://www.cnspharma.com             USA  Biotechnology   \n",
       "637                     https://www.lisata.com             USA  Biotechnology   \n",
       "638             https://www.biorestorative.com             USA  Biotechnology   \n",
       "639                     https://therivabio.com             USA  Biotechnology   \n",
       "640           https://www.dominariholdings.com             USA  Biotechnology   \n",
       "641                  https://www.oragenics.com             USA  Biotechnology   \n",
       "642                     https://www.qlgntx.com             USA  Biotechnology   \n",
       "643                        https://novabay.com             USA  Biotechnology   \n",
       "644               https://www.armatapharma.com             USA  Biotechnology   \n",
       "645                https://www.cosciensbio.com          Canada  Biotechnology   \n",
       "646                https://www.trawspharma.com             USA  Biotechnology   \n",
       "647                                        NaN             USA  Biotechnology   \n",
       "648                https://www.enterothera.com             USA  Biotechnology   \n",
       "649         https://www.sellaslifesciences.com             USA  Biotechnology   \n",
       "650         https://www.abeonatherapeutics.com             USA  Biotechnology   \n",
       "651                     https://tcbiopharm.com  United Kingdom  Biotechnology   \n",
       "652             https://markertherapeutics.com             USA  Biotechnology   \n",
       "653               https://plustherapeutics.com             USA  Biotechnology   \n",
       "654                  https://www.soligenix.com             USA  Biotechnology   \n",
       "655                 https://www.abvcpharma.com             USA  Biotechnology   \n",
       "656                     https://phiopharma.com             USA  Biotechnology   \n",
       "657           https://altamiratherapeutics.com         Bermuda  Biotechnology   \n",
       "658                     https://www.aditxt.com             USA  Biotechnology   \n",
       "659                   https://www.cervomed.com             USA  Biotechnology   \n",
       "660                https://www.palisadebio.com             USA  Biotechnology   \n",
       "661              https://www.biodexapharma.com  United Kingdom  Biotechnology   \n",
       "662                  https://www.sonnetbio.com             USA  Biotechnology   \n",
       "663                   https://www.cyclacel.com             USA  Biotechnology   \n",
       "664                   https://www.allarity.com             USA  Biotechnology   \n",
       "665                  https://www.cellectar.com             USA  Biotechnology   \n",
       "666                      https://jaguar.health             USA  Biotechnology   \n",
       "667                     https://windtreetx.com             USA  Biotechnology   \n",
       "668                https://www.tonixpharma.com             USA  Biotechnology   \n",
       "\n",
       "                                                                                                                                           BusinessSummary  \\\n",
       "0    Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the...   \n",
       "1    Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF...   \n",
       "2    United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medica...   \n",
       "3    Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncol...   \n",
       "4    Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ri...   \n",
       "5    Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. ...   \n",
       "6    argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, ...   \n",
       "7    BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develop...   \n",
       "8    Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare ...   \n",
       "9    Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabo...   \n",
       "10   Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in ...   \n",
       "11   Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders i...   \n",
       "12   BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is develop...   \n",
       "13   Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, an...   \n",
       "14   Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patient...   \n",
       "15   BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Euro...   \n",
       "16   Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics target...   \n",
       "17   Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine d...   \n",
       "18   Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a hum...   \n",
       "19   Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and...   \n",
       "20   BioMarin Pharmaceutical Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare disea...   \n",
       "21   Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable di...   \n",
       "22   Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United...   \n",
       "23   MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investi...   \n",
       "24   Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product can...   \n",
       "25   Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, ...   \n",
       "26   Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antib...   \n",
       "27   Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious im...   \n",
       "28   Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with ne...   \n",
       "29   Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular...   \n",
       "30   Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and...   \n",
       "31   Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with ...   \n",
       "32   Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. ...   \n",
       "33   Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. ...   \n",
       "34   Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rar...   \n",
       "35   Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, g...   \n",
       "36   CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularl...   \n",
       "37   Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of resp...   \n",
       "38   Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine ...   \n",
       "39   PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with ra...   \n",
       "40   Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment ...   \n",
       "41   Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/n...   \n",
       "42   Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company...   \n",
       "43   ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet...   \n",
       "44   Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic ...   \n",
       "45   Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) a...   \n",
       "46   Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers ...   \n",
       "47   Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of thera...   \n",
       "48   Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various d...   \n",
       "49   NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic...   \n",
       "50   IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, discovers and develops targeted therapeutics for pati...   \n",
       "51   Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infec...   \n",
       "52   Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead produc...   \n",
       "53   Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products primarily fo...   \n",
       "54   Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel th...   \n",
       "55   ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the ...   \n",
       "56   Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's l...   \n",
       "57   Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermati...   \n",
       "58   Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and in...   \n",
       "59   MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissue...   \n",
       "60   Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases c...   \n",
       "61   Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product c...   \n",
       "62   Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that pro...   \n",
       "63   Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, ...   \n",
       "64   Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The compa...   \n",
       "65   SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for un...   \n",
       "66   Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and infl...   \n",
       "67   Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in t...   \n",
       "68   Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's...   \n",
       "69   Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to h...   \n",
       "70   Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering disea...   \n",
       "71   Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious dis...   \n",
       "72   Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical n...   \n",
       "73   Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's...   \n",
       "74   ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercializa...   \n",
       "75   Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the func...   \n",
       "76   Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively d...   \n",
       "77   Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United State...   \n",
       "78   LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. ...   \n",
       "79   Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade diseas...   \n",
       "80   OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatm...   \n",
       "81   Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of ...   \n",
       "82   Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the...   \n",
       "83   Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candida...   \n",
       "84   BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company...   \n",
       "85   Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing ...   \n",
       "86   Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugat...   \n",
       "87   Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammatio...   \n",
       "88   Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of nov...   \n",
       "89   Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for g...   \n",
       "90   Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for ...   \n",
       "91   Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecu...   \n",
       "92   Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central ne...   \n",
       "93   uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III ...   \n",
       "94   Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products cand...   \n",
       "95   Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and d...   \n",
       "96   Telomir Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, is engaged in the advancement of age reversal science. The company is d...   \n",
       "97                                                                                                                                                     NaN   \n",
       "98   Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with ca...   \n",
       "99   Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company'...   \n",
       "100  BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat pa...   \n",
       "101  Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the Unit...   \n",
       "102  Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. T...   \n",
       "103  Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It deve...   \n",
       "104  Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-al...   \n",
       "105                                                                                                                                                    NaN   \n",
       "106  Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufactu...   \n",
       "107  Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The compan...   \n",
       "108  Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commerci...   \n",
       "109  Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders t...   \n",
       "110  CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. T...   \n",
       "111  Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamm...   \n",
       "112  Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders....   \n",
       "113  Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disor...   \n",
       "114  AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 ...   \n",
       "115  Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapie...   \n",
       "116  Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for p...   \n",
       "117  Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients ...   \n",
       "118  Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development i...   \n",
       "119  Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors ...   \n",
       "120  Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients wi...   \n",
       "121  Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, a...   \n",
       "122  ABIVAX Soci√©t√© Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mech...   \n",
       "123  Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-th...   \n",
       "124  Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PR...   \n",
       "125  Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to t...   \n",
       "126  Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The compan...   \n",
       "127  UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. I...   \n",
       "128  MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the...   \n",
       "129  CG Oncology, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing backbone bladder-sparing therapeutic...   \n",
       "130  Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipe...   \n",
       "131  Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies...   \n",
       "132  Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficera...   \n",
       "133  Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of mult...   \n",
       "134  Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse...   \n",
       "135  Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a ra...   \n",
       "136  Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healt...   \n",
       "137  Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company devel...   \n",
       "138  Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidat...   \n",
       "139  CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment o...   \n",
       "140  Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infe...   \n",
       "141  Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and ga...   \n",
       "142  Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases an...   \n",
       "143  Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients. Its therapeutics include antibodies an...   \n",
       "144  Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial...   \n",
       "145  Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kid...   \n",
       "146  Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists o...   \n",
       "147  Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses ...   \n",
       "148  Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The c...   \n",
       "149  Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. I...   \n",
       "150  Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device develo...   \n",
       "151  Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment o...   \n",
       "152  Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical ne...   \n",
       "153  enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines thro...   \n",
       "154  Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United ...   \n",
       "155  Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsyc...   \n",
       "156  INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease...   \n",
       "157  Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include...   \n",
       "158  Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its ...   \n",
       "159  Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases i...   \n",
       "160  Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology ...   \n",
       "161  Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its pr...   \n",
       "162  Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's...   \n",
       "163  Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and ...   \n",
       "164  CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of inf...   \n",
       "165  Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysre...   \n",
       "166  Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Bunt...   \n",
       "167  Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the Unite...   \n",
       "168  Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with gen...   \n",
       "169  Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatm...   \n",
       "170  Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical devel...   \n",
       "171  PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The comp...   \n",
       "172  Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the ...   \n",
       "173  Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid h...   \n",
       "174  ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and b...   \n",
       "175  Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acu...   \n",
       "176  Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator pro...   \n",
       "177  Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a form...   \n",
       "178  Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene thera...   \n",
       "179  Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, whic...   \n",
       "180  Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products in...   \n",
       "181  Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and ...   \n",
       "182  Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-b...   \n",
       "183  Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medic...   \n",
       "184  ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a need...   \n",
       "185  Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases i...   \n",
       "186  CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunol...   \n",
       "187  Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treat...   \n",
       "188  Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Ne...   \n",
       "189  MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechan...   \n",
       "190  Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United ...   \n",
       "191  Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Eu...   \n",
       "192  Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are...   \n",
       "193  Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of dise...   \n",
       "194  Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel ...   \n",
       "195  NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in ch...   \n",
       "196  CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs...   \n",
       "197  MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company de...   \n",
       "198  Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for...   \n",
       "199  GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurol...   \n",
       "200  Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therap...   \n",
       "201  Cullinan Therapeutics, Inc., a biopharmaceutical company, focuses on developing oncology therapies for cancer patients in the United States. The c...   \n",
       "202  OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States....   \n",
       "203  Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patient...   \n",
       "204  Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeuti...   \n",
       "205  89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver ...   \n",
       "206  Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramosti...   \n",
       "207  Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology,...   \n",
       "208  PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe...   \n",
       "209  Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet me...   \n",
       "210  Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that...   \n",
       "211  Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical ...   \n",
       "212  Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to...   \n",
       "213  Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver...   \n",
       "214  XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases...   \n",
       "215  Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs...   \n",
       "216  Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs where an or...   \n",
       "217  Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonu...   \n",
       "218  ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of can...   \n",
       "219  Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious d...   \n",
       "220  Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The ...   \n",
       "221  Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops...   \n",
       "222  Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United ...   \n",
       "223  Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetr...   \n",
       "224  Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of o...   \n",
       "225  Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha...   \n",
       "226  Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to trea...   \n",
       "227  Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory ...   \n",
       "228  Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthet...   \n",
       "229  Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment ...   \n",
       "230  IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmu...   \n",
       "231  Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with ge...   \n",
       "232  OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and o...   \n",
       "233  Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically...   \n",
       "234  Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients ...   \n",
       "235  Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders ...   \n",
       "236  Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncolog...   \n",
       "237  Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the t...   \n",
       "238  Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76...   \n",
       "239  REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the...   \n",
       "240  TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatme...   \n",
       "241  Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to t...   \n",
       "242  Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's le...   \n",
       "243  Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for disea...   \n",
       "244  Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States....   \n",
       "245  Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, t...   \n",
       "246  Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead c...   \n",
       "247  2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the U...   \n",
       "248  Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline ...   \n",
       "249  Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic late...   \n",
       "250  scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead pr...   \n",
       "251  Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological i...   \n",
       "252  NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from...   \n",
       "253  Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commer...   \n",
       "254  Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gen...   \n",
       "255  Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the ...   \n",
       "256  Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acut...   \n",
       "257  Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical need...   \n",
       "258  Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health condi...   \n",
       "259  ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products ...   \n",
       "260  Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the Unite...   \n",
       "261  Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel va...   \n",
       "262  AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention an...   \n",
       "263  Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology...   \n",
       "264  Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking t...   \n",
       "265  Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. Its product pipeline comprising ALTO-100, whi...   \n",
       "266  Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product ca...   \n",
       "267  Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-a...   \n",
       "268  Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel or...   \n",
       "269  LIXTE Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company, focuses on identifying targets for cancer drug development, and devel...   \n",
       "270  Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transfo...   \n",
       "271  Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develop...   \n",
       "272  Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO,...   \n",
       "273  Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovas...   \n",
       "274  Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in...   \n",
       "275  ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic ki...   \n",
       "276  RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeuti...   \n",
       "277  Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer,...   \n",
       "278  MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases w...   \n",
       "279  Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vascu...   \n",
       "280  Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified...   \n",
       "281  Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-relat...   \n",
       "282  C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for t...   \n",
       "283  Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to trea...   \n",
       "284  Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combine...   \n",
       "285  Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system d...   \n",
       "286  Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody ...   \n",
       "287  Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the ...   \n",
       "288  Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an ...   \n",
       "289  Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers G...   \n",
       "290  Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for ...   \n",
       "291  4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platf...   \n",
       "292  Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio cons...   \n",
       "293  Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company dev...   \n",
       "294  InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States....   \n",
       "295  Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases ...   \n",
       "296  Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline p...   \n",
       "297  Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various ...   \n",
       "298  Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and a...   \n",
       "299  Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet nee...   \n",
       "300  Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and M...   \n",
       "301  Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, ph...   \n",
       "302  Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs...   \n",
       "303  Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS...   \n",
       "304  Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmun...   \n",
       "305  Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product ca...   \n",
       "306  MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tis...   \n",
       "307  Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidate...   \n",
       "308  TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treat...   \n",
       "309  Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through t...   \n",
       "310  Sutro Biopharma, Inc. operates as a clinical-stage oncology company. The company develops site-specific and novel-format antibody drug conjugates ...   \n",
       "311  Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies...   \n",
       "312  Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United State...   \n",
       "313  Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of p...   \n",
       "314  Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an i...   \n",
       "315  ImmunoPrecise Antibodies Ltd., a biotechnology company, leverages multi-omics modeling and artificial intelligence through a series proprietary an...   \n",
       "316  Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. I...   \n",
       "317  Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for ...   \n",
       "318  DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases ...   \n",
       "319  Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, ...   \n",
       "320  MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the Unit...   \n",
       "321  Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of cancer treatments primarily...   \n",
       "322  FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for ...   \n",
       "323  Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (AD...   \n",
       "324  Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the Unite...   \n",
       "325  Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates again...   \n",
       "326  Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to all...   \n",
       "327  Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies...   \n",
       "328  Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The com...   \n",
       "329  Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for t...   \n",
       "330  Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various...   \n",
       "331  Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against ...   \n",
       "332  KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug ther...   \n",
       "333  Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmona...   \n",
       "334  Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products includ...   \n",
       "335  Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammator...   \n",
       "336  Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead an...   \n",
       "337  HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It deve...   \n",
       "338  Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment...   \n",
       "339  Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. Th...   \n",
       "340  Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for ...   \n",
       "341  Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune disease...   \n",
       "342  Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowe...   \n",
       "343  Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-4...   \n",
       "344  BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The...   \n",
       "345  Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patient...   \n",
       "346  Immutep Limited, a late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases ...   \n",
       "347  Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for...   \n",
       "348  Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its ...   \n",
       "349  MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine ...   \n",
       "350  AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious dis...   \n",
       "351  Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical n...   \n",
       "352  LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platf...   \n",
       "353  Moolec Science SA, a science-based food ingredient company, focuses on developing ingredients for food, pet food, animal feed, and dietary supplem...   \n",
       "354  NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, alloge...   \n",
       "355  CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized ...   \n",
       "356  Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the...   \n",
       "357  Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies a...   \n",
       "358  ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to ...   \n",
       "359  Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modul...   \n",
       "360  I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics in the fields of immuno-oncology and immuno-i...   \n",
       "361  Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious...   \n",
       "362  DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products....   \n",
       "363  Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for pati...   \n",
       "364  Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therap...   \n",
       "365  Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commerci...   \n",
       "366  AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA)...   \n",
       "367  Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious disease...   \n",
       "368  Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltr...   \n",
       "369  RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of ...   \n",
       "370  Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, ad...   \n",
       "371  Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancer...   \n",
       "372  Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing R...   \n",
       "373  Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for ...   \n",
       "374  Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of ...   \n",
       "375  Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infecti...   \n",
       "376  Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead p...   \n",
       "377  OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target...   \n",
       "378  Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue ...   \n",
       "379  Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in development of novel T cell immunotherapeutic candidates des...   \n",
       "380  ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for...   \n",
       "381                                                                                                                                                    NaN   \n",
       "382  Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debil...   \n",
       "383  Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology ther...   \n",
       "384  Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigeneti...   \n",
       "385  Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cel...   \n",
       "386  Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutatio...   \n",
       "387  Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the Unite...   \n",
       "388  Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its l...   \n",
       "389  Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synth...   \n",
       "390  HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade...   \n",
       "391  CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It i...   \n",
       "392  Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its ...   \n",
       "393  Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of so...   \n",
       "394  Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs an...   \n",
       "395  Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuro...   \n",
       "396  NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other ...   \n",
       "397  Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engine...   \n",
       "398  Century Therapeutics, Inc., a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatm...   \n",
       "399  GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor...   \n",
       "400  Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmona...   \n",
       "401  IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology...   \n",
       "402  Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growt...   \n",
       "403  MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, o...   \n",
       "404  Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular...   \n",
       "405  Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflam...   \n",
       "406  Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune dise...   \n",
       "407  ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. Th...   \n",
       "408  Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and v...   \n",
       "409  Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved cond...   \n",
       "410  AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune respons...   \n",
       "411  Zevra Therapeutics, Inc. discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company...   \n",
       "412  Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid...   \n",
       "413  BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid ...   \n",
       "414  Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252,...   \n",
       "415  Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates fo...   \n",
       "416  Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimm...   \n",
       "417  Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteog...   \n",
       "418  Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. T...   \n",
       "419  Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear ex...   \n",
       "420  Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases in the Un...   \n",
       "421  Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics....   \n",
       "422  Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen...   \n",
       "423  NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral inf...   \n",
       "424  PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies f...   \n",
       "425  Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell thera...   \n",
       "426  Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a ...   \n",
       "427  SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies...   \n",
       "428  Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops T cell reprogramming technologies for patients with solid tumors. The co...   \n",
       "429  Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoim...   \n",
       "430  Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics t...   \n",
       "431  Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Ge...   \n",
       "432  Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candi...   \n",
       "433  Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics ...   \n",
       "434  BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop trans...   \n",
       "435  Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic ...   \n",
       "436  Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system dis...   \n",
       "437  Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United...   \n",
       "438  Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and othe...   \n",
       "439  Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers ...   \n",
       "440  Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders i...   \n",
       "441  Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe ...   \n",
       "442  vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and ...   \n",
       "443  Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow ne...   \n",
       "444  Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1...   \n",
       "445  Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the ...   \n",
       "446  Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cell...   \n",
       "447  Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeut...   \n",
       "448  Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candid...   \n",
       "449  Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic disea...   \n",
       "450  Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer ...   \n",
       "451  PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular th...   \n",
       "452  Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer. Its l...   \n",
       "453  Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patien...   \n",
       "454  Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of ...   \n",
       "455  Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeut...   \n",
       "456  Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United...   \n",
       "457  Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment ...   \n",
       "458  IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell thera...   \n",
       "459  Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life...   \n",
       "460  Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technolo...   \n",
       "461  Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people wh...   \n",
       "462  GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the U...   \n",
       "463  Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel)...   \n",
       "464  BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanc...   \n",
       "465  LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vac...   \n",
       "466  Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based soluti...   \n",
       "467  60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the preven...   \n",
       "468  Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the Unit...   \n",
       "469  Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used ...   \n",
       "470  Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The compan...   \n",
       "471  Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of c...   \n",
       "472  Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The...   \n",
       "473  Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous s...   \n",
       "474  Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatme...   \n",
       "475  Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chroni...   \n",
       "476  Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candi...   \n",
       "477  Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate a...   \n",
       "478  EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the ...   \n",
       "479  ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. T...   \n",
       "480  bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the U...   \n",
       "481  Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. It is developing cell therapy platfo...   \n",
       "482  Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T ...   \n",
       "483  Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It devel...   \n",
       "484  Seres Therapeutics, Inc., a microbiome therapeutics company, develop microbiome therapeutics to treat the modulation of the colonic microbiome. It...   \n",
       "485  Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the t...   \n",
       "486  NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and...   \n",
       "487  Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer....   \n",
       "488  Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathway...   \n",
       "489  HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on it...   \n",
       "490  FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead p...   \n",
       "491  Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer ...   \n",
       "492  aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the U...   \n",
       "493  Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead...   \n",
       "494  Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally admini...   \n",
       "495  Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related d...   \n",
       "496  ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded prote...   \n",
       "497  NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system di...   \n",
       "498  Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic ...   \n",
       "499  Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human ti...   \n",
       "500  Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The co...   \n",
       "501  Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for ...   \n",
       "502  Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops...   \n",
       "503  Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune...   \n",
       "504  Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or preventio...   \n",
       "505  Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fi...   \n",
       "506  Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination,...   \n",
       "507  Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and del...   \n",
       "508  Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in th...   \n",
       "509  Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, a...   \n",
       "510  Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflamma...   \n",
       "511  Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nano...   \n",
       "512  Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeli...   \n",
       "513  Virax Biolabs Group Limited, a biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnos...   \n",
       "514  Eyenovia, Inc., a commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therape...   \n",
       "515  Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune...   \n",
       "516  PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United ...   \n",
       "517  Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada a...   \n",
       "518  Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical n...   \n",
       "519  Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients sufferi...   \n",
       "520  Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases a...   \n",
       "521  SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vita...   \n",
       "522  Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parki...   \n",
       "523  X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel th...   \n",
       "524  Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based ca...   \n",
       "525  Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipel...   \n",
       "526  Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR...   \n",
       "527  IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is...   \n",
       "528  Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus...   \n",
       "529  Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products ...   \n",
       "530  Kazia Therapeutics Limited operates as an oncology-focused biotechnology company. The company's lead development candidate is Paxalisib, a small m...   \n",
       "531  Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of ...   \n",
       "532  KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies fo...   \n",
       "533  BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and k...   \n",
       "534  Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies for hard to treat cancers. The company's...   \n",
       "535  Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical product...   \n",
       "536  Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technol...   \n",
       "537  Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The c...   \n",
       "538  Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies f...   \n",
       "539  Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous sy...   \n",
       "540  Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer pat...   \n",
       "541  Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti...   \n",
       "542  CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatme...   \n",
       "543  Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vacci...   \n",
       "544  Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associate...   \n",
       "545  Aptorum Group Limited, through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development...   \n",
       "546  XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights...   \n",
       "547  Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses vari...   \n",
       "548  PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its ...   \n",
       "549  BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. It...   \n",
       "550  Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperact...   \n",
       "551  Dar√© Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develop...   \n",
       "552  Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, ...   \n",
       "553  Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. ...   \n",
       "554  Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Em...   \n",
       "555  Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of ph...   \n",
       "556  Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and ...   \n",
       "557  GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based...   \n",
       "558  XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment ...   \n",
       "559  NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProT...   \n",
       "560  Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to tre...   \n",
       "561  Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherape...   \n",
       "562  XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat prog...   \n",
       "563  BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company...   \n",
       "564  Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing t...   \n",
       "565  Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat ...   \n",
       "566  Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for t...   \n",
       "567  Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug can...   \n",
       "568  Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and a...   \n",
       "569  SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-1...   \n",
       "570  Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodie...   \n",
       "571  Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or c...   \n",
       "572  Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeu...   \n",
       "573  Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinic...   \n",
       "574  Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-di...   \n",
       "575  Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. It...   \n",
       "576  Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other...   \n",
       "577  Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the trea...   \n",
       "578  CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Repu...   \n",
       "579  Skye Bioscience, Inc., a biopharmaceutical company, focuses on unlocking new therapeutic pathways for metabolic health through the development of ...   \n",
       "580  Vistagen Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurol...   \n",
       "581  Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncolog...   \n",
       "582  Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respira...   \n",
       "583  Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neur...   \n",
       "584  Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depres...   \n",
       "585  Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potent...   \n",
       "586  Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women...   \n",
       "587  VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno...   \n",
       "588  Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies an...   \n",
       "589  InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It o...   \n",
       "590  Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead...   \n",
       "591  Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 L...   \n",
       "592  Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment ...   \n",
       "593  Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical produ...   \n",
       "594  Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell ther...   \n",
       "595  Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory dise...   \n",
       "596  Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative an...   \n",
       "597  Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The...   \n",
       "598  180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, infla...   \n",
       "599  TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patent...   \n",
       "600  Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulatio...   \n",
       "601  iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer,...   \n",
       "602  Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-me...   \n",
       "603  Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of canc...   \n",
       "604  Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organi...   \n",
       "605  MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develop...   \n",
       "606  Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in...   \n",
       "607  ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflam...   \n",
       "608  Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of im...   \n",
       "609  CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of...   \n",
       "610  Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of ...   \n",
       "611  Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United Sta...   \n",
       "612  Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. ...   \n",
       "613  AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral d...   \n",
       "614                                                                                                                                                    NaN   \n",
       "615  Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-bas...   \n",
       "616  Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opi...   \n",
       "617  Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for ...   \n",
       "618  Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in o...   \n",
       "619  TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identi...   \n",
       "620  Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the ...   \n",
       "621  Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious di...   \n",
       "622  BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary ...   \n",
       "623  Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the t...   \n",
       "624  Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic pr...   \n",
       "625  MetaVia Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic dise...   \n",
       "626  GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases ...   \n",
       "627  Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming an...   \n",
       "628  Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therap...   \n",
       "629  Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and intern...   \n",
       "630  Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that ...   \n",
       "631  Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for ...   \n",
       "632  Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its ...   \n",
       "633  Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertens...   \n",
       "634  TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of...   \n",
       "635  Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine...   \n",
       "636  CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain...   \n",
       "637  Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative the...   \n",
       "638  BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem ...   \n",
       "639  Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the U...   \n",
       "640  Dominari Holdings Inc., through its subsidiaries, is engaged in wealth management, investment banking, sales and trading, and asset management. It...   \n",
       "641  Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology an...   \n",
       "642  Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and p...   \n",
       "643  NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray...   \n",
       "644  Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibi...   \n",
       "645  COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Can...   \n",
       "646  Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral...   \n",
       "647                                                                                                                                                    NaN   \n",
       "648  Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for t...   \n",
       "649  SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for ...   \n",
       "650  Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead cli...   \n",
       "651  TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogene...   \n",
       "652  Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immuno...   \n",
       "653  Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for...   \n",
       "654  Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United S...   \n",
       "655  ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United ...   \n",
       "656  Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an I...   \n",
       "657  Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and suppli...   \n",
       "658  Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monit...   \n",
       "659  CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its l...   \n",
       "660  Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the in...   \n",
       "661  Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 ...   \n",
       "662  Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The compa...   \n",
       "663  Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative...   \n",
       "664  Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion...   \n",
       "665  Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the t...   \n",
       "666  Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals w...   \n",
       "667  Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular disease...   \n",
       "668  Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics ...   \n",
       "\n",
       "       ipo_price  Price     Fall   days      RoK term profit  animal  \n",
       "0           0.09  75.69 82131.76  13095     2.55  Old  Alive   Mamut  \n",
       "1           4.50 463.73 10205.11  12200     3.69  Old  Alive   Mamut  \n",
       "2           6.09 361.81  5837.39   9315     8.48  Old  Alive   Mamut  \n",
       "3           1.88  68.55  3556.00  11366     0.60  Old  Alive   Mamut  \n",
       "4           7.00 245.44  3406.29   7504    -0.42  Old  Alive   Mamut  \n",
       "5          21.12 731.30  3361.78  12313     5.77  Old  Alive   Mamut  \n",
       "6          23.00 607.21  2540.02   2770    -0.40  Old  Alive   Mamut  \n",
       "7           0.29   6.15  2020.69   1439    -6.77  New  Alive  Gacela  \n",
       "8          10.64 163.64  1437.97   2645     1.43  Old  Alive   Mamut  \n",
       "9           1.50  17.32  1054.67   4422   -15.67  Old  Alive   Mamut  \n",
       "10          4.25  48.00  1029.41   7581     9.05  Old  Alive   Mamut  \n",
       "11          8.74  90.10   930.89   3316    -5.63  Old  Alive   Mamut  \n",
       "12         14.05 120.38   756.56   1895    -1.00  Old  Alive   Mamut  \n",
       "13         17.73 123.04   593.97   6409    20.06  Old  Alive   Mamut  \n",
       "14         18.83 129.87   589.70   3611    -4.25  Old  Alive   Mamut  \n",
       "15         28.32 179.35   533.30   3240   -28.15  Old  Alive   Mamut  \n",
       "16         10.59  62.34   488.67    963    -1.81  New  Alive   Mamut  \n",
       "17          8.00  47.03   487.87   3521     0.00  Old  Alive   Mamut  \n",
       "18          3.77  20.17   434.73   5678    53.42  Old  Alive   Mamut  \n",
       "19          7.30  38.47   426.99    816   -20.08  New  Alive   Mamut  \n",
       "20         13.00  66.01   407.77   9276     3.41  Old  Alive   Mamut  \n",
       "21         16.80  83.80   398.81   1047    -1.45  New  Alive   Mamut  \n",
       "22         18.87  93.19   393.85   3519    -4.33  Old  Alive   Mamut  \n",
       "23         10.49  51.34   389.42   1519    -3.25  Old  Alive   Mamut  \n",
       "24         18.75  86.86   363.25   1237     0.00  New  Alive   Mamut  \n",
       "25         12.23  55.40   352.98   7552     2.48  Old  Alive   Mamut  \n",
       "26         10.04  42.83   326.59   3134    -7.80  Old  Alive   Mamut  \n",
       "27         11.50  44.05   283.04   1313     0.00  New  Alive   Mamut  \n",
       "28         10.50  40.05   281.43   3695    -7.42  Old  Alive   Mamut  \n",
       "29         10.00  36.61   266.10  12268    -5.59  Old  Alive   Mamut  \n",
       "30         11.70  41.08   251.11   3050     6.07  Old  Alive   Mamut  \n",
       "31          6.10  21.38   250.49   6614     8.19  Old  Alive   Mamut  \n",
       "32         34.38 116.91   240.08  11717     2.28  Old  Alive   Mamut  \n",
       "33         26.15  87.72   235.45   1649    -5.37  Old  Alive   Mamut  \n",
       "34         13.21  42.44   221.27   1979    -3.58  Old  Alive   Mamut  \n",
       "35         39.00 123.71   217.21  10058     0.99  Old  Alive   Mamut  \n",
       "36         14.09  43.78   210.72   2981    -8.29  Old  Alive   Mamut  \n",
       "37         13.50  41.42   206.81   2790    -4.30  Old  Alive   Mamut  \n",
       "38          8.34  24.03   188.13   4032   -11.80  Old  Alive   Mamut  \n",
       "39         16.49  46.37   181.20   4198     0.58  Old  Alive   Mamut  \n",
       "40         15.00  41.98   179.87   2398    -5.69  Old  Alive   Mamut  \n",
       "41          5.00  13.51   170.20   1544    -6.21  Old  Alive  Gacela  \n",
       "42          9.95  26.28   164.12   2006    -8.68  Old  Alive   Mamut  \n",
       "43          6.70  17.26   157.61   7509     4.32  Old  Alive   Mamut  \n",
       "44         20.58  52.50   155.10   1523    -7.05  Old  Alive   Mamut  \n",
       "45         25.15  61.11   142.98   1285    -2.32  New  Alive   Mamut  \n",
       "46         14.75  35.03   137.49   9010     6.17  Old  Alive   Mamut  \n",
       "47         14.03  33.19   136.56   2595    -5.29  Old  Alive   Mamut  \n",
       "48          4.00   9.37   134.25   3758     0.04  Old  Alive   Mamut  \n",
       "49         10.61  24.69   132.66   1407    -6.96  New  Alive   Mamut  \n",
       "50         11.19  25.19   125.11   2035    -9.87  Old  Alive   Mamut  \n",
       "51         18.60  41.83   124.89   2202   -14.67  Old  Alive   Mamut  \n",
       "52         24.57  55.24   124.83   2626    -7.77  Old  Alive   Mamut  \n",
       "53          5.49  12.21   122.40     14     0.00  New  Alive  Gacela  \n",
       "54         24.51  53.66   118.93   2344    -6.01  Old  Alive   Mamut  \n",
       "55          8.55  18.59   117.43   4079     2.81  Old  Alive   Mamut  \n",
       "56          3.38   7.16   112.15   2954     0.00  Old  Alive  Gacela  \n",
       "57         21.23  44.50   109.61    522     0.00  New  Alive   Mamut  \n",
       "58          0.80   1.63   103.75   6180     0.00  Old  Alive  Gacela  \n",
       "59          4.64   9.16    97.55   6153     4.85  Old  Alive   Mamut  \n",
       "60          7.20  12.79    77.64   4382   -24.65  Old  Alive   Mamut  \n",
       "61          9.70  17.09    76.19   1309    -9.48  New  Alive   Mamut  \n",
       "62          8.65  15.17    75.38     34    -3.16  New  Alive  Gacela  \n",
       "63         10.19  17.83    74.98   3575    -1.32  Old  Alive   Mamut  \n",
       "64         15.37  26.82    74.50   4677    -7.67  Old  Alive   Mamut  \n",
       "65         22.63  38.30    69.24   1922   -10.34  Old  Alive   Mamut  \n",
       "66         14.52  23.81    63.98   2371   -11.64  Old  Alive   Mamut  \n",
       "67         18.32  28.89    57.70   2007   -13.20  Old  Alive   Mamut  \n",
       "68         28.90  45.01    55.74   1769    -7.52  Old  Alive   Mamut  \n",
       "69         15.00  23.15    54.33   1741    -8.58  Old  Alive   Mamut  \n",
       "70         27.00  41.00    51.85   1366     0.00  New  Alive  Gacela  \n",
       "71         18.75  27.93    48.96   1776    -6.71  Old  Alive   Mamut  \n",
       "72          3.25   4.70    44.62   1047     0.00  New  Alive  Gacela  \n",
       "73         13.59  18.58    36.75   7378    19.18  Old  Alive   Mamut  \n",
       "74         20.00  26.72    33.60    326     0.00  New  Alive   Mamut  \n",
       "75          4.57   5.89    28.88    719   -11.75  New  Alive  Gacela  \n",
       "76         33.26  42.13    26.67   1579    -6.83  Old  Alive   Mamut  \n",
       "77         31.28  38.97    24.58   4164   -16.48  Old  Alive   Mamut  \n",
       "78         25.13  30.97    23.24   1271    -8.06  New  Alive   Mamut  \n",
       "79         16.05  19.50    21.50   2273   -27.02  Old  Alive   Mamut  \n",
       "80          2.51   3.02    20.32    138    -4.30  New  Alive  Gacela  \n",
       "81         26.00  31.25    20.19    683    -6.86  New  Alive   Mamut  \n",
       "82          2.95   3.44    16.71    256   -25.93  New  Alive  Gacela  \n",
       "83         12.00  13.93    16.08   3212   -27.29  Old  Alive   Mamut  \n",
       "84          6.50   7.53    15.85  11246    -2.07  Old  Alive   Mamut  \n",
       "85         12.00  13.81    15.08   2035   -18.13  Old  Alive   Mamut  \n",
       "86         28.50  32.49    14.00   1649    -8.08  Old  Alive   Mamut  \n",
       "87         10.40  11.84    13.85   1470   -13.62  New  Alive   Mamut  \n",
       "88         42.25  45.78     8.36   3973   -11.95  Old  Alive   Mamut  \n",
       "89         23.90  25.73     7.66   1552   -11.78  Old  Alive   Mamut  \n",
       "90         21.45  22.97     7.09   2566   -15.27  Old  Alive   Mamut  \n",
       "91         19.01  20.27     6.63   1607   -12.65  Old  Alive   Mamut  \n",
       "92          8.00   8.46     5.75   6712     0.00  Old  Alive   Mamut  \n",
       "93         14.61  15.40     5.41   3968   -22.32  Old  Alive   Mamut  \n",
       "94         21.40  22.39     4.63     53    -6.00  New  Alive   Mamut  \n",
       "95         15.15  15.76     4.03     33     1.38  New  Alive   Mamut  \n",
       "96          5.00   5.20     4.00    312     0.00  New  Alive  Gacela  \n",
       "97          2.65   2.75     3.77     33     0.00  New  Alive  Gacela  \n",
       "98          3.52   3.64     3.41    389  -286.93  New  Alive   Mamut  \n",
       "99          8.61   8.62     0.12    126     0.00  New  Alive  Gacela  \n",
       "100        27.55  27.49    -0.22   2000    -9.74  Old  Alive   Mamut  \n",
       "101        11.10  10.92    -1.62   2336   -10.27  Old  Alive   Mamut  \n",
       "102        13.00  12.58    -3.23   2790   -12.09  Old  Alive   Mamut  \n",
       "103         7.00   6.75    -3.57   1239   -17.34  New  Alive  Gacela  \n",
       "104       318.15 304.50    -4.29   6524    -8.07  Old  Alive   Mamut  \n",
       "105         5.70   5.42    -4.91     35     0.00  New  Alive  Gacela  \n",
       "106        37.00  35.12    -5.08   1656    -5.62  Old  Alive   Mamut  \n",
       "107        17.00  16.08    -5.41   2469   -19.06  Old  Alive   Mamut  \n",
       "108        27.93  26.33    -5.73   2645   -11.48  Old  Alive   Mamut  \n",
       "109        20.08  18.83    -6.23   1714   -25.79  Old  Alive   Mamut  \n",
       "110        14.69  13.74    -6.47    400   -25.44  New  Alive   Mamut  \n",
       "111        13.45  12.58    -6.47   1537   -14.22  Old  Alive   Mamut  \n",
       "112        30.00  27.62    -7.93   1362    -4.69  New  Alive   Mamut  \n",
       "113        22.00  20.25    -7.95     67    -6.45  New  Alive   Mamut  \n",
       "114        17.00  15.59    -8.29   2882   -27.52  Old  Alive   Mamut  \n",
       "115        15.40  14.03    -8.90    256   -12.30  New  Alive  Gacela  \n",
       "116        20.80  18.77    -9.76    193   -10.86  New  Alive   Mamut  \n",
       "117        12.00  10.62   -11.50    151   -23.19  New   Dead  Gacela  \n",
       "118         7.20   6.33   -12.08   6528    -1.38  Old   Dead   Mamut  \n",
       "119        14.29  12.52   -12.39   2645   -18.30  Old   Dead  Gacela  \n",
       "120        37.01  32.39   -12.48   1581    10.58  Old   Dead   Mamut  \n",
       "121         8.73   7.63   -12.60   5549   -39.22  Old   Dead   Mamut  \n",
       "122         8.30   7.11   -14.34    424   -33.95  New   Dead  Gacela  \n",
       "123        17.21  14.62   -15.05    196  -142.78  New   Dead   Mamut  \n",
       "124        16.00  13.44   -16.00   3324    -7.21  Old   Dead   Mamut  \n",
       "125        10.16   8.47   -16.63   2266   -45.11  Old   Dead   Mamut  \n",
       "126        15.16  12.55   -17.22   2342   -23.61  Old   Dead   Mamut  \n",
       "127        13.98  11.35   -18.81   2784   -17.46  Old   Dead   Mamut  \n",
       "128        23.65  18.94   -19.92     95    -9.28  New   Dead   Mamut  \n",
       "129        37.17  28.76   -22.63    327    -4.86  New   Dead   Mamut  \n",
       "130        21.75  16.57   -23.82   1299    -7.30  New   Dead   Mamut  \n",
       "131         9.60   7.21   -24.90   2197   -10.77  Old   Dead   Mamut  \n",
       "132        23.41  17.50   -25.25     95    -7.32  New   Dead   Mamut  \n",
       "133        23.95  17.66   -26.26   1145     9.10  New   Dead   Mamut  \n",
       "134         5.74   4.14   -27.84   1173   -11.05  New   Dead  Gacela  \n",
       "135        10.72   7.63   -28.82     67   -38.70  New   Dead  Gacela  \n",
       "136         2.68   1.89   -29.48     92   -10.57  New   Dead  Gacela  \n",
       "137        10.05   6.88   -31.54    410   -34.78  New   Dead  Gacela  \n",
       "138         7.20   4.90   -31.94   3882   -16.39  Old   Dead  Gacela  \n",
       "139         4.00   2.72   -32.10    613   -10.20  New   Dead  Gacela  \n",
       "140        43.20  28.91   -33.08   1411    -4.42  New   Dead   Mamut  \n",
       "141        17.00  11.26   -33.76    825   -10.54  New   Dead  Gacela  \n",
       "142        13.15   8.69   -33.92   3798    -7.84  Old   Dead   Mamut  \n",
       "143         2.60   1.70   -34.62     92    -8.09  New   Dead  Gacela  \n",
       "144        14.43   9.36   -35.14   6410     0.78  Old   Dead   Mamut  \n",
       "145        18.44  11.90   -35.47    676     0.00  New   Dead   Mamut  \n",
       "146        15.00   9.63   -35.80   3380   -27.93  Old   Dead   Mamut  \n",
       "147         1.55   0.99   -36.06     49   -15.51  New   Dead  Gacela  \n",
       "148        29.00  18.40   -36.55   1411   -11.57  New   Dead   Mamut  \n",
       "149        13.30   8.39   -36.92    172   -51.21  New   Dead   Mamut  \n",
       "150        32.00  20.00   -37.50    546     1.49  New   Dead   Mamut  \n",
       "151        21.30  13.30   -37.56   1658   -26.34  Old   Dead   Mamut  \n",
       "152        15.35   9.51   -38.05   1621    -6.15  Old   Dead   Mamut  \n",
       "153         9.86   6.08   -38.34   1050   -17.13  New   Dead  Gacela  \n",
       "154        40.35  24.84   -38.43   1645     0.00  Old   Dead   Mamut  \n",
       "155        17.00  10.32   -39.29    460   -14.24  New   Dead   Mamut  \n",
       "156         7.99   4.75   -40.55   2143     0.00  Old   Dead  Gacela  \n",
       "157        22.10  12.90   -41.63   3147   -38.71  Old   Dead   Mamut  \n",
       "158        21.80  12.69   -41.79   1782   -11.30  Old   Dead   Mamut  \n",
       "159         6.50   3.74   -42.46   2064    -7.00  Old   Dead  Gacela  \n",
       "160        26.00  14.94   -42.54   1189   -13.07  New   Dead   Mamut  \n",
       "161        20.50  11.76   -42.63   5445    -4.06  Old   Dead   Mamut  \n",
       "162        14.80   8.41   -43.18   1145   -20.68  New   Dead  Gacela  \n",
       "163         1.67   0.94   -43.74   2219   -16.36  Old   Dead  Gacela  \n",
       "164        15.00   8.38   -44.13   5332   -10.07  Old   Dead  Gacela  \n",
       "165         3.67   2.04   -44.41   1097   -37.62  New   Dead  Gacela  \n",
       "166         9.59   5.31   -44.63   1784     0.00  Old   Dead  Gacela  \n",
       "167         6.30   3.48   -44.76   6354   -11.47  Old   Dead   Mamut  \n",
       "168        23.50  12.75   -45.74   1300   -16.15  New   Dead   Mamut  \n",
       "169        16.70   8.98   -46.22   1455    -0.50  New   Dead   Mamut  \n",
       "170        14.02   7.45   -46.86   1894   -51.28  Old   Dead   Mamut  \n",
       "171        38.50  20.35   -47.14   1492   -25.41  New   Dead  Gacela  \n",
       "172         7.89   4.17   -47.15   2051   -14.75  Old   Dead  Gacela  \n",
       "173         7.33   3.86   -47.30  10366    -9.01  Old   Dead   Mamut  \n",
       "174         9.38   4.92   -47.52  13741    -1.51  Old   Dead  Gacela  \n",
       "175         1.38   0.72   -47.77   9441   -56.57  Old   Dead   Mamut  \n",
       "176        14.25   7.38   -48.21   3191    -5.25  Old   Dead  Gacela  \n",
       "177        12.00   6.05   -49.58   2650     0.00  Old   Dead  Gacela  \n",
       "178        24.00  12.02   -49.92   3590   -21.18  Old   Dead   Mamut  \n",
       "179         4.48   2.24   -50.00   1435   -12.02  New   Dead  Gacela  \n",
       "180         6.05   3.02   -50.08   1888   -18.33  Old   Dead   Mamut  \n",
       "181        97.56  48.65   -50.13   7536    -8.84  Old   Dead   Mamut  \n",
       "182        18.15   8.92   -50.85     95   -36.26  New   Dead  Gacela  \n",
       "183         9.68   4.61   -52.38   6824   -11.17  Old   Dead   Mamut  \n",
       "184        25.00  11.90   -52.40   1474    -5.23  New   Dead   Mamut  \n",
       "185        25.57  12.06   -52.84   2008   -17.74  Old   Dead   Mamut  \n",
       "186         5.84   2.73   -53.25    552   -56.47  New   Dead  Gacela  \n",
       "187        11.00   5.13   -53.36   1098    -9.71  New   Dead  Gacela  \n",
       "188        11.40   5.26   -53.86   1596   -30.91  Old   Dead  Gacela  \n",
       "189         4.46   2.00   -55.16    873     0.00  New   Dead  Gacela  \n",
       "190       165.00  71.63   -56.59   8965    -5.29  Old   Dead   Mamut  \n",
       "191        22.96   9.88   -56.97   3868    -7.94  Old   Dead  Gacela  \n",
       "192        16.64   7.06   -57.57    763   -34.67  New   Dead  Gacela  \n",
       "193         9.67   4.10   -57.60   1477   -18.85  New   Dead   Mamut  \n",
       "194        13.26   5.53   -58.30   5353   -10.03  Old   Dead   Mamut  \n",
       "195         6.00   2.48   -58.67    496   -49.37  New   Dead  Gacela  \n",
       "196         8.95   3.69   -58.77   2512   -41.70  Old   Dead  Gacela  \n",
       "197        15.00   6.12   -59.20   2384   -31.64  Old   Dead   Mamut  \n",
       "198        19.05   7.68   -59.69   1607   -51.06  Old   Dead   Mamut  \n",
       "199        19.25   7.74   -59.79   1271   -10.67  New   Dead  Gacela  \n",
       "200        24.00   9.43   -60.71   2279    -5.26  Old   Dead  Gacela  \n",
       "201        29.91  11.75   -60.72   1439   -27.22  New   Dead   Mamut  \n",
       "202         9.76   3.79   -61.17   1174   -12.81  New   Dead   Mamut  \n",
       "203         6.15   2.33   -62.11    691   -33.08  New   Dead  Gacela  \n",
       "204        14.11   5.22   -63.00   3834    -4.87  Old   Dead   Mamut  \n",
       "205        20.80   7.69   -63.03   1863   -32.71  Old   Dead   Mamut  \n",
       "206         8.76   3.21   -63.36   2790   -15.86  Old   Dead  Gacela  \n",
       "207        18.39   6.73   -63.40   1411   -16.81  New   Dead  Gacela  \n",
       "208        12.89   4.68   -63.69    956   -63.08  New   Dead  Gacela  \n",
       "209         4.24   1.52   -64.15   5786    19.10  Old   Dead   Mamut  \n",
       "210        21.18   7.56   -64.31   1272   -25.66  New   Dead   Mamut  \n",
       "211        17.75   6.27   -64.68   3324     3.99  Old   Dead   Mamut  \n",
       "212        10.00   3.52   -64.80   1350   -26.10  New   Dead  Gacela  \n",
       "213        17.18   6.03   -64.90   4289   -89.98  Old   Dead   Mamut  \n",
       "214        20.03   6.95   -65.31   3534   -19.23  Old   Dead  Gacela  \n",
       "215         5.96   2.06   -65.44    536     0.00  New   Dead  Gacela  \n",
       "216         6.28   2.16   -65.61   2364   -11.46  Old   Dead  Gacela  \n",
       "217        19.50   6.45   -66.92   1561   -15.13  Old   Dead   Mamut  \n",
       "218        25.77   8.52   -66.94   1698   -22.99  Old   Dead   Mamut  \n",
       "219        52.85  17.21   -67.44   4227   -17.51  Old   Dead   Mamut  \n",
       "220        24.60   7.89   -67.93   1880   -51.59  Old   Dead   Mamut  \n",
       "221         7.24   2.28   -68.51    637     0.00  New   Dead  Gacela  \n",
       "222        10.31   3.24   -68.57    312   -71.71  New   Dead   Mamut  \n",
       "223        19.75   6.17   -68.76   3834   -23.83  Old   Dead  Gacela  \n",
       "224         7.92   2.47   -68.81   6440   -13.34  Old   Dead  Gacela  \n",
       "225        10.10   3.07   -69.60   1380   -16.21  New   Dead   Mamut  \n",
       "226        18.60   5.64   -69.68   1341   -70.58  New   Dead   Mamut  \n",
       "227        72.18  21.81   -69.78   1320   -13.90  New   Dead  Gacela  \n",
       "228        10.23   3.06   -70.09   1566   -43.30  Old   Dead   Mamut  \n",
       "229         5.90   1.76   -70.17   2505   -10.87  Old   Dead  Gacela  \n",
       "230        24.30   7.17   -70.49   1917   -50.89  Old   Dead   Mamut  \n",
       "231        13.50   3.96   -70.67   1979   -12.95  Old   Dead  Gacela  \n",
       "232         3.62   1.06   -70.72    945   -44.76  New   Dead  Gacela  \n",
       "233        18.12   5.30   -70.75   1516   -32.17  Old   Dead   Mamut  \n",
       "234        10.00   2.82   -71.80   1880   -74.45  Old   Dead   Mamut  \n",
       "235         6.62   1.83   -72.36   4095   -72.29  Old   Dead   Mamut  \n",
       "236        19.65   5.43   -72.37   1280   -31.52  New   Dead   Mamut  \n",
       "237        15.95   4.39   -72.48    519     0.00  New   Dead  Gacela  \n",
       "238         5.10   1.39   -72.75   1154   -19.62  New   Dead  Gacela  \n",
       "239        30.45   8.28   -72.81   3379   -52.83  Old   Dead   Mamut  \n",
       "240        10.50   2.85   -72.86   1250   -71.45  New   Dead   Mamut  \n",
       "241         3.75   1.01   -73.07  11186   -70.57  Old   Dead   Mamut  \n",
       "242         9.70   2.61   -73.09   1574   -14.79  Old   Dead   Mamut  \n",
       "243         9.71   2.61   -73.12   2252     0.00  Old   Dead  Gacela  \n",
       "244        12.30   3.25   -73.58   1523   -37.32  Old   Dead  Gacela  \n",
       "245         8.35   2.12   -74.57   2748   -43.53  Old   Dead  Gacela  \n",
       "246        17.76   4.44   -75.00   1607   -23.14  Old   Dead  Gacela  \n",
       "247        13.77   3.27   -76.25   1140   -79.84  New   Dead   Mamut  \n",
       "248        14.95   3.44   -76.96   1650   -50.87  Old   Dead  Gacela  \n",
       "249        18.07   4.12   -77.20   1075   -86.64  New   Dead   Mamut  \n",
       "250        14.10   3.19   -77.38   2587   -39.76  Old   Dead   Mamut  \n",
       "251        31.30   6.95   -77.80   1341   -12.58  New   Dead   Mamut  \n",
       "252         4.04   0.86   -78.71   1104   -57.19  New   Dead  Gacela  \n",
       "253       309.00  64.89   -79.00   1588    -6.33  Old   Dead   Mamut  \n",
       "254        98.20  20.60   -79.02   1803   -20.91  Old   Dead  Gacela  \n",
       "255        14.00   2.88   -79.43   4620    30.29  Old   Dead   Mamut  \n",
       "256         7.10   1.40   -80.28   1320     0.00  New   Dead  Gacela  \n",
       "257        16.98   3.33   -80.39   1467   -13.48  New   Dead   Mamut  \n",
       "258        49.99   9.78   -80.43   1922   -43.51  Old   Dead  Gacela  \n",
       "259        14.73   2.83   -80.79   3743   -10.93  Old   Dead   Mamut  \n",
       "260       132.50  25.38   -80.85   1825     0.00  Old   Dead  Gacela  \n",
       "261        29.85   5.67   -81.01   1488     0.07  New   Dead   Mamut  \n",
       "262        15.66   2.95   -81.16   3007   -12.38  Old   Dead   Mamut  \n",
       "263        15.37   2.88   -81.26    789   -52.64  New   Dead   Mamut  \n",
       "264        10.44   1.95   -81.32   1593   -31.62  Old   Dead   Mamut  \n",
       "265        20.70   3.83   -81.50    319   -62.22  New   Dead  Gacela  \n",
       "266        44.44   8.15   -81.66   2455   -28.28  Old   Dead   Mamut  \n",
       "267        13.42   2.45   -81.74   1621   -46.96  Old   Dead   Mamut  \n",
       "268        61.80  11.20   -81.88    697   -43.51  New   Dead  Gacela  \n",
       "269        11.00   1.99   -81.91   6263     0.00  Old   Dead  Gacela  \n",
       "270        18.00   3.23   -82.06    593  -110.33  New   Dead   Mamut  \n",
       "271        15.35   2.75   -82.08   1236   -50.04  New   Dead   Mamut  \n",
       "272        30.10   5.39   -82.11   3805  -113.51  Old   Dead   Mamut  \n",
       "273        31.92   5.71   -82.11   1279   -48.03  New   Dead   Mamut  \n",
       "274        69.30  12.34   -82.19  11215    -0.97  Old   Dead   Mamut  \n",
       "275        10.11   1.79   -82.25   1266    -8.06  New   Dead   Mamut  \n",
       "276         7.26   1.28   -82.37   1209     0.00  New   Dead  Gacela  \n",
       "277        12.00   2.11   -82.42   8140     0.00  Old   Dead  Gacela  \n",
       "278        12.10   2.10   -82.64   6584    -9.47  Old   Dead  Gacela  \n",
       "279        17.54   3.03   -82.73   1607   -50.97  Old   Dead  Gacela  \n",
       "280        14.25   2.46   -82.74    264  -121.05  New   Dead  Gacela  \n",
       "281        22.17   3.82   -82.77   2092    11.53  Old   Dead   Mamut  \n",
       "282        25.49   4.38   -82.82   1537   -37.84  Old   Dead   Mamut  \n",
       "283         8.50   1.46   -82.82   1352   -26.75  New   Dead  Gacela  \n",
       "284        21.59   3.69   -82.89   1244   -20.39  New   Dead   Mamut  \n",
       "285       417.00  70.18   -83.17   1523   -12.13  Old   Dead   Mamut  \n",
       "286        90.00  15.08   -83.24   3704   -26.23  Old   Dead  Gacela  \n",
       "287        34.01   5.60   -83.53   1359   -16.91  New   Dead  Gacela  \n",
       "288        15.90   2.60   -83.65   1225     0.00  New   Dead  Gacela  \n",
       "289        20.22   3.28   -83.78   2371    -6.58  Old   Dead   Mamut  \n",
       "290       291.00  46.71   -83.95   3687    -6.60  Old   Dead   Mamut  \n",
       "291        40.50   6.50   -83.95   1467   -54.64  New   Dead   Mamut  \n",
       "292        17.92   2.85   -84.09  15047     0.00  Old   Dead  Gacela  \n",
       "293        12.85   2.04   -84.12    319   -79.62  New   Dead   Mamut  \n",
       "294        15.00   2.36   -84.27   2597   -29.16  Old   Dead  Gacela  \n",
       "295        12.65   1.99   -84.27   1075  -117.24  New   Dead  Gacela  \n",
       "296        18.79   2.95   -84.30   4268   -35.44  Old   Dead  Gacela  \n",
       "297        40.30   6.30   -84.37   2000   -14.69  Old   Dead   Mamut  \n",
       "298         9.90   1.53   -84.55   1014   -17.15  New   Dead  Gacela  \n",
       "299        14.00   2.15   -84.64   2729   -30.43  Old   Dead   Mamut  \n",
       "300        15.00   2.29   -84.73    445   -73.00  New   Dead   Mamut  \n",
       "301        11.00   1.66   -84.91   1236   -61.12  New   Dead   Mamut  \n",
       "302        26.41   3.93   -85.12   1322   -24.45  New   Dead   Mamut  \n",
       "303        17.43   2.56   -85.31   1250   -20.37  New   Dead   Mamut  \n",
       "304        30.10   4.42   -85.32    312   -66.51  New   Dead  Gacela  \n",
       "305        11.12   1.61   -85.53   8894    -2.86  Old   Dead  Gacela  \n",
       "306       120.89  17.29   -85.70   3925    -8.02  Old   Dead  Gacela  \n",
       "307         5.00   0.71   -85.70   1254   -39.69  New   Dead  Gacela  \n",
       "308       225.00  32.02   -85.77   5342    -0.01  Old   Dead   Mamut  \n",
       "309         7.25   1.02   -85.93   3120   -33.50  Old   Dead  Gacela  \n",
       "310        15.20   2.12   -86.05   2273   -72.04  Old   Dead   Mamut  \n",
       "311        49.00   6.75   -86.22   1489   -28.52  New   Dead  Gacela  \n",
       "312         3.71   0.51   -86.26  11975   -19.42  Old   Dead  Gacela  \n",
       "313        15.06   2.05   -86.39   9021   -21.21  Old   Dead   Mamut  \n",
       "314        35.05   4.71   -86.56   1615   -48.07  Old   Dead   Mamut  \n",
       "315         3.00   0.40   -86.57   8380   -86.08  Old   Dead  Gacela  \n",
       "316        12.20   1.63   -86.64   1369   -49.56  New   Dead  Gacela  \n",
       "317        23.20   3.09   -86.68   1719   -94.13  Old   Dead   Mamut  \n",
       "318        41.08   5.38   -86.90   4519    -9.84  Old   Dead  Gacela  \n",
       "319         9.82   1.26   -87.17   1068   -18.15  New   Dead  Gacela  \n",
       "320        24.99   3.20   -87.19   4086   -49.18  Old   Dead   Mamut  \n",
       "321        12.61   1.61   -87.23   3694   -59.70  Old   Dead   Mamut  \n",
       "322        17.50   2.22   -87.31    320   -16.51  New   Dead  Gacela  \n",
       "323        13.20   1.62   -87.73   1166   -61.31  New   Dead  Gacela  \n",
       "324         9.75   1.19   -87.75   1190     0.00  New   Dead  Gacela  \n",
       "325         9.40   1.15   -87.77   2044   -68.96  Old   Dead  Gacela  \n",
       "326         4.80   0.58   -87.81    305     0.00  New   Dead  Gacela  \n",
       "327       374.40  45.33   -87.89   2371    -7.92  Old   Dead   Mamut  \n",
       "328        15.37   1.80   -88.29   2049   -51.53  Old   Dead  Gacela  \n",
       "329        16.32   1.91   -88.30   1243   -91.23  New   Dead   Mamut  \n",
       "330        26.85   3.08   -88.53   3967   -58.16  Old   Dead   Mamut  \n",
       "331        80.00   9.11   -88.61  10605   -16.45  Old   Dead   Mamut  \n",
       "332        77.84   8.69   -88.84   3540   -34.98  Old   Dead   Mamut  \n",
       "333        22.83   2.53   -88.92   1266  -121.55  New   Dead  Gacela  \n",
       "334        18.08   1.97   -89.10   2140   -91.48  Old   Dead   Mamut  \n",
       "335        21.02   2.28   -89.15   1153  -104.41  New   Dead  Gacela  \n",
       "336         7.89   0.86   -89.16   1271     0.00  New   Dead  Gacela  \n",
       "337        19.09   1.96   -89.73    963  -138.01  New   Dead  Gacela  \n",
       "338        16.10   1.65   -89.75   1327   -87.04  New   Dead  Gacela  \n",
       "339        20.10   2.03   -89.90   1265   -78.44  New   Dead  Gacela  \n",
       "340         9.94   1.00   -89.94   1077   -23.69  New   Dead  Gacela  \n",
       "341        25.00   2.49   -90.04   2370   -29.98  Old   Dead   Mamut  \n",
       "342       244.25  24.12   -90.12   3176   -13.57  Old   Dead   Mamut  \n",
       "343       239.00  23.51   -90.16   3938   -17.54  Old   Dead  Gacela  \n",
       "344        16.80   1.64   -90.24   2840   -25.84  Old   Dead  Gacela  \n",
       "345        30.34   2.93   -90.34   1509   -47.69  Old   Dead  Gacela  \n",
       "346        23.33   2.18   -90.66   4625   -14.15  Old   Dead  Gacela  \n",
       "347        11.50   1.07   -90.70   2602    36.02  Old   Dead  Gacela  \n",
       "348        17.59   1.63   -90.70   1236  -111.86  New   Dead  Gacela  \n",
       "349        70.40   6.54   -90.71   7447     3.68  Old   Dead   Mamut  \n",
       "350        15.40   1.43   -90.71    998     0.00  New   Dead  Gacela  \n",
       "351       371.25  34.07   -90.82   1523   -76.74  Old   Dead  Gacela  \n",
       "352        12.50   1.11   -91.12   1362  -100.22  New   Dead  Gacela  \n",
       "353         9.81   0.86   -91.23   1386   -24.46  New   Dead  Gacela  \n",
       "354         5.71   0.50   -91.24    442  -188.94  New   Dead  Gacela  \n",
       "355        12.90   1.11   -91.40   3358     9.50  Old   Dead   Mamut  \n",
       "356        24.06   2.07   -91.40   1545   -19.70  Old   Dead  Gacela  \n",
       "357        12.25   1.03   -91.59   2783   -87.26  Old   Dead  Gacela  \n",
       "358        34.64   2.87   -91.71   3430   -15.28  Old   Dead   Mamut  \n",
       "359        11.63   0.94   -91.92   2541   -73.83  Old   Dead  Gacela  \n",
       "360        12.50   1.00   -92.00   1796  -216.46  Old   Dead  Gacela  \n",
       "361        18.20   1.44   -92.09   3240  -182.23  Old   Dead   Mamut  \n",
       "362        45.80   3.57   -92.21   3709     0.00  Old   Dead   Mamut  \n",
       "363        14.10   1.08   -92.34   1237  -163.49  New   Dead  Gacela  \n",
       "364        25.00   1.89   -92.44   2259   -59.03  Old   Dead   Mamut  \n",
       "365        50.00   3.67   -92.66   2920     0.00  Old   Dead  Gacela  \n",
       "366         9.20   0.67   -92.67    512  -168.82  New   Dead  Gacela  \n",
       "367       320.00  22.88   -92.85   3534   -11.83  Old   Dead  Gacela  \n",
       "368       110.00   7.83   -92.88   5177   -17.09  Old   Dead   Mamut  \n",
       "369        13.00   0.91   -93.00   1874  -368.74  Old   Dead  Gacela  \n",
       "370        19.45   1.36   -93.01   1278   -45.90  New   Dead  Gacela  \n",
       "371        29.99   2.06   -93.13   1407   -40.20  New   Dead   Mamut  \n",
       "372       685.00  46.88   -93.16   1902   -20.50  Old   Dead   Mamut  \n",
       "373        37.50   2.56   -93.17   1782   -54.24  Old   Dead  Gacela  \n",
       "374        63.72   4.34   -93.19   4785   -96.72  Old   Dead  Gacela  \n",
       "375         9.97   0.68   -93.22   1135     0.00  New   Dead  Gacela  \n",
       "376       133.20   9.03   -93.22   2762   -15.50  Old   Dead   Mamut  \n",
       "377       150.00   9.86   -93.43   1349   -37.25  New   Dead  Gacela  \n",
       "378       151.65   9.85   -93.50   1436   -76.98  New   Dead  Gacela  \n",
       "379        14.10   0.91   -93.52   1327  -152.69  New   Dead   Mamut  \n",
       "380        30.00   1.89   -93.70   1674   -70.78  Old   Dead   Mamut  \n",
       "381       220.00  13.60   -93.82   3637      NaN  Old   Dead  Gacela  \n",
       "382        32.89   2.03   -93.83   2049   -34.66  Old   Dead  Gacela  \n",
       "383        16.00   0.97   -93.94   1152  -148.25  New   Dead  Gacela  \n",
       "384        16.00   0.97   -93.94   1236  -166.43  New   Dead  Gacela  \n",
       "385        18.49   1.12   -93.95   1369   -41.42  New   Dead  Gacela  \n",
       "386        16.55   0.99   -94.02   1357  -156.31  New   Dead   Mamut  \n",
       "387        19.35   1.14   -94.11   1530  -165.87  Old   Dead  Gacela  \n",
       "388        59.40   3.44   -94.21   1455    -7.91  New   Dead  Gacela  \n",
       "389        30.80   1.77   -94.25   1642  -132.67  Old   Dead   Mamut  \n",
       "390         6.30   0.36   -94.33   1246  -230.79  New   Dead  Gacela  \n",
       "391        55.90   3.16   -94.35   1586   -38.87  Old   Dead   Mamut  \n",
       "392        99.80   5.57   -94.42   1301  -241.36  New   Dead  Gacela  \n",
       "393        11.44   0.64   -94.44   1271  -110.94  New   Dead  Gacela  \n",
       "394        46.00   2.54   -94.48    729     0.00  New   Dead  Gacela  \n",
       "395         9.04   0.50   -94.52   1330  -171.43  New   Dead  Gacela  \n",
       "396        19.90   1.08   -94.57   2049  -213.50  Old   Dead  Gacela  \n",
       "397        35.10   1.89   -94.62   1412   -62.57  New   Dead   Mamut  \n",
       "398        22.83   1.22   -94.66   1278  -118.55  New   Dead   Mamut  \n",
       "399        44.10   2.35   -94.67   1544  -125.68  Old   Dead  Gacela  \n",
       "400        17.94   0.93   -94.82   2139   -31.79  Old   Dead   Mamut  \n",
       "401        15.65   0.81   -94.82   1138  -179.67  New   Dead  Gacela  \n",
       "402        32.00   1.65   -94.84   1362   -81.83  New   Dead  Gacela  \n",
       "403        12.00   0.62   -94.87   1159   -75.20  New   Dead  Gacela  \n",
       "404      1120.00  57.47   -94.87  10178     0.14  Old   Dead   Mamut  \n",
       "405        14.00   0.70   -95.00   2258   -42.24  Old   Dead  Gacela  \n",
       "406        47.90   2.34   -95.11   1621   -72.47  Old   Dead   Mamut  \n",
       "407        30.00   1.45   -95.17   1614  -195.78  Old   Dead  Gacela  \n",
       "408        48.00   2.32   -95.17   3120  -438.20  Old   Dead  Gacela  \n",
       "409        17.50   0.83   -95.23   1439     0.00  New   Dead  Gacela  \n",
       "410        58.90   2.81   -95.23   1467   -26.31  New   Dead   Mamut  \n",
       "411       179.20   8.48   -95.27   3533   -18.04  Old   Dead  Gacela  \n",
       "412        24.69   1.16   -95.30   1649  -118.99  Old   Dead   Mamut  \n",
       "413        31.02   1.45   -95.33   1462  -130.49  New   Dead  Gacela  \n",
       "414        96.79   4.51   -95.34   2210   -28.53  Old   Dead  Gacela  \n",
       "415        48.40   2.21   -95.43   3822  -159.86  Old   Dead  Gacela  \n",
       "416       420.00  18.68   -95.55   3100    -8.31  Old   Dead  Gacela  \n",
       "417        56.46   2.47   -95.63   1474   -63.39  New   Dead   Mamut  \n",
       "418        11.00   0.48   -95.64    515  -713.71  New   Dead  Gacela  \n",
       "419        16.05   0.70   -95.64   4059  -149.63  Old   Dead   Mamut  \n",
       "420        17.50   0.76   -95.65   2377  -112.86  Old   Dead  Gacela  \n",
       "421         9.89   0.43   -95.65    963     0.00  New   Dead  Gacela  \n",
       "422        41.50   1.76   -95.76   3556   -38.44  Old   Dead   Mamut  \n",
       "423        35.00   1.48   -95.77   6992   -36.55  Old   Dead  Gacela  \n",
       "424        37.51   1.58   -95.79   1544   -95.53  Old   Dead  Gacela  \n",
       "425       528.80  21.97   -95.85   1369   -44.96  New   Dead  Gacela  \n",
       "426       378.00  15.38   -95.93   5114   -50.89  Old   Dead  Gacela  \n",
       "427       101.50   4.08   -95.98   1407  -128.34  New   Dead  Gacela  \n",
       "428        16.89   0.67   -96.01   1279  -100.37  New   Dead   Mamut  \n",
       "429       266.25  10.33   -96.12   3715  -267.83  Old   Dead   Mamut  \n",
       "430       177.50   6.75   -96.20   2371  -205.08  Old   Dead  Gacela  \n",
       "431        57.00   2.15   -96.23   3749  -203.81  Old   Dead  Gacela  \n",
       "432        78.60   2.95   -96.25   2883   -56.09  Old   Dead  Gacela  \n",
       "433        12.77   0.48   -96.26   1166  -312.75  New   Dead  Gacela  \n",
       "434        11.03   0.41   -96.26   2476  -530.79  Old   Dead  Gacela  \n",
       "435       465.00  17.31   -96.28   2401   -12.28  Old   Dead  Gacela  \n",
       "436        71.20   2.65   -96.28   1189  -494.53  New   Dead  Gacela  \n",
       "437        16.00   0.58   -96.38   3513   -48.16  Old   Dead   Mamut  \n",
       "438        27.07   0.98   -96.38   1530  -162.68  Old   Dead  Gacela  \n",
       "439        67.50   2.41   -96.43   2496  -108.08  Old   Dead  Gacela  \n",
       "440       226.00   8.00   -96.46   1770  -130.39  Old   Dead  Gacela  \n",
       "441        13.64   0.48   -96.48   2511  -127.27  Old   Dead  Gacela  \n",
       "442       435.60  15.03   -96.55   3428   -56.46  Old   Dead  Gacela  \n",
       "443        17.11   0.58   -96.58   1551  -539.32  Old   Dead  Gacela  \n",
       "444        22.20   0.76   -96.58   1754  -189.80  Old   Dead  Gacela  \n",
       "445       133.08   4.48   -96.63   4708   -54.96  Old   Dead  Gacela  \n",
       "446        31.25   1.05   -96.64   2343  -163.38  Old   Dead   Mamut  \n",
       "447        86.00   2.69   -96.87   1470  -182.13  New   Dead  Gacela  \n",
       "448        89.24   2.75   -96.92   8922  -111.99  Old   Dead  Gacela  \n",
       "449        49.00   1.50   -96.94   3366  -207.25  Old   Dead  Gacela  \n",
       "450        26.20   0.80   -96.95   1544  -287.32  Old   Dead   Mamut  \n",
       "451        57.35   1.72   -97.00   4367     0.00  Old   Dead  Gacela  \n",
       "452       170.20   5.07   -97.02   1411   -77.37  New   Dead  Gacela  \n",
       "453       639.84  18.91   -97.04   8784     3.36  Old   Dead   Mamut  \n",
       "454       170.00   5.02   -97.05   4074   -36.23  Old   Dead  Gacela  \n",
       "455       450.00  13.26   -97.05   6517    -5.51  Old   Dead   Mamut  \n",
       "456       121.88   3.57   -97.07   8904  -167.29  Old   Dead  Gacela  \n",
       "457       877.50  25.41   -97.10  14096    -9.84  Old   Dead   Mamut  \n",
       "458        10.00   0.28   -97.15   1236  -150.07  New   Dead  Gacela  \n",
       "459        48.10   1.37   -97.15   5177  -219.29  Old   Dead   Mamut  \n",
       "460        24.73   0.68   -97.25   4149   -44.90  Old   Dead   Mamut  \n",
       "461        45.00   1.23   -97.27   4373  -117.31  Old   Dead  Gacela  \n",
       "462         9.01   0.24   -97.34   3994  -263.61  Old   Dead  Gacela  \n",
       "463        37.50   0.99   -97.36   1411  -173.02  New   Dead   Mamut  \n",
       "464        99.90   2.64   -97.36   1551   -70.80  Old   Dead  Gacela  \n",
       "465        94.80   2.49   -97.37   1230  -662.26  New   Dead   Mamut  \n",
       "466        20.88   0.55   -97.38   1229  -390.91  New   Dead  Gacela  \n",
       "467        56.16   1.41   -97.49    524  -256.20  New   Dead  Gacela  \n",
       "468        74.10   1.86   -97.49   1404   -63.78  New   Dead  Gacela  \n",
       "469       404.80   9.44   -97.67   1338   -97.00  New   Dead   Mamut  \n",
       "470        18.90   0.44   -97.67   1412  -285.00  New   Dead  Gacela  \n",
       "471        98.00   2.22   -97.73   1958   -69.12  Old   Dead   Mamut  \n",
       "472        17.00   0.38   -97.75   1530  -269.10  Old   Dead  Gacela  \n",
       "473        14.73   0.32   -97.81   1097  -311.49  New   Dead  Gacela  \n",
       "474         9.35   0.19   -97.96   1665  -422.99  Old   Dead  Gacela  \n",
       "475        12.91   0.26   -97.97   3973  -740.07  Old   Dead  Gacela  \n",
       "476       279.90   5.37   -98.08   3792   -90.50  Old   Dead   Mamut  \n",
       "477        97.80   1.85   -98.11   1142   -95.20  New   Dead  Gacela  \n",
       "478       401.60   7.46   -98.14   7264   -22.06  Old   Dead   Mamut  \n",
       "479        88.40   1.64   -98.14   3567     0.00  Old   Dead  Gacela  \n",
       "480       348.58   6.34   -98.18   4199  -397.88  Old   Dead   Mamut  \n",
       "481         9.90   0.18   -98.20   1461  -204.08  New   Dead  Gacela  \n",
       "482        25.39   0.45   -98.23   1601  -230.59  Old   Dead  Gacela  \n",
       "483       171.72   2.97   -98.27   3932  -113.28  Old   Dead  Gacela  \n",
       "484        51.40   0.88   -98.29   3462   -24.02  Old   Dead   Mamut  \n",
       "485        48.92   0.81   -98.34   8474   -57.02  Old   Dead  Gacela  \n",
       "486       115.60   1.91   -98.35   1418  -142.86  New   Dead  Gacela  \n",
       "487        32.15   0.53   -98.36   1411  -364.25  New   Dead  Gacela  \n",
       "488        69.75   1.11   -98.41   2006     0.00  Old   Dead  Gacela  \n",
       "489       140.00   2.13   -98.48   2070  -182.38  Old   Dead   Mamut  \n",
       "490        22.00   0.33   -98.49   3686  -506.23  Old   Dead   Mamut  \n",
       "491       401.20   5.98   -98.51   3709   -23.13  Old   Dead  Gacela  \n",
       "492       209.30   3.06   -98.54   3512   -26.48  Old   Dead  Gacela  \n",
       "493       339.30   4.91   -98.55   2517   -59.81  Old   Dead  Gacela  \n",
       "494       250.00   3.43   -98.63   2101     0.00  Old   Dead  Gacela  \n",
       "495       375.00   5.08   -98.65   1510  -294.29  Old   Dead  Gacela  \n",
       "496        72.00   0.93   -98.71   6551   -37.44  Old   Dead  Gacela  \n",
       "497        96.00   1.20   -98.75   2570  -160.30  Old   Dead  Gacela  \n",
       "498       780.00   9.52   -98.78   3463     0.00  Old   Dead  Gacela  \n",
       "499        33.00   0.40   -98.79   4690  -208.51  Old   Dead  Gacela  \n",
       "500       165.00   1.94   -98.82   4779  -176.84  Old   Dead   Mamut  \n",
       "501       123.75   1.45   -98.83   7742  -181.45  Old   Dead  Gacela  \n",
       "502        98.90   1.14   -98.85   1411  -241.40  New   Dead  Gacela  \n",
       "503       335.88   3.70   -98.90   2456  -180.37  Old   Dead  Gacela  \n",
       "504       101.25   1.09   -98.92   2335  -103.71  Old   Dead  Gacela  \n",
       "505       216.00   2.26   -98.95   2728   -55.30  Old   Dead  Gacela  \n",
       "506       523.20   5.44   -98.96   2091   -32.95  Old   Dead   Mamut  \n",
       "507        18.56   0.18   -99.01   1691  -551.77  Old   Dead  Gacela  \n",
       "508       480.00   4.59   -99.04   4355   -27.06  Old   Dead  Gacela  \n",
       "509       192.75   1.80   -99.07   2398   -72.61  Old   Dead  Gacela  \n",
       "510       172.80   1.58   -99.09   2135   -52.60  Old   Dead  Gacela  \n",
       "511        65.00   0.57   -99.13   3802  -850.18  Old   Dead  Gacela  \n",
       "512      2045.25  17.85   -99.13   3835   -16.56  Old   Dead   Mamut  \n",
       "513       182.00   1.57   -99.14    880   -90.43  New   Dead  Gacela  \n",
       "514         9.92   0.08   -99.15   2518  -382.84  Old   Dead  Gacela  \n",
       "515       990.00   8.34   -99.16   1117  -585.45  New   Dead  Gacela  \n",
       "516       220.00   1.84   -99.16   3366   -54.77  Old   Dead  Gacela  \n",
       "517       177.00   1.47   -99.17    763  -102.09  New   Dead  Gacela  \n",
       "518         9.94   0.08   -99.18    995     0.00  New   Dead  Gacela  \n",
       "519        32.00   0.26   -99.18   3792  -941.19  Old   Dead   Mamut  \n",
       "520       118.16   0.96   -99.18   2517  -153.18  Old   Dead   Mamut  \n",
       "521       245.00   1.99   -99.19   1370     0.00  New   Dead  Gacela  \n",
       "522       299.40   2.40   -99.20   7750   -83.70  Old   Dead  Gacela  \n",
       "523        84.18   0.67   -99.20   2588  -111.98  Old   Dead   Mamut  \n",
       "524       410.00   3.19   -99.22   1902   -80.02  Old   Dead  Gacela  \n",
       "525      2925.00  21.85   -99.25  11324   -19.03  Old   Dead   Mamut  \n",
       "526       375.00   2.79   -99.26   3729  -205.97  Old   Dead  Gacela  \n",
       "527        55.60   0.41   -99.26   6782   -33.11  Old   Dead  Gacela  \n",
       "528       562.50   4.08   -99.27   2707   -52.43  Old   Dead   Mamut  \n",
       "529       500.00   3.42   -99.32   3508  -238.10  Old   Dead  Gacela  \n",
       "530       526.66   3.55   -99.33   9477  -120.83  Old   Dead  Gacela  \n",
       "531       166.50   1.12   -99.33   2420  -150.33  Old   Dead  Gacela  \n",
       "532       924.50   6.18   -99.33   2707  -145.47  Old   Dead  Gacela  \n",
       "533        96.50   0.63   -99.34   2106  -229.20  Old   Dead  Gacela  \n",
       "534       612.00   4.01   -99.34   3092     0.00  Old   Dead  Gacela  \n",
       "535       131.25   0.81   -99.38   9020   -75.65  Old   Dead   Mamut  \n",
       "536       188.00   1.16   -99.38   2455  -294.29  Old   Dead  Gacela  \n",
       "537       580.80   3.58   -99.38   4697   -35.95  Old   Dead  Gacela  \n",
       "538        65.30   0.40   -99.39   1399     0.00  New   Dead  Gacela  \n",
       "539        60.00   0.37   -99.39   3833     0.00  Old   Dead  Gacela  \n",
       "540       638.00   3.83   -99.40   3315  -195.81  Old   Dead  Gacela  \n",
       "541      1648.19   9.64   -99.42   6824     2.34  Old   Dead   Mamut  \n",
       "542         9.93   0.06   -99.43   1113     0.00  New   Dead  Gacela  \n",
       "543       103.65   0.59   -99.43  15712   -49.80  Old   Dead   Mamut  \n",
       "544       417.75   2.36   -99.44   1461     0.00  New   Dead  Gacela  \n",
       "545       143.50   0.77   -99.47   2191  -237.62  Old   Dead  Gacela  \n",
       "546      5100.00  27.15   -99.47  14074    -4.63  Old   Dead  Gacela  \n",
       "547      4668.75  23.15   -99.50   2805     0.00  Old   Dead  Gacela  \n",
       "548       570.00   2.61   -99.54   1635  -132.73  Old   Dead  Gacela  \n",
       "549       156.35   0.66   -99.58   4661  -121.62  Old   Dead  Gacela  \n",
       "550      1068.00   4.21   -99.61   1105  -120.23  New   Dead  Gacela  \n",
       "551       822.00   3.18   -99.61   3904   -96.49  Old   Dead  Gacela  \n",
       "552       213.25   0.81   -99.62   2132     0.00  Old   Dead  Gacela  \n",
       "553       336.00   1.20   -99.64   3792   -70.13  Old   Dead  Gacela  \n",
       "554       680.00   2.29   -99.66    392   -75.51  New   Dead  Gacela  \n",
       "555       588.00   1.94   -99.67   5293  -134.04  Old   Dead  Gacela  \n",
       "556       708.00   2.32   -99.67   9506  -148.16  Old   Dead   Mamut  \n",
       "557       846.60   2.75   -99.68   2457     0.00  Old   Dead  Gacela  \n",
       "558       571.00   1.80   -99.68   7047     0.00  Old   Dead  Gacela  \n",
       "559       403.75   1.27   -99.69   2637  -668.41  Old   Dead  Gacela  \n",
       "560       525.60   1.58   -99.70   4452   -41.20  Old   Dead  Gacela  \n",
       "561       148.20   0.44   -99.70    550  -330.15  New   Dead  Gacela  \n",
       "562       406.05   1.19   -99.71   1181   -84.62  New   Dead  Gacela  \n",
       "563        75.45   0.22   -99.71   4892  -152.30  Old   Dead  Gacela  \n",
       "564       580.00   1.60   -99.72  13628    -2.23  Old   Dead   Mamut  \n",
       "565       479.28   1.31   -99.73   3681   -31.85  Old   Dead  Gacela  \n",
       "566       742.50   1.85   -99.75   1103  -176.28  New   Dead  Gacela  \n",
       "567      1620.00   3.92   -99.76   7448   -17.16  Old   Dead  Gacela  \n",
       "568       480.00   1.13   -99.76   3897   -95.69  Old   Dead  Gacela  \n",
       "569       117.00   0.27   -99.77   1205  -248.52  New   Dead  Gacela  \n",
       "570       683.20   1.48   -99.78   3108  -180.87  Old   Dead  Gacela  \n",
       "571       900.00   1.91   -99.79   4682  -102.92  Old   Dead  Gacela  \n",
       "572       850.00   1.80   -99.79   9713   -10.50  Old   Dead   Mamut  \n",
       "573       480.00   1.00   -99.79   3423  -142.93  Old   Dead  Gacela  \n",
       "574      5909.30  11.77   -99.80   3829    -7.67  Old   Dead  Gacela  \n",
       "575      1540.00   3.00   -99.81   8385  -440.66  Old   Dead  Gacela  \n",
       "576       210.77   0.41   -99.81   3967  -352.84  Old   Dead   Mamut  \n",
       "577       825.00   1.58   -99.81   4424   -84.47  Old   Dead  Gacela  \n",
       "578      1732.50   3.11   -99.82  10415   -47.39  Old   Dead   Mamut  \n",
       "579      1937.50   3.38   -99.83   3633   -23.58  Old   Dead  Gacela  \n",
       "580      1470.00   2.43   -99.83   4928   -65.85  Old   Dead  Gacela  \n",
       "581      1305.00   2.14   -99.84   1070     0.00  New   Dead  Gacela  \n",
       "582      3625.00   5.75   -99.84   3924   -50.50  Old   Dead  Gacela  \n",
       "583      2389.80   3.69   -99.85   2322  -220.16  Old   Dead  Gacela  \n",
       "584       250.00   0.36   -99.85   3515  -275.70  Old   Dead  Gacela  \n",
       "585       147.00   0.19   -99.87   2674  -222.43  Old   Dead  Gacela  \n",
       "586       864.00   1.12   -99.87   4422   -21.89  Old   Dead  Gacela  \n",
       "587      2067.12   2.56   -99.88   2518     0.00  Old   Dead  Gacela  \n",
       "588       705.00   0.86   -99.88   3667   -20.48  Old   Dead  Gacela  \n",
       "589      4389.00   5.26   -99.88   3879  -212.06  Old   Dead  Gacela  \n",
       "590       181.50   0.21   -99.89   3092 -1867.46  Old   Dead  Gacela  \n",
       "591      3849.12   4.38   -99.89   3744     0.00  Old   Dead  Gacela  \n",
       "592      1080.00   1.02   -99.91   6977   -93.35  Old   Dead  Gacela  \n",
       "593      1245.60   1.09   -99.91   1222     0.00  New   Dead  Gacela  \n",
       "594      2400.00   1.90   -99.92   7055  -478.33  Old   Dead  Gacela  \n",
       "595      1600.00   0.97   -99.94   3998   -69.14  Old   Dead  Gacela  \n",
       "596      2025.00   1.19   -99.94   1281  -110.41  New   Dead  Gacela  \n",
       "597      5446.52   3.05   -99.94   9079  -127.99  Old   Dead   Mamut  \n",
       "598      3686.00   1.93   -99.95   2730  -245.28  Old   Dead  Gacela  \n",
       "599       126.75   0.06   -99.95   1880 -6555.17  Old   Dead  Gacela  \n",
       "600     18720.00   9.23   -99.95   3352   -31.62  Old   Dead  Gacela  \n",
       "601      4750.00   2.31   -99.95   5964   -68.60  Old   Dead  Gacela  \n",
       "602      1687.50   0.80   -99.95   4418   -89.52  Old   Dead  Gacela  \n",
       "603      2450.00   1.11   -99.95   3938  -346.76  Old   Dead  Gacela  \n",
       "604       669.90   0.30   -99.96   4164 -1906.87  Old   Dead  Gacela  \n",
       "605      6991.07   2.70   -99.96   7670   153.46  Old   Dead  Gacela  \n",
       "606      2312.50   0.88   -99.96   9925  -184.36  Old   Dead  Gacela  \n",
       "607      3447.50   1.05   -99.97   1040  -425.31  New   Dead  Gacela  \n",
       "608      8250.00   2.19   -99.97   3329  -134.96  Old   Dead  Gacela  \n",
       "609      3125.00   0.69   -99.98  14985   -61.54  Old   Dead  Gacela  \n",
       "610      9281.25   1.80   -99.98   2730     0.00  Old   Dead  Gacela  \n",
       "611      3600.00   0.66   -99.98   6132  -449.13  Old   Dead  Gacela  \n",
       "612      2296.00   0.40   -99.98   1033  -435.34  New   Dead  Gacela  \n",
       "613      1320.00   0.22   -99.98  10385  -234.20  Old   Dead  Gacela  \n",
       "614     29750.00   4.93   -99.98   4316     0.00  Old   Dead  Gacela  \n",
       "615     28640.00   4.72   -99.98   7841   -84.79  Old   Dead   Mamut  \n",
       "616     34380.00   5.62   -99.98   2470     0.00  Old   Dead  Gacela  \n",
       "617     32400.00   3.32   -99.99   3595    58.52  Old   Dead  Gacela  \n",
       "618      1890.00   0.19   -99.99  11964  -314.43  Old   Dead  Gacela  \n",
       "619    105600.00   7.42   -99.99   1258  -376.97  New   Dead  Gacela  \n",
       "620      8400.00   0.59   -99.99   3963  -853.93  Old   Dead  Gacela  \n",
       "621     12858.95   0.84   -99.99   9423  -169.79  Old   Dead  Gacela  \n",
       "622     36450.00   2.08   -99.99  10261   -89.04  Old   Dead  Gacela  \n",
       "623      7068.60   0.40   -99.99   7256  -565.71  Old   Dead  Gacela  \n",
       "624     15900.00   0.66  -100.00   3060  -274.53  Old   Dead  Gacela  \n",
       "625     55200.00   2.19  -100.00   3056  -151.63  Old   Dead  Gacela  \n",
       "626     20529.60   0.80  -100.00   1406  -122.22  New   Dead  Gacela  \n",
       "627      7500.00   0.29  -100.00  12164  -156.70  Old   Dead  Gacela  \n",
       "628     10248.00   0.36  -100.00   1491  -571.81  New   Dead  Gacela  \n",
       "629    126795.58   3.56  -100.00  10561  -228.71  Old   Dead  Gacela  \n",
       "630      8210.53   0.20  -100.00   7021  -581.73  Old   Dead  Gacela  \n",
       "631    182336.00   4.09  -100.00   3072 -1247.94  Old   Dead  Gacela  \n",
       "632     74750.00   1.47  -100.00   3610  -336.50  Old   Dead  Gacela  \n",
       "633    300000.00   5.88  -100.00  11215   -65.44  Old   Dead  Gacela  \n",
       "634     63475.20   1.15  -100.00   3981     0.00  Old   Dead  Gacela  \n",
       "635    272250.00   4.10  -100.00  10659   -21.85  Old   Dead  Gacela  \n",
       "636      6855.00   0.10  -100.00   1866  -269.93  Old   Dead  Gacela  \n",
       "637    173437.50   2.58  -100.00   9423  -109.27  Old   Dead  Gacela  \n",
       "638    128000.00   1.45  -100.00   4395  -117.82  Old   Dead  Gacela  \n",
       "639    105000.00   1.18  -100.00   6574  -656.44  Old   Dead  Gacela  \n",
       "640    231547.86   1.54  -100.00  16345  -152.64  Old   Dead  Gacela  \n",
       "641     51000.00   0.33  -100.00   7601  -459.95  Old   Dead  Gacela  \n",
       "642    625000.00   3.87  -100.00   3465  -257.89  Old   Dead  Gacela  \n",
       "643    110862.50   0.57  -100.00   6262  -181.23  Old   Dead  Gacela  \n",
       "644    479062.50   2.19  -100.00  11169   -56.25  Old   Dead  Gacela  \n",
       "645    637500.00   2.90  -100.00   8987  -282.20  Old   Dead  Gacela  \n",
       "646   1118250.00   4.65  -100.00   4163  -145.18  Old   Dead  Gacela  \n",
       "647   7784915.00  21.94  -100.00   9993     0.00  Old   Dead   Mamut  \n",
       "648    209160.00   0.58  -100.00   2989  -737.64  Old   Dead  Gacela  \n",
       "649    315300.00   0.87  -100.00   6124     0.00  Old   Dead  Gacela  \n",
       "650   2291929.75   5.89  -100.00  16160   -21.38  Old   Dead  Gacela  \n",
       "651    212000.00   0.53  -100.00   1040  -286.47  New   Dead  Gacela  \n",
       "652   1785000.00   4.07  -100.00   8190     0.00  Old   Dead  Gacela  \n",
       "653    663750.00   1.27  -100.00   8560  -195.22  Old   Dead  Gacela  \n",
       "654   2160000.00   3.16  -100.00  11215  -102.75  Old   Dead  Gacela  \n",
       "655    364430.00   0.50  -100.00   7342  -136.38  Old   Dead  Gacela  \n",
       "656   2316600.00   2.81  -100.00   4604  -285.67  Old   Dead  Gacela  \n",
       "657    480000.00   0.43  -100.00   3786     0.00  Old   Dead  Gacela  \n",
       "658    404800.00   0.35  -100.00   1631  -762.44  Old   Dead  Gacela  \n",
       "659   2250000.00   1.90  -100.00   6052     0.00  Old   Dead  Gacela  \n",
       "660   3744000.00   1.77  -100.00   6472  -463.17  Old   Dead  Gacela  \n",
       "661  14700000.00   4.20  -100.00   3298  -267.22  Old   Dead  Gacela  \n",
       "662   8008000.00   1.81  -100.00   6622  -806.58  Old   Dead  Gacela  \n",
       "663   1842120.00   0.36  -100.00   7581  -934.26  Old   Dead  Gacela  \n",
       "664   8820000.00   1.02  -100.00   1092  -399.53  New   Dead  Gacela  \n",
       "665   8262000.00   0.26  -100.00   6977  -445.49  Old   Dead  Gacela  \n",
       "666 100000000.00   0.97  -100.00   3507  -272.25  Old   Dead  Gacela  \n",
       "667 155000000.00   0.35  -100.00  10725  -694.65  Old   Dead  Gacela  \n",
       "668 192000000.00   0.24  -100.00   4604   -91.64  Old   Dead   Mamut  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8afc08ab",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ticker</th>\n",
       "      <th>Company</th>\n",
       "      <th>Fall</th>\n",
       "      <th>days</th>\n",
       "      <th>RoK</th>\n",
       "      <th>MarketCap_M</th>\n",
       "      <th>revenueM</th>\n",
       "      <th>ebitdaM</th>\n",
       "      <th>Employees</th>\n",
       "      <th>term</th>\n",
       "      <th>profit</th>\n",
       "      <th>animal</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>TECH</td>\n",
       "      <td>Bio-Techne Corp</td>\n",
       "      <td>82131.76</td>\n",
       "      <td>13095</td>\n",
       "      <td>2.55</td>\n",
       "      <td>12101.22</td>\n",
       "      <td>1171.58</td>\n",
       "      <td>308.52</td>\n",
       "      <td>3100</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>VRTX</td>\n",
       "      <td>Vertex Pharmaceuticals, Inc</td>\n",
       "      <td>10205.11</td>\n",
       "      <td>12200</td>\n",
       "      <td>3.69</td>\n",
       "      <td>120546.75</td>\n",
       "      <td>10625.80</td>\n",
       "      <td>4446.60</td>\n",
       "      <td>5400</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>UTHR</td>\n",
       "      <td>United Therapeutics Corp</td>\n",
       "      <td>5837.39</td>\n",
       "      <td>9315</td>\n",
       "      <td>8.48</td>\n",
       "      <td>16644.81</td>\n",
       "      <td>2756.20</td>\n",
       "      <td>1412.10</td>\n",
       "      <td>1168</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>INCY</td>\n",
       "      <td>Incyte Corp</td>\n",
       "      <td>3556.00</td>\n",
       "      <td>11366</td>\n",
       "      <td>0.60</td>\n",
       "      <td>13446.97</td>\n",
       "      <td>4075.86</td>\n",
       "      <td>80.49</td>\n",
       "      <td>2524</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ALNY</td>\n",
       "      <td>Alnylam Pharmaceuticals Inc</td>\n",
       "      <td>3406.29</td>\n",
       "      <td>7504</td>\n",
       "      <td>-0.42</td>\n",
       "      <td>31470.08</td>\n",
       "      <td>2094.80</td>\n",
       "      <td>-132.15</td>\n",
       "      <td>2100</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>REGN</td>\n",
       "      <td>Regeneron Pharmaceuticals, Inc</td>\n",
       "      <td>3361.78</td>\n",
       "      <td>12313</td>\n",
       "      <td>5.77</td>\n",
       "      <td>79655.96</td>\n",
       "      <td>13847.10</td>\n",
       "      <td>4598.00</td>\n",
       "      <td>14165</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>ARGX</td>\n",
       "      <td>Argen X SE ADR</td>\n",
       "      <td>2540.02</td>\n",
       "      <td>2770</td>\n",
       "      <td>-0.40</td>\n",
       "      <td>37829.53</td>\n",
       "      <td>1908.66</td>\n",
       "      <td>-150.08</td>\n",
       "      <td>1148</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>BHST</td>\n",
       "      <td>BioHarvest Sciences Inc</td>\n",
       "      <td>2020.69</td>\n",
       "      <td>1439</td>\n",
       "      <td>-6.77</td>\n",
       "      <td>106.57</td>\n",
       "      <td>19.13</td>\n",
       "      <td>-7.21</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>KRYS</td>\n",
       "      <td>Krystal Biotech Inc</td>\n",
       "      <td>1437.97</td>\n",
       "      <td>2645</td>\n",
       "      <td>1.43</td>\n",
       "      <td>4820.55</td>\n",
       "      <td>241.52</td>\n",
       "      <td>69.14</td>\n",
       "      <td>229</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>TVTX</td>\n",
       "      <td>Travere Therapeutics Inc</td>\n",
       "      <td>1054.67</td>\n",
       "      <td>4422</td>\n",
       "      <td>-15.67</td>\n",
       "      <td>1523.10</td>\n",
       "      <td>203.45</td>\n",
       "      <td>-238.74</td>\n",
       "      <td>380</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>HALO</td>\n",
       "      <td>Halozyme Therapeutics Inc</td>\n",
       "      <td>1029.41</td>\n",
       "      <td>7581</td>\n",
       "      <td>9.05</td>\n",
       "      <td>6110.71</td>\n",
       "      <td>947.36</td>\n",
       "      <td>553.00</td>\n",
       "      <td>373</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>AXSM</td>\n",
       "      <td>Axsome Therapeutics Inc</td>\n",
       "      <td>930.89</td>\n",
       "      <td>3316</td>\n",
       "      <td>-5.63</td>\n",
       "      <td>4346.11</td>\n",
       "      <td>338.46</td>\n",
       "      <td>-244.62</td>\n",
       "      <td>607</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>BNTX</td>\n",
       "      <td>BioNTech SE ADR</td>\n",
       "      <td>756.56</td>\n",
       "      <td>1895</td>\n",
       "      <td>-1.00</td>\n",
       "      <td>27383.10</td>\n",
       "      <td>3040.10</td>\n",
       "      <td>-274.50</td>\n",
       "      <td>6133</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>JAZZ</td>\n",
       "      <td>Jazz Pharmaceuticals plc</td>\n",
       "      <td>593.97</td>\n",
       "      <td>6409</td>\n",
       "      <td>20.06</td>\n",
       "      <td>7568.92</td>\n",
       "      <td>3992.71</td>\n",
       "      <td>1518.48</td>\n",
       "      <td>2800</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>ASND</td>\n",
       "      <td>Ascendis Pharma A/S ADR</td>\n",
       "      <td>589.70</td>\n",
       "      <td>3611</td>\n",
       "      <td>-4.25</td>\n",
       "      <td>8163.27</td>\n",
       "      <td>317.63</td>\n",
       "      <td>-347.19</td>\n",
       "      <td>879</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>BGNE</td>\n",
       "      <td>BeiGene Ltd ADR</td>\n",
       "      <td>533.30</td>\n",
       "      <td>3240</td>\n",
       "      <td>-28.15</td>\n",
       "      <td>19806.62</td>\n",
       "      <td>23507.73</td>\n",
       "      <td>-5576.40</td>\n",
       "      <td>10600</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>BLTE</td>\n",
       "      <td>Belite Bio Inc ADR</td>\n",
       "      <td>488.67</td>\n",
       "      <td>963</td>\n",
       "      <td>-1.81</td>\n",
       "      <td>1948.48</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-35.30</td>\n",
       "      <td>20</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>VKTX</td>\n",
       "      <td>Viking Therapeutics Inc</td>\n",
       "      <td>487.87</td>\n",
       "      <td>3521</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5263.12</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>GMAB</td>\n",
       "      <td>Genmab ADR</td>\n",
       "      <td>434.73</td>\n",
       "      <td>5678</td>\n",
       "      <td>53.42</td>\n",
       "      <td>12832.72</td>\n",
       "      <td>19844.00</td>\n",
       "      <td>6855.00</td>\n",
       "      <td>2635</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>BHVN</td>\n",
       "      <td>Biohaven Ltd</td>\n",
       "      <td>426.99</td>\n",
       "      <td>816</td>\n",
       "      <td>-20.08</td>\n",
       "      <td>4190.50</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-841.60</td>\n",
       "      <td>239</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>BMRN</td>\n",
       "      <td>Biomarin Pharmaceutical Inc</td>\n",
       "      <td>407.77</td>\n",
       "      <td>9276</td>\n",
       "      <td>3.41</td>\n",
       "      <td>12490.81</td>\n",
       "      <td>2752.81</td>\n",
       "      <td>426.09</td>\n",
       "      <td>3401</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>ACLX</td>\n",
       "      <td>Arcellx Inc</td>\n",
       "      <td>398.81</td>\n",
       "      <td>1047</td>\n",
       "      <td>-1.45</td>\n",
       "      <td>4510.91</td>\n",
       "      <td>155.82</td>\n",
       "      <td>-65.30</td>\n",
       "      <td>130</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>BPMC</td>\n",
       "      <td>Blueprint Medicines Corp</td>\n",
       "      <td>393.85</td>\n",
       "      <td>3519</td>\n",
       "      <td>-4.33</td>\n",
       "      <td>6059.73</td>\n",
       "      <td>434.42</td>\n",
       "      <td>-262.13</td>\n",
       "      <td>638</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>MLTX</td>\n",
       "      <td>MoonLake Immunotherapeutics</td>\n",
       "      <td>389.42</td>\n",
       "      <td>1519</td>\n",
       "      <td>-3.25</td>\n",
       "      <td>3341.13</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-108.45</td>\n",
       "      <td>50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>NUVL</td>\n",
       "      <td>Nuvalent Inc</td>\n",
       "      <td>363.25</td>\n",
       "      <td>1237</td>\n",
       "      <td>0.00</td>\n",
       "      <td>6211.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>127</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>CORT</td>\n",
       "      <td>Corcept Therapeutics Inc</td>\n",
       "      <td>352.98</td>\n",
       "      <td>7552</td>\n",
       "      <td>2.48</td>\n",
       "      <td>5807.68</td>\n",
       "      <td>628.56</td>\n",
       "      <td>144.09</td>\n",
       "      <td>352</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>MRUS</td>\n",
       "      <td>Merus N.V</td>\n",
       "      <td>326.59</td>\n",
       "      <td>3134</td>\n",
       "      <td>-7.80</td>\n",
       "      <td>2930.25</td>\n",
       "      <td>35.93</td>\n",
       "      <td>-228.46</td>\n",
       "      <td>172</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>VERA</td>\n",
       "      <td>Vera Therapeutics Inc</td>\n",
       "      <td>283.04</td>\n",
       "      <td>1313</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2783.68</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>82</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>XENE</td>\n",
       "      <td>Xenon Pharmaceuticals Inc</td>\n",
       "      <td>281.43</td>\n",
       "      <td>3695</td>\n",
       "      <td>-7.42</td>\n",
       "      <td>3149.46</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-233.68</td>\n",
       "      <td>251</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>IONS</td>\n",
       "      <td>Ionis Pharmaceuticals Inc</td>\n",
       "      <td>266.10</td>\n",
       "      <td>12268</td>\n",
       "      <td>-5.59</td>\n",
       "      <td>6015.88</td>\n",
       "      <td>803.07</td>\n",
       "      <td>-336.27</td>\n",
       "      <td>927</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>PTGX</td>\n",
       "      <td>Protagonist Therapeutics Inc</td>\n",
       "      <td>251.11</td>\n",
       "      <td>3050</td>\n",
       "      <td>6.07</td>\n",
       "      <td>2470.93</td>\n",
       "      <td>323.80</td>\n",
       "      <td>150.07</td>\n",
       "      <td>126</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>CPRX</td>\n",
       "      <td>Catalyst Pharmaceuticals Inc</td>\n",
       "      <td>250.49</td>\n",
       "      <td>6614</td>\n",
       "      <td>8.19</td>\n",
       "      <td>2582.26</td>\n",
       "      <td>460.48</td>\n",
       "      <td>211.43</td>\n",
       "      <td>167</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>LGND</td>\n",
       "      <td>Ligand Pharmaceuticals, Inc</td>\n",
       "      <td>240.08</td>\n",
       "      <td>11717</td>\n",
       "      <td>2.28</td>\n",
       "      <td>2311.66</td>\n",
       "      <td>152.42</td>\n",
       "      <td>52.63</td>\n",
       "      <td>58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>PCVX</td>\n",
       "      <td>Vaxcyte Inc</td>\n",
       "      <td>235.45</td>\n",
       "      <td>1649</td>\n",
       "      <td>-5.37</td>\n",
       "      <td>11153.76</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-599.03</td>\n",
       "      <td>254</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>MIRM</td>\n",
       "      <td>Mirum Pharmaceuticals Inc</td>\n",
       "      <td>221.27</td>\n",
       "      <td>1979</td>\n",
       "      <td>-3.58</td>\n",
       "      <td>2034.91</td>\n",
       "      <td>307.03</td>\n",
       "      <td>-72.90</td>\n",
       "      <td>311</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>SRPT</td>\n",
       "      <td>Sarepta Therapeutics Inc</td>\n",
       "      <td>217.21</td>\n",
       "      <td>10058</td>\n",
       "      <td>0.99</td>\n",
       "      <td>12110.93</td>\n",
       "      <td>1640.35</td>\n",
       "      <td>119.67</td>\n",
       "      <td>1314</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>CRSP</td>\n",
       "      <td>CRISPR Therapeutics AG</td>\n",
       "      <td>210.72</td>\n",
       "      <td>2981</td>\n",
       "      <td>-8.29</td>\n",
       "      <td>3776.04</td>\n",
       "      <td>202.83</td>\n",
       "      <td>-313.08</td>\n",
       "      <td>407</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>VRNA</td>\n",
       "      <td>Verona Pharma Plc ADR</td>\n",
       "      <td>206.81</td>\n",
       "      <td>2790</td>\n",
       "      <td>-4.30</td>\n",
       "      <td>3492.56</td>\n",
       "      <td>5.62</td>\n",
       "      <td>-150.30</td>\n",
       "      <td>79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>XNCR</td>\n",
       "      <td>Xencor Inc</td>\n",
       "      <td>188.13</td>\n",
       "      <td>4032</td>\n",
       "      <td>-11.80</td>\n",
       "      <td>1715.96</td>\n",
       "      <td>85.16</td>\n",
       "      <td>-202.48</td>\n",
       "      <td>280</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>PTCT</td>\n",
       "      <td>PTC Therapeutics Inc</td>\n",
       "      <td>181.20</td>\n",
       "      <td>4198</td>\n",
       "      <td>0.58</td>\n",
       "      <td>3749.05</td>\n",
       "      <td>900.66</td>\n",
       "      <td>21.85</td>\n",
       "      <td>988</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>SRRK</td>\n",
       "      <td>Scholar Rock Holding Corp</td>\n",
       "      <td>179.87</td>\n",
       "      <td>2398</td>\n",
       "      <td>-5.69</td>\n",
       "      <td>4013.27</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-228.52</td>\n",
       "      <td>150</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>GLSI</td>\n",
       "      <td>Greenwich LifeSciences Inc</td>\n",
       "      <td>170.20</td>\n",
       "      <td>1544</td>\n",
       "      <td>-6.21</td>\n",
       "      <td>169.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-10.53</td>\n",
       "      <td>3</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>IMVT</td>\n",
       "      <td>Immunovant Inc</td>\n",
       "      <td>164.12</td>\n",
       "      <td>2006</td>\n",
       "      <td>-8.68</td>\n",
       "      <td>4055.67</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-352.16</td>\n",
       "      <td>207</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>ACAD</td>\n",
       "      <td>Acadia Pharmaceuticals Inc</td>\n",
       "      <td>157.61</td>\n",
       "      <td>7509</td>\n",
       "      <td>4.32</td>\n",
       "      <td>2885.24</td>\n",
       "      <td>929.24</td>\n",
       "      <td>124.54</td>\n",
       "      <td>620</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>TARS</td>\n",
       "      <td>Tarsus Pharmaceuticals Inc</td>\n",
       "      <td>155.10</td>\n",
       "      <td>1523</td>\n",
       "      <td>-7.05</td>\n",
       "      <td>1977.48</td>\n",
       "      <td>129.62</td>\n",
       "      <td>-139.46</td>\n",
       "      <td>244</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>JANX</td>\n",
       "      <td>Janux Therapeutics Inc</td>\n",
       "      <td>142.98</td>\n",
       "      <td>1285</td>\n",
       "      <td>-2.32</td>\n",
       "      <td>3609.44</td>\n",
       "      <td>13.05</td>\n",
       "      <td>-83.88</td>\n",
       "      <td>76</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>EXEL</td>\n",
       "      <td>Exelixis Inc</td>\n",
       "      <td>137.49</td>\n",
       "      <td>9010</td>\n",
       "      <td>6.17</td>\n",
       "      <td>10300.83</td>\n",
       "      <td>2081.60</td>\n",
       "      <td>635.96</td>\n",
       "      <td>1310</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>APLS</td>\n",
       "      <td>Apellis Pharmaceuticals Inc</td>\n",
       "      <td>136.56</td>\n",
       "      <td>2595</td>\n",
       "      <td>-5.29</td>\n",
       "      <td>4187.07</td>\n",
       "      <td>715.22</td>\n",
       "      <td>-221.51</td>\n",
       "      <td>702</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>AUPH</td>\n",
       "      <td>Aurinia Pharmaceuticals Inc</td>\n",
       "      <td>134.25</td>\n",
       "      <td>3758</td>\n",
       "      <td>0.04</td>\n",
       "      <td>1378.81</td>\n",
       "      <td>220.36</td>\n",
       "      <td>0.50</td>\n",
       "      <td>300</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NAMS</td>\n",
       "      <td>NewAmsterdam Pharma Company NV</td>\n",
       "      <td>132.66</td>\n",
       "      <td>1407</td>\n",
       "      <td>-6.96</td>\n",
       "      <td>2645.28</td>\n",
       "      <td>33.59</td>\n",
       "      <td>-184.06</td>\n",
       "      <td>62</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>IDYA</td>\n",
       "      <td>Ideaya Biosciences Inc</td>\n",
       "      <td>125.11</td>\n",
       "      <td>2035</td>\n",
       "      <td>-9.87</td>\n",
       "      <td>2251.55</td>\n",
       "      <td>3.92</td>\n",
       "      <td>-222.31</td>\n",
       "      <td>124</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>MRNA</td>\n",
       "      <td>Moderna Inc</td>\n",
       "      <td>124.89</td>\n",
       "      <td>2202</td>\n",
       "      <td>-14.67</td>\n",
       "      <td>16100.78</td>\n",
       "      <td>5081.00</td>\n",
       "      <td>-2362.00</td>\n",
       "      <td>5600</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>RYTM</td>\n",
       "      <td>Rhythm Pharmaceuticals Inc</td>\n",
       "      <td>124.83</td>\n",
       "      <td>2626</td>\n",
       "      <td>-7.77</td>\n",
       "      <td>3395.50</td>\n",
       "      <td>112.53</td>\n",
       "      <td>-263.92</td>\n",
       "      <td>226</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>JUNS</td>\n",
       "      <td>Jupiter Neurosciences Inc</td>\n",
       "      <td>122.40</td>\n",
       "      <td>14</td>\n",
       "      <td>0.00</td>\n",
       "      <td>337.64</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>4</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>CRNX</td>\n",
       "      <td>Crinetics Pharmaceuticals Inc</td>\n",
       "      <td>118.93</td>\n",
       "      <td>2344</td>\n",
       "      <td>-6.01</td>\n",
       "      <td>5066.26</td>\n",
       "      <td>1.04</td>\n",
       "      <td>-304.51</td>\n",
       "      <td>290</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>ADMA</td>\n",
       "      <td>Adma Biologics Inc</td>\n",
       "      <td>117.43</td>\n",
       "      <td>4079</td>\n",
       "      <td>2.81</td>\n",
       "      <td>4486.68</td>\n",
       "      <td>382.81</td>\n",
       "      <td>125.89</td>\n",
       "      <td>624</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>MNMD</td>\n",
       "      <td>Mind Medicine Inc</td>\n",
       "      <td>112.15</td>\n",
       "      <td>2954</td>\n",
       "      <td>0.00</td>\n",
       "      <td>542.65</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>57</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>APGE</td>\n",
       "      <td>Apogee Therapeutics Inc</td>\n",
       "      <td>109.61</td>\n",
       "      <td>522</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2686.39</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>91</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>DYAI</td>\n",
       "      <td>Dyadic International Inc., DE</td>\n",
       "      <td>103.75</td>\n",
       "      <td>6180</td>\n",
       "      <td>0.00</td>\n",
       "      <td>44.09</td>\n",
       "      <td>1.80</td>\n",
       "      <td>0.00</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>MDXG</td>\n",
       "      <td>Mimedx Group Inc</td>\n",
       "      <td>97.55</td>\n",
       "      <td>6153</td>\n",
       "      <td>4.85</td>\n",
       "      <td>1391.58</td>\n",
       "      <td>342.80</td>\n",
       "      <td>67.51</td>\n",
       "      <td>895</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>PRTA</td>\n",
       "      <td>Prothena Corporation plc</td>\n",
       "      <td>77.64</td>\n",
       "      <td>4382</td>\n",
       "      <td>-24.65</td>\n",
       "      <td>678.53</td>\n",
       "      <td>133.35</td>\n",
       "      <td>-167.23</td>\n",
       "      <td>173</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>OCS</td>\n",
       "      <td>Oculis Holding AG</td>\n",
       "      <td>76.19</td>\n",
       "      <td>1309</td>\n",
       "      <td>-9.48</td>\n",
       "      <td>717.26</td>\n",
       "      <td>0.87</td>\n",
       "      <td>-68.00</td>\n",
       "      <td>36</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>IZTC</td>\n",
       "      <td>Invizyne Technologies Inc</td>\n",
       "      <td>75.38</td>\n",
       "      <td>34</td>\n",
       "      <td>-3.16</td>\n",
       "      <td>148.27</td>\n",
       "      <td>-0.00</td>\n",
       "      <td>-4.68</td>\n",
       "      <td>29</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>SMMT</td>\n",
       "      <td>Summit Therapeutics Inc</td>\n",
       "      <td>74.98</td>\n",
       "      <td>3575</td>\n",
       "      <td>-1.32</td>\n",
       "      <td>13775.53</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-181.49</td>\n",
       "      <td>105</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>GLPG</td>\n",
       "      <td>Galapagos NV ADR</td>\n",
       "      <td>74.50</td>\n",
       "      <td>4677</td>\n",
       "      <td>-7.67</td>\n",
       "      <td>1773.29</td>\n",
       "      <td>260.09</td>\n",
       "      <td>-136.03</td>\n",
       "      <td>1123</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>SWTX</td>\n",
       "      <td>SpringWorks Therapeutics Inc</td>\n",
       "      <td>69.24</td>\n",
       "      <td>1922</td>\n",
       "      <td>-10.34</td>\n",
       "      <td>2827.43</td>\n",
       "      <td>135.49</td>\n",
       "      <td>-292.26</td>\n",
       "      <td>305</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>DNTH</td>\n",
       "      <td>Dianthus Therapeutics Inc</td>\n",
       "      <td>63.98</td>\n",
       "      <td>2371</td>\n",
       "      <td>-11.64</td>\n",
       "      <td>711.22</td>\n",
       "      <td>5.37</td>\n",
       "      <td>-82.81</td>\n",
       "      <td>53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>AKRO</td>\n",
       "      <td>Akero Therapeutics Inc</td>\n",
       "      <td>57.70</td>\n",
       "      <td>2007</td>\n",
       "      <td>-13.20</td>\n",
       "      <td>2040.23</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-269.27</td>\n",
       "      <td>60</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>RVMD</td>\n",
       "      <td>Revolution Medicines Inc</td>\n",
       "      <td>55.74</td>\n",
       "      <td>1769</td>\n",
       "      <td>-7.52</td>\n",
       "      <td>8262.18</td>\n",
       "      <td>0.74</td>\n",
       "      <td>-621.56</td>\n",
       "      <td>490</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>ELVN</td>\n",
       "      <td>Enliven Therapeutics Inc</td>\n",
       "      <td>54.33</td>\n",
       "      <td>1741</td>\n",
       "      <td>-8.58</td>\n",
       "      <td>1151.61</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-98.78</td>\n",
       "      <td>46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>DRUG</td>\n",
       "      <td>Bright Minds Biosciences Inc</td>\n",
       "      <td>51.85</td>\n",
       "      <td>1366</td>\n",
       "      <td>0.00</td>\n",
       "      <td>273.64</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>BEAM</td>\n",
       "      <td>Beam Therapeutics Inc</td>\n",
       "      <td>48.96</td>\n",
       "      <td>1776</td>\n",
       "      <td>-6.71</td>\n",
       "      <td>2395.57</td>\n",
       "      <td>349.64</td>\n",
       "      <td>-160.83</td>\n",
       "      <td>472</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>NVCT</td>\n",
       "      <td>Nuvectis Pharma Inc</td>\n",
       "      <td>44.62</td>\n",
       "      <td>1047</td>\n",
       "      <td>0.00</td>\n",
       "      <td>94.09</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>13</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>INVA</td>\n",
       "      <td>Innoviva Inc</td>\n",
       "      <td>36.75</td>\n",
       "      <td>7378</td>\n",
       "      <td>19.18</td>\n",
       "      <td>1153.11</td>\n",
       "      <td>352.74</td>\n",
       "      <td>221.19</td>\n",
       "      <td>112</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>AVBP</td>\n",
       "      <td>ArriVent BioPharma Inc</td>\n",
       "      <td>33.60</td>\n",
       "      <td>326</td>\n",
       "      <td>0.00</td>\n",
       "      <td>892.30</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>40</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>COYA</td>\n",
       "      <td>Coya Therapeutics Inc</td>\n",
       "      <td>28.88</td>\n",
       "      <td>719</td>\n",
       "      <td>-11.75</td>\n",
       "      <td>94.56</td>\n",
       "      <td>9.55</td>\n",
       "      <td>-11.11</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>KYMR</td>\n",
       "      <td>Kymera Therapeutics Inc</td>\n",
       "      <td>26.67</td>\n",
       "      <td>1579</td>\n",
       "      <td>-6.83</td>\n",
       "      <td>2788.79</td>\n",
       "      <td>87.56</td>\n",
       "      <td>-190.49</td>\n",
       "      <td>184</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>AGIO</td>\n",
       "      <td>Agios Pharmaceuticals Inc</td>\n",
       "      <td>24.58</td>\n",
       "      <td>4164</td>\n",
       "      <td>-16.48</td>\n",
       "      <td>2434.62</td>\n",
       "      <td>32.87</td>\n",
       "      <td>-401.29</td>\n",
       "      <td>383</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>LENZ</td>\n",
       "      <td>LENZ Therapeutics Inc</td>\n",
       "      <td>23.24</td>\n",
       "      <td>1271</td>\n",
       "      <td>-8.06</td>\n",
       "      <td>848.40</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-68.34</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>ARVN</td>\n",
       "      <td>Arvinas Inc</td>\n",
       "      <td>21.50</td>\n",
       "      <td>2273</td>\n",
       "      <td>-27.02</td>\n",
       "      <td>1304.86</td>\n",
       "      <td>161.10</td>\n",
       "      <td>-352.60</td>\n",
       "      <td>445</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>OSTX</td>\n",
       "      <td>OS Therapies Inc</td>\n",
       "      <td>20.32</td>\n",
       "      <td>138</td>\n",
       "      <td>-4.30</td>\n",
       "      <td>73.91</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-3.18</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>GPCR</td>\n",
       "      <td>Structure Therapeutics Inc ADR</td>\n",
       "      <td>20.19</td>\n",
       "      <td>683</td>\n",
       "      <td>-6.86</td>\n",
       "      <td>1775.08</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.84</td>\n",
       "      <td>136</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>EPRX</td>\n",
       "      <td>Eupraxia Pharmaceuticals Inc</td>\n",
       "      <td>16.71</td>\n",
       "      <td>256</td>\n",
       "      <td>-25.93</td>\n",
       "      <td>122.47</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.76</td>\n",
       "      <td>29</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>SNDX</td>\n",
       "      <td>Syndax Pharmaceuticals Inc</td>\n",
       "      <td>16.08</td>\n",
       "      <td>3212</td>\n",
       "      <td>-27.29</td>\n",
       "      <td>1177.08</td>\n",
       "      <td>16.00</td>\n",
       "      <td>-321.20</td>\n",
       "      <td>184</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>BCRX</td>\n",
       "      <td>Biocryst Pharmaceuticals Inc</td>\n",
       "      <td>15.85</td>\n",
       "      <td>11246</td>\n",
       "      <td>-2.07</td>\n",
       "      <td>1545.21</td>\n",
       "      <td>412.58</td>\n",
       "      <td>-31.94</td>\n",
       "      <td>536</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>BCYC</td>\n",
       "      <td>Bicycle Therapeutics Plc ADR</td>\n",
       "      <td>15.08</td>\n",
       "      <td>2035</td>\n",
       "      <td>-18.13</td>\n",
       "      <td>1043.98</td>\n",
       "      <td>36.90</td>\n",
       "      <td>-189.32</td>\n",
       "      <td>284</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>RNA</td>\n",
       "      <td>Avidity Biosciences Inc</td>\n",
       "      <td>14.00</td>\n",
       "      <td>1649</td>\n",
       "      <td>-8.08</td>\n",
       "      <td>3983.73</td>\n",
       "      <td>10.12</td>\n",
       "      <td>-322.04</td>\n",
       "      <td>253</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>ROIV</td>\n",
       "      <td>Roivant Sciences Ltd</td>\n",
       "      <td>13.85</td>\n",
       "      <td>1470</td>\n",
       "      <td>-13.62</td>\n",
       "      <td>8808.20</td>\n",
       "      <td>129.13</td>\n",
       "      <td>-1199.66</td>\n",
       "      <td>908</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>RARE</td>\n",
       "      <td>Ultragenyx Pharmaceutical Inc</td>\n",
       "      <td>8.36</td>\n",
       "      <td>3973</td>\n",
       "      <td>-11.95</td>\n",
       "      <td>4192.43</td>\n",
       "      <td>522.74</td>\n",
       "      <td>-501.06</td>\n",
       "      <td>1276</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>DYN</td>\n",
       "      <td>Dyne Therapeutics Inc</td>\n",
       "      <td>7.66</td>\n",
       "      <td>1552</td>\n",
       "      <td>-11.78</td>\n",
       "      <td>2656.09</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-312.84</td>\n",
       "      <td>173</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>DNLI</td>\n",
       "      <td>Denali Therapeutics Inc</td>\n",
       "      <td>7.09</td>\n",
       "      <td>2566</td>\n",
       "      <td>-15.27</td>\n",
       "      <td>3351.94</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-511.85</td>\n",
       "      <td>390</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>NRIX</td>\n",
       "      <td>Nurix Therapeutics Inc</td>\n",
       "      <td>6.63</td>\n",
       "      <td>1607</td>\n",
       "      <td>-12.65</td>\n",
       "      <td>1474.10</td>\n",
       "      <td>56.42</td>\n",
       "      <td>-186.40</td>\n",
       "      <td>284</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>AVXL</td>\n",
       "      <td>Anavex Life Sciences Corporation</td>\n",
       "      <td>5.75</td>\n",
       "      <td>6712</td>\n",
       "      <td>0.00</td>\n",
       "      <td>778.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>40</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>QURE</td>\n",
       "      <td>uniQure N.V</td>\n",
       "      <td>5.41</td>\n",
       "      <td>3968</td>\n",
       "      <td>-22.32</td>\n",
       "      <td>848.13</td>\n",
       "      <td>28.59</td>\n",
       "      <td>-189.32</td>\n",
       "      <td>480</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>SEPN</td>\n",
       "      <td>Septerna Inc</td>\n",
       "      <td>4.63</td>\n",
       "      <td>53</td>\n",
       "      <td>-6.00</td>\n",
       "      <td>963.09</td>\n",
       "      <td>0.84</td>\n",
       "      <td>-57.77</td>\n",
       "      <td>68</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>TLX</td>\n",
       "      <td>Telix Pharmaceuticals Ltd. ADR</td>\n",
       "      <td>4.03</td>\n",
       "      <td>33</td>\n",
       "      <td>1.38</td>\n",
       "      <td>5295.33</td>\n",
       "      <td>645.68</td>\n",
       "      <td>73.14</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>TELO</td>\n",
       "      <td>Telomir Pharmaceuticals Inc</td>\n",
       "      <td>4.00</td>\n",
       "      <td>312</td>\n",
       "      <td>0.00</td>\n",
       "      <td>146.98</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>1</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>MDCX</td>\n",
       "      <td>Medicus Pharma Ltd</td>\n",
       "      <td>3.77</td>\n",
       "      <td>33</td>\n",
       "      <td>0.00</td>\n",
       "      <td>34.86</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>MURA</td>\n",
       "      <td>Mural Oncology plc</td>\n",
       "      <td>3.41</td>\n",
       "      <td>389</td>\n",
       "      <td>-286.93</td>\n",
       "      <td>58.69</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-168.40</td>\n",
       "      <td>107</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>ACTU</td>\n",
       "      <td>Actuate Therapeutics Inc</td>\n",
       "      <td>0.12</td>\n",
       "      <td>126</td>\n",
       "      <td>0.00</td>\n",
       "      <td>169.73</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>11</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>BBIO</td>\n",
       "      <td>BridgeBio Pharma Inc</td>\n",
       "      <td>-0.22</td>\n",
       "      <td>2000</td>\n",
       "      <td>-9.74</td>\n",
       "      <td>5236.91</td>\n",
       "      <td>217.76</td>\n",
       "      <td>-509.90</td>\n",
       "      <td>550</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>LQDA</td>\n",
       "      <td>Liquidia Corp</td>\n",
       "      <td>-1.62</td>\n",
       "      <td>2336</td>\n",
       "      <td>-10.27</td>\n",
       "      <td>933.54</td>\n",
       "      <td>14.84</td>\n",
       "      <td>-95.84</td>\n",
       "      <td>145</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>ZYME</td>\n",
       "      <td>Zymeworks BC Inc</td>\n",
       "      <td>-3.23</td>\n",
       "      <td>2790</td>\n",
       "      <td>-12.09</td>\n",
       "      <td>948.44</td>\n",
       "      <td>62.20</td>\n",
       "      <td>-114.71</td>\n",
       "      <td>294</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>CADL</td>\n",
       "      <td>Candel Therapeutics Inc</td>\n",
       "      <td>-3.57</td>\n",
       "      <td>1239</td>\n",
       "      <td>-17.34</td>\n",
       "      <td>199.89</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-34.66</td>\n",
       "      <td>42</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>MDGL</td>\n",
       "      <td>Madrigal Pharmaceuticals Inc</td>\n",
       "      <td>-4.29</td>\n",
       "      <td>6524</td>\n",
       "      <td>-8.07</td>\n",
       "      <td>6782.82</td>\n",
       "      <td>76.81</td>\n",
       "      <td>-547.18</td>\n",
       "      <td>376</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>ACOG</td>\n",
       "      <td>Alpha Cognition Inc</td>\n",
       "      <td>-4.91</td>\n",
       "      <td>35</td>\n",
       "      <td>0.00</td>\n",
       "      <td>79.14</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>LEGN</td>\n",
       "      <td>Legend Biotech Corp ADR</td>\n",
       "      <td>-5.08</td>\n",
       "      <td>1656</td>\n",
       "      <td>-5.62</td>\n",
       "      <td>6055.68</td>\n",
       "      <td>520.18</td>\n",
       "      <td>-340.56</td>\n",
       "      <td>2400</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>RCUS</td>\n",
       "      <td>Arcus Biosciences Inc</td>\n",
       "      <td>-5.41</td>\n",
       "      <td>2469</td>\n",
       "      <td>-19.06</td>\n",
       "      <td>1510.86</td>\n",
       "      <td>263.00</td>\n",
       "      <td>-288.00</td>\n",
       "      <td>577</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>ZLAB</td>\n",
       "      <td>Zai Lab Limited ADR</td>\n",
       "      <td>-5.73</td>\n",
       "      <td>2645</td>\n",
       "      <td>-11.48</td>\n",
       "      <td>2846.68</td>\n",
       "      <td>355.75</td>\n",
       "      <td>-326.92</td>\n",
       "      <td>2175</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>KROS</td>\n",
       "      <td>Keros Therapeutics Inc</td>\n",
       "      <td>-6.23</td>\n",
       "      <td>1714</td>\n",
       "      <td>-25.79</td>\n",
       "      <td>786.65</td>\n",
       "      <td>0.65</td>\n",
       "      <td>-202.89</td>\n",
       "      <td>160</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>CRGX</td>\n",
       "      <td>CARGO Therapeutics Inc</td>\n",
       "      <td>-6.47</td>\n",
       "      <td>400</td>\n",
       "      <td>-25.44</td>\n",
       "      <td>667.40</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-169.78</td>\n",
       "      <td>170</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>IMNM</td>\n",
       "      <td>Immunome Inc</td>\n",
       "      <td>-6.47</td>\n",
       "      <td>1537</td>\n",
       "      <td>-14.22</td>\n",
       "      <td>776.46</td>\n",
       "      <td>10.13</td>\n",
       "      <td>-110.44</td>\n",
       "      <td>55</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>EWTX</td>\n",
       "      <td>Edgewise Therapeutics Inc</td>\n",
       "      <td>-7.93</td>\n",
       "      <td>1362</td>\n",
       "      <td>-4.69</td>\n",
       "      <td>3095.37</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-145.18</td>\n",
       "      <td>108</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>UPB</td>\n",
       "      <td>Upstream Bio Inc</td>\n",
       "      <td>-7.95</td>\n",
       "      <td>67</td>\n",
       "      <td>-6.45</td>\n",
       "      <td>1018.87</td>\n",
       "      <td>2.21</td>\n",
       "      <td>-65.72</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>ANAB</td>\n",
       "      <td>AnaptysBio Inc</td>\n",
       "      <td>-8.29</td>\n",
       "      <td>2882</td>\n",
       "      <td>-27.52</td>\n",
       "      <td>506.64</td>\n",
       "      <td>57.17</td>\n",
       "      <td>-139.45</td>\n",
       "      <td>117</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>CTNM</td>\n",
       "      <td>Contineum Therapeutics Inc</td>\n",
       "      <td>-8.90</td>\n",
       "      <td>256</td>\n",
       "      <td>-12.30</td>\n",
       "      <td>352.12</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-43.30</td>\n",
       "      <td>31</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>RAPP</td>\n",
       "      <td>Rapport Therapeutics Inc</td>\n",
       "      <td>-9.76</td>\n",
       "      <td>193</td>\n",
       "      <td>-10.86</td>\n",
       "      <td>678.86</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-73.70</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>ARTV</td>\n",
       "      <td>Artiva Biotherapeutics Inc</td>\n",
       "      <td>-11.50</td>\n",
       "      <td>151</td>\n",
       "      <td>-23.19</td>\n",
       "      <td>252.61</td>\n",
       "      <td>2.60</td>\n",
       "      <td>-58.57</td>\n",
       "      <td>82</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>CSBR</td>\n",
       "      <td>Champions Oncology Inc</td>\n",
       "      <td>-12.08</td>\n",
       "      <td>6528</td>\n",
       "      <td>-1.38</td>\n",
       "      <td>84.96</td>\n",
       "      <td>51.66</td>\n",
       "      <td>-1.17</td>\n",
       "      <td>210</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>CELC</td>\n",
       "      <td>Celcuity Inc</td>\n",
       "      <td>-12.39</td>\n",
       "      <td>2645</td>\n",
       "      <td>-18.30</td>\n",
       "      <td>465.98</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-85.28</td>\n",
       "      <td>55</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>HRMY</td>\n",
       "      <td>Harmony Biosciences Holdings Inc</td>\n",
       "      <td>-12.48</td>\n",
       "      <td>1581</td>\n",
       "      <td>10.58</td>\n",
       "      <td>1885.45</td>\n",
       "      <td>681.88</td>\n",
       "      <td>199.56</td>\n",
       "      <td>246</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>OMER</td>\n",
       "      <td>Omeros Corporation</td>\n",
       "      <td>-12.60</td>\n",
       "      <td>5549</td>\n",
       "      <td>-39.22</td>\n",
       "      <td>439.84</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-172.51</td>\n",
       "      <td>198</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>ABVX</td>\n",
       "      <td>Abivax ADR</td>\n",
       "      <td>-14.34</td>\n",
       "      <td>424</td>\n",
       "      <td>-33.95</td>\n",
       "      <td>500.36</td>\n",
       "      <td>9.03</td>\n",
       "      <td>-169.87</td>\n",
       "      <td>62</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>INBX</td>\n",
       "      <td>Inhibrx Biosciences Inc</td>\n",
       "      <td>-15.05</td>\n",
       "      <td>196</td>\n",
       "      <td>-142.78</td>\n",
       "      <td>210.77</td>\n",
       "      <td>1.69</td>\n",
       "      <td>-300.93</td>\n",
       "      <td>166</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>WVE</td>\n",
       "      <td>Wave Life Sciences Ltd</td>\n",
       "      <td>-16.00</td>\n",
       "      <td>3324</td>\n",
       "      <td>-7.21</td>\n",
       "      <td>2051.39</td>\n",
       "      <td>53.61</td>\n",
       "      <td>-147.98</td>\n",
       "      <td>266</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>KOD</td>\n",
       "      <td>Kodiak Sciences Inc</td>\n",
       "      <td>-16.63</td>\n",
       "      <td>2266</td>\n",
       "      <td>-45.11</td>\n",
       "      <td>427.31</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-192.78</td>\n",
       "      <td>111</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>REPL</td>\n",
       "      <td>Replimune Group Inc</td>\n",
       "      <td>-17.22</td>\n",
       "      <td>2342</td>\n",
       "      <td>-23.61</td>\n",
       "      <td>960.41</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-226.71</td>\n",
       "      <td>331</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>URGN</td>\n",
       "      <td>UroGen Pharma Ltd</td>\n",
       "      <td>-18.81</td>\n",
       "      <td>2784</td>\n",
       "      <td>-17.46</td>\n",
       "      <td>476.85</td>\n",
       "      <td>89.36</td>\n",
       "      <td>-83.28</td>\n",
       "      <td>217</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>MBX</td>\n",
       "      <td>MBX Biosciences Inc</td>\n",
       "      <td>-19.92</td>\n",
       "      <td>95</td>\n",
       "      <td>-9.28</td>\n",
       "      <td>639.61</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-59.35</td>\n",
       "      <td>38</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>CGON</td>\n",
       "      <td>Cg Oncology Inc</td>\n",
       "      <td>-22.63</td>\n",
       "      <td>327</td>\n",
       "      <td>-4.86</td>\n",
       "      <td>1975.46</td>\n",
       "      <td>0.68</td>\n",
       "      <td>-95.94</td>\n",
       "      <td>61</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>CNTA</td>\n",
       "      <td>Centessa Pharmaceuticals plc ADR</td>\n",
       "      <td>-23.82</td>\n",
       "      <td>1299</td>\n",
       "      <td>-7.30</td>\n",
       "      <td>2208.40</td>\n",
       "      <td>6.85</td>\n",
       "      <td>-161.30</td>\n",
       "      <td>76</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>IMTX</td>\n",
       "      <td>Immatics N.V</td>\n",
       "      <td>-24.90</td>\n",
       "      <td>2197</td>\n",
       "      <td>-10.77</td>\n",
       "      <td>883.67</td>\n",
       "      <td>70.87</td>\n",
       "      <td>-95.19</td>\n",
       "      <td>542</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>BCAX</td>\n",
       "      <td>Bicara Therapeutics Inc</td>\n",
       "      <td>-25.25</td>\n",
       "      <td>95</td>\n",
       "      <td>-7.32</td>\n",
       "      <td>947.38</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-69.38</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>TRDA</td>\n",
       "      <td>Entrada Therapeutics Inc</td>\n",
       "      <td>-26.26</td>\n",
       "      <td>1145</td>\n",
       "      <td>9.10</td>\n",
       "      <td>673.93</td>\n",
       "      <td>215.23</td>\n",
       "      <td>61.30</td>\n",
       "      <td>177</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>NTRB</td>\n",
       "      <td>Nutriband Inc</td>\n",
       "      <td>-27.84</td>\n",
       "      <td>1173</td>\n",
       "      <td>-11.05</td>\n",
       "      <td>49.42</td>\n",
       "      <td>2.02</td>\n",
       "      <td>-5.46</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>CAMP</td>\n",
       "      <td>CAMP4 Therapeutics Corp</td>\n",
       "      <td>-28.82</td>\n",
       "      <td>67</td>\n",
       "      <td>-38.70</td>\n",
       "      <td>128.22</td>\n",
       "      <td>0.35</td>\n",
       "      <td>-49.62</td>\n",
       "      <td>58</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>IBO</td>\n",
       "      <td>Impact BioMedical Inc</td>\n",
       "      <td>-29.48</td>\n",
       "      <td>92</td>\n",
       "      <td>-10.57</td>\n",
       "      <td>26.69</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-2.82</td>\n",
       "      <td>1</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>LXEO</td>\n",
       "      <td>Lexeo Therapeutics Inc</td>\n",
       "      <td>-31.54</td>\n",
       "      <td>410</td>\n",
       "      <td>-34.78</td>\n",
       "      <td>234.19</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-81.46</td>\n",
       "      <td>69</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>ALDX</td>\n",
       "      <td>Aldeyra Therapeutics Inc</td>\n",
       "      <td>-31.94</td>\n",
       "      <td>3882</td>\n",
       "      <td>-16.39</td>\n",
       "      <td>301.32</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-49.39</td>\n",
       "      <td>9</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>GDTC</td>\n",
       "      <td>CytoMed Therapeutics Ltd</td>\n",
       "      <td>-32.10</td>\n",
       "      <td>613</td>\n",
       "      <td>-10.20</td>\n",
       "      <td>30.58</td>\n",
       "      <td>0.45</td>\n",
       "      <td>-3.12</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>IMCR</td>\n",
       "      <td>Immunocore Holdings plc ADR</td>\n",
       "      <td>-33.08</td>\n",
       "      <td>1411</td>\n",
       "      <td>-4.42</td>\n",
       "      <td>1467.46</td>\n",
       "      <td>296.31</td>\n",
       "      <td>-64.89</td>\n",
       "      <td>497</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>THRD</td>\n",
       "      <td>Third Harmonic Bio Inc</td>\n",
       "      <td>-33.76</td>\n",
       "      <td>825</td>\n",
       "      <td>-10.54</td>\n",
       "      <td>501.05</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-52.79</td>\n",
       "      <td>51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>OCUL</td>\n",
       "      <td>Ocular Therapeutix Inc</td>\n",
       "      <td>-33.92</td>\n",
       "      <td>3798</td>\n",
       "      <td>-7.84</td>\n",
       "      <td>1411.81</td>\n",
       "      <td>61.10</td>\n",
       "      <td>-110.75</td>\n",
       "      <td>267</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>KAPA</td>\n",
       "      <td>Kairos Pharma Ltd</td>\n",
       "      <td>-34.62</td>\n",
       "      <td>92</td>\n",
       "      <td>-8.09</td>\n",
       "      <td>21.39</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-1.73</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>FOLD</td>\n",
       "      <td>Amicus Therapeutics Inc</td>\n",
       "      <td>-35.14</td>\n",
       "      <td>6410</td>\n",
       "      <td>0.78</td>\n",
       "      <td>2958.18</td>\n",
       "      <td>493.67</td>\n",
       "      <td>23.09</td>\n",
       "      <td>500</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>MLYS</td>\n",
       "      <td>Mineralys Therapeutics Inc</td>\n",
       "      <td>-35.47</td>\n",
       "      <td>676</td>\n",
       "      <td>0.00</td>\n",
       "      <td>605.19</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>28</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>KURA</td>\n",
       "      <td>Kura Oncology Inc</td>\n",
       "      <td>-35.80</td>\n",
       "      <td>3380</td>\n",
       "      <td>-27.93</td>\n",
       "      <td>775.69</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-216.64</td>\n",
       "      <td>142</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>PLRZ</td>\n",
       "      <td>Polyrizon Ltd</td>\n",
       "      <td>-36.06</td>\n",
       "      <td>49</td>\n",
       "      <td>-15.51</td>\n",
       "      <td>4.19</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-0.65</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>PHVS</td>\n",
       "      <td>Pharvaris NV</td>\n",
       "      <td>-36.55</td>\n",
       "      <td>1411</td>\n",
       "      <td>-11.57</td>\n",
       "      <td>1003.31</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-116.10</td>\n",
       "      <td>83</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>ALMS</td>\n",
       "      <td>Alumis Inc</td>\n",
       "      <td>-36.92</td>\n",
       "      <td>172</td>\n",
       "      <td>-51.21</td>\n",
       "      <td>466.81</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-239.06</td>\n",
       "      <td>107</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>FTRE</td>\n",
       "      <td>Fortrea Holdings Inc</td>\n",
       "      <td>-37.50</td>\n",
       "      <td>546</td>\n",
       "      <td>1.49</td>\n",
       "      <td>1821.81</td>\n",
       "      <td>2975.60</td>\n",
       "      <td>27.10</td>\n",
       "      <td>15500</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>PLRX</td>\n",
       "      <td>Pliant Therapeutics Inc</td>\n",
       "      <td>-37.56</td>\n",
       "      <td>1658</td>\n",
       "      <td>-26.34</td>\n",
       "      <td>834.91</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-219.95</td>\n",
       "      <td>166</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>PSTX</td>\n",
       "      <td>Poseida Therapeutics Inc</td>\n",
       "      <td>-38.05</td>\n",
       "      <td>1621</td>\n",
       "      <td>-6.15</td>\n",
       "      <td>926.91</td>\n",
       "      <td>150.86</td>\n",
       "      <td>-57.02</td>\n",
       "      <td>350</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>ENGN</td>\n",
       "      <td>enGene Holdings Inc</td>\n",
       "      <td>-38.34</td>\n",
       "      <td>1050</td>\n",
       "      <td>-17.13</td>\n",
       "      <td>321.15</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-55.00</td>\n",
       "      <td>31</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>RPRX</td>\n",
       "      <td>Royalty Pharma plc</td>\n",
       "      <td>-38.43</td>\n",
       "      <td>1645</td>\n",
       "      <td>0.00</td>\n",
       "      <td>14729.57</td>\n",
       "      <td>2266.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>NMRA</td>\n",
       "      <td>Neumora Therapeutics Inc</td>\n",
       "      <td>-39.29</td>\n",
       "      <td>460</td>\n",
       "      <td>-14.24</td>\n",
       "      <td>1756.17</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-250.00</td>\n",
       "      <td>124</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>INMB</td>\n",
       "      <td>INmune Bio Inc</td>\n",
       "      <td>-40.55</td>\n",
       "      <td>2143</td>\n",
       "      <td>0.00</td>\n",
       "      <td>112.64</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.00</td>\n",
       "      <td>11</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>NTLA</td>\n",
       "      <td>Intellia Therapeutics Inc</td>\n",
       "      <td>-41.63</td>\n",
       "      <td>3147</td>\n",
       "      <td>-38.71</td>\n",
       "      <td>1362.74</td>\n",
       "      <td>43.09</td>\n",
       "      <td>-527.52</td>\n",
       "      <td>526</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>ARQT</td>\n",
       "      <td>Arcutis Biotherapeutics Inc</td>\n",
       "      <td>-41.79</td>\n",
       "      <td>1782</td>\n",
       "      <td>-11.30</td>\n",
       "      <td>1588.30</td>\n",
       "      <td>138.71</td>\n",
       "      <td>-179.41</td>\n",
       "      <td>296</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>MREO</td>\n",
       "      <td>Mereo Biopharma Group Plc ADR</td>\n",
       "      <td>-42.46</td>\n",
       "      <td>2064</td>\n",
       "      <td>-7.00</td>\n",
       "      <td>535.25</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-37.48</td>\n",
       "      <td>33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>TYRA</td>\n",
       "      <td>Tyra Biosciences Inc</td>\n",
       "      <td>-42.54</td>\n",
       "      <td>1189</td>\n",
       "      <td>-13.07</td>\n",
       "      <td>762.08</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-99.59</td>\n",
       "      <td>49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>MESO</td>\n",
       "      <td>Mesoblast Ltd ADR</td>\n",
       "      <td>-42.63</td>\n",
       "      <td>5445</td>\n",
       "      <td>-4.06</td>\n",
       "      <td>1380.90</td>\n",
       "      <td>5.90</td>\n",
       "      <td>-56.08</td>\n",
       "      <td>73</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>AURA</td>\n",
       "      <td>Aura Biosciences Inc</td>\n",
       "      <td>-43.18</td>\n",
       "      <td>1145</td>\n",
       "      <td>-20.68</td>\n",
       "      <td>444.07</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-91.84</td>\n",
       "      <td>88</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>TLSA</td>\n",
       "      <td>Tiziana Life Sciences Ltd</td>\n",
       "      <td>-43.74</td>\n",
       "      <td>2219</td>\n",
       "      <td>-16.36</td>\n",
       "      <td>96.49</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.79</td>\n",
       "      <td>9</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>CRMD</td>\n",
       "      <td>CorMedix Inc</td>\n",
       "      <td>-44.13</td>\n",
       "      <td>5332</td>\n",
       "      <td>-10.07</td>\n",
       "      <td>504.23</td>\n",
       "      <td>12.26</td>\n",
       "      <td>-50.77</td>\n",
       "      <td>82</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>IMMX</td>\n",
       "      <td>Immix Biopharma Inc</td>\n",
       "      <td>-44.41</td>\n",
       "      <td>1097</td>\n",
       "      <td>-37.62</td>\n",
       "      <td>53.64</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.18</td>\n",
       "      <td>14</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>ANVS</td>\n",
       "      <td>Annovis Bio Inc</td>\n",
       "      <td>-44.63</td>\n",
       "      <td>1784</td>\n",
       "      <td>0.00</td>\n",
       "      <td>68.99</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>6</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>ABUS</td>\n",
       "      <td>Arbutus Biopharma Corp</td>\n",
       "      <td>-44.76</td>\n",
       "      <td>6354</td>\n",
       "      <td>-11.47</td>\n",
       "      <td>672.70</td>\n",
       "      <td>6.74</td>\n",
       "      <td>-77.14</td>\n",
       "      <td>73</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>DAWN</td>\n",
       "      <td>Day One Biopharmaceuticals Inc</td>\n",
       "      <td>-45.74</td>\n",
       "      <td>1300</td>\n",
       "      <td>-16.15</td>\n",
       "      <td>1272.68</td>\n",
       "      <td>101.95</td>\n",
       "      <td>-205.50</td>\n",
       "      <td>174</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>PHAR</td>\n",
       "      <td>Pharming Group N.V. ADR</td>\n",
       "      <td>-46.22</td>\n",
       "      <td>1455</td>\n",
       "      <td>-0.50</td>\n",
       "      <td>614.52</td>\n",
       "      <td>285.74</td>\n",
       "      <td>-3.06</td>\n",
       "      <td>382</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>VIR</td>\n",
       "      <td>Vir Biotechnology Inc</td>\n",
       "      <td>-46.86</td>\n",
       "      <td>1894</td>\n",
       "      <td>-51.28</td>\n",
       "      <td>1041.16</td>\n",
       "      <td>78.62</td>\n",
       "      <td>-533.94</td>\n",
       "      <td>587</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>PRTC</td>\n",
       "      <td>PureTech Health Plc ADR</td>\n",
       "      <td>-47.14</td>\n",
       "      <td>1492</td>\n",
       "      <td>-25.41</td>\n",
       "      <td>530.32</td>\n",
       "      <td>0.47</td>\n",
       "      <td>-134.73</td>\n",
       "      <td>90</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>TRVI</td>\n",
       "      <td>Trevi Therapeutics Inc</td>\n",
       "      <td>-47.15</td>\n",
       "      <td>2051</td>\n",
       "      <td>-14.75</td>\n",
       "      <td>325.91</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-48.07</td>\n",
       "      <td>27</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>GERN</td>\n",
       "      <td>Geron Corp</td>\n",
       "      <td>-47.30</td>\n",
       "      <td>10366</td>\n",
       "      <td>-9.01</td>\n",
       "      <td>2303.15</td>\n",
       "      <td>29.48</td>\n",
       "      <td>-207.45</td>\n",
       "      <td>141</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>ICCC</td>\n",
       "      <td>Immucell Corp</td>\n",
       "      <td>-47.52</td>\n",
       "      <td>13741</td>\n",
       "      <td>-1.51</td>\n",
       "      <td>41.80</td>\n",
       "      <td>23.22</td>\n",
       "      <td>-0.63</td>\n",
       "      <td>75</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>VERU</td>\n",
       "      <td>Veru Inc</td>\n",
       "      <td>-47.77</td>\n",
       "      <td>9441</td>\n",
       "      <td>-56.57</td>\n",
       "      <td>114.97</td>\n",
       "      <td>14.09</td>\n",
       "      <td>-65.04</td>\n",
       "      <td>189</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>CRVS</td>\n",
       "      <td>Corvus Pharmaceuticals Inc</td>\n",
       "      <td>-48.21</td>\n",
       "      <td>3191</td>\n",
       "      <td>-5.25</td>\n",
       "      <td>443.38</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.28</td>\n",
       "      <td>28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>FENC</td>\n",
       "      <td>Fennec Pharmaceuticals Inc</td>\n",
       "      <td>-49.58</td>\n",
       "      <td>2650</td>\n",
       "      <td>0.00</td>\n",
       "      <td>164.08</td>\n",
       "      <td>49.35</td>\n",
       "      <td>0.00</td>\n",
       "      <td>29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>RCKT</td>\n",
       "      <td>Rocket Pharmaceuticals Inc</td>\n",
       "      <td>-49.92</td>\n",
       "      <td>3590</td>\n",
       "      <td>-21.18</td>\n",
       "      <td>1250.52</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-264.84</td>\n",
       "      <td>268</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>LEXX</td>\n",
       "      <td>Lexaria Bioscience Corp</td>\n",
       "      <td>-50.00</td>\n",
       "      <td>1435</td>\n",
       "      <td>-12.02</td>\n",
       "      <td>37.70</td>\n",
       "      <td>0.41</td>\n",
       "      <td>-4.53</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>IPHA</td>\n",
       "      <td>Innate Pharma ADR</td>\n",
       "      <td>-50.08</td>\n",
       "      <td>1888</td>\n",
       "      <td>-18.33</td>\n",
       "      <td>196.20</td>\n",
       "      <td>33.79</td>\n",
       "      <td>-35.96</td>\n",
       "      <td>168</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>CYTK</td>\n",
       "      <td>Cytokinetics Inc</td>\n",
       "      <td>-50.13</td>\n",
       "      <td>7536</td>\n",
       "      <td>-8.84</td>\n",
       "      <td>5785.05</td>\n",
       "      <td>3.22</td>\n",
       "      <td>-511.14</td>\n",
       "      <td>423</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>ZBIO</td>\n",
       "      <td>Zenas Biopharma Inc</td>\n",
       "      <td>-50.85</td>\n",
       "      <td>95</td>\n",
       "      <td>-36.26</td>\n",
       "      <td>366.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-132.91</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>VNDA</td>\n",
       "      <td>Vanda Pharmaceuticals Inc</td>\n",
       "      <td>-52.38</td>\n",
       "      <td>6824</td>\n",
       "      <td>-11.17</td>\n",
       "      <td>269.97</td>\n",
       "      <td>190.86</td>\n",
       "      <td>-30.16</td>\n",
       "      <td>203</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>SPRY</td>\n",
       "      <td>ARS Pharmaceuticals Inc</td>\n",
       "      <td>-52.40</td>\n",
       "      <td>1474</td>\n",
       "      <td>-5.23</td>\n",
       "      <td>1155.05</td>\n",
       "      <td>2.57</td>\n",
       "      <td>-60.44</td>\n",
       "      <td>24</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>STOK</td>\n",
       "      <td>Stoke Therapeutics Inc</td>\n",
       "      <td>-52.84</td>\n",
       "      <td>2008</td>\n",
       "      <td>-17.74</td>\n",
       "      <td>648.32</td>\n",
       "      <td>16.74</td>\n",
       "      <td>-115.03</td>\n",
       "      <td>110</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>CALC</td>\n",
       "      <td>CalciMedica Inc</td>\n",
       "      <td>-53.25</td>\n",
       "      <td>552</td>\n",
       "      <td>-56.47</td>\n",
       "      <td>37.88</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.39</td>\n",
       "      <td>13</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>GNTA</td>\n",
       "      <td>Genenta Science SpA ADR</td>\n",
       "      <td>-53.36</td>\n",
       "      <td>1098</td>\n",
       "      <td>-9.71</td>\n",
       "      <td>96.94</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-9.41</td>\n",
       "      <td>14</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>OBIO</td>\n",
       "      <td>Orchestra BioMed Holdings Inc</td>\n",
       "      <td>-53.86</td>\n",
       "      <td>1596</td>\n",
       "      <td>-30.91</td>\n",
       "      <td>193.49</td>\n",
       "      <td>2.65</td>\n",
       "      <td>-59.81</td>\n",
       "      <td>56</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>MAIA</td>\n",
       "      <td>MAIA Biotechnology Inc</td>\n",
       "      <td>-55.16</td>\n",
       "      <td>873</td>\n",
       "      <td>0.00</td>\n",
       "      <td>55.73</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>13</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>INSM</td>\n",
       "      <td>Insmed Inc</td>\n",
       "      <td>-56.59</td>\n",
       "      <td>8965</td>\n",
       "      <td>-5.29</td>\n",
       "      <td>13129.69</td>\n",
       "      <td>342.96</td>\n",
       "      <td>-695.06</td>\n",
       "      <td>912</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>TBPH</td>\n",
       "      <td>Theravance Biopharma Inc</td>\n",
       "      <td>-56.97</td>\n",
       "      <td>3868</td>\n",
       "      <td>-7.94</td>\n",
       "      <td>481.91</td>\n",
       "      <td>63.19</td>\n",
       "      <td>-38.24</td>\n",
       "      <td>99</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>ACRV</td>\n",
       "      <td>Acrivon Therapeutics Inc</td>\n",
       "      <td>-57.57</td>\n",
       "      <td>763</td>\n",
       "      <td>-34.67</td>\n",
       "      <td>217.95</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-75.56</td>\n",
       "      <td>58</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>HUMA</td>\n",
       "      <td>Humacyte Inc</td>\n",
       "      <td>-57.60</td>\n",
       "      <td>1477</td>\n",
       "      <td>-18.85</td>\n",
       "      <td>558.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-105.28</td>\n",
       "      <td>183</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>CDXS</td>\n",
       "      <td>Codexis Inc</td>\n",
       "      <td>-58.30</td>\n",
       "      <td>5353</td>\n",
       "      <td>-10.03</td>\n",
       "      <td>456.53</td>\n",
       "      <td>64.45</td>\n",
       "      <td>-45.78</td>\n",
       "      <td>174</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>NRXS</td>\n",
       "      <td>Neuraxis Inc</td>\n",
       "      <td>-58.67</td>\n",
       "      <td>496</td>\n",
       "      <td>-49.37</td>\n",
       "      <td>17.52</td>\n",
       "      <td>2.27</td>\n",
       "      <td>-8.65</td>\n",
       "      <td>19</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>CLGN</td>\n",
       "      <td>CollPlant Biotechnologies Ltd</td>\n",
       "      <td>-58.77</td>\n",
       "      <td>2512</td>\n",
       "      <td>-41.70</td>\n",
       "      <td>41.51</td>\n",
       "      <td>0.69</td>\n",
       "      <td>-17.31</td>\n",
       "      <td>75</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>MGTX</td>\n",
       "      <td>MeiraGTx Holdings plc</td>\n",
       "      <td>-59.20</td>\n",
       "      <td>2384</td>\n",
       "      <td>-31.64</td>\n",
       "      <td>490.80</td>\n",
       "      <td>8.12</td>\n",
       "      <td>-155.31</td>\n",
       "      <td>387</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>ITOS</td>\n",
       "      <td>ITeos Therapeutics Inc</td>\n",
       "      <td>-59.69</td>\n",
       "      <td>1607</td>\n",
       "      <td>-51.06</td>\n",
       "      <td>283.87</td>\n",
       "      <td>35.00</td>\n",
       "      <td>-144.95</td>\n",
       "      <td>157</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>GHRS</td>\n",
       "      <td>GH Research PLC</td>\n",
       "      <td>-59.79</td>\n",
       "      <td>1271</td>\n",
       "      <td>-10.67</td>\n",
       "      <td>426.63</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-45.53</td>\n",
       "      <td>49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>YMAB</td>\n",
       "      <td>Y-Mabs Therapeutics Inc</td>\n",
       "      <td>-60.71</td>\n",
       "      <td>2279</td>\n",
       "      <td>-5.26</td>\n",
       "      <td>444.31</td>\n",
       "      <td>84.55</td>\n",
       "      <td>-23.35</td>\n",
       "      <td>100</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>201</th>\n",
       "      <td>CGEM</td>\n",
       "      <td>Cullinan Therapeutics Inc</td>\n",
       "      <td>-60.72</td>\n",
       "      <td>1439</td>\n",
       "      <td>-27.22</td>\n",
       "      <td>687.09</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-187.05</td>\n",
       "      <td>85</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>OABI</td>\n",
       "      <td>OmniAb Inc</td>\n",
       "      <td>-61.17</td>\n",
       "      <td>1174</td>\n",
       "      <td>-12.81</td>\n",
       "      <td>458.64</td>\n",
       "      <td>20.41</td>\n",
       "      <td>-58.73</td>\n",
       "      <td>106</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>203</th>\n",
       "      <td>GNLX</td>\n",
       "      <td>Genelux Corp</td>\n",
       "      <td>-62.11</td>\n",
       "      <td>691</td>\n",
       "      <td>-33.08</td>\n",
       "      <td>81.51</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-26.96</td>\n",
       "      <td>24</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>ARDX</td>\n",
       "      <td>Ardelyx Inc</td>\n",
       "      <td>-63.00</td>\n",
       "      <td>3834</td>\n",
       "      <td>-4.87</td>\n",
       "      <td>1276.64</td>\n",
       "      <td>251.85</td>\n",
       "      <td>-62.15</td>\n",
       "      <td>267</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>ETNB</td>\n",
       "      <td>89bio Inc</td>\n",
       "      <td>-63.03</td>\n",
       "      <td>1863</td>\n",
       "      <td>-32.71</td>\n",
       "      <td>928.90</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-303.81</td>\n",
       "      <td>70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>SVRA</td>\n",
       "      <td>Savara Inc</td>\n",
       "      <td>-63.36</td>\n",
       "      <td>2790</td>\n",
       "      <td>-15.86</td>\n",
       "      <td>559.48</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-88.72</td>\n",
       "      <td>37</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>TERN</td>\n",
       "      <td>Terns Pharmaceuticals Inc</td>\n",
       "      <td>-63.40</td>\n",
       "      <td>1411</td>\n",
       "      <td>-16.81</td>\n",
       "      <td>592.87</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-99.66</td>\n",
       "      <td>66</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>PEPG</td>\n",
       "      <td>PepGen Inc</td>\n",
       "      <td>-63.69</td>\n",
       "      <td>956</td>\n",
       "      <td>-63.08</td>\n",
       "      <td>147.01</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-92.73</td>\n",
       "      <td>76</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>THTX</td>\n",
       "      <td>Theratechnologies Inc</td>\n",
       "      <td>-64.15</td>\n",
       "      <td>5786</td>\n",
       "      <td>19.10</td>\n",
       "      <td>75.41</td>\n",
       "      <td>84.32</td>\n",
       "      <td>14.40</td>\n",
       "      <td>103</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>GLUE</td>\n",
       "      <td>Monte Rosa Therapeutics Inc</td>\n",
       "      <td>-64.31</td>\n",
       "      <td>1272</td>\n",
       "      <td>-25.66</td>\n",
       "      <td>471.83</td>\n",
       "      <td>14.98</td>\n",
       "      <td>-121.07</td>\n",
       "      <td>133</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>VYGR</td>\n",
       "      <td>Voyager Therapeutics Inc</td>\n",
       "      <td>-64.68</td>\n",
       "      <td>3324</td>\n",
       "      <td>3.99</td>\n",
       "      <td>353.97</td>\n",
       "      <td>163.78</td>\n",
       "      <td>14.13</td>\n",
       "      <td>162</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>SLXN</td>\n",
       "      <td>Silexion Therapeutics Corp</td>\n",
       "      <td>-64.80</td>\n",
       "      <td>1350</td>\n",
       "      <td>-26.10</td>\n",
       "      <td>5.21</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-1.36</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>213</th>\n",
       "      <td>ENTA</td>\n",
       "      <td>Enanta Pharmaceuticals Inc</td>\n",
       "      <td>-64.90</td>\n",
       "      <td>4289</td>\n",
       "      <td>-89.98</td>\n",
       "      <td>133.74</td>\n",
       "      <td>71.96</td>\n",
       "      <td>-120.34</td>\n",
       "      <td>145</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>XBIT</td>\n",
       "      <td>XBiotech Inc</td>\n",
       "      <td>-65.31</td>\n",
       "      <td>3534</td>\n",
       "      <td>-19.23</td>\n",
       "      <td>210.95</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-40.57</td>\n",
       "      <td>82</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>INTS</td>\n",
       "      <td>Intensity Therapeutics Inc</td>\n",
       "      <td>-65.44</td>\n",
       "      <td>536</td>\n",
       "      <td>0.00</td>\n",
       "      <td>30.74</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>216</th>\n",
       "      <td>ENTX</td>\n",
       "      <td>Entera Bio Ltd</td>\n",
       "      <td>-65.61</td>\n",
       "      <td>2364</td>\n",
       "      <td>-11.46</td>\n",
       "      <td>79.93</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-9.16</td>\n",
       "      <td>17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217</th>\n",
       "      <td>SLN</td>\n",
       "      <td>Silence Therapeutics Plc ADR</td>\n",
       "      <td>-66.92</td>\n",
       "      <td>1561</td>\n",
       "      <td>-15.13</td>\n",
       "      <td>318.23</td>\n",
       "      <td>17.90</td>\n",
       "      <td>-48.16</td>\n",
       "      <td>109</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>ORIC</td>\n",
       "      <td>ORIC Pharmaceuticals Inc</td>\n",
       "      <td>-66.94</td>\n",
       "      <td>1698</td>\n",
       "      <td>-22.99</td>\n",
       "      <td>581.47</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-133.69</td>\n",
       "      <td>112</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219</th>\n",
       "      <td>ARCT</td>\n",
       "      <td>Arcturus Therapeutics Holdings Inc</td>\n",
       "      <td>-67.44</td>\n",
       "      <td>4227</td>\n",
       "      <td>-17.51</td>\n",
       "      <td>439.90</td>\n",
       "      <td>160.40</td>\n",
       "      <td>-77.01</td>\n",
       "      <td>180</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>220</th>\n",
       "      <td>PHAT</td>\n",
       "      <td>Phathom Pharmaceuticals Inc</td>\n",
       "      <td>-67.93</td>\n",
       "      <td>1880</td>\n",
       "      <td>-51.59</td>\n",
       "      <td>556.59</td>\n",
       "      <td>26.27</td>\n",
       "      <td>-287.14</td>\n",
       "      <td>452</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>ZURA</td>\n",
       "      <td>Zura Bio Ltd</td>\n",
       "      <td>-68.51</td>\n",
       "      <td>637</td>\n",
       "      <td>0.00</td>\n",
       "      <td>162.58</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>14</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>MGX</td>\n",
       "      <td>Metagenomi Inc</td>\n",
       "      <td>-68.57</td>\n",
       "      <td>312</td>\n",
       "      <td>-71.71</td>\n",
       "      <td>116.20</td>\n",
       "      <td>55.08</td>\n",
       "      <td>-83.33</td>\n",
       "      <td>236</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>LRMR</td>\n",
       "      <td>Larimar Therapeutics Inc</td>\n",
       "      <td>-68.76</td>\n",
       "      <td>3834</td>\n",
       "      <td>-23.83</td>\n",
       "      <td>308.19</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-73.44</td>\n",
       "      <td>42</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>ORMP</td>\n",
       "      <td>Oramed Pharmaceuticals, Inc</td>\n",
       "      <td>-68.81</td>\n",
       "      <td>6440</td>\n",
       "      <td>-13.34</td>\n",
       "      <td>96.35</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.85</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td>DRTS</td>\n",
       "      <td>Alpha Tau Medical Ltd</td>\n",
       "      <td>-69.60</td>\n",
       "      <td>1380</td>\n",
       "      <td>-16.21</td>\n",
       "      <td>217.32</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-35.22</td>\n",
       "      <td>121</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>226</th>\n",
       "      <td>BMEA</td>\n",
       "      <td>Biomea Fusion Inc</td>\n",
       "      <td>-69.68</td>\n",
       "      <td>1341</td>\n",
       "      <td>-70.58</td>\n",
       "      <td>212.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-149.62</td>\n",
       "      <td>107</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>TRML</td>\n",
       "      <td>Tourmaline Bio Inc</td>\n",
       "      <td>-69.78</td>\n",
       "      <td>1320</td>\n",
       "      <td>-13.90</td>\n",
       "      <td>566.70</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-78.78</td>\n",
       "      <td>74</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>228</th>\n",
       "      <td>TNGX</td>\n",
       "      <td>Tango Therapeutics Inc</td>\n",
       "      <td>-70.09</td>\n",
       "      <td>1566</td>\n",
       "      <td>-43.30</td>\n",
       "      <td>316.88</td>\n",
       "      <td>43.38</td>\n",
       "      <td>-137.20</td>\n",
       "      <td>140</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>229</th>\n",
       "      <td>RENB</td>\n",
       "      <td>Renovaro Inc</td>\n",
       "      <td>-70.17</td>\n",
       "      <td>2505</td>\n",
       "      <td>-10.87</td>\n",
       "      <td>250.77</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.27</td>\n",
       "      <td>25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>IGMS</td>\n",
       "      <td>IGM Biosciences Inc</td>\n",
       "      <td>-70.49</td>\n",
       "      <td>1917</td>\n",
       "      <td>-50.89</td>\n",
       "      <td>440.04</td>\n",
       "      <td>2.92</td>\n",
       "      <td>-223.95</td>\n",
       "      <td>198</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>231</th>\n",
       "      <td>FULC</td>\n",
       "      <td>Fulcrum Therapeutics Inc</td>\n",
       "      <td>-70.67</td>\n",
       "      <td>1979</td>\n",
       "      <td>-12.95</td>\n",
       "      <td>238.41</td>\n",
       "      <td>81.63</td>\n",
       "      <td>-30.88</td>\n",
       "      <td>76</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>232</th>\n",
       "      <td>OKYO</td>\n",
       "      <td>OKYO Pharma Limited</td>\n",
       "      <td>-70.72</td>\n",
       "      <td>945</td>\n",
       "      <td>-44.76</td>\n",
       "      <td>35.19</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.75</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>FHTX</td>\n",
       "      <td>Foghorn Therapeutics Inc</td>\n",
       "      <td>-70.75</td>\n",
       "      <td>1516</td>\n",
       "      <td>-32.17</td>\n",
       "      <td>306.32</td>\n",
       "      <td>25.52</td>\n",
       "      <td>-98.53</td>\n",
       "      <td>116</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>CABA</td>\n",
       "      <td>Cabaletta Bio Inc</td>\n",
       "      <td>-71.80</td>\n",
       "      <td>1880</td>\n",
       "      <td>-74.45</td>\n",
       "      <td>132.46</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-98.61</td>\n",
       "      <td>136</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235</th>\n",
       "      <td>FATE</td>\n",
       "      <td>Fate Therapeutics Inc</td>\n",
       "      <td>-72.36</td>\n",
       "      <td>4095</td>\n",
       "      <td>-72.29</td>\n",
       "      <td>227.79</td>\n",
       "      <td>13.45</td>\n",
       "      <td>-164.67</td>\n",
       "      <td>181</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>MOLN</td>\n",
       "      <td>Molecular Partners AG ADR</td>\n",
       "      <td>-72.37</td>\n",
       "      <td>1280</td>\n",
       "      <td>-31.52</td>\n",
       "      <td>197.22</td>\n",
       "      <td>6.00</td>\n",
       "      <td>-62.16</td>\n",
       "      <td>167</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>237</th>\n",
       "      <td>SGMT</td>\n",
       "      <td>Sagimet Biosciences Inc</td>\n",
       "      <td>-72.48</td>\n",
       "      <td>519</td>\n",
       "      <td>0.00</td>\n",
       "      <td>184.48</td>\n",
       "      <td>2.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>CNTX</td>\n",
       "      <td>Context Therapeutics Inc</td>\n",
       "      <td>-72.75</td>\n",
       "      <td>1154</td>\n",
       "      <td>-19.62</td>\n",
       "      <td>102.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.01</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>RGNX</td>\n",
       "      <td>Regenxbio Inc</td>\n",
       "      <td>-72.81</td>\n",
       "      <td>3379</td>\n",
       "      <td>-52.83</td>\n",
       "      <td>423.12</td>\n",
       "      <td>84.33</td>\n",
       "      <td>-223.55</td>\n",
       "      <td>344</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240</th>\n",
       "      <td>TCRX</td>\n",
       "      <td>Tscan Therapeutics Inc</td>\n",
       "      <td>-72.86</td>\n",
       "      <td>1250</td>\n",
       "      <td>-71.45</td>\n",
       "      <td>160.65</td>\n",
       "      <td>9.36</td>\n",
       "      <td>-114.79</td>\n",
       "      <td>188</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>NKTR</td>\n",
       "      <td>Nektar Therapeutics</td>\n",
       "      <td>-73.07</td>\n",
       "      <td>11186</td>\n",
       "      <td>-70.57</td>\n",
       "      <td>184.46</td>\n",
       "      <td>93.14</td>\n",
       "      <td>-130.18</td>\n",
       "      <td>137</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>NUVB</td>\n",
       "      <td>Nuvation Bio Inc</td>\n",
       "      <td>-73.09</td>\n",
       "      <td>1574</td>\n",
       "      <td>-14.79</td>\n",
       "      <td>905.37</td>\n",
       "      <td>2.16</td>\n",
       "      <td>-133.93</td>\n",
       "      <td>203</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>RVPH</td>\n",
       "      <td>Reviva Pharmaceuticals Holdings Inc</td>\n",
       "      <td>-73.12</td>\n",
       "      <td>2252</td>\n",
       "      <td>0.00</td>\n",
       "      <td>76.91</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>15</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>OPT</td>\n",
       "      <td>Opthea Limited ADR</td>\n",
       "      <td>-73.58</td>\n",
       "      <td>1523</td>\n",
       "      <td>-37.32</td>\n",
       "      <td>513.98</td>\n",
       "      <td>0.26</td>\n",
       "      <td>-191.82</td>\n",
       "      <td>33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245</th>\n",
       "      <td>IMRN</td>\n",
       "      <td>Immuron Limited ADR</td>\n",
       "      <td>-74.57</td>\n",
       "      <td>2748</td>\n",
       "      <td>-43.53</td>\n",
       "      <td>11.97</td>\n",
       "      <td>4.90</td>\n",
       "      <td>-5.21</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>246</th>\n",
       "      <td>ANNX</td>\n",
       "      <td>Annexon Inc</td>\n",
       "      <td>-75.00</td>\n",
       "      <td>1607</td>\n",
       "      <td>-23.14</td>\n",
       "      <td>539.37</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-124.79</td>\n",
       "      <td>71</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>TSVT</td>\n",
       "      <td>2seventy bio Inc</td>\n",
       "      <td>-76.25</td>\n",
       "      <td>1140</td>\n",
       "      <td>-79.84</td>\n",
       "      <td>168.18</td>\n",
       "      <td>45.62</td>\n",
       "      <td>-134.27</td>\n",
       "      <td>274</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>LTRN</td>\n",
       "      <td>Lantern Pharma Inc</td>\n",
       "      <td>-76.96</td>\n",
       "      <td>1650</td>\n",
       "      <td>-50.87</td>\n",
       "      <td>38.39</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-19.53</td>\n",
       "      <td>21</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>249</th>\n",
       "      <td>AMLX</td>\n",
       "      <td>Amylyx Pharmaceuticals Inc</td>\n",
       "      <td>-77.20</td>\n",
       "      <td>1075</td>\n",
       "      <td>-86.64</td>\n",
       "      <td>286.53</td>\n",
       "      <td>196.48</td>\n",
       "      <td>-248.25</td>\n",
       "      <td>384</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>SCPH</td>\n",
       "      <td>scPharmaceuticals Inc</td>\n",
       "      <td>-77.38</td>\n",
       "      <td>2587</td>\n",
       "      <td>-39.76</td>\n",
       "      <td>160.13</td>\n",
       "      <td>30.28</td>\n",
       "      <td>-63.67</td>\n",
       "      <td>135</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>RXRX</td>\n",
       "      <td>Recursion Pharmaceuticals Inc</td>\n",
       "      <td>-77.80</td>\n",
       "      <td>1341</td>\n",
       "      <td>-12.58</td>\n",
       "      <td>2893.71</td>\n",
       "      <td>65.18</td>\n",
       "      <td>-364.15</td>\n",
       "      <td>500</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>252</th>\n",
       "      <td>NRSN</td>\n",
       "      <td>NeuroSense Therapeutics Ltd</td>\n",
       "      <td>-78.71</td>\n",
       "      <td>1104</td>\n",
       "      <td>-57.19</td>\n",
       "      <td>20.44</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-11.69</td>\n",
       "      <td>18</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>IRON</td>\n",
       "      <td>Disc Medicine Inc</td>\n",
       "      <td>-79.00</td>\n",
       "      <td>1588</td>\n",
       "      <td>-6.33</td>\n",
       "      <td>1969.36</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-124.71</td>\n",
       "      <td>82</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>JSPR</td>\n",
       "      <td>Jasper Therapeutics Inc</td>\n",
       "      <td>-79.02</td>\n",
       "      <td>1803</td>\n",
       "      <td>-20.91</td>\n",
       "      <td>321.78</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-67.27</td>\n",
       "      <td>45</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>PBYI</td>\n",
       "      <td>Puma Biotechnology Inc</td>\n",
       "      <td>-79.43</td>\n",
       "      <td>4620</td>\n",
       "      <td>30.29</td>\n",
       "      <td>147.26</td>\n",
       "      <td>243.57</td>\n",
       "      <td>44.60</td>\n",
       "      <td>185</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>ANEB</td>\n",
       "      <td>Anebulo Pharmaceuticals Inc</td>\n",
       "      <td>-80.28</td>\n",
       "      <td>1320</td>\n",
       "      <td>0.00</td>\n",
       "      <td>33.71</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>NBTX</td>\n",
       "      <td>Nanobiotix ADR</td>\n",
       "      <td>-80.39</td>\n",
       "      <td>1467</td>\n",
       "      <td>-13.48</td>\n",
       "      <td>165.44</td>\n",
       "      <td>42.20</td>\n",
       "      <td>-22.30</td>\n",
       "      <td>110</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>CYBN</td>\n",
       "      <td>Cybin Inc</td>\n",
       "      <td>-80.43</td>\n",
       "      <td>1922</td>\n",
       "      <td>-43.51</td>\n",
       "      <td>198.12</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-86.20</td>\n",
       "      <td>50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>PRQR</td>\n",
       "      <td>ProQR Therapeutics N.V</td>\n",
       "      <td>-80.79</td>\n",
       "      <td>3743</td>\n",
       "      <td>-10.93</td>\n",
       "      <td>261.59</td>\n",
       "      <td>18.39</td>\n",
       "      <td>-28.60</td>\n",
       "      <td>156</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>MNPR</td>\n",
       "      <td>Monopar Therapeutics Inc</td>\n",
       "      <td>-80.85</td>\n",
       "      <td>1825</td>\n",
       "      <td>0.00</td>\n",
       "      <td>140.92</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>9</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>MRVI</td>\n",
       "      <td>Maravai LifeSciences Holdings Inc</td>\n",
       "      <td>-81.01</td>\n",
       "      <td>1488</td>\n",
       "      <td>0.07</td>\n",
       "      <td>1409.11</td>\n",
       "      <td>276.92</td>\n",
       "      <td>1.04</td>\n",
       "      <td>580</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>262</th>\n",
       "      <td>ACIU</td>\n",
       "      <td>AC Immune SA</td>\n",
       "      <td>-81.16</td>\n",
       "      <td>3007</td>\n",
       "      <td>-12.38</td>\n",
       "      <td>288.91</td>\n",
       "      <td>40.97</td>\n",
       "      <td>-35.76</td>\n",
       "      <td>133</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>263</th>\n",
       "      <td>PRME</td>\n",
       "      <td>Prime Medicine Inc</td>\n",
       "      <td>-81.26</td>\n",
       "      <td>789</td>\n",
       "      <td>-52.64</td>\n",
       "      <td>393.48</td>\n",
       "      <td>0.80</td>\n",
       "      <td>-207.13</td>\n",
       "      <td>234</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>NAUT</td>\n",
       "      <td>Nautilus Biotechnology Inc</td>\n",
       "      <td>-81.32</td>\n",
       "      <td>1593</td>\n",
       "      <td>-31.62</td>\n",
       "      <td>251.13</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-79.40</td>\n",
       "      <td>161</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>ANRO</td>\n",
       "      <td>Alto Neuroscience Inc</td>\n",
       "      <td>-81.50</td>\n",
       "      <td>319</td>\n",
       "      <td>-62.22</td>\n",
       "      <td>101.14</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-62.93</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>COGT</td>\n",
       "      <td>Cogent Biosciences Inc</td>\n",
       "      <td>-81.66</td>\n",
       "      <td>2455</td>\n",
       "      <td>-28.28</td>\n",
       "      <td>912.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-258.01</td>\n",
       "      <td>164</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>IVA</td>\n",
       "      <td>Inventiva ADR</td>\n",
       "      <td>-81.74</td>\n",
       "      <td>1621</td>\n",
       "      <td>-46.96</td>\n",
       "      <td>209.46</td>\n",
       "      <td>19.27</td>\n",
       "      <td>-98.36</td>\n",
       "      <td>123</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>268</th>\n",
       "      <td>CVKD</td>\n",
       "      <td>Cadrenal Therapeutics Inc</td>\n",
       "      <td>-81.88</td>\n",
       "      <td>697</td>\n",
       "      <td>-43.51</td>\n",
       "      <td>18.25</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.94</td>\n",
       "      <td>4</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>269</th>\n",
       "      <td>LIXT</td>\n",
       "      <td>Lixte Biotechnology Holdings Inc</td>\n",
       "      <td>-81.91</td>\n",
       "      <td>6263</td>\n",
       "      <td>0.00</td>\n",
       "      <td>4.72</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>SLRN</td>\n",
       "      <td>Acelyrin Inc</td>\n",
       "      <td>-82.06</td>\n",
       "      <td>593</td>\n",
       "      <td>-110.33</td>\n",
       "      <td>338.10</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-373.01</td>\n",
       "      <td>135</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271</th>\n",
       "      <td>TNYA</td>\n",
       "      <td>Tenaya Therapeutics Inc</td>\n",
       "      <td>-82.08</td>\n",
       "      <td>1236</td>\n",
       "      <td>-50.04</td>\n",
       "      <td>228.16</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-114.18</td>\n",
       "      <td>140</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>272</th>\n",
       "      <td>SAGE</td>\n",
       "      <td>Sage Therapeutics Inc</td>\n",
       "      <td>-82.11</td>\n",
       "      <td>3805</td>\n",
       "      <td>-113.51</td>\n",
       "      <td>326.97</td>\n",
       "      <td>106.40</td>\n",
       "      <td>-371.15</td>\n",
       "      <td>487</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>VERV</td>\n",
       "      <td>Verve Therapeutics Inc</td>\n",
       "      <td>-82.11</td>\n",
       "      <td>1279</td>\n",
       "      <td>-48.03</td>\n",
       "      <td>458.03</td>\n",
       "      <td>24.40</td>\n",
       "      <td>-219.97</td>\n",
       "      <td>255</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>CDMO</td>\n",
       "      <td>Avid Bioservices Inc</td>\n",
       "      <td>-82.19</td>\n",
       "      <td>11215</td>\n",
       "      <td>-0.97</td>\n",
       "      <td>790.59</td>\n",
       "      <td>142.36</td>\n",
       "      <td>-7.69</td>\n",
       "      <td>371</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>PROK</td>\n",
       "      <td>ProKidney Corp</td>\n",
       "      <td>-82.25</td>\n",
       "      <td>1266</td>\n",
       "      <td>-8.06</td>\n",
       "      <td>1811.82</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-145.99</td>\n",
       "      <td>163</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>RNXT</td>\n",
       "      <td>RenovoRx Inc</td>\n",
       "      <td>-82.37</td>\n",
       "      <td>1209</td>\n",
       "      <td>0.00</td>\n",
       "      <td>30.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>GALT</td>\n",
       "      <td>Galectin Therapeutics Inc</td>\n",
       "      <td>-82.42</td>\n",
       "      <td>8140</td>\n",
       "      <td>0.00</td>\n",
       "      <td>144.98</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>14</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>MNOV</td>\n",
       "      <td>Medicinova Inc</td>\n",
       "      <td>-82.64</td>\n",
       "      <td>6584</td>\n",
       "      <td>-9.47</td>\n",
       "      <td>103.49</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-9.80</td>\n",
       "      <td>13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>279</th>\n",
       "      <td>INZY</td>\n",
       "      <td>Inozyme Pharma Inc</td>\n",
       "      <td>-82.73</td>\n",
       "      <td>1607</td>\n",
       "      <td>-50.97</td>\n",
       "      <td>194.01</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-98.89</td>\n",
       "      <td>59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>280</th>\n",
       "      <td>BOLD</td>\n",
       "      <td>Boundless Bio Inc</td>\n",
       "      <td>-82.74</td>\n",
       "      <td>264</td>\n",
       "      <td>-121.05</td>\n",
       "      <td>55.97</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-67.75</td>\n",
       "      <td>72</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>GNFT</td>\n",
       "      <td>Genfit ADR</td>\n",
       "      <td>-82.77</td>\n",
       "      <td>2092</td>\n",
       "      <td>11.53</td>\n",
       "      <td>189.64</td>\n",
       "      <td>80.47</td>\n",
       "      <td>21.86</td>\n",
       "      <td>169</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>CCCC</td>\n",
       "      <td>C4 Therapeutics Inc</td>\n",
       "      <td>-82.82</td>\n",
       "      <td>1537</td>\n",
       "      <td>-37.84</td>\n",
       "      <td>304.24</td>\n",
       "      <td>33.67</td>\n",
       "      <td>-115.13</td>\n",
       "      <td>145</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>CMPX</td>\n",
       "      <td>Compass Therapeutics Inc</td>\n",
       "      <td>-82.82</td>\n",
       "      <td>1352</td>\n",
       "      <td>-26.75</td>\n",
       "      <td>205.01</td>\n",
       "      <td>0.85</td>\n",
       "      <td>-54.83</td>\n",
       "      <td>32</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>ABSI</td>\n",
       "      <td>Absci Corp</td>\n",
       "      <td>-82.89</td>\n",
       "      <td>1244</td>\n",
       "      <td>-20.39</td>\n",
       "      <td>439.90</td>\n",
       "      <td>4.21</td>\n",
       "      <td>-89.71</td>\n",
       "      <td>155</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>PRAX</td>\n",
       "      <td>Praxis Precision Medicines Inc</td>\n",
       "      <td>-83.17</td>\n",
       "      <td>1523</td>\n",
       "      <td>-12.13</td>\n",
       "      <td>1349.00</td>\n",
       "      <td>1.60</td>\n",
       "      <td>-163.59</td>\n",
       "      <td>82</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>CRBP</td>\n",
       "      <td>Corbus Pharmaceuticals Holdings Inc</td>\n",
       "      <td>-83.24</td>\n",
       "      <td>3704</td>\n",
       "      <td>-26.23</td>\n",
       "      <td>173.92</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-45.62</td>\n",
       "      <td>19</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>DSGN</td>\n",
       "      <td>Design Therapeutics Inc</td>\n",
       "      <td>-83.53</td>\n",
       "      <td>1359</td>\n",
       "      <td>-16.91</td>\n",
       "      <td>356.15</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-60.22</td>\n",
       "      <td>54</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>CLYM</td>\n",
       "      <td>Climb Bio Inc</td>\n",
       "      <td>-83.65</td>\n",
       "      <td>1225</td>\n",
       "      <td>0.00</td>\n",
       "      <td>162.68</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>9</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>XERS</td>\n",
       "      <td>Xeris Biopharma Holdings Inc</td>\n",
       "      <td>-83.78</td>\n",
       "      <td>2371</td>\n",
       "      <td>-6.58</td>\n",
       "      <td>502.40</td>\n",
       "      <td>187.36</td>\n",
       "      <td>-33.06</td>\n",
       "      <td>377</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>SLNO</td>\n",
       "      <td>Soleno Therapeutics Inc</td>\n",
       "      <td>-83.95</td>\n",
       "      <td>3687</td>\n",
       "      <td>-6.60</td>\n",
       "      <td>2066.62</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-136.50</td>\n",
       "      <td>33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>FDMT</td>\n",
       "      <td>4D Molecular Therapeutics Inc</td>\n",
       "      <td>-83.95</td>\n",
       "      <td>1467</td>\n",
       "      <td>-54.64</td>\n",
       "      <td>299.56</td>\n",
       "      <td>0.02</td>\n",
       "      <td>-163.69</td>\n",
       "      <td>147</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>ANIX</td>\n",
       "      <td>Anixa Biosciences Inc</td>\n",
       "      <td>-84.09</td>\n",
       "      <td>15047</td>\n",
       "      <td>0.00</td>\n",
       "      <td>90.10</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>GUTS</td>\n",
       "      <td>Fractyl Health Inc</td>\n",
       "      <td>-84.12</td>\n",
       "      <td>319</td>\n",
       "      <td>-79.62</td>\n",
       "      <td>101.49</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-80.81</td>\n",
       "      <td>122</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>IFRX</td>\n",
       "      <td>InflaRx N.V</td>\n",
       "      <td>-84.27</td>\n",
       "      <td>2597</td>\n",
       "      <td>-29.16</td>\n",
       "      <td>136.02</td>\n",
       "      <td>0.11</td>\n",
       "      <td>-39.67</td>\n",
       "      <td>62</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>VIGL</td>\n",
       "      <td>Vigil Neuroscience Inc</td>\n",
       "      <td>-84.27</td>\n",
       "      <td>1075</td>\n",
       "      <td>-117.24</td>\n",
       "      <td>76.44</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-89.62</td>\n",
       "      <td>64</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>CMRX</td>\n",
       "      <td>Chimerix Inc</td>\n",
       "      <td>-84.30</td>\n",
       "      <td>4268</td>\n",
       "      <td>-35.44</td>\n",
       "      <td>261.71</td>\n",
       "      <td>0.16</td>\n",
       "      <td>-92.74</td>\n",
       "      <td>72</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>ADPT</td>\n",
       "      <td>Adaptive Biotechnologies Corp</td>\n",
       "      <td>-84.37</td>\n",
       "      <td>2000</td>\n",
       "      <td>-14.69</td>\n",
       "      <td>1000.59</td>\n",
       "      <td>177.28</td>\n",
       "      <td>-146.95</td>\n",
       "      <td>709</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>ABP</td>\n",
       "      <td>Abpro Holdings Inc</td>\n",
       "      <td>-84.55</td>\n",
       "      <td>1014</td>\n",
       "      <td>-17.15</td>\n",
       "      <td>65.94</td>\n",
       "      <td>0.07</td>\n",
       "      <td>-11.31</td>\n",
       "      <td>15</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>MRSN</td>\n",
       "      <td>Mersana Therapeutics Inc</td>\n",
       "      <td>-84.64</td>\n",
       "      <td>2729</td>\n",
       "      <td>-30.43</td>\n",
       "      <td>255.71</td>\n",
       "      <td>34.84</td>\n",
       "      <td>-77.80</td>\n",
       "      <td>123</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>ANL</td>\n",
       "      <td>Adlai Nortye Ltd. ADR</td>\n",
       "      <td>-84.73</td>\n",
       "      <td>445</td>\n",
       "      <td>-73.00</td>\n",
       "      <td>87.08</td>\n",
       "      <td>5.00</td>\n",
       "      <td>-63.57</td>\n",
       "      <td>127</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>RANI</td>\n",
       "      <td>Rani Therapeutics Holdings Inc</td>\n",
       "      <td>-84.91</td>\n",
       "      <td>1236</td>\n",
       "      <td>-61.12</td>\n",
       "      <td>93.10</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-56.90</td>\n",
       "      <td>140</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>VALN</td>\n",
       "      <td>Valneva SE ADR</td>\n",
       "      <td>-85.12</td>\n",
       "      <td>1322</td>\n",
       "      <td>-24.45</td>\n",
       "      <td>311.41</td>\n",
       "      <td>158.54</td>\n",
       "      <td>-76.15</td>\n",
       "      <td>676</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>ERAS</td>\n",
       "      <td>Erasca Inc</td>\n",
       "      <td>-85.31</td>\n",
       "      <td>1250</td>\n",
       "      <td>-20.37</td>\n",
       "      <td>740.74</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-150.91</td>\n",
       "      <td>126</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>KYTX</td>\n",
       "      <td>Kyverna Therapeutics Inc</td>\n",
       "      <td>-85.32</td>\n",
       "      <td>312</td>\n",
       "      <td>-66.51</td>\n",
       "      <td>183.05</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.75</td>\n",
       "      <td>96</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>305</th>\n",
       "      <td>CGEN</td>\n",
       "      <td>Compugen Ltd</td>\n",
       "      <td>-85.53</td>\n",
       "      <td>8894</td>\n",
       "      <td>-2.86</td>\n",
       "      <td>142.36</td>\n",
       "      <td>42.72</td>\n",
       "      <td>-4.07</td>\n",
       "      <td>68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>306</th>\n",
       "      <td>MDWD</td>\n",
       "      <td>MediWound Ltd</td>\n",
       "      <td>-85.70</td>\n",
       "      <td>3925</td>\n",
       "      <td>-8.02</td>\n",
       "      <td>180.73</td>\n",
       "      <td>20.14</td>\n",
       "      <td>-14.50</td>\n",
       "      <td>100</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>UNCY</td>\n",
       "      <td>Unicycive Therapeutics Inc</td>\n",
       "      <td>-85.70</td>\n",
       "      <td>1254</td>\n",
       "      <td>-39.69</td>\n",
       "      <td>72.66</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-28.84</td>\n",
       "      <td>14</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>TGTX</td>\n",
       "      <td>TG Therapeutics Inc</td>\n",
       "      <td>-85.77</td>\n",
       "      <td>5342</td>\n",
       "      <td>-0.01</td>\n",
       "      <td>5354.88</td>\n",
       "      <td>264.79</td>\n",
       "      <td>-0.41</td>\n",
       "      <td>319</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>CLSD</td>\n",
       "      <td>Clearside Biomedical Inc</td>\n",
       "      <td>-85.93</td>\n",
       "      <td>3120</td>\n",
       "      <td>-33.50</td>\n",
       "      <td>76.60</td>\n",
       "      <td>7.52</td>\n",
       "      <td>-25.66</td>\n",
       "      <td>30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>STRO</td>\n",
       "      <td>Sutro Biopharma Inc</td>\n",
       "      <td>-86.05</td>\n",
       "      <td>2273</td>\n",
       "      <td>-72.04</td>\n",
       "      <td>170.69</td>\n",
       "      <td>160.96</td>\n",
       "      <td>-122.96</td>\n",
       "      <td>302</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>OLMA</td>\n",
       "      <td>Olema Pharmaceuticals Inc</td>\n",
       "      <td>-86.22</td>\n",
       "      <td>1489</td>\n",
       "      <td>-28.52</td>\n",
       "      <td>475.32</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-135.54</td>\n",
       "      <td>74</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>LCTX</td>\n",
       "      <td>Lineage Cell Therapeutics Inc</td>\n",
       "      <td>-86.26</td>\n",
       "      <td>11975</td>\n",
       "      <td>-19.42</td>\n",
       "      <td>110.21</td>\n",
       "      <td>6.19</td>\n",
       "      <td>-21.40</td>\n",
       "      <td>68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>SGMO</td>\n",
       "      <td>Sangamo Therapeutics Inc</td>\n",
       "      <td>-86.39</td>\n",
       "      <td>9021</td>\n",
       "      <td>-21.21</td>\n",
       "      <td>551.87</td>\n",
       "      <td>52.29</td>\n",
       "      <td>-117.03</td>\n",
       "      <td>405</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>RLAY</td>\n",
       "      <td>Relay Therapeutics Inc</td>\n",
       "      <td>-86.56</td>\n",
       "      <td>1615</td>\n",
       "      <td>-48.07</td>\n",
       "      <td>810.13</td>\n",
       "      <td>10.01</td>\n",
       "      <td>-389.45</td>\n",
       "      <td>294</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>IPA</td>\n",
       "      <td>ImmunoPrecise Antibodies Ltd</td>\n",
       "      <td>-86.57</td>\n",
       "      <td>8380</td>\n",
       "      <td>-86.08</td>\n",
       "      <td>13.36</td>\n",
       "      <td>24.09</td>\n",
       "      <td>-11.50</td>\n",
       "      <td>72</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>GANX</td>\n",
       "      <td>Gain Therapeutics Inc</td>\n",
       "      <td>-86.64</td>\n",
       "      <td>1369</td>\n",
       "      <td>-49.56</td>\n",
       "      <td>44.03</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.82</td>\n",
       "      <td>29</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>317</th>\n",
       "      <td>ZNTL</td>\n",
       "      <td>Zentalis Pharmaceuticals Inc</td>\n",
       "      <td>-86.68</td>\n",
       "      <td>1719</td>\n",
       "      <td>-94.13</td>\n",
       "      <td>220.92</td>\n",
       "      <td>40.56</td>\n",
       "      <td>-207.96</td>\n",
       "      <td>124</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>318</th>\n",
       "      <td>DMAC</td>\n",
       "      <td>DiaMedica Therapeutics Inc</td>\n",
       "      <td>-86.90</td>\n",
       "      <td>4519</td>\n",
       "      <td>-9.84</td>\n",
       "      <td>227.06</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-22.35</td>\n",
       "      <td>18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>CDIO</td>\n",
       "      <td>Cardio Diagnostics Holdings Inc</td>\n",
       "      <td>-87.17</td>\n",
       "      <td>1068</td>\n",
       "      <td>-18.15</td>\n",
       "      <td>45.29</td>\n",
       "      <td>0.04</td>\n",
       "      <td>-8.22</td>\n",
       "      <td>7</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>320</th>\n",
       "      <td>MGNX</td>\n",
       "      <td>Macrogenics Inc</td>\n",
       "      <td>-87.19</td>\n",
       "      <td>4086</td>\n",
       "      <td>-49.18</td>\n",
       "      <td>202.73</td>\n",
       "      <td>141.33</td>\n",
       "      <td>-99.71</td>\n",
       "      <td>339</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>CHRS</td>\n",
       "      <td>Coherus Biosciences Inc</td>\n",
       "      <td>-87.23</td>\n",
       "      <td>3694</td>\n",
       "      <td>-59.70</td>\n",
       "      <td>195.86</td>\n",
       "      <td>304.34</td>\n",
       "      <td>-116.92</td>\n",
       "      <td>235</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>FBLG</td>\n",
       "      <td>FibroBiologics Inc</td>\n",
       "      <td>-87.31</td>\n",
       "      <td>320</td>\n",
       "      <td>-16.51</td>\n",
       "      <td>74.86</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.36</td>\n",
       "      <td>10</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>323</th>\n",
       "      <td>PYXS</td>\n",
       "      <td>Pyxis Oncology Inc</td>\n",
       "      <td>-87.73</td>\n",
       "      <td>1166</td>\n",
       "      <td>-61.31</td>\n",
       "      <td>99.90</td>\n",
       "      <td>16.15</td>\n",
       "      <td>-61.25</td>\n",
       "      <td>54</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>ESLA</td>\n",
       "      <td>Estrella Immunopharma Inc</td>\n",
       "      <td>-87.75</td>\n",
       "      <td>1190</td>\n",
       "      <td>0.00</td>\n",
       "      <td>45.95</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>APLT</td>\n",
       "      <td>Applied Therapeutics Inc</td>\n",
       "      <td>-87.77</td>\n",
       "      <td>2044</td>\n",
       "      <td>-68.96</td>\n",
       "      <td>133.81</td>\n",
       "      <td>-0.21</td>\n",
       "      <td>-92.28</td>\n",
       "      <td>37</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>326</th>\n",
       "      <td>CHRO</td>\n",
       "      <td>Channel Therapeutics Corporation</td>\n",
       "      <td>-87.81</td>\n",
       "      <td>305</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.56</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>4</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>327</th>\n",
       "      <td>TECX</td>\n",
       "      <td>Tectonic Therapeutic Inc</td>\n",
       "      <td>-87.89</td>\n",
       "      <td>2371</td>\n",
       "      <td>-7.92</td>\n",
       "      <td>656.79</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-52.02</td>\n",
       "      <td>44</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>328</th>\n",
       "      <td>MIST</td>\n",
       "      <td>Milestone Pharmaceuticals Inc</td>\n",
       "      <td>-88.29</td>\n",
       "      <td>2049</td>\n",
       "      <td>-51.53</td>\n",
       "      <td>95.46</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-49.19</td>\n",
       "      <td>47</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>CRBU</td>\n",
       "      <td>Caribou Biosciences Inc</td>\n",
       "      <td>-88.30</td>\n",
       "      <td>1243</td>\n",
       "      <td>-91.23</td>\n",
       "      <td>172.96</td>\n",
       "      <td>11.48</td>\n",
       "      <td>-157.80</td>\n",
       "      <td>158</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>RVNC</td>\n",
       "      <td>Revance Therapeutics Inc</td>\n",
       "      <td>-88.53</td>\n",
       "      <td>3967</td>\n",
       "      <td>-58.16</td>\n",
       "      <td>322.57</td>\n",
       "      <td>256.94</td>\n",
       "      <td>-187.62</td>\n",
       "      <td>597</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>NVAX</td>\n",
       "      <td>Novavax, Inc</td>\n",
       "      <td>-88.61</td>\n",
       "      <td>10605</td>\n",
       "      <td>-16.45</td>\n",
       "      <td>1478.51</td>\n",
       "      <td>885.19</td>\n",
       "      <td>-243.25</td>\n",
       "      <td>1543</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>332</th>\n",
       "      <td>KALV</td>\n",
       "      <td>KalVista Pharmaceuticals Inc</td>\n",
       "      <td>-88.84</td>\n",
       "      <td>3540</td>\n",
       "      <td>-34.98</td>\n",
       "      <td>442.29</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-154.72</td>\n",
       "      <td>150</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333</th>\n",
       "      <td>AVTE</td>\n",
       "      <td>Aerovate Therapeutics Inc</td>\n",
       "      <td>-88.92</td>\n",
       "      <td>1266</td>\n",
       "      <td>-121.55</td>\n",
       "      <td>74.01</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-89.96</td>\n",
       "      <td>51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>ALEC</td>\n",
       "      <td>Alector Inc</td>\n",
       "      <td>-89.10</td>\n",
       "      <td>2140</td>\n",
       "      <td>-91.48</td>\n",
       "      <td>193.91</td>\n",
       "      <td>61.51</td>\n",
       "      <td>-177.39</td>\n",
       "      <td>241</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>335</th>\n",
       "      <td>VTYX</td>\n",
       "      <td>Ventyx Biosciences Inc</td>\n",
       "      <td>-89.15</td>\n",
       "      <td>1153</td>\n",
       "      <td>-104.41</td>\n",
       "      <td>159.10</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-166.12</td>\n",
       "      <td>75</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>ACXP</td>\n",
       "      <td>Acurx Pharmaceuticals Inc</td>\n",
       "      <td>-89.16</td>\n",
       "      <td>1271</td>\n",
       "      <td>0.00</td>\n",
       "      <td>13.94</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>4</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>HLVX</td>\n",
       "      <td>HilleVax Inc</td>\n",
       "      <td>-89.73</td>\n",
       "      <td>963</td>\n",
       "      <td>-138.01</td>\n",
       "      <td>97.12</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-134.04</td>\n",
       "      <td>90</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>338</th>\n",
       "      <td>HOWL</td>\n",
       "      <td>Werewolf Therapeutics Inc</td>\n",
       "      <td>-89.75</td>\n",
       "      <td>1327</td>\n",
       "      <td>-87.04</td>\n",
       "      <td>73.97</td>\n",
       "      <td>3.39</td>\n",
       "      <td>-64.38</td>\n",
       "      <td>45</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339</th>\n",
       "      <td>ABOS</td>\n",
       "      <td>Acumen Pharmaceuticals Inc</td>\n",
       "      <td>-89.90</td>\n",
       "      <td>1265</td>\n",
       "      <td>-78.44</td>\n",
       "      <td>118.36</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-92.84</td>\n",
       "      <td>51</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>340</th>\n",
       "      <td>TVGN</td>\n",
       "      <td>Tevogen Bio Holdings Inc</td>\n",
       "      <td>-89.94</td>\n",
       "      <td>1077</td>\n",
       "      <td>-23.69</td>\n",
       "      <td>178.55</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-42.29</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>AUTL</td>\n",
       "      <td>Autolus Therapeutics plc ADR</td>\n",
       "      <td>-90.04</td>\n",
       "      <td>2370</td>\n",
       "      <td>-29.98</td>\n",
       "      <td>686.59</td>\n",
       "      <td>10.09</td>\n",
       "      <td>-205.86</td>\n",
       "      <td>463</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>SYRE</td>\n",
       "      <td>Spyre Therapeutics Inc</td>\n",
       "      <td>-90.12</td>\n",
       "      <td>3176</td>\n",
       "      <td>-13.57</td>\n",
       "      <td>1433.61</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-194.51</td>\n",
       "      <td>30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>NGNE</td>\n",
       "      <td>Neurogene Inc</td>\n",
       "      <td>-90.16</td>\n",
       "      <td>3938</td>\n",
       "      <td>-17.54</td>\n",
       "      <td>373.30</td>\n",
       "      <td>0.92</td>\n",
       "      <td>-65.47</td>\n",
       "      <td>91</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>344</th>\n",
       "      <td>BYSI</td>\n",
       "      <td>BeyondSpring Inc</td>\n",
       "      <td>-90.24</td>\n",
       "      <td>2840</td>\n",
       "      <td>-25.84</td>\n",
       "      <td>64.70</td>\n",
       "      <td>1.88</td>\n",
       "      <td>-16.72</td>\n",
       "      <td>36</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>AVIR</td>\n",
       "      <td>Atea Pharmaceuticals Inc</td>\n",
       "      <td>-90.34</td>\n",
       "      <td>1509</td>\n",
       "      <td>-47.69</td>\n",
       "      <td>261.84</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-124.88</td>\n",
       "      <td>75</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>346</th>\n",
       "      <td>IMMP</td>\n",
       "      <td>Immutep Limited ADR</td>\n",
       "      <td>-90.66</td>\n",
       "      <td>4625</td>\n",
       "      <td>-14.15</td>\n",
       "      <td>314.84</td>\n",
       "      <td>3.84</td>\n",
       "      <td>-44.54</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>347</th>\n",
       "      <td>SPRO</td>\n",
       "      <td>Spero Therapeutics Inc</td>\n",
       "      <td>-90.70</td>\n",
       "      <td>2602</td>\n",
       "      <td>36.02</td>\n",
       "      <td>58.33</td>\n",
       "      <td>118.46</td>\n",
       "      <td>21.01</td>\n",
       "      <td>46</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>348</th>\n",
       "      <td>IMRX</td>\n",
       "      <td>Immuneering Corp</td>\n",
       "      <td>-90.70</td>\n",
       "      <td>1236</td>\n",
       "      <td>-111.86</td>\n",
       "      <td>53.72</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-60.09</td>\n",
       "      <td>66</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>349</th>\n",
       "      <td>MNKD</td>\n",
       "      <td>Mannkind Corp</td>\n",
       "      <td>-90.71</td>\n",
       "      <td>7447</td>\n",
       "      <td>3.68</td>\n",
       "      <td>1729.13</td>\n",
       "      <td>267.20</td>\n",
       "      <td>63.69</td>\n",
       "      <td>411</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>350</th>\n",
       "      <td>ANTX</td>\n",
       "      <td>AN2 Therapeutics Inc</td>\n",
       "      <td>-90.71</td>\n",
       "      <td>998</td>\n",
       "      <td>0.00</td>\n",
       "      <td>40.34</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>41</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>ALGS</td>\n",
       "      <td>Aligos Therapeutics Inc</td>\n",
       "      <td>-90.82</td>\n",
       "      <td>1523</td>\n",
       "      <td>-76.74</td>\n",
       "      <td>120.77</td>\n",
       "      <td>6.00</td>\n",
       "      <td>-92.68</td>\n",
       "      <td>68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>352</th>\n",
       "      <td>LVTX</td>\n",
       "      <td>LAVA Therapeutics NV</td>\n",
       "      <td>-91.12</td>\n",
       "      <td>1362</td>\n",
       "      <td>-100.22</td>\n",
       "      <td>26.82</td>\n",
       "      <td>7.40</td>\n",
       "      <td>-26.88</td>\n",
       "      <td>37</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>353</th>\n",
       "      <td>MLEC</td>\n",
       "      <td>Moolec Science SA</td>\n",
       "      <td>-91.23</td>\n",
       "      <td>1386</td>\n",
       "      <td>-24.46</td>\n",
       "      <td>33.36</td>\n",
       "      <td>5.63</td>\n",
       "      <td>-8.16</td>\n",
       "      <td>52</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>NKGN</td>\n",
       "      <td>NKGen Biotech Inc</td>\n",
       "      <td>-91.24</td>\n",
       "      <td>442</td>\n",
       "      <td>-188.94</td>\n",
       "      <td>16.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-30.23</td>\n",
       "      <td>63</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>CTMX</td>\n",
       "      <td>CytomX Therapeutics Inc</td>\n",
       "      <td>-91.40</td>\n",
       "      <td>3358</td>\n",
       "      <td>9.50</td>\n",
       "      <td>90.00</td>\n",
       "      <td>126.62</td>\n",
       "      <td>8.55</td>\n",
       "      <td>120</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>TSHA</td>\n",
       "      <td>Taysha Gene Therapies Inc</td>\n",
       "      <td>-91.40</td>\n",
       "      <td>1545</td>\n",
       "      <td>-19.70</td>\n",
       "      <td>411.94</td>\n",
       "      <td>9.91</td>\n",
       "      <td>-81.15</td>\n",
       "      <td>52</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>OVID</td>\n",
       "      <td>Ovid Therapeutics Inc</td>\n",
       "      <td>-91.59</td>\n",
       "      <td>2783</td>\n",
       "      <td>-87.26</td>\n",
       "      <td>74.56</td>\n",
       "      <td>0.63</td>\n",
       "      <td>-65.06</td>\n",
       "      <td>25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>IBRX</td>\n",
       "      <td>ImmunityBio Inc</td>\n",
       "      <td>-91.71</td>\n",
       "      <td>3430</td>\n",
       "      <td>-15.28</td>\n",
       "      <td>2234.30</td>\n",
       "      <td>7.33</td>\n",
       "      <td>-341.30</td>\n",
       "      <td>672</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>CUE</td>\n",
       "      <td>Cue Biopharma Inc</td>\n",
       "      <td>-91.92</td>\n",
       "      <td>2541</td>\n",
       "      <td>-73.83</td>\n",
       "      <td>64.62</td>\n",
       "      <td>8.30</td>\n",
       "      <td>-47.71</td>\n",
       "      <td>53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>IMAB</td>\n",
       "      <td>I-Mab ADR</td>\n",
       "      <td>-92.00</td>\n",
       "      <td>1796</td>\n",
       "      <td>-216.46</td>\n",
       "      <td>78.19</td>\n",
       "      <td>3.49</td>\n",
       "      <td>-169.25</td>\n",
       "      <td>34</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>EDIT</td>\n",
       "      <td>Editas Medicine Inc</td>\n",
       "      <td>-92.09</td>\n",
       "      <td>3240</td>\n",
       "      <td>-182.23</td>\n",
       "      <td>122.17</td>\n",
       "      <td>61.76</td>\n",
       "      <td>-222.63</td>\n",
       "      <td>265</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>DBVT</td>\n",
       "      <td>DBV Technologies ADR</td>\n",
       "      <td>-92.21</td>\n",
       "      <td>3709</td>\n",
       "      <td>0.00</td>\n",
       "      <td>70.91</td>\n",
       "      <td>12.52</td>\n",
       "      <td>0.00</td>\n",
       "      <td>108</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>RLYB</td>\n",
       "      <td>Rallybio Corp</td>\n",
       "      <td>-92.34</td>\n",
       "      <td>1237</td>\n",
       "      <td>-163.49</td>\n",
       "      <td>42.73</td>\n",
       "      <td>0.60</td>\n",
       "      <td>-69.86</td>\n",
       "      <td>43</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>ALLO</td>\n",
       "      <td>Allogene Therapeutics Inc</td>\n",
       "      <td>-92.44</td>\n",
       "      <td>2259</td>\n",
       "      <td>-59.03</td>\n",
       "      <td>431.92</td>\n",
       "      <td>0.04</td>\n",
       "      <td>-254.97</td>\n",
       "      <td>232</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>CKPT</td>\n",
       "      <td>Checkpoint Therapeutics Inc</td>\n",
       "      <td>-92.66</td>\n",
       "      <td>2920</td>\n",
       "      <td>0.00</td>\n",
       "      <td>165.54</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.00</td>\n",
       "      <td>23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>AEON</td>\n",
       "      <td>AEON Biopharma Inc</td>\n",
       "      <td>-92.67</td>\n",
       "      <td>512</td>\n",
       "      <td>-168.82</td>\n",
       "      <td>25.98</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-43.86</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>CDTX</td>\n",
       "      <td>Cidara Therapeutics Inc</td>\n",
       "      <td>-92.85</td>\n",
       "      <td>3534</td>\n",
       "      <td>-11.83</td>\n",
       "      <td>254.44</td>\n",
       "      <td>53.87</td>\n",
       "      <td>-30.11</td>\n",
       "      <td>69</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>368</th>\n",
       "      <td>IOVA</td>\n",
       "      <td>Iovance Biotherapeutics Inc</td>\n",
       "      <td>-92.88</td>\n",
       "      <td>5177</td>\n",
       "      <td>-17.09</td>\n",
       "      <td>2389.48</td>\n",
       "      <td>90.86</td>\n",
       "      <td>-408.32</td>\n",
       "      <td>557</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369</th>\n",
       "      <td>RAPT</td>\n",
       "      <td>RAPT Therapeutics Inc</td>\n",
       "      <td>-93.00</td>\n",
       "      <td>1874</td>\n",
       "      <td>-368.74</td>\n",
       "      <td>30.81</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-113.61</td>\n",
       "      <td>70</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370</th>\n",
       "      <td>ATAI</td>\n",
       "      <td>ATAI Life Sciences N.V</td>\n",
       "      <td>-93.01</td>\n",
       "      <td>1278</td>\n",
       "      <td>-45.90</td>\n",
       "      <td>223.18</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-102.44</td>\n",
       "      <td>83</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>371</th>\n",
       "      <td>ADAG</td>\n",
       "      <td>Adagene Inc ADR</td>\n",
       "      <td>-93.13</td>\n",
       "      <td>1407</td>\n",
       "      <td>-40.20</td>\n",
       "      <td>89.87</td>\n",
       "      <td>0.82</td>\n",
       "      <td>-36.13</td>\n",
       "      <td>174</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>372</th>\n",
       "      <td>KRRO</td>\n",
       "      <td>Korro Bio Inc</td>\n",
       "      <td>-93.16</td>\n",
       "      <td>1902</td>\n",
       "      <td>-20.50</td>\n",
       "      <td>451.18</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-92.47</td>\n",
       "      <td>101</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>373</th>\n",
       "      <td>BDTX</td>\n",
       "      <td>Black Diamond Therapeutics Inc</td>\n",
       "      <td>-93.17</td>\n",
       "      <td>1782</td>\n",
       "      <td>-54.24</td>\n",
       "      <td>149.38</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-81.02</td>\n",
       "      <td>54</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>LUMO</td>\n",
       "      <td>Lumos Pharma Inc</td>\n",
       "      <td>-93.19</td>\n",
       "      <td>4785</td>\n",
       "      <td>-96.72</td>\n",
       "      <td>37.54</td>\n",
       "      <td>2.20</td>\n",
       "      <td>-36.31</td>\n",
       "      <td>30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>OCEA</td>\n",
       "      <td>Ocean Biomedical Inc</td>\n",
       "      <td>-93.22</td>\n",
       "      <td>1135</td>\n",
       "      <td>0.00</td>\n",
       "      <td>22.32</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>376</th>\n",
       "      <td>ALT</td>\n",
       "      <td>Altimmune Inc</td>\n",
       "      <td>-93.22</td>\n",
       "      <td>2762</td>\n",
       "      <td>-15.50</td>\n",
       "      <td>640.12</td>\n",
       "      <td>0.05</td>\n",
       "      <td>-99.19</td>\n",
       "      <td>59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>377</th>\n",
       "      <td>OKUR</td>\n",
       "      <td>OnKure Therapeutics Inc</td>\n",
       "      <td>-93.43</td>\n",
       "      <td>1349</td>\n",
       "      <td>-37.25</td>\n",
       "      <td>121.12</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-45.12</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>SRZN</td>\n",
       "      <td>Surrozen Inc</td>\n",
       "      <td>-93.50</td>\n",
       "      <td>1436</td>\n",
       "      <td>-76.98</td>\n",
       "      <td>32.50</td>\n",
       "      <td>10.00</td>\n",
       "      <td>-25.02</td>\n",
       "      <td>42</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>BRNS</td>\n",
       "      <td>Barinthus Biotherapeutics Plc. ADR</td>\n",
       "      <td>-93.52</td>\n",
       "      <td>1327</td>\n",
       "      <td>-152.69</td>\n",
       "      <td>39.19</td>\n",
       "      <td>14.97</td>\n",
       "      <td>-59.84</td>\n",
       "      <td>130</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>380</th>\n",
       "      <td>ADCT</td>\n",
       "      <td>Adc Therapeutics SA</td>\n",
       "      <td>-93.70</td>\n",
       "      <td>1674</td>\n",
       "      <td>-70.78</td>\n",
       "      <td>193.38</td>\n",
       "      <td>70.72</td>\n",
       "      <td>-136.87</td>\n",
       "      <td>273</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>381</th>\n",
       "      <td>PVLA</td>\n",
       "      <td>Pieris Pharmaceuticals Inc</td>\n",
       "      <td>-93.82</td>\n",
       "      <td>3637</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>382</th>\n",
       "      <td>QNCX</td>\n",
       "      <td>Quince Therapeutics Inc</td>\n",
       "      <td>-93.83</td>\n",
       "      <td>2049</td>\n",
       "      <td>-34.66</td>\n",
       "      <td>84.04</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-29.13</td>\n",
       "      <td>32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>383</th>\n",
       "      <td>XLO</td>\n",
       "      <td>Xilio Therapeutics Inc</td>\n",
       "      <td>-93.94</td>\n",
       "      <td>1152</td>\n",
       "      <td>-148.25</td>\n",
       "      <td>42.11</td>\n",
       "      <td>4.62</td>\n",
       "      <td>-62.43</td>\n",
       "      <td>73</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>384</th>\n",
       "      <td>OMGA</td>\n",
       "      <td>Omega Therapeutics Inc</td>\n",
       "      <td>-93.94</td>\n",
       "      <td>1236</td>\n",
       "      <td>-166.43</td>\n",
       "      <td>47.40</td>\n",
       "      <td>6.31</td>\n",
       "      <td>-78.89</td>\n",
       "      <td>93</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>385</th>\n",
       "      <td>CNTB</td>\n",
       "      <td>Connect Biopharma Holdings Ltd ADR</td>\n",
       "      <td>-93.95</td>\n",
       "      <td>1369</td>\n",
       "      <td>-41.42</td>\n",
       "      <td>60.23</td>\n",
       "      <td>24.12</td>\n",
       "      <td>-24.95</td>\n",
       "      <td>81</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>ACHL</td>\n",
       "      <td>Achilles Therapeutics Plc ADR</td>\n",
       "      <td>-94.02</td>\n",
       "      <td>1357</td>\n",
       "      <td>-156.31</td>\n",
       "      <td>42.16</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-65.90</td>\n",
       "      <td>204</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387</th>\n",
       "      <td>STTK</td>\n",
       "      <td>Shattuck Labs Inc</td>\n",
       "      <td>-94.11</td>\n",
       "      <td>1530</td>\n",
       "      <td>-165.87</td>\n",
       "      <td>52.04</td>\n",
       "      <td>4.12</td>\n",
       "      <td>-86.32</td>\n",
       "      <td>75</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>388</th>\n",
       "      <td>IKT</td>\n",
       "      <td>Inhibikase Therapeutics Inc</td>\n",
       "      <td>-94.21</td>\n",
       "      <td>1455</td>\n",
       "      <td>-7.91</td>\n",
       "      <td>239.88</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-18.98</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>389</th>\n",
       "      <td>RPTX</td>\n",
       "      <td>Repare Therapeutics Inc</td>\n",
       "      <td>-94.25</td>\n",
       "      <td>1642</td>\n",
       "      <td>-132.67</td>\n",
       "      <td>68.02</td>\n",
       "      <td>66.52</td>\n",
       "      <td>-90.24</td>\n",
       "      <td>179</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>HCWB</td>\n",
       "      <td>HCW Biologics Inc</td>\n",
       "      <td>-94.33</td>\n",
       "      <td>1246</td>\n",
       "      <td>-230.79</td>\n",
       "      <td>15.85</td>\n",
       "      <td>3.92</td>\n",
       "      <td>-36.58</td>\n",
       "      <td>45</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>391</th>\n",
       "      <td>CVAC</td>\n",
       "      <td>CureVac N.V</td>\n",
       "      <td>-94.35</td>\n",
       "      <td>1586</td>\n",
       "      <td>-38.87</td>\n",
       "      <td>695.45</td>\n",
       "      <td>65.86</td>\n",
       "      <td>-270.34</td>\n",
       "      <td>999</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>392</th>\n",
       "      <td>SNTI</td>\n",
       "      <td>Senti Biosciences Inc</td>\n",
       "      <td>-94.42</td>\n",
       "      <td>1301</td>\n",
       "      <td>-241.36</td>\n",
       "      <td>23.45</td>\n",
       "      <td>0.34</td>\n",
       "      <td>-56.60</td>\n",
       "      <td>48</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>ELEV</td>\n",
       "      <td>Elevation Oncology Inc</td>\n",
       "      <td>-94.44</td>\n",
       "      <td>1271</td>\n",
       "      <td>-110.94</td>\n",
       "      <td>37.84</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-41.98</td>\n",
       "      <td>29</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>394</th>\n",
       "      <td>LIPO</td>\n",
       "      <td>Lipella Pharmaceuticals Inc</td>\n",
       "      <td>-94.48</td>\n",
       "      <td>729</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.26</td>\n",
       "      <td>0.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395</th>\n",
       "      <td>PTIX</td>\n",
       "      <td>Protagenic Therapeutics Inc</td>\n",
       "      <td>-94.52</td>\n",
       "      <td>1330</td>\n",
       "      <td>-171.43</td>\n",
       "      <td>3.50</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.00</td>\n",
       "      <td>1</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>396</th>\n",
       "      <td>NXTC</td>\n",
       "      <td>Nextcure Inc</td>\n",
       "      <td>-94.57</td>\n",
       "      <td>2049</td>\n",
       "      <td>-213.50</td>\n",
       "      <td>28.29</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-60.40</td>\n",
       "      <td>82</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>397</th>\n",
       "      <td>SANA</td>\n",
       "      <td>Sana Biotechnology Inc</td>\n",
       "      <td>-94.62</td>\n",
       "      <td>1412</td>\n",
       "      <td>-62.57</td>\n",
       "      <td>437.61</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-273.80</td>\n",
       "      <td>328</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>398</th>\n",
       "      <td>IPSC</td>\n",
       "      <td>Century Therapeutics Inc</td>\n",
       "      <td>-94.66</td>\n",
       "      <td>1278</td>\n",
       "      <td>-118.55</td>\n",
       "      <td>99.48</td>\n",
       "      <td>2.68</td>\n",
       "      <td>-117.93</td>\n",
       "      <td>152</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>GOVX</td>\n",
       "      <td>Geovax Labs Inc</td>\n",
       "      <td>-94.67</td>\n",
       "      <td>1544</td>\n",
       "      <td>-125.68</td>\n",
       "      <td>21.61</td>\n",
       "      <td>0.30</td>\n",
       "      <td>-27.16</td>\n",
       "      <td>17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>400</th>\n",
       "      <td>GOSS</td>\n",
       "      <td>Gossamer Bio Inc</td>\n",
       "      <td>-94.82</td>\n",
       "      <td>2139</td>\n",
       "      <td>-31.79</td>\n",
       "      <td>194.38</td>\n",
       "      <td>105.32</td>\n",
       "      <td>-61.80</td>\n",
       "      <td>135</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>IOBT</td>\n",
       "      <td>IO Biotech Inc</td>\n",
       "      <td>-94.82</td>\n",
       "      <td>1138</td>\n",
       "      <td>-179.67</td>\n",
       "      <td>51.85</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-93.16</td>\n",
       "      <td>74</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>402</th>\n",
       "      <td>IKNA</td>\n",
       "      <td>Ikena Oncology Inc</td>\n",
       "      <td>-94.84</td>\n",
       "      <td>1362</td>\n",
       "      <td>-81.83</td>\n",
       "      <td>77.70</td>\n",
       "      <td>0.66</td>\n",
       "      <td>-63.58</td>\n",
       "      <td>14</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>403</th>\n",
       "      <td>INKT</td>\n",
       "      <td>MiNK Therapeutics Inc</td>\n",
       "      <td>-94.87</td>\n",
       "      <td>1159</td>\n",
       "      <td>-75.20</td>\n",
       "      <td>22.94</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.25</td>\n",
       "      <td>31</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>VCEL</td>\n",
       "      <td>Vericel Corp</td>\n",
       "      <td>-94.87</td>\n",
       "      <td>10178</td>\n",
       "      <td>0.14</td>\n",
       "      <td>2786.78</td>\n",
       "      <td>226.84</td>\n",
       "      <td>3.95</td>\n",
       "      <td>314</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>EQ</td>\n",
       "      <td>Equillium Inc</td>\n",
       "      <td>-95.00</td>\n",
       "      <td>2258</td>\n",
       "      <td>-42.24</td>\n",
       "      <td>22.68</td>\n",
       "      <td>42.62</td>\n",
       "      <td>-9.58</td>\n",
       "      <td>45</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>NKTX</td>\n",
       "      <td>Nkarta Inc</td>\n",
       "      <td>-95.11</td>\n",
       "      <td>1621</td>\n",
       "      <td>-72.47</td>\n",
       "      <td>163.01</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-118.14</td>\n",
       "      <td>159</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>ALXO</td>\n",
       "      <td>Alx Oncology Holdings Inc</td>\n",
       "      <td>-95.17</td>\n",
       "      <td>1614</td>\n",
       "      <td>-195.78</td>\n",
       "      <td>81.22</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-159.01</td>\n",
       "      <td>89</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>MBRX</td>\n",
       "      <td>Moleculin Biotech Inc</td>\n",
       "      <td>-95.17</td>\n",
       "      <td>3120</td>\n",
       "      <td>-438.20</td>\n",
       "      <td>6.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-28.79</td>\n",
       "      <td>18</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>SILO</td>\n",
       "      <td>SILO Pharma Inc</td>\n",
       "      <td>-95.23</td>\n",
       "      <td>1439</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.95</td>\n",
       "      <td>0.07</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>ABCL</td>\n",
       "      <td>AbCellera Biologics Inc</td>\n",
       "      <td>-95.23</td>\n",
       "      <td>1467</td>\n",
       "      <td>-26.31</td>\n",
       "      <td>844.75</td>\n",
       "      <td>32.96</td>\n",
       "      <td>-222.24</td>\n",
       "      <td>586</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>ZVRA</td>\n",
       "      <td>Zevra Therapeutics Inc</td>\n",
       "      <td>-95.27</td>\n",
       "      <td>3533</td>\n",
       "      <td>-18.04</td>\n",
       "      <td>450.49</td>\n",
       "      <td>24.49</td>\n",
       "      <td>-81.27</td>\n",
       "      <td>65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>GBIO</td>\n",
       "      <td>Generation Bio Co</td>\n",
       "      <td>-95.30</td>\n",
       "      <td>1649</td>\n",
       "      <td>-118.99</td>\n",
       "      <td>77.48</td>\n",
       "      <td>18.58</td>\n",
       "      <td>-92.19</td>\n",
       "      <td>174</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>BCAB</td>\n",
       "      <td>BioAtla Inc</td>\n",
       "      <td>-95.33</td>\n",
       "      <td>1462</td>\n",
       "      <td>-130.49</td>\n",
       "      <td>65.27</td>\n",
       "      <td>11.00</td>\n",
       "      <td>-85.17</td>\n",
       "      <td>65</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>SER</td>\n",
       "      <td>Serina Therapeutics Inc</td>\n",
       "      <td>-95.34</td>\n",
       "      <td>2210</td>\n",
       "      <td>-28.53</td>\n",
       "      <td>38.98</td>\n",
       "      <td>3.16</td>\n",
       "      <td>-11.12</td>\n",
       "      <td>9</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>NERV</td>\n",
       "      <td>Minerva Neurosciences Inc</td>\n",
       "      <td>-95.43</td>\n",
       "      <td>3822</td>\n",
       "      <td>-159.86</td>\n",
       "      <td>15.32</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.49</td>\n",
       "      <td>9</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>RNAC</td>\n",
       "      <td>Cartesian Therapeutics Inc</td>\n",
       "      <td>-95.55</td>\n",
       "      <td>3100</td>\n",
       "      <td>-8.31</td>\n",
       "      <td>478.31</td>\n",
       "      <td>47.94</td>\n",
       "      <td>-39.76</td>\n",
       "      <td>37</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>SEER</td>\n",
       "      <td>Seer Inc</td>\n",
       "      <td>-95.63</td>\n",
       "      <td>1474</td>\n",
       "      <td>-63.39</td>\n",
       "      <td>146.24</td>\n",
       "      <td>14.61</td>\n",
       "      <td>-92.70</td>\n",
       "      <td>147</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>TSBX</td>\n",
       "      <td>Turnstone Biologics Corp</td>\n",
       "      <td>-95.64</td>\n",
       "      <td>515</td>\n",
       "      <td>-713.71</td>\n",
       "      <td>10.87</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-77.58</td>\n",
       "      <td>80</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>KPTI</td>\n",
       "      <td>Karyopharm Therapeutics Inc</td>\n",
       "      <td>-95.64</td>\n",
       "      <td>4059</td>\n",
       "      <td>-149.63</td>\n",
       "      <td>83.96</td>\n",
       "      <td>148.44</td>\n",
       "      <td>-125.63</td>\n",
       "      <td>325</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>VRCA</td>\n",
       "      <td>Verrica Pharmaceuticals Inc</td>\n",
       "      <td>-95.65</td>\n",
       "      <td>2377</td>\n",
       "      <td>-112.86</td>\n",
       "      <td>65.03</td>\n",
       "      <td>9.21</td>\n",
       "      <td>-73.39</td>\n",
       "      <td>100</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>KLTO</td>\n",
       "      <td>Klotho Neurosciences Inc</td>\n",
       "      <td>-95.65</td>\n",
       "      <td>963</td>\n",
       "      <td>0.00</td>\n",
       "      <td>9.43</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>CLLS</td>\n",
       "      <td>Cellectis ADR</td>\n",
       "      <td>-95.76</td>\n",
       "      <td>3556</td>\n",
       "      <td>-38.44</td>\n",
       "      <td>174.85</td>\n",
       "      <td>36.04</td>\n",
       "      <td>-67.22</td>\n",
       "      <td>216</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>NNVC</td>\n",
       "      <td>NanoViricides Inc</td>\n",
       "      <td>-95.77</td>\n",
       "      <td>6992</td>\n",
       "      <td>-36.55</td>\n",
       "      <td>21.23</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.76</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>PMVP</td>\n",
       "      <td>PMV Pharmaceuticals Inc</td>\n",
       "      <td>-95.79</td>\n",
       "      <td>1544</td>\n",
       "      <td>-95.53</td>\n",
       "      <td>80.73</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-77.12</td>\n",
       "      <td>63</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>TIL</td>\n",
       "      <td>Instil Bio Inc</td>\n",
       "      <td>-95.85</td>\n",
       "      <td>1369</td>\n",
       "      <td>-44.96</td>\n",
       "      <td>146.83</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-66.02</td>\n",
       "      <td>49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>ASMB</td>\n",
       "      <td>Assembly Biosciences Inc</td>\n",
       "      <td>-95.93</td>\n",
       "      <td>5114</td>\n",
       "      <td>-50.89</td>\n",
       "      <td>98.78</td>\n",
       "      <td>21.48</td>\n",
       "      <td>-50.27</td>\n",
       "      <td>65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>SABS</td>\n",
       "      <td>SAB Biotherapeutics Inc</td>\n",
       "      <td>-95.98</td>\n",
       "      <td>1407</td>\n",
       "      <td>-128.34</td>\n",
       "      <td>36.55</td>\n",
       "      <td>1.51</td>\n",
       "      <td>-46.91</td>\n",
       "      <td>57</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>LYEL</td>\n",
       "      <td>Lyell Immunopharma Inc</td>\n",
       "      <td>-96.01</td>\n",
       "      <td>1279</td>\n",
       "      <td>-100.37</td>\n",
       "      <td>195.87</td>\n",
       "      <td>0.06</td>\n",
       "      <td>-196.60</td>\n",
       "      <td>224</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429</th>\n",
       "      <td>ATRA</td>\n",
       "      <td>Atara Biotherapeutics Inc</td>\n",
       "      <td>-96.12</td>\n",
       "      <td>3715</td>\n",
       "      <td>-267.83</td>\n",
       "      <td>60.53</td>\n",
       "      <td>62.39</td>\n",
       "      <td>-162.12</td>\n",
       "      <td>165</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>KZR</td>\n",
       "      <td>Kezar Life Sciences Inc</td>\n",
       "      <td>-96.20</td>\n",
       "      <td>2371</td>\n",
       "      <td>-205.08</td>\n",
       "      <td>48.01</td>\n",
       "      <td>7.00</td>\n",
       "      <td>-98.46</td>\n",
       "      <td>58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>AFMD</td>\n",
       "      <td>Affimed N.V</td>\n",
       "      <td>-96.23</td>\n",
       "      <td>3749</td>\n",
       "      <td>-203.81</td>\n",
       "      <td>34.92</td>\n",
       "      <td>7.43</td>\n",
       "      <td>-71.17</td>\n",
       "      <td>76</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>LPTX</td>\n",
       "      <td>Leap Therapeutics Inc</td>\n",
       "      <td>-96.25</td>\n",
       "      <td>2883</td>\n",
       "      <td>-56.09</td>\n",
       "      <td>115.34</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-64.69</td>\n",
       "      <td>54</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>CGTX</td>\n",
       "      <td>Cognition Therapeutics Inc</td>\n",
       "      <td>-96.26</td>\n",
       "      <td>1166</td>\n",
       "      <td>-312.75</td>\n",
       "      <td>18.74</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-58.61</td>\n",
       "      <td>25</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>BTAI</td>\n",
       "      <td>BioXcel Therapeutics Inc</td>\n",
       "      <td>-96.26</td>\n",
       "      <td>2476</td>\n",
       "      <td>-530.79</td>\n",
       "      <td>19.65</td>\n",
       "      <td>2.40</td>\n",
       "      <td>-104.30</td>\n",
       "      <td>74</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>435</th>\n",
       "      <td>XCUR</td>\n",
       "      <td>Exicure Inc</td>\n",
       "      <td>-96.28</td>\n",
       "      <td>2401</td>\n",
       "      <td>-12.28</td>\n",
       "      <td>47.22</td>\n",
       "      <td>0.50</td>\n",
       "      <td>-5.80</td>\n",
       "      <td>5</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>436</th>\n",
       "      <td>KTTA</td>\n",
       "      <td>Pasithea Therapeutics Corp</td>\n",
       "      <td>-96.28</td>\n",
       "      <td>1189</td>\n",
       "      <td>-494.53</td>\n",
       "      <td>3.29</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.27</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>437</th>\n",
       "      <td>ADAP</td>\n",
       "      <td>Adaptimmune Therapeutics Plc ADR</td>\n",
       "      <td>-96.38</td>\n",
       "      <td>3513</td>\n",
       "      <td>-48.16</td>\n",
       "      <td>151.33</td>\n",
       "      <td>141.46</td>\n",
       "      <td>-72.88</td>\n",
       "      <td>449</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438</th>\n",
       "      <td>KRON</td>\n",
       "      <td>Kronos Bio Inc</td>\n",
       "      <td>-96.38</td>\n",
       "      <td>1530</td>\n",
       "      <td>-162.68</td>\n",
       "      <td>57.93</td>\n",
       "      <td>8.41</td>\n",
       "      <td>-94.24</td>\n",
       "      <td>58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>AADI</td>\n",
       "      <td>Aadi Bioscience Inc</td>\n",
       "      <td>-96.43</td>\n",
       "      <td>2496</td>\n",
       "      <td>-108.08</td>\n",
       "      <td>58.66</td>\n",
       "      <td>25.07</td>\n",
       "      <td>-63.40</td>\n",
       "      <td>53</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>440</th>\n",
       "      <td>ADXN</td>\n",
       "      <td>Addex Therapeutics Ltd ADR</td>\n",
       "      <td>-96.46</td>\n",
       "      <td>1770</td>\n",
       "      <td>-130.39</td>\n",
       "      <td>8.49</td>\n",
       "      <td>0.86</td>\n",
       "      <td>-11.07</td>\n",
       "      <td>23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>441</th>\n",
       "      <td>SLGL</td>\n",
       "      <td>Sol-Gel Technologies Ltd</td>\n",
       "      <td>-96.48</td>\n",
       "      <td>2511</td>\n",
       "      <td>-127.27</td>\n",
       "      <td>12.98</td>\n",
       "      <td>6.56</td>\n",
       "      <td>-16.52</td>\n",
       "      <td>36</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>442</th>\n",
       "      <td>VTVT</td>\n",
       "      <td>vTv Therapeutics Inc</td>\n",
       "      <td>-96.55</td>\n",
       "      <td>3428</td>\n",
       "      <td>-56.46</td>\n",
       "      <td>40.33</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-22.77</td>\n",
       "      <td>16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>443</th>\n",
       "      <td>ATHA</td>\n",
       "      <td>Athira Pharma Inc</td>\n",
       "      <td>-96.58</td>\n",
       "      <td>1551</td>\n",
       "      <td>-539.32</td>\n",
       "      <td>22.33</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-120.43</td>\n",
       "      <td>65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>444</th>\n",
       "      <td>PASG</td>\n",
       "      <td>Passage Bio Inc</td>\n",
       "      <td>-96.58</td>\n",
       "      <td>1754</td>\n",
       "      <td>-189.80</td>\n",
       "      <td>44.60</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-84.65</td>\n",
       "      <td>58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>445</th>\n",
       "      <td>VSTM</td>\n",
       "      <td>Verastem Inc</td>\n",
       "      <td>-96.63</td>\n",
       "      <td>4708</td>\n",
       "      <td>-54.96</td>\n",
       "      <td>208.29</td>\n",
       "      <td>10.00</td>\n",
       "      <td>-114.48</td>\n",
       "      <td>73</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>446</th>\n",
       "      <td>ALLK</td>\n",
       "      <td>Allakos Inc</td>\n",
       "      <td>-96.64</td>\n",
       "      <td>2343</td>\n",
       "      <td>-163.38</td>\n",
       "      <td>94.70</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-154.72</td>\n",
       "      <td>131</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>447</th>\n",
       "      <td>SNPX</td>\n",
       "      <td>Synaptogenix Inc</td>\n",
       "      <td>-96.87</td>\n",
       "      <td>1470</td>\n",
       "      <td>-182.13</td>\n",
       "      <td>3.75</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.83</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>448</th>\n",
       "      <td>SAVA</td>\n",
       "      <td>Cassava Sciences Inc</td>\n",
       "      <td>-96.92</td>\n",
       "      <td>8922</td>\n",
       "      <td>-111.99</td>\n",
       "      <td>127.97</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-143.32</td>\n",
       "      <td>29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>SYBX</td>\n",
       "      <td>Synlogic Inc</td>\n",
       "      <td>-96.94</td>\n",
       "      <td>3366</td>\n",
       "      <td>-207.25</td>\n",
       "      <td>17.37</td>\n",
       "      <td>3.17</td>\n",
       "      <td>-36.00</td>\n",
       "      <td>6</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>450</th>\n",
       "      <td>PRLD</td>\n",
       "      <td>Prelude Therapeutics Inc</td>\n",
       "      <td>-96.95</td>\n",
       "      <td>1544</td>\n",
       "      <td>-287.32</td>\n",
       "      <td>49.30</td>\n",
       "      <td>3.00</td>\n",
       "      <td>-141.65</td>\n",
       "      <td>128</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>451</th>\n",
       "      <td>PMCB</td>\n",
       "      <td>PharmaCyte Biotech Inc</td>\n",
       "      <td>-97.00</td>\n",
       "      <td>4367</td>\n",
       "      <td>0.00</td>\n",
       "      <td>12.98</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>452</th>\n",
       "      <td>ELTX</td>\n",
       "      <td>Elicio Therapeutics Inc</td>\n",
       "      <td>-97.02</td>\n",
       "      <td>1411</td>\n",
       "      <td>-77.37</td>\n",
       "      <td>52.99</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-41.00</td>\n",
       "      <td>32</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>453</th>\n",
       "      <td>RIGL</td>\n",
       "      <td>Rigel Pharmaceuticals</td>\n",
       "      <td>-97.04</td>\n",
       "      <td>8784</td>\n",
       "      <td>3.36</td>\n",
       "      <td>337.15</td>\n",
       "      <td>157.37</td>\n",
       "      <td>11.32</td>\n",
       "      <td>147</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>454</th>\n",
       "      <td>LPCN</td>\n",
       "      <td>Lipocine Inc</td>\n",
       "      <td>-97.05</td>\n",
       "      <td>4074</td>\n",
       "      <td>-36.23</td>\n",
       "      <td>26.69</td>\n",
       "      <td>4.80</td>\n",
       "      <td>-9.67</td>\n",
       "      <td>17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>455</th>\n",
       "      <td>CAPR</td>\n",
       "      <td>Capricor Therapeutics Inc</td>\n",
       "      <td>-97.05</td>\n",
       "      <td>6517</td>\n",
       "      <td>-5.51</td>\n",
       "      <td>631.12</td>\n",
       "      <td>23.23</td>\n",
       "      <td>-34.77</td>\n",
       "      <td>101</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>CRIS</td>\n",
       "      <td>Curis Inc</td>\n",
       "      <td>-97.07</td>\n",
       "      <td>8904</td>\n",
       "      <td>-167.29</td>\n",
       "      <td>29.47</td>\n",
       "      <td>10.16</td>\n",
       "      <td>-49.30</td>\n",
       "      <td>49</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>CLDX</td>\n",
       "      <td>Celldex Therapeutics Inc</td>\n",
       "      <td>-97.10</td>\n",
       "      <td>14096</td>\n",
       "      <td>-9.84</td>\n",
       "      <td>1738.22</td>\n",
       "      <td>9.98</td>\n",
       "      <td>-171.06</td>\n",
       "      <td>160</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>458</th>\n",
       "      <td>INAB</td>\n",
       "      <td>IN8bio Inc</td>\n",
       "      <td>-97.15</td>\n",
       "      <td>1236</td>\n",
       "      <td>-150.07</td>\n",
       "      <td>20.41</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-30.63</td>\n",
       "      <td>39</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>459</th>\n",
       "      <td>EVGN</td>\n",
       "      <td>Evogene Ltd</td>\n",
       "      <td>-97.15</td>\n",
       "      <td>5177</td>\n",
       "      <td>-219.29</td>\n",
       "      <td>8.97</td>\n",
       "      <td>9.45</td>\n",
       "      <td>-19.67</td>\n",
       "      <td>142</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>460</th>\n",
       "      <td>PGEN</td>\n",
       "      <td>Precigen Inc</td>\n",
       "      <td>-97.25</td>\n",
       "      <td>4149</td>\n",
       "      <td>-44.90</td>\n",
       "      <td>197.28</td>\n",
       "      <td>4.39</td>\n",
       "      <td>-88.58</td>\n",
       "      <td>202</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>461</th>\n",
       "      <td>ATNM</td>\n",
       "      <td>Actinium Pharmaceuticals Inc</td>\n",
       "      <td>-97.27</td>\n",
       "      <td>4373</td>\n",
       "      <td>-117.31</td>\n",
       "      <td>39.62</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-46.48</td>\n",
       "      <td>49</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>462</th>\n",
       "      <td>GLYC</td>\n",
       "      <td>GlycoMimetics Inc</td>\n",
       "      <td>-97.34</td>\n",
       "      <td>3994</td>\n",
       "      <td>-263.61</td>\n",
       "      <td>15.47</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-40.78</td>\n",
       "      <td>35</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>463</th>\n",
       "      <td>VOR</td>\n",
       "      <td>Vor Biopharma Inc</td>\n",
       "      <td>-97.36</td>\n",
       "      <td>1411</td>\n",
       "      <td>-173.02</td>\n",
       "      <td>70.05</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.20</td>\n",
       "      <td>168</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>464</th>\n",
       "      <td>BIVI</td>\n",
       "      <td>BioVie Inc</td>\n",
       "      <td>-97.36</td>\n",
       "      <td>1551</td>\n",
       "      <td>-70.80</td>\n",
       "      <td>45.13</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.95</td>\n",
       "      <td>14</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>465</th>\n",
       "      <td>LSB</td>\n",
       "      <td>LakeShore Biopharma Co Ltd</td>\n",
       "      <td>-97.37</td>\n",
       "      <td>1230</td>\n",
       "      <td>-662.26</td>\n",
       "      <td>47.70</td>\n",
       "      <td>573.42</td>\n",
       "      <td>-315.90</td>\n",
       "      <td>758</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>466</th>\n",
       "      <td>IVVD</td>\n",
       "      <td>Invivyd Inc</td>\n",
       "      <td>-97.38</td>\n",
       "      <td>1229</td>\n",
       "      <td>-390.91</td>\n",
       "      <td>53.89</td>\n",
       "      <td>2.26</td>\n",
       "      <td>-210.66</td>\n",
       "      <td>94</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>467</th>\n",
       "      <td>SXTP</td>\n",
       "      <td>60 Degrees Pharmaceuticals Inc</td>\n",
       "      <td>-97.49</td>\n",
       "      <td>524</td>\n",
       "      <td>-256.20</td>\n",
       "      <td>3.47</td>\n",
       "      <td>0.44</td>\n",
       "      <td>-8.89</td>\n",
       "      <td>3</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>468</th>\n",
       "      <td>LGVN</td>\n",
       "      <td>Longeveron Inc</td>\n",
       "      <td>-97.49</td>\n",
       "      <td>1404</td>\n",
       "      <td>-63.78</td>\n",
       "      <td>27.00</td>\n",
       "      <td>1.23</td>\n",
       "      <td>-17.22</td>\n",
       "      <td>23</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>469</th>\n",
       "      <td>DNA</td>\n",
       "      <td>Ginkgo Bioworks Holdings Inc</td>\n",
       "      <td>-97.67</td>\n",
       "      <td>1338</td>\n",
       "      <td>-97.00</td>\n",
       "      <td>542.03</td>\n",
       "      <td>217.95</td>\n",
       "      <td>-525.77</td>\n",
       "      <td>1218</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>470</th>\n",
       "      <td>SNSE</td>\n",
       "      <td>Sensei Biotherapeutics Inc</td>\n",
       "      <td>-97.67</td>\n",
       "      <td>1412</td>\n",
       "      <td>-285.00</td>\n",
       "      <td>10.87</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-30.98</td>\n",
       "      <td>28</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>471</th>\n",
       "      <td>CELU</td>\n",
       "      <td>Celularity Inc</td>\n",
       "      <td>-97.73</td>\n",
       "      <td>1958</td>\n",
       "      <td>-69.12</td>\n",
       "      <td>51.94</td>\n",
       "      <td>42.69</td>\n",
       "      <td>-35.90</td>\n",
       "      <td>120</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>472</th>\n",
       "      <td>SPRB</td>\n",
       "      <td>Spruce Biosciences Inc</td>\n",
       "      <td>-97.75</td>\n",
       "      <td>1530</td>\n",
       "      <td>-269.10</td>\n",
       "      <td>16.05</td>\n",
       "      <td>7.10</td>\n",
       "      <td>-43.19</td>\n",
       "      <td>29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>473</th>\n",
       "      <td>BNOX</td>\n",
       "      <td>Bionomics Ltd. ADR</td>\n",
       "      <td>-97.81</td>\n",
       "      <td>1097</td>\n",
       "      <td>-311.49</td>\n",
       "      <td>5.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.35</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>474</th>\n",
       "      <td>VINC</td>\n",
       "      <td>Vincerx Pharma Inc</td>\n",
       "      <td>-97.96</td>\n",
       "      <td>1665</td>\n",
       "      <td>-422.99</td>\n",
       "      <td>6.48</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.41</td>\n",
       "      <td>42</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>475</th>\n",
       "      <td>CARA</td>\n",
       "      <td>Cara Therapeutics Inc</td>\n",
       "      <td>-97.97</td>\n",
       "      <td>3973</td>\n",
       "      <td>-740.07</td>\n",
       "      <td>14.15</td>\n",
       "      <td>11.00</td>\n",
       "      <td>-104.72</td>\n",
       "      <td>55</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>476</th>\n",
       "      <td>ADVM</td>\n",
       "      <td>Adverum Biotechnologies Inc</td>\n",
       "      <td>-98.08</td>\n",
       "      <td>3792</td>\n",
       "      <td>-90.50</td>\n",
       "      <td>109.42</td>\n",
       "      <td>1.00</td>\n",
       "      <td>-99.02</td>\n",
       "      <td>121</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>CLDI</td>\n",
       "      <td>Calidi Biotherapeutics Inc</td>\n",
       "      <td>-98.11</td>\n",
       "      <td>1142</td>\n",
       "      <td>-95.20</td>\n",
       "      <td>30.65</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-29.18</td>\n",
       "      <td>41</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>478</th>\n",
       "      <td>EYPT</td>\n",
       "      <td>EyePoint Pharmaceuticals Inc</td>\n",
       "      <td>-98.14</td>\n",
       "      <td>7264</td>\n",
       "      <td>-22.06</td>\n",
       "      <td>519.39</td>\n",
       "      <td>45.71</td>\n",
       "      <td>-114.58</td>\n",
       "      <td>121</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479</th>\n",
       "      <td>EPIX</td>\n",
       "      <td>Essa Pharma Inc</td>\n",
       "      <td>-98.14</td>\n",
       "      <td>3567</td>\n",
       "      <td>0.00</td>\n",
       "      <td>72.35</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>50</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>BLUE</td>\n",
       "      <td>Bluebird bio Inc</td>\n",
       "      <td>-98.18</td>\n",
       "      <td>4199</td>\n",
       "      <td>-397.88</td>\n",
       "      <td>75.93</td>\n",
       "      <td>54.90</td>\n",
       "      <td>-302.11</td>\n",
       "      <td>375</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>481</th>\n",
       "      <td>COEP</td>\n",
       "      <td>Coeptis Therapeutics Holdings Inc</td>\n",
       "      <td>-98.20</td>\n",
       "      <td>1461</td>\n",
       "      <td>-204.08</td>\n",
       "      <td>7.85</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.02</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>482</th>\n",
       "      <td>ALVR</td>\n",
       "      <td>AlloVir Inc</td>\n",
       "      <td>-98.23</td>\n",
       "      <td>1601</td>\n",
       "      <td>-230.59</td>\n",
       "      <td>52.24</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-120.46</td>\n",
       "      <td>8</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>483</th>\n",
       "      <td>GLMD</td>\n",
       "      <td>Galmed Pharmaceuticals Ltd</td>\n",
       "      <td>-98.27</td>\n",
       "      <td>3932</td>\n",
       "      <td>-113.28</td>\n",
       "      <td>5.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.14</td>\n",
       "      <td>3</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>484</th>\n",
       "      <td>MCRB</td>\n",
       "      <td>Seres Therapeutics Inc</td>\n",
       "      <td>-98.29</td>\n",
       "      <td>3462</td>\n",
       "      <td>-24.02</td>\n",
       "      <td>151.96</td>\n",
       "      <td>126.32</td>\n",
       "      <td>-36.50</td>\n",
       "      <td>233</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>485</th>\n",
       "      <td>ONCY</td>\n",
       "      <td>Oncolytics Biotech, Inc</td>\n",
       "      <td>-98.34</td>\n",
       "      <td>8474</td>\n",
       "      <td>-57.02</td>\n",
       "      <td>63.92</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-36.45</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>486</th>\n",
       "      <td>NLSP</td>\n",
       "      <td>NLS Pharmaceutics Ltd</td>\n",
       "      <td>-98.35</td>\n",
       "      <td>1418</td>\n",
       "      <td>-142.86</td>\n",
       "      <td>4.41</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.30</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>487</th>\n",
       "      <td>BOLT</td>\n",
       "      <td>Bolt Biotherapeutics Inc</td>\n",
       "      <td>-98.36</td>\n",
       "      <td>1411</td>\n",
       "      <td>-364.25</td>\n",
       "      <td>19.83</td>\n",
       "      <td>11.17</td>\n",
       "      <td>-72.23</td>\n",
       "      <td>100</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>488</th>\n",
       "      <td>ARTL</td>\n",
       "      <td>Artelo Biosciences Inc</td>\n",
       "      <td>-98.41</td>\n",
       "      <td>2006</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>489</th>\n",
       "      <td>HOOK</td>\n",
       "      <td>Hookipa Pharma Inc</td>\n",
       "      <td>-98.48</td>\n",
       "      <td>2070</td>\n",
       "      <td>-182.38</td>\n",
       "      <td>26.16</td>\n",
       "      <td>52.16</td>\n",
       "      <td>-47.71</td>\n",
       "      <td>151</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>490</th>\n",
       "      <td>FGEN</td>\n",
       "      <td>FibroGen Inc</td>\n",
       "      <td>-98.49</td>\n",
       "      <td>3686</td>\n",
       "      <td>-506.23</td>\n",
       "      <td>32.76</td>\n",
       "      <td>173.82</td>\n",
       "      <td>-165.84</td>\n",
       "      <td>486</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>491</th>\n",
       "      <td>TARA</td>\n",
       "      <td>Protara Therapeutics Inc</td>\n",
       "      <td>-98.51</td>\n",
       "      <td>3709</td>\n",
       "      <td>-23.13</td>\n",
       "      <td>189.79</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-43.90</td>\n",
       "      <td>26</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>492</th>\n",
       "      <td>ATYR</td>\n",
       "      <td>Atyr Pharma Inc</td>\n",
       "      <td>-98.54</td>\n",
       "      <td>3512</td>\n",
       "      <td>-26.48</td>\n",
       "      <td>254.35</td>\n",
       "      <td>0.24</td>\n",
       "      <td>-67.34</td>\n",
       "      <td>56</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>SLDB</td>\n",
       "      <td>Solid Biosciences Inc</td>\n",
       "      <td>-98.55</td>\n",
       "      <td>2517</td>\n",
       "      <td>-59.81</td>\n",
       "      <td>183.79</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-109.92</td>\n",
       "      <td>88</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>CYCN</td>\n",
       "      <td>Cyclerion Therapeutics Inc</td>\n",
       "      <td>-98.63</td>\n",
       "      <td>2101</td>\n",
       "      <td>0.00</td>\n",
       "      <td>9.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>1</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>GLTO</td>\n",
       "      <td>Galecto Inc</td>\n",
       "      <td>-98.65</td>\n",
       "      <td>1510</td>\n",
       "      <td>-294.29</td>\n",
       "      <td>6.83</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.10</td>\n",
       "      <td>13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>PMN</td>\n",
       "      <td>ProMIS Neurosciences Inc</td>\n",
       "      <td>-98.71</td>\n",
       "      <td>6551</td>\n",
       "      <td>-37.44</td>\n",
       "      <td>29.78</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-11.15</td>\n",
       "      <td>6</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>NRXP</td>\n",
       "      <td>NRX Pharmaceuticals Inc</td>\n",
       "      <td>-98.75</td>\n",
       "      <td>2570</td>\n",
       "      <td>-160.30</td>\n",
       "      <td>14.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.26</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>498</th>\n",
       "      <td>ATXS</td>\n",
       "      <td>Astria Therapeutics Inc</td>\n",
       "      <td>-98.78</td>\n",
       "      <td>3463</td>\n",
       "      <td>0.00</td>\n",
       "      <td>545.72</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>499</th>\n",
       "      <td>ONVO</td>\n",
       "      <td>Organovo Holdings Inc</td>\n",
       "      <td>-98.79</td>\n",
       "      <td>4690</td>\n",
       "      <td>-208.51</td>\n",
       "      <td>5.99</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-12.49</td>\n",
       "      <td>12</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>FBIO</td>\n",
       "      <td>Fortress Biotech Inc</td>\n",
       "      <td>-98.82</td>\n",
       "      <td>4779</td>\n",
       "      <td>-176.84</td>\n",
       "      <td>51.07</td>\n",
       "      <td>82.62</td>\n",
       "      <td>-90.31</td>\n",
       "      <td>186</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>501</th>\n",
       "      <td>BCLI</td>\n",
       "      <td>Brainstorm Cell Therapeutics, Inc</td>\n",
       "      <td>-98.83</td>\n",
       "      <td>7742</td>\n",
       "      <td>-181.45</td>\n",
       "      <td>8.84</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.04</td>\n",
       "      <td>29</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>502</th>\n",
       "      <td>EVAX</td>\n",
       "      <td>Evaxion Biotech A/S ADR</td>\n",
       "      <td>-98.85</td>\n",
       "      <td>1411</td>\n",
       "      <td>-241.40</td>\n",
       "      <td>6.16</td>\n",
       "      <td>3.30</td>\n",
       "      <td>-14.87</td>\n",
       "      <td>49</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>503</th>\n",
       "      <td>QTTB</td>\n",
       "      <td>Q32 Bio Inc</td>\n",
       "      <td>-98.90</td>\n",
       "      <td>2456</td>\n",
       "      <td>-180.37</td>\n",
       "      <td>42.63</td>\n",
       "      <td>-14.66</td>\n",
       "      <td>-76.89</td>\n",
       "      <td>42</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>504</th>\n",
       "      <td>ADIL</td>\n",
       "      <td>Adial Pharmaceuticals Inc</td>\n",
       "      <td>-98.92</td>\n",
       "      <td>2335</td>\n",
       "      <td>-103.71</td>\n",
       "      <td>7.01</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.27</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>505</th>\n",
       "      <td>ALRN</td>\n",
       "      <td>Aileron Therapeutics Inc</td>\n",
       "      <td>-98.95</td>\n",
       "      <td>2728</td>\n",
       "      <td>-55.30</td>\n",
       "      <td>45.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-25.40</td>\n",
       "      <td>15</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>506</th>\n",
       "      <td>DTIL</td>\n",
       "      <td>Precision Biosciences Inc</td>\n",
       "      <td>-98.96</td>\n",
       "      <td>2091</td>\n",
       "      <td>-32.95</td>\n",
       "      <td>36.36</td>\n",
       "      <td>75.10</td>\n",
       "      <td>-11.98</td>\n",
       "      <td>108</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>507</th>\n",
       "      <td>LYRA</td>\n",
       "      <td>Lyra Therapeutics Inc</td>\n",
       "      <td>-99.01</td>\n",
       "      <td>1691</td>\n",
       "      <td>-551.77</td>\n",
       "      <td>12.15</td>\n",
       "      <td>1.47</td>\n",
       "      <td>-67.04</td>\n",
       "      <td>88</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>508</th>\n",
       "      <td>RZLT</td>\n",
       "      <td>Rezolute Inc</td>\n",
       "      <td>-99.04</td>\n",
       "      <td>4355</td>\n",
       "      <td>-27.06</td>\n",
       "      <td>260.16</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-70.39</td>\n",
       "      <td>59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>509</th>\n",
       "      <td>ITRM</td>\n",
       "      <td>Iterum Therapeutics Plc</td>\n",
       "      <td>-99.07</td>\n",
       "      <td>2398</td>\n",
       "      <td>-72.61</td>\n",
       "      <td>51.45</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-37.36</td>\n",
       "      <td>14</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>510</th>\n",
       "      <td>CMMB</td>\n",
       "      <td>Chemomab Therapeutics Ltd ADR</td>\n",
       "      <td>-99.09</td>\n",
       "      <td>2135</td>\n",
       "      <td>-52.60</td>\n",
       "      <td>30.36</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.97</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>511</th>\n",
       "      <td>MTNB</td>\n",
       "      <td>Matinas Biopharma Holdings Inc</td>\n",
       "      <td>-99.13</td>\n",
       "      <td>3802</td>\n",
       "      <td>-850.18</td>\n",
       "      <td>2.75</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.38</td>\n",
       "      <td>32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512</th>\n",
       "      <td>VRDN</td>\n",
       "      <td>Viridian Therapeutics Inc</td>\n",
       "      <td>-99.13</td>\n",
       "      <td>3835</td>\n",
       "      <td>-16.56</td>\n",
       "      <td>1706.24</td>\n",
       "      <td>0.30</td>\n",
       "      <td>-282.47</td>\n",
       "      <td>94</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513</th>\n",
       "      <td>VRAX</td>\n",
       "      <td>Virax Biolabs Group Ltd</td>\n",
       "      <td>-99.14</td>\n",
       "      <td>880</td>\n",
       "      <td>-90.43</td>\n",
       "      <td>6.69</td>\n",
       "      <td>0.16</td>\n",
       "      <td>-6.05</td>\n",
       "      <td>17</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514</th>\n",
       "      <td>EYEN</td>\n",
       "      <td>Eyenovia Inc</td>\n",
       "      <td>-99.15</td>\n",
       "      <td>2518</td>\n",
       "      <td>-382.84</td>\n",
       "      <td>9.09</td>\n",
       "      <td>0.03</td>\n",
       "      <td>-34.80</td>\n",
       "      <td>57</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>515</th>\n",
       "      <td>APLM</td>\n",
       "      <td>Apollomics Inc</td>\n",
       "      <td>-99.16</td>\n",
       "      <td>1117</td>\n",
       "      <td>-585.45</td>\n",
       "      <td>9.07</td>\n",
       "      <td>2.10</td>\n",
       "      <td>-53.10</td>\n",
       "      <td>45</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>516</th>\n",
       "      <td>PDSB</td>\n",
       "      <td>PDS Biotechnology Corporation</td>\n",
       "      <td>-99.16</td>\n",
       "      <td>3366</td>\n",
       "      <td>-54.77</td>\n",
       "      <td>72.39</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-39.65</td>\n",
       "      <td>25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>517</th>\n",
       "      <td>CMND</td>\n",
       "      <td>Clearmind Medicine Inc</td>\n",
       "      <td>-99.17</td>\n",
       "      <td>763</td>\n",
       "      <td>-102.09</td>\n",
       "      <td>5.74</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-5.86</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>518</th>\n",
       "      <td>CDT</td>\n",
       "      <td>Conduit Pharmaceuticals Inc</td>\n",
       "      <td>-99.18</td>\n",
       "      <td>995</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8.86</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>7</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>519</th>\n",
       "      <td>MRNS</td>\n",
       "      <td>Marinus Pharmaceuticals Inc</td>\n",
       "      <td>-99.18</td>\n",
       "      <td>3792</td>\n",
       "      <td>-941.19</td>\n",
       "      <td>13.67</td>\n",
       "      <td>30.26</td>\n",
       "      <td>-128.66</td>\n",
       "      <td>165</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>ACET</td>\n",
       "      <td>Adicet Bio Inc</td>\n",
       "      <td>-99.18</td>\n",
       "      <td>2517</td>\n",
       "      <td>-153.18</td>\n",
       "      <td>79.32</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-121.50</td>\n",
       "      <td>143</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>521</th>\n",
       "      <td>ICU</td>\n",
       "      <td>SeaStar Medical Holding Corp</td>\n",
       "      <td>-99.19</td>\n",
       "      <td>1370</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8.21</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>12</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>522</th>\n",
       "      <td>ATHE</td>\n",
       "      <td>Alterity Therapeutics Ltd ADR</td>\n",
       "      <td>-99.20</td>\n",
       "      <td>7750</td>\n",
       "      <td>-83.70</td>\n",
       "      <td>23.38</td>\n",
       "      <td>4.02</td>\n",
       "      <td>-19.57</td>\n",
       "      <td>10</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>XFOR</td>\n",
       "      <td>X4 Pharmaceuticals Inc</td>\n",
       "      <td>-99.20</td>\n",
       "      <td>2588</td>\n",
       "      <td>-111.98</td>\n",
       "      <td>110.00</td>\n",
       "      <td>0.56</td>\n",
       "      <td>-123.18</td>\n",
       "      <td>127</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>524</th>\n",
       "      <td>APRE</td>\n",
       "      <td>Aprea Therapeutics Inc</td>\n",
       "      <td>-99.22</td>\n",
       "      <td>1902</td>\n",
       "      <td>-80.02</td>\n",
       "      <td>17.72</td>\n",
       "      <td>1.28</td>\n",
       "      <td>-14.18</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>525</th>\n",
       "      <td>ARWR</td>\n",
       "      <td>Arrowhead Pharmaceuticals Inc</td>\n",
       "      <td>-99.25</td>\n",
       "      <td>11324</td>\n",
       "      <td>-19.03</td>\n",
       "      <td>2783.59</td>\n",
       "      <td>19.65</td>\n",
       "      <td>-529.78</td>\n",
       "      <td>525</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>526</th>\n",
       "      <td>CTXR</td>\n",
       "      <td>Citius Pharmaceuticals Inc</td>\n",
       "      <td>-99.26</td>\n",
       "      <td>3729</td>\n",
       "      <td>-205.97</td>\n",
       "      <td>19.94</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-41.07</td>\n",
       "      <td>22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>527</th>\n",
       "      <td>IGC</td>\n",
       "      <td>IGC Pharma Inc</td>\n",
       "      <td>-99.26</td>\n",
       "      <td>6782</td>\n",
       "      <td>-33.11</td>\n",
       "      <td>28.39</td>\n",
       "      <td>1.06</td>\n",
       "      <td>-9.40</td>\n",
       "      <td>67</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>528</th>\n",
       "      <td>CBUS</td>\n",
       "      <td>Cibus Inc</td>\n",
       "      <td>-99.27</td>\n",
       "      <td>2707</td>\n",
       "      <td>-52.43</td>\n",
       "      <td>115.02</td>\n",
       "      <td>4.15</td>\n",
       "      <td>-60.30</td>\n",
       "      <td>183</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>529</th>\n",
       "      <td>SCNI</td>\n",
       "      <td>Scinai Immunotherapeutics Ltd ADR</td>\n",
       "      <td>-99.32</td>\n",
       "      <td>3508</td>\n",
       "      <td>-238.10</td>\n",
       "      <td>2.94</td>\n",
       "      <td>0.28</td>\n",
       "      <td>-7.00</td>\n",
       "      <td>31</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>530</th>\n",
       "      <td>KZIA</td>\n",
       "      <td>Kazia Therapeutics Limited ADR</td>\n",
       "      <td>-99.33</td>\n",
       "      <td>9477</td>\n",
       "      <td>-120.83</td>\n",
       "      <td>14.50</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.52</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>531</th>\n",
       "      <td>UBX</td>\n",
       "      <td>Unity Biotechnology Inc</td>\n",
       "      <td>-99.33</td>\n",
       "      <td>2420</td>\n",
       "      <td>-150.33</td>\n",
       "      <td>18.20</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.36</td>\n",
       "      <td>19</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532</th>\n",
       "      <td>KALA</td>\n",
       "      <td>Kala Bio Inc</td>\n",
       "      <td>-99.33</td>\n",
       "      <td>2707</td>\n",
       "      <td>-145.47</td>\n",
       "      <td>28.17</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-40.98</td>\n",
       "      <td>43</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>533</th>\n",
       "      <td>PHGE</td>\n",
       "      <td>BiomX Inc</td>\n",
       "      <td>-99.34</td>\n",
       "      <td>2106</td>\n",
       "      <td>-229.20</td>\n",
       "      <td>12.09</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-27.71</td>\n",
       "      <td>58</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>534</th>\n",
       "      <td>XBIO</td>\n",
       "      <td>Xenetic Biosciences Inc</td>\n",
       "      <td>-99.34</td>\n",
       "      <td>3092</td>\n",
       "      <td>0.00</td>\n",
       "      <td>6.34</td>\n",
       "      <td>2.52</td>\n",
       "      <td>0.00</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>535</th>\n",
       "      <td>LXRX</td>\n",
       "      <td>Lexicon Pharmaceuticals Inc</td>\n",
       "      <td>-99.38</td>\n",
       "      <td>9020</td>\n",
       "      <td>-75.65</td>\n",
       "      <td>278.31</td>\n",
       "      <td>5.23</td>\n",
       "      <td>-210.55</td>\n",
       "      <td>285</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>536</th>\n",
       "      <td>GNPX</td>\n",
       "      <td>Genprex Inc</td>\n",
       "      <td>-99.38</td>\n",
       "      <td>2455</td>\n",
       "      <td>-294.29</td>\n",
       "      <td>8.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-26.28</td>\n",
       "      <td>21</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>537</th>\n",
       "      <td>GRCE</td>\n",
       "      <td>Grace Therapeutics Inc</td>\n",
       "      <td>-99.38</td>\n",
       "      <td>4697</td>\n",
       "      <td>-35.95</td>\n",
       "      <td>36.91</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-13.27</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>538</th>\n",
       "      <td>VRPX</td>\n",
       "      <td>Virpax Pharmaceuticals Inc</td>\n",
       "      <td>-99.39</td>\n",
       "      <td>1399</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2.85</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>7</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>539</th>\n",
       "      <td>RLMD</td>\n",
       "      <td>Relmada Therapeutics Inc</td>\n",
       "      <td>-99.39</td>\n",
       "      <td>3833</td>\n",
       "      <td>0.00</td>\n",
       "      <td>11.73</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>540</th>\n",
       "      <td>PPBT</td>\n",
       "      <td>Purple Biotech Ltd ADR</td>\n",
       "      <td>-99.40</td>\n",
       "      <td>3315</td>\n",
       "      <td>-195.81</td>\n",
       "      <td>10.02</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-19.62</td>\n",
       "      <td>20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>541</th>\n",
       "      <td>GYRE</td>\n",
       "      <td>Gyre Therapeutics Inc</td>\n",
       "      <td>-99.42</td>\n",
       "      <td>6824</td>\n",
       "      <td>2.34</td>\n",
       "      <td>857.36</td>\n",
       "      <td>111.59</td>\n",
       "      <td>20.08</td>\n",
       "      <td>593</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>542</th>\n",
       "      <td>CERO</td>\n",
       "      <td>CERo Therapeutics Holdings Inc</td>\n",
       "      <td>-99.43</td>\n",
       "      <td>1113</td>\n",
       "      <td>0.00</td>\n",
       "      <td>7.67</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>543</th>\n",
       "      <td>VXRT</td>\n",
       "      <td>Vaxart Inc</td>\n",
       "      <td>-99.43</td>\n",
       "      <td>15712</td>\n",
       "      <td>-49.80</td>\n",
       "      <td>133.05</td>\n",
       "      <td>13.93</td>\n",
       "      <td>-66.26</td>\n",
       "      <td>109</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>544</th>\n",
       "      <td>DWTX</td>\n",
       "      <td>Dogwood Therapeutics Inc</td>\n",
       "      <td>-99.44</td>\n",
       "      <td>1461</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.26</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>4</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>APM</td>\n",
       "      <td>Aptorum Group Ltd</td>\n",
       "      <td>-99.47</td>\n",
       "      <td>2191</td>\n",
       "      <td>-237.62</td>\n",
       "      <td>4.04</td>\n",
       "      <td>0.43</td>\n",
       "      <td>-9.60</td>\n",
       "      <td>3</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>546</th>\n",
       "      <td>XOMA</td>\n",
       "      <td>XOMA Royalty Corp</td>\n",
       "      <td>-99.47</td>\n",
       "      <td>14074</td>\n",
       "      <td>-4.63</td>\n",
       "      <td>327.79</td>\n",
       "      <td>21.61</td>\n",
       "      <td>-15.17</td>\n",
       "      <td>13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>547</th>\n",
       "      <td>FBRX</td>\n",
       "      <td>Forte Biosciences Inc</td>\n",
       "      <td>-99.50</td>\n",
       "      <td>2805</td>\n",
       "      <td>0.00</td>\n",
       "      <td>27.72</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>11</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>548</th>\n",
       "      <td>PYPD</td>\n",
       "      <td>Polypid Ltd</td>\n",
       "      <td>-99.54</td>\n",
       "      <td>1635</td>\n",
       "      <td>-132.73</td>\n",
       "      <td>16.53</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.94</td>\n",
       "      <td>59</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>549</th>\n",
       "      <td>BCTX</td>\n",
       "      <td>BriaCell Therapeutics Corp</td>\n",
       "      <td>-99.58</td>\n",
       "      <td>4661</td>\n",
       "      <td>-121.62</td>\n",
       "      <td>27.34</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-33.25</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>550</th>\n",
       "      <td>CING</td>\n",
       "      <td>Cingulate Inc</td>\n",
       "      <td>-99.61</td>\n",
       "      <td>1105</td>\n",
       "      <td>-120.23</td>\n",
       "      <td>12.95</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.57</td>\n",
       "      <td>13</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>551</th>\n",
       "      <td>DARE</td>\n",
       "      <td>Dare Bioscience Inc</td>\n",
       "      <td>-99.61</td>\n",
       "      <td>3904</td>\n",
       "      <td>-96.49</td>\n",
       "      <td>27.67</td>\n",
       "      <td>2.84</td>\n",
       "      <td>-26.70</td>\n",
       "      <td>23</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>552</th>\n",
       "      <td>HOTH</td>\n",
       "      <td>Hoth Therapeutics Inc</td>\n",
       "      <td>-99.62</td>\n",
       "      <td>2132</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5.59</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>553</th>\n",
       "      <td>ENLV</td>\n",
       "      <td>Enlivex Therapeutics Ltd</td>\n",
       "      <td>-99.64</td>\n",
       "      <td>3792</td>\n",
       "      <td>-70.13</td>\n",
       "      <td>25.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.89</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>554</th>\n",
       "      <td>ELAB</td>\n",
       "      <td>Elevai Labs Inc</td>\n",
       "      <td>-99.66</td>\n",
       "      <td>392</td>\n",
       "      <td>-75.51</td>\n",
       "      <td>6.33</td>\n",
       "      <td>2.47</td>\n",
       "      <td>-4.78</td>\n",
       "      <td>18</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>555</th>\n",
       "      <td>EDSA</td>\n",
       "      <td>Edesa Biotech Inc</td>\n",
       "      <td>-99.67</td>\n",
       "      <td>5293</td>\n",
       "      <td>-134.04</td>\n",
       "      <td>6.17</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.27</td>\n",
       "      <td>16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>556</th>\n",
       "      <td>INO</td>\n",
       "      <td>Inovio Pharmaceuticals Inc</td>\n",
       "      <td>-99.67</td>\n",
       "      <td>9506</td>\n",
       "      <td>-148.16</td>\n",
       "      <td>77.61</td>\n",
       "      <td>0.59</td>\n",
       "      <td>-114.99</td>\n",
       "      <td>127</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>557</th>\n",
       "      <td>GTBP</td>\n",
       "      <td>GT Biopharma Inc</td>\n",
       "      <td>-99.68</td>\n",
       "      <td>2457</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5.61</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>558</th>\n",
       "      <td>XTLB</td>\n",
       "      <td>X.T.L. Biopharmaceuticals Ltd. ADR</td>\n",
       "      <td>-99.68</td>\n",
       "      <td>7047</td>\n",
       "      <td>0.00</td>\n",
       "      <td>9.10</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>559</th>\n",
       "      <td>NCNA</td>\n",
       "      <td>NuCana plc ADR</td>\n",
       "      <td>-99.69</td>\n",
       "      <td>2637</td>\n",
       "      <td>-668.41</td>\n",
       "      <td>4.97</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-33.22</td>\n",
       "      <td>25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>560</th>\n",
       "      <td>RGLS</td>\n",
       "      <td>Regulus Therapeutics Inc</td>\n",
       "      <td>-99.70</td>\n",
       "      <td>4452</td>\n",
       "      <td>-41.20</td>\n",
       "      <td>107.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-44.26</td>\n",
       "      <td>32</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>561</th>\n",
       "      <td>AZTR</td>\n",
       "      <td>Azitra Inc</td>\n",
       "      <td>-99.70</td>\n",
       "      <td>550</td>\n",
       "      <td>-330.15</td>\n",
       "      <td>3.35</td>\n",
       "      <td>0.10</td>\n",
       "      <td>-11.06</td>\n",
       "      <td>10</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>562</th>\n",
       "      <td>XRTX</td>\n",
       "      <td>XORTX Therapeutics Inc</td>\n",
       "      <td>-99.71</td>\n",
       "      <td>1181</td>\n",
       "      <td>-84.62</td>\n",
       "      <td>3.90</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-3.30</td>\n",
       "      <td>2</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>563</th>\n",
       "      <td>BLRX</td>\n",
       "      <td>Bioline Rx Ltd ADR</td>\n",
       "      <td>-99.71</td>\n",
       "      <td>4892</td>\n",
       "      <td>-152.30</td>\n",
       "      <td>21.72</td>\n",
       "      <td>17.05</td>\n",
       "      <td>-33.08</td>\n",
       "      <td>79</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>564</th>\n",
       "      <td>HRTX</td>\n",
       "      <td>Heron Therapeutics Inc</td>\n",
       "      <td>-99.72</td>\n",
       "      <td>13628</td>\n",
       "      <td>-2.23</td>\n",
       "      <td>255.52</td>\n",
       "      <td>137.74</td>\n",
       "      <td>-5.70</td>\n",
       "      <td>126</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>565</th>\n",
       "      <td>VANI</td>\n",
       "      <td>Vivani Medical Inc</td>\n",
       "      <td>-99.73</td>\n",
       "      <td>3681</td>\n",
       "      <td>-31.85</td>\n",
       "      <td>78.19</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.90</td>\n",
       "      <td>36</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>566</th>\n",
       "      <td>PBM</td>\n",
       "      <td>Psyence Biomedical Ltd</td>\n",
       "      <td>-99.75</td>\n",
       "      <td>1103</td>\n",
       "      <td>-176.28</td>\n",
       "      <td>1.56</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-2.75</td>\n",
       "      <td>0</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>567</th>\n",
       "      <td>CRDF</td>\n",
       "      <td>Cardiff Oncology Inc</td>\n",
       "      <td>-99.76</td>\n",
       "      <td>7448</td>\n",
       "      <td>-17.16</td>\n",
       "      <td>268.09</td>\n",
       "      <td>0.69</td>\n",
       "      <td>-46.00</td>\n",
       "      <td>31</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>568</th>\n",
       "      <td>IMUX</td>\n",
       "      <td>Immunic Inc</td>\n",
       "      <td>-99.76</td>\n",
       "      <td>3897</td>\n",
       "      <td>-95.69</td>\n",
       "      <td>99.99</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-95.68</td>\n",
       "      <td>85</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>569</th>\n",
       "      <td>SPRC</td>\n",
       "      <td>SciSparc Ltd</td>\n",
       "      <td>-99.77</td>\n",
       "      <td>1205</td>\n",
       "      <td>-248.52</td>\n",
       "      <td>2.37</td>\n",
       "      <td>1.75</td>\n",
       "      <td>-5.89</td>\n",
       "      <td>3</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>570</th>\n",
       "      <td>OTLK</td>\n",
       "      <td>Outlook Therapeutics Inc</td>\n",
       "      <td>-99.78</td>\n",
       "      <td>3108</td>\n",
       "      <td>-180.87</td>\n",
       "      <td>33.83</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-61.19</td>\n",
       "      <td>24</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>571</th>\n",
       "      <td>COCP</td>\n",
       "      <td>Cocrystal Pharma Inc</td>\n",
       "      <td>-99.79</td>\n",
       "      <td>4682</td>\n",
       "      <td>-102.92</td>\n",
       "      <td>20.55</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.15</td>\n",
       "      <td>12</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>572</th>\n",
       "      <td>PLX</td>\n",
       "      <td>Protalix BioTherapeutics Inc</td>\n",
       "      <td>-99.79</td>\n",
       "      <td>9713</td>\n",
       "      <td>-10.50</td>\n",
       "      <td>128.86</td>\n",
       "      <td>38.05</td>\n",
       "      <td>-13.53</td>\n",
       "      <td>208</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>573</th>\n",
       "      <td>INDP</td>\n",
       "      <td>Indaptus Therapeutics Inc</td>\n",
       "      <td>-99.79</td>\n",
       "      <td>3423</td>\n",
       "      <td>-142.93</td>\n",
       "      <td>11.53</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.48</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>574</th>\n",
       "      <td>BNTC</td>\n",
       "      <td>Benitec Biopharma Inc</td>\n",
       "      <td>-99.80</td>\n",
       "      <td>3829</td>\n",
       "      <td>-7.67</td>\n",
       "      <td>292.06</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-22.40</td>\n",
       "      <td>16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>575</th>\n",
       "      <td>PRTG</td>\n",
       "      <td>Portage Biotech Inc</td>\n",
       "      <td>-99.81</td>\n",
       "      <td>8385</td>\n",
       "      <td>-440.66</td>\n",
       "      <td>3.64</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.04</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>576</th>\n",
       "      <td>CARM</td>\n",
       "      <td>Carisma Therapeutics Inc</td>\n",
       "      <td>-99.81</td>\n",
       "      <td>3967</td>\n",
       "      <td>-352.84</td>\n",
       "      <td>17.96</td>\n",
       "      <td>20.27</td>\n",
       "      <td>-63.37</td>\n",
       "      <td>107</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>577</th>\n",
       "      <td>CANF</td>\n",
       "      <td>Can-Fite Biopharma Ltd ADR</td>\n",
       "      <td>-99.81</td>\n",
       "      <td>4424</td>\n",
       "      <td>-84.47</td>\n",
       "      <td>9.21</td>\n",
       "      <td>0.67</td>\n",
       "      <td>-7.78</td>\n",
       "      <td>8</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>578</th>\n",
       "      <td>CASI</td>\n",
       "      <td>CASI Pharmaceuticals Inc</td>\n",
       "      <td>-99.82</td>\n",
       "      <td>10415</td>\n",
       "      <td>-47.39</td>\n",
       "      <td>48.70</td>\n",
       "      <td>23.10</td>\n",
       "      <td>-23.08</td>\n",
       "      <td>176</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>579</th>\n",
       "      <td>SKYE</td>\n",
       "      <td>Skye Bioscience Inc</td>\n",
       "      <td>-99.83</td>\n",
       "      <td>3633</td>\n",
       "      <td>-23.58</td>\n",
       "      <td>99.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.46</td>\n",
       "      <td>11</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>580</th>\n",
       "      <td>VTGN</td>\n",
       "      <td>Vistagen Therapeutics Inc</td>\n",
       "      <td>-99.83</td>\n",
       "      <td>4928</td>\n",
       "      <td>-65.85</td>\n",
       "      <td>69.05</td>\n",
       "      <td>0.88</td>\n",
       "      <td>-45.47</td>\n",
       "      <td>39</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>THAR</td>\n",
       "      <td>Tharimmune Inc</td>\n",
       "      <td>-99.84</td>\n",
       "      <td>1070</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.22</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>582</th>\n",
       "      <td>PULM</td>\n",
       "      <td>Pulmatrix Inc</td>\n",
       "      <td>-99.84</td>\n",
       "      <td>3924</td>\n",
       "      <td>-50.50</td>\n",
       "      <td>22.06</td>\n",
       "      <td>11.39</td>\n",
       "      <td>-11.14</td>\n",
       "      <td>22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>583</th>\n",
       "      <td>VCNX</td>\n",
       "      <td>Vaccinex Inc</td>\n",
       "      <td>-99.85</td>\n",
       "      <td>2322</td>\n",
       "      <td>-220.16</td>\n",
       "      <td>9.77</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-21.51</td>\n",
       "      <td>37</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>584</th>\n",
       "      <td>ENVB</td>\n",
       "      <td>Enveric Biosciences Inc</td>\n",
       "      <td>-99.85</td>\n",
       "      <td>3515</td>\n",
       "      <td>-275.70</td>\n",
       "      <td>3.58</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-9.87</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>585</th>\n",
       "      <td>MBIO</td>\n",
       "      <td>Mustang Bio Inc</td>\n",
       "      <td>-99.87</td>\n",
       "      <td>2674</td>\n",
       "      <td>-222.43</td>\n",
       "      <td>9.23</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.53</td>\n",
       "      <td>80</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>ATOS</td>\n",
       "      <td>Atossa Therapeutics Inc</td>\n",
       "      <td>-99.87</td>\n",
       "      <td>4422</td>\n",
       "      <td>-21.89</td>\n",
       "      <td>134.61</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-29.46</td>\n",
       "      <td>12</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>587</th>\n",
       "      <td>VYNE</td>\n",
       "      <td>VYNE Therapeutics Inc</td>\n",
       "      <td>-99.88</td>\n",
       "      <td>2518</td>\n",
       "      <td>0.00</td>\n",
       "      <td>37.76</td>\n",
       "      <td>0.49</td>\n",
       "      <td>0.00</td>\n",
       "      <td>10</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>588</th>\n",
       "      <td>OCGN</td>\n",
       "      <td>Ocugen Inc</td>\n",
       "      <td>-99.88</td>\n",
       "      <td>3667</td>\n",
       "      <td>-20.48</td>\n",
       "      <td>246.78</td>\n",
       "      <td>4.70</td>\n",
       "      <td>-50.53</td>\n",
       "      <td>65</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>589</th>\n",
       "      <td>INM</td>\n",
       "      <td>InMed Pharmaceuticals Inc</td>\n",
       "      <td>-99.88</td>\n",
       "      <td>3879</td>\n",
       "      <td>-212.06</td>\n",
       "      <td>3.73</td>\n",
       "      <td>4.60</td>\n",
       "      <td>-7.91</td>\n",
       "      <td>13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>590</th>\n",
       "      <td>SYRS</td>\n",
       "      <td>Syros Pharmaceuticals Inc</td>\n",
       "      <td>-99.89</td>\n",
       "      <td>3092</td>\n",
       "      <td>-1867.46</td>\n",
       "      <td>5.90</td>\n",
       "      <td>0.39</td>\n",
       "      <td>-110.18</td>\n",
       "      <td>68</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>591</th>\n",
       "      <td>ELDN</td>\n",
       "      <td>Eledon Pharmaceuticals Inc</td>\n",
       "      <td>-99.89</td>\n",
       "      <td>3744</td>\n",
       "      <td>0.00</td>\n",
       "      <td>267.03</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>592</th>\n",
       "      <td>IRD</td>\n",
       "      <td>Opus Genetics Inc</td>\n",
       "      <td>-99.91</td>\n",
       "      <td>6977</td>\n",
       "      <td>-93.35</td>\n",
       "      <td>31.57</td>\n",
       "      <td>8.38</td>\n",
       "      <td>-29.47</td>\n",
       "      <td>14</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>593</th>\n",
       "      <td>DRMA</td>\n",
       "      <td>Dermata Therapeutics Inc</td>\n",
       "      <td>-99.91</td>\n",
       "      <td>1222</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2.18</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>594</th>\n",
       "      <td>TCRT</td>\n",
       "      <td>Alaunos Therapeutics Inc</td>\n",
       "      <td>-99.92</td>\n",
       "      <td>7055</td>\n",
       "      <td>-478.33</td>\n",
       "      <td>2.63</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-12.58</td>\n",
       "      <td>1</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>595</th>\n",
       "      <td>AKTX</td>\n",
       "      <td>Akari Therapeutics Plc ADR</td>\n",
       "      <td>-99.94</td>\n",
       "      <td>3998</td>\n",
       "      <td>-69.14</td>\n",
       "      <td>26.15</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-18.08</td>\n",
       "      <td>6</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>596</th>\n",
       "      <td>ALZN</td>\n",
       "      <td>Alzamend Neuro Inc</td>\n",
       "      <td>-99.94</td>\n",
       "      <td>1281</td>\n",
       "      <td>-110.41</td>\n",
       "      <td>6.63</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.32</td>\n",
       "      <td>4</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>597</th>\n",
       "      <td>AGEN</td>\n",
       "      <td>Agenus Inc</td>\n",
       "      <td>-99.94</td>\n",
       "      <td>9079</td>\n",
       "      <td>-127.99</td>\n",
       "      <td>66.82</td>\n",
       "      <td>160.43</td>\n",
       "      <td>-85.52</td>\n",
       "      <td>389</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>598</th>\n",
       "      <td>ATNF</td>\n",
       "      <td>180 Life Sciences Corp</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>2730</td>\n",
       "      <td>-245.28</td>\n",
       "      <td>3.60</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.83</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>TFFP</td>\n",
       "      <td>Tff Pharmaceuticals Inc</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>1880</td>\n",
       "      <td>-6555.17</td>\n",
       "      <td>0.29</td>\n",
       "      <td>1.20</td>\n",
       "      <td>-19.01</td>\n",
       "      <td>19</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>AVTX</td>\n",
       "      <td>Avalo Therapeutics Inc</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>3352</td>\n",
       "      <td>-31.62</td>\n",
       "      <td>98.57</td>\n",
       "      <td>0.82</td>\n",
       "      <td>-31.17</td>\n",
       "      <td>19</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>601</th>\n",
       "      <td>IBIO</td>\n",
       "      <td>iBio Inc</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>5964</td>\n",
       "      <td>-68.60</td>\n",
       "      <td>21.50</td>\n",
       "      <td>0.18</td>\n",
       "      <td>-14.75</td>\n",
       "      <td>16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>602</th>\n",
       "      <td>TPST</td>\n",
       "      <td>Tempest Therapeutics Inc</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>4418</td>\n",
       "      <td>-89.52</td>\n",
       "      <td>34.91</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.25</td>\n",
       "      <td>17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>603</th>\n",
       "      <td>PCSA</td>\n",
       "      <td>Processa Pharmaceuticals Inc</td>\n",
       "      <td>-99.95</td>\n",
       "      <td>3938</td>\n",
       "      <td>-346.76</td>\n",
       "      <td>3.40</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-11.79</td>\n",
       "      <td>13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>604</th>\n",
       "      <td>SCPX</td>\n",
       "      <td>Scorpius Holdings Inc</td>\n",
       "      <td>-99.96</td>\n",
       "      <td>4164</td>\n",
       "      <td>-1906.87</td>\n",
       "      <td>1.31</td>\n",
       "      <td>9.85</td>\n",
       "      <td>-24.98</td>\n",
       "      <td>82</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>605</th>\n",
       "      <td>MEIP</td>\n",
       "      <td>MEI Pharma Inc</td>\n",
       "      <td>-99.96</td>\n",
       "      <td>7670</td>\n",
       "      <td>153.46</td>\n",
       "      <td>17.19</td>\n",
       "      <td>65.30</td>\n",
       "      <td>26.38</td>\n",
       "      <td>28</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>606</th>\n",
       "      <td>PTN</td>\n",
       "      <td>Palatin Technologies Inc</td>\n",
       "      <td>-99.96</td>\n",
       "      <td>9925</td>\n",
       "      <td>-184.36</td>\n",
       "      <td>16.24</td>\n",
       "      <td>4.49</td>\n",
       "      <td>-29.94</td>\n",
       "      <td>30</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>ZVSA</td>\n",
       "      <td>ZyVersa Therapeutics Inc</td>\n",
       "      <td>-99.97</td>\n",
       "      <td>1040</td>\n",
       "      <td>-425.31</td>\n",
       "      <td>2.41</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-10.25</td>\n",
       "      <td>7</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>608</th>\n",
       "      <td>CELZ</td>\n",
       "      <td>Creative Medical Technology Holdings Inc</td>\n",
       "      <td>-99.97</td>\n",
       "      <td>3329</td>\n",
       "      <td>-134.96</td>\n",
       "      <td>4.09</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-5.52</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>609</th>\n",
       "      <td>CVM</td>\n",
       "      <td>Cel-Sci Corp</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>14985</td>\n",
       "      <td>-61.54</td>\n",
       "      <td>41.47</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-25.52</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>610</th>\n",
       "      <td>ATXI</td>\n",
       "      <td>Avenue Therapeutics Inc</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>2730</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>611</th>\n",
       "      <td>BPTH</td>\n",
       "      <td>Bio-Path Holdings Inc</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>6132</td>\n",
       "      <td>-449.13</td>\n",
       "      <td>2.89</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.98</td>\n",
       "      <td>10</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>612</th>\n",
       "      <td>ONCO</td>\n",
       "      <td>Onconetix Inc</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>1033</td>\n",
       "      <td>-435.34</td>\n",
       "      <td>3.48</td>\n",
       "      <td>1.46</td>\n",
       "      <td>-15.15</td>\n",
       "      <td>12</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>613</th>\n",
       "      <td>AIM</td>\n",
       "      <td>AIM ImmunoTech Inc</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>10385</td>\n",
       "      <td>-234.20</td>\n",
       "      <td>13.39</td>\n",
       "      <td>0.20</td>\n",
       "      <td>-31.36</td>\n",
       "      <td>26</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>614</th>\n",
       "      <td>HURA</td>\n",
       "      <td>TuHURA Biosciences Inc</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>4316</td>\n",
       "      <td>0.00</td>\n",
       "      <td>175.06</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>615</th>\n",
       "      <td>PLUR</td>\n",
       "      <td>Pluri Inc</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>7841</td>\n",
       "      <td>-84.79</td>\n",
       "      <td>25.83</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-21.90</td>\n",
       "      <td>106</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>616</th>\n",
       "      <td>ENSC</td>\n",
       "      <td>Ensysce Biosciences Inc</td>\n",
       "      <td>-99.98</td>\n",
       "      <td>2470</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8.36</td>\n",
       "      <td>1.44</td>\n",
       "      <td>0.00</td>\n",
       "      <td>7</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>617</th>\n",
       "      <td>KPRX</td>\n",
       "      <td>Kiora Pharmaceuticals Inc</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>3595</td>\n",
       "      <td>58.52</td>\n",
       "      <td>10.80</td>\n",
       "      <td>16.02</td>\n",
       "      <td>6.32</td>\n",
       "      <td>12</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>618</th>\n",
       "      <td>APTO</td>\n",
       "      <td>Aptose Biosciences Inc</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>11964</td>\n",
       "      <td>-314.43</td>\n",
       "      <td>11.50</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-36.16</td>\n",
       "      <td>35</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>619</th>\n",
       "      <td>RNAZ</td>\n",
       "      <td>TransCode Therapeutics Inc</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>1258</td>\n",
       "      <td>-376.97</td>\n",
       "      <td>4.69</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-17.68</td>\n",
       "      <td>10</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>620</th>\n",
       "      <td>HEPA</td>\n",
       "      <td>Hepion Pharmaceuticals Inc</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>3963</td>\n",
       "      <td>-853.93</td>\n",
       "      <td>3.69</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.51</td>\n",
       "      <td>22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>621</th>\n",
       "      <td>IMNN</td>\n",
       "      <td>Imunon Inc</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>9423</td>\n",
       "      <td>-169.79</td>\n",
       "      <td>12.18</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-20.68</td>\n",
       "      <td>33</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>622</th>\n",
       "      <td>BCDA</td>\n",
       "      <td>BioCardia Inc</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>10261</td>\n",
       "      <td>-89.04</td>\n",
       "      <td>9.58</td>\n",
       "      <td>0.43</td>\n",
       "      <td>-8.53</td>\n",
       "      <td>16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>623</th>\n",
       "      <td>MTEM</td>\n",
       "      <td>Molecular Templates Inc</td>\n",
       "      <td>-99.99</td>\n",
       "      <td>7256</td>\n",
       "      <td>-565.71</td>\n",
       "      <td>2.45</td>\n",
       "      <td>25.47</td>\n",
       "      <td>-13.86</td>\n",
       "      <td>62</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>624</th>\n",
       "      <td>QNRX</td>\n",
       "      <td>Quoin Pharmaceuticals Ltd ADR</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3060</td>\n",
       "      <td>-274.53</td>\n",
       "      <td>3.22</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.84</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>625</th>\n",
       "      <td>MTVA</td>\n",
       "      <td>MetaVia Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3056</td>\n",
       "      <td>-151.63</td>\n",
       "      <td>19.04</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-28.87</td>\n",
       "      <td>8</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>626</th>\n",
       "      <td>GRI</td>\n",
       "      <td>GRI Bio Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1406</td>\n",
       "      <td>-122.22</td>\n",
       "      <td>6.84</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.36</td>\n",
       "      <td>4</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>627</th>\n",
       "      <td>ERNA</td>\n",
       "      <td>Eterna Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>12164</td>\n",
       "      <td>-156.70</td>\n",
       "      <td>13.95</td>\n",
       "      <td>0.16</td>\n",
       "      <td>-21.86</td>\n",
       "      <td>8</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>628</th>\n",
       "      <td>REVB</td>\n",
       "      <td>Revelation Biosciences Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1491</td>\n",
       "      <td>-571.81</td>\n",
       "      <td>1.49</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.52</td>\n",
       "      <td>9</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>629</th>\n",
       "      <td>TTNP</td>\n",
       "      <td>Titan Pharmaceuticals, Inc. (de)</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>10561</td>\n",
       "      <td>-228.71</td>\n",
       "      <td>3.10</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-7.09</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>630</th>\n",
       "      <td>VIRX</td>\n",
       "      <td>Viracta Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7021</td>\n",
       "      <td>-581.73</td>\n",
       "      <td>8.43</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-49.04</td>\n",
       "      <td>40</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>631</th>\n",
       "      <td>APVO</td>\n",
       "      <td>Aptevo Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3072</td>\n",
       "      <td>-1247.94</td>\n",
       "      <td>1.94</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.21</td>\n",
       "      <td>40</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>632</th>\n",
       "      <td>SLRX</td>\n",
       "      <td>Salarius Pharmaceuticals Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3610</td>\n",
       "      <td>-336.50</td>\n",
       "      <td>2.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-6.73</td>\n",
       "      <td>2</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>633</th>\n",
       "      <td>TENX</td>\n",
       "      <td>Tenax Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>11215</td>\n",
       "      <td>-65.44</td>\n",
       "      <td>19.91</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-13.03</td>\n",
       "      <td>5</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>634</th>\n",
       "      <td>TNFA</td>\n",
       "      <td>TNF Pharmaceuticals Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3981</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>6</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>635</th>\n",
       "      <td>ACHV</td>\n",
       "      <td>Achieve Life Sciences Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>10659</td>\n",
       "      <td>-21.85</td>\n",
       "      <td>142.03</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-31.04</td>\n",
       "      <td>22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>636</th>\n",
       "      <td>CNSP</td>\n",
       "      <td>Cns Pharmaceuticals Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1866</td>\n",
       "      <td>-269.93</td>\n",
       "      <td>5.92</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-15.98</td>\n",
       "      <td>3</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>637</th>\n",
       "      <td>LSTA</td>\n",
       "      <td>Lisata Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>9423</td>\n",
       "      <td>-109.27</td>\n",
       "      <td>21.90</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-23.93</td>\n",
       "      <td>25</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>638</th>\n",
       "      <td>BRTX</td>\n",
       "      <td>BioRestorative Therapies Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4395</td>\n",
       "      <td>-117.82</td>\n",
       "      <td>10.10</td>\n",
       "      <td>0.38</td>\n",
       "      <td>-11.90</td>\n",
       "      <td>11</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>639</th>\n",
       "      <td>TOVX</td>\n",
       "      <td>Theriva Biologics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6574</td>\n",
       "      <td>-656.44</td>\n",
       "      <td>3.26</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-21.40</td>\n",
       "      <td>22</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>640</th>\n",
       "      <td>DOMH</td>\n",
       "      <td>Dominari Holdings Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>16345</td>\n",
       "      <td>-152.64</td>\n",
       "      <td>9.29</td>\n",
       "      <td>12.59</td>\n",
       "      <td>-14.18</td>\n",
       "      <td>26</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>641</th>\n",
       "      <td>OGEN</td>\n",
       "      <td>Oragenics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7601</td>\n",
       "      <td>-459.95</td>\n",
       "      <td>4.27</td>\n",
       "      <td>0.01</td>\n",
       "      <td>-19.64</td>\n",
       "      <td>5</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>642</th>\n",
       "      <td>QLGN</td>\n",
       "      <td>Qualigen Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3465</td>\n",
       "      <td>-257.89</td>\n",
       "      <td>3.23</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.33</td>\n",
       "      <td>4</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>NBY</td>\n",
       "      <td>Novabay Pharmaceuticals Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6262</td>\n",
       "      <td>-181.23</td>\n",
       "      <td>2.77</td>\n",
       "      <td>13.06</td>\n",
       "      <td>-5.02</td>\n",
       "      <td>24</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>ARMP</td>\n",
       "      <td>Armata Pharmaceuticals Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>11169</td>\n",
       "      <td>-56.25</td>\n",
       "      <td>72.73</td>\n",
       "      <td>3.72</td>\n",
       "      <td>-40.91</td>\n",
       "      <td>66</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>CSCI</td>\n",
       "      <td>COSCIENS Biopharma Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>8987</td>\n",
       "      <td>-282.20</td>\n",
       "      <td>9.10</td>\n",
       "      <td>4.83</td>\n",
       "      <td>-25.68</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>TRAW</td>\n",
       "      <td>Traws Pharma Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4163</td>\n",
       "      <td>-145.18</td>\n",
       "      <td>14.21</td>\n",
       "      <td>0.23</td>\n",
       "      <td>-20.63</td>\n",
       "      <td>17</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>ORKA</td>\n",
       "      <td>Oruka Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>9993</td>\n",
       "      <td>0.00</td>\n",
       "      <td>789.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>ENTO</td>\n",
       "      <td>Entero Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>2989</td>\n",
       "      <td>-737.64</td>\n",
       "      <td>2.71</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-19.99</td>\n",
       "      <td>9</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>SLS</td>\n",
       "      <td>SELLAS Life Sciences Group Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6124</td>\n",
       "      <td>0.00</td>\n",
       "      <td>64.76</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>ABEO</td>\n",
       "      <td>Abeona Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>16160</td>\n",
       "      <td>-21.38</td>\n",
       "      <td>256.04</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-54.75</td>\n",
       "      <td>84</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>651</th>\n",
       "      <td>TCBP</td>\n",
       "      <td>TC BioPharm (Holdings) plc ADR</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1040</td>\n",
       "      <td>-286.47</td>\n",
       "      <td>4.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-12.92</td>\n",
       "      <td>41</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>MRKR</td>\n",
       "      <td>Marker Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>8190</td>\n",
       "      <td>0.00</td>\n",
       "      <td>36.85</td>\n",
       "      <td>3.73</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>653</th>\n",
       "      <td>PSTV</td>\n",
       "      <td>Plus Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>8560</td>\n",
       "      <td>-195.22</td>\n",
       "      <td>6.90</td>\n",
       "      <td>5.51</td>\n",
       "      <td>-13.47</td>\n",
       "      <td>20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>654</th>\n",
       "      <td>SNGX</td>\n",
       "      <td>Soligenix Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>11215</td>\n",
       "      <td>-102.75</td>\n",
       "      <td>7.65</td>\n",
       "      <td>0.36</td>\n",
       "      <td>-7.86</td>\n",
       "      <td>13</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>ABVC</td>\n",
       "      <td>ABVC BioPharma Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7342</td>\n",
       "      <td>-136.38</td>\n",
       "      <td>6.24</td>\n",
       "      <td>0.14</td>\n",
       "      <td>-8.51</td>\n",
       "      <td>16</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>656</th>\n",
       "      <td>PHIO</td>\n",
       "      <td>Phio Pharmaceuticals Corp</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4604</td>\n",
       "      <td>-285.67</td>\n",
       "      <td>3.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-8.57</td>\n",
       "      <td>8</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>657</th>\n",
       "      <td>CYTO</td>\n",
       "      <td>Altamira Therapeutics Ltd</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3786</td>\n",
       "      <td>0.00</td>\n",
       "      <td>1.58</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>10</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>658</th>\n",
       "      <td>ADTX</td>\n",
       "      <td>Aditxt Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1631</td>\n",
       "      <td>-762.44</td>\n",
       "      <td>4.34</td>\n",
       "      <td>0.33</td>\n",
       "      <td>-33.09</td>\n",
       "      <td>47</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>CRVO</td>\n",
       "      <td>CervoMed Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6052</td>\n",
       "      <td>0.00</td>\n",
       "      <td>16.09</td>\n",
       "      <td>10.07</td>\n",
       "      <td>0.00</td>\n",
       "      <td>8</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>PALI</td>\n",
       "      <td>Palisade Bio Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6472</td>\n",
       "      <td>-463.17</td>\n",
       "      <td>3.15</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-14.59</td>\n",
       "      <td>9</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>BDRX</td>\n",
       "      <td>Biodexa Pharmaceuticals Plc ADR</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3298</td>\n",
       "      <td>-267.22</td>\n",
       "      <td>2.41</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-6.44</td>\n",
       "      <td>21</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>SONN</td>\n",
       "      <td>Sonnet BioTherapeutics Holdings Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6622</td>\n",
       "      <td>-806.58</td>\n",
       "      <td>1.52</td>\n",
       "      <td>0.06</td>\n",
       "      <td>-12.26</td>\n",
       "      <td>12</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>CYCC</td>\n",
       "      <td>Cyclacel Pharmaceuticals Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>7581</td>\n",
       "      <td>-934.26</td>\n",
       "      <td>2.16</td>\n",
       "      <td>0.08</td>\n",
       "      <td>-20.18</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>ALLR</td>\n",
       "      <td>Allarity Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>1092</td>\n",
       "      <td>-399.53</td>\n",
       "      <td>4.23</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-16.90</td>\n",
       "      <td>5</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665</th>\n",
       "      <td>CLRB</td>\n",
       "      <td>Cellectar Biosciences Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>6977</td>\n",
       "      <td>-445.49</td>\n",
       "      <td>10.64</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-47.40</td>\n",
       "      <td>20</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>666</th>\n",
       "      <td>JAGX</td>\n",
       "      <td>Jaguar Health Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>3507</td>\n",
       "      <td>-272.25</td>\n",
       "      <td>10.81</td>\n",
       "      <td>10.18</td>\n",
       "      <td>-29.43</td>\n",
       "      <td>49</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>WINT</td>\n",
       "      <td>Windtree Therapeutics Inc</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>10725</td>\n",
       "      <td>-694.65</td>\n",
       "      <td>3.55</td>\n",
       "      <td>0.00</td>\n",
       "      <td>-24.66</td>\n",
       "      <td>0</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>668</th>\n",
       "      <td>TNXP</td>\n",
       "      <td>Tonix Pharmaceuticals Holding Corp</td>\n",
       "      <td>-100.00</td>\n",
       "      <td>4604</td>\n",
       "      <td>-91.64</td>\n",
       "      <td>99.05</td>\n",
       "      <td>12.46</td>\n",
       "      <td>-90.77</td>\n",
       "      <td>103</td>\n",
       "      <td>Old</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Ticker                                   Company     Fall   days      RoK  \\\n",
       "0     TECH                           Bio-Techne Corp 82131.76  13095     2.55   \n",
       "1     VRTX               Vertex Pharmaceuticals, Inc 10205.11  12200     3.69   \n",
       "2     UTHR                  United Therapeutics Corp  5837.39   9315     8.48   \n",
       "3     INCY                               Incyte Corp  3556.00  11366     0.60   \n",
       "4     ALNY               Alnylam Pharmaceuticals Inc  3406.29   7504    -0.42   \n",
       "5     REGN            Regeneron Pharmaceuticals, Inc  3361.78  12313     5.77   \n",
       "6     ARGX                            Argen X SE ADR  2540.02   2770    -0.40   \n",
       "7     BHST                   BioHarvest Sciences Inc  2020.69   1439    -6.77   \n",
       "8     KRYS                       Krystal Biotech Inc  1437.97   2645     1.43   \n",
       "9     TVTX                  Travere Therapeutics Inc  1054.67   4422   -15.67   \n",
       "10    HALO                 Halozyme Therapeutics Inc  1029.41   7581     9.05   \n",
       "11    AXSM                   Axsome Therapeutics Inc   930.89   3316    -5.63   \n",
       "12    BNTX                           BioNTech SE ADR   756.56   1895    -1.00   \n",
       "13    JAZZ                  Jazz Pharmaceuticals plc   593.97   6409    20.06   \n",
       "14    ASND                   Ascendis Pharma A/S ADR   589.70   3611    -4.25   \n",
       "15    BGNE                           BeiGene Ltd ADR   533.30   3240   -28.15   \n",
       "16    BLTE                        Belite Bio Inc ADR   488.67    963    -1.81   \n",
       "17    VKTX                   Viking Therapeutics Inc   487.87   3521     0.00   \n",
       "18    GMAB                                Genmab ADR   434.73   5678    53.42   \n",
       "19    BHVN                              Biohaven Ltd   426.99    816   -20.08   \n",
       "20    BMRN               Biomarin Pharmaceutical Inc   407.77   9276     3.41   \n",
       "21    ACLX                               Arcellx Inc   398.81   1047    -1.45   \n",
       "22    BPMC                  Blueprint Medicines Corp   393.85   3519    -4.33   \n",
       "23    MLTX               MoonLake Immunotherapeutics   389.42   1519    -3.25   \n",
       "24    NUVL                              Nuvalent Inc   363.25   1237     0.00   \n",
       "25    CORT                  Corcept Therapeutics Inc   352.98   7552     2.48   \n",
       "26    MRUS                                 Merus N.V   326.59   3134    -7.80   \n",
       "27    VERA                     Vera Therapeutics Inc   283.04   1313     0.00   \n",
       "28    XENE                 Xenon Pharmaceuticals Inc   281.43   3695    -7.42   \n",
       "29    IONS                 Ionis Pharmaceuticals Inc   266.10  12268    -5.59   \n",
       "30    PTGX              Protagonist Therapeutics Inc   251.11   3050     6.07   \n",
       "31    CPRX              Catalyst Pharmaceuticals Inc   250.49   6614     8.19   \n",
       "32    LGND               Ligand Pharmaceuticals, Inc   240.08  11717     2.28   \n",
       "33    PCVX                               Vaxcyte Inc   235.45   1649    -5.37   \n",
       "34    MIRM                 Mirum Pharmaceuticals Inc   221.27   1979    -3.58   \n",
       "35    SRPT                  Sarepta Therapeutics Inc   217.21  10058     0.99   \n",
       "36    CRSP                    CRISPR Therapeutics AG   210.72   2981    -8.29   \n",
       "37    VRNA                     Verona Pharma Plc ADR   206.81   2790    -4.30   \n",
       "38    XNCR                                Xencor Inc   188.13   4032   -11.80   \n",
       "39    PTCT                      PTC Therapeutics Inc   181.20   4198     0.58   \n",
       "40    SRRK                 Scholar Rock Holding Corp   179.87   2398    -5.69   \n",
       "41    GLSI                Greenwich LifeSciences Inc   170.20   1544    -6.21   \n",
       "42    IMVT                            Immunovant Inc   164.12   2006    -8.68   \n",
       "43    ACAD                Acadia Pharmaceuticals Inc   157.61   7509     4.32   \n",
       "44    TARS                Tarsus Pharmaceuticals Inc   155.10   1523    -7.05   \n",
       "45    JANX                    Janux Therapeutics Inc   142.98   1285    -2.32   \n",
       "46    EXEL                              Exelixis Inc   137.49   9010     6.17   \n",
       "47    APLS               Apellis Pharmaceuticals Inc   136.56   2595    -5.29   \n",
       "48    AUPH               Aurinia Pharmaceuticals Inc   134.25   3758     0.04   \n",
       "49    NAMS            NewAmsterdam Pharma Company NV   132.66   1407    -6.96   \n",
       "50    IDYA                    Ideaya Biosciences Inc   125.11   2035    -9.87   \n",
       "51    MRNA                               Moderna Inc   124.89   2202   -14.67   \n",
       "52    RYTM                Rhythm Pharmaceuticals Inc   124.83   2626    -7.77   \n",
       "53    JUNS                 Jupiter Neurosciences Inc   122.40     14     0.00   \n",
       "54    CRNX             Crinetics Pharmaceuticals Inc   118.93   2344    -6.01   \n",
       "55    ADMA                        Adma Biologics Inc   117.43   4079     2.81   \n",
       "56    MNMD                         Mind Medicine Inc   112.15   2954     0.00   \n",
       "57    APGE                   Apogee Therapeutics Inc   109.61    522     0.00   \n",
       "58    DYAI             Dyadic International Inc., DE   103.75   6180     0.00   \n",
       "59    MDXG                          Mimedx Group Inc    97.55   6153     4.85   \n",
       "60    PRTA                  Prothena Corporation plc    77.64   4382   -24.65   \n",
       "61     OCS                         Oculis Holding AG    76.19   1309    -9.48   \n",
       "62    IZTC                 Invizyne Technologies Inc    75.38     34    -3.16   \n",
       "63    SMMT                   Summit Therapeutics Inc    74.98   3575    -1.32   \n",
       "64    GLPG                          Galapagos NV ADR    74.50   4677    -7.67   \n",
       "65    SWTX              SpringWorks Therapeutics Inc    69.24   1922   -10.34   \n",
       "66    DNTH                 Dianthus Therapeutics Inc    63.98   2371   -11.64   \n",
       "67    AKRO                    Akero Therapeutics Inc    57.70   2007   -13.20   \n",
       "68    RVMD                  Revolution Medicines Inc    55.74   1769    -7.52   \n",
       "69    ELVN                  Enliven Therapeutics Inc    54.33   1741    -8.58   \n",
       "70    DRUG              Bright Minds Biosciences Inc    51.85   1366     0.00   \n",
       "71    BEAM                     Beam Therapeutics Inc    48.96   1776    -6.71   \n",
       "72    NVCT                       Nuvectis Pharma Inc    44.62   1047     0.00   \n",
       "73    INVA                              Innoviva Inc    36.75   7378    19.18   \n",
       "74    AVBP                    ArriVent BioPharma Inc    33.60    326     0.00   \n",
       "75    COYA                     Coya Therapeutics Inc    28.88    719   -11.75   \n",
       "76    KYMR                   Kymera Therapeutics Inc    26.67   1579    -6.83   \n",
       "77    AGIO                 Agios Pharmaceuticals Inc    24.58   4164   -16.48   \n",
       "78    LENZ                     LENZ Therapeutics Inc    23.24   1271    -8.06   \n",
       "79    ARVN                               Arvinas Inc    21.50   2273   -27.02   \n",
       "80    OSTX                          OS Therapies Inc    20.32    138    -4.30   \n",
       "81    GPCR            Structure Therapeutics Inc ADR    20.19    683    -6.86   \n",
       "82    EPRX              Eupraxia Pharmaceuticals Inc    16.71    256   -25.93   \n",
       "83    SNDX                Syndax Pharmaceuticals Inc    16.08   3212   -27.29   \n",
       "84    BCRX              Biocryst Pharmaceuticals Inc    15.85  11246    -2.07   \n",
       "85    BCYC              Bicycle Therapeutics Plc ADR    15.08   2035   -18.13   \n",
       "86     RNA                   Avidity Biosciences Inc    14.00   1649    -8.08   \n",
       "87    ROIV                      Roivant Sciences Ltd    13.85   1470   -13.62   \n",
       "88    RARE             Ultragenyx Pharmaceutical Inc     8.36   3973   -11.95   \n",
       "89     DYN                     Dyne Therapeutics Inc     7.66   1552   -11.78   \n",
       "90    DNLI                   Denali Therapeutics Inc     7.09   2566   -15.27   \n",
       "91    NRIX                    Nurix Therapeutics Inc     6.63   1607   -12.65   \n",
       "92    AVXL          Anavex Life Sciences Corporation     5.75   6712     0.00   \n",
       "93    QURE                               uniQure N.V     5.41   3968   -22.32   \n",
       "94    SEPN                              Septerna Inc     4.63     53    -6.00   \n",
       "95     TLX            Telix Pharmaceuticals Ltd. ADR     4.03     33     1.38   \n",
       "96    TELO               Telomir Pharmaceuticals Inc     4.00    312     0.00   \n",
       "97    MDCX                        Medicus Pharma Ltd     3.77     33     0.00   \n",
       "98    MURA                        Mural Oncology plc     3.41    389  -286.93   \n",
       "99    ACTU                  Actuate Therapeutics Inc     0.12    126     0.00   \n",
       "100   BBIO                      BridgeBio Pharma Inc    -0.22   2000    -9.74   \n",
       "101   LQDA                             Liquidia Corp    -1.62   2336   -10.27   \n",
       "102   ZYME                          Zymeworks BC Inc    -3.23   2790   -12.09   \n",
       "103   CADL                   Candel Therapeutics Inc    -3.57   1239   -17.34   \n",
       "104   MDGL              Madrigal Pharmaceuticals Inc    -4.29   6524    -8.07   \n",
       "105   ACOG                       Alpha Cognition Inc    -4.91     35     0.00   \n",
       "106   LEGN                   Legend Biotech Corp ADR    -5.08   1656    -5.62   \n",
       "107   RCUS                     Arcus Biosciences Inc    -5.41   2469   -19.06   \n",
       "108   ZLAB                       Zai Lab Limited ADR    -5.73   2645   -11.48   \n",
       "109   KROS                    Keros Therapeutics Inc    -6.23   1714   -25.79   \n",
       "110   CRGX                    CARGO Therapeutics Inc    -6.47    400   -25.44   \n",
       "111   IMNM                              Immunome Inc    -6.47   1537   -14.22   \n",
       "112   EWTX                 Edgewise Therapeutics Inc    -7.93   1362    -4.69   \n",
       "113    UPB                          Upstream Bio Inc    -7.95     67    -6.45   \n",
       "114   ANAB                            AnaptysBio Inc    -8.29   2882   -27.52   \n",
       "115   CTNM                Contineum Therapeutics Inc    -8.90    256   -12.30   \n",
       "116   RAPP                  Rapport Therapeutics Inc    -9.76    193   -10.86   \n",
       "117   ARTV                Artiva Biotherapeutics Inc   -11.50    151   -23.19   \n",
       "118   CSBR                    Champions Oncology Inc   -12.08   6528    -1.38   \n",
       "119   CELC                              Celcuity Inc   -12.39   2645   -18.30   \n",
       "120   HRMY          Harmony Biosciences Holdings Inc   -12.48   1581    10.58   \n",
       "121   OMER                        Omeros Corporation   -12.60   5549   -39.22   \n",
       "122   ABVX                                Abivax ADR   -14.34    424   -33.95   \n",
       "123   INBX                   Inhibrx Biosciences Inc   -15.05    196  -142.78   \n",
       "124    WVE                    Wave Life Sciences Ltd   -16.00   3324    -7.21   \n",
       "125    KOD                       Kodiak Sciences Inc   -16.63   2266   -45.11   \n",
       "126   REPL                       Replimune Group Inc   -17.22   2342   -23.61   \n",
       "127   URGN                         UroGen Pharma Ltd   -18.81   2784   -17.46   \n",
       "128    MBX                       MBX Biosciences Inc   -19.92     95    -9.28   \n",
       "129   CGON                           Cg Oncology Inc   -22.63    327    -4.86   \n",
       "130   CNTA          Centessa Pharmaceuticals plc ADR   -23.82   1299    -7.30   \n",
       "131   IMTX                              Immatics N.V   -24.90   2197   -10.77   \n",
       "132   BCAX                   Bicara Therapeutics Inc   -25.25     95    -7.32   \n",
       "133   TRDA                  Entrada Therapeutics Inc   -26.26   1145     9.10   \n",
       "134   NTRB                             Nutriband Inc   -27.84   1173   -11.05   \n",
       "135   CAMP                   CAMP4 Therapeutics Corp   -28.82     67   -38.70   \n",
       "136    IBO                     Impact BioMedical Inc   -29.48     92   -10.57   \n",
       "137   LXEO                    Lexeo Therapeutics Inc   -31.54    410   -34.78   \n",
       "138   ALDX                  Aldeyra Therapeutics Inc   -31.94   3882   -16.39   \n",
       "139   GDTC                  CytoMed Therapeutics Ltd   -32.10    613   -10.20   \n",
       "140   IMCR               Immunocore Holdings plc ADR   -33.08   1411    -4.42   \n",
       "141   THRD                    Third Harmonic Bio Inc   -33.76    825   -10.54   \n",
       "142   OCUL                    Ocular Therapeutix Inc   -33.92   3798    -7.84   \n",
       "143   KAPA                         Kairos Pharma Ltd   -34.62     92    -8.09   \n",
       "144   FOLD                   Amicus Therapeutics Inc   -35.14   6410     0.78   \n",
       "145   MLYS                Mineralys Therapeutics Inc   -35.47    676     0.00   \n",
       "146   KURA                         Kura Oncology Inc   -35.80   3380   -27.93   \n",
       "147   PLRZ                             Polyrizon Ltd   -36.06     49   -15.51   \n",
       "148   PHVS                              Pharvaris NV   -36.55   1411   -11.57   \n",
       "149   ALMS                                Alumis Inc   -36.92    172   -51.21   \n",
       "150   FTRE                      Fortrea Holdings Inc   -37.50    546     1.49   \n",
       "151   PLRX                   Pliant Therapeutics Inc   -37.56   1658   -26.34   \n",
       "152   PSTX                  Poseida Therapeutics Inc   -38.05   1621    -6.15   \n",
       "153   ENGN                       enGene Holdings Inc   -38.34   1050   -17.13   \n",
       "154   RPRX                        Royalty Pharma plc   -38.43   1645     0.00   \n",
       "155   NMRA                  Neumora Therapeutics Inc   -39.29    460   -14.24   \n",
       "156   INMB                            INmune Bio Inc   -40.55   2143     0.00   \n",
       "157   NTLA                 Intellia Therapeutics Inc   -41.63   3147   -38.71   \n",
       "158   ARQT               Arcutis Biotherapeutics Inc   -41.79   1782   -11.30   \n",
       "159   MREO             Mereo Biopharma Group Plc ADR   -42.46   2064    -7.00   \n",
       "160   TYRA                      Tyra Biosciences Inc   -42.54   1189   -13.07   \n",
       "161   MESO                         Mesoblast Ltd ADR   -42.63   5445    -4.06   \n",
       "162   AURA                      Aura Biosciences Inc   -43.18   1145   -20.68   \n",
       "163   TLSA                 Tiziana Life Sciences Ltd   -43.74   2219   -16.36   \n",
       "164   CRMD                              CorMedix Inc   -44.13   5332   -10.07   \n",
       "165   IMMX                       Immix Biopharma Inc   -44.41   1097   -37.62   \n",
       "166   ANVS                           Annovis Bio Inc   -44.63   1784     0.00   \n",
       "167   ABUS                    Arbutus Biopharma Corp   -44.76   6354   -11.47   \n",
       "168   DAWN            Day One Biopharmaceuticals Inc   -45.74   1300   -16.15   \n",
       "169   PHAR                   Pharming Group N.V. ADR   -46.22   1455    -0.50   \n",
       "170    VIR                     Vir Biotechnology Inc   -46.86   1894   -51.28   \n",
       "171   PRTC                   PureTech Health Plc ADR   -47.14   1492   -25.41   \n",
       "172   TRVI                    Trevi Therapeutics Inc   -47.15   2051   -14.75   \n",
       "173   GERN                                Geron Corp   -47.30  10366    -9.01   \n",
       "174   ICCC                             Immucell Corp   -47.52  13741    -1.51   \n",
       "175   VERU                                  Veru Inc   -47.77   9441   -56.57   \n",
       "176   CRVS                Corvus Pharmaceuticals Inc   -48.21   3191    -5.25   \n",
       "177   FENC                Fennec Pharmaceuticals Inc   -49.58   2650     0.00   \n",
       "178   RCKT                Rocket Pharmaceuticals Inc   -49.92   3590   -21.18   \n",
       "179   LEXX                   Lexaria Bioscience Corp   -50.00   1435   -12.02   \n",
       "180   IPHA                         Innate Pharma ADR   -50.08   1888   -18.33   \n",
       "181   CYTK                          Cytokinetics Inc   -50.13   7536    -8.84   \n",
       "182   ZBIO                       Zenas Biopharma Inc   -50.85     95   -36.26   \n",
       "183   VNDA                 Vanda Pharmaceuticals Inc   -52.38   6824   -11.17   \n",
       "184   SPRY                   ARS Pharmaceuticals Inc   -52.40   1474    -5.23   \n",
       "185   STOK                    Stoke Therapeutics Inc   -52.84   2008   -17.74   \n",
       "186   CALC                           CalciMedica Inc   -53.25    552   -56.47   \n",
       "187   GNTA                   Genenta Science SpA ADR   -53.36   1098    -9.71   \n",
       "188   OBIO             Orchestra BioMed Holdings Inc   -53.86   1596   -30.91   \n",
       "189   MAIA                    MAIA Biotechnology Inc   -55.16    873     0.00   \n",
       "190   INSM                                Insmed Inc   -56.59   8965    -5.29   \n",
       "191   TBPH                  Theravance Biopharma Inc   -56.97   3868    -7.94   \n",
       "192   ACRV                  Acrivon Therapeutics Inc   -57.57    763   -34.67   \n",
       "193   HUMA                              Humacyte Inc   -57.60   1477   -18.85   \n",
       "194   CDXS                               Codexis Inc   -58.30   5353   -10.03   \n",
       "195   NRXS                              Neuraxis Inc   -58.67    496   -49.37   \n",
       "196   CLGN             CollPlant Biotechnologies Ltd   -58.77   2512   -41.70   \n",
       "197   MGTX                     MeiraGTx Holdings plc   -59.20   2384   -31.64   \n",
       "198   ITOS                    ITeos Therapeutics Inc   -59.69   1607   -51.06   \n",
       "199   GHRS                           GH Research PLC   -59.79   1271   -10.67   \n",
       "200   YMAB                   Y-Mabs Therapeutics Inc   -60.71   2279    -5.26   \n",
       "201   CGEM                 Cullinan Therapeutics Inc   -60.72   1439   -27.22   \n",
       "202   OABI                                OmniAb Inc   -61.17   1174   -12.81   \n",
       "203   GNLX                              Genelux Corp   -62.11    691   -33.08   \n",
       "204   ARDX                               Ardelyx Inc   -63.00   3834    -4.87   \n",
       "205   ETNB                                 89bio Inc   -63.03   1863   -32.71   \n",
       "206   SVRA                                Savara Inc   -63.36   2790   -15.86   \n",
       "207   TERN                 Terns Pharmaceuticals Inc   -63.40   1411   -16.81   \n",
       "208   PEPG                                PepGen Inc   -63.69    956   -63.08   \n",
       "209   THTX                     Theratechnologies Inc   -64.15   5786    19.10   \n",
       "210   GLUE               Monte Rosa Therapeutics Inc   -64.31   1272   -25.66   \n",
       "211   VYGR                  Voyager Therapeutics Inc   -64.68   3324     3.99   \n",
       "212   SLXN                Silexion Therapeutics Corp   -64.80   1350   -26.10   \n",
       "213   ENTA                Enanta Pharmaceuticals Inc   -64.90   4289   -89.98   \n",
       "214   XBIT                              XBiotech Inc   -65.31   3534   -19.23   \n",
       "215   INTS                Intensity Therapeutics Inc   -65.44    536     0.00   \n",
       "216   ENTX                            Entera Bio Ltd   -65.61   2364   -11.46   \n",
       "217    SLN              Silence Therapeutics Plc ADR   -66.92   1561   -15.13   \n",
       "218   ORIC                  ORIC Pharmaceuticals Inc   -66.94   1698   -22.99   \n",
       "219   ARCT        Arcturus Therapeutics Holdings Inc   -67.44   4227   -17.51   \n",
       "220   PHAT               Phathom Pharmaceuticals Inc   -67.93   1880   -51.59   \n",
       "221   ZURA                              Zura Bio Ltd   -68.51    637     0.00   \n",
       "222    MGX                            Metagenomi Inc   -68.57    312   -71.71   \n",
       "223   LRMR                  Larimar Therapeutics Inc   -68.76   3834   -23.83   \n",
       "224   ORMP               Oramed Pharmaceuticals, Inc   -68.81   6440   -13.34   \n",
       "225   DRTS                     Alpha Tau Medical Ltd   -69.60   1380   -16.21   \n",
       "226   BMEA                         Biomea Fusion Inc   -69.68   1341   -70.58   \n",
       "227   TRML                        Tourmaline Bio Inc   -69.78   1320   -13.90   \n",
       "228   TNGX                    Tango Therapeutics Inc   -70.09   1566   -43.30   \n",
       "229   RENB                              Renovaro Inc   -70.17   2505   -10.87   \n",
       "230   IGMS                       IGM Biosciences Inc   -70.49   1917   -50.89   \n",
       "231   FULC                  Fulcrum Therapeutics Inc   -70.67   1979   -12.95   \n",
       "232   OKYO                       OKYO Pharma Limited   -70.72    945   -44.76   \n",
       "233   FHTX                  Foghorn Therapeutics Inc   -70.75   1516   -32.17   \n",
       "234   CABA                         Cabaletta Bio Inc   -71.80   1880   -74.45   \n",
       "235   FATE                     Fate Therapeutics Inc   -72.36   4095   -72.29   \n",
       "236   MOLN                 Molecular Partners AG ADR   -72.37   1280   -31.52   \n",
       "237   SGMT                   Sagimet Biosciences Inc   -72.48    519     0.00   \n",
       "238   CNTX                  Context Therapeutics Inc   -72.75   1154   -19.62   \n",
       "239   RGNX                             Regenxbio Inc   -72.81   3379   -52.83   \n",
       "240   TCRX                    Tscan Therapeutics Inc   -72.86   1250   -71.45   \n",
       "241   NKTR                       Nektar Therapeutics   -73.07  11186   -70.57   \n",
       "242   NUVB                          Nuvation Bio Inc   -73.09   1574   -14.79   \n",
       "243   RVPH       Reviva Pharmaceuticals Holdings Inc   -73.12   2252     0.00   \n",
       "244    OPT                        Opthea Limited ADR   -73.58   1523   -37.32   \n",
       "245   IMRN                       Immuron Limited ADR   -74.57   2748   -43.53   \n",
       "246   ANNX                               Annexon Inc   -75.00   1607   -23.14   \n",
       "247   TSVT                          2seventy bio Inc   -76.25   1140   -79.84   \n",
       "248   LTRN                        Lantern Pharma Inc   -76.96   1650   -50.87   \n",
       "249   AMLX                Amylyx Pharmaceuticals Inc   -77.20   1075   -86.64   \n",
       "250   SCPH                     scPharmaceuticals Inc   -77.38   2587   -39.76   \n",
       "251   RXRX             Recursion Pharmaceuticals Inc   -77.80   1341   -12.58   \n",
       "252   NRSN               NeuroSense Therapeutics Ltd   -78.71   1104   -57.19   \n",
       "253   IRON                         Disc Medicine Inc   -79.00   1588    -6.33   \n",
       "254   JSPR                   Jasper Therapeutics Inc   -79.02   1803   -20.91   \n",
       "255   PBYI                    Puma Biotechnology Inc   -79.43   4620    30.29   \n",
       "256   ANEB               Anebulo Pharmaceuticals Inc   -80.28   1320     0.00   \n",
       "257   NBTX                            Nanobiotix ADR   -80.39   1467   -13.48   \n",
       "258   CYBN                                 Cybin Inc   -80.43   1922   -43.51   \n",
       "259   PRQR                    ProQR Therapeutics N.V   -80.79   3743   -10.93   \n",
       "260   MNPR                  Monopar Therapeutics Inc   -80.85   1825     0.00   \n",
       "261   MRVI         Maravai LifeSciences Holdings Inc   -81.01   1488     0.07   \n",
       "262   ACIU                              AC Immune SA   -81.16   3007   -12.38   \n",
       "263   PRME                        Prime Medicine Inc   -81.26    789   -52.64   \n",
       "264   NAUT                Nautilus Biotechnology Inc   -81.32   1593   -31.62   \n",
       "265   ANRO                     Alto Neuroscience Inc   -81.50    319   -62.22   \n",
       "266   COGT                    Cogent Biosciences Inc   -81.66   2455   -28.28   \n",
       "267    IVA                             Inventiva ADR   -81.74   1621   -46.96   \n",
       "268   CVKD                 Cadrenal Therapeutics Inc   -81.88    697   -43.51   \n",
       "269   LIXT          Lixte Biotechnology Holdings Inc   -81.91   6263     0.00   \n",
       "270   SLRN                              Acelyrin Inc   -82.06    593  -110.33   \n",
       "271   TNYA                   Tenaya Therapeutics Inc   -82.08   1236   -50.04   \n",
       "272   SAGE                     Sage Therapeutics Inc   -82.11   3805  -113.51   \n",
       "273   VERV                    Verve Therapeutics Inc   -82.11   1279   -48.03   \n",
       "274   CDMO                      Avid Bioservices Inc   -82.19  11215    -0.97   \n",
       "275   PROK                            ProKidney Corp   -82.25   1266    -8.06   \n",
       "276   RNXT                              RenovoRx Inc   -82.37   1209     0.00   \n",
       "277   GALT                 Galectin Therapeutics Inc   -82.42   8140     0.00   \n",
       "278   MNOV                            Medicinova Inc   -82.64   6584    -9.47   \n",
       "279   INZY                        Inozyme Pharma Inc   -82.73   1607   -50.97   \n",
       "280   BOLD                         Boundless Bio Inc   -82.74    264  -121.05   \n",
       "281   GNFT                                Genfit ADR   -82.77   2092    11.53   \n",
       "282   CCCC                       C4 Therapeutics Inc   -82.82   1537   -37.84   \n",
       "283   CMPX                  Compass Therapeutics Inc   -82.82   1352   -26.75   \n",
       "284   ABSI                                Absci Corp   -82.89   1244   -20.39   \n",
       "285   PRAX            Praxis Precision Medicines Inc   -83.17   1523   -12.13   \n",
       "286   CRBP       Corbus Pharmaceuticals Holdings Inc   -83.24   3704   -26.23   \n",
       "287   DSGN                   Design Therapeutics Inc   -83.53   1359   -16.91   \n",
       "288   CLYM                             Climb Bio Inc   -83.65   1225     0.00   \n",
       "289   XERS              Xeris Biopharma Holdings Inc   -83.78   2371    -6.58   \n",
       "290   SLNO                   Soleno Therapeutics Inc   -83.95   3687    -6.60   \n",
       "291   FDMT             4D Molecular Therapeutics Inc   -83.95   1467   -54.64   \n",
       "292   ANIX                     Anixa Biosciences Inc   -84.09  15047     0.00   \n",
       "293   GUTS                        Fractyl Health Inc   -84.12    319   -79.62   \n",
       "294   IFRX                               InflaRx N.V   -84.27   2597   -29.16   \n",
       "295   VIGL                    Vigil Neuroscience Inc   -84.27   1075  -117.24   \n",
       "296   CMRX                              Chimerix Inc   -84.30   4268   -35.44   \n",
       "297   ADPT             Adaptive Biotechnologies Corp   -84.37   2000   -14.69   \n",
       "298    ABP                        Abpro Holdings Inc   -84.55   1014   -17.15   \n",
       "299   MRSN                  Mersana Therapeutics Inc   -84.64   2729   -30.43   \n",
       "300    ANL                     Adlai Nortye Ltd. ADR   -84.73    445   -73.00   \n",
       "301   RANI            Rani Therapeutics Holdings Inc   -84.91   1236   -61.12   \n",
       "302   VALN                            Valneva SE ADR   -85.12   1322   -24.45   \n",
       "303   ERAS                                Erasca Inc   -85.31   1250   -20.37   \n",
       "304   KYTX                  Kyverna Therapeutics Inc   -85.32    312   -66.51   \n",
       "305   CGEN                              Compugen Ltd   -85.53   8894    -2.86   \n",
       "306   MDWD                             MediWound Ltd   -85.70   3925    -8.02   \n",
       "307   UNCY                Unicycive Therapeutics Inc   -85.70   1254   -39.69   \n",
       "308   TGTX                       TG Therapeutics Inc   -85.77   5342    -0.01   \n",
       "309   CLSD                  Clearside Biomedical Inc   -85.93   3120   -33.50   \n",
       "310   STRO                       Sutro Biopharma Inc   -86.05   2273   -72.04   \n",
       "311   OLMA                 Olema Pharmaceuticals Inc   -86.22   1489   -28.52   \n",
       "312   LCTX             Lineage Cell Therapeutics Inc   -86.26  11975   -19.42   \n",
       "313   SGMO                  Sangamo Therapeutics Inc   -86.39   9021   -21.21   \n",
       "314   RLAY                    Relay Therapeutics Inc   -86.56   1615   -48.07   \n",
       "315    IPA              ImmunoPrecise Antibodies Ltd   -86.57   8380   -86.08   \n",
       "316   GANX                     Gain Therapeutics Inc   -86.64   1369   -49.56   \n",
       "317   ZNTL              Zentalis Pharmaceuticals Inc   -86.68   1719   -94.13   \n",
       "318   DMAC                DiaMedica Therapeutics Inc   -86.90   4519    -9.84   \n",
       "319   CDIO           Cardio Diagnostics Holdings Inc   -87.17   1068   -18.15   \n",
       "320   MGNX                           Macrogenics Inc   -87.19   4086   -49.18   \n",
       "321   CHRS                   Coherus Biosciences Inc   -87.23   3694   -59.70   \n",
       "322   FBLG                        FibroBiologics Inc   -87.31    320   -16.51   \n",
       "323   PYXS                        Pyxis Oncology Inc   -87.73   1166   -61.31   \n",
       "324   ESLA                 Estrella Immunopharma Inc   -87.75   1190     0.00   \n",
       "325   APLT                  Applied Therapeutics Inc   -87.77   2044   -68.96   \n",
       "326   CHRO          Channel Therapeutics Corporation   -87.81    305     0.00   \n",
       "327   TECX                  Tectonic Therapeutic Inc   -87.89   2371    -7.92   \n",
       "328   MIST             Milestone Pharmaceuticals Inc   -88.29   2049   -51.53   \n",
       "329   CRBU                   Caribou Biosciences Inc   -88.30   1243   -91.23   \n",
       "330   RVNC                  Revance Therapeutics Inc   -88.53   3967   -58.16   \n",
       "331   NVAX                              Novavax, Inc   -88.61  10605   -16.45   \n",
       "332   KALV              KalVista Pharmaceuticals Inc   -88.84   3540   -34.98   \n",
       "333   AVTE                 Aerovate Therapeutics Inc   -88.92   1266  -121.55   \n",
       "334   ALEC                               Alector Inc   -89.10   2140   -91.48   \n",
       "335   VTYX                    Ventyx Biosciences Inc   -89.15   1153  -104.41   \n",
       "336   ACXP                 Acurx Pharmaceuticals Inc   -89.16   1271     0.00   \n",
       "337   HLVX                              HilleVax Inc   -89.73    963  -138.01   \n",
       "338   HOWL                 Werewolf Therapeutics Inc   -89.75   1327   -87.04   \n",
       "339   ABOS                Acumen Pharmaceuticals Inc   -89.90   1265   -78.44   \n",
       "340   TVGN                  Tevogen Bio Holdings Inc   -89.94   1077   -23.69   \n",
       "341   AUTL              Autolus Therapeutics plc ADR   -90.04   2370   -29.98   \n",
       "342   SYRE                    Spyre Therapeutics Inc   -90.12   3176   -13.57   \n",
       "343   NGNE                             Neurogene Inc   -90.16   3938   -17.54   \n",
       "344   BYSI                          BeyondSpring Inc   -90.24   2840   -25.84   \n",
       "345   AVIR                  Atea Pharmaceuticals Inc   -90.34   1509   -47.69   \n",
       "346   IMMP                       Immutep Limited ADR   -90.66   4625   -14.15   \n",
       "347   SPRO                    Spero Therapeutics Inc   -90.70   2602    36.02   \n",
       "348   IMRX                          Immuneering Corp   -90.70   1236  -111.86   \n",
       "349   MNKD                             Mannkind Corp   -90.71   7447     3.68   \n",
       "350   ANTX                      AN2 Therapeutics Inc   -90.71    998     0.00   \n",
       "351   ALGS                   Aligos Therapeutics Inc   -90.82   1523   -76.74   \n",
       "352   LVTX                      LAVA Therapeutics NV   -91.12   1362  -100.22   \n",
       "353   MLEC                         Moolec Science SA   -91.23   1386   -24.46   \n",
       "354   NKGN                         NKGen Biotech Inc   -91.24    442  -188.94   \n",
       "355   CTMX                   CytomX Therapeutics Inc   -91.40   3358     9.50   \n",
       "356   TSHA                 Taysha Gene Therapies Inc   -91.40   1545   -19.70   \n",
       "357   OVID                     Ovid Therapeutics Inc   -91.59   2783   -87.26   \n",
       "358   IBRX                           ImmunityBio Inc   -91.71   3430   -15.28   \n",
       "359    CUE                         Cue Biopharma Inc   -91.92   2541   -73.83   \n",
       "360   IMAB                                 I-Mab ADR   -92.00   1796  -216.46   \n",
       "361   EDIT                       Editas Medicine Inc   -92.09   3240  -182.23   \n",
       "362   DBVT                      DBV Technologies ADR   -92.21   3709     0.00   \n",
       "363   RLYB                             Rallybio Corp   -92.34   1237  -163.49   \n",
       "364   ALLO                 Allogene Therapeutics Inc   -92.44   2259   -59.03   \n",
       "365   CKPT               Checkpoint Therapeutics Inc   -92.66   2920     0.00   \n",
       "366   AEON                        AEON Biopharma Inc   -92.67    512  -168.82   \n",
       "367   CDTX                   Cidara Therapeutics Inc   -92.85   3534   -11.83   \n",
       "368   IOVA               Iovance Biotherapeutics Inc   -92.88   5177   -17.09   \n",
       "369   RAPT                     RAPT Therapeutics Inc   -93.00   1874  -368.74   \n",
       "370   ATAI                    ATAI Life Sciences N.V   -93.01   1278   -45.90   \n",
       "371   ADAG                           Adagene Inc ADR   -93.13   1407   -40.20   \n",
       "372   KRRO                             Korro Bio Inc   -93.16   1902   -20.50   \n",
       "373   BDTX            Black Diamond Therapeutics Inc   -93.17   1782   -54.24   \n",
       "374   LUMO                          Lumos Pharma Inc   -93.19   4785   -96.72   \n",
       "375   OCEA                      Ocean Biomedical Inc   -93.22   1135     0.00   \n",
       "376    ALT                             Altimmune Inc   -93.22   2762   -15.50   \n",
       "377   OKUR                   OnKure Therapeutics Inc   -93.43   1349   -37.25   \n",
       "378   SRZN                              Surrozen Inc   -93.50   1436   -76.98   \n",
       "379   BRNS        Barinthus Biotherapeutics Plc. ADR   -93.52   1327  -152.69   \n",
       "380   ADCT                       Adc Therapeutics SA   -93.70   1674   -70.78   \n",
       "381   PVLA                Pieris Pharmaceuticals Inc   -93.82   3637      NaN   \n",
       "382   QNCX                   Quince Therapeutics Inc   -93.83   2049   -34.66   \n",
       "383    XLO                    Xilio Therapeutics Inc   -93.94   1152  -148.25   \n",
       "384   OMGA                    Omega Therapeutics Inc   -93.94   1236  -166.43   \n",
       "385   CNTB        Connect Biopharma Holdings Ltd ADR   -93.95   1369   -41.42   \n",
       "386   ACHL             Achilles Therapeutics Plc ADR   -94.02   1357  -156.31   \n",
       "387   STTK                         Shattuck Labs Inc   -94.11   1530  -165.87   \n",
       "388    IKT               Inhibikase Therapeutics Inc   -94.21   1455    -7.91   \n",
       "389   RPTX                   Repare Therapeutics Inc   -94.25   1642  -132.67   \n",
       "390   HCWB                         HCW Biologics Inc   -94.33   1246  -230.79   \n",
       "391   CVAC                               CureVac N.V   -94.35   1586   -38.87   \n",
       "392   SNTI                     Senti Biosciences Inc   -94.42   1301  -241.36   \n",
       "393   ELEV                    Elevation Oncology Inc   -94.44   1271  -110.94   \n",
       "394   LIPO               Lipella Pharmaceuticals Inc   -94.48    729     0.00   \n",
       "395   PTIX               Protagenic Therapeutics Inc   -94.52   1330  -171.43   \n",
       "396   NXTC                              Nextcure Inc   -94.57   2049  -213.50   \n",
       "397   SANA                    Sana Biotechnology Inc   -94.62   1412   -62.57   \n",
       "398   IPSC                  Century Therapeutics Inc   -94.66   1278  -118.55   \n",
       "399   GOVX                           Geovax Labs Inc   -94.67   1544  -125.68   \n",
       "400   GOSS                          Gossamer Bio Inc   -94.82   2139   -31.79   \n",
       "401   IOBT                            IO Biotech Inc   -94.82   1138  -179.67   \n",
       "402   IKNA                        Ikena Oncology Inc   -94.84   1362   -81.83   \n",
       "403   INKT                     MiNK Therapeutics Inc   -94.87   1159   -75.20   \n",
       "404   VCEL                              Vericel Corp   -94.87  10178     0.14   \n",
       "405     EQ                             Equillium Inc   -95.00   2258   -42.24   \n",
       "406   NKTX                                Nkarta Inc   -95.11   1621   -72.47   \n",
       "407   ALXO                 Alx Oncology Holdings Inc   -95.17   1614  -195.78   \n",
       "408   MBRX                     Moleculin Biotech Inc   -95.17   3120  -438.20   \n",
       "409   SILO                           SILO Pharma Inc   -95.23   1439     0.00   \n",
       "410   ABCL                   AbCellera Biologics Inc   -95.23   1467   -26.31   \n",
       "411   ZVRA                    Zevra Therapeutics Inc   -95.27   3533   -18.04   \n",
       "412   GBIO                         Generation Bio Co   -95.30   1649  -118.99   \n",
       "413   BCAB                               BioAtla Inc   -95.33   1462  -130.49   \n",
       "414    SER                   Serina Therapeutics Inc   -95.34   2210   -28.53   \n",
       "415   NERV                 Minerva Neurosciences Inc   -95.43   3822  -159.86   \n",
       "416   RNAC                Cartesian Therapeutics Inc   -95.55   3100    -8.31   \n",
       "417   SEER                                  Seer Inc   -95.63   1474   -63.39   \n",
       "418   TSBX                  Turnstone Biologics Corp   -95.64    515  -713.71   \n",
       "419   KPTI               Karyopharm Therapeutics Inc   -95.64   4059  -149.63   \n",
       "420   VRCA               Verrica Pharmaceuticals Inc   -95.65   2377  -112.86   \n",
       "421   KLTO                  Klotho Neurosciences Inc   -95.65    963     0.00   \n",
       "422   CLLS                             Cellectis ADR   -95.76   3556   -38.44   \n",
       "423   NNVC                         NanoViricides Inc   -95.77   6992   -36.55   \n",
       "424   PMVP                   PMV Pharmaceuticals Inc   -95.79   1544   -95.53   \n",
       "425    TIL                            Instil Bio Inc   -95.85   1369   -44.96   \n",
       "426   ASMB                  Assembly Biosciences Inc   -95.93   5114   -50.89   \n",
       "427   SABS                   SAB Biotherapeutics Inc   -95.98   1407  -128.34   \n",
       "428   LYEL                    Lyell Immunopharma Inc   -96.01   1279  -100.37   \n",
       "429   ATRA                 Atara Biotherapeutics Inc   -96.12   3715  -267.83   \n",
       "430    KZR                   Kezar Life Sciences Inc   -96.20   2371  -205.08   \n",
       "431   AFMD                               Affimed N.V   -96.23   3749  -203.81   \n",
       "432   LPTX                     Leap Therapeutics Inc   -96.25   2883   -56.09   \n",
       "433   CGTX                Cognition Therapeutics Inc   -96.26   1166  -312.75   \n",
       "434   BTAI                  BioXcel Therapeutics Inc   -96.26   2476  -530.79   \n",
       "435   XCUR                               Exicure Inc   -96.28   2401   -12.28   \n",
       "436   KTTA                Pasithea Therapeutics Corp   -96.28   1189  -494.53   \n",
       "437   ADAP          Adaptimmune Therapeutics Plc ADR   -96.38   3513   -48.16   \n",
       "438   KRON                            Kronos Bio Inc   -96.38   1530  -162.68   \n",
       "439   AADI                       Aadi Bioscience Inc   -96.43   2496  -108.08   \n",
       "440   ADXN                Addex Therapeutics Ltd ADR   -96.46   1770  -130.39   \n",
       "441   SLGL                  Sol-Gel Technologies Ltd   -96.48   2511  -127.27   \n",
       "442   VTVT                      vTv Therapeutics Inc   -96.55   3428   -56.46   \n",
       "443   ATHA                         Athira Pharma Inc   -96.58   1551  -539.32   \n",
       "444   PASG                           Passage Bio Inc   -96.58   1754  -189.80   \n",
       "445   VSTM                              Verastem Inc   -96.63   4708   -54.96   \n",
       "446   ALLK                               Allakos Inc   -96.64   2343  -163.38   \n",
       "447   SNPX                          Synaptogenix Inc   -96.87   1470  -182.13   \n",
       "448   SAVA                      Cassava Sciences Inc   -96.92   8922  -111.99   \n",
       "449   SYBX                              Synlogic Inc   -96.94   3366  -207.25   \n",
       "450   PRLD                  Prelude Therapeutics Inc   -96.95   1544  -287.32   \n",
       "451   PMCB                    PharmaCyte Biotech Inc   -97.00   4367     0.00   \n",
       "452   ELTX                   Elicio Therapeutics Inc   -97.02   1411   -77.37   \n",
       "453   RIGL                     Rigel Pharmaceuticals   -97.04   8784     3.36   \n",
       "454   LPCN                              Lipocine Inc   -97.05   4074   -36.23   \n",
       "455   CAPR                 Capricor Therapeutics Inc   -97.05   6517    -5.51   \n",
       "456   CRIS                                 Curis Inc   -97.07   8904  -167.29   \n",
       "457   CLDX                  Celldex Therapeutics Inc   -97.10  14096    -9.84   \n",
       "458   INAB                                IN8bio Inc   -97.15   1236  -150.07   \n",
       "459   EVGN                               Evogene Ltd   -97.15   5177  -219.29   \n",
       "460   PGEN                              Precigen Inc   -97.25   4149   -44.90   \n",
       "461   ATNM              Actinium Pharmaceuticals Inc   -97.27   4373  -117.31   \n",
       "462   GLYC                         GlycoMimetics Inc   -97.34   3994  -263.61   \n",
       "463    VOR                         Vor Biopharma Inc   -97.36   1411  -173.02   \n",
       "464   BIVI                                BioVie Inc   -97.36   1551   -70.80   \n",
       "465    LSB                LakeShore Biopharma Co Ltd   -97.37   1230  -662.26   \n",
       "466   IVVD                               Invivyd Inc   -97.38   1229  -390.91   \n",
       "467   SXTP            60 Degrees Pharmaceuticals Inc   -97.49    524  -256.20   \n",
       "468   LGVN                            Longeveron Inc   -97.49   1404   -63.78   \n",
       "469    DNA              Ginkgo Bioworks Holdings Inc   -97.67   1338   -97.00   \n",
       "470   SNSE                Sensei Biotherapeutics Inc   -97.67   1412  -285.00   \n",
       "471   CELU                            Celularity Inc   -97.73   1958   -69.12   \n",
       "472   SPRB                    Spruce Biosciences Inc   -97.75   1530  -269.10   \n",
       "473   BNOX                        Bionomics Ltd. ADR   -97.81   1097  -311.49   \n",
       "474   VINC                        Vincerx Pharma Inc   -97.96   1665  -422.99   \n",
       "475   CARA                     Cara Therapeutics Inc   -97.97   3973  -740.07   \n",
       "476   ADVM               Adverum Biotechnologies Inc   -98.08   3792   -90.50   \n",
       "477   CLDI                Calidi Biotherapeutics Inc   -98.11   1142   -95.20   \n",
       "478   EYPT              EyePoint Pharmaceuticals Inc   -98.14   7264   -22.06   \n",
       "479   EPIX                           Essa Pharma Inc   -98.14   3567     0.00   \n",
       "480   BLUE                          Bluebird bio Inc   -98.18   4199  -397.88   \n",
       "481   COEP         Coeptis Therapeutics Holdings Inc   -98.20   1461  -204.08   \n",
       "482   ALVR                               AlloVir Inc   -98.23   1601  -230.59   \n",
       "483   GLMD                Galmed Pharmaceuticals Ltd   -98.27   3932  -113.28   \n",
       "484   MCRB                    Seres Therapeutics Inc   -98.29   3462   -24.02   \n",
       "485   ONCY                   Oncolytics Biotech, Inc   -98.34   8474   -57.02   \n",
       "486   NLSP                     NLS Pharmaceutics Ltd   -98.35   1418  -142.86   \n",
       "487   BOLT                  Bolt Biotherapeutics Inc   -98.36   1411  -364.25   \n",
       "488   ARTL                    Artelo Biosciences Inc   -98.41   2006     0.00   \n",
       "489   HOOK                        Hookipa Pharma Inc   -98.48   2070  -182.38   \n",
       "490   FGEN                              FibroGen Inc   -98.49   3686  -506.23   \n",
       "491   TARA                  Protara Therapeutics Inc   -98.51   3709   -23.13   \n",
       "492   ATYR                           Atyr Pharma Inc   -98.54   3512   -26.48   \n",
       "493   SLDB                     Solid Biosciences Inc   -98.55   2517   -59.81   \n",
       "494   CYCN                Cyclerion Therapeutics Inc   -98.63   2101     0.00   \n",
       "495   GLTO                               Galecto Inc   -98.65   1510  -294.29   \n",
       "496    PMN                  ProMIS Neurosciences Inc   -98.71   6551   -37.44   \n",
       "497   NRXP                   NRX Pharmaceuticals Inc   -98.75   2570  -160.30   \n",
       "498   ATXS                   Astria Therapeutics Inc   -98.78   3463     0.00   \n",
       "499   ONVO                     Organovo Holdings Inc   -98.79   4690  -208.51   \n",
       "500   FBIO                      Fortress Biotech Inc   -98.82   4779  -176.84   \n",
       "501   BCLI         Brainstorm Cell Therapeutics, Inc   -98.83   7742  -181.45   \n",
       "502   EVAX                   Evaxion Biotech A/S ADR   -98.85   1411  -241.40   \n",
       "503   QTTB                               Q32 Bio Inc   -98.90   2456  -180.37   \n",
       "504   ADIL                 Adial Pharmaceuticals Inc   -98.92   2335  -103.71   \n",
       "505   ALRN                  Aileron Therapeutics Inc   -98.95   2728   -55.30   \n",
       "506   DTIL                 Precision Biosciences Inc   -98.96   2091   -32.95   \n",
       "507   LYRA                     Lyra Therapeutics Inc   -99.01   1691  -551.77   \n",
       "508   RZLT                              Rezolute Inc   -99.04   4355   -27.06   \n",
       "509   ITRM                   Iterum Therapeutics Plc   -99.07   2398   -72.61   \n",
       "510   CMMB             Chemomab Therapeutics Ltd ADR   -99.09   2135   -52.60   \n",
       "511   MTNB            Matinas Biopharma Holdings Inc   -99.13   3802  -850.18   \n",
       "512   VRDN                 Viridian Therapeutics Inc   -99.13   3835   -16.56   \n",
       "513   VRAX                   Virax Biolabs Group Ltd   -99.14    880   -90.43   \n",
       "514   EYEN                              Eyenovia Inc   -99.15   2518  -382.84   \n",
       "515   APLM                            Apollomics Inc   -99.16   1117  -585.45   \n",
       "516   PDSB             PDS Biotechnology Corporation   -99.16   3366   -54.77   \n",
       "517   CMND                    Clearmind Medicine Inc   -99.17    763  -102.09   \n",
       "518    CDT               Conduit Pharmaceuticals Inc   -99.18    995     0.00   \n",
       "519   MRNS               Marinus Pharmaceuticals Inc   -99.18   3792  -941.19   \n",
       "520   ACET                            Adicet Bio Inc   -99.18   2517  -153.18   \n",
       "521    ICU              SeaStar Medical Holding Corp   -99.19   1370     0.00   \n",
       "522   ATHE             Alterity Therapeutics Ltd ADR   -99.20   7750   -83.70   \n",
       "523   XFOR                    X4 Pharmaceuticals Inc   -99.20   2588  -111.98   \n",
       "524   APRE                    Aprea Therapeutics Inc   -99.22   1902   -80.02   \n",
       "525   ARWR             Arrowhead Pharmaceuticals Inc   -99.25  11324   -19.03   \n",
       "526   CTXR                Citius Pharmaceuticals Inc   -99.26   3729  -205.97   \n",
       "527    IGC                            IGC Pharma Inc   -99.26   6782   -33.11   \n",
       "528   CBUS                                 Cibus Inc   -99.27   2707   -52.43   \n",
       "529   SCNI         Scinai Immunotherapeutics Ltd ADR   -99.32   3508  -238.10   \n",
       "530   KZIA            Kazia Therapeutics Limited ADR   -99.33   9477  -120.83   \n",
       "531    UBX                   Unity Biotechnology Inc   -99.33   2420  -150.33   \n",
       "532   KALA                              Kala Bio Inc   -99.33   2707  -145.47   \n",
       "533   PHGE                                 BiomX Inc   -99.34   2106  -229.20   \n",
       "534   XBIO                   Xenetic Biosciences Inc   -99.34   3092     0.00   \n",
       "535   LXRX               Lexicon Pharmaceuticals Inc   -99.38   9020   -75.65   \n",
       "536   GNPX                               Genprex Inc   -99.38   2455  -294.29   \n",
       "537   GRCE                    Grace Therapeutics Inc   -99.38   4697   -35.95   \n",
       "538   VRPX                Virpax Pharmaceuticals Inc   -99.39   1399     0.00   \n",
       "539   RLMD                  Relmada Therapeutics Inc   -99.39   3833     0.00   \n",
       "540   PPBT                    Purple Biotech Ltd ADR   -99.40   3315  -195.81   \n",
       "541   GYRE                     Gyre Therapeutics Inc   -99.42   6824     2.34   \n",
       "542   CERO            CERo Therapeutics Holdings Inc   -99.43   1113     0.00   \n",
       "543   VXRT                                Vaxart Inc   -99.43  15712   -49.80   \n",
       "544   DWTX                  Dogwood Therapeutics Inc   -99.44   1461     0.00   \n",
       "545    APM                         Aptorum Group Ltd   -99.47   2191  -237.62   \n",
       "546   XOMA                         XOMA Royalty Corp   -99.47  14074    -4.63   \n",
       "547   FBRX                     Forte Biosciences Inc   -99.50   2805     0.00   \n",
       "548   PYPD                               Polypid Ltd   -99.54   1635  -132.73   \n",
       "549   BCTX                BriaCell Therapeutics Corp   -99.58   4661  -121.62   \n",
       "550   CING                             Cingulate Inc   -99.61   1105  -120.23   \n",
       "551   DARE                       Dare Bioscience Inc   -99.61   3904   -96.49   \n",
       "552   HOTH                     Hoth Therapeutics Inc   -99.62   2132     0.00   \n",
       "553   ENLV                  Enlivex Therapeutics Ltd   -99.64   3792   -70.13   \n",
       "554   ELAB                           Elevai Labs Inc   -99.66    392   -75.51   \n",
       "555   EDSA                         Edesa Biotech Inc   -99.67   5293  -134.04   \n",
       "556    INO                Inovio Pharmaceuticals Inc   -99.67   9506  -148.16   \n",
       "557   GTBP                          GT Biopharma Inc   -99.68   2457     0.00   \n",
       "558   XTLB        X.T.L. Biopharmaceuticals Ltd. ADR   -99.68   7047     0.00   \n",
       "559   NCNA                            NuCana plc ADR   -99.69   2637  -668.41   \n",
       "560   RGLS                  Regulus Therapeutics Inc   -99.70   4452   -41.20   \n",
       "561   AZTR                                Azitra Inc   -99.70    550  -330.15   \n",
       "562   XRTX                    XORTX Therapeutics Inc   -99.71   1181   -84.62   \n",
       "563   BLRX                        Bioline Rx Ltd ADR   -99.71   4892  -152.30   \n",
       "564   HRTX                    Heron Therapeutics Inc   -99.72  13628    -2.23   \n",
       "565   VANI                        Vivani Medical Inc   -99.73   3681   -31.85   \n",
       "566    PBM                    Psyence Biomedical Ltd   -99.75   1103  -176.28   \n",
       "567   CRDF                      Cardiff Oncology Inc   -99.76   7448   -17.16   \n",
       "568   IMUX                               Immunic Inc   -99.76   3897   -95.69   \n",
       "569   SPRC                              SciSparc Ltd   -99.77   1205  -248.52   \n",
       "570   OTLK                  Outlook Therapeutics Inc   -99.78   3108  -180.87   \n",
       "571   COCP                      Cocrystal Pharma Inc   -99.79   4682  -102.92   \n",
       "572    PLX              Protalix BioTherapeutics Inc   -99.79   9713   -10.50   \n",
       "573   INDP                 Indaptus Therapeutics Inc   -99.79   3423  -142.93   \n",
       "574   BNTC                     Benitec Biopharma Inc   -99.80   3829    -7.67   \n",
       "575   PRTG                       Portage Biotech Inc   -99.81   8385  -440.66   \n",
       "576   CARM                  Carisma Therapeutics Inc   -99.81   3967  -352.84   \n",
       "577   CANF                Can-Fite Biopharma Ltd ADR   -99.81   4424   -84.47   \n",
       "578   CASI                  CASI Pharmaceuticals Inc   -99.82  10415   -47.39   \n",
       "579   SKYE                       Skye Bioscience Inc   -99.83   3633   -23.58   \n",
       "580   VTGN                 Vistagen Therapeutics Inc   -99.83   4928   -65.85   \n",
       "581   THAR                            Tharimmune Inc   -99.84   1070     0.00   \n",
       "582   PULM                             Pulmatrix Inc   -99.84   3924   -50.50   \n",
       "583   VCNX                              Vaccinex Inc   -99.85   2322  -220.16   \n",
       "584   ENVB                   Enveric Biosciences Inc   -99.85   3515  -275.70   \n",
       "585   MBIO                           Mustang Bio Inc   -99.87   2674  -222.43   \n",
       "586   ATOS                   Atossa Therapeutics Inc   -99.87   4422   -21.89   \n",
       "587   VYNE                     VYNE Therapeutics Inc   -99.88   2518     0.00   \n",
       "588   OCGN                                Ocugen Inc   -99.88   3667   -20.48   \n",
       "589    INM                 InMed Pharmaceuticals Inc   -99.88   3879  -212.06   \n",
       "590   SYRS                 Syros Pharmaceuticals Inc   -99.89   3092 -1867.46   \n",
       "591   ELDN                Eledon Pharmaceuticals Inc   -99.89   3744     0.00   \n",
       "592    IRD                         Opus Genetics Inc   -99.91   6977   -93.35   \n",
       "593   DRMA                  Dermata Therapeutics Inc   -99.91   1222     0.00   \n",
       "594   TCRT                  Alaunos Therapeutics Inc   -99.92   7055  -478.33   \n",
       "595   AKTX                Akari Therapeutics Plc ADR   -99.94   3998   -69.14   \n",
       "596   ALZN                        Alzamend Neuro Inc   -99.94   1281  -110.41   \n",
       "597   AGEN                                Agenus Inc   -99.94   9079  -127.99   \n",
       "598   ATNF                    180 Life Sciences Corp   -99.95   2730  -245.28   \n",
       "599   TFFP                   Tff Pharmaceuticals Inc   -99.95   1880 -6555.17   \n",
       "600   AVTX                    Avalo Therapeutics Inc   -99.95   3352   -31.62   \n",
       "601   IBIO                                  iBio Inc   -99.95   5964   -68.60   \n",
       "602   TPST                  Tempest Therapeutics Inc   -99.95   4418   -89.52   \n",
       "603   PCSA              Processa Pharmaceuticals Inc   -99.95   3938  -346.76   \n",
       "604   SCPX                     Scorpius Holdings Inc   -99.96   4164 -1906.87   \n",
       "605   MEIP                            MEI Pharma Inc   -99.96   7670   153.46   \n",
       "606    PTN                  Palatin Technologies Inc   -99.96   9925  -184.36   \n",
       "607   ZVSA                  ZyVersa Therapeutics Inc   -99.97   1040  -425.31   \n",
       "608   CELZ  Creative Medical Technology Holdings Inc   -99.97   3329  -134.96   \n",
       "609    CVM                              Cel-Sci Corp   -99.98  14985   -61.54   \n",
       "610   ATXI                   Avenue Therapeutics Inc   -99.98   2730     0.00   \n",
       "611   BPTH                     Bio-Path Holdings Inc   -99.98   6132  -449.13   \n",
       "612   ONCO                             Onconetix Inc   -99.98   1033  -435.34   \n",
       "613    AIM                        AIM ImmunoTech Inc   -99.98  10385  -234.20   \n",
       "614   HURA                    TuHURA Biosciences Inc   -99.98   4316     0.00   \n",
       "615   PLUR                                 Pluri Inc   -99.98   7841   -84.79   \n",
       "616   ENSC                   Ensysce Biosciences Inc   -99.98   2470     0.00   \n",
       "617   KPRX                 Kiora Pharmaceuticals Inc   -99.99   3595    58.52   \n",
       "618   APTO                    Aptose Biosciences Inc   -99.99  11964  -314.43   \n",
       "619   RNAZ                TransCode Therapeutics Inc   -99.99   1258  -376.97   \n",
       "620   HEPA                Hepion Pharmaceuticals Inc   -99.99   3963  -853.93   \n",
       "621   IMNN                                Imunon Inc   -99.99   9423  -169.79   \n",
       "622   BCDA                             BioCardia Inc   -99.99  10261   -89.04   \n",
       "623   MTEM                   Molecular Templates Inc   -99.99   7256  -565.71   \n",
       "624   QNRX             Quoin Pharmaceuticals Ltd ADR  -100.00   3060  -274.53   \n",
       "625   MTVA                               MetaVia Inc  -100.00   3056  -151.63   \n",
       "626    GRI                               GRI Bio Inc  -100.00   1406  -122.22   \n",
       "627   ERNA                   Eterna Therapeutics Inc  -100.00  12164  -156.70   \n",
       "628   REVB                Revelation Biosciences Inc  -100.00   1491  -571.81   \n",
       "629   TTNP          Titan Pharmaceuticals, Inc. (de)  -100.00  10561  -228.71   \n",
       "630   VIRX                  Viracta Therapeutics Inc  -100.00   7021  -581.73   \n",
       "631   APVO                   Aptevo Therapeutics Inc  -100.00   3072 -1247.94   \n",
       "632   SLRX              Salarius Pharmaceuticals Inc  -100.00   3610  -336.50   \n",
       "633   TENX                    Tenax Therapeutics Inc  -100.00  11215   -65.44   \n",
       "634   TNFA                   TNF Pharmaceuticals Inc  -100.00   3981     0.00   \n",
       "635   ACHV                 Achieve Life Sciences Inc  -100.00  10659   -21.85   \n",
       "636   CNSP                   Cns Pharmaceuticals Inc  -100.00   1866  -269.93   \n",
       "637   LSTA                   Lisata Therapeutics Inc  -100.00   9423  -109.27   \n",
       "638   BRTX              BioRestorative Therapies Inc  -100.00   4395  -117.82   \n",
       "639   TOVX                     Theriva Biologics Inc  -100.00   6574  -656.44   \n",
       "640   DOMH                     Dominari Holdings Inc  -100.00  16345  -152.64   \n",
       "641   OGEN                             Oragenics Inc  -100.00   7601  -459.95   \n",
       "642   QLGN                 Qualigen Therapeutics Inc  -100.00   3465  -257.89   \n",
       "643    NBY               Novabay Pharmaceuticals Inc  -100.00   6262  -181.23   \n",
       "644   ARMP                Armata Pharmaceuticals Inc  -100.00  11169   -56.25   \n",
       "645   CSCI                    COSCIENS Biopharma Inc  -100.00   8987  -282.20   \n",
       "646   TRAW                          Traws Pharma Inc  -100.00   4163  -145.18   \n",
       "647   ORKA                    Oruka Therapeutics Inc  -100.00   9993     0.00   \n",
       "648   ENTO                   Entero Therapeutics Inc  -100.00   2989  -737.64   \n",
       "649    SLS            SELLAS Life Sciences Group Inc  -100.00   6124     0.00   \n",
       "650   ABEO                   Abeona Therapeutics Inc  -100.00  16160   -21.38   \n",
       "651   TCBP            TC BioPharm (Holdings) plc ADR  -100.00   1040  -286.47   \n",
       "652   MRKR                   Marker Therapeutics Inc  -100.00   8190     0.00   \n",
       "653   PSTV                     Plus Therapeutics Inc  -100.00   8560  -195.22   \n",
       "654   SNGX                             Soligenix Inc  -100.00  11215  -102.75   \n",
       "655   ABVC                        ABVC BioPharma Inc  -100.00   7342  -136.38   \n",
       "656   PHIO                 Phio Pharmaceuticals Corp  -100.00   4604  -285.67   \n",
       "657   CYTO                 Altamira Therapeutics Ltd  -100.00   3786     0.00   \n",
       "658   ADTX                                Aditxt Inc  -100.00   1631  -762.44   \n",
       "659   CRVO                              CervoMed Inc  -100.00   6052     0.00   \n",
       "660   PALI                          Palisade Bio Inc  -100.00   6472  -463.17   \n",
       "661   BDRX           Biodexa Pharmaceuticals Plc ADR  -100.00   3298  -267.22   \n",
       "662   SONN       Sonnet BioTherapeutics Holdings Inc  -100.00   6622  -806.58   \n",
       "663   CYCC              Cyclacel Pharmaceuticals Inc  -100.00   7581  -934.26   \n",
       "664   ALLR                 Allarity Therapeutics Inc  -100.00   1092  -399.53   \n",
       "665   CLRB                 Cellectar Biosciences Inc  -100.00   6977  -445.49   \n",
       "666   JAGX                         Jaguar Health Inc  -100.00   3507  -272.25   \n",
       "667   WINT                 Windtree Therapeutics Inc  -100.00  10725  -694.65   \n",
       "668   TNXP        Tonix Pharmaceuticals Holding Corp  -100.00   4604   -91.64   \n",
       "\n",
       "     MarketCap_M  revenueM  ebitdaM  Employees term profit  animal  \n",
       "0       12101.22   1171.58   308.52       3100  Old  Alive   Mamut  \n",
       "1      120546.75  10625.80  4446.60       5400  Old  Alive   Mamut  \n",
       "2       16644.81   2756.20  1412.10       1168  Old  Alive   Mamut  \n",
       "3       13446.97   4075.86    80.49       2524  Old  Alive   Mamut  \n",
       "4       31470.08   2094.80  -132.15       2100  Old  Alive   Mamut  \n",
       "5       79655.96  13847.10  4598.00      14165  Old  Alive   Mamut  \n",
       "6       37829.53   1908.66  -150.08       1148  Old  Alive   Mamut  \n",
       "7         106.57     19.13    -7.21          0  New  Alive  Gacela  \n",
       "8        4820.55    241.52    69.14        229  Old  Alive   Mamut  \n",
       "9        1523.10    203.45  -238.74        380  Old  Alive   Mamut  \n",
       "10       6110.71    947.36   553.00        373  Old  Alive   Mamut  \n",
       "11       4346.11    338.46  -244.62        607  Old  Alive   Mamut  \n",
       "12      27383.10   3040.10  -274.50       6133  Old  Alive   Mamut  \n",
       "13       7568.92   3992.71  1518.48       2800  Old  Alive   Mamut  \n",
       "14       8163.27    317.63  -347.19        879  Old  Alive   Mamut  \n",
       "15      19806.62  23507.73 -5576.40      10600  Old  Alive   Mamut  \n",
       "16       1948.48      0.00   -35.30         20  New  Alive   Mamut  \n",
       "17       5263.12      0.00     0.00         30  Old  Alive   Mamut  \n",
       "18      12832.72  19844.00  6855.00       2635  Old  Alive   Mamut  \n",
       "19       4190.50      0.00  -841.60        239  New  Alive   Mamut  \n",
       "20      12490.81   2752.81   426.09       3401  Old  Alive   Mamut  \n",
       "21       4510.91    155.82   -65.30        130  New  Alive   Mamut  \n",
       "22       6059.73    434.42  -262.13        638  Old  Alive   Mamut  \n",
       "23       3341.13      0.00  -108.45         50  Old  Alive   Mamut  \n",
       "24       6211.42      0.00     0.00        127  New  Alive   Mamut  \n",
       "25       5807.68    628.56   144.09        352  Old  Alive   Mamut  \n",
       "26       2930.25     35.93  -228.46        172  Old  Alive   Mamut  \n",
       "27       2783.68      0.00     0.00         82  New  Alive   Mamut  \n",
       "28       3149.46      0.00  -233.68        251  Old  Alive   Mamut  \n",
       "29       6015.88    803.07  -336.27        927  Old  Alive   Mamut  \n",
       "30       2470.93    323.80   150.07        126  Old  Alive   Mamut  \n",
       "31       2582.26    460.48   211.43        167  Old  Alive   Mamut  \n",
       "32       2311.66    152.42    52.63         58  Old  Alive   Mamut  \n",
       "33      11153.76      0.00  -599.03        254  Old  Alive   Mamut  \n",
       "34       2034.91    307.03   -72.90        311  Old  Alive   Mamut  \n",
       "35      12110.93   1640.35   119.67       1314  Old  Alive   Mamut  \n",
       "36       3776.04    202.83  -313.08        407  Old  Alive   Mamut  \n",
       "37       3492.56      5.62  -150.30         79  Old  Alive   Mamut  \n",
       "38       1715.96     85.16  -202.48        280  Old  Alive   Mamut  \n",
       "39       3749.05    900.66    21.85        988  Old  Alive   Mamut  \n",
       "40       4013.27      0.00  -228.52        150  Old  Alive   Mamut  \n",
       "41        169.57      0.00   -10.53          3  Old  Alive  Gacela  \n",
       "42       4055.67      0.00  -352.16        207  Old  Alive   Mamut  \n",
       "43       2885.24    929.24   124.54        620  Old  Alive   Mamut  \n",
       "44       1977.48    129.62  -139.46        244  Old  Alive   Mamut  \n",
       "45       3609.44     13.05   -83.88         76  New  Alive   Mamut  \n",
       "46      10300.83   2081.60   635.96       1310  Old  Alive   Mamut  \n",
       "47       4187.07    715.22  -221.51        702  Old  Alive   Mamut  \n",
       "48       1378.81    220.36     0.50        300  Old  Alive   Mamut  \n",
       "49       2645.28     33.59  -184.06         62  New  Alive   Mamut  \n",
       "50       2251.55      3.92  -222.31        124  Old  Alive   Mamut  \n",
       "51      16100.78   5081.00 -2362.00       5600  Old  Alive   Mamut  \n",
       "52       3395.50    112.53  -263.92        226  Old  Alive   Mamut  \n",
       "53        337.64      0.00     0.00          4  New  Alive  Gacela  \n",
       "54       5066.26      1.04  -304.51        290  Old  Alive   Mamut  \n",
       "55       4486.68    382.81   125.89        624  Old  Alive   Mamut  \n",
       "56        542.65      0.00     0.00         57  Old  Alive  Gacela  \n",
       "57       2686.39      0.00     0.00         91  New  Alive   Mamut  \n",
       "58         44.09      1.80     0.00          7  Old  Alive  Gacela  \n",
       "59       1391.58    342.80    67.51        895  Old  Alive   Mamut  \n",
       "60        678.53    133.35  -167.23        173  Old  Alive   Mamut  \n",
       "61        717.26      0.87   -68.00         36  New  Alive   Mamut  \n",
       "62        148.27     -0.00    -4.68         29  New  Alive  Gacela  \n",
       "63      13775.53      0.00  -181.49        105  Old  Alive   Mamut  \n",
       "64       1773.29    260.09  -136.03       1123  Old  Alive   Mamut  \n",
       "65       2827.43    135.49  -292.26        305  Old  Alive   Mamut  \n",
       "66        711.22      5.37   -82.81         53  Old  Alive   Mamut  \n",
       "67       2040.23      0.00  -269.27         60  Old  Alive   Mamut  \n",
       "68       8262.18      0.74  -621.56        490  Old  Alive   Mamut  \n",
       "69       1151.61      0.00   -98.78         46  Old  Alive   Mamut  \n",
       "70        273.64      0.00     0.00          0  New  Alive  Gacela  \n",
       "71       2395.57    349.64  -160.83        472  Old  Alive   Mamut  \n",
       "72         94.09      0.00     0.00         13  New  Alive  Gacela  \n",
       "73       1153.11    352.74   221.19        112  Old  Alive   Mamut  \n",
       "74        892.30      0.00     0.00         40  New  Alive   Mamut  \n",
       "75         94.56      9.55   -11.11          8  New  Alive  Gacela  \n",
       "76       2788.79     87.56  -190.49        184  Old  Alive   Mamut  \n",
       "77       2434.62     32.87  -401.29        383  Old  Alive   Mamut  \n",
       "78        848.40      0.00   -68.34          0  New  Alive   Mamut  \n",
       "79       1304.86    161.10  -352.60        445  Old  Alive   Mamut  \n",
       "80         73.91      0.00    -3.18          0  New  Alive  Gacela  \n",
       "81       1775.08      0.00  -121.84        136  New  Alive   Mamut  \n",
       "82        122.47      0.00   -31.76         29  New  Alive  Gacela  \n",
       "83       1177.08     16.00  -321.20        184  Old  Alive   Mamut  \n",
       "84       1545.21    412.58   -31.94        536  Old  Alive   Mamut  \n",
       "85       1043.98     36.90  -189.32        284  Old  Alive   Mamut  \n",
       "86       3983.73     10.12  -322.04        253  Old  Alive   Mamut  \n",
       "87       8808.20    129.13 -1199.66        908  New  Alive   Mamut  \n",
       "88       4192.43    522.74  -501.06       1276  Old  Alive   Mamut  \n",
       "89       2656.09      0.00  -312.84        173  Old  Alive   Mamut  \n",
       "90       3351.94      0.00  -511.85        390  Old  Alive   Mamut  \n",
       "91       1474.10     56.42  -186.40        284  Old  Alive   Mamut  \n",
       "92        778.42      0.00     0.00         40  Old  Alive   Mamut  \n",
       "93        848.13     28.59  -189.32        480  Old  Alive   Mamut  \n",
       "94        963.09      0.84   -57.77         68  New  Alive   Mamut  \n",
       "95       5295.33    645.68    73.14          0  New  Alive   Mamut  \n",
       "96        146.98      0.00     0.00          1  New  Alive  Gacela  \n",
       "97         34.86      0.00     0.00          0  New  Alive  Gacela  \n",
       "98         58.69      0.00  -168.40        107  New  Alive   Mamut  \n",
       "99        169.73      0.00     0.00         11  New  Alive  Gacela  \n",
       "100      5236.91    217.76  -509.90        550  Old  Alive   Mamut  \n",
       "101       933.54     14.84   -95.84        145  Old  Alive   Mamut  \n",
       "102       948.44     62.20  -114.71        294  Old  Alive   Mamut  \n",
       "103       199.89      0.00   -34.66         42  New  Alive  Gacela  \n",
       "104      6782.82     76.81  -547.18        376  Old  Alive   Mamut  \n",
       "105        79.14      0.00     0.00          0  New  Alive  Gacela  \n",
       "106      6055.68    520.18  -340.56       2400  Old  Alive   Mamut  \n",
       "107      1510.86    263.00  -288.00        577  Old  Alive   Mamut  \n",
       "108      2846.68    355.75  -326.92       2175  Old  Alive   Mamut  \n",
       "109       786.65      0.65  -202.89        160  Old  Alive   Mamut  \n",
       "110       667.40      0.00  -169.78        170  New  Alive   Mamut  \n",
       "111       776.46     10.13  -110.44         55  Old  Alive   Mamut  \n",
       "112      3095.37      0.00  -145.18        108  New  Alive   Mamut  \n",
       "113      1018.87      2.21   -65.72          0  New  Alive   Mamut  \n",
       "114       506.64     57.17  -139.45        117  Old  Alive   Mamut  \n",
       "115       352.12      0.00   -43.30         31  New  Alive  Gacela  \n",
       "116       678.86      0.00   -73.70          0  New  Alive   Mamut  \n",
       "117       252.61      2.60   -58.57         82  New   Dead  Gacela  \n",
       "118        84.96     51.66    -1.17        210  Old   Dead   Mamut  \n",
       "119       465.98      0.00   -85.28         55  Old   Dead  Gacela  \n",
       "120      1885.45    681.88   199.56        246  Old   Dead   Mamut  \n",
       "121       439.84      0.00  -172.51        198  Old   Dead   Mamut  \n",
       "122       500.36      9.03  -169.87         62  New   Dead  Gacela  \n",
       "123       210.77      1.69  -300.93        166  New   Dead   Mamut  \n",
       "124      2051.39     53.61  -147.98        266  Old   Dead   Mamut  \n",
       "125       427.31      0.00  -192.78        111  Old   Dead   Mamut  \n",
       "126       960.41      0.00  -226.71        331  Old   Dead   Mamut  \n",
       "127       476.85     89.36   -83.28        217  Old   Dead   Mamut  \n",
       "128       639.61      0.00   -59.35         38  New   Dead   Mamut  \n",
       "129      1975.46      0.68   -95.94         61  New   Dead   Mamut  \n",
       "130      2208.40      6.85  -161.30         76  New   Dead   Mamut  \n",
       "131       883.67     70.87   -95.19        542  Old   Dead   Mamut  \n",
       "132       947.38      0.00   -69.38          0  New   Dead   Mamut  \n",
       "133       673.93    215.23    61.30        177  New   Dead   Mamut  \n",
       "134        49.42      2.02    -5.46          0  New   Dead  Gacela  \n",
       "135       128.22      0.35   -49.62         58  New   Dead  Gacela  \n",
       "136        26.69      0.00    -2.82          1  New   Dead  Gacela  \n",
       "137       234.19      0.00   -81.46         69  New   Dead  Gacela  \n",
       "138       301.32      0.00   -49.39          9  Old   Dead  Gacela  \n",
       "139        30.58      0.45    -3.12          0  New   Dead  Gacela  \n",
       "140      1467.46    296.31   -64.89        497  New   Dead   Mamut  \n",
       "141       501.05      0.00   -52.79         51  New   Dead  Gacela  \n",
       "142      1411.81     61.10  -110.75        267  Old   Dead   Mamut  \n",
       "143        21.39      0.00    -1.73          0  New   Dead  Gacela  \n",
       "144      2958.18    493.67    23.09        500  Old   Dead   Mamut  \n",
       "145       605.19      0.00     0.00         28  New   Dead   Mamut  \n",
       "146       775.69      0.00  -216.64        142  Old   Dead   Mamut  \n",
       "147         4.19      0.00    -0.65          0  New   Dead  Gacela  \n",
       "148      1003.31      0.00  -116.10         83  New   Dead   Mamut  \n",
       "149       466.81      0.00  -239.06        107  New   Dead   Mamut  \n",
       "150      1821.81   2975.60    27.10      15500  New   Dead   Mamut  \n",
       "151       834.91      0.00  -219.95        166  Old   Dead   Mamut  \n",
       "152       926.91    150.86   -57.02        350  Old   Dead   Mamut  \n",
       "153       321.15      0.00   -55.00         31  New   Dead  Gacela  \n",
       "154     14729.57   2266.00     0.00          0  Old   Dead   Mamut  \n",
       "155      1756.17      0.00  -250.00        124  New   Dead   Mamut  \n",
       "156       112.64      0.04     0.00         11  Old   Dead  Gacela  \n",
       "157      1362.74     43.09  -527.52        526  Old   Dead   Mamut  \n",
       "158      1588.30    138.71  -179.41        296  Old   Dead   Mamut  \n",
       "159       535.25      1.00   -37.48         33  Old   Dead  Gacela  \n",
       "160       762.08      0.00   -99.59         49  New   Dead   Mamut  \n",
       "161      1380.90      5.90   -56.08         73  Old   Dead   Mamut  \n",
       "162       444.07      0.00   -91.84         88  New   Dead  Gacela  \n",
       "163        96.49      0.00   -15.79          9  Old   Dead  Gacela  \n",
       "164       504.23     12.26   -50.77         82  Old   Dead  Gacela  \n",
       "165        53.64      0.00   -20.18         14  New   Dead  Gacela  \n",
       "166        68.99      0.00     0.00          6  Old   Dead  Gacela  \n",
       "167       672.70      6.74   -77.14         73  Old   Dead   Mamut  \n",
       "168      1272.68    101.95  -205.50        174  New   Dead   Mamut  \n",
       "169       614.52    285.74    -3.06        382  New   Dead   Mamut  \n",
       "170      1041.16     78.62  -533.94        587  Old   Dead   Mamut  \n",
       "171       530.32      0.47  -134.73         90  New   Dead  Gacela  \n",
       "172       325.91      0.00   -48.07         27  Old   Dead  Gacela  \n",
       "173      2303.15     29.48  -207.45        141  Old   Dead   Mamut  \n",
       "174        41.80     23.22    -0.63         75  Old   Dead  Gacela  \n",
       "175       114.97     14.09   -65.04        189  Old   Dead   Mamut  \n",
       "176       443.38      0.00   -23.28         28  Old   Dead  Gacela  \n",
       "177       164.08     49.35     0.00         29  Old   Dead  Gacela  \n",
       "178      1250.52      0.00  -264.84        268  Old   Dead   Mamut  \n",
       "179        37.70      0.41    -4.53          5  New   Dead  Gacela  \n",
       "180       196.20     33.79   -35.96        168  Old   Dead   Mamut  \n",
       "181      5785.05      3.22  -511.14        423  Old   Dead   Mamut  \n",
       "182       366.51      0.00  -132.91          0  New   Dead  Gacela  \n",
       "183       269.97    190.86   -30.16        203  Old   Dead   Mamut  \n",
       "184      1155.05      2.57   -60.44         24  New   Dead   Mamut  \n",
       "185       648.32     16.74  -115.03        110  Old   Dead   Mamut  \n",
       "186        37.88      0.00   -21.39         13  New   Dead  Gacela  \n",
       "187        96.94      0.00    -9.41         14  New   Dead  Gacela  \n",
       "188       193.49      2.65   -59.81         56  Old   Dead  Gacela  \n",
       "189        55.73      0.00     0.00         13  New   Dead  Gacela  \n",
       "190     13129.69    342.96  -695.06        912  Old   Dead   Mamut  \n",
       "191       481.91     63.19   -38.24         99  Old   Dead  Gacela  \n",
       "192       217.95      0.00   -75.56         58  New   Dead  Gacela  \n",
       "193       558.42      0.00  -105.28        183  New   Dead   Mamut  \n",
       "194       456.53     64.45   -45.78        174  Old   Dead   Mamut  \n",
       "195        17.52      2.27    -8.65         19  New   Dead  Gacela  \n",
       "196        41.51      0.69   -17.31         75  Old   Dead  Gacela  \n",
       "197       490.80      8.12  -155.31        387  Old   Dead   Mamut  \n",
       "198       283.87     35.00  -144.95        157  Old   Dead   Mamut  \n",
       "199       426.63      0.00   -45.53         49  New   Dead  Gacela  \n",
       "200       444.31     84.55   -23.35        100  Old   Dead  Gacela  \n",
       "201       687.09      0.00  -187.05         85  New   Dead   Mamut  \n",
       "202       458.64     20.41   -58.73        106  New   Dead   Mamut  \n",
       "203        81.51      0.01   -26.96         24  New   Dead  Gacela  \n",
       "204      1276.64    251.85   -62.15        267  Old   Dead   Mamut  \n",
       "205       928.90      0.00  -303.81         70  Old   Dead   Mamut  \n",
       "206       559.48      0.00   -88.72         37  Old   Dead  Gacela  \n",
       "207       592.87      0.00   -99.66         66  New   Dead  Gacela  \n",
       "208       147.01      0.00   -92.73         76  New   Dead  Gacela  \n",
       "209        75.41     84.32    14.40        103  Old   Dead   Mamut  \n",
       "210       471.83     14.98  -121.07        133  New   Dead   Mamut  \n",
       "211       353.97    163.78    14.13        162  Old   Dead   Mamut  \n",
       "212         5.21      0.00    -1.36          0  New   Dead  Gacela  \n",
       "213       133.74     71.96  -120.34        145  Old   Dead   Mamut  \n",
       "214       210.95      0.00   -40.57         82  Old   Dead  Gacela  \n",
       "215        30.74      0.00     0.00          5  New   Dead  Gacela  \n",
       "216        79.93      0.10    -9.16         17  Old   Dead  Gacela  \n",
       "217       318.23     17.90   -48.16        109  Old   Dead   Mamut  \n",
       "218       581.47      0.00  -133.69        112  Old   Dead   Mamut  \n",
       "219       439.90    160.40   -77.01        180  Old   Dead   Mamut  \n",
       "220       556.59     26.27  -287.14        452  Old   Dead   Mamut  \n",
       "221       162.58      0.00     0.00         14  New   Dead  Gacela  \n",
       "222       116.20     55.08   -83.33        236  New   Dead   Mamut  \n",
       "223       308.19      0.00   -73.44         42  Old   Dead  Gacela  \n",
       "224        96.35      0.00   -12.85          0  Old   Dead  Gacela  \n",
       "225       217.32      0.00   -35.22        121  New   Dead   Mamut  \n",
       "226       212.00      0.00  -149.62        107  New   Dead   Mamut  \n",
       "227       566.70      0.00   -78.78         74  New   Dead  Gacela  \n",
       "228       316.88     43.38  -137.20        140  Old   Dead   Mamut  \n",
       "229       250.77      0.00   -27.27         25  Old   Dead  Gacela  \n",
       "230       440.04      2.92  -223.95        198  Old   Dead   Mamut  \n",
       "231       238.41     81.63   -30.88         76  Old   Dead  Gacela  \n",
       "232        35.19      0.00   -15.75          8  New   Dead  Gacela  \n",
       "233       306.32     25.52   -98.53        116  Old   Dead   Mamut  \n",
       "234       132.46      0.00   -98.61        136  Old   Dead   Mamut  \n",
       "235       227.79     13.45  -164.67        181  Old   Dead   Mamut  \n",
       "236       197.22      6.00   -62.16        167  New   Dead   Mamut  \n",
       "237       184.48      2.00     0.00          8  New   Dead  Gacela  \n",
       "238       102.00      0.00   -20.01          5  New   Dead  Gacela  \n",
       "239       423.12     84.33  -223.55        344  Old   Dead   Mamut  \n",
       "240       160.65      9.36  -114.79        188  New   Dead   Mamut  \n",
       "241       184.46     93.14  -130.18        137  Old   Dead   Mamut  \n",
       "242       905.37      2.16  -133.93        203  Old   Dead   Mamut  \n",
       "243        76.91      0.00     0.00         15  Old   Dead  Gacela  \n",
       "244       513.98      0.26  -191.82         33  Old   Dead  Gacela  \n",
       "245        11.97      4.90    -5.21          7  Old   Dead  Gacela  \n",
       "246       539.37      0.00  -124.79         71  Old   Dead  Gacela  \n",
       "247       168.18     45.62  -134.27        274  New   Dead   Mamut  \n",
       "248        38.39      0.00   -19.53         21  Old   Dead  Gacela  \n",
       "249       286.53    196.48  -248.25        384  New   Dead   Mamut  \n",
       "250       160.13     30.28   -63.67        135  Old   Dead   Mamut  \n",
       "251      2893.71     65.18  -364.15        500  New   Dead   Mamut  \n",
       "252        20.44      0.00   -11.69         18  New   Dead  Gacela  \n",
       "253      1969.36      0.00  -124.71         82  Old   Dead   Mamut  \n",
       "254       321.78      0.00   -67.27         45  Old   Dead  Gacela  \n",
       "255       147.26    243.57    44.60        185  Old   Dead   Mamut  \n",
       "256        33.71      0.00     0.00          2  New   Dead  Gacela  \n",
       "257       165.44     42.20   -22.30        110  New   Dead   Mamut  \n",
       "258       198.12      0.00   -86.20         50  Old   Dead  Gacela  \n",
       "259       261.59     18.39   -28.60        156  Old   Dead   Mamut  \n",
       "260       140.92      0.00     0.00          9  Old   Dead  Gacela  \n",
       "261      1409.11    276.92     1.04        580  New   Dead   Mamut  \n",
       "262       288.91     40.97   -35.76        133  Old   Dead   Mamut  \n",
       "263       393.48      0.80  -207.13        234  New   Dead   Mamut  \n",
       "264       251.13      0.00   -79.40        161  Old   Dead   Mamut  \n",
       "265       101.14      0.00   -62.93          0  New   Dead  Gacela  \n",
       "266       912.42      0.00  -258.01        164  Old   Dead   Mamut  \n",
       "267       209.46     19.27   -98.36        123  Old   Dead   Mamut  \n",
       "268        18.25      0.00    -7.94          4  New   Dead  Gacela  \n",
       "269         4.72      0.00     0.00          3  Old   Dead  Gacela  \n",
       "270       338.10      0.00  -373.01        135  New   Dead   Mamut  \n",
       "271       228.16      0.00  -114.18        140  New   Dead   Mamut  \n",
       "272       326.97    106.40  -371.15        487  Old   Dead   Mamut  \n",
       "273       458.03     24.40  -219.97        255  New   Dead   Mamut  \n",
       "274       790.59    142.36    -7.69        371  Old   Dead   Mamut  \n",
       "275      1811.82      0.00  -145.99        163  New   Dead   Mamut  \n",
       "276        30.00      0.00     0.00          8  New   Dead  Gacela  \n",
       "277       144.98      0.00     0.00         14  Old   Dead  Gacela  \n",
       "278       103.49      1.00    -9.80         13  Old   Dead  Gacela  \n",
       "279       194.01      0.00   -98.89         59  Old   Dead  Gacela  \n",
       "280        55.97      0.00   -67.75         72  New   Dead  Gacela  \n",
       "281       189.64     80.47    21.86        169  Old   Dead   Mamut  \n",
       "282       304.24     33.67  -115.13        145  Old   Dead   Mamut  \n",
       "283       205.01      0.85   -54.83         32  New   Dead  Gacela  \n",
       "284       439.90      4.21   -89.71        155  New   Dead   Mamut  \n",
       "285      1349.00      1.60  -163.59         82  Old   Dead   Mamut  \n",
       "286       173.92      0.00   -45.62         19  Old   Dead  Gacela  \n",
       "287       356.15      0.00   -60.22         54  New   Dead  Gacela  \n",
       "288       162.68      0.00     0.00          9  New   Dead  Gacela  \n",
       "289       502.40    187.36   -33.06        377  Old   Dead   Mamut  \n",
       "290      2066.62      0.00  -136.50         33  Old   Dead   Mamut  \n",
       "291       299.56      0.02  -163.69        147  New   Dead   Mamut  \n",
       "292        90.10      0.00     0.00          4  Old   Dead  Gacela  \n",
       "293       101.49      0.10   -80.81        122  New   Dead   Mamut  \n",
       "294       136.02      0.11   -39.67         62  Old   Dead  Gacela  \n",
       "295        76.44      0.00   -89.62         64  New   Dead  Gacela  \n",
       "296       261.71      0.16   -92.74         72  Old   Dead  Gacela  \n",
       "297      1000.59    177.28  -146.95        709  Old   Dead   Mamut  \n",
       "298        65.94      0.07   -11.31         15  New   Dead  Gacela  \n",
       "299       255.71     34.84   -77.80        123  Old   Dead   Mamut  \n",
       "300        87.08      5.00   -63.57        127  New   Dead   Mamut  \n",
       "301        93.10      0.00   -56.90        140  New   Dead   Mamut  \n",
       "302       311.41    158.54   -76.15        676  New   Dead   Mamut  \n",
       "303       740.74      0.00  -150.91        126  New   Dead   Mamut  \n",
       "304       183.05      0.00  -121.75         96  New   Dead  Gacela  \n",
       "305       142.36     42.72    -4.07         68  Old   Dead  Gacela  \n",
       "306       180.73     20.14   -14.50        100  Old   Dead  Gacela  \n",
       "307        72.66      0.00   -28.84         14  New   Dead  Gacela  \n",
       "308      5354.88    264.79    -0.41        319  Old   Dead   Mamut  \n",
       "309        76.60      7.52   -25.66         30  Old   Dead  Gacela  \n",
       "310       170.69    160.96  -122.96        302  Old   Dead   Mamut  \n",
       "311       475.32      0.00  -135.54         74  New   Dead  Gacela  \n",
       "312       110.21      6.19   -21.40         68  Old   Dead  Gacela  \n",
       "313       551.87     52.29  -117.03        405  Old   Dead   Mamut  \n",
       "314       810.13     10.01  -389.45        294  Old   Dead   Mamut  \n",
       "315        13.36     24.09   -11.50         72  Old   Dead  Gacela  \n",
       "316        44.03      0.00   -21.82         29  New   Dead  Gacela  \n",
       "317       220.92     40.56  -207.96        124  Old   Dead   Mamut  \n",
       "318       227.06      0.00   -22.35         18  Old   Dead  Gacela  \n",
       "319        45.29      0.04    -8.22          7  New   Dead  Gacela  \n",
       "320       202.73    141.33   -99.71        339  Old   Dead   Mamut  \n",
       "321       195.86    304.34  -116.92        235  Old   Dead   Mamut  \n",
       "322        74.86      0.00   -12.36         10  New   Dead  Gacela  \n",
       "323        99.90     16.15   -61.25         54  New   Dead  Gacela  \n",
       "324        45.95      0.00     0.00          0  New   Dead  Gacela  \n",
       "325       133.81     -0.21   -92.28         37  Old   Dead  Gacela  \n",
       "326         3.56      0.00     0.00          4  New   Dead  Gacela  \n",
       "327       656.79      0.00   -52.02         44  Old   Dead   Mamut  \n",
       "328        95.46      0.00   -49.19         47  Old   Dead  Gacela  \n",
       "329       172.96     11.48  -157.80        158  New   Dead   Mamut  \n",
       "330       322.57    256.94  -187.62        597  Old   Dead   Mamut  \n",
       "331      1478.51    885.19  -243.25       1543  Old   Dead   Mamut  \n",
       "332       442.29      0.00  -154.72        150  Old   Dead   Mamut  \n",
       "333        74.01      0.00   -89.96         51  New   Dead  Gacela  \n",
       "334       193.91     61.51  -177.39        241  Old   Dead   Mamut  \n",
       "335       159.10      0.00  -166.12         75  New   Dead  Gacela  \n",
       "336        13.94      0.00     0.00          4  New   Dead  Gacela  \n",
       "337        97.12      0.00  -134.04         90  New   Dead  Gacela  \n",
       "338        73.97      3.39   -64.38         45  New   Dead  Gacela  \n",
       "339       118.36      0.00   -92.84         51  New   Dead  Gacela  \n",
       "340       178.55      0.00   -42.29          0  New   Dead  Gacela  \n",
       "341       686.59     10.09  -205.86        463  Old   Dead   Mamut  \n",
       "342      1433.61      0.00  -194.51         30  Old   Dead   Mamut  \n",
       "343       373.30      0.92   -65.47         91  Old   Dead  Gacela  \n",
       "344        64.70      1.88   -16.72         36  Old   Dead  Gacela  \n",
       "345       261.84      0.00  -124.88         75  Old   Dead  Gacela  \n",
       "346       314.84      3.84   -44.54          0  Old   Dead  Gacela  \n",
       "347        58.33    118.46    21.01         46  Old   Dead  Gacela  \n",
       "348        53.72      0.00   -60.09         66  New   Dead  Gacela  \n",
       "349      1729.13    267.20    63.69        411  Old   Dead   Mamut  \n",
       "350        40.34      0.00     0.00         41  New   Dead  Gacela  \n",
       "351       120.77      6.00   -92.68         68  Old   Dead  Gacela  \n",
       "352        26.82      7.40   -26.88         37  New   Dead  Gacela  \n",
       "353        33.36      5.63    -8.16         52  New   Dead  Gacela  \n",
       "354        16.00      0.00   -30.23         63  New   Dead  Gacela  \n",
       "355        90.00    126.62     8.55        120  Old   Dead   Mamut  \n",
       "356       411.94      9.91   -81.15         52  Old   Dead  Gacela  \n",
       "357        74.56      0.63   -65.06         25  Old   Dead  Gacela  \n",
       "358      2234.30      7.33  -341.30        672  Old   Dead   Mamut  \n",
       "359        64.62      8.30   -47.71         53  Old   Dead  Gacela  \n",
       "360        78.19      3.49  -169.25         34  Old   Dead  Gacela  \n",
       "361       122.17     61.76  -222.63        265  Old   Dead   Mamut  \n",
       "362        70.91     12.52     0.00        108  Old   Dead   Mamut  \n",
       "363        42.73      0.60   -69.86         43  New   Dead  Gacela  \n",
       "364       431.92      0.04  -254.97        232  Old   Dead   Mamut  \n",
       "365       165.54      0.08     0.00         23  Old   Dead  Gacela  \n",
       "366        25.98      0.00   -43.86          5  New   Dead  Gacela  \n",
       "367       254.44     53.87   -30.11         69  Old   Dead  Gacela  \n",
       "368      2389.48     90.86  -408.32        557  Old   Dead   Mamut  \n",
       "369        30.81      0.00  -113.61         70  Old   Dead  Gacela  \n",
       "370       223.18      0.33  -102.44         83  New   Dead  Gacela  \n",
       "371        89.87      0.82   -36.13        174  New   Dead   Mamut  \n",
       "372       451.18      0.00   -92.47        101  Old   Dead   Mamut  \n",
       "373       149.38      0.00   -81.02         54  Old   Dead  Gacela  \n",
       "374        37.54      2.20   -36.31         30  Old   Dead  Gacela  \n",
       "375        22.32      0.00     0.00          0  New   Dead  Gacela  \n",
       "376       640.12      0.05   -99.19         59  Old   Dead   Mamut  \n",
       "377       121.12      0.00   -45.12          0  New   Dead  Gacela  \n",
       "378        32.50     10.00   -25.02         42  New   Dead  Gacela  \n",
       "379        39.19     14.97   -59.84        130  New   Dead   Mamut  \n",
       "380       193.38     70.72  -136.87        273  Old   Dead   Mamut  \n",
       "381         0.00      0.00     0.00          0  Old   Dead  Gacela  \n",
       "382        84.04      0.00   -29.13         32  Old   Dead  Gacela  \n",
       "383        42.11      4.62   -62.43         73  New   Dead  Gacela  \n",
       "384        47.40      6.31   -78.89         93  New   Dead  Gacela  \n",
       "385        60.23     24.12   -24.95         81  New   Dead  Gacela  \n",
       "386        42.16      0.00   -65.90        204  New   Dead   Mamut  \n",
       "387        52.04      4.12   -86.32         75  Old   Dead  Gacela  \n",
       "388       239.88      0.08   -18.98          8  New   Dead  Gacela  \n",
       "389        68.02     66.52   -90.24        179  Old   Dead   Mamut  \n",
       "390        15.85      3.92   -36.58         45  New   Dead  Gacela  \n",
       "391       695.45     65.86  -270.34        999  Old   Dead   Mamut  \n",
       "392        23.45      0.34   -56.60         48  New   Dead  Gacela  \n",
       "393        37.84      0.00   -41.98         29  New   Dead  Gacela  \n",
       "394         3.26      0.51     0.00          5  New   Dead  Gacela  \n",
       "395         3.50      0.00    -6.00          1  New   Dead  Gacela  \n",
       "396        28.29      0.00   -60.40         82  Old   Dead  Gacela  \n",
       "397       437.61      0.00  -273.80        328  New   Dead   Mamut  \n",
       "398        99.48      2.68  -117.93        152  New   Dead   Mamut  \n",
       "399        21.61      0.30   -27.16         17  Old   Dead  Gacela  \n",
       "400       194.38    105.32   -61.80        135  Old   Dead   Mamut  \n",
       "401        51.85      0.00   -93.16         74  New   Dead  Gacela  \n",
       "402        77.70      0.66   -63.58         14  New   Dead  Gacela  \n",
       "403        22.94      0.00   -17.25         31  New   Dead  Gacela  \n",
       "404      2786.78    226.84     3.95        314  Old   Dead   Mamut  \n",
       "405        22.68     42.62    -9.58         45  Old   Dead  Gacela  \n",
       "406       163.01      0.00  -118.14        159  Old   Dead   Mamut  \n",
       "407        81.22      0.00  -159.01         89  Old   Dead  Gacela  \n",
       "408         6.57      0.00   -28.79         18  Old   Dead  Gacela  \n",
       "409         3.95      0.07     0.00          3  New   Dead  Gacela  \n",
       "410       844.75     32.96  -222.24        586  New   Dead   Mamut  \n",
       "411       450.49     24.49   -81.27         65  Old   Dead  Gacela  \n",
       "412        77.48     18.58   -92.19        174  Old   Dead   Mamut  \n",
       "413        65.27     11.00   -85.17         65  New   Dead  Gacela  \n",
       "414        38.98      3.16   -11.12          9  Old   Dead  Gacela  \n",
       "415        15.32      0.00   -24.49          9  Old   Dead  Gacela  \n",
       "416       478.31     47.94   -39.76         37  Old   Dead  Gacela  \n",
       "417       146.24     14.61   -92.70        147  New   Dead   Mamut  \n",
       "418        10.87      0.00   -77.58         80  New   Dead  Gacela  \n",
       "419        83.96    148.44  -125.63        325  Old   Dead   Mamut  \n",
       "420        65.03      9.21   -73.39        100  Old   Dead  Gacela  \n",
       "421         9.43      0.00     0.00          0  New   Dead  Gacela  \n",
       "422       174.85     36.04   -67.22        216  Old   Dead   Mamut  \n",
       "423        21.23      0.00    -7.76          7  Old   Dead  Gacela  \n",
       "424        80.73      0.00   -77.12         63  Old   Dead  Gacela  \n",
       "425       146.83      0.00   -66.02         49  New   Dead  Gacela  \n",
       "426        98.78     21.48   -50.27         65  Old   Dead  Gacela  \n",
       "427        36.55      1.51   -46.91         57  New   Dead  Gacela  \n",
       "428       195.87      0.06  -196.60        224  New   Dead   Mamut  \n",
       "429        60.53     62.39  -162.12        165  Old   Dead   Mamut  \n",
       "430        48.01      7.00   -98.46         58  Old   Dead  Gacela  \n",
       "431        34.92      7.43   -71.17         76  Old   Dead  Gacela  \n",
       "432       115.34      0.00   -64.69         54  Old   Dead  Gacela  \n",
       "433        18.74      0.00   -58.61         25  New   Dead  Gacela  \n",
       "434        19.65      2.40  -104.30         74  Old   Dead  Gacela  \n",
       "435        47.22      0.50    -5.80          5  Old   Dead  Gacela  \n",
       "436         3.29      0.00   -16.27          8  New   Dead  Gacela  \n",
       "437       151.33    141.46   -72.88        449  Old   Dead   Mamut  \n",
       "438        57.93      8.41   -94.24         58  Old   Dead  Gacela  \n",
       "439        58.66     25.07   -63.40         53  Old   Dead  Gacela  \n",
       "440         8.49      0.86   -11.07         23  Old   Dead  Gacela  \n",
       "441        12.98      6.56   -16.52         36  Old   Dead  Gacela  \n",
       "442        40.33      1.00   -22.77         16  Old   Dead  Gacela  \n",
       "443        22.33      0.00  -120.43         65  Old   Dead  Gacela  \n",
       "444        44.60      0.00   -84.65         58  Old   Dead  Gacela  \n",
       "445       208.29     10.00  -114.48         73  Old   Dead  Gacela  \n",
       "446        94.70      0.00  -154.72        131  Old   Dead   Mamut  \n",
       "447         3.75      0.00    -6.83          5  New   Dead  Gacela  \n",
       "448       127.97      0.00  -143.32         29  Old   Dead  Gacela  \n",
       "449        17.37      3.17   -36.00          6  Old   Dead  Gacela  \n",
       "450        49.30      3.00  -141.65        128  Old   Dead   Mamut  \n",
       "451        12.98      0.00     0.00          2  Old   Dead  Gacela  \n",
       "452        52.99      0.00   -41.00         32  New   Dead  Gacela  \n",
       "453       337.15    157.37    11.32        147  Old   Dead   Mamut  \n",
       "454        26.69      4.80    -9.67         17  Old   Dead  Gacela  \n",
       "455       631.12     23.23   -34.77        101  Old   Dead   Mamut  \n",
       "456        29.47     10.16   -49.30         49  Old   Dead  Gacela  \n",
       "457      1738.22      9.98  -171.06        160  Old   Dead   Mamut  \n",
       "458        20.41      0.00   -30.63         39  New   Dead  Gacela  \n",
       "459         8.97      9.45   -19.67        142  Old   Dead   Mamut  \n",
       "460       197.28      4.39   -88.58        202  Old   Dead   Mamut  \n",
       "461        39.62      0.08   -46.48         49  Old   Dead  Gacela  \n",
       "462        15.47      0.01   -40.78         35  Old   Dead  Gacela  \n",
       "463        70.05      0.00  -121.20        168  New   Dead   Mamut  \n",
       "464        45.13      0.00   -31.95         14  Old   Dead  Gacela  \n",
       "465        47.70    573.42  -315.90        758  New   Dead   Mamut  \n",
       "466        53.89      2.26  -210.66         94  New   Dead  Gacela  \n",
       "467         3.47      0.44    -8.89          3  New   Dead  Gacela  \n",
       "468        27.00      1.23   -17.22         23  New   Dead  Gacela  \n",
       "469       542.03    217.95  -525.77       1218  New   Dead   Mamut  \n",
       "470        10.87      0.00   -30.98         28  New   Dead  Gacela  \n",
       "471        51.94     42.69   -35.90        120  Old   Dead   Mamut  \n",
       "472        16.05      7.10   -43.19         29  Old   Dead  Gacela  \n",
       "473         5.57      0.00   -17.35          8  New   Dead  Gacela  \n",
       "474         6.48      0.00   -27.41         42  Old   Dead  Gacela  \n",
       "475        14.15     11.00  -104.72         55  Old   Dead  Gacela  \n",
       "476       109.42      1.00   -99.02        121  Old   Dead   Mamut  \n",
       "477        30.65      0.00   -29.18         41  New   Dead  Gacela  \n",
       "478       519.39     45.71  -114.58        121  Old   Dead   Mamut  \n",
       "479        72.35      0.00     0.00         50  Old   Dead  Gacela  \n",
       "480        75.93     54.90  -302.11        375  Old   Dead   Mamut  \n",
       "481         7.85      0.00   -16.02          5  New   Dead  Gacela  \n",
       "482        52.24      0.00  -120.46          8  Old   Dead  Gacela  \n",
       "483         5.42      0.00    -6.14          3  Old   Dead  Gacela  \n",
       "484       151.96    126.32   -36.50        233  Old   Dead   Mamut  \n",
       "485        63.92      0.00   -36.45          0  Old   Dead  Gacela  \n",
       "486         4.41      0.00    -6.30          0  New   Dead  Gacela  \n",
       "487        19.83     11.17   -72.23        100  New   Dead  Gacela  \n",
       "488         3.42      0.00     0.00          5  Old   Dead  Gacela  \n",
       "489        26.16     52.16   -47.71        151  Old   Dead   Mamut  \n",
       "490        32.76    173.82  -165.84        486  Old   Dead   Mamut  \n",
       "491       189.79      0.00   -43.90         26  Old   Dead  Gacela  \n",
       "492       254.35      0.24   -67.34         56  Old   Dead  Gacela  \n",
       "493       183.79      0.00  -109.92         88  Old   Dead  Gacela  \n",
       "494         9.57      0.00     0.00          1  Old   Dead  Gacela  \n",
       "495         6.83      0.00   -20.10         13  Old   Dead  Gacela  \n",
       "496        29.78      0.00   -11.15          6  Old   Dead  Gacela  \n",
       "497        14.51      0.00   -23.26          0  Old   Dead  Gacela  \n",
       "498       545.72      0.00     0.00         59  Old   Dead  Gacela  \n",
       "499         5.99      0.10   -12.49         12  Old   Dead  Gacela  \n",
       "500        51.07     82.62   -90.31        186  Old   Dead   Mamut  \n",
       "501         8.84      0.00   -16.04         29  Old   Dead  Gacela  \n",
       "502         6.16      3.30   -14.87         49  New   Dead  Gacela  \n",
       "503        42.63    -14.66   -76.89         42  Old   Dead  Gacela  \n",
       "504         7.01      0.00    -7.27          4  Old   Dead  Gacela  \n",
       "505        45.93      0.00   -25.40         15  Old   Dead  Gacela  \n",
       "506        36.36     75.10   -11.98        108  Old   Dead   Mamut  \n",
       "507        12.15      1.47   -67.04         88  Old   Dead  Gacela  \n",
       "508       260.16      0.00   -70.39         59  Old   Dead  Gacela  \n",
       "509        51.45      0.00   -37.36         14  Old   Dead  Gacela  \n",
       "510        30.36      0.00   -15.97          0  Old   Dead  Gacela  \n",
       "511         2.75      0.00   -23.38         32  Old   Dead  Gacela  \n",
       "512      1706.24      0.30  -282.47         94  Old   Dead   Mamut  \n",
       "513         6.69      0.16    -6.05         17  New   Dead  Gacela  \n",
       "514         9.09      0.03   -34.80         57  Old   Dead  Gacela  \n",
       "515         9.07      2.10   -53.10         45  New   Dead  Gacela  \n",
       "516        72.39      0.00   -39.65         25  Old   Dead  Gacela  \n",
       "517         5.74      0.00    -5.86          0  New   Dead  Gacela  \n",
       "518         8.86      0.00     0.00          7  New   Dead  Gacela  \n",
       "519        13.67     30.26  -128.66        165  Old   Dead   Mamut  \n",
       "520        79.32      0.00  -121.50        143  Old   Dead   Mamut  \n",
       "521         8.21      0.00     0.00         12  New   Dead  Gacela  \n",
       "522        23.38      4.02   -19.57         10  Old   Dead  Gacela  \n",
       "523       110.00      0.56  -123.18        127  Old   Dead   Mamut  \n",
       "524        17.72      1.28   -14.18          7  Old   Dead  Gacela  \n",
       "525      2783.59     19.65  -529.78        525  Old   Dead   Mamut  \n",
       "526        19.94      0.00   -41.07         22  Old   Dead  Gacela  \n",
       "527        28.39      1.06    -9.40         67  Old   Dead  Gacela  \n",
       "528       115.02      4.15   -60.30        183  Old   Dead   Mamut  \n",
       "529         2.94      0.28    -7.00         31  Old   Dead  Gacela  \n",
       "530        14.50      0.00   -17.52          0  Old   Dead  Gacela  \n",
       "531        18.20      0.00   -27.36         19  Old   Dead  Gacela  \n",
       "532        28.17      0.00   -40.98         43  Old   Dead  Gacela  \n",
       "533        12.09      0.00   -27.71         58  Old   Dead  Gacela  \n",
       "534         6.34      2.52     0.00          4  Old   Dead  Gacela  \n",
       "535       278.31      5.23  -210.55        285  Old   Dead   Mamut  \n",
       "536         8.93      0.00   -26.28         21  Old   Dead  Gacela  \n",
       "537        36.91      0.00   -13.27          0  Old   Dead  Gacela  \n",
       "538         2.85      0.00     0.00          7  New   Dead  Gacela  \n",
       "539        11.73      0.00     0.00         20  Old   Dead  Gacela  \n",
       "540        10.02      0.00   -19.62         20  Old   Dead  Gacela  \n",
       "541       857.36    111.59    20.08        593  Old   Dead   Mamut  \n",
       "542         7.67      0.00     0.00          8  New   Dead  Gacela  \n",
       "543       133.05     13.93   -66.26        109  Old   Dead   Mamut  \n",
       "544         3.26      0.00     0.00          4  New   Dead  Gacela  \n",
       "545         4.04      0.43    -9.60          3  Old   Dead  Gacela  \n",
       "546       327.79     21.61   -15.17         13  Old   Dead  Gacela  \n",
       "547        27.72      0.00     0.00         11  Old   Dead  Gacela  \n",
       "548        16.53      0.00   -21.94         59  Old   Dead  Gacela  \n",
       "549        27.34      0.00   -33.25          0  Old   Dead  Gacela  \n",
       "550        12.95      0.00   -15.57         13  New   Dead  Gacela  \n",
       "551        27.67      2.84   -26.70         23  Old   Dead  Gacela  \n",
       "552         5.59      0.00     0.00          2  Old   Dead  Gacela  \n",
       "553        25.51      0.00   -17.89          0  Old   Dead  Gacela  \n",
       "554         6.33      2.47    -4.78         18  New   Dead  Gacela  \n",
       "555         6.17      0.00    -8.27         16  Old   Dead  Gacela  \n",
       "556        77.61      0.59  -114.99        127  Old   Dead   Mamut  \n",
       "557         5.61      0.00     0.00          2  Old   Dead  Gacela  \n",
       "558         9.10      0.00     0.00          0  Old   Dead  Gacela  \n",
       "559         4.97      0.00   -33.22         25  Old   Dead  Gacela  \n",
       "560       107.42      0.00   -44.26         32  Old   Dead  Gacela  \n",
       "561         3.35      0.10   -11.06         10  New   Dead  Gacela  \n",
       "562         3.90      0.00    -3.30          2  New   Dead  Gacela  \n",
       "563        21.72     17.05   -33.08         79  Old   Dead  Gacela  \n",
       "564       255.52    137.74    -5.70        126  Old   Dead   Mamut  \n",
       "565        78.19      0.00   -24.90         36  Old   Dead  Gacela  \n",
       "566         1.56      0.00    -2.75          0  New   Dead  Gacela  \n",
       "567       268.09      0.69   -46.00         31  Old   Dead  Gacela  \n",
       "568        99.99      0.00   -95.68         85  Old   Dead  Gacela  \n",
       "569         2.37      1.75    -5.89          3  New   Dead  Gacela  \n",
       "570        33.83      0.00   -61.19         24  Old   Dead  Gacela  \n",
       "571        20.55      0.00   -21.15         12  Old   Dead  Gacela  \n",
       "572       128.86     38.05   -13.53        208  Old   Dead   Mamut  \n",
       "573        11.53      0.00   -16.48          7  Old   Dead  Gacela  \n",
       "574       292.06      0.00   -22.40         16  Old   Dead  Gacela  \n",
       "575         3.64      0.00   -16.04          7  Old   Dead  Gacela  \n",
       "576        17.96     20.27   -63.37        107  Old   Dead   Mamut  \n",
       "577         9.21      0.67    -7.78          8  Old   Dead  Gacela  \n",
       "578        48.70     23.10   -23.08        176  Old   Dead   Mamut  \n",
       "579        99.51      0.00   -23.46         11  Old   Dead  Gacela  \n",
       "580        69.05      0.88   -45.47         39  Old   Dead  Gacela  \n",
       "581         3.22      0.00     0.00          2  New   Dead  Gacela  \n",
       "582        22.06     11.39   -11.14         22  Old   Dead  Gacela  \n",
       "583         9.77      0.36   -21.51         37  Old   Dead  Gacela  \n",
       "584         3.58      0.00    -9.87          7  Old   Dead  Gacela  \n",
       "585         9.23      0.00   -20.53         80  Old   Dead  Gacela  \n",
       "586       134.61      0.00   -29.46         12  Old   Dead  Gacela  \n",
       "587        37.76      0.49     0.00         10  Old   Dead  Gacela  \n",
       "588       246.78      4.70   -50.53         65  Old   Dead  Gacela  \n",
       "589         3.73      4.60    -7.91         13  Old   Dead  Gacela  \n",
       "590         5.90      0.39  -110.18         68  Old   Dead  Gacela  \n",
       "591       267.03      0.00     0.00         20  Old   Dead  Gacela  \n",
       "592        31.57      8.38   -29.47         14  Old   Dead  Gacela  \n",
       "593         2.18      0.00     0.00          8  New   Dead  Gacela  \n",
       "594         2.63      0.01   -12.58          1  Old   Dead  Gacela  \n",
       "595        26.15      0.00   -18.08          6  Old   Dead  Gacela  \n",
       "596         6.63      0.00    -7.32          4  New   Dead  Gacela  \n",
       "597        66.82    160.43   -85.52        389  Old   Dead   Mamut  \n",
       "598         3.60      0.00    -8.83          4  Old   Dead  Gacela  \n",
       "599         0.29      1.20   -19.01         19  Old   Dead  Gacela  \n",
       "600        98.57      0.82   -31.17         19  Old   Dead  Gacela  \n",
       "601        21.50      0.18   -14.75         16  Old   Dead  Gacela  \n",
       "602        34.91      0.00   -31.25         17  Old   Dead  Gacela  \n",
       "603         3.40      0.00   -11.79         13  Old   Dead  Gacela  \n",
       "604         1.31      9.85   -24.98         82  Old   Dead  Gacela  \n",
       "605        17.19     65.30    26.38         28  Old   Dead  Gacela  \n",
       "606        16.24      4.49   -29.94         30  Old   Dead  Gacela  \n",
       "607         2.41      0.00   -10.25          7  New   Dead  Gacela  \n",
       "608         4.09      0.01    -5.52          4  Old   Dead  Gacela  \n",
       "609        41.47      0.00   -25.52          0  Old   Dead  Gacela  \n",
       "610         3.57      0.00     0.00          3  Old   Dead  Gacela  \n",
       "611         2.89      0.00   -12.98         10  Old   Dead  Gacela  \n",
       "612         3.48      1.46   -15.15         12  New   Dead  Gacela  \n",
       "613        13.39      0.20   -31.36         26  Old   Dead  Gacela  \n",
       "614       175.06      0.00     0.00          0  Old   Dead  Gacela  \n",
       "615        25.83      0.33   -21.90        106  Old   Dead   Mamut  \n",
       "616         8.36      1.44     0.00          7  Old   Dead  Gacela  \n",
       "617        10.80     16.02     6.32         12  Old   Dead  Gacela  \n",
       "618        11.50      0.00   -36.16         35  Old   Dead  Gacela  \n",
       "619         4.69      0.00   -17.68         10  New   Dead  Gacela  \n",
       "620         3.69      0.00   -31.51         22  Old   Dead  Gacela  \n",
       "621        12.18      0.00   -20.68         33  Old   Dead  Gacela  \n",
       "622         9.58      0.43    -8.53         16  Old   Dead  Gacela  \n",
       "623         2.45     25.47   -13.86         62  Old   Dead  Gacela  \n",
       "624         3.22      0.00    -8.84          4  Old   Dead  Gacela  \n",
       "625        19.04      0.00   -28.87          8  Old   Dead  Gacela  \n",
       "626         6.84      0.00    -8.36          4  New   Dead  Gacela  \n",
       "627        13.95      0.16   -21.86          8  Old   Dead  Gacela  \n",
       "628         1.49      0.00    -8.52          9  New   Dead  Gacela  \n",
       "629         3.10      0.00    -7.09          4  Old   Dead  Gacela  \n",
       "630         8.43      0.00   -49.04         40  Old   Dead  Gacela  \n",
       "631         1.94      0.00   -24.21         40  Old   Dead  Gacela  \n",
       "632         2.00      0.00    -6.73          2  Old   Dead  Gacela  \n",
       "633        19.91      0.00   -13.03          5  Old   Dead  Gacela  \n",
       "634         3.00      0.00     0.00          6  Old   Dead  Gacela  \n",
       "635       142.03      0.00   -31.04         22  Old   Dead  Gacela  \n",
       "636         5.92      0.00   -15.98          3  Old   Dead  Gacela  \n",
       "637        21.90      0.00   -23.93         25  Old   Dead  Gacela  \n",
       "638        10.10      0.38   -11.90         11  Old   Dead  Gacela  \n",
       "639         3.26      0.00   -21.40         22  Old   Dead  Gacela  \n",
       "640         9.29     12.59   -14.18         26  Old   Dead  Gacela  \n",
       "641         4.27      0.01   -19.64          5  Old   Dead  Gacela  \n",
       "642         3.23      0.00    -8.33          4  Old   Dead  Gacela  \n",
       "643         2.77     13.06    -5.02         24  Old   Dead  Gacela  \n",
       "644        72.73      3.72   -40.91         66  Old   Dead  Gacela  \n",
       "645         9.10      4.83   -25.68          0  Old   Dead  Gacela  \n",
       "646        14.21      0.23   -20.63         17  Old   Dead  Gacela  \n",
       "647       789.57      0.00     0.00          0  Old   Dead   Mamut  \n",
       "648         2.71      0.00   -19.99          9  Old   Dead  Gacela  \n",
       "649        64.76      0.00     0.00         16  Old   Dead  Gacela  \n",
       "650       256.04      0.00   -54.75         84  Old   Dead  Gacela  \n",
       "651         4.51      0.00   -12.92         41  New   Dead  Gacela  \n",
       "652        36.85      3.73     0.00          8  Old   Dead  Gacela  \n",
       "653         6.90      5.51   -13.47         20  Old   Dead  Gacela  \n",
       "654         7.65      0.36    -7.86         13  Old   Dead  Gacela  \n",
       "655         6.24      0.14    -8.51         16  Old   Dead  Gacela  \n",
       "656         3.00      0.00    -8.57          8  Old   Dead  Gacela  \n",
       "657         1.58      0.00     0.00         10  Old   Dead  Gacela  \n",
       "658         4.34      0.33   -33.09         47  Old   Dead  Gacela  \n",
       "659        16.09     10.07     0.00          8  Old   Dead  Gacela  \n",
       "660         3.15      0.00   -14.59          9  Old   Dead  Gacela  \n",
       "661         2.41      0.08    -6.44         21  Old   Dead  Gacela  \n",
       "662         1.52      0.06   -12.26         12  Old   Dead  Gacela  \n",
       "663         2.16      0.08   -20.18          0  Old   Dead  Gacela  \n",
       "664         4.23      0.00   -16.90          5  New   Dead  Gacela  \n",
       "665        10.64      0.00   -47.40         20  Old   Dead  Gacela  \n",
       "666        10.81     10.18   -29.43         49  Old   Dead  Gacela  \n",
       "667         3.55      0.00   -24.66          0  Old   Dead  Gacela  \n",
       "668        99.05     12.46   -90.77        103  Old   Dead   Mamut  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[['Ticker', 'Company','Fall','days','RoK','MarketCap_M', 'revenueM','ebitdaM','Employees','term','profit','animal']]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bb894abd",
   "metadata": {},
   "source": [
    "Empresas con Beneficios seg√∫n tama√±o capital > 600 M o empleados >100"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "7dcd1eb0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= 0) & (df['Fall'] <= 1000)]\n",
    "\n",
    "sns.histplot(x='Fall', hue='animal', data=df_filtered, bins=50,  multiple='stack')\n",
    "plt.title(\"Gaussian Distribution seg√∫n rendimiento del valor en Bolsa\")\n",
    "plt.xlabel(\"Rendimiento en %\")\n",
    "plt.ylabel(\"Cantidad de Empresas\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "0ae5595b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= -150) & (df['Fall'] <= 15)]\n",
    "\n",
    "sns.histplot(x='Fall', hue='animal', data=df_filtered, bins=50,  multiple='stack')\n",
    "plt.title(\"Gaussian Distribution seg√∫n rendimiento del valor en Bolsa\")\n",
    "plt.xlabel(\"Rendimiento en %\")\n",
    "plt.ylabel(\"Cantidad de Empresas\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "821103b0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= -100) & (df['Fall'] <= 50) & (df['days'] <= 7000)]\n",
    "sns.scatterplot(x='days', y='Fall', hue= 'animal', data= df_filtered)\n",
    "plt.axhline(y=-40, color='grey', linestyle='--', linewidth=1)  # Horizontal line at y=-40\n",
    "plt.axvline(x=1000, color='grey', linestyle='--', linewidth=1)  # Vertical line at x=1000\n",
    "plt.title(\"Gaussian Distribution Rendimiento en funci√≥n de d√≠as desde la IPO\")\n",
    "plt.xlabel(\"Dias en el Mercado\")\n",
    "plt.ylabel(\"Rendimiento\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "6b96bab9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Numero de Empresas seg√∫n cuadrante:\n",
      "Quadrant 1 (Beneficio Largo Plazo): 50\n",
      "Quadrant 2 (Beneficio Corto Plazo): 33\n",
      "Quadrant 3 (P√©rdida Corto Plazo): 35\n",
      "Quadrant 4 (P√©rdida Largo Plazo): 413\n"
     ]
    }
   ],
   "source": [
    "# Define the quadrant boundaries\n",
    "x_boundary = 1000  # Vertical line at x=1000\n",
    "y_boundary = -40   # Horizontal line at y=-40\n",
    "\n",
    "# Calculate counts for each quadrant\n",
    "quadrant_1 = df_filtered[(df_filtered['days'] > x_boundary) & (df_filtered['Fall'] > y_boundary)]\n",
    "quadrant_2 = df_filtered[(df_filtered['days'] <= x_boundary) & (df_filtered['Fall'] > y_boundary)]\n",
    "quadrant_3 = df_filtered[(df_filtered['days'] <= x_boundary) & (df_filtered['Fall'] <= y_boundary)]\n",
    "quadrant_4 = df_filtered[(df_filtered['days'] > x_boundary) & (df_filtered['Fall'] <= y_boundary)]\n",
    "\n",
    "# Print the number of points in each quadrant\n",
    "print(\"Numero de Empresas seg√∫n cuadrante:\")\n",
    "print(f\"Quadrant 1 (Beneficio Largo Plazo): {len(quadrant_1)}\")\n",
    "print(f\"Quadrant 2 (Beneficio Corto Plazo): {len(quadrant_2)}\")\n",
    "print(f\"Quadrant 3 (P√©rdida Corto Plazo): {len(quadrant_3)}\")\n",
    "print(f\"Quadrant 4 (P√©rdida Largo Plazo): {len(quadrant_4)}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "fbf5e231",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= -100) & (df['Fall'] <= 50) & (df['ebitdaM']  >= -100) & (df['ebitdaM'] <= 50) ]\n",
    "sns.scatterplot(x='Fall', y='ebitdaM', hue= 'animal', data= df_filtered)\n",
    "plt.axhline(y=-0, color='grey', linestyle='--', linewidth=1)  # Horizontal line at y=-40\n",
    "plt.axvline(x=0, color='grey', linestyle='--', linewidth=1)  # Vertical line at x=1000\n",
    "plt.title(\"Rendimiento en funci√≥n del beneficio Ebitda\")\n",
    "plt.xlabel(\"Rendimiento\")\n",
    "plt.ylabel(\"ebitda\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "05b25dd7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= -100) & (df['Fall'] <= 50) & (df['ebitdaM']  >= -100) & (df['ebitdaM'] <= 50) & (df['MarketCap_M'] <= 1000) ]\n",
    "sns.scatterplot(x='Fall', y='MarketCap_M', hue= 'animal', data= df_filtered)\n",
    "plt.axhline(y=500, color='grey', linestyle='--', linewidth=1)  # Horizontal line at y=-40\n",
    "plt.axvline(x=0, color='grey', linestyle='--', linewidth=1)  # Vertical line at x=1000\n",
    "plt.title(\"Rendimiento en funci√≥n de la Capitalizaci√≥n\")\n",
    "plt.xlabel(\"Rendimiento\")\n",
    "plt.ylabel(\"Capitalizaci√≥n\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "d366ebf1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= -100) & (df['Fall'] <= 50)  & (df['MarketCap_M'] <= 1000) & (df['revenueM'] <= 300) ]\n",
    "sns.scatterplot(x='Fall', y='revenueM', hue= 'animal', data= df_filtered)\n",
    "plt.axhline(y=100, color='grey', linestyle='--', linewidth=1)  # Horizontal line at y=-40\n",
    "plt.axvline(x=0, color='grey', linestyle='--', linewidth=1)  # Vertical line at x=1000\n",
    "plt.title(\"Rendimiento en funci√≥n de las ventas\")\n",
    "plt.xlabel(\"Rendimiento\")\n",
    "plt.ylabel(\"Revenue\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "6a14e3d0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= -100) & (df['Fall'] <= 50)  & (df['MarketCap_M'] <= 1000) & (df['Employees'] <= 400) ]\n",
    "sns.scatterplot(x='Fall', y='Employees', hue= 'animal', data= df_filtered)\n",
    "plt.axhline(y=100, color='grey', linestyle='--', linewidth=1)  # Horizontal line at y=-40\n",
    "plt.axvline(x=0, color='grey', linestyle='--', linewidth=1)  # Vertical line at x=1000\n",
    "plt.title(\"Rendimiento en funci√≥n de los empleados\")\n",
    "plt.xlabel(\"Rendimiento del valor en la Bolsa\")\n",
    "plt.ylabel(\"Empleados\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "d9da898f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Mapa de correlaciones,vemos que no aporta gran cosa\n",
    "numeric_columns = df.select_dtypes(include=['number']).columns                \n",
    "correlation_matrix = df[numeric_columns].corr() \n",
    "sns.heatmap(correlation_matrix)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "b31f5dd9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: >"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.heatmap(correlation_matrix)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9df11f4d",
   "metadata": {},
   "source": [
    "# PRE-SELECCI√ìN DE EMPRESAS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "ee739e7e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "21\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ticker</th>\n",
       "      <th>Company</th>\n",
       "      <th>ipo_date</th>\n",
       "      <th>days</th>\n",
       "      <th>Fall</th>\n",
       "      <th>MarketCap_M</th>\n",
       "      <th>Employees</th>\n",
       "      <th>ebitdaM</th>\n",
       "      <th>RoK</th>\n",
       "      <th>revenueM</th>\n",
       "      <th>term</th>\n",
       "      <th>profit</th>\n",
       "      <th>animal</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>JUNS</td>\n",
       "      <td>Jupiter Neurosciences Inc</td>\n",
       "      <td>2024-12-03</td>\n",
       "      <td>14</td>\n",
       "      <td>122.40</td>\n",
       "      <td>337.64</td>\n",
       "      <td>4</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>MDCX</td>\n",
       "      <td>Medicus Pharma Ltd</td>\n",
       "      <td>2024-11-14</td>\n",
       "      <td>33</td>\n",
       "      <td>3.77</td>\n",
       "      <td>34.86</td>\n",
       "      <td>0</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>IZTC</td>\n",
       "      <td>Invizyne Technologies Inc</td>\n",
       "      <td>2024-11-13</td>\n",
       "      <td>34</td>\n",
       "      <td>75.38</td>\n",
       "      <td>148.27</td>\n",
       "      <td>29</td>\n",
       "      <td>-4.68</td>\n",
       "      <td>-3.16</td>\n",
       "      <td>-0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ACOG</td>\n",
       "      <td>Alpha Cognition Inc</td>\n",
       "      <td>2024-11-12</td>\n",
       "      <td>35</td>\n",
       "      <td>-4.91</td>\n",
       "      <td>79.14</td>\n",
       "      <td>0</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CAMP</td>\n",
       "      <td>CAMP4 Therapeutics Corp</td>\n",
       "      <td>2024-10-11</td>\n",
       "      <td>67</td>\n",
       "      <td>-28.82</td>\n",
       "      <td>128.22</td>\n",
       "      <td>58</td>\n",
       "      <td>-49.62</td>\n",
       "      <td>-38.70</td>\n",
       "      <td>0.35</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IBO</td>\n",
       "      <td>Impact BioMedical Inc</td>\n",
       "      <td>2024-09-16</td>\n",
       "      <td>92</td>\n",
       "      <td>-29.48</td>\n",
       "      <td>26.69</td>\n",
       "      <td>1</td>\n",
       "      <td>-2.82</td>\n",
       "      <td>-10.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>ACTU</td>\n",
       "      <td>Actuate Therapeutics Inc</td>\n",
       "      <td>2024-08-13</td>\n",
       "      <td>126</td>\n",
       "      <td>0.12</td>\n",
       "      <td>169.73</td>\n",
       "      <td>11</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>OSTX</td>\n",
       "      <td>OS Therapies Inc</td>\n",
       "      <td>2024-08-01</td>\n",
       "      <td>138</td>\n",
       "      <td>20.32</td>\n",
       "      <td>73.91</td>\n",
       "      <td>0</td>\n",
       "      <td>-3.18</td>\n",
       "      <td>-4.30</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>ARTV</td>\n",
       "      <td>Artiva Biotherapeutics Inc</td>\n",
       "      <td>2024-07-19</td>\n",
       "      <td>151</td>\n",
       "      <td>-11.50</td>\n",
       "      <td>252.61</td>\n",
       "      <td>82</td>\n",
       "      <td>-58.57</td>\n",
       "      <td>-23.19</td>\n",
       "      <td>2.60</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>INBX</td>\n",
       "      <td>Inhibrx Biosciences Inc</td>\n",
       "      <td>2024-06-04</td>\n",
       "      <td>196</td>\n",
       "      <td>-15.05</td>\n",
       "      <td>210.77</td>\n",
       "      <td>166</td>\n",
       "      <td>-300.93</td>\n",
       "      <td>-142.78</td>\n",
       "      <td>1.69</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>CTNM</td>\n",
       "      <td>Contineum Therapeutics Inc</td>\n",
       "      <td>2024-04-05</td>\n",
       "      <td>256</td>\n",
       "      <td>-8.90</td>\n",
       "      <td>352.12</td>\n",
       "      <td>31</td>\n",
       "      <td>-43.30</td>\n",
       "      <td>-12.30</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>EPRX</td>\n",
       "      <td>Eupraxia Pharmaceuticals Inc</td>\n",
       "      <td>2024-04-05</td>\n",
       "      <td>256</td>\n",
       "      <td>16.71</td>\n",
       "      <td>122.47</td>\n",
       "      <td>29</td>\n",
       "      <td>-31.76</td>\n",
       "      <td>-25.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>TELO</td>\n",
       "      <td>Telomir Pharmaceuticals Inc</td>\n",
       "      <td>2024-02-09</td>\n",
       "      <td>312</td>\n",
       "      <td>4.00</td>\n",
       "      <td>146.98</td>\n",
       "      <td>1</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>MURA</td>\n",
       "      <td>Mural Oncology plc</td>\n",
       "      <td>2023-11-24</td>\n",
       "      <td>389</td>\n",
       "      <td>3.41</td>\n",
       "      <td>58.69</td>\n",
       "      <td>107</td>\n",
       "      <td>-168.40</td>\n",
       "      <td>-286.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Mamut</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>ABVX</td>\n",
       "      <td>Abivax ADR</td>\n",
       "      <td>2023-10-20</td>\n",
       "      <td>424</td>\n",
       "      <td>-14.34</td>\n",
       "      <td>500.36</td>\n",
       "      <td>62</td>\n",
       "      <td>-169.87</td>\n",
       "      <td>-33.95</td>\n",
       "      <td>9.03</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>COYA</td>\n",
       "      <td>Coya Therapeutics Inc</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>719</td>\n",
       "      <td>28.88</td>\n",
       "      <td>94.56</td>\n",
       "      <td>8</td>\n",
       "      <td>-11.11</td>\n",
       "      <td>-11.75</td>\n",
       "      <td>9.55</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>NVCT</td>\n",
       "      <td>Nuvectis Pharma Inc</td>\n",
       "      <td>2022-02-04</td>\n",
       "      <td>1047</td>\n",
       "      <td>44.62</td>\n",
       "      <td>94.09</td>\n",
       "      <td>13</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>NTRB</td>\n",
       "      <td>Nutriband Inc</td>\n",
       "      <td>2021-10-01</td>\n",
       "      <td>1173</td>\n",
       "      <td>-27.84</td>\n",
       "      <td>49.42</td>\n",
       "      <td>0</td>\n",
       "      <td>-5.46</td>\n",
       "      <td>-11.05</td>\n",
       "      <td>2.02</td>\n",
       "      <td>New</td>\n",
       "      <td>Dead</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>CADL</td>\n",
       "      <td>Candel Therapeutics Inc</td>\n",
       "      <td>2021-07-27</td>\n",
       "      <td>1239</td>\n",
       "      <td>-3.57</td>\n",
       "      <td>199.89</td>\n",
       "      <td>42</td>\n",
       "      <td>-34.66</td>\n",
       "      <td>-17.34</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>DRUG</td>\n",
       "      <td>Bright Minds Biosciences Inc</td>\n",
       "      <td>2021-03-22</td>\n",
       "      <td>1366</td>\n",
       "      <td>51.85</td>\n",
       "      <td>273.64</td>\n",
       "      <td>0</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>New</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>GLSI</td>\n",
       "      <td>Greenwich LifeSciences Inc</td>\n",
       "      <td>2020-09-25</td>\n",
       "      <td>1544</td>\n",
       "      <td>170.20</td>\n",
       "      <td>169.57</td>\n",
       "      <td>3</td>\n",
       "      <td>-10.53</td>\n",
       "      <td>-6.21</td>\n",
       "      <td>0.00</td>\n",
       "      <td>Old</td>\n",
       "      <td>Alive</td>\n",
       "      <td>Gacela</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Ticker                       Company    ipo_date  days   Fall  MarketCap_M  \\\n",
       "0    JUNS     Jupiter Neurosciences Inc  2024-12-03    14 122.40       337.64   \n",
       "1    MDCX            Medicus Pharma Ltd  2024-11-14    33   3.77        34.86   \n",
       "2    IZTC     Invizyne Technologies Inc  2024-11-13    34  75.38       148.27   \n",
       "3    ACOG           Alpha Cognition Inc  2024-11-12    35  -4.91        79.14   \n",
       "4    CAMP       CAMP4 Therapeutics Corp  2024-10-11    67 -28.82       128.22   \n",
       "5     IBO         Impact BioMedical Inc  2024-09-16    92 -29.48        26.69   \n",
       "6    ACTU      Actuate Therapeutics Inc  2024-08-13   126   0.12       169.73   \n",
       "7    OSTX              OS Therapies Inc  2024-08-01   138  20.32        73.91   \n",
       "8    ARTV    Artiva Biotherapeutics Inc  2024-07-19   151 -11.50       252.61   \n",
       "9    INBX       Inhibrx Biosciences Inc  2024-06-04   196 -15.05       210.77   \n",
       "10   CTNM    Contineum Therapeutics Inc  2024-04-05   256  -8.90       352.12   \n",
       "11   EPRX  Eupraxia Pharmaceuticals Inc  2024-04-05   256  16.71       122.47   \n",
       "12   TELO   Telomir Pharmaceuticals Inc  2024-02-09   312   4.00       146.98   \n",
       "13   MURA            Mural Oncology plc  2023-11-24   389   3.41        58.69   \n",
       "14   ABVX                    Abivax ADR  2023-10-20   424 -14.34       500.36   \n",
       "15   COYA         Coya Therapeutics Inc  2022-12-29   719  28.88        94.56   \n",
       "16   NVCT           Nuvectis Pharma Inc  2022-02-04  1047  44.62        94.09   \n",
       "17   NTRB                 Nutriband Inc  2021-10-01  1173 -27.84        49.42   \n",
       "18   CADL       Candel Therapeutics Inc  2021-07-27  1239  -3.57       199.89   \n",
       "19   DRUG  Bright Minds Biosciences Inc  2021-03-22  1366  51.85       273.64   \n",
       "20   GLSI    Greenwich LifeSciences Inc  2020-09-25  1544 170.20       169.57   \n",
       "\n",
       "    Employees  ebitdaM     RoK  revenueM term profit  animal  \n",
       "0           4     0.00    0.00      0.00  New  Alive  Gacela  \n",
       "1           0     0.00    0.00      0.00  New  Alive  Gacela  \n",
       "2          29    -4.68   -3.16     -0.00  New  Alive  Gacela  \n",
       "3           0     0.00    0.00      0.00  New  Alive  Gacela  \n",
       "4          58   -49.62  -38.70      0.35  New   Dead  Gacela  \n",
       "5           1    -2.82  -10.57      0.00  New   Dead  Gacela  \n",
       "6          11     0.00    0.00      0.00  New  Alive  Gacela  \n",
       "7           0    -3.18   -4.30      0.00  New  Alive  Gacela  \n",
       "8          82   -58.57  -23.19      2.60  New   Dead  Gacela  \n",
       "9         166  -300.93 -142.78      1.69  New   Dead   Mamut  \n",
       "10         31   -43.30  -12.30      0.00  New  Alive  Gacela  \n",
       "11         29   -31.76  -25.93      0.00  New  Alive  Gacela  \n",
       "12          1     0.00    0.00      0.00  New  Alive  Gacela  \n",
       "13        107  -168.40 -286.93      0.00  New  Alive   Mamut  \n",
       "14         62  -169.87  -33.95      9.03  New   Dead  Gacela  \n",
       "15          8   -11.11  -11.75      9.55  New  Alive  Gacela  \n",
       "16         13     0.00    0.00      0.00  New  Alive  Gacela  \n",
       "17          0    -5.46  -11.05      2.02  New   Dead  Gacela  \n",
       "18         42   -34.66  -17.34      0.00  New  Alive  Gacela  \n",
       "19          0     0.00    0.00      0.00  New  Alive  Gacela  \n",
       "20          3   -10.53   -6.21      0.00  Old  Alive  Gacela  "
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_target = df[(df['Fall'] >= -30) & (df['Fall'] <= 1000) & (df['MarketCap_M'] <= 600) & (df['days'] <= 2000)]\n",
    "print(len(df_target))\n",
    "df_target = df_target.sort_values(by=['days'], ascending=[True])\n",
    "df_target = df_target.reset_index()\n",
    "df_target[['Ticker', 'Company', 'ipo_date','days','Fall', 'MarketCap_M', 'Employees', 'ebitdaM','RoK','revenueM','term','profit','animal']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "276f5067",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "sns.scatterplot(x='days', y='Fall', hue= 'animal', data= df_target)\n",
    "plt.axhline(y=-0, color='grey', linestyle='--', linewidth=1)  # Horizontal line at y=-40\n",
    "plt.axvline(x=365, color='grey', linestyle='--', linewidth=1)  # Vertical line at x=1000\n",
    "plt.title(\"Gaussian Distribution Rendimiento en funci√≥n de d√≠as desde la IPO\")\n",
    "plt.xlabel(\"Dias en el Mercado\")\n",
    "plt.ylabel(\"Rendimiento\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "4bbdebd0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DataFrame has been saved to: output\\ticker_target_list_2024-12-18_.csv\n"
     ]
    }
   ],
   "source": [
    "# Extract the 'Ticker' column into a list\n",
    "ticker_target_list = df_target['Ticker'].tolist()\n",
    "\n",
    "# Convert the list back to a DataFrame for saving to CSV\n",
    "ticker_target_list = pd.DataFrame(ticker_target_list, columns=['Ticker'])\n",
    "\n",
    "# Save to directory\n",
    "output_directory = \"output\"\n",
    "# Create the directory if it doesn't exist\n",
    "os.makedirs(output_directory, exist_ok=True)\n",
    "\n",
    "date_string = datetime.now().strftime(\"%Y-%m-%d\")\n",
    "file_name = f\"ticker_target_list_{date_string}_.csv\"\n",
    "\n",
    "# Construct the full path\n",
    "file_path = os.path.join(output_directory, file_name)\n",
    "\n",
    "# Save the DataFrame to a CSV file\n",
    "ticker_target_list.to_csv(file_path, index=False)\n",
    "\n",
    "print(f\"DataFrame has been saved to: {file_path}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7d18e020",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "12d7189a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "630a6b1b",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7fef6d00",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "efb951b3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Figure size 1000x600 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x300 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "#df_filtered = df[(df_filtered['Fall'] >= -150) & (df['Fall'] <= 20)]\n",
    "df_filtered = df[(df['Fall'] >= -100) & (df['Fall'] <= 20)]\n",
    "g = sns.FacetGrid(df_filtered, col='animal')\n",
    "g.map(sns.histplot, \"Fall\");"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "61882bcd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Figure size 1000x600 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x300 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "#df_filtered = df[(df_filtered['Fall'] >= -150) & (df['Fall'] <= 20)]\n",
    "df_filtered = df[(df['ebitdaM'] >= -100) & (df['ebitdaM'] <= 100)]\n",
    "g = sns.FacetGrid(df_filtered, col='animal')\n",
    "g.map(sns.histplot, \"ebitdaM\");"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "4187c479",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Figure size 1000x600 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x300 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "#df_filtered = df[(df_filtered['Fall'] >= -150) & (df['Fall'] <= 20)]\n",
    "df_filtered = df[(df['ebitdaM'] >= -100) & (df['ebitdaM'] <= 100)]\n",
    "g = sns.FacetGrid(df_filtered, col='term')\n",
    "g.map(sns.histplot, \"ebitdaM\");"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "f32ff947",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 6))\n",
    "df_filtered = df[(df['Fall'] >= -150) & (df['Fall'] <= 15)]\n",
    "\n",
    "sns.histplot(x='ebitdaM', hue='animal', data=df_filtered, bins=50,  multiple='stack')\n",
    "plt.title(\"Gaussian Distribution seg√∫n rendimiento del valor en Bolsa\")\n",
    "plt.xlabel(\"Rendimiento en %\")\n",
    "plt.ylabel(\"Cantidad de Empresas\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8fdcbc16",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4e429c23",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4ca3b014",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "610fc8b8",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "117cabf7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "35a09566",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b42a1bb1",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
